Citrus Sinensis ID: 018633

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350---
Protein Sequence
MGSIMSKFKDRTDERTLMVRTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL
Secondary Structure (PSIPRED)
cccccHHHcccHHHHHHHHHHHHHHHHHHcccHHHHHHHHHcccccccEEEEcHHHHHHHHccccccccccccccccccEEEEEEEcccEEEEEEEcccccccHHHHHHHHHHHHHHHccccccccEEcEEccccEEEEEEEEcccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEEEEccccccccHHHHHHcccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccccccHHHHcccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHc
Secondary Structure Prediction (SSPRO)
ccEEEEEEEcccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHcHcHHEEEEEEEccccEEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHHHEEccccccccHcccccEEEccccccEEEEEEEccccHccHHHHHHccccHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHcccHHHHccHHHcccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mgsimskfkdrtdertLMVRTDKRALMMRSGASVLKELIAssngkyypyriFSAQEIKLATnsydqknviakdtsyNLYTMYKGFWQERLISVLQFyghecrprayesCINNVTYAARMSHNHILKLIGccletpipilVFESVQYGtlwdrilgapqphfeplLLKHRLKIAMDIVHALAYlhfgfprpivfrnfktscilfneenVAKLFDFslsisipegethitdtvmgtwgycapeymrtgvfneksdvFSFGVFLFELLtgwdvsdlvkdthdlacpsneylknyfednrfteivdpIIVEDVLSIEKEQQLHASAQLSFEcikdspadrpsmVDVAKKLRQIYRSL
Flexible Loop (DISEMBL)
mgsimskfkdrtdertlmvrtdkralmmrSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECikdspadrpsmvDVAKKLRQIYRSL
Low Complexity Region (SEG)
MGSIMSKFKDRTDERTLMVRTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL
Disordered region (IsUnstruct)
*******************************ASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFEC*************************
Disordered Region (DISOPRED)
**************************************************IFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW**************PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR**
Disordered Region (DISEMBL)
MGSIMSKFKDRTDERTLMVRTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL
Disordered Region (DISPRO)
MGSIMSKFKDRT**********************************YPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGSIMSKFKDRTDERTLMVRTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	353	2.2.26 [Sep-21-2011]
Q9LSV3	433	Putative wall-associated	no	no	0.889	0.725	0.323	2e-47
Q9LMN8	741	Wall-associated receptor	no	no	0.878	0.418	0.331	4e-46
Q9LMN7	733	Wall-associated receptor	no	no	0.878	0.422	0.331	3e-45
Q9LMP1	732	Wall-associated receptor	no	no	0.886	0.427	0.322	2e-44
Q7X8C5	748	Wall-associated receptor	no	no	0.895	0.422	0.348	3e-44
Q9LMN6	738	Wall-associated receptor	no	no	0.878	0.420	0.316	2e-43
Q9S9M2	761	Wall-associated receptor	no	no	0.895	0.415	0.342	3e-43
Q9LMT9	764	Putative wall-associated	no	no	0.886	0.409	0.333	7e-43
Q39191	735	Wall-associated receptor	no	no	0.875	0.420	0.327	7e-43
Q9M092	786	Wall-associated receptor	no	no	0.883	0.396	0.330	2e-42

>sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1

 Score =  189 bits (481), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 108/334 (32%), Positives = 188/334 (56%), Gaps = 20/334 (5%)

Query: 20  RTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLY 79
           +  ++    ++G  +L E ++ +      ++IF+ +++K ATN YD   ++ +   +   
Sbjct: 64  KIQRQLFFEKNGGGMLIERLSGAGSSNIDFKIFTEEDMKEATNGYDVSRILGQGGQW--- 120

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL 139
           T+YKG   +  I  ++           E  IN V   ++++H +++KL+GCCLET +P+L
Sbjct: 121 TVYKGILPDNSIVAIK-KTRLGDNNQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLL 179

Query: 140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           V+E +  G+L+D + G+       L  +HRL+IA+++  A+AYLH G   PI+ R+ KT 
Sbjct: 180 VYEFITGGSLFDHLHGSM--FVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTE 237

Query: 200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
            IL +E   AK+ DF  S   P  +  +T  V GT GY  PEY  T + NEKSDV+SFGV
Sbjct: 238 NILLDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGV 297

Query: 260 FLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF----EDNRFTEIVDPIIVEDVLSIEKE 315
            L EL++G       +        ++++L +YF    ++NR  EI+D    + VL+ E +
Sbjct: 298 VLMELISGQKALCFERP------ETSKHLVSYFVLATKENRLHEIID----DQVLNEENQ 347

Query: 316 QQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
           +++H +A+++ EC +    +RP M++VA +L  +
Sbjct: 348 REIHEAARVAVECTRLKGEERPRMIEVAAELETL 381

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2

 Score =  185 bits (470), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 110/332 (33%), Positives = 187/332 (56%), Gaps = 22/332 (6%)

Query: 23  KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
           +R    ++G  +L + ++ +      ++IF+ + +K ATN YD+  ++ +       T+Y
Sbjct: 374 RRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKEATNGYDESRILGQGGQG---TVY 430

Query: 83  KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
           KG   +  I  ++        R  +  I+ V   ++++H +++K++GCCLET +P+LV+E
Sbjct: 431 KGILPDNTIVAIK-KARLADSRQVDQFIHEVLVLSQINHRNVVKILGCCLETEVPLLVYE 489

Query: 143 SVQYGTLWDRILGAPQPHFEP-LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 201
            +  GTL+D + G+    F+  L  +HRL+IA+++   LAYLH     PI+ R+ KT+ I
Sbjct: 490 FITNGTLFDHLHGSI---FDSSLTWEHRLRIAIEVAGTLAYLHSSASIPIIHRDIKTANI 546

Query: 202 LFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFL 261
           L +E   AK+ DF  S  IP  +  +T  V GT GY  PEY  TG+ NEKSDV+SFGV L
Sbjct: 547 LLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVL 606

Query: 262 FELLTGWDVSDLVKDTHDLACPSNEYLKNYF----EDNRFTEIVDPIIVEDVLSIEKEQQ 317
            ELL+G       +        ++++L +YF    E+NR  EI+D    + VL+ +  ++
Sbjct: 607 MELLSGQKALCFERP------QASKHLVSYFVSATEENRLHEIID----DQVLNEDNLKE 656

Query: 318 LHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
           +  +A+++ EC +    +RP M +VA KL  +
Sbjct: 657 IQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1

 Score =  182 bits (463), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 110/332 (33%), Positives = 188/332 (56%), Gaps = 22/332 (6%)

Query: 23  KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
           ++    ++G  +L + ++ +       +IF+ + +K AT+ Y++  ++ +       T+Y
Sbjct: 367 RQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNESRILGQGGQG---TVY 423

Query: 83  KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
           KG  Q+  I  ++      R +  E  IN V   ++++H +++KL+GCCLET +P+LV+E
Sbjct: 424 KGILQDNSIVAIKKARLGDRSQV-EQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYE 482

Query: 143 SVQYGTLWDRILGAPQPHFEP-LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 201
            +  GTL+D + G+    F+  L  +HRL+IA+++   LAYLH     PI+ R+ KT+ I
Sbjct: 483 FISSGTLFDHLHGS---MFDSSLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANI 539

Query: 202 LFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFL 261
           L +E   AK+ DF  S  IP  +  +T  V GT GY  PEY  TG+ NEKSDV+SFGV L
Sbjct: 540 LLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVL 599

Query: 262 FELLTGWDVSDLVKDTHDLACPSNEYLKNYF----EDNRFTEIVDPIIVEDVLSIEKEQQ 317
            ELL+G       +        S+++L +YF    ++NR  EI+D  ++ +      +++
Sbjct: 600 MELLSGEKALCFERPQ------SSKHLVSYFVSAMKENRLHEIIDGQVMNEY----NQRE 649

Query: 318 LHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
           +  SA+++ EC +    +RPSM +VA +L  +
Sbjct: 650 IQESARIAVECTRIMGEERPSMKEVAAELEAL 681

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1

 Score =  180 bits (456), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 106/329 (32%), Positives = 182/329 (55%), Gaps = 16/329 (4%)

Query: 23  KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
           ++    ++G  +L + ++ +       +IF+ + +K ATN Y +  ++ +       T+Y
Sbjct: 363 RQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNGYHESRILGQGGQG---TVY 419

Query: 83  KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
           KG   +  I  ++      R +  E  IN V   ++++H +++K++GCCLET +P+LV+E
Sbjct: 420 KGILPDNSIVAIKKARLGNRSQV-EQFINEVLVLSQINHRNVVKVLGCCLETEVPLLVYE 478

Query: 143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL 202
            +  GTL+D + G+   +   L  +HRL+IA ++  +LAYLH     PI+ R+ KT+ IL
Sbjct: 479 FINSGTLFDHLHGSL--YDSSLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANIL 536

Query: 203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLF 262
            ++   AK+ DF  S  IP  +  +T  V GT GY  PEY  TG+ NEKSDV+SFGV L 
Sbjct: 537 LDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLM 596

Query: 263 ELLTGWDVSDLVKDTHDLACPSN--EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHA 320
           ELL+G       +      CP N      +  ++NRF EI+D      V++ + ++++  
Sbjct: 597 ELLSGQKALCFERP----HCPKNLVSCFASATKNNRFHEIIDG----QVMNEDNQREIQE 648

Query: 321 SAQLSFECIKDSPADRPSMVDVAKKLRQI 349
           +A+++ EC +    +RP M +VA +L  +
Sbjct: 649 AARIAAECTRLMGEERPRMKEVAAELEAL 677

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  179 bits (454), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 115/330 (34%), Positives = 180/330 (54%), Gaps = 14/330 (4%)

Query: 24  RALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYK 83
           R    R+G  +LK+ +A   G     RIFS+ E++ AT+++++  V+ +       T+YK
Sbjct: 376 RKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQG---TVYK 432

Query: 84  GFWQE-RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
           G   + R+++V +    +      E  IN V   A+++H +I+KL+GCCLET +P+LV+E
Sbjct: 433 GMLVDGRIVAVKRSKAVD--EDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYE 490

Query: 143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL 202
            V  G L  R+      +   +  + RL IA++I  AL+YLH     PI  R+ KT+ IL
Sbjct: 491 FVPNGDLCKRLHDESDDY--TMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNIL 548

Query: 203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLF 262
            +E N AK+ DF  S S+   +TH+T  V GT+GY  PEY ++  F EKSDV+SFGV L 
Sbjct: 549 LDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLV 608

Query: 263 ELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASA 322
           ELLTG   S  V+   +    +  +     ++NR  +IVD  I ++        Q+ + A
Sbjct: 609 ELLTGEKPSSRVRSEENRGLAA--HFVEAVKENRVLDIVDDRIKDEC----NMDQVMSVA 662

Query: 323 QLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
            L+  C+      RP+M +V+ +L  I  S
Sbjct: 663 NLARRCLNRKGKKRPNMREVSIELEMIRSS 692

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1

 Score =  176 bits (446), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 105/332 (31%), Positives = 184/332 (55%), Gaps = 22/332 (6%)

Query: 23  KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
           ++    ++G  +L + ++ +       +IF+ + +K AT+ YD+  ++ +       T+Y
Sbjct: 369 RQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRILGQGGQG---TVY 425

Query: 83  KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
           KG   +  I  ++           E  IN V   ++++H +++KL+GCCLET +P+LV+E
Sbjct: 426 KGILPDNSIVAIK-KARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYE 484

Query: 143 SVQYGTLWDRILGAPQPHFEP-LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 201
            +  GTL+D + G+    F+  L  +HRL++A++I   LAYLH     PI+ R+ KT+ I
Sbjct: 485 FISSGTLFDHLHGS---MFDSSLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANI 541

Query: 202 LFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFL 261
           L +E   AK+ DF  S  IP  +  +   V GT GY  PEY  TG+ NEKSDV+SFGV L
Sbjct: 542 LLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVL 601

Query: 262 FELLTGWDVSDLVKDTHDLACPSNEYLKNYF----EDNRFTEIVDPIIVEDVLSIEKEQQ 317
            ELL+G       +        +++++ +YF    ++NR  EI+D      V++   +++
Sbjct: 602 MELLSGQKALCFERPQ------TSKHIVSYFASATKENRLHEIIDG----QVMNENNQRE 651

Query: 318 LHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
           +  +A+++ EC + +  +RP M +VA +L  +
Sbjct: 652 IQKAARIAVECTRLTGEERPGMKEVAAELEAL 683

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  176 bits (445), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 113/330 (34%), Positives = 185/330 (56%), Gaps = 14/330 (4%)

Query: 24  RALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYK 83
           R    R+G  +LK+ +A   G     +IFS+ E++ AT++++   V+ +       T+YK
Sbjct: 384 RVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQG---TVYK 440

Query: 84  GFWQE-RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
           G   + R+++V +    +      E  IN V   A+++H +I+KL+GCCLET +P+LV+E
Sbjct: 441 GMLVDGRIVAVKRSKAMD--EDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYE 498

Query: 143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL 202
            V  G L  R+      +   +  + RL IA++I  AL+YLH     PI  R+ KT+ IL
Sbjct: 499 FVPNGDLCKRLRDECDDYI--MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNIL 556

Query: 203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLF 262
            +E+   K+ DF  S S+   +TH+T  V GT+GY  PEY ++  F +KSDV+SFGV L 
Sbjct: 557 LDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLV 616

Query: 263 ELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASA 322
           EL+TG + S  V+   +    +  +     ++NRF +IVD  I +D  +++   Q+ A A
Sbjct: 617 ELITGKNPSSRVQSEENRGFAA--HFVAAVKENRFLDIVDERI-KDECNLD---QVMAVA 670

Query: 323 QLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
           +L+  C+      RP+M +V+ +L +I  S
Sbjct: 671 KLAKRCLNRKGKKRPNMREVSVELERIRSS 700

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1

 Score =  174 bits (442), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 110/330 (33%), Positives = 181/330 (54%), Gaps = 17/330 (5%)

Query: 23  KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
           KR    R+G  +L++ + ++ G+    ++FS++E++ AT++++   VI +       T+Y
Sbjct: 413 KRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGGQG---TVY 469

Query: 83  KGFWQE-RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF 141
           KG   + R ++V +   +       +  IN V   ++++H H++KL+GCCLET +PILV+
Sbjct: 470 KGMLVDGRSVAVKK--SNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVY 527

Query: 142 ESVQYGTLWDRILGAPQPHFE--PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           E +  G L+  +       F+    L   R++IA+DI  A +YLH     PI  R+ K++
Sbjct: 528 EFIPNGNLFQHL----HEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIKST 583

Query: 200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
            IL +E+  AK+ DF  S S+    TH T  + GT GY  PEY  +  F EKSDV+SFGV
Sbjct: 584 NILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSFGV 643

Query: 260 FLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLH 319
            L EL+TG      + +T ++   + +Y +    +NR  EI+D  I  D     K +Q+ 
Sbjct: 644 VLVELITGEKPVITLSETQEITGLA-DYFRLAMRENRLFEIIDARIRNDC----KLEQVI 698

Query: 320 ASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
           A A L+  C+K +   RP M +V+  L +I
Sbjct: 699 AVANLALRCLKKTGKTRPDMREVSTALERI 728

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2

 Score =  174 bits (442), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 105/321 (32%), Positives = 173/321 (53%), Gaps = 12/321 (3%)

Query: 29  RSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQE 88
           ++G  +L + ++ +       +IF+   +K ATN Y +  ++ +       T+YKG   +
Sbjct: 374 QNGGGMLTQRLSGAGPSNVDVKIFTEDGMKKATNGYAESRILGQGGQG---TVYKGILPD 430

Query: 89  RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGT 148
             I  ++           E  IN V   ++++H +++KL+GCCLET +P+LV+E +  GT
Sbjct: 431 NSIVAIK-KARLGDSSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITNGT 489

Query: 149 LWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV 208
           L+D + G+       L  +HRLKIA+++   LAYLH     PI+ R+ KT+ IL +    
Sbjct: 490 LFDHLHGSMID--SSLTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLT 547

Query: 209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           AK+ DF  S  IP  +  +   V GT GY  PEY  TG+ NEKSDV+SFGV L ELL+G 
Sbjct: 548 AKVADFGASRLIPMDKEELETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQ 607

Query: 269 DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFEC 328
                 +        S+++L +YF        +D II  +V++ +  +++  +A+++ EC
Sbjct: 608 KALCFKRP------QSSKHLVSYFATATKENRLDEIIGGEVMNEDNLKEIQEAARIAAEC 661

Query: 329 IKDSPADRPSMVDVAKKLRQI 349
            +    +RP M +VA KL  +
Sbjct: 662 TRLMGEERPRMKEVAAKLEAL 682

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2

 Score =  173 bits (438), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/324 (33%), Positives = 182/324 (56%), Gaps = 12/324 (3%)

Query: 30  SGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQE- 88
           +G  +L++ + +  G     RIF+++E++ AT ++ +  V+         T+YKG   + 
Sbjct: 410 NGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQG---TVYKGMLVDG 466

Query: 89  RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGT 148
           R ++V +           +  IN V   ++++H H++KL+GCCLET +PILV+E +  G 
Sbjct: 467 RTVAVKK--SKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGN 524

Query: 149 LWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV 208
           L+  I       +  ++   RL+IA+DI  AL+YLH     PI  R+ K++ IL +E+  
Sbjct: 525 LFKHIHEEEADDY-TMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYR 583

Query: 209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           AK+ DF  S S+   +TH T  + GT GY  PEY R+  + EKSDV+SFGV L EL+TG 
Sbjct: 584 AKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGD 643

Query: 269 DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFEC 328
               +V++T ++   + E+ +   ++ R ++I+D  I +D     K +Q+ A A L+ +C
Sbjct: 644 KPVIMVQNTQEIIALA-EHFRVAMKERRLSDIMDARIRDD----SKPEQVMAVANLAMKC 698

Query: 329 IKDSPADRPSMVDVAKKLRQIYRS 352
           +     +RP+M +V  +L +I  S
Sbjct: 699 LSSRGRNRPNMREVFTELERICTS 722

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	353
255582635	331	receptor protein kinase, putative [Ricin	0.917	0.978	0.465	9e-80
224123144	344	predicted protein [Populus trichocarpa]	0.920	0.944	0.449	6e-74
255542662	330	serine-threonine protein kinase, plant-t	0.912	0.975	0.447	3e-68
255542658	356	serine-threonine protein kinase, plant-t	0.943	0.935	0.427	3e-66
255542656	331	serine-threonine protein kinase, plant-t	0.875	0.933	0.448	4e-66
297740943	321	unnamed protein product [Vitis vinifera]	0.889	0.978	0.400	4e-55
359495254	331	PREDICTED: wall-associated receptor kina	0.883	0.942	0.403	5e-55
255542676	247	serine-threonine protein kinase, plant-t	0.645	0.923	0.5	8e-54
359493231	497	PREDICTED: inactive serine/threonine-pro	0.923	0.655	0.380	5e-52
296081092	1111	unnamed protein product [Vitis vinifera]	0.943	0.299	0.372	1e-51

>gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis]

 Score =  303 bits (776), Expect = 9e-80,   Method: Compositional matrix adjust.
 Identities = 154/331 (46%), Positives = 217/331 (65%), Gaps = 7/331 (2%)

Query: 20  RTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLY 79
           + +   + + +G  +L++LIAS +G+  P RIFSA E+  AT+ YD + +I +D+ Y LY
Sbjct: 5   KAESERISLMNGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKIITQDSGYKLY 64

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPI 138
               G   ER ISV +F   + +   Y+ C N++ +A +MS H + LKL+GCCLET IP+
Sbjct: 65  N---GLLHERTISVKKF---KDKSEQYKYCYNDIMFATQMSKHKNFLKLLGCCLETQIPV 118

Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LVFE ++YGTL  R+ G  +  ++PLL +HRLKIA++I +A++YLH  F RPIVFRN K 
Sbjct: 119 LVFEPIEYGTLAGRLYGPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKP 178

Query: 199 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFG 258
             I  +E +VAKL DFSL++SIPEGE+H+ D + G WG  APEY +T  FNE  DV++FG
Sbjct: 179 LNIFLDECHVAKLSDFSLAVSIPEGESHVKDMLAGAWGLIAPEYAKTSCFNESQDVYNFG 238

Query: 259 VFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQL 318
           VFL  LLTG  V D  +          +++K +  D+RF E VD II+ +    EK+QQL
Sbjct: 239 VFLLMLLTGQKVVDSYRPQAGEELGLVDHVKKFIADDRFYETVDSIILGEGSLPEKDQQL 298

Query: 319 HASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
            A   LSF CI ++  DRP M+DVAK+LR+I
Sbjct: 299 QAFTLLSFRCISEADEDRPMMIDVAKELRKI 329

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa]

 Score =  283 bits (725), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 150/334 (44%), Positives = 214/334 (64%), Gaps = 9/334 (2%)

Query: 20  RTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLY 79
           + +K    +++G+ +L++L+   +GK    R FSA E+K ATN+YD + ++  D+ Y LY
Sbjct: 12  KVNKETAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDPQKILTGDSGYKLY 71

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPI 138
              KGF Q R +SV +F   +     YE C N++ YA++MS H   +KL+GCCLE  IPI
Sbjct: 72  ---KGFLQGRPVSVKKFKDDD---EQYEYCFNDIVYASKMSVHKSFMKLLGCCLEARIPI 125

Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LVFE V   TL D + G+ +   +PLL   R KIAMD+ +A+A+LH  F +PIVFRN K 
Sbjct: 126 LVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKPIVFRNIKP 185

Query: 199 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFG 258
             IL ++ + AKL DFS+SISIP+GE+H+ D+V G  G  APEY+ TG FNEK DVF+FG
Sbjct: 186 LNILLDDNHEAKLSDFSISISIPKGESHVRDSVAGATGLIAPEYLTTGNFNEKQDVFNFG 245

Query: 259 VFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQL 318
           VFL  LL+G  V D  +   ++     +++K   ED+RF +++D  I+ +     KEQQL
Sbjct: 246 VFLLVLLSGQMVVDFSRPEKEILL--QDHVKKCIEDDRFNKVIDSTIIAEGTWPGKEQQL 303

Query: 319 HASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
            A   LS  CI +   DRP+M+DV+K+LR+IY S
Sbjct: 304 QAYTALSLRCISELAEDRPTMIDVSKELRKIYWS 337

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  265 bits (676), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 148/331 (44%), Positives = 203/331 (61%), Gaps = 9/331 (2%)

Query: 23  KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
           K A ++ +G+ +L++ +A  NG+  P R FS++E++ AT +Y++K V+  D  + LY   
Sbjct: 4   KEAFLI-NGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVLKLDGYFELY--- 59

Query: 83  KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVF 141
           KGF Q+R + V +F        A    IN + YA+ MS H + +KL+GCCLETP PILVF
Sbjct: 60  KGFLQDRPVIVKKFLEVGVEQLA----INEIVYASAMSVHINSIKLLGCCLETPSPILVF 115

Query: 142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 201
           ES +  TL DRI+     HFEP+  K RLKI  DI + + Y+H  FPRPIV RN K S I
Sbjct: 116 ESAKEKTLADRIIDRNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNI 175

Query: 202 LFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFL 261
           L +E+ VAKL DFSL +SIPEG++ + D + GT G  A E + TG FNEKSDV+SFGV L
Sbjct: 176 LLDEDYVAKLSDFSLCVSIPEGKSRVRDIMAGTMGLIASESLATGYFNEKSDVYSFGVVL 235

Query: 262 FELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHAS 321
             +LTG    D  +           ++K + E   F E+VDPIIV +     K Q+L   
Sbjct: 236 LVVLTGQRSFDFSRTETGEQFLLVNHVKKHIETGGFKEMVDPIIVAEEAGNRKGQELEDF 295

Query: 322 AQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
             L+  CI DS  +RP+M++VAK+LR IY S
Sbjct: 296 RDLALRCIHDSAEERPTMIEVAKQLRHIYLS 326

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  258 bits (659), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 158/370 (42%), Positives = 215/370 (58%), Gaps = 37/370 (10%)

Query: 4   IMSKFKDRTDERTLMVRTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNS 63
           + S F+D  DE            +MR+G  +L++ IA +NG+  P R FS  E++ ATNS
Sbjct: 1   MFSCFRDNMDE--------NETALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNS 52

Query: 64  YDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HN 122
           Y Q NVI +      +T+YKGF ++R + +++ Y +    R     IN++ +A+ MS H 
Sbjct: 53  YSQNNVIYEG---GWHTLYKGFLRDRPV-IVKRYRNNIHERV--CPINDIVFASEMSRHK 106

Query: 123 HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAY 182
           ++LKL+GCCLE+ IPILVFE  + G L D I       F PLL K RLKIA+D  + +AY
Sbjct: 107 NVLKLLGCCLESEIPILVFEYAEKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAY 166

Query: 183 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEY 242
           LH   PRP+V R+   S I  +E+ VAK+ DF++S+SI EGETHI D V+GT GY APEY
Sbjct: 167 LHTACPRPVVHRDITLSNIWLDEDYVAKVTDFTVSMSILEGETHIEDFVLGTCGYAAPEY 226

Query: 243 MRTGVFNEKSDVFSFGVFLFELLT-------GWDVSDLVKDTH-DLACPS---------- 284
           +R+G+FNEK DVFSFGV L  LLT        W+  +++KD   D    S          
Sbjct: 227 VRSGIFNEKIDVFSFGVLLLVLLTDQKPFQGNWE--NILKDARFDEIIGSLIVEKGLWSE 284

Query: 285 NEYLKNYFEDNR--FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDV 342
            E L+ +    R      +DPIIVE+    EKEQQL A   L  +CI     +RP + DV
Sbjct: 285 KEQLETFLTRTRQKLDLTIDPIIVEEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDV 344

Query: 343 AKKLRQIYRS 352
           AK+LR  Y S
Sbjct: 345 AKQLRHFYLS 354

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  258 bits (658), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 149/332 (44%), Positives = 203/332 (61%), Gaps = 23/332 (6%)

Query: 27  MMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW 86
           +MR+G S+L++ +A +NG+  P R FS +E++ ATNSY Q NV   D +  LY   KG  
Sbjct: 14  LMRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHNVFYIDGTCRLY---KGLI 70

Query: 87  QERLISVLQF-YGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVFESV 144
           ++R + V ++ Y H       E  ++++  A+ MS H ++LKL+GCCLE+ IPI VFE  
Sbjct: 71  RDRPVIVKKYDYKHPS-----EDPVSDIVIASEMSVHRNVLKLLGCCLESEIPIPVFEYA 125

Query: 145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN 204
           + GTL D +          LL K RLKIA+D+   +AYLH  FPRPIV R+   + IL +
Sbjct: 126 EKGTLEDYVQKTA------LLWKDRLKIAVDVASVIAYLHTAFPRPIVHRDISLASILLD 179

Query: 205 EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
           E+  AK+  FSLSISIPEGETHI D V GT GY APEY    +FNEK DV+SFGV L  L
Sbjct: 180 EDCAAKVTGFSLSISIPEGETHIEDEVAGTIGYVAPEYFMKRMFNEKIDVYSFGVVLLVL 239

Query: 265 LTGWDV---SDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHAS 321
           LTG      S    ++H L      +++   ++ RF EI+DP I+E+    EKEQQL + 
Sbjct: 240 LTGHGPILRSPTTNESHALVV----FVEAKIKNERFNEIIDPAILEEGPWPEKEQQLKSF 295

Query: 322 AQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
             L+ +C +    DRP + DVAK+LR IY SL
Sbjct: 296 LTLAMQCTRKDEEDRPEITDVAKQLRHIYHSL 327

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297740943|emb|CBI31255.3| unnamed protein product [Vitis vinifera]

 Score =  221 bits (563), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 133/332 (40%), Positives = 193/332 (58%), Gaps = 18/332 (5%)

Query: 23  KRALMMRSGASVLKELIASSNGKYY-PYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTM 81
           K+  M+++G+ +LKE I+  NGKY+ P R F  +E++ AT+ Y+   +   D    ++  
Sbjct: 2   KKESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCIW-- 59

Query: 82  YKGFWQERLISV-LQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPIL 139
           YKG  + R ISV   FY         E  IN +  A++MS H + LKL+GCCLET IPIL
Sbjct: 60  YKGSLEGRTISVRTNFY------EGVEMAINEIVIASQMSAHKNALKLLGCCLETRIPIL 113

Query: 140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           V+E    G+L DRI   P P    L  K RL+IA DI + +AYLH  FPR I+  + K S
Sbjct: 114 VYEFPSGGSLIDRIFSPPNP----LSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPS 169

Query: 200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
               +++  AKL DFSLSI++PEGE H+ D + GT+GY APE + +GV+ EK+DVFSFG+
Sbjct: 170 SFFLDQDCAAKLSDFSLSITLPEGEMHVEDEIRGTFGYLAPETLISGVYTEKNDVFSFGI 229

Query: 260 FLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLH 319
            L ELL G     ++   H+      +Y +++        IVDPII+     I +E Q  
Sbjct: 230 LLLELLIGKRAHSIM---HEERASIQDYAQSFVNTYDINGIVDPIILAQPRGIHEELQFQ 286

Query: 320 ASAQLSFECIKDSPADRPSMVDVAKKLRQIYR 351
           A   L+  C      +RP++V+ AK++R+I +
Sbjct: 287 AIFDLAMRCSMKDMDERPTIVNAAKEVRRIQK 318

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359495254|ref|XP_002271826.2| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera]

 Score =  221 bits (562), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 133/330 (40%), Positives = 192/330 (58%), Gaps = 18/330 (5%)

Query: 23  KRALMMRSGASVLKELIASSNGKYY-PYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTM 81
           K+  M+++G+ +LKE I+  NGKY+ P R F  +E++ AT+ Y+   +   D    ++  
Sbjct: 10  KKESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCIW-- 67

Query: 82  YKGFWQERLISV-LQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPIL 139
           YKG  + R ISV   FY         E  IN +  A++MS H + LKL+GCCLET IPIL
Sbjct: 68  YKGSLEGRTISVRTNFY------EGVEMAINEIVIASQMSAHKNALKLLGCCLETRIPIL 121

Query: 140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           V+E    G+L DRI   P P    L  K RL+IA DI + +AYLH  FPR I+  + K S
Sbjct: 122 VYEFPSGGSLIDRIFSPPNP----LSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPS 177

Query: 200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
               +++  AKL DFSLSI++PEGE H+ D + GT+GY APE + +GV+ EK+DVFSFG+
Sbjct: 178 SFFLDQDCAAKLSDFSLSITLPEGEMHVEDEIRGTFGYLAPETLISGVYTEKNDVFSFGI 237

Query: 260 FLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLH 319
            L ELL G     ++   H+      +Y +++        IVDPII+     I +E Q  
Sbjct: 238 LLLELLIGKRAHSIM---HEERASIQDYAQSFVNTYDINGIVDPIILAQPRGIHEELQFQ 294

Query: 320 ASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
           A   L+  C      +RP++V+ AK++R+I
Sbjct: 295 AIFDLAMRCSMKDMDERPTIVNAAKEVRRI 324

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542676|ref|XP_002512401.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548362|gb|EEF49853.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  217 bits (552), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 122/244 (50%), Positives = 162/244 (66%), Gaps = 16/244 (6%)

Query: 27  MMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW 86
           +MR+G  +L++ IA +NG+  P R FS +E++ ATNSY Q NVI +      +T YKGF 
Sbjct: 8   LMRNGGILLEKSIAFNNGRGNPIRCFSVEELQTATNSYSQNNVIYEG---GWHTHYKGFL 64

Query: 87  QERLISVLQFYGHECRPRAYESC--INNVTYAARMS-HNHILKLIGCCLETPIPILVFES 143
           +ER + V ++     R   +E    IN++ +A+ MS H ++LKL+GCCLE+ IPILVFE 
Sbjct: 65  RERPVIVKRY-----RTNIHERVCPINDIVFASEMSRHKNVLKLLGCCLESEIPILVFEY 119

Query: 144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF 203
            + G L D I       F     + RLKIA+D  + +AYLH  FPRP+V R+   S +  
Sbjct: 120 AEKGNLHDYIYKTDSASF-----RRRLKIAVDAANVIAYLHTAFPRPVVHRHITLSNVWL 174

Query: 204 NEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFE 263
           +E++VAK+ DFSLS+SIPEGETHI D VMGT GY APEY R+G+FNEK DVFSFGV L  
Sbjct: 175 DEDSVAKVTDFSLSMSIPEGETHIEDFVMGTCGYAAPEYARSGIFNEKIDVFSFGVLLLV 234

Query: 264 LLTG 267
           LLTG
Sbjct: 235 LLTG 238

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493231|ref|XP_002265528.2| PREDICTED: inactive serine/threonine-protein kinase At1g67470-like [Vitis vinifera]

 Score =  211 bits (536), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 128/336 (38%), Positives = 192/336 (57%), Gaps = 10/336 (2%)

Query: 23  KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
           +    +++G+ +L++L++S NG+  P R FS +E++ ATN Y+  ++I    +Y+ +  Y
Sbjct: 5   REEFFLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYN-SSLIFDRWTYSEW--Y 61

Query: 83  KGFWQERLISVLQFYGHECRPRAY-ESCINNVTYAARMS-HNHILKLIGCCLETPIPILV 140
           KG  + R +SV +F  H     A+ E  I  +T+A ++S H ++LKL GCCLET  P+LV
Sbjct: 62  KGSLEGRFVSVRKF--HPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLETQTPVLV 119

Query: 141 FESVQYGT--LWDRILGAPQPHF-EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 197
           +E    G   L+D I  +      + L  K RL+I+ DI H +AYLH  FPR I+ R   
Sbjct: 120 YEYPVNGVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAIIHREVT 179

Query: 198 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
            S    +E+ V KL +F  +I++PEG  ++ D VMG  G+ APEY  TG+  EK DVFSF
Sbjct: 180 LSFFFLDEDCVPKLSNFFFAIALPEGRKYVVDGVMGIEGFIAPEYEMTGMVTEKVDVFSF 239

Query: 258 GVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQ 317
           G  L ELLTG    D     +D      + +K Y ED+     VD  I+     I +E Q
Sbjct: 240 GKLLLELLTGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRGGEIHEELQ 299

Query: 318 LHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
           L A  +L+  CI  +   RP+MV++AK+LR+I R +
Sbjct: 300 LLAVTKLALRCIMTAAEQRPTMVEIAKELRRIQRGI 335

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296081092|emb|CBI18286.3| unnamed protein product [Vitis vinifera]

 Score =  209 bits (532), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 128/344 (37%), Positives = 192/344 (55%), Gaps = 11/344 (3%)

Query: 15  RTLMVRTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDT 74
           + LM +  +    +++G+ +L++L++S NG+  P R FS +E++ ATN Y+   +  +  
Sbjct: 612 KKLMAK-KREEFFLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNSSLIFDR-- 668

Query: 75  SYNLYTMYKGFWQERLISVLQFYGHECRPRAY-ESCINNVTYAARMS-HNHILKLIGCCL 132
            +     YKG  + R +SV +F  H     A+ E  I  +T+A ++S H ++LKL GCCL
Sbjct: 669 -WTYSEWYKGSLEGRFVSVRKF--HPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCL 725

Query: 133 ETPIPILVFESVQYGT--LWDRILGAPQPHF-EPLLLKHRLKIAMDIVHALAYLHFGFPR 189
           ET  P+LV+E    G   L+D I  +      + L  K RL+I+ DI H +AYLH  FPR
Sbjct: 726 ETQTPVLVYEYPVNGVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPR 785

Query: 190 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFN 249
            I+ R    S    +E+ V KL +F  +I++PEG  ++ D VMG  G+ APEY  TG+  
Sbjct: 786 AIIHREVTLSFFFLDEDCVPKLSNFFFAIALPEGRKYVVDGVMGIEGFIAPEYEMTGMVT 845

Query: 250 EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDV 309
           EK DVFSFG  L ELLTG    D     +D      + +K Y ED+     VD  I+   
Sbjct: 846 EKVDVFSFGKLLLELLTGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRG 905

Query: 310 LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
             I +E QL A  +L+  CI  +   RP+MV++AK+LR+I R +
Sbjct: 906 GEIHEELQLLAVTKLALRCIMTAAEQRPTMVEIAKELRRIQRGI 949

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	353
TAIR|locus:2076671	355	AT3G57730 [Arabidopsis thalian	0.968	0.963	0.360	1.1e-50
TAIR|locus:2076586	351	AT3G57710 [Arabidopsis thalian	0.917	0.923	0.356	3.7e-48
TAIR|locus:2076681	359	AT3G57720 [Arabidopsis thalian	0.957	0.941	0.341	7.7e-48
TAIR|locus:2076596	340	AT3G57700 [Arabidopsis thalian	0.898	0.932	0.346	2.3e-46
TAIR|locus:2094468	433	AT3G25490 [Arabidopsis thalian	0.889	0.725	0.326	2.1e-45
TAIR|locus:2014897	741	WAK3 "wall associated kinase 3	0.878	0.418	0.331	6e-44
TAIR|locus:2014962	733	WAK5 "wall associated kinase 5	0.861	0.414	0.337	3.4e-43
TAIR|locus:2200562	748	WAKL2 "wall associated kinase-	0.912	0.430	0.359	3.8e-43
TAIR|locus:2014912	732	WAK2 "wall-associated kinase 2	0.869	0.419	0.331	1.2e-42
TAIR|locus:2126316	786	AT4G31100 [Arabidopsis thalian	0.903	0.405	0.329	6.2e-42

TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)]

 Score = 527 (190.6 bits), Expect = 1.1e-50, P = 1.1e-50
 Identities = 128/355 (36%), Positives = 198/355 (55%)

Query:     1 MGSIMSKFKD--RTDERTLMVRTDKRAL-MMRSGASVLKELIASSNGKYYPYRIFSAQEI 57
             M S++ K K   RT       ++ K+    + +G+  LKELI   NGK  P R F++ +I
Sbjct:     1 MESMVKKLKQNLRTGSWKKKEKSMKKERWFLENGSIFLKELIVDCNGKSIPIRSFTSSQI 60

Query:    58 KLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAA 117
             + AT ++D    +A++     Y  YKG  ++R   + +F  ++           ++  +A
Sbjct:    61 RKATKNFDLSCFVAEE---GFYIWYKGVIEDRSYMIKRFSEYKVTDYRVSEVYKDIVLSA 117

Query:   118 RMS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMD 175
             RMS HN+ LKL+GCCLE P P+LVFE  ++G L  R  G      E LL L  RLKI  +
Sbjct:   118 RMSNHNNFLKLLGCCLEFPFPVLVFEFAEHGVLNYRG-GITVNGEESLLPLSLRLKIGKE 176

Query:   176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGT 234
             I +ALAYLH  FP+ I++R+ K   +  +    AKL D S SIS+ EG++ I  + V+GT
Sbjct:   177 IANALAYLHMAFPKIIIYRDVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAEDVLGT 236

Query:   235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             +GY  P Y  T +  E +DV+SFGVFL  ++TG  V     D + +      Y+K   E+
Sbjct:   237 YGYLDPLYFATRIVTEYTDVYSFGVFLMVVITGISVYFTGSDGYPVGILG--YMKGLAEN 294

Query:   295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
              +  EIV P+I++++ S ++  Q+ A   L+  C ++   DRP M+ VAK+L++I
Sbjct:   295 GKLNEIVYPMIMKEMTSAQR-LQVEACVLLALRCCEERVEDRPKMIQVAKELKRI 348

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)]

 Score = 503 (182.1 bits), Expect = 3.7e-48, P = 3.7e-48
 Identities = 121/339 (35%), Positives = 195/339 (57%)

Query:    22 DK-RALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYT 80
             DK +   + +G+  L+EL+A  NGK  P R FS ++I  ATN++D    +++D  Y  Y 
Sbjct:    17 DKAKRWFLDNGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQDV-Y--YK 73

Query:    81 MYKGFWQERLISVLQFYGHECRPRAY--ESCINNVTYAARMS-HNHILKLIGCCLETPIP 137
              Y+G  ++R   + +F   E   + +  +   N++  +ARMS H++ L+L+GCCLE P P
Sbjct:    74 WYRGEIEDRSYMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCLEFPFP 133

Query:   138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKH--RLKIAMDIVHALAYLHFGFPRPIVFRN 195
             +LVFE  ++G +  R  G    + E  LL    RLKI  +I +A+ YLH  FP+ I+ R+
Sbjct:   134 VLVFEFAEHGAMNQR--GGVIVNGEESLLPWSVRLKIGKEIANAVTYLHTAFPKIIIHRD 191

Query:   196 FKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDV 254
              K   +  ++   AKL D S SIS+PEG++ I  + V+GT+GY  P Y +T    E +DV
Sbjct:   192 VKPMHVFLDKNWTAKLSDLSFSISLPEGKSRIEAEWVLGTFGYIDPLYHKTCFVTEYTDV 251

Query:   255 FSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEK 314
             +SFG+ L  ++TG      + D  DL    +  ++   E+ +  E++DP +++D+ S ++
Sbjct:   252 YSFGICLLVIITGKPAIMTISDG-DLQGILS-LVRELCENGKLDEVIDPRLMKDITSGQR 309

Query:   315 EQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
               Q+ A   L+  C K+   DRP M+ VAK+L+QI  SL
Sbjct:   310 -LQVEACVVLALRCCKERDEDRPKMIQVAKELKQIEASL 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)]

 Score = 500 (181.1 bits), Expect = 7.7e-48, P = 7.7e-48
 Identities = 120/351 (34%), Positives = 192/351 (54%)

Query:     3 SIMSKFKDRTDERTLMVRTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATN 62
             S+ S   ++  E+   ++ +K    + +G+  LKELIA  NGK  P R FS+ +I  AT+
Sbjct:    11 SLRSGSLEKRKEKEKDIQEEK--WFLDNGSIFLKELIADCNGKSIPIRNFSSDQILKATS 68

Query:    63 SYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-H 121
             ++     +   T+   Y  YKG  ++R   + +F  ++          N +  +ARMS H
Sbjct:    69 NFGSSCFV---TAEGFYVWYKGIIEDRSYMIKRFSEYKVTQYRVAEVYNEIVLSARMSNH 125

Query:   122 NHILKLIGCCLETPIPILVFESVQYGTLWDR--ILGAPQPHFEPLLLKHRLKIAMDIVHA 179
             N+ LKLIG CLE  +P+LVFE  ++G L  R  ++   +    PL L  RLKI  +I +A
Sbjct:   126 NNFLKLIGFCLEFSLPVLVFEYAEHGVLNHRGGVIVNGEEVILPLSL--RLKIGKEIANA 183

Query:   180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTWGYC 238
             + YLH  FP+ ++ R+ K   +  +E    KL DFS+SI++PEG++ I  + V GT GY 
Sbjct:   184 VTYLHMAFPKILIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYL 243

Query:   239 APEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT 298
              P Y  T +  E +DV+SFGVFL  +LTG           D    ++ Y+K + E+ +  
Sbjct:   244 DPVYYTTKMVTEYTDVYSFGVFLMVILTGKPALASTSSDGDYKHIAS-YVKGFHENGQLD 302

Query:   299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
              ++DP ++ED+ S +K   + A   L+  C +    +RP M+ +AK+L+QI
Sbjct:   303 GVIDPKVMEDITSAQKVH-VEACVVLALRCCELRDENRPKMIQIAKELKQI 352

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)]

 Score = 486 (176.1 bits), Expect = 2.3e-46, P = 2.3e-46
 Identities = 115/332 (34%), Positives = 183/332 (55%)

Query:    27 MMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW 86
             + ++G+ +L+ELIA+S G Y P R FS+ +I  ATN +D   VI++D     +  YKG  
Sbjct:    19 LQKNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDWNYVISEDR----FVWYKGMI 74

Query:    87 QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVFESVQ 145
             + R + + +F   +C     ++   ++  ++ MS H ++LKL+GCCLE P P+LV E  +
Sbjct:    75 ENRPVLIKKF--QDCSVFDADNFYRDIAVSSLMSSHKNVLKLLGCCLEFPRPVLVCEYPE 132

Query:   146 YGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE 205
             +G L    +   +          RL+IA +I  A+AYLH  FPR I+ R+ K + I  +E
Sbjct:   133 HGAL--NCIRCGKEGVRSFPWNVRLRIAKEIADAVAYLHTEFPRTIIHRDLKLANIFLDE 190

Query:   206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELL 265
                AKL  FSLSI +PEGET + D V  T  Y  P+Y  TG+  E  D++S G+ +  +L
Sbjct:   191 NWSAKLSSFSLSIVLPEGETGVNDMVCRTSSYIEPDYFNTGLVTENVDIYSLGIIMLIIL 250

Query:   266 TGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLS-IEKEQQLHASA-- 322
             TG    +     +    P   Y+  + E    TE++DP I++     I K  +L   A  
Sbjct:   251 TGKSEYNSEVAVYLPVLPV--YVGKFLERGLLTELIDPSILDSTSDDIPKHSRLQMEAFI 308

Query:   323 QLSFECIKDSPADR-PSMVDVAKKLRQIYRSL 353
             +L+F C++  P +  P M+DVAK+L++I + +
Sbjct:   309 ELAFRCVRFRPGENVPRMIDVAKELKKIEKHI 340

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)]

 Score = 477 (173.0 bits), Expect = 2.1e-45, P = 2.1e-45
 Identities = 109/334 (32%), Positives = 191/334 (57%)

Query:    20 RTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLY 79
             +  ++    ++G  +L E ++ +      ++IF+ +++K ATN YD   ++ +   +   
Sbjct:    64 KIQRQLFFEKNGGGMLIERLSGAGSSNIDFKIFTEEDMKEATNGYDVSRILGQGGQW--- 120

Query:    80 TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL 139
             T+YKG   +  I  ++        +  E  IN V   ++++H +++KL+GCCLET +P+L
Sbjct:   121 TVYKGILPDNSIVAIKKTRLGDNNQV-EQFINEVLVLSQINHRNVVKLLGCCLETEVPLL 179

Query:   140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
             V+E +  G+L+D + G+       L  +HRL+IA+++  A+AYLH G   PI+ R+ KT 
Sbjct:   180 VYEFITGGSLFDHLHGSM--FVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTE 237

Query:   200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
              IL +E   AK+ DF  S   P  +  +T  V GT GY  PEY  T + NEKSDV+SFGV
Sbjct:   238 NILLDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGV 297

Query:   260 FLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF----EDNRFTEIVDPIIVEDVLSIEKE 315
              L EL++G     L  +  +    ++++L +YF    ++NR  EI+D    + VL+ E +
Sbjct:   298 VLMELISGQKA--LCFERPE----TSKHLVSYFVLATKENRLHEIID----DQVLNEENQ 347

Query:   316 QQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
             +++H +A+++ EC +    +RP M++VA +L  +
Sbjct:   348 REIHEAARVAVECTRLKGEERPRMIEVAAELETL 381

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 468 (169.8 bits), Expect = 6.0e-44, P = 6.0e-44
 Identities = 110/332 (33%), Positives = 187/332 (56%)

Query:    23 KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
             +R    ++G  +L + ++ +      ++IF+ + +K ATN YD+  ++ +       T+Y
Sbjct:   374 RRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKEATNGYDESRILGQGGQG---TVY 430

Query:    83 KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
             KG   +  I  ++        R  +  I+ V   ++++H +++K++GCCLET +P+LV+E
Sbjct:   431 KGILPDNTIVAIK-KARLADSRQVDQFIHEVLVLSQINHRNVVKILGCCLETEVPLLVYE 489

Query:   143 SVQYGTLWDRILGAPQPHFEPLLL-KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 201
              +  GTL+D + G+    F+  L  +HRL+IA+++   LAYLH     PI+ R+ KT+ I
Sbjct:   490 FITNGTLFDHLHGSI---FDSSLTWEHRLRIAIEVAGTLAYLHSSASIPIIHRDIKTANI 546

Query:   202 LFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFL 261
             L +E   AK+ DF  S  IP  +  +T  V GT GY  PEY  TG+ NEKSDV+SFGV L
Sbjct:   547 LLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVL 606

Query:   262 FELLTGWDVSDLVKDTHDLACPSNEYLKNYF----EDNRFTEIVDPIIVEDVLSIEKEQQ 317
              ELL+G       +        ++++L +YF    E+NR  EI+D    + VL+ +  ++
Sbjct:   607 MELLSGQKALCFERPQ------ASKHLVSYFVSATEENRLHEIID----DQVLNEDNLKE 656

Query:   318 LHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
             +  +A+++ EC +    +RP M +VA KL  +
Sbjct:   657 IQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 461 (167.3 bits), Expect = 3.4e-43, P = 3.4e-43
 Identities = 110/326 (33%), Positives = 186/326 (57%)

Query:    29 RSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQE 88
             ++G  +L + ++ +       +IF+ + +K AT+ Y++  ++ +       T+YKG  Q+
Sbjct:   373 QNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNESRILGQGGQG---TVYKGILQD 429

Query:    89 RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGT 148
               I  ++      R +  E  IN V   ++++H +++KL+GCCLET +P+LV+E +  GT
Sbjct:   430 NSIVAIKKARLGDRSQV-EQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGT 488

Query:   149 LWDRILGAPQPHFEPLLL-KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN 207
             L+D + G+    F+  L  +HRL+IA+++   LAYLH     PI+ R+ KT+ IL +E  
Sbjct:   489 LFDHLHGSM---FDSSLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENL 545

Query:   208 VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
              AK+ DF  S  IP  +  +T  V GT GY  PEY  TG+ NEKSDV+SFGV L ELL+G
Sbjct:   546 TAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSG 605

Query:   268 WDVSDLVKDTHDLACPSNEYLKNYF----EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQ 323
                    +        S+++L +YF    ++NR  EI+D  ++ +      ++++  SA+
Sbjct:   606 EKALCFERPQ------SSKHLVSYFVSAMKENRLHEIIDGQVMNEY----NQREIQESAR 655

Query:   324 LSFECIKDSPADRPSMVDVAKKLRQI 349
             ++ EC +    +RPSM +VA +L  +
Sbjct:   656 IAVECTRIMGEERPSMKEVAAELEAL 681

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 461 (167.3 bits), Expect = 3.8e-43, P = 3.8e-43
 Identities = 123/342 (35%), Positives = 191/342 (55%)

Query:    14 ERTLMVRTDKRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKD 73
             +R  ++R   R    R+G  +LK+ +A   G     RIFS+ E++ AT+++++  V+ + 
Sbjct:   368 KRRKLIRM--RKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQG 425

Query:    74 TSYNLYTMYKGFWQE-RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL 132
                   T+YKG   + R+++V +    +   R  E  IN V   A+++H +I+KL+GCCL
Sbjct:   426 GQG---TVYKGMLVDGRIVAVKRSKAVD-EDRV-EEFINEVVVLAQINHRNIVKLLGCCL 480

Query:   133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 192
             ET +P+LV+E V  G L  R+      +   +  + RL IA++I  AL+YLH     PI 
Sbjct:   481 ETEVPVLVYEFVPNGDLCKRLHDESDDY--TMTWEVRLHIAIEIAGALSYLHSAASFPIY 538

Query:   193 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
              R+ KT+ IL +E N AK+ DF  S S+   +TH+T  V GT+GY  PEY ++  F EKS
Sbjct:   539 HRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKS 598

Query:   253 DVFSFGVFLFELLTGWDVSDLVK--DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVL 310
             DV+SFGV L ELLTG   S  V+  +   LA    E +K    +NR  +IVD  I +D  
Sbjct:   599 DVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVK----ENRVLDIVDDRI-KDEC 653

Query:   311 SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
             +++   Q+ + A L+  C+      RP+M +V+ +L  I  S
Sbjct:   654 NMD---QVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 456 (165.6 bits), Expect = 1.2e-42, P = 1.2e-42
 Identities = 107/323 (33%), Positives = 181/323 (56%)

Query:    29 RSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQE 88
             ++G  +L + ++ +       +IF+ + +K ATN Y +  ++ +       T+YKG   +
Sbjct:   369 QNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNGYHESRILGQGGQG---TVYKGILPD 425

Query:    89 RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGT 148
               I  ++      R +  E  IN V   ++++H +++K++GCCLET +P+LV+E +  GT
Sbjct:   426 NSIVAIKKARLGNRSQV-EQFINEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFINSGT 484

Query:   149 LWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV 208
             L+D + G+   +   L  +HRL+IA ++  +LAYLH     PI+ R+ KT+ IL ++   
Sbjct:   485 LFDHLHGSL--YDSSLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLT 542

Query:   209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             AK+ DF  S  IP  +  +T  V GT GY  PEY  TG+ NEKSDV+SFGV L ELL+G 
Sbjct:   543 AKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQ 602

Query:   269 DVSDLVKDTHDLACPSN--EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSF 326
                   +  H   CP N      +  ++NRF EI+D      V++ + ++++  +A+++ 
Sbjct:   603 KALCFERP-H---CPKNLVSCFASATKNNRFHEIIDG----QVMNEDNQREIQEAARIAA 654

Query:   327 ECIKDSPADRPSMVDVAKKLRQI 349
             EC +    +RP M +VA +L  +
Sbjct:   655 ECTRLMGEERPRMKEVAAELEAL 677

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009751 "response to salicylic acid stimulus" evidence=IDA

GO:0009311 "oligosaccharide metabolic process" evidence=IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0009992 "cellular water homeostasis" evidence=IMP;IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA

GO:0010027 "thylakoid membrane organization" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0016226 "iron-sulfur cluster assembly" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)]

 Score = 451 (163.8 bits), Expect = 6.2e-42, P = 6.2e-42
 Identities = 109/331 (32%), Positives = 185/331 (55%)

Query:    23 KRALMMRSGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMY 82
             K+    R+G  +L++ + +  G     RIF+++E++ AT ++ +  V+         T+Y
Sbjct:   403 KKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQG---TVY 459

Query:    83 KGFWQE-RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF 141
             KG   + R ++V +           +  IN V   ++++H H++KL+GCCLET +PILV+
Sbjct:   460 KGMLVDGRTVAVKK--SKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVY 517

Query:   142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 201
             E +  G L+  I       +  ++   RL+IA+DI  AL+YLH     PI  R+ K++ I
Sbjct:   518 EFIINGNLFKHIHEEEADDYT-MIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNI 576

Query:   202 LFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFL 261
             L +E+  AK+ DF  S S+   +TH T  + GT GY  PEY R+  + EKSDV+SFGV L
Sbjct:   577 LLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVIL 636

Query:   262 FELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHAS 321
              EL+TG     +V++T ++   + E+ +   ++ R ++I+D  I +D     K +Q+ A 
Sbjct:   637 AELITGDKPVIMVQNTQEIIALA-EHFRVAMKERRLSDIMDARIRDD----SKPEQVMAV 691

Query:   322 AQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
             A L+ +C+     +RP+M +V  +L +I  S
Sbjct:   692 ANLAMKCLSSRGRNRPNMREVFTELERICTS 722

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_LG_XIII000087 hypothetical protein (344 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	353
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-26
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-25
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-25
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-20
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-15
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-15
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-12
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-11
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-10
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-10
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-09
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-08
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-08
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-08
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-07
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-06
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-06
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-06
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-06
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-06
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-06
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-05
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-05
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-05
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-05
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-05
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-04
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-04
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-04
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-04
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.001
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.001
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.001
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	0.001
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.002
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	0.002
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	0.002
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	0.002
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	0.002
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.002
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.003
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	0.003
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.003
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.004
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	0.004
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.004
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  105 bits (264), Expect = 2e-26
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 48/240 (20%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            ++ H +++KL+G C E     +V E ++ G L    L   +P    L L   L  A+ I
Sbjct: 56  RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL-LSYLRKNRPK---LSLSDLLSFALQI 111

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
              + YL     +  + R+      L  E  V K+ DF LS  + + + +          
Sbjct: 112 ARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSDLVKDTHD---LACPSNE 286
           + APE ++ G F  KSDV+SFGV L+E+ T       G    ++++   +   L  P N 
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPN- 227

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
                           P  + D++                +C  + P DRP+  ++ + L
Sbjct: 228 ---------------CPPELYDLML---------------QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 4e-26
 Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 57/248 (22%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWD----RILGAPQPHFEPLLLKHRLKIAM 174
           + H ++++L+G C E     LV E ++ G L D         P P    L LK  L  A+
Sbjct: 53  LGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
            I   + YL     +  V R+      L  E+ V K+ DF LS  + + + +   T  G 
Sbjct: 113 QIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT--GG 167

Query: 235 -----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKDTHD 279
                W   APE ++ G+F  KSDV+SFGV L+E+ T       G    +V + ++  + 
Sbjct: 168 KLPIRW--MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225

Query: 280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM 339
           L  P     + Y                               +L   C +  P DRP+ 
Sbjct: 226 LPKPEYCPDELY-------------------------------ELMLSCWQLDPEDRPTF 254

Query: 340 VDVAKKLR 347
            ++ ++L 
Sbjct: 255 SELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  103 bits (258), Expect = 5e-26
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 10/165 (6%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
                E  +  +    +++H +I+KL G   +     LV E  + G+L D +    + + 
Sbjct: 31  SSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL----KENE 86

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISI 220
             L     L+I + I+  L YLH      I+ R+ K   IL + +N   KL DF LS  +
Sbjct: 87  GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143

Query: 221 PEGETHITDTVMGTWGYCAPE-YMRTGVFNEKSDVFSFGVFLFEL 264
              +  +  T++GT  Y APE  +  G ++EKSD++S GV L+EL
Sbjct: 144 TSDK-SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  102 bits (258), Expect = 2e-25
 Identities = 57/182 (31%), Positives = 85/182 (46%), Gaps = 26/182 (14%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           +SH +I++L+G C +     +V E +  G L D +    + H E L LK  L++A+ I  
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAK 113

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY- 237
            + YL     +  V R+      L  E  V K+ DF LS  I E +           G  
Sbjct: 114 GMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY----YRKRGGGKL 166

Query: 238 ----CAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKDTHDLACP 283
                APE ++ G F  KSDV+SFGV L+E+ T       G    +V +L++D + L  P
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP 226

Query: 284 SN 285
            N
Sbjct: 227 EN 228

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  103 bits (258), Expect = 2e-25
 Identities = 56/240 (23%), Positives = 95/240 (39%), Gaps = 47/240 (19%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            ++ H +I+KL+G C E    ++V E +  G L    L   +P    L L   L  A+ I
Sbjct: 56  RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL-LDYLRKNRPKE--LSLSDLLSFALQI 112

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
              + YL     +  + R+      L  E  V K+ DF LS  + + + +          
Sbjct: 113 ARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSDLVKDTHD---LACPSNE 286
           + APE ++ G F  KSDV+SFGV L+E+ T       G   +++++       L  P N 
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPN- 228

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
                           P  +  ++                +C  + P DRP+  ++ + L
Sbjct: 229 ---------------CPPELYKLML---------------QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 88.4 bits (220), Expect = 3e-20
 Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 10/150 (6%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H +I++L     +     LV E  + G L+D +    +        +        I+
Sbjct: 53  KLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARF---YLRQIL 107

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
            AL YLH    + IV R+ K   IL +E+   KL DF L+  +  GE     T +GT  Y
Sbjct: 108 SALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEY 162

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            APE +    + +  D++S GV L+ELLTG
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTG 192

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 52/152 (34%), Positives = 73/152 (48%), Gaps = 10/152 (6%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            R+SH +I++LI    +     LV E  + G L+D +             K   KIA+ I
Sbjct: 53  RRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAK---KIALQI 107

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
           +  L YLH      I+ R+ K   IL +E  V K+ DF L+       +    T +GT  
Sbjct: 108 LRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLA-KKLLKSSSSLTTFVGTPW 163

Query: 237 YCAPEYMRTG-VFNEKSDVFSFGVFLFELLTG 267
           Y APE +  G  +  K DV+S GV L+ELLTG
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTG 195

Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 79.4 bits (196), Expect = 7e-17
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 38/246 (15%)

Query: 118 RMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
            + H +I+K  G C +       L+ E +  G+L D +    Q H + + LK  L  +  
Sbjct: 62  TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQ 117

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT- 234
           I   + YL     +  + R+     IL   E++ K+ DF L+  +PE + +      G  
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 235 ---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY 291
              W Y APE +RT  F+  SDV+SFGV L+EL T  D             P  E+L+  
Sbjct: 175 PIFW-Y-APECLRTSKFSSASDVWSFGVTLYELFTYGD-----PSQS----PPAEFLRMI 223

Query: 292 FEDNRFTEIVDPIIVEDVLSIEKE-QQLHASA-------QLSFECIKDSPADRPSMVDVA 343
                       +IV  +L + KE ++L            L   C +  P DRPS  D+ 
Sbjct: 224 GIAQ------GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277

Query: 344 KKLRQI 349
             + ++
Sbjct: 278 LIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.9 bits (187), Expect = 8e-16
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 13/153 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
            + H ++++L G  L  P+ ++V E    G+L DR+    +      L+      A+ I 
Sbjct: 52  SLDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIA 107

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT----VMG 233
           + + YL     +  + R+     IL   ++  K+ DF L  ++P+ E H        V  
Sbjct: 108 NGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            W  CAPE +RT  F+  SDV+ FGV L+E+ T
Sbjct: 165 AW--CAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.0 bits (182), Expect = 4e-15
 Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 33/250 (13%)

Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP 159
               +     +N +   + + H +I+      ++    ++  E    GTL+D+I+     
Sbjct: 37  RLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ 96

Query: 160 HFEPLLLKHRLKIAM--DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS 217
            FE       + +     IV A++Y+H      I+ R+ KT  I   +  + KL DF +S
Sbjct: 97  LFE-----EEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148

Query: 218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT 277
             I   E  + +TV+GT  Y +PE  +   +N KSD+++ G  L+ELLT           
Sbjct: 149 -KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT----------- 196

Query: 278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP 337
                     LK  F+      +V   IV+   +            L    ++  P  RP
Sbjct: 197 ----------LKRTFDATNPLNLVVK-IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245

Query: 338 SMVDVAKKLR 347
           +  +V  +  
Sbjct: 246 TADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.5 bits (181), Expect = 5e-15
 Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 60/251 (23%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMD 175
           A++ H  I++LIG C   P+ +LV E    G L   +    + P  +   L H++ + M 
Sbjct: 51  AQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM- 108

Query: 176 IVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
                AYL   HF      V R+     +L    + AK+ DF +S ++  G  +   T  
Sbjct: 109 -----AYLESKHF------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157

Query: 233 GTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDL 280
           G W   + APE +  G F+ KSDV+S+GV L+E           + G +V  +++    L
Sbjct: 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL 217

Query: 281 ACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV 340
             P                   P  +  ++                 C K  P DRP+  
Sbjct: 218 PRPEE----------------CPQEIYSIML---------------SCWKYRPEDRPTFS 246

Query: 341 DVAKKLRQIYR 351
           ++    R+   
Sbjct: 247 ELESTFRRDPE 257

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 73.0 bits (180), Expect = 7e-15
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 9/164 (5%)

Query: 104 RAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP 163
              E  IN +    +  H +I+K  G  L+     +V E    G+L D +    Q   E 
Sbjct: 39  EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES 98

Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
            +      +  +++  L YLH      I+ R+ K + IL   +   KL DF LS  + + 
Sbjct: 99  QIAY----VCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151

Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +    +T++GT  + APE +    ++ K+D++S G+   EL  G
Sbjct: 152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 74.4 bits (181), Expect = 9e-15
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 24/234 (10%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
              +I+KL     +     LV E V  G+L D +         PL     L I   I+ A
Sbjct: 56  HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSA 113

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSISIPEGETH-----ITDTVMG 233
           L YLH    + I+ R+ K   IL + +  V KL DF L+  +P+  +      +  T +G
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 234 TWGYCAPEYMRTGVFNE---KSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN 290
           T GY APE +           SD++S G+ L+ELLTG    +  K+    +  +++ LK 
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN----SSATSQTLKI 226

Query: 291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK 344
                   E+  P +   +     E    A++ L  + +   P +R S      
Sbjct: 227 ------ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 73.0 bits (180), Expect = 9e-15
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 11/153 (7%)

Query: 118 RMSHNHILKLIGCCL-ETPIPILVF-ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
            + H +I++  G    E    + +F E V  G+L   +           +++   +    
Sbjct: 55  SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTR---Q 109

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGT 234
           I+  LAYLH      IV R+ K + IL + + V KL DF  +  + + ET   T +V GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + APE +R   +   +D++S G  + E+ TG
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 65/235 (27%), Positives = 98/235 (41%), Gaps = 19/235 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H +I+KLIG C       L+ E ++   L + +          L  + R KIA+ I 
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIA 790

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
            AL +LH      +V  N     I+ + ++   L      +S+P G          +  Y
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----RLSLP-GLLCTDTKCFISSAY 844

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF 297
            APE   T    EKSD++ FG+ L ELLTG   +D     H       E+ +  + D   
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV---EWARYCYSDCHL 901

Query: 298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
              +DP I  DV S+ + + +     L+  C    P  RP   DV K L    RS
Sbjct: 902 DMWIDPSIRGDV-SVNQNEIVEV-MNLALHCTATDPTARPCANDVLKTLESASRS 954

Length = 968

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 13/174 (7%)

Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAP 157
           EC  +        +     + H +I+K  GCC E       L+ E V  G+L D +   P
Sbjct: 44  ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---P 100

Query: 158 QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS 217
           +     L L   L  A  I   +AYLH    +  + R+     +L + + + K+ DF L+
Sbjct: 101 K---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154

Query: 218 ISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD 269
            ++PEG  +  + +       + A E ++   F+  SDV+SFGV L+ELLT  D
Sbjct: 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCD 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 17/162 (10%)

Query: 123 HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAY 182
           +I+   G  L      +  E +  G+L DRI         P+ ++   KIA+ +V  L Y
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSL-DRIY----KKGGPIPVEILGKIAVAVVEGLTY 118

Query: 183 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGTWGYCAP 240
           L+      I+ R+ K S IL N     KL DF +S     GE    I DT +GT  Y +P
Sbjct: 119 LYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSP 171

Query: 241 EYMRTGVFNEKSDVFSFGVFLFELLTG---WDVSDLVKDTHD 279
           E ++ G +  KSDV+S G+ + EL  G   +  S++  D  D
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 8e-14
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 10/147 (6%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
            + H ++++L+G  L+     +V E +  G+L D +    +       L  +L  A+D+ 
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVIT---LAQQLGFALDVC 112

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             + YL     +  V R+     +L +E+ VAK+ DF L+    +G+      V  T   
Sbjct: 113 EGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--- 166

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFEL 264
            APE +R   F+ KSDV+SFG+ L+E+
Sbjct: 167 -APEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 59/244 (24%), Positives = 98/244 (40%), Gaps = 42/244 (17%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWD---------RILGAPQPHFEPLLLKHR 169
             H +I+K  G C E   PI+VFE +++G L             L +P      L L   
Sbjct: 65  FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 170 LKIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
           L+IA+ I   + YL   HF      V R+  T   L   + V K+ DF +S  +   + +
Sbjct: 125 LQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178

Query: 227 -ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN 285
            +    M    +  PE +    F  +SDV+SFGV L+E+ T                   
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT------------------- 219

Query: 286 EYLKN-YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK 344
            Y K  ++  +   E+++  I +  L             +   C K  P  R ++ D+ +
Sbjct: 220 -YGKQPWYGLSN-EEVIE-CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Query: 345 KLRQ 348
           +L++
Sbjct: 277 RLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.5 bits (170), Expect = 1e-13
 Identities = 55/166 (33%), Positives = 78/166 (46%), Gaps = 22/166 (13%)

Query: 116 AARMS---HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP--LLLKHRL 170
           A  MS   H +I+KL+G CL      ++ E ++ G L   +  A    F P  L LK  L
Sbjct: 50  AHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELL 109

Query: 171 KIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI------- 220
            I +D+     YL   HF   R +  RN   S   ++ + V K+ DF L+  I       
Sbjct: 110 DICLDVAKGCVYLEQMHF-IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            EGE  +    M      APE +  G F  +SDV+SFGV ++E+LT
Sbjct: 169 KEGEGLLPVRWM------APESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 64.8 bits (158), Expect = 5e-12
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 13/164 (7%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E  I+     A++  ++I++     L+     +V E  + G L   +    G P P  E 
Sbjct: 44  EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLP--ED 101

Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
            + +      + I+  LA+LH    + I+ R+ K+  +  +  +  K+ D  ++  + + 
Sbjct: 102 QVWR----FFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD- 153

Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            T+  +T++GT  Y +PE      +NEKSDV++ GV L+E  TG
Sbjct: 154 NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 57/256 (22%), Positives = 99/256 (38%), Gaps = 52/256 (20%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTL-----WDRILGAP--------------Q 158
           +++H H++KL G C +    +L+ E  +YG+L       R +G                 
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 159 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
           P    L +   +  A  I   + YL       +V R+     +L  E    K+ DF LS 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 219 SIPEGETHIT---DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVK 275
            + E ++++      +   W   A E +   ++  +SDV+SFGV L+E++T      L  
Sbjct: 176 DVYEEDSYVKRSKGRIPVKW--MAIESLFDHIYTTQSDVWSFGVLLWEIVT------LGG 227

Query: 276 DTHDLACPSNEY--LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSP 333
           + +    P   +  LK  +   R                  E        L   C K  P
Sbjct: 228 NPYPGIAPERLFNLLKTGYRMER-----------------PENCSEEMYNLMLTCWKQEP 270

Query: 334 ADRPSMVDVAKKLRQI 349
             RP+  D++K+L ++
Sbjct: 271 DKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 64.1 bits (157), Expect = 7e-12
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 4/96 (4%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
            A +IV AL YLH      I++R+ K   IL + +   KL DF L+  +    +  T+T 
Sbjct: 98  YAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTF 153

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    + +  D +S GV L+E+LTG
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 9e-12
 Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 30/223 (13%)

Query: 80  TMYKGFWQ--------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCC 131
           T+YKG W            I VL+    E  P+A +  ++     A + H H+++L+G C
Sbjct: 22  TVYKGVWIPEGEKVKIPVAIKVLR---EETSPKANKEILDEAYVMASVDHPHVVRLLGIC 78

Query: 132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 191
           L +    L+ + +  G L D +    + H + +  ++ L   + I   ++YL     + +
Sbjct: 79  L-SSQVQLITQLMPLGCLLDYV----RNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 192 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNE 250
           V R+     +L       K+ DF L+  +   E     +       + A E +   ++  
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 251 KSDVFSFGVFLFELLT----------GWDVSDLVKDTHDLACP 283
           KSDV+S+GV ++EL+T            ++ DL++    L  P
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP 233

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 22/163 (13%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLK 167
           + H HI++  G C E    ++VFE +++G L +R L +  P  +            L L 
Sbjct: 64  LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLG 122

Query: 168 HRLKIAMDIVHALAY---LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
             L IA  I   + Y   LHF      V R+  T   L  +  V K+ DF +S  I   +
Sbjct: 123 QMLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Query: 225 TH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + +    M    +  PE +    F  +SD++SFGV L+E+ T
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 62.5 bits (153), Expect = 4e-11
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL--GAPQPHF-EP 163
           E  +N V    +++H +I+K      E     +V E    G L  +I         F E 
Sbjct: 44  EDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE 103

Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
            +L   +++ +    AL YLH    R I+ R+ K   I      + KL DF +S  +   
Sbjct: 104 QILDWFVQLCL----ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGIS-KVLSS 155

Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
              +  TV+GT  Y +PE  +   +N KSD++S G  L+EL T 
Sbjct: 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 21/192 (10%)

Query: 81  MYKGFWQER----LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-TP 135
           ++ G+W E+    + ++ +    E      E  I       ++SH  +++L G C E +P
Sbjct: 20  VWLGYWLEKRKVAIKTIREGAMSE------EDFIEEAQVMMKLSHPKLVQLYGVCTERSP 73

Query: 136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 195
           I  LVFE +++G L D  L A +  F    L   L + +D+   +AYL       ++ R+
Sbjct: 74  I-CLVFEFMEHGCLSD-YLRAQRGKFSQETL---LGMCLDVCEGMAYLE---SSNVIHRD 125

Query: 196 FKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDV 254
                 L  E  V K+ DF ++   + +  T  T T      + +PE      ++ KSDV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KWSSPEVFSFSKYSSKSDV 184

Query: 255 FSFGVFLFELLT 266
           +SFGV ++E+ +
Sbjct: 185 WSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 38/209 (18%)

Query: 116 AARMS---HNHILKLIGCCLETPIPILVFESVQYGTL-----------------WDRILG 155
           AA M+   H +I+KL+G C       L+FE + YG L                       
Sbjct: 59  AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 156 APQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS 215
               +  PL    +L IA  +   +AYL     R  V R+  T   L  E  V K+ DF 
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 175

Query: 216 LSISIPEGETHI---TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL-------- 264
           LS +I   + +     D +   W    PE +    +  +SDV+++GV L+E+        
Sbjct: 176 LSRNIYSADYYKASENDAIPIRW--MPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Query: 265 --LTGWDVSDLVKDTHDLACPSNEYLKNY 291
             +   +V   V+D + L+CP N  L+ Y
Sbjct: 234 YGMAHEEVIYYVRDGNVLSCPDNCPLELY 262

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 49/232 (21%)

Query: 118 RMSHNHILKLIGCC-LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++ H  +++L   C LE PI I V E ++YG+L + + G        L L   + +A  +
Sbjct: 57  KLRHPKLIQLYAVCTLEEPIYI-VTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQV 112

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
              +AYL     +  + R+     +L  E N+ K+ DF L+  I E      +       
Sbjct: 113 ASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACPSNE 286
           + APE      F+ KSDV+SFG+ L E+          +T  +V   V   + + CP   
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG- 228

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS 338
                                        ++L+    +  +C K+ P DRP+
Sbjct: 229 ---------------------------CPKELY---DIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 11/148 (7%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++ H+++++L+G  +E    + +V E +  G+L D +    +       L   LK ++D+
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDV 111

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
             A+ YL        V R+     +L +E+NVAK+ DF L+    +  +   DT      
Sbjct: 112 CEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVK 164

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
           + APE +R   F+ KSDV+SFG+ L+E+
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 18/198 (9%)

Query: 80  TMYKGFW-QERLISVLQFYGH----ECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+Y G   Q +LI+V Q            + YE     V     + H +I++ +G CL+ 
Sbjct: 15  TVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74

Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
               +  E V  G++   IL    P  EP+  K+       I+  +AYLH      +V R
Sbjct: 75  NTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKY----TKQILDGVAYLH---NNCVVHR 126

Query: 195 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM-----GTWGYCAPEYMRTGVFN 249
           + K + ++     + KL DF  +  +     H T + M     GT  + APE +    + 
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG 186

Query: 250 EKSDVFSFGVFLFELLTG 267
            KSD++S G  +FE+ TG
Sbjct: 187 RKSDIWSIGCTVFEMATG 204

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 5/92 (5%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV AL YLH    + I+ R+ K   IL +E+    + DF+++  +      +T +  GT 
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTP 163

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GY APE +    ++   D +S GV  +E L G
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 39/101 (38%), Positives = 51/101 (50%), Gaps = 6/101 (5%)

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           R+ IA +IV AL +LH      I++R+ K   IL + E    L DF LS      E    
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 229 DTVMGTWGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTG 267
            +  GT  Y APE +R G    ++  D +S GV  FELLTG
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 10/96 (10%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THIT 228
           KIA  ++  L+YLH    R I+ R+ K S IL   +   KL DF +S     GE    + 
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLA 160

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
            T  GT  Y APE ++   ++  SDV+S G+ L E+
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 17/193 (8%)

Query: 80  TMYKGFWQE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP 137
            +YKG   E    +++ Q    + +  A +S +  +     + H +I+K IG    +   
Sbjct: 15  VVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74

Query: 138 ILVFESVQYGTLWDRILGAPQPHFEPL---LLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            ++ E  + G+L   I       F P    L+   +     ++  LAYLH    + ++ R
Sbjct: 75  YIILEYAENGSLRQII-----KKFGPFPESLVAVYVY---QVLQGLAYLH---EQGVIHR 123

Query: 195 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDV 254
           + K + IL  ++ V KL DF ++  + +  +    +V+GT  + APE +     +  SD+
Sbjct: 124 DIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSGASTASDI 182

Query: 255 FSFGVFLFELLTG 267
           +S G  + ELLTG
Sbjct: 183 WSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 58.8 bits (142), Expect = 5e-10
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 21/154 (13%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILG---APQPHFEPLLLKHRLKI 172
           ++ H ++++L+G  L   + I V E +  G L +  R  G                 L+ 
Sbjct: 55  KLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQL--------LQF 105

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           ++D+   + YL     + +V R+     IL +E+ VAK+ DF L+     G     D   
Sbjct: 106 SLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSK 158

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + APE ++   F+ KSDV+S+GV L+E+ +
Sbjct: 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 9/99 (9%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THIT 228
           KIA+ ++  L YLH      I+ R+ K S IL N     KL DF +S     G+    + 
Sbjct: 104 KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLA 156

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            T +GT  Y APE ++   ++ KSD++S G+ L EL TG
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 43/248 (17%)

Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         LV E + YG+L D +    Q H E L  +  L  A  I
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQI 117

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-- 234
              + YL     +  V R+  T  IL   EN  K+ DF L+  +P+ + +      G   
Sbjct: 118 CKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174

Query: 235 --WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF 292
             W Y APE +    F+  SDV+SFGV L+EL T  D S           P  E+++   
Sbjct: 175 IFW-Y-APESLTESKFSVASDVWSFGVVLYELFTYSDKS---------CSPPAEFMRMMG 223

Query: 293 EDNRFTEIVDPIIVEDVLSIEKEQQ-----------LHASAQLSFECIKDSPADRPSMVD 341
            D +       +IV  ++ + K              ++A   +  EC  + P+ RPS  +
Sbjct: 224 NDKQ-----GQMIVYHLIELLKNNGRLPAPPGCPAEIYA---IMKECWNNDPSQRPSFSE 275

Query: 342 VAKKLRQI 349
           +A ++  I
Sbjct: 276 LALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 58.4 bits (142), Expect = 7e-10
 Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 14/101 (13%)

Query: 176 IVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS--------ISIPEGETH 226
           IV AL YLH  G    I+ R+ K   IL +     KL DF LS        I++ + E  
Sbjct: 102 IVLALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
               V GT  Y APE +     ++  D +S G  L+E L G
Sbjct: 158 DKRIV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 58.4 bits (142), Expect = 9e-10
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 3/100 (3%)

Query: 170 LKIAMDIVHALAYLHFG-FPRPIVF-RNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
            +I   ++ AL   H    P   V  R+ K + I  +  N  KL DF L+  +    +  
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSF 166

Query: 228 TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             T +GT  Y +PE +    ++EKSD++S G  ++EL   
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 7/149 (4%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           R+ H H++ L   C       ++ E ++ G+L    L +P+   + L +   + +A  + 
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA-FLRSPEG--QVLPVASLIDMACQVA 114

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +AYL     +  + R+     IL  E+ V K+ DF L+  I E + +++      + +
Sbjct: 115 EGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKW 170

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE    G F+ KSDV+SFG+ L+E+ T
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 14/155 (9%)

Query: 120 SHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
            H +I+KLIG C++  PI I V E V  G+L   +          L +K  L++++D   
Sbjct: 50  DHPNIVKLIGVCVQKQPIYI-VMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAA 104

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD---TVMGTW 235
            + YL     +  + R+      L  E NV K+ DF +S     G   ++D    +   W
Sbjct: 105 GMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDV 270
              APE +  G +  +SDV+S+G+ L+E  +  D 
Sbjct: 162 --TAPEALNYGRYTSESDVWSYGILLWETFSLGDT 194

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 36/243 (14%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF-EPLL 165
           E+    V   A+M H +I+       E     +V E    G L  RI       F E  +
Sbjct: 44  EASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI 103

Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGE 224
           L   ++I++ + H    +H    R I+ R+ K+  I  ++   VAKL DF ++  + +  
Sbjct: 104 LSWFVQISLGLKH----IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-S 155

Query: 225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS 284
             +  T +GT  Y +PE  +   +N K+D++S G  L+EL T                  
Sbjct: 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT------------------ 197

Query: 285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEK--EQQLHASAQLSFECIKDSPADRPSMVDV 342
              LK+ FE N   ++V  I       I     + L +   L  +  K SP DRPS+  +
Sbjct: 198 ---LKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRS---LISQLFKVSPRDRPSITSI 251

Query: 343 AKK 345
            K+
Sbjct: 252 LKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 24/164 (14%)

Query: 117 ARMSHNHILKLI--GCCLETPIPIL--VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           AR+ H +I+ L+  G   E P  +L  VFE V   TL + +  A             +  
Sbjct: 33  ARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVL--AADGALPAGETGRLMLQ 87

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLFDFSLSISIP----EGET 225
            +D   ALA  H    + IV R+ K   I+ ++  V   AK+ DF +   +P        
Sbjct: 88  VLD---ALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVA 141

Query: 226 HITDT--VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +T T  V+GT  YCAPE +R       SD++++G+   E LTG
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 39/194 (20%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRI-----------LGAPQPHFEPLLLKHR 169
           H +I+ L+G C +     +V E   +G L D +              P+P  E L  K  
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + +L     +  + R+     +L  E++V K+ DF L+  I     H  D
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHID 186

Query: 230 TVMGT--------WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVS 271
               T        W   APE +   V+  +SDV+SFGV L+E+ T            ++ 
Sbjct: 187 YYRKTTNGRLPVKW--MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244

Query: 272 DLVKDTHDLACPSN 285
            L+K+ + +  P N
Sbjct: 245 KLLKEGYRMEKPQN 258

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 56.1 bits (136), Expect = 6e-09
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 36/213 (16%)

Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           +V E +  G+L D +           +L     IA  I+  L YLH    R I+ R+ K 
Sbjct: 76  IVLEYMDGGSLADLL--KKVGKIPEPVLA---YIARQILKGLDYLHT--KRHIIHRDIKP 128

Query: 199 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFG 258
           S +L N +   K+ DF +S  + E      +T +GT  Y +PE ++   ++  +D++S G
Sbjct: 129 SNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLG 187

Query: 259 VFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQL 318
           + L E   G               P   +L        F E++  I      S+  E   
Sbjct: 188 LTLLECALG-------------KFP---FLPP--GQPSFFELMQAICDGPPPSLPAE--- 226

Query: 319 HASAQL-SF--ECIKDSPADRPSMVDVAKKLRQ 348
             S +   F   C++  P  RPS    A +L Q
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPS----AAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 43/145 (29%), Positives = 64/145 (44%), Gaps = 8/145 (5%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I V E    G L   +    Q +   L L   +  +  +  AL
Sbjct: 66  HPHIVKLIGVITENPVWI-VMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTAL 120

Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177

Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 5/92 (5%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           +V A  YLH    R I++R+ K   +L +     KL DF  +  +  G+   T T  GT 
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTP 156

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            Y APE +    ++   D +S G+ L+ELLTG
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 28/169 (16%)

Query: 116 AARM---SHNHILKLIGCCLET------PIPILVFESVQYGTL-----WDRILGAPQPHF 161
           AA M    H +++KLIG C E       P P+++   +++G L     + R+ G P    
Sbjct: 52  AACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP---- 107

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           E L L+  LK  +DI   + YL     R  + R+      +  E+    + DF LS  I 
Sbjct: 108 EKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY 164

Query: 222 EG----ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            G    +  I    +    + A E +   V+  KSDV++FGV ++E+ T
Sbjct: 165 SGDYYRQGRIAKMPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 5/95 (5%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A  I+  L +LH    R IV+R+ K   +L ++    ++ D  L++ +  G+        
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++  V++   D F+ G  L+E++ G
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 18/154 (11%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H ++++L+G C   P   ++ E + YG L D +    +     ++L   L +A  I  
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISS 115

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG-- 236
           A+ YL     +  + R+      L  E ++ K+ DF LS  +        DT     G  
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHAGAK 166

Query: 237 ----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + APE +    F+ KSDV++FGV L+E+ T
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.3 bits (133), Expect = 9e-09
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 7/96 (7%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L ++H  F   +V+R+ K + IL +E    ++ D  L+    + + H +   +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 156

Query: 233 GTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++ GV ++  +D FS G  LF+LL G
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 7/96 (7%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L ++H  F   +V+R+ K + IL +E    ++ D  L+    + + H +   +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 156

Query: 233 GTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++ G  ++  +D FS G  LF+LL G
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 23/191 (12%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLL 165
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   P L
Sbjct: 46  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL 104

Query: 166 LKHRLKIA--MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           +    +IA  M  V  + Y+H         R+ + + IL  E  V K+ DF L+  I + 
Sbjct: 105 VDMAAQIASGMAYVERMNYVH---------RDLRAANILVGENLVCKVADFGLARLIEDN 155

Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDL 273
           E            + APE    G F  KSDV+SFG+ L EL T            +V D 
Sbjct: 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 215

Query: 274 VKDTHDLACPS 284
           V+  + + CP 
Sbjct: 216 VERGYRMPCPP 226

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 35/192 (18%)

Query: 121 HNHILKLIGCCL-ETPIPILVFESVQYGTLWD--RILGAPQP---------HFEPLLLKH 168
           H +I+ L+G C  E P+ ++V E    G L +  R    P P           E L  K 
Sbjct: 77  HKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            +  A  +   + YL     R  + R+     +L  E+NV K+ DF L+     G   I 
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA----RGVHDID 188

Query: 229 DTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---L 273
                + G     + APE +   V+  +SDV+SFG+ ++E+ T       G  V +   L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248

Query: 274 VKDTHDLACPSN 285
           +++ H +  PSN
Sbjct: 249 LREGHRMDKPSN 260

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 9/172 (5%)

Query: 101 CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH 160
           C  +     +      ++ +H +I++LIG   E     ++ E +  G L    L   +P 
Sbjct: 48  CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPR 106

Query: 161 FE---PLLLKHRLKIAMDIVHALAYLH-FGF-PRPIVFRNFKTSCILFNEENVAKLFDFS 215
            E    L +K  L  A D+     YL    F  R I  RN   +C       VAK+ DF 
Sbjct: 107 PERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCK--GPGRVAKIADFG 164

Query: 216 LSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           ++  I     +      M    +  PE    G+F  K+DV+SFGV L+E+ +
Sbjct: 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 13/170 (7%)

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGET 225
           +H    A +I  AL +LH    R I++R+ K   +L + +   KL D+ +    +  G+T
Sbjct: 96  EHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152

Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN 285
             T T  GT  Y APE +R   +    D ++ GV +FE++ G    D++ D  D+   + 
Sbjct: 153 --TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TE 208

Query: 286 EYLKNYFEDN-----RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIK 330
           +YL     +      RF  +    +++  L+ + +++L    Q  F  IK
Sbjct: 209 DYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIK 258

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L +LH    + I++R+ K   +L +++   K+ DF +      GE     T  
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KASTFC 157

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE ++   +NE  D +SFGV L+E+L G
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 23/164 (14%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL------------GAPQPHFEPLLL 166
           + H HI+K  G C +    I+VFE +++G L ++ L            G P+     L L
Sbjct: 64  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 167 KHRLKIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
              L IA  I   + YL   HF      V R+  T   L     + K+ DF +S  +   
Sbjct: 123 SQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176

Query: 224 ETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + +    M    +  PE +    F  +SDV+SFGV L+E+ T
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 17/173 (9%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H +I+KLIG C +     +V E V  G      L   +   + L  K  +K A+D    +
Sbjct: 51  HPNIVKLIGVCTQRQPIYIVMELVPGGDF----LSFLRKKKDELKTKQLVKFALDAAAGM 106

Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  + R+      L  E NV K+ DF +S    +G    +        + AP
Sbjct: 107 AYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAP 163

Query: 241 EYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACP 283
           E +  G ++ +SDV+S+G+ L+E           +T     + V+  + ++CP
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCP 216

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 9/160 (5%)

Query: 108 SCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
           +  N       +SH +I++     LE    ++V E    GTL + I        +     
Sbjct: 45  AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE---D 101

Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETH 226
             L   + I+ AL ++H    + I+ R+ KT  IL ++ + V K+ DF +S  +      
Sbjct: 102 TILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKS 156

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              TV+GT  Y +PE      +N+KSD+++ G  L+EL +
Sbjct: 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 49/152 (32%), Positives = 68/152 (44%), Gaps = 18/152 (11%)

Query: 121 HNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
           H+ +++L   C E  PI I V E +  G+L D  L + +     L L   + +A  I   
Sbjct: 60  HDKLVQLYAVCSEEEPIYI-VTEYMSKGSLLD-FLKSGEGKK--LRLPQLVDMAAQIAEG 115

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT----- 234
           +AYL     R  + R+     IL  E  V K+ DF L+  I   E        G      
Sbjct: 116 MAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIK 169

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           W   APE    G F  KSDV+SFG+ L E++T
Sbjct: 170 W--TAPEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 23/157 (14%)

Query: 119 MSHNH-ILKLIGCCLETPIPIL-VFESVQYGTLW-----DRILGAPQPHFEPLLLKHRLK 171
           ++ NH  L  + CC +TP  +  V E V  G L       R     +  F          
Sbjct: 51  LARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF---------- 100

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDT 230
            A +I  AL +LH    + I++R+ K   +L + E   KL DF +    I  G+T  T T
Sbjct: 101 YAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TST 155

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             GT  Y APE ++  ++    D ++ GV L+E+L G
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 15/158 (9%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----PLLLKHRLK 171
            ++SH ++++L+G C E     ++ E    G L  + L A +   E     PL  K ++ 
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL-KQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 172 IAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           +   I   + +L    F   R +  RN    C++ ++    K+   SLS  +   E +  
Sbjct: 122 LCTQIALGMDHLSNARF-VHRDLAARN----CLVSSQ-REVKVSLLSLSKDVYNSEYYKL 175

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              +    + APE ++   F+ KSDV+SFGV ++E+ T
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 16/194 (8%)

Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W       ++   ++       P+A    ++     A M H H+++L+G CL +
Sbjct: 22  TVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-S 80

Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
           P   LV + + +G L D +      H + +  +  L   + I   + YL     R +V R
Sbjct: 81  PTIQLVTQLMPHGCLLDYV----HEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHR 133

Query: 195 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW--GYCAPEYMRTGVFNEKS 252
           +     +L    N  K+ DF L+  + EG+    +   G     + A E +    F  +S
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 192

Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 193 DVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 4/96 (4%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I    +  L YLH       + R+ K   IL NEE  AKL DF +S           +TV
Sbjct: 104 ILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTV 159

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   +N K+D++S G+   E+  G
Sbjct: 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 6/96 (6%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI-SIPEGETHITDTV 231
           A +IV  L +LH    R I++R+ K   +L + E   K+ DF +    I  G T  T T 
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D ++ GV L+E+L G
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 54.1 bits (131), Expect = 3e-08
 Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 8/161 (4%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  IN +       H +I+      L      +V E +  G+L D I      +F  +  
Sbjct: 60  ELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNE 115

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
                +  +++  L YLH    + ++ R+ K+  IL +++   KL DF  +  + + ++ 
Sbjct: 116 PQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
              +V+GT  + APE ++   +  K D++S G+   E+  G
Sbjct: 173 RN-SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 18/160 (11%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTL--------WDRILGAPQPHFEPLLLKHRL 170
           + H HI+K  G C+E    I+VFE +++G L         D +L A       L     L
Sbjct: 64  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 171 KIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH- 226
            IA  I   + YL   HF      V R+  T   L  E  + K+ DF +S  +   + + 
Sbjct: 124 HIAQQIAAGMVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           +    M    +  PE +    F  +SDV+S GV L+E+ T
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 20/165 (12%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
           + +I  AL +LH    R I++R+ K   +L + E   KL D+ +    I  G+T  T T 
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTF 156

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY 291
            GT  Y APE +R   +    D ++ GV +FE++ G    D+V  + +    + +YL   
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL--- 213

Query: 292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR 336
           F+          +I+E  + I +   + AS+ L     KD P +R
Sbjct: 214 FQ----------VILEKQIRIPRSLSVKASSVLKGFLNKD-PKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 39/145 (26%), Positives = 72/145 (49%), Gaps = 11/145 (7%)

Query: 124 ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL 183
           I K  G  L+ P   ++ E  + G++  R L    P  E    K+   I  +++ AL Y+
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAE----KYISVIIREVLVALKYI 117

Query: 184 HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM 243
           H      ++ R+ K + IL       KL DF ++  + +  +  + T +GT  + APE +
Sbjct: 118 H---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS-TFVGTPYWMAPEVI 173

Query: 244 RTGV-FNEKSDVFSFGVFLFELLTG 267
             G  ++ K+D++S G+ ++E+ TG
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L +A+D +H+L          I++R+ K   IL +EE   KL DF LS    + E     
Sbjct: 107 LALALDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AY 156

Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +  GT  Y APE +      + +D +SFGV +FE+LTG
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 53/254 (20%), Positives = 109/254 (42%), Gaps = 48/254 (18%)

Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTL--WDRIL--------GAPQP 159
           +N  +     + +H+++L+G   +    ++V E + +G L  + R L        G P P
Sbjct: 57  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 160 HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
                 L+  +++A +I   +AYL+    +  V R+      +   +   K+ DF ++  
Sbjct: 117 T-----LQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168

Query: 220 IPEGETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLV 274
           I E + +      G  G     + APE ++ GVF   SD++SFGV L      W+++ L 
Sbjct: 169 IYETDYYRK----GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLA 218

Query: 275 KDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPA 334
           +  +     SNE +  +  D  + +  D             +++    ++   C + +P 
Sbjct: 219 EQPYQGL--SNEQVLKFVMDGGYLDQPDNC----------PERVTDLMRM---CWQFNPK 263

Query: 335 DRPSMVDVAKKLRQ 348
            RP+ +++   L+ 
Sbjct: 264 MRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 44/194 (22%), Positives = 89/194 (45%), Gaps = 16/194 (8%)

Query: 80  TMYKGFWQE-----RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W       ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 22  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81

Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 82  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHR 133

Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H  +       + A E +   ++  +S
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH-AEGGKVPIKWMALESILHRIYTHQS 192

Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 193 DVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 12/147 (8%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
           SH +I++LIG C +     +V E VQ G      L    P    L +K  +++  +    
Sbjct: 51  SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGPR---LKVKELIQMVENAAAG 106

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG---ETHITDTVMGTWG 236
           + YL     +  + R+      L  E+NV K+ DF +S    +G    T     +   W 
Sbjct: 107 MEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW- 162

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFE 263
             APE +  G ++ +SDV+SFG+ L+E
Sbjct: 163 -TAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 7/149 (4%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I + E ++ G+L D  L  P+     L +   + +A  I 
Sbjct: 57  QLQHPRLVRLYAVVTQEPIYI-ITEYMENGSLVD-FLKTPEGI--KLTINKLIDMAAQIA 112

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     +  + R+ + + IL +E    K+ DF L+  I + E    +       +
Sbjct: 113 EGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 29/227 (12%)

Query: 75  SYNLYTMYKGFWQ----ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGC 130
           S N  T+ KG ++    E+ ++V         P   +  +       ++ + +I+++IG 
Sbjct: 5   SGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI 64

Query: 131 CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL--LKHRLKIAMDIVHALAYLHFGFP 188
           C E    +LV E  + G L ++ L   +   E  +  L H++ + M  +    ++H    
Sbjct: 65  C-EAESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH---- 118

Query: 189 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW--GYCAPEYMRTG 246
           R +  RN     +L   ++ AK+ DF LS ++   E +      G W   + APE M   
Sbjct: 119 RDLAARN-----VLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 247 VFNEKSDVFSFGVFLFELLT----------GWDVSDLVKDTHDLACP 283
            F+ KSDV+SFGV ++E  +          G +V+ +++    + CP
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP 220

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 45/160 (28%), Positives = 68/160 (42%), Gaps = 22/160 (13%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 168
           H +I+ L+G C       +  E   YG L D     R+L    P F         L  + 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVL-ETDPAFAKEHGTASTLTSQQ 120

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            L+ A D+   + YL     +  + R+     +L  E   +K+ DF LS     GE    
Sbjct: 121 LLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYV 173

Query: 229 DTVMGTWG--YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              MG     + A E +   V+  KSDV+SFGV L+E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 52.4 bits (125), Expect = 8e-08
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 13/163 (7%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLL 165
           E+ +       ++ H+ ++ L     E PI I V E +  G+L D +      + + P L
Sbjct: 46  EAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL 104

Query: 166 LKHRLKIA--MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           +    +IA  M  +  + Y+H         R+ + + IL  +  V K+ DF L+  I + 
Sbjct: 105 VDMAAQIADGMAYIERMNYIH---------RDLRAANILVGDNLVCKIADFGLARLIEDN 155

Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           E            + APE    G F  KSDV+SFG+ L EL+T
Sbjct: 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 9/151 (5%)

Query: 122 NHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPLLLKHRLKIAMDI 176
           +H+++L+G        ++V E +  G L       R      P   P  L+  +++A +I
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTW 235
              +AYL     +  V R+      +  E+   K+ DF ++  I E + +      +   
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + APE ++ GVF  KSDV+SFGV L+E+ T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 4/94 (4%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
           +I+ AL +LH      IV+R+ K   IL + E    L DF LS      E   T +  GT
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169

Query: 235 WGYCAPEYMRTGVFNEKS-DVFSFGVFLFELLTG 267
             Y APE +R    + K+ D +S G+ +FELLTG
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 35/148 (23%), Positives = 59/148 (39%), Gaps = 27/148 (18%)

Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
            V E    G L   I        +    +     A +I+ AL YLH    + I+ R+ K 
Sbjct: 79  FVLEYAPNGELLQYIR--KYGSLDEKCTRF---YAAEILLALEYLH---SKGIIHRDLKP 130

Query: 199 SCILFNEENVAKLFDF---------SLSISIPEGETHI----------TDTVMGTWGYCA 239
             IL +++   K+ DF         S   S     T+I            + +GT  Y +
Sbjct: 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVS 190

Query: 240 PEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           PE +      + SD+++ G  ++++LTG
Sbjct: 191 PELLNEKPAGKSSDLWALGCIIYQMLTG 218

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 37/106 (34%), Positives = 52/106 (49%), Gaps = 18/106 (16%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           KIA+ IV AL YLH      ++ R+ K S +L N     KL DF +S        ++ D+
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157

Query: 231 VMGTWG-----YCAPEY----MRTGVFNEKSDVFSFGVFLFELLTG 267
           V  T       Y APE     +    ++ KSDV+S G+ + EL TG
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 4/95 (4%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L +LH    + IV+R+ K   IL + +   K+ DF +      G+   T T  
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFC 157

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +    +N   D +SFGV L+E+L G
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 38/240 (15%)

Query: 121 HNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGA---PQPHFEPLLLKHRLK 171
           H ++++LIG CL+T      P P+++   +++G L   +L +     P + P   +  +K
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVK 116

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
              DI   + YL     +  + R+      + NE     + DF LS  I  G+ +    +
Sbjct: 117 FMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173

Query: 232 MGT-WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN 290
                 + A E +   V+  KSDV+SFGV ++E+ T        +         N  + +
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--------RGQTPYPGVENSEIYD 225

Query: 291 YF-EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
           Y  + NR  +  D               L     L   C   +P DRPS   +  +L + 
Sbjct: 226 YLRQGNRLKQPPDC--------------LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 12/124 (9%)

Query: 151 DRILGAP-QPHFEPLLLKH------RL-KIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL 202
           D I GAP   HF  L  K       R+  I + +V AL YLH    + IV R+   + I+
Sbjct: 89  DLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIM 146

Query: 203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLF 262
             E++   + DF L+    +       +V+GT  Y  PE ++   + EK+DV++FG  L+
Sbjct: 147 LGEDDKVTITDFGLAKQ--KQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILY 204

Query: 263 ELLT 266
           ++ T
Sbjct: 205 QMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 25/169 (14%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-------RILGAPQP 159
           ES +       ++ H+ +++L     E PI I V E +  G+L D       R L  P  
Sbjct: 46  ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPN- 103

Query: 160 HFEPLLLKHRLKIA--MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS 217
                L+    ++A  M  +  + Y+H         R+ +++ IL  +  V K+ DF L+
Sbjct: 104 -----LVDMAAQVAAGMAYIERMNYIH---------RDLRSANILVGDGLVCKIADFGLA 149

Query: 218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             I + E            + APE    G F  KSDV+SFG+ L EL+T
Sbjct: 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 7/148 (4%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H+ ++KL     + PI I+  E +  G+L D  L + +   +PL     +  +  I  
Sbjct: 58  LQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLD-FLKSDEGSKQPL--PKLIDFSAQIAE 113

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYC 238
            +A++     R  + R+ + + IL +   V K+ DF L+  I + E    +       + 
Sbjct: 114 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170

Query: 239 APEYMRTGVFNEKSDVFSFGVFLFELLT 266
           APE +  G F  KSDV+SFG+ L E++T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 13/155 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMD 175
            + H +I++ +G   E     +  E V  G+L    R    P    E  ++ +       
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY----TKQ 116

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGT 234
           I+  L YLH      IV R+ K   +L N    V K+ DF  S  +  G    T+T  GT
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGT 172

Query: 235 WGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTG 267
             Y APE +  G   +   +D++S G  + E+ TG
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMG 233
           +I  AL +LH    + I++R+ K   IL + +   KL DF L   SI EG   +T T  G
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCG 162

Query: 234 TWGYCAPE-YMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y APE  MR+G   +  D +S G  ++++LTG
Sbjct: 163 TIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I   L  LH      IV+R+ K   IL ++    ++ D  L++ +PEG+T I   V 
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV- 162

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++   +    D ++ G  L+E++ G
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 40/256 (15%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPH 160
           E  +          H +++KLIG  L +      PIP+++   +++G L   +L   +  
Sbjct: 46  EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIG 104

Query: 161 FEPLLLKHR--LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
            EP  L  +  ++  +DI   + YL     +  + R+      + NE     + DF LS 
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Query: 219 SIPEGETHITDTVMG---TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVK 275
            I  G+ +           W   A E +   V+   SDV++FGV ++E++T        +
Sbjct: 162 KIYSGDYYRQGCASKLPVKW--LALESLADNVYTTHSDVWAFGVTMWEIMT--------R 211

Query: 276 DTHDLACPSNEYLKNYF-EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPA 334
                A   N  + NY  + NR  +   P  +EDV             +L  +C    P 
Sbjct: 212 GQTPYAGVENSEIYNYLIKGNRLKQ--PPDCLEDVY------------ELMCQCWSPEPK 257

Query: 335 DRPSMVDVAKKLRQIY 350
            RPS   +  +L  I+
Sbjct: 258 CRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 13/153 (8%)

Query: 118 RMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++SH ++++L G C +  PI I V E +  G L + +    +     L  +  L +  D+
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFI-VTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDV 109

Query: 177 VHALAYL--HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
             A+ YL  +    R +  RN    C L  E+NV K+ DF L+  + + +   +      
Sbjct: 110 CEAMEYLESNGFIHRDLAARN----C-LVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP 164

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             +  PE      F+ KSDV+SFGV ++E+ + 
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.5 bits (120), Expect = 4e-07
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 22/160 (13%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 168
           H +I+ L+G C       L  E   +G L D     R+L    P F         L  + 
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL-ETDPAFAIANSTASTLSSQQ 113

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            L  A D+   + YL     +  + R+     IL  E  VAK+ DF LS     G+    
Sbjct: 114 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYV 166

Query: 229 DTVMGTWG--YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              MG     + A E +   V+   SDV+S+GV L+E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 39/129 (30%), Positives = 59/129 (45%), Gaps = 8/129 (6%)

Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LV   +  G L   I     P FE    +  L  A +I+  L  LH       V+R+ K 
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLH---RENTVYRDLKP 130

Query: 199 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFG 258
             IL ++    ++ D  L++ IPEGE+ I   V GT GY APE +    +    D +  G
Sbjct: 131 ENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQRYTLSPDYWGLG 188

Query: 259 VFLFELLTG 267
             ++E++ G
Sbjct: 189 CLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 11/96 (11%)

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS------ISIPEGETHITDT 230
           +  L  +H    + ++ R+ K++ IL     + KL DF  S      +S   G T     
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT----- 204

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             GT  Y APE  R   +++K+D+FS GV L+ELLT
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 39/212 (18%)

Query: 57  IKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYA 116
           +  ATNS+  + V  K  SY+     +  WQ+                     I  V + 
Sbjct: 37  VYFATNSHTNEVVAVKKMSYSGKQTNEK-WQD--------------------IIKEVKFL 75

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            ++ H + ++  GC L+     LV E    G+  D +    + H +PL       I    
Sbjct: 76  QQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAITHGA 130

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF-SLSISIPEGETHITDTVMGTW 235
           +  LAYLH      ++ R+ K   IL  E    KL DF S S S P       ++ +GT 
Sbjct: 131 LQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTP 181

Query: 236 GYCAPEY---MRTGVFNEKSDVFSFGVFLFEL 264
            + APE    M  G ++ K DV+S G+   EL
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 37/108 (34%), Positives = 53/108 (49%), Gaps = 5/108 (4%)

Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
           LK +LK A+ I   + YL     R  V R+     +L   E+  K+ DF L+ +I   + 
Sbjct: 108 LKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164

Query: 226 HIT--DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVS 271
           + T  D +     + APE +    F   SDV+SFGV L+ELLT  D  
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 5/95 (5%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
           +IV AL +LH      I++R+ K   IL +      L DF LS    E E     +  GT
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169

Query: 235 WGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTG 267
             Y AP+ +R G    ++  D +S GV ++ELLTG
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 36/162 (22%), Positives = 73/162 (45%), Gaps = 5/162 (3%)

Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE 162
            +A + C+  +    ++ H +++K +   +E     +V E    G L  R++   +    
Sbjct: 43  AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKR 101

Query: 163 PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 222
            +  +   K  + +  AL ++H    + I+ R+ K + +      V KL D  L      
Sbjct: 102 LIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG-RFFS 157

Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
            +T    +++GT  Y +PE +    +N KSD++S G  L+E+
Sbjct: 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 37/247 (14%)

Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF- 161
           P+  E     V   + M H +I++      E     +V +  + G L+ +I       F 
Sbjct: 40  PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP 99

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           E  +L   ++I +    AL ++H    R I+ R+ K+  I   ++   KL DF ++  + 
Sbjct: 100 EDQILDWFVQICL----ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIA-RVL 151

Query: 222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA 281
                +  T +GT  Y +PE      +N KSD+++ G  L+E+ T               
Sbjct: 152 NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT--------------- 196

Query: 282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASA---QLSFECIKDSPADRPS 338
                 LK+ FE      +V  II      +      H S     L  +  K +P DRPS
Sbjct: 197 ------LKHAFEAGNMKNLVLKIIRGSYPPVS----SHYSYDLRNLVSQLFKRNPRDRPS 246

Query: 339 MVDVAKK 345
           +  + +K
Sbjct: 247 VNSILEK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 26/182 (14%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ---PHFEPLLLKHRLKIAM 174
           ++ + +I+++IG C E    +LV E    G L ++ L   +        + L H++ + M
Sbjct: 51  QLDNPYIVRMIGVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGM 108

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
             +    ++H    R +  RN     +L   ++ AK+ DF LS ++   +++      G 
Sbjct: 109 KYLEGKNFVH----RDLAARN-----VLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159

Query: 235 W--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKDTHDLAC 282
           W   + APE +    F+ +SDV+S+G+ ++E  +          G +V   ++    L C
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC 219

Query: 283 PS 284
           P+
Sbjct: 220 PA 221

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 25/90 (27%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L +LH    R I++R+ K   +L + +   ++ D  L++ + +G++  T    GT 
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTP 161

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELL 265
           G+ APE ++   ++   D F+ GV L+E++
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 49.8 bits (120), Expect = 7e-07
 Identities = 48/162 (29%), Positives = 67/162 (41%), Gaps = 30/162 (18%)

Query: 118 RMSHNHILKLIG-CCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAM 174
            + H +I+KL+     E  +  LVFE        D  + L        P L+K    I  
Sbjct: 54  ELKHPNIVKLLDVIHTERKL-YLVFEYCDM----DLKKYLDKRPGPLSPNLIKS---IMY 105

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVM 232
            ++  LAY H      I+ R+ K   IL N + V KL DF L+    IP      T  V+
Sbjct: 106 QLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVV 160

Query: 233 GTWGYCAPE------YMRTGVFNEKSDVFSFGVFLFELLTGW 268
             W Y APE      +  T V     D++S G    E++TG 
Sbjct: 161 TLW-YRAPEILLGSKHYSTAV-----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 38/212 (17%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK-IA--M 174
           + SH++I++L G   +    +++ E ++ G L D+ L      F    L   L+ IA  M
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI---PEGETHITDTV 231
             +  + Y+H    R +  RN     IL N     K+ DF LS  +   PEG T+ T   
Sbjct: 121 KYLSDMNYVH----RDLAARN-----ILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGG 170

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-----GWDVS--DLVKDTHD----- 279
                + APE +    F   SDV+SFG+ ++E+++      WD+S  +++K  +D     
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230

Query: 280 --LACPSNEY---LKNYFEDN----RFTEIVD 302
             + CPS  Y   L+ + +D     RF +IV+
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.4 bits (118), Expect = 8e-07
 Identities = 48/197 (24%), Positives = 79/197 (40%), Gaps = 37/197 (18%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH------------FEPL 164
           + + H +I+ L+G C +     ++FE + +G L +  L    PH               L
Sbjct: 63  SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE-FLVRNSPHSDVGAESGDETVKSSL 121

Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
                L IA+ I   + YL        V R+      L  E    K+ DF LS  I   +
Sbjct: 122 DCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Query: 225 THITDTVMGT------WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW--- 268
            +    V         W    PE +  G F  +SD++SFGV L+E+ +       G+   
Sbjct: 179 YY---RVQSKSLLPVRW--MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233

Query: 269 DVSDLVKDTHDLACPSN 285
           +V ++++    L CP +
Sbjct: 234 EVIEMIRSRQLLPCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 20/156 (12%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           +  H +I++L G   ++   +++ E ++ G+L D+ L      F    L   + +   I 
Sbjct: 61  QFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQL---VGMLRGIA 116

Query: 178 HALAYL--HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
             + YL       R +  RN     IL N   V K+ DF LS  + + E   T T  G  
Sbjct: 117 SGMKYLSEMNYVHRDLAARN-----ILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGK 169

Query: 234 ---TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               W   APE +    F   SDV+SFG+ ++E+++
Sbjct: 170 IPIRW--TAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 8/97 (8%)

Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           ++IAM    AL YLH    + I+ R+ KT  +     N+ K+ D  ++  + E +  +  
Sbjct: 109 VQIAM----ALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA-RVLENQCDMAS 160

Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           T++GT  Y +PE      +N KSDV++ G  ++E+ T
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 195

Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255

Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 256 KEGHRMDKPSN 266

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 20/171 (11%)

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGET 225
           +H    + +I  AL YLH    R I++R+ K   +L + E   KL D+ +    +  G+T
Sbjct: 96  EHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152

Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN 285
             T T  GT  Y APE +R   +    D ++ GV +FE++ G    D+V  + +    + 
Sbjct: 153 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 210

Query: 286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR 336
           +YL   F+          +I+E  + I +   + A++ L     KD P +R
Sbjct: 211 DYL---FQ----------VILEKQIRIPRSLSVKAASVLKSFLNKD-PKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 23/159 (14%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI--LGAPQPHFEPLLLKHRLKIAMDI 176
           + H +I++ +G  L+     +  E V  G++   +   GA    FE  L+++ ++    I
Sbjct: 63  LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVR---QI 115

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT------ 230
           +  L YLH    R I+ R+ K + IL + +   K+ DF +S  +   E +   T      
Sbjct: 116 LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGAR 169

Query: 231 --VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + G+  + APE ++   +  K+D++S G  + E+LTG
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 16/194 (8%)

Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W       ++   ++       P+A +  ++     A +   ++ +L+G CL +
Sbjct: 22  TVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81

Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  LV + + YG L D +    + + + +  +  L   + I   ++YL       +V R
Sbjct: 82  TVQ-LVTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHR 133

Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L    N  K+ DF L+  + I E E H  D       + A E +    F  +S
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVPIKWMALESILHRRFTHQS 192

Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 193 DVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 7/96 (7%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +IV AL YLH    + IV+R+ K   IL ++E   KL DF  +  + +     T T+ 
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLC 159

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           GT  Y APE +++   N+  D ++ G+ ++E+L G+
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 13/100 (13%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H++  +H         R+ K   +L ++    KL DF   + + E      DT 
Sbjct: 153 LALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203

Query: 232 MGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE +++    G +  + D +S GVFLFE+L G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 6/97 (6%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           +IA+ +V  L YL   +   I+ R+ K S +L N     KL DF +S  +      I  T
Sbjct: 99  RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKT 152

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y APE +    +   SDV+S G+   EL  G
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 17/167 (10%)

Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    +++ E +  G L       R      P   P 
Sbjct: 57  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116

Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            LK  +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E +
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173

Query: 225 THITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 174 YYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 19/155 (12%)

Query: 118 RMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++SH  +++L G C  + PI I V E +  G L +  L      F+P  L   L++  D+
Sbjct: 55  KLSHEKLVQLYGVCTKQRPIYI-VTEYMSNGCLLN-YLREHGKRFQPSQL---LEMCKDV 109

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-- 234
              +AYL     +  + R+      L +++   K+ DF LS  + + E     + +G+  
Sbjct: 110 CEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKF 163

Query: 235 ---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              W    PE +    F+ KSDV++FGV ++E+ +
Sbjct: 164 PVRWS--PPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 17/155 (10%)

Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAM 174
           + H +I++L             +VFE + +    D   +L +P+  F    +K  +K   
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH----DLTGLLDSPEVKFTESQIKCYMK--- 107

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDTVMG 233
            ++  L YLH      I+ R+ K S IL N + V KL DF L+           T+ V+ 
Sbjct: 108 QLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT 164

Query: 234 TWGYCAPE-YMRTGVFNEKSDVFSFGVFLFELLTG 267
            W Y  PE  +    +  + D++S G  L EL  G
Sbjct: 165 LW-YRPPELLLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG---ETHITDTVMGTW 235
            L YLH       + R+ K   IL  E+   K+ DF +S S+ +G      +  T +GT 
Sbjct: 114 GLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 236 GYCAPEYM--RTGVFNEKSDVFSFGVFLFELLTG 267
            + APE M    G ++ K+D++SFG+   EL TG
Sbjct: 171 CWMAPEVMEQVHG-YDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 35/149 (23%), Positives = 65/149 (43%), Gaps = 7/149 (4%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++SH  +++L G C +     +V E ++ G L +  L   Q      +L   L +  D+ 
Sbjct: 55  KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN-YLRQRQGKLSKDML---LSMCQDVC 110

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             + YL        + R+      L +   V K+ DF ++  + + E   +        +
Sbjct: 111 EGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             PE      ++ KSDV+SFGV ++E+ T
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 37/193 (19%)

Query: 121 HNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHF-----------EPLLLKH 168
           H +I+ L+G C +  P+ +LV E    G L + +     P             E L  K 
Sbjct: 77  HKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  +     H  
Sbjct: 136 LVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-----HNI 187

Query: 229 DTVMGTWG------YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD--- 272
           D    T        + APE +   V+  +SDV+SFGV L+E+ T       G  V +   
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247

Query: 273 LVKDTHDLACPSN 285
           L+K+ H +  P+N
Sbjct: 248 LLKEGHRMDKPAN 260

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
           A +I   L +LH    + I++R+ K   ++ + E   K+ DF +   +I  G+T  T T 
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTF 161

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    + +  D ++FGV L+E+L G
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 25/77 (32%), Positives = 41/77 (53%), Gaps = 2/77 (2%)

Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNE 250
           IV+R+ K   IL ++    ++ D  L++ IPEGET      +GT GY APE +    +  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTF 180

Query: 251 KSDVFSFGVFLFELLTG 267
             D +  G  ++E++ G
Sbjct: 181 SPDWWGLGCLIYEMIQG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 39/149 (26%), Positives = 72/149 (48%), Gaps = 8/149 (5%)

Query: 119 MSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           + H+ +++L      E PI I+  E +  G+L D +          +LL   +  +  I 
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIIT-EYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQIA 113

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +AY+     +  + R+ + + +L +E  + K+ DF L+  I + E    +       +
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L+E++T
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 28/100 (28%), Positives = 51/100 (51%), Gaps = 13/100 (13%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H++ ++H         R+ K   +L ++    KL DF   + +        DT 
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203

Query: 232 MGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE +++    G +  + D +S GVFL+E+L G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 39/166 (23%), Positives = 77/166 (46%), Gaps = 17/166 (10%)

Query: 107 ESCINNVTYAARMSHNHILK-----LIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           E  +N +   A ++H +I+      L G  L      +V E   +G L  + +   +   
Sbjct: 44  EDAVNEIRILASVNHPNIISYKEAFLDGNKL-----CIVMEYAPFGDLS-KAISKRKKKR 97

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           + +  +   +I + ++  L  LH    + I+ R+ K++ IL    ++ K+ D  +S  + 
Sbjct: 98  KLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154

Query: 222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +    +  T +GT  Y APE  +   ++ KSD++S G  L+E+ T 
Sbjct: 155 KN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 38/162 (23%), Positives = 76/162 (46%), Gaps = 12/162 (7%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLL 165
           E     +T  ++    ++ K  G  L+     ++ E +  G+  D +   P   F+   +
Sbjct: 47  EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM 106

Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
           LK  LK  +D +H+   +H         R+ K + +L +E+   KL DF ++  + + + 
Sbjct: 107 LKEILK-GLDYLHSEKKIH---------RDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156

Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
              +T +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 157 K-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 44/188 (23%), Positives = 78/188 (41%), Gaps = 27/188 (14%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  +   + +   
Sbjct: 140 VSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID-YYKK 195

Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 255

Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 256 HRMDKPAN 263

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 10/111 (9%)

Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
           P   +E  LL +++ +A+D VH+   +H         R+ K++ I      + KL DF  
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVHSRKMMH---------RDLKSANIFLMPTGIIKLGDFGF 215

Query: 217 SISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           S    +  +  +  +  GT  Y APE      +++K+D++S GV L+ELLT
Sbjct: 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 13/100 (13%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H++ ++H         R+ K   +L ++    KL DF   + + +      DT 
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203

Query: 232 MGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE +++    G +  + D +S GVFL+E+L G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 14/104 (13%)

Query: 171 KIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           K+ + IV AL YL   H      ++ R+ K S IL +     KL DF +S  + + +   
Sbjct: 118 KMTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171

Query: 228 TDTVMGTWGYCAPEYM----RTGVFNEKSDVFSFGVFLFELLTG 267
                G   Y APE +        ++ ++DV+S G+ L EL TG
Sbjct: 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 18/230 (7%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H +++ LI          LVFE V + T+ D +   P      L      K    I+
Sbjct: 56  QLRHENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG----LDESRVRKYLFQIL 110

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             + + H      I+ R+ K   IL ++  V KL DF  + ++       TD V   W Y
Sbjct: 111 RGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW-Y 166

Query: 238 CAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDV----SDLVKDTHDLACPSN--EYLKN 290
            APE +     +    D+++ G  + E+LTG  +    SD+ +  H + C  N     + 
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226

Query: 291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSF--ECIKDSPADRPS 338
            F+ N     +    V+++  +EK     +   L    +C++  P DRPS
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 5/97 (5%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  LAYL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L EL  G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 47.8 bits (113), Expect = 3e-06
 Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 18/163 (11%)

Query: 106 YESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL 165
           ++  I  V +  R+ H + ++  GC L      LV E    G+  D +    + H +PL 
Sbjct: 69  WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQ 123

Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF-SLSISIPEGE 224
                 I    +  LAYLH      ++ R+ K   IL  E    KL DF S SI+ P   
Sbjct: 124 EVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177

Query: 225 THITDTVMGTWGYCAPEY---MRTGVFNEKSDVFSFGVFLFEL 264
               ++ +GT  + APE    M  G ++ K DV+S G+   EL
Sbjct: 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 16/102 (15%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  +++  L YLH       + R+ K + IL +EE   KL DF +S         +T T+
Sbjct: 103 ILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTM 152

Query: 232 ------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
                 +GT  + APE ++   ++EK+D++S G+   EL  G
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 22/160 (13%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 168
           H +I+ L+G C       L  E   +G L D     R+L    P F         L  + 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL-ETDPAFAIANSTASTLSSQQ 125

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            L  A D+   + YL     +  + R+     IL  E  VAK+ DF LS     G+    
Sbjct: 126 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYV 178

Query: 229 DTVMGTWG--YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              MG     + A E +   V+   SDV+S+GV L+E+++
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 22/77 (28%), Positives = 43/77 (55%), Gaps = 2/77 (2%)

Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNE 250
           IV+R+ K   +L +++   +L D  L++ + +G+T       GT GY APE ++   ++ 
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173

Query: 251 KSDVFSFGVFLFELLTG 267
             D F+ G  ++E++ G
Sbjct: 174 PVDWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 46/163 (28%), Positives = 72/163 (44%), Gaps = 18/163 (11%)

Query: 106 YESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL 165
           ++  I  V +  ++ H + ++  GC L      LV E    G+  D +    + H +PL 
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQ 113

Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF-SLSISIPEGE 224
                 +    +  LAYLH      ++ R+ K   IL +E  + KL DF S SI  P   
Sbjct: 114 EVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167

Query: 225 THITDTVMGTWGYCAPEY---MRTGVFNEKSDVFSFGVFLFEL 264
               +  +GT  + APE    M  G ++ K DV+S G+   EL
Sbjct: 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--IT 228
           KI++ ++  L YL       I+ R+ K S IL N     KL DF +S     G+    + 
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           ++ +GT  Y +PE ++   +  +SD++S G+ L E+  G
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 46.8 bits (111), Expect = 6e-06
 Identities = 36/169 (21%), Positives = 73/169 (43%), Gaps = 18/169 (10%)

Query: 106 YESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL 165
            E+    +   AR++H HI++++G   E     L  E +  G++   +L       E ++
Sbjct: 47  VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVI 105

Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSISIPEGE 224
           + +  ++    +  L+YLH      I+ R+ K + +L +      ++ DF  +  +    
Sbjct: 106 INYTEQL----LRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL---A 155

Query: 225 THITDT------VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
              T        ++GT  + APE +R   +    DV+S G  + E+ T 
Sbjct: 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 6/101 (5%)

Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETH 226
           H +  A +I   L +LH    + I++R+ K   ++ + E   K+ DF +   ++ +G T 
Sbjct: 102 HAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT- 157

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            T T  GT  Y APE +    + +  D ++FGV L+E+L G
Sbjct: 158 -TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 33/112 (29%), Positives = 54/112 (48%), Gaps = 16/112 (14%)

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI- 220
           EPL L+  +  +  +   + +L     R  + R+     IL +E NV K+ DF L+  I 
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224

Query: 221 --PE----GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             P+    G+  +    M      APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 225 KDPDYVRKGDARLPLKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
           ++V A  YLH    + I++R+ K   +L + +   K+ DF  +  +P+     T T+ GT
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGT 178

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE +++    +  D ++ GV L+E + G+
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY 212

Length = 329

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 62/247 (25%), Positives = 105/247 (42%), Gaps = 52/247 (21%)

Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPL---LLKHRLKIA-- 173
           SH ++L L+G CL +   P++V   +++G L + I         P    L+   L++A  
Sbjct: 54  SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKG 110

Query: 174 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---THITDT 230
           M+ + +  ++H    R +  RN    C+L +E    K+ DF L+  I + E    H    
Sbjct: 111 MEYLASKKFVH----RDLAARN----CML-DESFTVKVADFGLARDIYDKEYYSVHNHTG 161

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW-----DVSDLVKDTHDLACPSN 285
                 + A E ++T  F  KSDV+SFGV L+EL+T       DV     D+ D+     
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDIT---- 212

Query: 286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK 345
                Y    R   ++ P    D L            ++   C    P  RP+  ++  +
Sbjct: 213 ----VYLLQGR--RLLQPEYCPDPLY-----------EVMLSCWHPKPEMRPTFSELVSR 255

Query: 346 LRQIYRS 352
           + QI+ +
Sbjct: 256 IEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 5/97 (5%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++  L YLH  F   I+ R+ K S +L  ++   K+ DF L+ +       +T  V
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 232 MGTWGYCAPEYM-RTGVFNEKSDVFSFGVFLFELLTG 267
           +  W Y APE +     +    D+++ G  L ELL  
Sbjct: 170 VTLW-YRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 12/149 (8%)

Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
           H  I++  GC L     + +F E +  G++ D++       +  L      K    I+  
Sbjct: 63  HERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEG 116

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTWGY 237
           + YLH      IV R+ K + IL +     KL DF  S  +    +  T   +V GT  +
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            +PE +    +  K+DV+S G  + E+LT
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 7/95 (7%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A  +V AL YLH      IV+R+ K   +L + +   K+ DF  +  +       T T+ 
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLC 159

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE + +  + +  D ++ G+ ++E+L G
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 4/95 (4%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +IV  L +LH    + I++R+ K   ++ + +   K+ DF +      G+   + T  
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS-TFC 157

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE ++   +    D +SFGV L+E+L G
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 60/257 (23%), Positives = 95/257 (36%), Gaps = 55/257 (21%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYG--TLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           +SH  I+ LI          +V    +    T  DR          PL L+  + I   +
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS--------GPLPLEQAITIQRRL 194

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV----- 231
           + ALAYLH    R I+ R+ KT  I  +E   A L DF  +  +        DT      
Sbjct: 195 LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH----PDTPQCYGW 247

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELL-------------TGWDVSDLVK--D 276
            GT    +PE +    +  K+D++S G+ LFE+              +   +  +++   
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307

Query: 277 THDLACPSNE------YLKNYFEDNRFTEIVDPIIVEDVLSIEKE----------QQLHA 320
            H L  P N       + K Y    R    + P+I +  + ++ E          Q+   
Sbjct: 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367

Query: 321 SAQ--LSFECIKDSPAD 335
           SAQ  LS       P +
Sbjct: 368 SAQDILSLPLFTKEPIN 384

Length = 392

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 24/162 (14%)

Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I  V +  ++ H + ++  GC L      LV E    G+  D +    + H +PL     
Sbjct: 63  IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDIL----EVHKKPL---QE 114

Query: 170 LKIA---MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF-SLSISIPEGET 225
           ++IA      +  LAYLH       + R+ K   IL  E    KL DF S S+  P    
Sbjct: 115 VEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167

Query: 226 HITDTVMGTWGYCAPEY---MRTGVFNEKSDVFSFGVFLFEL 264
              ++ +GT  + APE    M  G ++ K DV+S G+   EL
Sbjct: 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 38/165 (23%), Positives = 75/165 (45%), Gaps = 13/165 (7%)

Query: 104 RAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF-- 161
           +A + C+  +    +++H +++K +   +E     +V E    G L   I      +F  
Sbjct: 44  KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK-----YFKK 98

Query: 162 EPLLLKHRL--KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
           +  L+  R   K  + +  A+ ++H    R ++ R+ K + +      V KL D  L   
Sbjct: 99  QKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-R 154

Query: 220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
               +T    +++GT  Y +PE +    +N KSD++S G  L+E+
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 5/95 (5%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I   L  LH      IV+R+ K   IL ++    ++ D  L++ IPEGET I   V 
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV- 162

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++   +    D +  G  ++E++ G
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 8/102 (7%)

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHI 227
           +  IA ++V AL +LH      IV+R+ K   IL +      L DF LS  ++ + +T  
Sbjct: 99  KFYIA-ELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152

Query: 228 TDTVMGTWGYCAPE-YMRTGVFNEKSDVFSFGVFLFELLTGW 268
           T+T  GT  Y APE  +    + +  D +S GV +FE+  GW
Sbjct: 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW 194

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 13/165 (7%)

Query: 104 RAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF-- 161
           +A   CI  +    +++H +++K     +E     +V E    G L   I      HF  
Sbjct: 44  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKK 98

Query: 162 EPLLLKHRL--KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
           +  L+  +   K  + +  AL ++H    R ++ R+ K + +      V KL D  L   
Sbjct: 99  QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-R 154

Query: 220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
               +T    +++GT  Y +PE +    +N KSD++S G  L+E+
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 11/152 (7%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H +I+ L           LVFE V+   L   +L A      P  ++        ++
Sbjct: 56  QLRHENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVR---SYIWQLL 110

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTWG 236
            A+AY H      I+ R+ K   IL +E  V KL DF  + ++     + +TD V   W 
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW- 166

Query: 237 YCAPEYMRTGVFNEKS-DVFSFGVFLFELLTG 267
           Y APE +       K  DV++ G  + ELL G
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 8/98 (8%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           +   ++V  +  LH    R I+ R+ K   +L ++    KL DF LS +           
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKK 152

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            +GT  Y APE +     ++ SD +S G  +FE L G+
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGY 190

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 6/96 (6%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
           A +I   L +LH    R I++R+ K   ++ + E   K+ DF +    + +G T  T T 
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTF 161

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    + +  D +++GV L+E+L G
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 4/95 (4%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A ++  A+ YLH      I++R+ K   IL + +    L DF L     E E   T T  
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFC 157

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +R   ++   D +  G  L+E+L G
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 16/157 (10%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQ-YGTLWD-----RILGAPQPHFEPLLLKHRL-K 171
           +SH +IL ++  C+E   P  V      +G L       R+  A  P     L   +L  
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ---ALSTQQLVH 121

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKT-SCILFNEENVAKLFDFSLSISIPEGETH-ITD 229
           +A+ I   ++YLH    R ++ ++    +C++  E  V K+ D +LS  +   + H + D
Sbjct: 122 MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQV-KITDNALSRDLFPMDYHCLGD 177

Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                  + A E +    ++  SDV+SFGV L+EL+T
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 5/94 (5%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGETHITDTVMG 233
           +IV AL YLH    + +V+R+ K   ++ +++   K+ DF L    I +G T    T  G
Sbjct: 103 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCG 158

Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y APE +    +    D +  GV ++E++ G
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 32/95 (33%), Positives = 44/95 (46%), Gaps = 4/95 (4%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I  AL YLH      I++R+ K   IL + +    L DF L     E     T T  
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTFC 157

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +R   ++   D +  G  L+E+L G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 19/154 (12%)

Query: 119 MSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM--- 174
           + H +I++ +G    E  + I + E V  G+L  ++L       EP+       I +   
Sbjct: 59  LQHPNIVQYLGTEREEDNLYIFL-ELVPGGSL-AKLLKKYGSFPEPV-------IRLYTR 109

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
            I+  L YLH    R  V R+ K + IL +   V KL DF ++  + E       +  G+
Sbjct: 110 QILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGS 164

Query: 235 WGYCAPEY-MRTGVFNEKSDVFSFGVFLFELLTG 267
             + APE   + G +   +D++S G  + E+ TG
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 4/105 (3%)

Query: 163 PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 222
           PL   +   I  +I+  L YLH       + R+ K + +L +E+   KL DF ++  + +
Sbjct: 97  PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153

Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +    +T +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 154 TQIK-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 14/98 (14%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD----- 229
           +IV AL YLH G    IV+R+ K   ++ +++   K+ DF L     EG   ITD     
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC---KEG---ITDAATMK 153

Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGETHITDTV 231
           A +I  AL YLH      IV+R+ K   IL + +    L DF L    I + +T  T T 
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTF 156

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +R   ++   D +  G  L+E+L G
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 17/153 (11%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
           +H +I+ L+G C      +++ E   YG L +  L   +  F  L L+  L  +  +   
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLN-FLRRKRESF--LTLEDLLSFSYQVAKG 153

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT----- 234
           +A+L     +  + R+     +L     + K+ DF L+  I     ++   V G      
Sbjct: 154 MAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207

Query: 235 -WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            W   APE +   V+  +SDV+S+G+ L+E+ +
Sbjct: 208 KW--MAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 20/162 (12%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLL 165
           +R+S  +I +L+G C   P   ++ E ++ G L                 +    F   L
Sbjct: 74  SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS-TL 132

Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
           L    +IA  + + L  L+F      V R+  T   L  +    K+ DF +S ++   + 
Sbjct: 133 LYMATQIASGMRY-LESLNF------VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 226 H-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +         + A E +  G F  KSDV++FGV L+E+LT
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 17/105 (16%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           KIA+  V AL YL       I+ R+ K S IL +     KL DF +S         + D+
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDS 161

Query: 231 V-----MGTWGYCAPEYMRTGV---FNEKSDVFSFGVFLFELLTG 267
           +      G   Y APE +       ++ +SDV+S G+ L+E+ TG
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMG 233
           +IV AL YLH      +V+R+ K   ++ +++   K+ DF L    I +G T    T  G
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 157

Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y APE +    +    D +  GV ++E++ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGETHITDTVMG 233
           +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T    T  G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 157

Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y APE +    +    D +  GV ++E++ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 6/96 (6%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
           A ++  AL +LH      +++R+ K   IL + E   KL DF +    I  G T  T T 
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTF 156

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE ++   +    D ++ GV ++E++ G
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 16/151 (10%)

Query: 118 RMSHNHILKLIGCCLETPIPILV---FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM 174
            ++H  ++++    +   I  +V   + S  Y  L  R          PL +   L I  
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS--------RPLPIDQALIIEK 164

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
            I+  L YLH    + I+ R+ KT  I  N+ +   + D   +   P         + GT
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLG-LAGT 219

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELL 265
               APE +    +N K+D++S G+ LFE+L
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 4/96 (4%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  +I+  L YLH       + R+ K + +L +E    KL DF ++  + + +    +T 
Sbjct: 106 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTF 161

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 30/123 (24%), Positives = 47/123 (38%), Gaps = 37/123 (30%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG--------- 223
           A+D VH L ++H         R+ K   IL + +   KL DF L   + +          
Sbjct: 113 ALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 224 -------------------ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
                                   ++ +GT  Y APE +R   +  + D +S GV L+E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 265 LTG 267
           L G
Sbjct: 224 LYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 4/95 (4%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I  AL YLH      IV+R+ K   IL + +    L DF L     E     T T  
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFC 157

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +    ++   D +  G  L+E+L G
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 9/91 (9%)

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYC 238
           AL +LH      ++ R+ K   IL   +   KL DF +S +  +      DT +GT  + 
Sbjct: 115 ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQKRDTFIGTPYWM 170

Query: 239 APEYMRTGVF-----NEKSDVFSFGVFLFEL 264
           APE +    F     + K+D++S G+ L EL
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 43.2 bits (101), Expect = 1e-04
 Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 6/97 (6%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDT 230
           +  + + AL +LH      ++ R+ K+  +L   +   KL DF     I PE       T
Sbjct: 120 VCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--ST 174

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           ++GT  + APE +    +  K D++S G+   E++ G
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 47/179 (26%), Positives = 71/179 (39%), Gaps = 27/179 (15%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A++  H    +H         R+ K   IL  ++   KL DF  +  +       TD V 
Sbjct: 112 AVNFCHKHNCIH---------RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA 162

Query: 233 GTWGYCAPEYMRTG--VFNEKSDVFSFGVFLFELLTG---W----DVSDLVKDTHDLA-- 281
             W Y APE +  G   +    DV++ G    ELLTG   W    DV  L      L   
Sbjct: 163 TRW-YRAPELL-VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL 220

Query: 282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSF--ECIKDSPADRPS 338
            P ++ +   F  N+F + +     E    +E +    +S  LSF   C++  P +R S
Sbjct: 221 IPRHQQI---FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 14/101 (13%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           IA+D VH L Y+H         R+ K   IL +     +L DF   + + E  T  +   
Sbjct: 113 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163

Query: 232 MGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE ++      G +  + D +S GV ++E+L G
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 24/96 (25%), Positives = 50/96 (52%), Gaps = 4/96 (4%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+YLH    + ++ R+ K+  IL   +   KL DF     + + E     ++
Sbjct: 123 VCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSL 178

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 42/155 (27%), Positives = 61/155 (39%), Gaps = 16/155 (10%)

Query: 116 AARMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM 174
           A    H  ++ L   C +T   +  V E    G L   I      H +       +  A 
Sbjct: 56  ANSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHI------HTDVFSEPRAVFYAA 108

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVM 232
            +V  L YLH      IV+R+ K   +L + E   K+ DF L     EG      T T  
Sbjct: 109 CVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFC 162

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  + APE +    +    D +  GV ++E+L G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 1/85 (1%)

Query: 183 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD-TVMGTWGYCAPE 241
           + F   R  + R+     IL +E NV K+ DF L+  I +   ++   +      + APE
Sbjct: 187 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246

Query: 242 YMRTGVFNEKSDVFSFGVFLFELLT 266
            +   V+  +SDV+SFGV L+E+ +
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 6/107 (5%)

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           + L L+  +  +  +   + +L     R  + R+     IL +E NV K+ DF L+  I 
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230

Query: 222 EGETHIT--DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           +   ++   D  +    + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 231 KDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+    +    +T  V   W
Sbjct: 129 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRW 182

Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 183 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 25/179 (13%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H++I++L G        ++V E +  G L D  L   + H   L+    + +   +   +
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFL---RKHEGQLVAGQLMGMLPGLASGM 120

Query: 181 AYL-HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG--- 236
            YL   G+    V +      +L N + V K+  F     + E ++    T M       
Sbjct: 121 KYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVL 173

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-----GWDVS--DLVKDTHD---LACPSN 285
           + APE ++   F+  SDV+SFG+ ++E+++      WD+S  D++K   D   L  P N
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRN 232

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 14/130 (10%)

Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LV +  + G LW  I      +     +K   + A ++V AL  LH      IV R+   
Sbjct: 62  LVLQHAEGGKLWSHIS--KFLNIPEECVK---RWAAEMVVALDALH---REGIVCRDLNP 113

Query: 199 SCILFNEENVAKLFDFSLSISI-PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
           + IL ++    +L  FS    +    +    + +     YCAPE        E  D +S 
Sbjct: 114 NNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSL 168

Query: 258 GVFLFELLTG 267
           G  LFELLTG
Sbjct: 169 GAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 9/101 (8%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A  I+  +AYLH    R IV R+ K S +L N     K+ DF +S  + +       +V
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229

Query: 232 MGTWGYCAPEYMRTGVFNEK-----SDVFSFGVFLFELLTG 267
            GT  Y +PE + T + +        D++S GV + E   G
Sbjct: 230 -GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269

Length = 353

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 6/94 (6%)

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDTVMG 233
           + + AL +LH      ++ R+ K+  IL   +   KL DF     I PE       T++G
Sbjct: 123 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVG 177

Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  + APE +    +  K D++S G+   E++ G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 31/165 (18%)

Query: 182 YLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPE 241
           Y+H    R I+ R+ K   I F + N+ K+ DF +S  +  G   +  T  GT  Y +PE
Sbjct: 121 YMH---QRRILHRDLKAKNI-FLKNNLLKIGDFGVS-RLLMGSCDLATTFTGTPYYMSPE 175

Query: 242 YMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV 301
            ++   ++ KSD++S G  L+E                + C     L + FE   F  +V
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYE----------------MCC-----LAHAFEGQNFLSVV 214

Query: 302 DPIIVEDVLSIEK--EQQLHASAQLSFECIKDSPADRPSMVDVAK 344
             I+     S+ +   +QL++  Q      KD P+ RPS  ++ +
Sbjct: 215 LRIVEGPTPSLPETYSRQLNSIMQSMLN--KD-PSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 6/97 (6%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDT 230
           +  + + AL +LH      ++ R+ K+  IL   +   KL DF     I PE       T
Sbjct: 120 VCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--ST 174

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           ++GT  + APE +    +  K D++S G+   E++ G
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 9/98 (9%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD---TVM 232
           ++  LAYLH      IV R+ K + I  +   V KL DF  ++ +    T + +   ++ 
Sbjct: 108 LLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Query: 233 GTWGYCAPEYMRTGVFNEK---SDVFSFGVFLFELLTG 267
           GT  Y APE +  G        +D++S G  + E+ TG
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 4/96 (4%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +  + + AL +LH      ++ R+ K+  IL   +   KL DF     I   ++  +  V
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  + APE +    +  K D++S G+   E++ G
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 23/96 (23%), Positives = 49/96 (51%), Gaps = 4/96 (4%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+ LH    + ++ R+ K+  IL   +   KL DF     + + E     ++
Sbjct: 121 VCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSL 176

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 27/101 (26%), Positives = 49/101 (48%), Gaps = 14/101 (13%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D VH L Y+H         R+ K   +L ++    +L DF   + +    T  ++  
Sbjct: 113 LAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163

Query: 232 MGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE ++      G +  + D +S GV ++E+L G
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 26/166 (15%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK-IA--MDIV 177
           H +I+ L G   ++   +++ E ++ G L D  L      F  + L   L+ IA  M  +
Sbjct: 64  HPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG- 236
             + Y+H    R +  RN     IL N   V K+ DF LS  + +  +  T T   + G 
Sbjct: 123 SEMNYVH----RDLAARN-----ILVNSNLVCKVSDFGLSRFLEDDTSDPTYT--SSLGG 171

Query: 237 -----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-----GWDVSD 272
                + APE +    F   SDV+S+G+ ++E+++      WD+S+
Sbjct: 172 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 34/149 (22%), Positives = 71/149 (47%), Gaps = 9/149 (6%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H +I++L+G C    +  LV +    G+L D +    + H + L  +  L   + I  
Sbjct: 66  LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHV----RQHRDSLDPQRLLNWCVQIAK 120

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGTWGY 237
            + YL       +V RN     IL   +++ ++ DF ++ +  P+ + +          +
Sbjct: 121 GMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177

Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            A E +  G +  +SDV+S+GV ++E+++
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 10/99 (10%)

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            L  A++ +H            +++R+ K   IL + +    L DF L   +   +   T
Sbjct: 101 ELLCALENLHKFN---------VIYRDLKPENILLDYQGHIALCDFGLC-KLNMKDDDKT 150

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +T  GT  Y APE +    + +  D ++ GV L+E+LTG
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 13/96 (13%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A+D +H L Y+H         R+ K    L +     KL DF LS  I        ++V+
Sbjct: 113 AVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVV 159

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           G+  Y APE +R   ++   D +S G  L+E L G+
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGF 195

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 24/92 (26%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++ AL YLH    + ++ R+ K+  IL   +   KL DF     I + +     +++GT 
Sbjct: 126 VLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTP 181

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            + APE +    +  + D++S G+ + E++ G
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 57/257 (22%), Positives = 98/257 (38%), Gaps = 63/257 (24%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLL 165
           A + H +I+ L+G   +     ++FE +  G L + ++    PH +              
Sbjct: 62  AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLI-MRSPHSDVGCSSDEDGTVKSS 120

Query: 166 LKHR--LKIAMDIVHALAYL--HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           L H   L IA+ I   + YL  HF   + +  RN     IL  E+   K+ D  LS  I 
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN-----ILIGEQLHVKISDLGLSREIY 175

Query: 222 EGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDV 270
             + + +    +    +  PE +  G F+  SD++SFGV L+E+           +  +V
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235

Query: 271 SDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIK 330
            ++V+    L C  +   + Y                                L  EC +
Sbjct: 236 IEMVRKRQLLPCSEDCPPRMY-------------------------------SLMTECWQ 264

Query: 331 DSPADRPSMVDVAKKLR 347
           + P+ RP   D+  +LR
Sbjct: 265 EGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 29/161 (18%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK--HRLK--- 171
           A  +H +I+KL+G           ++    G LW  I   P    + ++L+    L    
Sbjct: 64  ATCNHPYIVKLLGA--------FYWD----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQ 111

Query: 172 ---IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
              I   ++ AL YLH      I+ R+ K   +L   +   KL DF +S    +      
Sbjct: 112 IQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK-TLQRR 167

Query: 229 DTVMGTWGYCAPEY-----MRTGVFNEKSDVFSFGVFLFEL 264
           D+ +GT  + APE      M+   ++ K+D++S G+ L E+
Sbjct: 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 26/185 (14%)

Query: 102 RPRAYESCINN----VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL--- 154
           RP A ++  N+    V   +R+   +I++L+G C++     ++ E ++ G L ++ L   
Sbjct: 55  RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSH 113

Query: 155 -----------GAPQPHFEPLL-LKHRLKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCI 201
                        P  H  P +     L +A+ I   + YL    F    V R+  T   
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF----VHRDLATRNC 169

Query: 202 LFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVF 260
           L  E    K+ DF +S ++  G+ + I    +    + A E +  G F   SDV++FGV 
Sbjct: 170 LVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229

Query: 261 LFELL 265
           L+E+L
Sbjct: 230 LWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 40.1 bits (94), Expect = 9e-04
 Identities = 23/92 (25%), Positives = 48/92 (52%), Gaps = 4/92 (4%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++ AL++LH    + ++ R+ K+  IL   +   KL DF     + + E     +++GT 
Sbjct: 124 VLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTP 179

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            + APE +    +  + D++S G+ + E++ G
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 22/77 (28%), Positives = 43/77 (55%), Gaps = 4/77 (5%)

Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNE 250
           IV+R+ K   +L +++   K+ DF  +  + +  T+   T+ GT  Y APE +      +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTY---TLCGTPEYIAPEILLNVGHGK 207

Query: 251 KSDVFSFGVFLFELLTG 267
            +D ++ G+F++E+L G
Sbjct: 208 AADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 40/213 (18%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK-IA-- 173
            +  H +I+ L G   ++   ++V E ++ G+L D  L      F  + L   L+ IA  
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASG 118

Query: 174 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 233
           M  +  + Y+H    R +  RN     IL N   V K+ DF LS  + +       T  G
Sbjct: 119 MKYLSDMGYVH----RDLAARN-----ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169

Query: 234 T----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-----GWDVS--DLVKDTHD--- 279
                W   APE +    F   SDV+S+G+ ++E+++      W++S  D++K   +   
Sbjct: 170 KIPIRW--TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR 227

Query: 280 ----LACPSNEYL-------KNYFEDNRFTEIV 301
               + CP+  +        K+  E  +F +IV
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 39.8 bits (94), Expect = 0.001
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 14/152 (9%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
            H +I+KL     E      VFE ++ G L+  +       F   +++    I   I+  
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRS---IIYQILQG 111

Query: 180 LAYLH-FGFPRPIVF-RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
           LA++H  GF     F R+ K   +L +   V K+ DF L+  I     + TD V   W Y
Sbjct: 112 LAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYVSTRW-Y 164

Query: 238 CAPE-YMRTGVFNEKSDVFSFGVFLFELLTGW 268
            APE  +R+  ++   D+++ G  + EL T  
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.5 bits (94), Expect = 0.001
 Identities = 33/119 (27%), Positives = 55/119 (46%), Gaps = 25/119 (21%)

Query: 172 IAMDIVHALAYLHFGFPRP----IVFRNFKTSCILF-----------------NEENVAK 210
           I   ++HALAY H     P    ++ R+ K   I                   N   +AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYM--RTGVFNEKSDVFSFGVFLFELLTG 267
           + DF LS +I  G   +  + +GT  Y +PE +   T  +++KSD+++ G  ++EL +G
Sbjct: 183 IGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Length = 1021

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 39.5 bits (93), Expect = 0.001
 Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 15/96 (15%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
            +  L YLH  +   I+ R+ K + +L   + V KL DF L+ S       +T  V+  W
Sbjct: 111 TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW 167

Query: 236 GYCAPE------YMRTGVFNEKSDVFSFGVFLFELL 265
            Y APE      +   GV     D++S G    ELL
Sbjct: 168 -YRAPELLFGARHYGVGV-----DMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 2/98 (2%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG-ETHITD 229
           K+   I   +  +H+     IV R+ K   +L +  +V KL DF  + ++ EG   + T+
Sbjct: 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160

Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            V   W Y +PE +    + +  D++S G  L EL  G
Sbjct: 161 YVATRW-YRSPELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 8/93 (8%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      +V R+ K S IL NE    K+ DF L+      +  +T  V  T 
Sbjct: 117 ILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYV-STR 169

Query: 236 GYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTG 267
            Y APE M T   ++ + D++S G    E+L G
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 39.1 bits (92), Expect = 0.002
 Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 16/122 (13%)

Query: 152 RILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL 211
           +++ +PQP    L   H       I+  L YLH      ++ R+ K S IL N     K+
Sbjct: 92  KVIKSPQP----LTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKI 144

Query: 212 FDFSLSISI---PEGETHITDTVMGTWGYCAPEYMRTGVFNEKS---DVFSFGVFLFELL 265
            DF L+  +    + +  +T+ V+  W Y APE +     +  +   D++S G    ELL
Sbjct: 145 CDFGLARGVDPDEDEKGFLTEYVVTRW-YRAPELL--LSSSRYTKAIDIWSVGCIFAELL 201

Query: 266 TG 267
           T 
Sbjct: 202 TR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 39.1 bits (92), Expect = 0.002
 Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 20/111 (18%)

Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH- 226
           H+  I   ++ AL Y+H G    ++ R+ K S IL N +   KL DF L+ S+ E E + 
Sbjct: 108 HKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164

Query: 227 ----ITDTVMGTWGYCAPE------YMRTGVFNEKSDVFSFGVFLFELLTG 267
               +TD V   W Y APE          GV     D++S G  L E+L G
Sbjct: 165 ENPVLTDYVATRW-YRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 39.2 bits (92), Expect = 0.002
 Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 8/96 (8%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVM 232
           I+  L Y+H      ++ R+ K S +L N     K+ DF L+        H   +T+ V 
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 233 GTWGYCAPEYMRTGVFNEKS-DVFSFGVFLFELLTG 267
             W Y APE M       K+ D++S G  L E+L+ 
Sbjct: 172 TRW-YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 15/122 (12%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L Y+H      I+ R+ K S +  NE+   ++ DF L+    + +  +T  V   W
Sbjct: 127 LLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRW 180

Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGW------DVSDLVKDTHDLA-CPSNEY 287
            Y APE M   + +N+  D++S G  + ELL G       D  D +K   ++   PS E 
Sbjct: 181 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 288 LK 289
           LK
Sbjct: 240 LK 241

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 38.7 bits (91), Expect = 0.003
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 5/90 (5%)

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYC 238
            +A+LH      I+ R+ KTS +L N   + K+ DF L+          T  V+  W Y 
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW-YR 173

Query: 239 APE-YMRTGVFNEKSDVFSFGVFLFELLTG 267
           APE  +    ++   D++S G    ELLT 
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (90), Expect = 0.003
 Identities = 30/103 (29%), Positives = 46/103 (44%), Gaps = 13/103 (12%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITD 229
           I  + +  LAYLH      ++ R+ K   IL  +    KL DF +S  +    G  +   
Sbjct: 118 ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN--- 171

Query: 230 TVMGTWGYCAPE-----YMRTGVFNEKSDVFSFGVFLFELLTG 267
           T +GT  + APE           ++ +SDV+S G+   EL  G
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 30/127 (23%), Positives = 54/127 (42%), Gaps = 20/127 (15%)

Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL---FNEENV----A 209
            +   E   +   L I   I   + Y+H    + ++ R+ K   IL   F E  +    A
Sbjct: 103 SKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGA 159

Query: 210 KLF-----DFSLSISIP-EGETHITDTVMG----TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            +F     +  L I +      + + T+ G    T  Y APE +     +E +D+++ GV
Sbjct: 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219

Query: 260 FLFELLT 266
            L+++LT
Sbjct: 220 ILYQMLT 226

Length = 932

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 38.4 bits (90), Expect = 0.004
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 31/213 (14%)

Query: 95  QFYGHECRPRAYES--CINNVT--YAARM--SHNHILKLIGCCLETPIP--ILVFESVQY 146
           ++Y  +C  + ++S   +NN+    A R    H +IL+LI    +       LVFE +  
Sbjct: 25  KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD- 83

Query: 147 GTLWDRILGAPQPHFEPLLLKHRLKIAM-DIVHALAYLHFGFPRPIVF-RNFKTSCILFN 204
             L++ I G  +P     L + R+K  M  ++ +L ++H    R  +F R+ K   IL  
Sbjct: 84  MNLYELIKGRKRP-----LPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIK 134

Query: 205 EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFE 263
           ++ + KL DF     I     + T+ +   W Y APE + T G +  K D+++ G   FE
Sbjct: 135 DDIL-KLADFGSCRGIYSKPPY-TEYISTRW-YRAPECLLTDGYYGPKMDIWAVGCVFFE 191

Query: 264 LLT------GWDVSDLVKDTHD-LACPSNEYLK 289
           +L+      G +  D +   HD L  P  E LK
Sbjct: 192 ILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 38.4 bits (90), Expect = 0.004
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S I  NE+   K+ DF L+      +  +T  V   W
Sbjct: 127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVATRW 180

Query: 236 GYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTG 267
            Y APE M     +N+  D++S G  + ELLTG
Sbjct: 181 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 38/167 (22%), Positives = 71/167 (42%), Gaps = 33/167 (19%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTL-------WDRILGAPQPHFEPLLLKHRLK 171
           ++H ++L+ +G C+E+   +LV E    G L          +    Q     +L +   +
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD---VLQRMACE 108

Query: 172 IAMDI--VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +A  +  +H   ++H         RN    C L  + +V K+ D+ L++     + +IT 
Sbjct: 109 VASGLLWLHQADFIHSDL----ALRN----CQLTADLSV-KIGDYGLALEQYPEDYYITK 159

Query: 230 ---TVMGTWGYCAPEYM-------RTGVFNEKSDVFSFGVFLFELLT 266
               V   W   APE +             +KS+++S GV ++EL T
Sbjct: 160 DCHAVPLRW--LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 50/203 (24%), Positives = 78/203 (38%), Gaps = 35/203 (17%)

Query: 82  YKGFWQERLISVLQFYGHECR---------PRAYESCINNVTYAARMSHNHILKLIGCCL 132
           YKG  + +    +   G E            R   +     +  +++SH H++KL G C+
Sbjct: 12  YKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCV 71

Query: 133 ETPIPILVFESVQYGTL--WDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 190
                I+V E V++G L  +               L  +L +A  +  AL YL     + 
Sbjct: 72  RDE-NIMVEEYVKFGPLDVFLHREKNNVS------LHWKLDVAKQLASALHYLE---DKK 121

Query: 191 IVFRNFKTSCILF-----NEENV--AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM 243
           +V  N     IL      NE  V   KL D  + I++   E  +       W   APE +
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI---PW--IAPECI 176

Query: 244 RTGVFNEKS--DVFSFGVFLFEL 264
           R G  +     D +SFG  L E+
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	353
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
smart00090	237	RIO RIO-like kinase.	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
KOG1243	690	consensus Protein kinase [General function predict	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.45
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.33
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.14
COG4248	637	Uncharacterized protein with protein kinase and he	99.12
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.89
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.86
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.77
PRK09902	216	hypothetical protein; Provisional	98.76
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.56
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.54
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.48
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.42
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.33
PF01636	239	APH: Phosphotransferase enzyme family This family	98.27
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.24
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.18
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.15
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.1
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.09
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.07
PRK10593	297	hypothetical protein; Provisional	97.92
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.83
PRK05231	319	homoserine kinase; Provisional	97.81
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.75
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.66
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.62
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.55
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.45
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.45
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.27
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.25
KOG2270	520	consensus Serine/threonine protein kinase involved	96.94
PLN02236	344	choline kinase	96.91
PLN02756	418	S-methyl-5-thioribose kinase	96.9
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.81
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.69
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.61
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.61
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.6
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.27
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.11
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.95
COG2334	331	Putative homoserine kinase type II (protein kinase	95.51
PRK11768	325	serine/threonine protein kinase; Provisional	95.47
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.45
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.45
PRK12396	409	5-methylribose kinase; Reviewed	95.43
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	93.73
PTZ00384	383	choline kinase; Provisional	93.72
PHA03111	444	Ser/Thr kinase; Provisional	93.58

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-58  Score=424.51  Aligned_cols=288  Identities=38%  Similarity=0.627  Sum_probs=249.3

Q ss_pred             CcceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceee
Q 018633           48 PYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILK  126 (353)
Q Consensus        48 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~  126 (353)
                      +.+.|+++|+..+|++|+..++||+||||   .||+|.. ++..||||++.......  ..+|.+|+.++.+++|||+|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg---~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~  135 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFG---TVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVK  135 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCe---EEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCccc
Confidence            67889999999999999999999999999   9999999 55899999887663211  455999999999999999999


Q ss_pred             ccceeeeCC-ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          127 LIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       127 ~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      ++|||.+.+ +.+||+|||++|||.++|......   +++|.++++|+.++|+||+|||+.+...||||||||+|||+|+
T Consensus       136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~  212 (361)
T KOG1187|consen  136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE  212 (361)
T ss_pred             EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence            999999998 599999999999999999886531   7899999999999999999999887778999999999999999


Q ss_pred             CCceEEeccCCccccCC-CCCcccccc-ccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCC
Q 018633          206 ENVAKLFDFSLSISIPE-GETHITDTV-MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACP  283 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~  283 (353)
                      ++.+||+|||+|+..+. ...  .... .||.+|+|||+...+..+.++||||||+++.|++||+.+.+......  ...
T Consensus       213 ~~~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~--~~~  288 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG--ELS  288 (361)
T ss_pred             CCCEEccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc--ccc
Confidence            99999999999976644 221  2222 79999999999999999999999999999999999998887544222  234


Q ss_pred             hHHHHHHHhhcCcccccccchhhh-ccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVE-DVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      +..|.+..+....+.+++|+.+.. .....   .....+..++..|++.+|..||+|.+|++.|+.+.
T Consensus       289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~---~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDE---KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHHHHHCcchhheeCCCccCCCCChH---HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            788888888888999999999873 33211   45667899999999999999999999999997664

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-54  Score=393.98  Aligned_cols=258  Identities=26%  Similarity=0.398  Sum_probs=214.3

Q ss_pred             cCCCCceeeCCCCCccEEEEEEeCCeE-EEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-ccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFWQERL-ISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-IPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~lv~  141 (353)
                      ......||+|+||   +||+|.|.|.. ||||++..........+.|.+|+.+|.+++|||||+++|+|.+.. ..+|||
T Consensus        43 l~~~~~iG~G~~g---~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   43 LPIEEVLGSGSFG---TVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hhhhhhcccCCce---eEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            3444559999999   99999998888 999999877555555789999999999999999999999999887 799999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC-eEeeccCCCceeecCCC-ceEEeccCCccc
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP-IVFRNFKTSCILFNEEN-VAKLFDFSLSIS  219 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~dlkp~Nill~~~~-~~kl~dfg~a~~  219 (353)
                      ||+++|+|.+++.....   ..+++..++.|+.|||+||.|||   +++ ||||||||+|||++.++ ++||+|||+++.
T Consensus       120 Ey~~~GsL~~~l~~~~~---~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRK---RKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EeCCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999999999987411   57999999999999999999999   888 99999999999999998 999999999987


Q ss_pred             cCCCCCccccccccCCccccccccc--cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMR--TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ..... .......||+.|||||++.  ...|+.++||||||+++|||+||..||.....        .+.......... 
T Consensus       194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~~-  263 (362)
T KOG0192|consen  194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGGL-  263 (362)
T ss_pred             ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCC-
Confidence            64322 1223468999999999999  56899999999999999999999999984432        111112211111 


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                                  .+..+..++..+..|+..||+.||+.||++.+++..|+.+...
T Consensus       264 ------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  264 ------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             ------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence                        1111224777888999999999999999999999999988764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-54  Score=377.95  Aligned_cols=251  Identities=21%  Similarity=0.280  Sum_probs=213.5

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc-cEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI-PILV  140 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-~~lv  140 (353)
                      ....+.||+|..|   +||++.+  ++..+|+|.+... ..+...+++.+|+++++..+||+||.+||+|..++. ..|+
T Consensus        81 le~~~~lG~G~gG---~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   81 LERLGVLGSGNGG---TVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             hhhhhhcccCCCc---EEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            4455679999999   9999999  7999999999443 367778899999999999999999999999999985 9999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      ||||++|||.+++...     +.+++...-.|+.+|++||.|||.  .++||||||||+|||+++.|.+||+|||.+..+
T Consensus       157 mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             hhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            9999999999998765     468999999999999999999993  399999999999999999999999999999887


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..+   ..++..||..|||||.+.+..|+.++||||||++++|+++|+.|+.......                ..+.++
T Consensus       230 vnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~----------------~~~~~L  290 (364)
T KOG0581|consen  230 VNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY----------------LDIFEL  290 (364)
T ss_pred             hhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC----------------CCHHHH
Confidence            544   4678899999999999999999999999999999999999999987431111                122233


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ++.++.+..+......++.++.+++..||+.||.+|||+.++++
T Consensus       291 l~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  291 LCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            44444433333222248899999999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-54  Score=361.95  Aligned_cols=259  Identities=20%  Similarity=0.276  Sum_probs=217.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccc-eeeeCCc-c
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIG-CCLETPI-P  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~-~~~~~~~-~  137 (353)
                      .+|.+.+.||+|+||   .||++..  ++..||.|.+.-+.......+....|+.+|++|+|||||++++ .+.+++. +
T Consensus        19 ~~y~Il~~IG~GsFg---~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFG---EVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcch---heEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            457788899999999   8888887  9999999999877778888899999999999999999999999 4555555 8


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeecCCCceEEeccC
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      +||||||..|+|.+.++...... ..+++..+|+++.|++.||..+|+.. .+  |+||||||.||+++.+|.+||+|||
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccch
Confidence            99999999999999887554322 67899999999999999999999311 44  9999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +++.+.... ....+.+||+.||+||.+.+.+|+.+|||||+||++|||+.-++||...                     
T Consensus       174 L~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---------------------  231 (375)
T KOG0591|consen  174 LGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---------------------  231 (375)
T ss_pred             hHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---------------------
Confidence            999986544 3467789999999999999999999999999999999999999999843                     


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ++.++-.++..++.++.....++..+.+||..|+..||+.||+...++..+.
T Consensus       232 n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  232 NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            2222333344445554444589999999999999999999998555554443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-52  Score=384.83  Aligned_cols=248  Identities=21%  Similarity=0.310  Sum_probs=215.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ..|...++||+|||+   .||.+..  +|..||+|++.+.. ......+...+|+++.++|+|||||+++++|++.+..|
T Consensus        18 ~~Y~~g~~LGkGgFA---~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY   94 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFA---RCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY   94 (592)
T ss_pred             ceeeeeeeeccCcce---EEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence            458999999999999   9999998  89999999997643 24567788999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      ||.|+|+.++|..+++..     .++++.+++.++.||+.||.|||   +++|+|||||..|++++++.++||+|||+|.
T Consensus        95 ivLELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             EEEEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceee
Confidence            999999999999988854     57999999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .+..+ .....+.+||+.|.|||++.....+..+||||+||++|-|+.|++||...                     .+.
T Consensus       167 ~le~~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk---------------------~vk  224 (592)
T KOG0575|consen  167 QLEYD-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK---------------------TVK  224 (592)
T ss_pred             eecCc-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc---------------------hHH
Confidence            88543 23467889999999999999889999999999999999999999999832                     223


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.++.+...++..+.  ..+.+..+||.++|+.||.+|||+++|+.
T Consensus       225 ety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  225 ETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            333333333322221  56777889999999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-52  Score=379.06  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=212.2

Q ss_pred             CCCceeeCCCCCccEEEEEEeCCe-EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           66 QKNVIAKDTSYNLYTMYKGFWQER-LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        66 ~~~~lg~G~~g~~~~v~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      ..+.||+|.||   .||.|.|++. .||+|.+....   -..+.|.+|+.+|++|+|+|||+++|+|..+...|||||||
T Consensus       210 l~~~LG~G~FG---~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  210 LIRELGSGQFG---EVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHhcCCccc---eEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            34679999999   9999999666 99999998762   23467889999999999999999999999988999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      +.|+|.++|+....   ..+...+.+.++.|||+|++||+   ++++|||||.++|||++++..+||+|||+|+...++.
T Consensus       284 ~~GsLl~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  284 PKGSLLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             ccCcHHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999997433   56888999999999999999999   9999999999999999999999999999999665555


Q ss_pred             CccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      ........-+..|.|||.+..+.|+.+||||||||+||||+| |+.|+..        ....+.+...-++.+.      
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------msn~ev~~~le~GyRl------  423 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------MSNEEVLELLERGYRL------  423 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------CCHHHHHHHHhccCcC------
Confidence            444444445678999999999999999999999999999999 7777662        2222233322222221      


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                              +.|..|+..+.++|..||..+|++|||++.+...|+.+..
T Consensus       424 --------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  424 --------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             --------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence                    2233788999999999999999999999999999998865

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-51  Score=363.15  Aligned_cols=201  Identities=23%  Similarity=0.373  Sum_probs=185.5

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..++|...+.||+|+||   +||+|.+  ++..||||.+......+...+.+..|+.+|+.++|||||.+++++.+++..
T Consensus         8 ~~~~y~~~~~iG~Gsfa---vVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFA---VVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             ccccceehhhccCcceE---EEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            34678888889999999   9999999  789999999988766778888999999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC------CceEE
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE------NVAKL  211 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~------~~~kl  211 (353)
                      |+|||||.||+|.++++..     ..+++.+++.++.|+|.||++||   +++||||||||+|||++..      ..+||
T Consensus        85 ~lVMEyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence            9999999999999999887     46899999999999999999999   9999999999999999765      56899


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCc
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDL  273 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~  273 (353)
                      +|||+|+.+..+.  ...+.+|++.|||||++....|+.|+|+||+|+++|++++|+.||+.
T Consensus       157 ADFGfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  157 ADFGFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             cccchhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            9999999986433  36788999999999999999999999999999999999999999983

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-52  Score=367.73  Aligned_cols=252  Identities=19%  Similarity=0.280  Sum_probs=206.2

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChh-----HHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPR-----AYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      ..+.|-..+.||+|+||   .|-+|..  +++.||||++.+......     ......+|+++|++|+|||||+++++++
T Consensus       170 ~~d~yii~~~LGsGafg---~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFG---LVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE  246 (475)
T ss_pred             hcceeEeeeeecCCcee---EEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence            34567788999999999   9999988  899999999976642221     2233579999999999999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC---Cce
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE---NVA  209 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~  209 (353)
                      ..+..|+||||+.||.|.+++..+     ..+.+..-..++.|++.|+.|||   ++||+||||||+|||+..+   ..+
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEE
Confidence            999999999999999999999876     35677777889999999999999   9999999999999999766   789


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCC---CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV---FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      ||+|||+|+.....  ....+.+||+.|.|||++.+..   +..++|+||+||+||-+++|.+||.......        
T Consensus       319 KItDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--------  388 (475)
T KOG0615|consen  319 KITDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--------  388 (475)
T ss_pred             Eecccchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------
Confidence            99999999987533  3467899999999999997655   3348899999999999999999997322211        


Q ss_pred             HHHHHhhcCcccccccchhhhccch--HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLS--IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                  .+.+++..+.+..  ......+++..+||.+||..||++|||+.|+++
T Consensus       389 ------------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 ------------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ------------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                        1222223332221  122367888999999999999999999999875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-49  Score=337.70  Aligned_cols=266  Identities=20%  Similarity=0.274  Sum_probs=213.7

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      .|+...++|+|+||   .||++++  +|+.||||++......+...+-.++|+++|+++.|||+|.++++|.....+++|
T Consensus         3 kYE~LgkvGEGSYG---vV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYG---VVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             HHhhhhccccCcce---EEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            47777889999999   9999999  899999999987765666677789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +|||+. ++.+.|...+    ..++...+..++.|++.|+.|+|   ++++|||||||+|||+..+|.+||||||+|+.+
T Consensus        80 FE~~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eeecch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence            999984 7777777766    46889999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCC------CChHHHHHHHhh
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA------CPSNEYLKNYFE  293 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~  293 (353)
                      .. .....+.++.|..|+|||.+.+ ..|+.++||||+||++.||++|.+.|....+.+.+.      ..+.......|.
T Consensus       152 ~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  152 SA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             cC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            64 2233455678999999999988 569999999999999999999999998766544221      111112222222


Q ss_pred             cC------cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DN------RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+      ++++.-++   ....... +..+..+++++.+||+.||++|+|.++++.
T Consensus       231 ~N~~F~Gv~lP~~~~~---epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHP---EPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCc---cchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            22      22222111   1111111 145567899999999999999999998874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-49  Score=347.84  Aligned_cols=243  Identities=21%  Similarity=0.271  Sum_probs=204.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .+.|+..++||+|+||   .||..+.  +++.+|+|++++.... ....+...+|..+|.+++||+||+++-.|.+...+
T Consensus        24 ~~dF~~lkviGkG~fG---kV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFG---KVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             hhheeeeeeeeccCCc---eEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            4679999999999999   6665555  8999999999876543 33567789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+|+||+.||.|.-+|.+.     ..+++..+.-++.+|+.||.|||   +++||||||||+|||+|.+|+++|+|||++
T Consensus       101 ylVld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~  172 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLC  172 (357)
T ss_pred             EEEEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccc
Confidence            9999999999999999876     46899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      +..... ...+.+.+||+.|||||++....|+..+|.||||+++|||++|.+||.....                     
T Consensus       173 k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---------------------  230 (357)
T KOG0598|consen  173 KEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---------------------  230 (357)
T ss_pred             hhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---------------------
Confidence            865433 2346678999999999999999999999999999999999999999973221                     


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP  337 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  337 (353)
                      ..+++.++.+..... +...+.+..+++.+.|+.||++|.
T Consensus       231 ~~~~~~I~~~k~~~~-p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  231 KKMYDKILKGKLPLP-PGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHHHHhcCcCCCC-CccCCHHHHHHHHHHhccCHHHhc
Confidence            222333333221111 113567788999999999999996

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-49  Score=354.65  Aligned_cols=269  Identities=18%  Similarity=0.250  Sum_probs=212.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHH--HHHHHHHhhcC-CCceeeccceeeeC
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESC--INNVTYAARMS-HNHILKLIGCCLET  134 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~--~~E~~~l~~l~-H~niv~~~~~~~~~  134 (353)
                      .-++|...+.||.|.||   .||+|+.  ++..||||+++....+   .++.  ++|+..|++|+ |||||++.+++.+.
T Consensus         8 ~m~RY~~i~klGDGTfG---sV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFG---SVYLAKSKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHHhcCCcce---eEEEeeecCCCceeeHHHHHhhhcc---HHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            34678888999999999   9999998  8899999999877433   3333  68999999999 99999999999988


Q ss_pred             C-ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 P-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      + .+++|||||+ .+|++++++..    ..|++..++.|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+|
T Consensus        82 ~~~L~fVfE~Md-~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   82 DRILYFVFEFMD-CNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             CceEeeeHHhhh-hhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecc
Confidence            7 8999999997 79999999875    68999999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~  285 (353)
                      ||+|+.+.....  .+.++.|..|+|||++.. +.|+.+.|+||+|||++|+.+-++.|.+..+.+.+       +.|..
T Consensus       154 FGLARev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  154 FGLAREVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             cccccccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence            999998865443  456778999999998764 56999999999999999999999999877664421       11111


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +-+.....-.+...+.-+...+.........++.++.+||.+|+.|||++||||.++++
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            11111111011111111111111111111257788999999999999999999999876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-48  Score=349.70  Aligned_cols=268  Identities=19%  Similarity=0.239  Sum_probs=215.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--Ccc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PIP  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~  137 (353)
                      +.|+....||+|.||   .||++.+  +|+.||+|++..+...+....-..+|+.+|++|.||||+++.+...+.  ..+
T Consensus       117 ~~feki~kIGeGTyg---~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYG---QVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             HHHHHHHHhcCcchh---heeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            567888899999999   9999999  899999999987765566667778999999999999999999998876  689


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+|+|||+ -+|..++....    ..|+..++..++.|++.||+|||   +++|+|||||.+|||||.+|.+||+|||+|
T Consensus       194 YlVFeYMd-hDL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  194 YLVFEYMD-HDLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             EEEEeccc-chhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccce
Confidence            99999998 59999887654    57999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHHH
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYLK  289 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~  289 (353)
                      +.+........+..+-|..|+|||++.+.. |+.+.|+||.||||.||++|+++|+...+...+       +.+...+| 
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W-  344 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW-  344 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc-
Confidence            988766655566778899999999998864 999999999999999999999999865553321       11222221 


Q ss_pred             HHhhcCccc--ccccchhh-hccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFEDNRFT--EIVDPIIV-EDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .   ..+++  ..+.+... .......-...+...++|+..+|..||++|.||.+++.
T Consensus       345 ~---~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  345 P---VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             c---cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1   11111  11111110 00000111245677889999999999999999998875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=340.47  Aligned_cols=253  Identities=22%  Similarity=0.286  Sum_probs=202.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC--c
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP--I  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~  136 (353)
                      ..+|...+.||+|+||   .||.+..  ++...|||.+....  ....+.+.+|+.+|.+++|||||+++|......  .
T Consensus        16 ~~~~~~~~~lG~Gs~G---~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFG---SVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccce---EEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            3457778899999999   9999999  47999999987652  222677899999999999999999999855544  5


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-CCceEEeccC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFS  215 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~dfg  215 (353)
                      +++.|||+++|||.+++....    ..+++..+..++.|++.||.|||   +++++||||||+|||++. ++.+||+|||
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g----~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYG----GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCc
Confidence            899999999999999998875    25899999999999999999999   999999999999999999 7999999999


Q ss_pred             CccccCC--CCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          216 LSISIPE--GETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       216 ~a~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      +++....  ..........||+.|||||++..+. ...++|||||||++.||+||..||....       ....+.-...
T Consensus       164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-------~~~~~~~~ig  236 (313)
T KOG0198|consen  164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-------EEAEALLLIG  236 (313)
T ss_pred             cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-------chHHHHHHHh
Confidence            9987653  1122234578999999999998633 3459999999999999999999987430       0011111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .....+             ..+...+....+++.+|+..+|+.||||.++++.
T Consensus       237 ~~~~~P-------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  237 REDSLP-------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ccCCCC-------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            111111             1122566778899999999999999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.3e-47  Score=341.02  Aligned_cols=264  Identities=17%  Similarity=0.250  Sum_probs=209.6

Q ss_pred             CcceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceee
Q 018633           48 PYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILK  126 (353)
Q Consensus        48 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~  126 (353)
                      ..+.++.+++     +......||+|++|   .||+|.++++.||||.+...... ....+.|.+|+.+|.+++|||||+
T Consensus        11 ~~~~i~~~~i-----~~~~~~~i~~g~~~---~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~   82 (283)
T PHA02988         11 DIKCIESDDI-----DKYTSVLIKENDQN---SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK   82 (283)
T ss_pred             cceecCHHHc-----CCCCCeEEeeCCce---EEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence            3455566666     23334679999999   99999999999999999765322 223577889999999999999999


Q ss_pred             ccceeee----CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCce
Q 018633          127 LIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCI  201 (353)
Q Consensus       127 ~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Ni  201 (353)
                      ++|++.+    ....++||||+++|+|.+++...     ..+++...+.++.|++.||.|||   + .+++||||||+||
T Consensus        83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~ni  154 (283)
T PHA02988         83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSF  154 (283)
T ss_pred             EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhE
Confidence            9999876    34688999999999999999764     35788999999999999999999   6 4889999999999


Q ss_pred             eecCCCceEEeccCCccccCCCCCccccccccCCcccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCccccccC
Q 018633          202 LFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD  279 (353)
Q Consensus       202 ll~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~  279 (353)
                      |++.++.+||+|||+++......    ....|+..|+|||++.+  ..++.++|||||||++|||++|..||.....   
T Consensus       155 ll~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---  227 (283)
T PHA02988        155 LVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---  227 (283)
T ss_pred             EECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---
Confidence            99999999999999987653322    23467889999999976  6799999999999999999999999974321   


Q ss_pred             CCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                           .+............         ..    +..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       228 -----~~~~~~i~~~~~~~---------~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~~  282 (283)
T PHA02988        228 -----KEIYDLIINKNNSL---------KL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFY  282 (283)
T ss_pred             -----HHHHHHHHhcCCCC---------CC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHhc
Confidence                 11111111111000         00    113566788999999999999999999999999988653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.9e-48  Score=321.98  Aligned_cols=268  Identities=17%  Similarity=0.193  Sum_probs=213.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +.|...++||+|.||   .||+|.+  +|+.||||++.............++|++.|+.++|+||+.++++|.+...+-|
T Consensus         2 ~rY~~~~~lGEG~~g---vVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYG---VVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceE---EEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            357778899999999   9999999  89999999998776555666778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+||++ .+|+..+++..    ..++..++..++.++++||+|||   ++.|+||||||.|+|++++|.+||+|||+|+.
T Consensus        79 VfEfm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   79 VFEFMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             EEEecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhc
Confidence            999998 79999998765    67899999999999999999999   99999999999999999999999999999999


Q ss_pred             cCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHHHHH
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYLKNY  291 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~~  291 (353)
                      +...... ....+-|..|+|||.+.+.. |+...||||.|||+.||+-|.+-|....+.+.+       +.|-.+.|.++
T Consensus       151 f~~p~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  151 FGSPNRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             cCCCCcc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            8655443 23336789999999998765 999999999999999999998888765553321       11111111111


Q ss_pred             hhcCcccccc--cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          292 FEDNRFTEIV--DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       292 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..-..+.++.  .......   . -...+....+|+.+||.+||.+|+|+.++++.
T Consensus       230 ~~lpdY~~~~~~P~~~~~~---l-f~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNN---L-FPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccHHHHhcCCCCcccc---c-cccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111111100  0000000   1 11456677999999999999999999998864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.1e-48  Score=353.37  Aligned_cols=247  Identities=22%  Similarity=0.317  Sum_probs=214.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||||..  +.+.||+|.+.+.--.....+.+.+|+++++.++|||||.++++|++..++|+
T Consensus         2 e~yhv~e~iG~Gsfg---~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFG---RVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccc---eeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            467888899999999   9999998  78899999998775566778889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+|||. |+|..++...     ..++++.+..++.|++.||.|||   +++|+|||+||.|||++.+|.+|++|||+|+.
T Consensus        79 Vte~a~-g~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   79 VTEYAV-GDLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             Eehhhh-hhHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhh
Confidence            999998 5999999876     47999999999999999999999   99999999999999999999999999999988


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ... .+.......||+.|||||+..+.+|+..+|.||+||++||+++|++||...                     .+..
T Consensus       150 m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---------------------si~~  207 (808)
T KOG0597|consen  150 MST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---------------------SITQ  207 (808)
T ss_pred             ccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---------------------HHHH
Confidence            754 334456778999999999999999999999999999999999999998722                     1222


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ++..++.++..++.  ..+..+.+++...|..||..|.|..+++.
T Consensus       208 Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  208 LVKSILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHHhcCCCCCcc--cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            33333333333322  77888999999999999999999988764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-47  Score=338.10  Aligned_cols=263  Identities=21%  Similarity=0.285  Sum_probs=215.3

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...+.|....+||.|..+   .||+|..  .+..||||++.-..++.. .+.+.+|+..|+.++||||++++.+|..+..
T Consensus        23 ~n~~~YeL~e~IG~G~sa---~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASA---VVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             CCccceeEEEEEecccee---EeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            445679999999999999   9999998  889999999988876655 7889999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      +|+||.||.+||+.+++...-.   ..+++..+..|++++++||.|||   .+|.||||||+.||||+++|.+||+|||.
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCcee
Confidence            9999999999999999987654   45889999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCc--cc-cccccCCcccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          217 SISIPEGETH--IT-DTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       217 a~~~~~~~~~--~~-~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      +..+......  .. ++..||+.|||||++..  ..|+.|+||||||++..||.+|..||..+..        .+.+..-
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--------mkvLl~t  244 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--------MKVLLLT  244 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--------HHHHHHH
Confidence            7655433221  12 56789999999999754  3599999999999999999999999984332        2222222


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .. +..+...    ...............+.+++..||..||..|||++++++
T Consensus       245 Lq-n~pp~~~----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  245 LQ-NDPPTLL----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hc-CCCCCcc----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            21 1111111    111122223366778999999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=351.67  Aligned_cols=270  Identities=23%  Similarity=0.380  Sum_probs=219.2

Q ss_pred             cHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           53 SAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        53 ~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      +.+++..-.+.......||+|.||   +||+|.|-| .||||+++....++...+.|.+|+..+++-+|.||+-|+|+|.
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFG---tV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFG---TVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             cccccccCHHHhhccceecccccc---ceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            335555555666778889999999   999999965 4899999999889999999999999999999999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                      ..+. .||+.+|+|.||+.+++...    ..|...+.+.|+.|||.|+.|||   .++|||||||..||++.+++.+||+
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIg  530 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIG  530 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEe
Confidence            8877 89999999999999998765    57888999999999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCC-CCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          213 DFSLSISIPE-GETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       213 dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      |||++..-.. ..........|...|||||++.   ..+|+..+||||||+++|||+||..||........+        
T Consensus       531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--------  602 (678)
T KOG0193|consen  531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--------  602 (678)
T ss_pred             cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--------
Confidence            9999865321 1112234456778899999985   356999999999999999999999998832222211        


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                         |.-++-      .+..+.. .....++.++.+|+..||.++|++||++.+|+..|+.+..+
T Consensus       603 ---fmVGrG------~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  603 ---FMVGRG------YLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ---EEeccc------ccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence               000000      0001111 11126788999999999999999999999999999888764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-47  Score=348.04  Aligned_cols=250  Identities=22%  Similarity=0.300  Sum_probs=208.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC---hhHHHHHHHHHHHHhhcC-CCceeeccceee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR---PRAYESCINNVTYAARMS-HNHILKLIGCCL  132 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~  132 (353)
                      ...++|...+.||+|+||   .|+.|..  ++..||+|++......   ....+.+.+|+.++++++ ||||+++++++.
T Consensus        14 ~~~g~y~~~~~lG~Gsfg---kV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~   90 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFG---KVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA   90 (370)
T ss_pred             cccCceeeeeeecCCCCe---eEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence            456789999999999999   9999988  7899999977664211   134556678999999999 999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEE
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKL  211 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl  211 (353)
                      .....++||||+.+|+|.+.+...     .++.+..+..++.|++.|++|||   +++|+||||||+|||++.+ +++||
T Consensus        91 t~~~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl  162 (370)
T KOG0583|consen   91 TPTKIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKL  162 (370)
T ss_pred             cCCeEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEE
Confidence            999999999999999999999884     46888999999999999999999   9999999999999999999 99999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCC-CC-ccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FN-EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      +|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||+.....            
T Consensus       163 ~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------------  229 (370)
T KOG0583|consen  163 SDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------------  229 (370)
T ss_pred             eccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------------
Confidence            9999998763 2233467889999999999999877 86 7899999999999999999999852211            


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHH-HHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQ-LHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                               .+...+..+.+..  +... +.++..|+.+||..||..|+|+.+++
T Consensus       230 ---------~l~~ki~~~~~~~--p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  230 ---------NLYRKIRKGEFKI--PSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ---------HHHHHHhcCCccC--CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                     1111111111111  1133 67788999999999999999999998

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.7e-47  Score=364.70  Aligned_cols=260  Identities=23%  Similarity=0.333  Sum_probs=216.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +-...+.||+|.||   +||+|..       ....||||.++... +.+.+.+|.+|+++++.++|||||+|+|+|..++
T Consensus       487 ~i~~~~eLGegaFG---kVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  487 DIVFKEELGEGAFG---KVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             heeehhhhcCchhh---hhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            34445679999999   9999987       34679999998774 4557889999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCC---------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPH---------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE  206 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  206 (353)
                      .+|+|+|||..|+|.++|+......         ..+++..+.+.|+.|||.|+.||-   ++.+|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence            9999999999999999998654311         134888999999999999999999   9999999999999999999


Q ss_pred             CceEEeccCCccccCCCCCcccc-ccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCCh
Q 018633          207 NVAKLFDFSLSISIPEGETHITD-TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~  284 (353)
                      ..+||+|||+++.+-..+..... ...-+.+|||||.+..+.||.+||||||||+|||+++ |..|+.....        
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence            99999999999876544433222 3344679999999999999999999999999999998 8888764333        


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                       +.+-+....+.+             ...|+.++.++.+||..||+.+|.+|||++||-.+|...-.
T Consensus       712 -~EVIe~i~~g~l-------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  712 -QEVIECIRAGQL-------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -HHHHHHHHcCCc-------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence             223333333332             12233889999999999999999999999999999987643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-46  Score=347.50  Aligned_cols=265  Identities=18%  Similarity=0.326  Sum_probs=206.1

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecccee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCC  131 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~  131 (353)
                      ..++|...+.||+|+||   .||+|.+       .+..||+|++.... .......+.+|+.++.++ +||||++++++|
T Consensus         5 ~~~~~~~~~~lG~G~fg---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           5 PRDRLRLGKVLGHGAFG---KVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             chhHceeeeEeccCCcc---eEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            34678889999999999   8888864       34689999987542 334556799999999999 899999999998


Q ss_pred             eeC-CccEEEEEeccCCChhhhhccCCCC---------------------------------------------------
Q 018633          132 LET-PIPILVFESVQYGTLWDRILGAPQP---------------------------------------------------  159 (353)
Q Consensus       132 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------  159 (353)
                      ... +..++||||+++|+|.+++......                                                   
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            764 4578999999999999988753210                                                   


Q ss_pred             ------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc-cccccc
Q 018633          160 ------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVM  232 (353)
Q Consensus       160 ------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~  232 (353)
                            ...++++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                  0134778888999999999999999   999999999999999999999999999999765332221 123345


Q ss_pred             cCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccch
Q 018633          233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLS  311 (353)
Q Consensus       233 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (353)
                      ++..|+|||++.+..++.++|||||||++|||++ |..||.......       ... .....+....            
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~-~~~~~~~~~~------------  297 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFC-QRLKDGTRMR------------  297 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHH-HHHhcCCCCC------------
Confidence            6678999999988889999999999999999997 999987432111       111 1111111000            


Q ss_pred             HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          312 IEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       312 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                       .+...+..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus       298 -~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         298 -APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             0113456788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-47  Score=347.79  Aligned_cols=248  Identities=19%  Similarity=0.266  Sum_probs=210.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ..|.....||+|+.|   .||.+..  ++..||||++...  .....+-+++|+.+|+..+|+|||++++.|.-.+.+|+
T Consensus       273 ~~y~~~~kigqgaSG---~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATG---GVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhcchhhhcccccc---ceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            457777899999999   8888887  8889999999877  45566778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||||+||+|.|.+...      .+++.++..|+++++.||+|||   .++|+|||||.+|||++.+|.+||+|||++..
T Consensus       348 VMEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaq  418 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQ  418 (550)
T ss_pred             EEeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeec
Confidence            99999999999998764      4899999999999999999999   99999999999999999999999999999988


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      +..... ...+.+||+.|||||+.....|+++.||||||++++||+.|.+||.......        .+.... ....++
T Consensus       419 i~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--------AlyLIa-~ng~P~  488 (550)
T KOG0578|consen  419 ISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIA-TNGTPK  488 (550)
T ss_pred             cccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH--------HHHHHh-hcCCCC
Confidence            765443 4567889999999999999999999999999999999999999987421111        111111 111111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +           ..++..+..+.+++.+||..||++|+|+.++|+
T Consensus       489 l-----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  489 L-----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             c-----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            1           112367888999999999999999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=350.05  Aligned_cols=243  Identities=21%  Similarity=0.339  Sum_probs=204.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      +..++.+-||+|+.|   .||.|++.++.||||+++..         -..+++-|++|+||||+.|.|+|....-+||||
T Consensus       124 e~IsELeWlGSGaQG---AVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  124 EEISELEWLGSGAQG---AVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             HHhhhhhhhccCccc---ceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence            334456779999999   99999999999999997533         235788899999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      |||+.|.|+..|+..     .++.......|..+||.|+.|||   .+.|||||||.-||||..+..+||+|||.++...
T Consensus       192 EfCa~GqL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             eccccccHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            999999999999876     46788888999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      +.  .....++||..|||||++.+.+.+.|+|||||||+||||+||..||..........                 -+-
T Consensus       264 ~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-----------------GVG  324 (904)
T KOG4721|consen  264 DK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-----------------GVG  324 (904)
T ss_pred             hh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-----------------ecc
Confidence            43  22456789999999999999999999999999999999999999987443322100                 000


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      .+.+    ..+.+..++..+.=|+.+||+..|.+|||+++++..|+
T Consensus       325 sNsL----~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  325 SNSL----HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             CCcc----cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            1111    11122277788888999999999999999999999885

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-47  Score=345.00  Aligned_cols=253  Identities=19%  Similarity=0.237  Sum_probs=210.4

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeee
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLE  133 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~  133 (353)
                      .+..++|.-.+.||.|+|+   +|+++..  +++.+|||++.+... .....+-+..|-.+|.+| .||.||+|+-.|.+
T Consensus        69 kk~~~DF~Fg~~lGeGSYS---tV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD  145 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYS---TVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD  145 (604)
T ss_pred             cCChhhcchhheeccccce---eEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence            3455678889999999999   9999998  899999999976653 233345567899999999 69999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      ...+|+|+||+++|+|.++|.+.     ..|++...+.++.+|+.||+|||   ++|||||||||+|||+|++|+++|+|
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITD  217 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITD  217 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEee
Confidence            99999999999999999999887     46899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCc----------c--ccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCC
Q 018633          214 FSLSISIPEGETH----------I--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA  281 (353)
Q Consensus       214 fg~a~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~  281 (353)
                      ||.|+.+......          .  ....+||..|.+||++.+...+..+|+|+|||++|+|+.|.+||...++..   
T Consensus       218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---  294 (604)
T KOG0592|consen  218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---  294 (604)
T ss_pred             ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---
Confidence            9999887543221          0  145789999999999999999999999999999999999999998543322   


Q ss_pred             CChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                        ++.+++.-++..  ++..++.+.+|+.+.|..||.+|+|+.+|.+
T Consensus       295 ------------------iFqkI~~l~y~f--p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  295 ------------------IFQKIQALDYEF--PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ------------------HHHHHHHhcccC--CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                              111111111111  1144567789999999999999999988754

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=339.93  Aligned_cols=249  Identities=18%  Similarity=0.264  Sum_probs=211.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ..|+....||+|+||   .||+|.+  +++.||+|++.... .....+.+.+|+.+|.+++++||.++||.+..+..+|+
T Consensus        13 ~~~~~~~~IgrGsfG---~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFG---EVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             cccccchhccccccc---eeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            347777899999999   9999999  89999999998764 45556788999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      +||||.||++.+.+....     .+.+..+.-++++++.||.|||   .++.+|||||+.|||+..+|.+||+|||++..
T Consensus        89 iMey~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQ  160 (467)
T ss_pred             HHHHhcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeee
Confidence            999999999999997653     4477778889999999999999   99999999999999999999999999999988


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ....... ..+..||+.|||||++....|+.++||||||++.+||.+|.+|+.......                  +.-
T Consensus       161 l~~~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------------------vlf  221 (467)
T KOG0201|consen  161 LTNTVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------------------VLF  221 (467)
T ss_pred             eechhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce------------------EEE
Confidence            7554443 478899999999999998899999999999999999999999986433211                  111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ++    ....++.....++..+.+++..||+.||+.||||.++++.
T Consensus       222 lI----pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  222 LI----PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ec----cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            11    1222222223677889999999999999999999999863

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-47  Score=350.01  Aligned_cols=268  Identities=22%  Similarity=0.342  Sum_probs=216.1

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--C-C--eE-EEEEEecCC-CCChhHHHHHHHHHHHHhhcCCCce
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--Q-E--RL-ISVLQFYGH-ECRPRAYESCINNVTYAARMSHNHI  124 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~-~--~~-vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~H~ni  124 (353)
                      +....++...++-...++||+|+||   .||+|.+  . +  .. ||||..... ........+|++|+++|++++||||
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFG---eV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV  223 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFG---EVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV  223 (474)
T ss_pred             ccccccEEeccCccccceeeccccc---EEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence            3444555556666677999999999   9999999  2 2  23 899998863 2467788999999999999999999


Q ss_pred             eeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          125 LKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       125 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                      |++||++.....+++|||+|+||+|.++|+...    ..++..++..++.+.|.||+|||   ++++|||||..+|+|++
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~  296 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYS  296 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheec
Confidence            999999999999999999999999999999875    35899999999999999999999   99999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACP  283 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~  283 (353)
                      .++.+||+|||+++....-... .....-+..|+|||.+....|+.++|||||||++||+++ |..||.......     
T Consensus       297 ~~~~vKISDFGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-----  370 (474)
T KOG0194|consen  297 KKGVVKISDFGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-----  370 (474)
T ss_pred             CCCeEEeCccccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-----
Confidence            9999999999998765311111 112234678999999999999999999999999999999 788887433221     


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                          +....            .....+...+...+..+..++.+||..+|++||||.++.+.|+.+..
T Consensus       371 ----v~~kI------------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  371 ----VKAKI------------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             ----HHHHH------------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                11111            11111111122556677888999999999999999999999998865

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-46  Score=342.66  Aligned_cols=252  Identities=20%  Similarity=0.269  Sum_probs=217.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc-cE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI-PI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-~~  138 (353)
                      ++|...+++|+|+||   .++....  +++.+|+|++.....+....+...+|+.++++++|||||.+.+.|+.++. .+
T Consensus         4 ~~Ye~~~~iG~GafG---~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFG---SALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             chhhhhhhcCccccc---hhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            568889999999999   6554444  78899999998887777778889999999999999999999999999988 99


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      |||+||+||+|.+.+....+   ..++++.+..|+.|++.|+.|||   +++|+|||||+.||++..++.++|+|||+|+
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhh
Confidence            99999999999999987764   57899999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...... ....+..||+.|++||.+.+.+|+.|+|||||||++|||++-+++|...+                     ..
T Consensus       155 ~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---------------------m~  212 (426)
T KOG0589|consen  155 ILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---------------------MS  212 (426)
T ss_pred             hcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---------------------hH
Confidence            986544 24677899999999999999999999999999999999999999987322                     22


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .++.++......+. +..++.++..++..||..+|..||++.+++..
T Consensus       213 ~Li~ki~~~~~~Pl-p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  213 ELILKINRGLYSPL-PSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHHhhccCCCC-CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            22222222222222 22788899999999999999999999999876

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-46  Score=347.55  Aligned_cols=249  Identities=20%  Similarity=0.255  Sum_probs=212.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCC-CCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGH-ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .+-|...+.||+|+.|   .|-.|++  +|+.+|||++.+. .........+.+|+.+|+-+.||||+.+|+++++..++
T Consensus        11 iGpwkLgkTLG~Gstg---~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTG---CVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             ccceeccccccCCCCc---eehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            3568889999999999   9999999  9999999999766 33445566788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+|.||+++|-|.+++...     +++++.++.+++.||+.|+.|+|   ..+|+||||||+|+|+|..+++||+|||+|
T Consensus        88 ylvlEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMA  159 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMA  159 (786)
T ss_pred             EEEEEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeecccee
Confidence            9999999999999999877     57999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ..-..+  ....+.||+++|+|||++.+.+|. .++||||.|||||.|+||+.||+..                     +
T Consensus       160 sLe~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---------------------N  216 (786)
T KOG0588|consen  160 SLEVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---------------------N  216 (786)
T ss_pred             ecccCC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---------------------c
Confidence            764332  335778999999999999999986 7999999999999999999999822                     2


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      +..++.+...+.+.-  |...+.+..+|+.+|+..||+.|.|+++|++.
T Consensus       217 ir~LLlKV~~G~f~M--Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  217 IRVLLLKVQRGVFEM--PSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             HHHHHHHHHcCcccC--CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            222222222222211  12566778899999999999999999999863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=317.17  Aligned_cols=237  Identities=20%  Similarity=0.267  Sum_probs=204.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|+..+.||.|+||   +|...+.  ++..+|+|++.... ......+...+|-++|+.+.||+++++++.|.+.+.+|
T Consensus        44 ~dfe~~~tlGtGSFG---rV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFG---RVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             hhhhheeeeccCccc---eEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            457888899999999   9888887  89999999997663 23445667889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||++||.|..++++.     ..+++..++.++.||+.||+|||   +++|++|||||+|||+|.+|.+||+|||+|+
T Consensus       121 mvmeyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             EEEeccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence            999999999999999876     47999999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .....    +.+.+||+.|+|||++....++.++|.|||||++|||+.|.+||.....                     .
T Consensus       193 ~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------------------~  247 (355)
T KOG0616|consen  193 RVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------------------I  247 (355)
T ss_pred             EecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------------H
Confidence            87432    5678999999999999999999999999999999999999999973322                     2


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCC
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR  336 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  336 (353)
                      .++++++.+....+  ...+..+.+|+...|+.|-..|
T Consensus       248 ~iY~KI~~~~v~fP--~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  248 QIYEKILEGKVKFP--SYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHHHhCcccCC--cccCHHHHHHHHHHHhhhhHhh
Confidence            34444444443222  2566778889999999998888

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-45  Score=327.79  Aligned_cols=255  Identities=16%  Similarity=0.231  Sum_probs=204.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++|...+.||+|+||   .||+|.+     .+..||+|.+.... .......|.+|+.++.+++||||++++|++..++.
T Consensus         5 ~~~~~~~~ig~G~fg---~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           5 KSIKIERILGTGRFG---ELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             HHeEEeeeecccCCC---eEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            468888999999999   8888875     35689999987653 34455779999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++|+|.+++....    ..+++..++.++.|++.||+|||   +++++||||||+|||++.++.++++|||.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence            999999999999999987643    46889999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +...............++..|+|||++.+..++.++|||||||++||+++ |..||.....        ...... ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~-~~~~  224 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKA-VEDG  224 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHH-HHCC
Confidence            75542222111122345678999999998899999999999999999875 9999864321        111111 1111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ...         .    .+..++..+.+++.+||+.+|++|||+.++.+.|.++
T Consensus       225 ~~~---------~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 FRL---------P----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCC---------C----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            100         0    0114566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.1e-45  Score=328.57  Aligned_cols=272  Identities=19%  Similarity=0.238  Sum_probs=205.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++.+  +++.||+|++..........+.+.+|+.++++++||||+++++++..++..++
T Consensus         1 ~~y~~~~~lg~g~~~---~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYG---VVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCE---EEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            468888999999999   9999998  68899999997654445556778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++++++..+. ...    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++..
T Consensus        78 v~e~~~~~~l~~~~-~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848          78 VFEYVEKNMLELLE-EMP----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             EEecCCCCHHHHHH-hcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            99999977665443 322    35888999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHHh
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNYF  292 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~  292 (353)
                      .............||..|+|||++.+..++.++|||||||++|||++|+.||........       .............
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            644333223345789999999999888899999999999999999999999975332110       0000111111111


Q ss_pred             hcCcccccccchhhh--ccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVE--DVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....+.....+....  ..........+..+.+|+.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111110000000  0000111135667999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-46  Score=366.41  Aligned_cols=260  Identities=24%  Similarity=0.408  Sum_probs=213.7

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe---CCe----EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW---QER----LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~---~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      -+..+.||+|.||   .||+|..   .+.    .||+|.+.... +.+...+|++|..+|++++|||||+++|+|.+...
T Consensus       694 v~l~~~lG~G~FG---~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFG---EVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             eEeeeeecccccc---ceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            3456789999999   9999998   333    48999987763 67778899999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCC--ccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHF--EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      .+|++|||++|+|..+|++.+...+  ..+.....+.++.|||+|+.||+   ++++|||||..+|+|++....+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999998733211  46888899999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCcccccc-ccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          215 SLSISIPEGETHITDTV-MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |+|+.+-..+....... .-...|||||.+..+.|+.|+|||||||++||++| |..||......+        ....+.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~~~~~  918 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VLLDVL  918 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HHHHHH
Confidence            99995433333222222 34568999999999999999999999999999999 777876433322        112222


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .++++              +.|..++..+.++|.+||+.+|++||++..+++.+.++...
T Consensus       919 ~ggRL--------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  919 EGGRL--------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             hCCcc--------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            22221              12237889999999999999999999999999999888754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.1e-45  Score=329.00  Aligned_cols=252  Identities=17%  Similarity=0.265  Sum_probs=200.5

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +|...+.||+|+||   .||++.+  +++.||+|.+..... .......+.+|+.++.+++|+||+++++++.+++..++
T Consensus         1 ~f~~~~~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~l   77 (285)
T cd05631           1 TFRHYRVLGKGGFG---EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCL   77 (285)
T ss_pred             CceEEEEEecCCCE---EEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEE
Confidence            36778899999999   9999988  789999999865421 22334568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|.+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++..
T Consensus        78 v~e~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          78 VLTIMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             EEEecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            9999999999888764332   35789999999999999999999   99999999999999999999999999999977


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ......  .....||..|+|||++.+..++.++|||||||++|+|++|..||.......     .............   
T Consensus       152 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~---  221 (285)
T cd05631         152 IPEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREEVDRRVKEDQ---  221 (285)
T ss_pred             cCCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHHhhccc---
Confidence            543221  234578999999999998899999999999999999999999997433211     0000111000000   


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                                 ...+...+..+.+|+.+||+.||.+|||     +.++++
T Consensus       222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                       0001134567789999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=329.51  Aligned_cols=255  Identities=22%  Similarity=0.246  Sum_probs=203.0

Q ss_pred             HHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChh------------HHHHHHHHHHHHhhcCCC
Q 018633           57 IKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPR------------AYESCINNVTYAARMSHN  122 (353)
Q Consensus        57 ~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~H~  122 (353)
                      =.+..+.|.....||+|.||   .|-++..  +++.||||++.+.....+            ..+...+|+.+|+++.||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yG---kVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYG---KVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             cceehhheehhhhhcCCccc---eEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            34556899999999999999   9999998  899999999965542111            225788999999999999


Q ss_pred             ceeeccceeeeC--CccEEEEEeccCCChhhhhccCCCCCCcc-ccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          123 HILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEP-LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       123 niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      |||+++.+..+.  +.+|||+|||..|.+...=-.      .+ +.+.++++++.+++.||+|||   .++||||||||+
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d------~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPs  239 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD------KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPS  239 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCccccCCCC------cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchh
Confidence            999999998754  579999999998887543221      33 899999999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCC----ccccccccCCccccccccccCC----CCccccchhhHHHHHHHHhCCCCC
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGET----HITDTVMGTWGYCAPEYMRTGV----FNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~tg~~p~  271 (353)
                      |+|++++|++||+|||.+..+..+..    .......||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            99999999999999999877633211    1123468999999999998733    347899999999999999999998


Q ss_pred             CccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          272 DLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....                     ..++.+++.......+..+...+.+.+||.++|..||+.|++..+|..
T Consensus       320 ~~~~---------------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  320 FDDF---------------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             ccch---------------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            7322                     222333333333222222256778899999999999999999988764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.9e-45  Score=340.33  Aligned_cols=261  Identities=16%  Similarity=0.254  Sum_probs=203.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCL  132 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~  132 (353)
                      .++|...+.||+|+||   .||++.+       ++..||+|++.... .....+.+.+|+.++..+ +||||++++++|.
T Consensus        34 ~~~~~~~~~LG~G~fG---~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFG---KVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccc---eEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            4568889999999999   8888864       45689999986542 234557789999999999 7999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCC-----------------------------------------------------
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQP-----------------------------------------------------  159 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  159 (353)
                      ..+..++||||+++|+|.+++......                                                     
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            999999999999999999988653210                                                     


Q ss_pred             -----------------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          160 -----------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       160 -----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                                       ....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             0024788889999999999999999   99999999999999999999999999999876643


Q ss_pred             CCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          223 GETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       223 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      .... ......++..|+|||++.+..++.++|||||||++|||++ |..||......        .............. 
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~~-  337 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--------SKFYKMIKEGYRML-  337 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--------HHHHHHHHhCccCC-
Confidence            3221 1223345677999999998899999999999999999998 88887632211        11111111111000 


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                                  .+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       338 ------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 ------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                        0012345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.5e-45  Score=339.51  Aligned_cols=262  Identities=16%  Similarity=0.288  Sum_probs=204.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCL  132 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~  132 (353)
                      .++|...+.||+|+||   .||++.+       ++..||+|++.... .....+.+.+|+.+++.+ +|||||+++++|.
T Consensus        37 ~~~~~~~~~LG~G~fg---~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFG---KVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcc---cEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            4578899999999999   8888775       23579999997553 334567789999999999 7999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCC------------------------------------------------------
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQ------------------------------------------------------  158 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  158 (353)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            99999999999999999998854210                                                      


Q ss_pred             -----------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc-
Q 018633          159 -----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-  226 (353)
Q Consensus       159 -----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~-  226 (353)
                                 ....++++..++.++.||+.||.|||   +++|+||||||+|||++.++.++|+|||+++........ 
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                       00124788889999999999999999   999999999999999999999999999998765433221 


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPII  305 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (353)
                      ......++..|+|||++....++.++|||||||++|||++ |..||.......        ......... ...      
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------~~~~~~~~~-~~~------  334 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVKRG-YQM------  334 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------HHHHHHHcc-cCc------
Confidence            1223345667999999988889999999999999999997 999986432111        011111110 000      


Q ss_pred             hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          306 VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       306 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                        .    .+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       335 --~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 --S----RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             --c----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence              0    00023467889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-45  Score=330.56  Aligned_cols=245  Identities=21%  Similarity=0.252  Sum_probs=200.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++..  +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         1 ~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   77 (291)
T cd05612           1 DDLERIKTVGTGTFG---RVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLY   77 (291)
T ss_pred             CCceeeeeeecCCCe---EEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEE
Confidence            368888999999999   9999998  689999999864321 2234567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus        78 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~  149 (291)
T cd05612          78 MLMEYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK  149 (291)
T ss_pred             EEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcch
Confidence            999999999999998765     35788999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .....    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ......... ... 
T Consensus       150 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~-~~~-  215 (291)
T cd05612         150 KLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILA-GKL-  215 (291)
T ss_pred             hccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCc-
Confidence            65332    2245689999999999988899999999999999999999999864221        111111111 110 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                      .         .    +...+..+.+|+.+||+.||.+||+     +.++++
T Consensus       216 ~---------~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         216 E---------F----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             C---------C----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            0         0    0133456789999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-44  Score=321.85  Aligned_cols=254  Identities=21%  Similarity=0.344  Sum_probs=205.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .+|...+.||+|+||   .||+|.+  .+..||+|.+...   ......+.+|+++++.++||||+++++++..++..++
T Consensus         6 ~~~~~~~~ig~g~~~---~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYG---EVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccc---eEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            347788899999999   9999988  6889999998654   3345679999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++..
T Consensus        80 v~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            9999999999999865432   45789999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..||.....        .+.... ...... 
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~-~~~~~~-  223 (263)
T cd05052         154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYEL-LEKGYR-  223 (263)
T ss_pred             cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH-HHCCCC-
Confidence            64433222222334567999999988889999999999999999998 8888763221        111111 111100 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                              ..    .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       224 --------~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 --------ME----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --------CC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                    00    0114456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-44  Score=326.04  Aligned_cols=264  Identities=20%  Similarity=0.260  Sum_probs=200.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe------------------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW------------------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH  123 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~------------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n  123 (353)
                      +.|...+.||+|+||   .||++.+                  ++..||+|.+.... .......|.+|+.++.+++|||
T Consensus         5 ~~~~~~~~lg~G~fg---~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           5 GHLLFKEKLGEGQFG---EVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhCeeeeEecccCCe---EEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence            457888899999999   8888864                  23469999987642 3445678999999999999999


Q ss_pred             eeeccceeeeCCccEEEEEeccCCChhhhhccCCC--------------CCCccccHHHHHHHHHHHHHHHHHHhcCCCC
Q 018633          124 ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ--------------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPR  189 (353)
Q Consensus       124 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  189 (353)
                      |+++++++.+.+..++||||+++|+|.+++.....              .....+++..++.++.|++.||.|||   ++
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~  157 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SL  157 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HC
Confidence            99999999999999999999999999998864321              01134678889999999999999999   99


Q ss_pred             CeEeeccCCCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhC-
Q 018633          190 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG-  267 (353)
Q Consensus       190 ~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg-  267 (353)
                      +|+||||||+|||++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||+++ 
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            999999999999999999999999999876543322 112334557889999999888899999999999999999974 


Q ss_pred             -CCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          268 -WDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       268 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                       ..||.......     ........+........      ..    .+..++..+.+++.+||+.||++|||+.+|.+.|
T Consensus       238 ~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~------~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l  302 (304)
T cd05096         238 KEQPYGELTDEQ-----VIENAGEFFRDQGRQVY------LF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL  302 (304)
T ss_pred             CCCCCCcCCHHH-----HHHHHHHHhhhcccccc------cc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence             45655322111     00111111111000000      00    0013456788999999999999999999999887


Q ss_pred             H
Q 018633          347 R  347 (353)
Q Consensus       347 ~  347 (353)
                      +
T Consensus       303 ~  303 (304)
T cd05096         303 T  303 (304)
T ss_pred             h
Confidence            5

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.9e-45  Score=327.91  Aligned_cols=270  Identities=19%  Similarity=0.237  Sum_probs=200.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||+|..  ++..||+|++.... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus         5 ~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           5 ETYVKLDKLGEGTYA---TVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccceEeeEEecCCCE---EEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            458888999999999   9999988  78899999986542 22334567899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++ |+|.+++....    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~  152 (288)
T cd07871          81 VFEYLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA  152 (288)
T ss_pred             EEeCCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence            999997 59998886543    35788899999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHH
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNY  291 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~  291 (353)
                      ...... ......++..|+|||++.+ ..++.++||||+||++|+|+||..||........       ...+....+...
T Consensus       153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         153 KSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             ccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence            533221 1234567899999999865 4589999999999999999999999974332110       001111111111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....+.....+................+..+|+.+||++||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11111111111110000000000123456789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.7e-45  Score=333.60  Aligned_cols=242  Identities=16%  Similarity=0.183  Sum_probs=196.1

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      ++||+|+||   .||++..  +++.||+|++..... .......+.+|+.++.+++||||+++++++...+..|+||||+
T Consensus         1 ~~lG~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence            469999999   9999987  789999999875421 2344567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        78 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          78 NGGELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            999999988764     46789999999999999999999   9999999999999999999999999999987542221


Q ss_pred             CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccch
Q 018633          225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPI  304 (353)
Q Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (353)
                       .......||+.|+|||++.+..++.++|||||||++|||++|..||.....        ........ .... .     
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~-~~~~-~-----  213 (323)
T cd05571         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELIL-MEEI-R-----  213 (323)
T ss_pred             -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHH-cCCC-C-----
Confidence             123345799999999999988899999999999999999999999863221        11111111 0000 0     


Q ss_pred             hhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          305 IVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       305 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                          .    +...+..+.+++.+||..||++||     ++.++++
T Consensus       214 ----~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         214 ----F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ----C----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                0    113456788999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.4e-44  Score=331.47  Aligned_cols=198  Identities=20%  Similarity=0.270  Sum_probs=174.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|+..+.||+|+||   .||++.+  ++..+|+|.+.... .....+.+.+|+.++++++||||+++++++..++..+
T Consensus         4 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGG---VVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCE---EEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            3678889999999999   9999998  68889999887542 3445678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC-CeEeeccCCCceeecCCCceEEeccCCc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.++|+|||++
T Consensus        80 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  151 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (331)
T ss_pred             EEeecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence            999999999999998764     35788999999999999999999   64 6999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDL  273 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~  273 (353)
                      .......   .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         152 GQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ccccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            7653321   3345789999999999988899999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=329.00  Aligned_cols=250  Identities=18%  Similarity=0.241  Sum_probs=203.1

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      +...++|+...+||+|+||   .||.++-  +|..+|+|++++... .....+.+..|-.+|....+|+||++|-.|.+.
T Consensus       137 r~~~~DFe~Lk~IgkGAfG---eVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFG---EVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             cCCcccchhheeeccccce---eEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            3456889999999999999   8888877  899999999987753 345567788999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ..+||||||+|||++..+|...     ..|++..+..++.+++.|+..||   ..|+|||||||+|+|||..|++||+||
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccc
Confidence            9999999999999999999876     57999999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCC----------------------CCc------------------------cccccccCCccccccccccCCC
Q 018633          215 SLSISIPEG----------------------ETH------------------------ITDTVMGTWGYCAPEYMRTGVF  248 (353)
Q Consensus       215 g~a~~~~~~----------------------~~~------------------------~~~~~~gt~~y~aPE~~~~~~~  248 (353)
                      |++..+...                      ...                        .....+||+.|+|||++.+..|
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            998543210                      000                        0112569999999999999999


Q ss_pred             CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHc
Q 018633          249 NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFEC  328 (353)
Q Consensus       249 ~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  328 (353)
                      +..+|.||||||+|||+.|.+||.......     ...-+..+...-.+++              ....+.+..+||.+|
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~-----T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rl  426 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQE-----TYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRL  426 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHH
Confidence            999999999999999999999998433221     0011111111111111              114457788999999


Q ss_pred             hhcCCCCCCC
Q 018633          329 IKDSPADRPS  338 (353)
Q Consensus       329 l~~dP~~Rps  338 (353)
                      +. ||++|.-
T Consensus       427 l~-d~~~RLG  435 (550)
T KOG0605|consen  427 LC-DPENRLG  435 (550)
T ss_pred             hc-CHHHhcC
Confidence            98 9999975

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.8e-45  Score=334.77  Aligned_cols=245  Identities=17%  Similarity=0.253  Sum_probs=199.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..... .....+.+.+|+.++.+++||||+++++++.+++..
T Consensus        17 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         17 LSDFEMGETLGTGSFG---RVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             chheEEEEEEEecCCe---EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            3568888999999999   9999998  688999999865421 223456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        94 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  165 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFA  165 (329)
T ss_pred             EEEEcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCc
Confidence            9999999999999998765     35788889999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ........ ....
T Consensus       166 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~-~~~~  232 (329)
T PTZ00263        166 KKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKIL-AGRL  232 (329)
T ss_pred             eEcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHh-cCCc
Confidence            766432    2245789999999999988899999999999999999999999863221        11111111 1110


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVA  343 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl  343 (353)
                      .          .    +...+..+.+|+.+||+.||.+||+     +.+++
T Consensus       233 ~----------~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        233 K----------F----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             C----------C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            0          0    0023456779999999999999997     56665

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.1e-44  Score=316.43  Aligned_cols=254  Identities=18%  Similarity=0.310  Sum_probs=205.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++|...+.||+|+||   .||+|.. ++..||+|.+...   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFG---EVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCc---eEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            568888999999999   9999988 6778999987654   23457899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++.....   ..+++..++.++.|++.||+|||   +++++||||||+||+++.++.++|+|||++...
T Consensus        80 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             EecCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceec
Confidence            999999999999875432   45788899999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ............++..|+|||++....++.++||||||+++|+|+| |..||.....        .. ............
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~-~~~~~~~~~~~~  224 (261)
T cd05072         154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SD-VMSALQRGYRMP  224 (261)
T ss_pred             CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HH-HHHHHHcCCCCC
Confidence            4433222233445678999999988889999999999999999998 8888863211        11 111111110000


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                                   .....+.++.+++.+||+.+|++|||++++.+.|+++
T Consensus       225 -------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 -------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                         0013455688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3e-44  Score=318.74  Aligned_cols=250  Identities=18%  Similarity=0.319  Sum_probs=200.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++|+..+.||+|+||   .||++.+ .+..+|+|.+....   ...+.|.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~---~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFG---VVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCc---eEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            347778889999999   9999988 56689999886542   2346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||.++..
T Consensus        78 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          78 TEFMENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             EEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            99999999999887543    35789999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ............++..|+|||++.+..++.++||||||+++|+|++ |..||.....        .+...........  
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~~--  220 (256)
T cd05114         151 LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFRL--  220 (256)
T ss_pred             CCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCC--
Confidence            4332222223345668999999988889999999999999999999 8888863221        1111111111110  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                       ..+           ...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       221 -~~~-----------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 -YRP-----------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -CCC-----------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             000           02345678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.5e-44  Score=322.16  Aligned_cols=258  Identities=21%  Similarity=0.347  Sum_probs=205.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CC-----eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QE-----RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ++|...+.||+|+||   .||+|..  .+     ..||+|.+.... .......|.+|+.++.+++||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFG---KVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCC---cEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            357788899999999   8888876  22     579999886542 345567799999999999999999999999998


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCC-----------ccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHF-----------EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF  203 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  203 (353)
                      ...+++|||+++|+|.+++........           ..+++..++.++.|++.||.|||   +++++|+||||+||++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~  157 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLV  157 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEE
Confidence            999999999999999999875432111           35788899999999999999999   9999999999999999


Q ss_pred             cCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCC
Q 018633          204 NEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLA  281 (353)
Q Consensus       204 ~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~  281 (353)
                      +.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||......    
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----  233 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----  233 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            9999999999999876533221 12233456788999999988889999999999999999998 99998642211    


Q ss_pred             CChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                          + ...........             ..+..++.++.+|+.+||+.||++|||+.+|++.|++
T Consensus       234 ----~-~~~~i~~~~~~-------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 ----E-VIEMIRSRQLL-------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----H-HHHHHHcCCcC-------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                1 11111111111             0112567889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=330.86  Aligned_cols=239  Identities=19%  Similarity=0.230  Sum_probs=193.3

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ||+|+||   .||++.+  ++..||+|++.... ........+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus         1 lg~G~~g---~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFG---KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING   77 (312)
T ss_pred             CCcCCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence            6999999   9999988  68899999986432 1334556788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      |+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||+++...... .
T Consensus        78 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~  148 (312)
T cd05585          78 GELFHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-D  148 (312)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-C
Confidence            9999998764     35889999999999999999999   9999999999999999999999999999987543222 2


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIV  306 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (353)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....        ..+........ .          
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~-~----------  209 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQE-P----------  209 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcC-C----------
Confidence            2345679999999999998889999999999999999999999987321        11111111110 0          


Q ss_pred             hccchHHHHHHHHHHHHHHHHchhcCCCCCCC---HHHHH
Q 018633          307 EDVLSIEKEQQLHASAQLSFECIKDSPADRPS---MVDVA  343 (353)
Q Consensus       307 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~~vl  343 (353)
                        ..  .+...+..+.+++.+||+.||++||+   +.+++
T Consensus       210 --~~--~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         210 --LR--FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             --CC--CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence              00  01134567789999999999999986   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-44  Score=319.75  Aligned_cols=248  Identities=28%  Similarity=0.446  Sum_probs=194.6

Q ss_pred             CCceeeCCCCCccEEEEEEeC------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFWQ------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      .+.||.|.||   .||+|.+.      +..|+||.+... ......+.|.+|++.+++++||||++++|+|...+..++|
T Consensus         4 ~~~ig~G~fg---~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    4 IKQIGEGSFG---KVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEESSE---EEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             eeEEccCCCc---EEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccc
Confidence            4679999999   99999986      788999999653 2455688999999999999999999999999988889999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+++|+|.+++.....   ..+++..++.|+.|++.||.|||   +++++|+||+|+|||+++++.+||+|||++...
T Consensus        80 ~e~~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             EE--TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             cccccccccccccccccc---ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            999999999999988622   46899999999999999999999   899999999999999999999999999999776


Q ss_pred             CCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          221 PEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       221 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ..... .......+...|+|||.+.+..++.++||||||+++||+++ |..|+....        ..+..... ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~-~~~~~~  224 (259)
T PF07714_consen  154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKL-KQGQRL  224 (259)
T ss_dssp             TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHH-HTTEET
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccc-cccccc
Confidence            32222 22234456778999999998889999999999999999999 678875321        11122222 111111


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      .             .+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus       225 ~-------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 P-------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             T-------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             e-------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1             0114566788999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-44  Score=329.51  Aligned_cols=254  Identities=18%  Similarity=0.215  Sum_probs=204.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||+|++..... .......+.+|+.++..++||||+++++++.+.+..|
T Consensus         1 ~~y~~~~~ig~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYG---QVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCe---EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEE
Confidence            368888999999999   9999998  688999999865421 2234567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus        78 lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~  149 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK  149 (333)
T ss_pred             EEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence            999999999999998754     35788999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....    ......||+.|+|||++.+..++.++|||||||++|||++|..||.....        .+.........   
T Consensus       150 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~---  214 (333)
T cd05600         150 GIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWK---  214 (333)
T ss_pred             cccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhcc---
Confidence            6533    23456789999999999988999999999999999999999999874321        11111111100   


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..........    .....+..+.+++.+||..+|++|||+.++++.
T Consensus       215 ~~~~~~~~~~----~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 ETLQRPVYDD----PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccCCCCCc----cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000000000    001446678899999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=336.80  Aligned_cols=265  Identities=22%  Similarity=0.341  Sum_probs=222.0

Q ss_pred             HHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeecccee
Q 018633           54 AQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCC  131 (353)
Q Consensus        54 ~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~  131 (353)
                      +++++....+..-.+.||-|.||   .||.|.|  ..-.||||.++.+   .-..++|+.|+.+|+.+.|||+|+++|+|
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYG---eVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVC  332 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYG---EVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC  332 (1157)
T ss_pred             cchhhccchheeeeeccCCCccc---ceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence            35666666667778899999999   9999999  5678999999776   33468899999999999999999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                      .....+|||+|||.+|+|.++|++...   ..++.-..+.++.||+.|+.||.   .+++|||||..+|.|+.++..+||
T Consensus       333 T~EpPFYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  333 THEPPFYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             ccCCCeEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEe
Confidence            999999999999999999999987654   46777778899999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      +|||+++....+..+......-++.|.|||.+..+.|+.++|||+|||+|||+.| |..||.....        .+. -.
T Consensus       407 ADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqV-Y~  477 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQV-YG  477 (1157)
T ss_pred             eccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHH-HH
Confidence            9999999886655544444444678999999999999999999999999999998 7778764322        221 11


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      +.+             ..+.-..++.|+..+.+||.+||++.|.+||++.|+-+.++.++.+
T Consensus       478 LLE-------------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  478 LLE-------------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             HHh-------------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            111             1222223347889999999999999999999999999999988753

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.9e-44  Score=317.45  Aligned_cols=262  Identities=19%  Similarity=0.278  Sum_probs=209.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||+|..  ++..||+|.+.... ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus         2 ~~~~i~~~l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (267)
T cd08228           2 ANFQIEKKIGRGQFS---EVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN   78 (267)
T ss_pred             cceeeeeeeccCCCe---eEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence            578889999999999   9999988  78999999876432 23455667899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|+||+++|+|.+++....... ..++...++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++.
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQK-RLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccce
Confidence            9999999999998885432111 35788899999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......      ...... ....... 
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~-~~~~~~~-  225 (267)
T cd08228         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQ-KIEQCDY-  225 (267)
T ss_pred             eccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHH-HHhcCCC-
Confidence            7643221 223456888999999998888999999999999999999999998532211      111111 1111111 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                                 ++......+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus       226 -----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 -----------PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----------CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                       11111245577899999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.3e-45  Score=313.26  Aligned_cols=269  Identities=18%  Similarity=0.228  Sum_probs=209.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--Cc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PI  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~  136 (353)
                      .++|...+.|++|+||   .||+|.+  +++.||+|+++.........-.-++|+.+|.+++|||||.+-.+....  +.
T Consensus        75 v~efe~lnrI~EGtyG---iVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYG---VVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             HHHHHHHhhcccCcce---eEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            3568888999999999   9999999  899999999987743333344568999999999999999999987643  56


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .|+|||||+ -+|..++....    +++...++..++.|+++|+.|||   .+.|+||||||+|+|+...|.+||+|||+
T Consensus       152 iy~VMe~~E-hDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  152 IYIVMEYVE-HDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             eeeeHHHHH-hhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccch
Confidence            999999998 59999998776    57899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHH
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYL  288 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~  288 (353)
                      |+.+..... ..+..+-|..|+|||.+.+.. |+.+.|+||+|||+.|++++++.|....+.+.+       +.|....|
T Consensus       224 AR~ygsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  224 AREYGSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             hhhhcCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence            999865432 345567789999999998765 999999999999999999999999865543311       11111111


Q ss_pred             HHHh-----hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYF-----EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+.     ....+.......+.+.+...   ..+..-.+|+...|.+||.+|.|+.+.++
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~---~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGAL---SLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhcccc---ccchhHHHHHHHHhccCccccccHHHhhc
Confidence            1100     01111121222222222211   13467789999999999999999999875

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.5e-44  Score=344.66  Aligned_cols=250  Identities=20%  Similarity=0.229  Sum_probs=200.5

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--C-CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--Q-ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      |...+.||+|++|   .||++..  + +..||+|.+...  .......+.+|+.+++.++|||||++++++...+..|+|
T Consensus        69 y~~~~~lg~G~~g---~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         69 YVLTTLVGRNPTT---AAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             EEEEEEEEeCCCc---EEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            7888999999999   7887776  3 678888877554  445556788899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++|+|.+++....... .++++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEH-LPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EECCCCCCHHHHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            99999999998876432111 46888999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ......... +..  
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~-~~~--  288 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLY-GKY--  288 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC--
Confidence            43322 123456799999999999988899999999999999999999999863211        111111111 111  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                .+ .+...+..+.+++.+||..||+.|||+.+++.
T Consensus       289 ----------~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 ----------DP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ----------CC-CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                      00 01134567889999999999999999999875

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.6e-44  Score=326.47  Aligned_cols=256  Identities=20%  Similarity=0.357  Sum_probs=203.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCe----EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QER----LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      .+|...+.||+|+||   .||+|.+  ++.    .||+|.+.... .....+++.+|+.+++.++||||++++|+|... 
T Consensus         7 ~~f~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           7 TEFKKIKVLGSGAFG---TVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhceeeeeeecCCCc---eEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            458899999999999   9999987  333    48999986542 345567899999999999999999999998764 


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++|+||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccc
Confidence            5789999999999999998654    45788899999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          216 LSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       216 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +++......... .....++..|+|||++....++.++||||||+++|||++ |..||....        ..+. .....
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~-~~~~~  225 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEI-SSILE  225 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHH-HHHHh
Confidence            998765433211 122334668999999998899999999999999999998 999886321        1111 11111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ......             .+..++..+.+++.+||..+|++|||+.+++..|.++..
T Consensus       226 ~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         226 KGERLP-------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCCCCC-------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            111000             001344567899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-43  Score=332.19  Aligned_cols=262  Identities=15%  Similarity=0.141  Sum_probs=197.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++.+  +++.||+|....        ..+.+|+.++++++|||||++++++......++
T Consensus        92 ~~y~~~~~lg~G~~g---~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEG---FAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCe---EEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            579999999999999   9999988  788999997532        356889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+|++. ++|..++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       161 v~e~~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             EEecCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            999996 7898888654     35788999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc-Cccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED-NRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  298 (353)
                      .............||+.|+|||++.+..++.++|||||||++|||++|..|+............ ...+...... +..+
T Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~l~~i~~~~g~~p  310 (391)
T PHA03212        232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS-DRQIKLIIRRSGTHP  310 (391)
T ss_pred             cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCch-hHHHHHHHHHhcCCh
Confidence            4332222233457999999999999888999999999999999999999887543221110000 0000000000 0000


Q ss_pred             c--------cccchh----------hhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          299 E--------IVDPII----------VEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       299 ~--------~~~~~~----------~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .        .++...          ....+ .......+..+.+|+.+||+.||++|||+.++++
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0        000000          00000 0111134567889999999999999999999985

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=335.27  Aligned_cols=245  Identities=19%  Similarity=0.266  Sum_probs=210.0

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcC-CCceeeccceeeeC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMS-HNHILKLIGCCLET  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~  134 (353)
                      ...++|....+||+|+||   +|+.+..  +++.+|||+++++. ......+..+.|.+|+.... ||.+++++.+|.+.
T Consensus       365 ~~l~~F~~l~vLGkGsFG---kV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFG---KVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             ccccceEEEEEeccCcCc---eEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            445678899999999999   9999998  78899999998876 35667788899999999886 99999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      +++|+||||+.||++..+.+.      ..+++..+.-++..|+.||.|||   +++||+||||.+|||+|.+|++||+||
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADF  512 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADF  512 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccc
Confidence            999999999999996555443      46899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      |+++..... ...+.+.+||+.|+|||++.+..|+.++|.|||||+||||+.|..||....+.                 
T Consensus       513 GlcKe~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------  574 (694)
T KOG0694|consen  513 GLCKEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------  574 (694)
T ss_pred             ccccccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------
Confidence            999876432 23578899999999999999999999999999999999999999999854332                 


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                          ++.|.++..+..  .|...+.+..+++.++|..+|++|.-+
T Consensus       575 ----e~FdsI~~d~~~--yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  575 ----EVFDSIVNDEVR--YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----HHHHHHhcCCCC--CCCcccHHHHHHHHHHhccCcccccCC
Confidence                233333333322  122678888999999999999999855

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-44  Score=316.63  Aligned_cols=255  Identities=21%  Similarity=0.352  Sum_probs=204.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .++|...+.||+|++|   .||+|.+ .++.||+|.+....   ...+.+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~---~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFG---EVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCc---cEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            4568888999999999   9999888 66789999987542   235678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++.....   ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.++|+|||++..
T Consensus        79 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             eeecccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            9999999999999876532   35789999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ..............+..|+|||++.+..++.++||||||+++|||+| |..||......        . ........ ..
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~-~~~~~~~~-~~  222 (261)
T cd05068         153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------E-VLQQVDQG-YR  222 (261)
T ss_pred             ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------H-HHHHHHcC-CC
Confidence            65322211122223457999999988889999999999999999999 88888632211        1 11111111 00


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .        .    .+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       223 ~--------~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 M--------P----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             C--------C----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            0        0    0113456788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.2e-44  Score=328.74  Aligned_cols=242  Identities=16%  Similarity=0.185  Sum_probs=196.0

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      ++||+|+||   .||++..  +++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         1 ~~lG~G~~g---~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence            469999999   9999887  789999999975421 2345567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++|+|.+.+...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        78 ~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          78 NGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence            999999888654     35889999999999999999999   9999999999999999999999999999987542221


Q ss_pred             CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccch
Q 018633          225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPI  304 (353)
Q Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (353)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|..||......        ........ ...       
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~-~~~-------  212 (328)
T cd05593         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM-EDI-------  212 (328)
T ss_pred             -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhcc-CCc-------
Confidence             1233457899999999999888999999999999999999999998632211        11111100 000       


Q ss_pred             hhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          305 IVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       305 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                         ..    +...+..+.+++.+||..||++||     ++.++++
T Consensus       213 ---~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         213 ---KF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ---cC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence               00    013455678999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=343.60  Aligned_cols=254  Identities=19%  Similarity=0.288  Sum_probs=216.4

Q ss_pred             CCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .+.++||.|.||   .|++|.+     ....||||.++... ..+.+.+|+.|+.||.+++||||++|-|+.......+|
T Consensus       632 ~Ie~VIGaGEFG---EVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  632 KIEKVIGAGEFG---EVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             EEEEEEeccccc---ceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            346899999999   9999998     35689999998874 66778899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+|||++|+|+.+|+.+.    ..+.+.+...++++||.|+.||-   +.+.|||||.++|||++.+..+||+|||+++.
T Consensus       708 iTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             EhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999887    45899999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCCcccccccc--CCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          220 IPEGETHITDTVMG--TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       220 ~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      +.++......+..|  +.+|.|||.+....++.+|||||||+++||.++ |..||-...+.        +.++...++-+
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------dVIkaIe~gyR  852 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVIKAIEQGYR  852 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------HHHHHHHhccC
Confidence            76554333333333  468999999999999999999999999999887 88887632222        22333322222


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      +              +.|.+++..|.+||..||++|-.+||.+.+|+..|.++.+
T Consensus       853 L--------------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  853 L--------------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             C--------------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            2              2233789999999999999999999999999999999875

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-43  Score=315.75  Aligned_cols=255  Identities=19%  Similarity=0.272  Sum_probs=205.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeC-----CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQ-----ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++|+..+.||+|+||   .||+|.+.     ...||+|.+.... .......|.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~lg~g~~g---~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFG---EVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccc---eEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            568889999999999   99999882     3579999886542 34456779999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+|+||||+|||++.++.++|+|||+
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          80 VMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccch
Confidence            999999999999999987654    36889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          217 SISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       217 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      +......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....        .. .......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~-~~~~~~~  223 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QD-VIKAVED  223 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HH-HHHHHHc
Confidence            9876422211 1122334578999999998889999999999999999998 9888753211        11 1111111


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .....             .+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus       224 ~~~~~-------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 GYRLP-------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCC-------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10000             0113456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-43  Score=319.76  Aligned_cols=262  Identities=21%  Similarity=0.300  Sum_probs=208.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++|...+.||+|+||   .||++..       ++..+|+|.+...  .......+.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~~---~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFG---KVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             hHHeeeccccCCcCCe---eEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            3568889999999999   8887763       3466899988765  45567789999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCC--------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQ--------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      .+..++||||+++++|.+++.....        .....+++..++.++.|++.||.|||   +++++||||||+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~  155 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGE  155 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEcc
Confidence            9999999999999999999875431        11135899999999999999999999   999999999999999999


Q ss_pred             CCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCC
Q 018633          206 ENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACP  283 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~  283 (353)
                      ++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||......      
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------  229 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------  229 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence            99999999999876533221 11223445778999999988889999999999999999999 88887633211      


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                        ..... .........             +...+..+.+++.+||+.+|.+|||+.++++.|+++..+
T Consensus       230 --~~~~~-i~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         230 --EVIEC-ITQGRVLQR-------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             --HHHHH-HHcCCcCCC-------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence              11111 111111100             013445689999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.4e-44  Score=334.24  Aligned_cols=264  Identities=16%  Similarity=0.276  Sum_probs=206.9

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeecccee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCC  131 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~  131 (353)
                      ..+.|...+.||+|+||   .||+|.+.       ...||||++.... .....+.|.+|+.+++++. |||||+++++|
T Consensus        35 ~~~~~~~~~~LG~G~fG---~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFG---KVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             cccceehhheecCCCCc---eEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            35678888999999999   99999862       2469999996542 3445678999999999996 99999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCC----------------------------------------------------
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQP----------------------------------------------------  159 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  159 (353)
                      ...+..|+|||||++|+|.+++......                                                    
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999999887643110                                                    


Q ss_pred             ---------------------------------------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCc
Q 018633          160 ---------------------------------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC  200 (353)
Q Consensus       160 ---------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  200 (353)
                                                             ....+++..++.++.|++.||.|||   +++|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence                                                   0024678888999999999999999   9999999999999


Q ss_pred             eeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCcccccc
Q 018633          201 ILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTH  278 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~  278 (353)
                      ||++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999876543222 11233456778999999988889999999999999999997 888886322111


Q ss_pred             CCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                              ...........             ...+...+..+.+++.+||+.+|++|||+.+|.+.|+++.+
T Consensus       348 --------~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 --------TFYNKIKSGYR-------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             --------HHHHHHhcCCC-------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                    11111111100             00011455678899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=314.73  Aligned_cols=272  Identities=19%  Similarity=0.207  Sum_probs=210.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee---
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE---  133 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~---  133 (353)
                      .....|...+.||+|+||   .|+.+.+  ++..||||++..........++..+|+++|+.++|+||+.+++++..   
T Consensus        19 ~i~~~y~~~~~iG~GAyG---vVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYG---VVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eccceecccccccCccee---eEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            344556667889999999   9999998  88999999998766678888999999999999999999999999875   


Q ss_pred             --CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          134 --TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       134 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                        -+..|+|+|+|+ .+|...++..     ..++...+..+++|+++||.|+|   +.+|+||||||+|+|++.+..+||
T Consensus        96 ~~f~DvYiV~elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen   96 DKFNDVYLVFELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             cccceeEEehhHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEe
Confidence              246899999995 7898888775     45899999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCC-ccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCC
Q 018633          212 FDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LAC  282 (353)
Q Consensus       212 ~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~  282 (353)
                      +|||+|+....... ...+..+.|..|.|||++.. ..|+.+.||||+|||+.||++|++.|.+....+.       .+.
T Consensus       167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT  246 (359)
T ss_pred             ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence            99999998754311 11245677999999998754 5699999999999999999999999987655332       122


Q ss_pred             ChHHHHHHHhhcCccccccc---chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVD---PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +..+.+...- ..+....+.   ..-..+.....+ .......+|+.+||..||.+|+|++|+++
T Consensus       247 P~~e~l~~i~-s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  247 PSEEDLQKIR-SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             CCHHHHHHhc-cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            2222221111 000000100   000011111111 44566789999999999999999999875

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-44  Score=331.22  Aligned_cols=247  Identities=16%  Similarity=0.226  Sum_probs=200.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ..++|...+.||+|+||   .||+|.+   .+..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        28 ~~~~y~~~~~ig~G~~g---~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFG---RVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             ChhhcEEEEEEeecCCe---EEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            34568889999999999   9999986   236899999864321 2344567889999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCC
Confidence            999999999999999999765     35789999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ++......    .....||+.|+|||++.+..++.++|||||||++|||++|..||......        ........ .
T Consensus       177 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~-~  243 (340)
T PTZ00426        177 FAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILE-G  243 (340)
T ss_pred             CCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhc-C
Confidence            99765322    23457899999999998888999999999999999999999999743211        11111111 1


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                      .. .         .    +...+..+.+++.+||+.||++|+     |+.++++
T Consensus       244 ~~-~---------~----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        244 II-Y---------F----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CC-C---------C----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            00 0         0    012344567899999999999995     7888765

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.4e-43  Score=313.44  Aligned_cols=262  Identities=20%  Similarity=0.305  Sum_probs=210.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|+..+.||+|+||   .||+|..  +++.||+|.+..... .....+.+.+|+.++++++|+||+++++++...+..+
T Consensus         2 ~~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFS---VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN   78 (267)
T ss_pred             CceeeeeeeccCCce---EEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            578899999999999   9999998  689999998864322 3444678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++....... ..+++..++.++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccC-CCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceee
Confidence            9999999999999886532211 45789999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ........ ...... 
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-  225 (267)
T cd08224         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKK-IEKCDY-  225 (267)
T ss_pred             eccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhh-hhcCCC-
Confidence            6543221 12344678889999999888899999999999999999999999863221      11111111 111111 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                                 .+......+..+.+++.+||..+|++|||+.+|++.|.++.
T Consensus       226 -----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 -----------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                       11111145667889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-45  Score=299.93  Aligned_cols=249  Identities=17%  Similarity=0.292  Sum_probs=209.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|+..+.||+|-||   .||.|..  ++..||+|++.+... ..+...++.+|+++-+.|+||||+++|++|.+....
T Consensus        21 l~dfeigr~LgkgkFG---~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFG---NVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             hhhccccccccCCccc---cEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            4678999999999999   9999998  788999999976542 233456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+++||.++|+|+..|.....   ..+++.....++.|+|.||.|+|   .++||||||||+|+|++..+.+|++|||-+
T Consensus        98 yLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             EEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            999999999999999986543   46888889999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ...+   .....+.+||..|.+||...+...+...|+|++|++.||++.|.+||.......        -.+...    -
T Consensus       172 V~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--------tYkrI~----k  236 (281)
T KOG0580|consen  172 VHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--------TYKRIR----K  236 (281)
T ss_pred             eecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--------HHHHHH----H
Confidence            7654   223567899999999999999999999999999999999999999997433111        111111    1


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .++..+           ...+....++|.+|+..+|.+|.+..+++.
T Consensus       237 ~~~~~p-----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  237 VDLKFP-----------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ccccCC-----------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence            111111           156677889999999999999999999875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-43  Score=326.80  Aligned_cols=198  Identities=19%  Similarity=0.279  Sum_probs=174.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|+..+.||+|+||   .||++.+  ++..+|+|.+.... .......+.+|++++++++||||++++++|.+++..+
T Consensus         4 ~~~y~~~~~lg~g~~g---~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGG---VVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCE---EEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            3679999999999999   9999998  67889999886542 3445677999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   + .+|+||||||+|||++.++.+||+|||++
T Consensus        80 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~  151 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (333)
T ss_pred             EEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence            999999999999998754     35788899999999999999999   6 47999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDL  273 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~  273 (353)
                      ......   ......|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       152 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         152 GQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            765322   12345689999999999888899999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.9e-44  Score=328.26  Aligned_cols=242  Identities=17%  Similarity=0.197  Sum_probs=195.0

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      ++||+|+||   .||++..  ++..||+|++..... .......+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         1 ~~lG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence            469999999   9999887  789999999875421 2334567788999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++|+|..++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        78 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          78 NGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            999998888654     35789999999999999999999   9999999999999999999999999999986532221


Q ss_pred             CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccch
Q 018633          225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPI  304 (353)
Q Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (353)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|..||......        ........ ...       
T Consensus       150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~~-~~~-------  212 (323)
T cd05595         150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILM-EEI-------  212 (323)
T ss_pred             C-ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc-CCC-------
Confidence            1 223457899999999999889999999999999999999999998632211        11111110 000       


Q ss_pred             hhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          305 IVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       305 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                         ..    +...+..+.+++.+||+.||++||     ++.++++
T Consensus       213 ---~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 ---RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ---CC----CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence               00    013456678999999999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=318.80  Aligned_cols=248  Identities=20%  Similarity=0.286  Sum_probs=208.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ...|+..+.||+|.||   .|-++..  .|+.||||.+.++.. ..+..-.+.+|++||..|+||||+.+|.+|++.+..
T Consensus        52 kHRyE~~etLGkGTYG---KVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYG---KVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             hhHHHHHHHhcCCccc---ceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            3568888899999999   8888877  899999999977642 455566789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      .|||||..+|.|+|++...     ..+++.+++.+++||.+|+.|+|   .++++|||||.+|||+|.++++||+|||++
T Consensus       129 vivMEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             EEEEEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchh
Confidence            9999999999999999876     46999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ..+.....  ..+++|++-|.+||.+.+.+|. +..|.||||++||-|+.|..||+...        ....+.+. ..+.
T Consensus       201 Nly~~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQI-s~Ga  269 (668)
T KOG0611|consen  201 NLYADKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQI-SRGA  269 (668)
T ss_pred             hhhccccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHh-hccc
Confidence            88754433  5788999999999999999975 78999999999999999999998432        11122211 1111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      +.+.               ..+....-||.+||..+|++|-|+.+|...
T Consensus       270 YrEP---------------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  270 YREP---------------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ccCC---------------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            1111               223344568999999999999999998753

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.3e-43  Score=315.14  Aligned_cols=261  Identities=21%  Similarity=0.294  Sum_probs=208.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .+|...+.||+|+||   .||++.+       ++..+++|.+...  .....+.+.+|+.++++++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g---~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFG---KVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCC---eEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            357778899999999   8888874       3456888888655  455567899999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF  203 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  203 (353)
                      +..++||||+++++|.+++......           ....+++..++.++.|++.||.|||   +++++||||||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence            9999999999999999998754310           1134789999999999999999999   9999999999999999


Q ss_pred             cCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCC
Q 018633          204 NEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLA  281 (353)
Q Consensus       204 ~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~  281 (353)
                      +.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||+| |..||......    
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----  232 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----  232 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999999876543221 11233456788999999998889999999999999999999 99997643211    


Q ss_pred             CChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                          . .............             +...+..+.+++.+||+.+|++|||+.++++.|.++...
T Consensus       233 ----~-~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         233 ----E-VIECITQGRVLER-------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ----H-HHHHHhCCCCCCC-------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                1 1111111111111             013456788999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.5e-44  Score=328.44  Aligned_cols=253  Identities=15%  Similarity=0.138  Sum_probs=202.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++..  +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus         1 ~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFG---EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY   77 (330)
T ss_pred             CCceEEEEEEeccCE---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEE
Confidence            468888999999999   9999888  788999999975422 2334567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++....    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus        78 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             EEECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence            9999999999999997653    36889999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccc------cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMR------TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ..............||+.|+|||++.      ...++.++|||||||++|||++|..||.....        ........
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~  222 (330)
T cd05601         151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIM  222 (330)
T ss_pred             ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHH
Confidence            76543332233457899999999986      45578999999999999999999999863221        11111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .........+           ....+..+.+|+..||. +|.+|||+.++++
T Consensus       223 ~~~~~~~~~~-----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         223 NFQRFLKFPE-----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCCccCCCC-----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1111100000           01345667889999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.7e-43  Score=310.76  Aligned_cols=247  Identities=22%  Similarity=0.311  Sum_probs=197.8

Q ss_pred             ceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           69 VIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .||+|+||   .||+|.+    ++..+|+|++..........+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus         2 ~lg~G~~g---~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFG---TVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCc---ceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            58999999   8888865    5789999998766445566788999999999999999999999875 45678999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++|+|.+++...     ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.++|+|||++.......
T Consensus        78 ~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          78 ELGPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            999999998654     35789999999999999999999   9999999999999999999999999999987764433


Q ss_pred             Ccc--ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          225 THI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       225 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      ...  .....++..|+|||.+....++.++|+||||+++|||++ |..||......        .. ...........  
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~-~~~i~~~~~~~--  218 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EV-TQMIESGERME--  218 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HH-HHHHHCCCCCC--
Confidence            211  122234578999999988889999999999999999998 99998632211        11 11111111111  


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                             .    +...+..+.+++.+||+.||++|||+.+|.+.|++.
T Consensus       219 -------~----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 -------C----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -------C----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                   0    113456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-43  Score=320.84  Aligned_cols=264  Identities=19%  Similarity=0.265  Sum_probs=198.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||+|..  +++.||+|++.... .......+.+|+.+++.++||||+++++++.+....+
T Consensus         4 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYA---TVYKGKSKVNGKLVALKVIRLQE-EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCE---EEEEEEECCCCCEEEEEEecccc-ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence            4679999999999999   9999998  78899999987542 1223346788999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||++ ++|.+++....    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus        80 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  151 (303)
T cd07869          80 LVFEYVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR  151 (303)
T ss_pred             EEEECCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence            9999996 78888886543    45788899999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh---c
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE---D  294 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~  294 (353)
                      ...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......       ........   .
T Consensus       152 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~  223 (303)
T cd07869         152 AKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-------DQLERIFLVLGT  223 (303)
T ss_pred             eccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-------HHHHHHHHHhCC
Confidence            543222 12234568899999999865 458889999999999999999999997533211       11111000   0


Q ss_pred             C---------cccccccchhh----hccchH-HHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 N---------RFTEIVDPIIV----EDVLSI-EKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~---------~~~~~~~~~~~----~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .         ..+........    ...... .....+..+.+|+.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0         00000000000    000000 00012356789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.6e-44  Score=343.19  Aligned_cols=262  Identities=19%  Similarity=0.213  Sum_probs=209.3

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      .+.....++|...+.||+|+||   .||++.+  +++.||||++............+.+|+..+..++|+||+++++.+.
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG---~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATG---TVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCE---EEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            3444566789999999999999   9999987  7899999999766555666778899999999999999999988775


Q ss_pred             eCC--------ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          133 ETP--------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       133 ~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                      ..+        ..++||||+++|+|.+++....... ..+++..+..++.|++.||.|||   +++|+||||||+|||++
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~-~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~  177 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-RTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLC  177 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEe
Confidence            432        3679999999999999886543211 46889999999999999999999   99999999999999999


Q ss_pred             CCCceEEeccCCccccCCCC-CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACP  283 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~  283 (353)
                      .++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..||....        
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------  249 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------  249 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------
Confidence            99999999999987654322 112345679999999999999899999999999999999999999986321        


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .......... .....             .+...+..+.+++.+||+.||++|||+.+++..
T Consensus       250 ~~~~~~~~~~-~~~~~-------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        250 MEEVMHKTLA-GRYDP-------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHHHhc-CCCCC-------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111111111 11100             011455678899999999999999999998763

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=333.82  Aligned_cols=253  Identities=17%  Similarity=0.211  Sum_probs=203.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++.+  +++.||+|++..... .......+.+|+.++..++||||+++++++.+++..|
T Consensus         1 ~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFG---EVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcE---EEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEE
Confidence            368888999999999   9999998  689999999875422 1244567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++.
T Consensus        78 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             EEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            999999999999998765     35889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCC----------------------------CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCC
Q 018633          219 SIPEGE----------------------------THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDV  270 (353)
Q Consensus       219 ~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p  270 (353)
                      ......                            ........||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence            664332                            1122345789999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-HHHHHHH
Q 018633          271 SDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-MVDVAKK  345 (353)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~vl~~  345 (353)
                      |......        ...........      .......     ...+..+.+++.+||. ||.+||+ +.++++.
T Consensus       230 f~~~~~~--------~~~~~i~~~~~------~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         230 FYSDTLQ--------ETYNKIINWKE------SLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCHH--------HHHHHHhccCC------cccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            8743211        11111111000      0000000     0245678899999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.1e-43  Score=317.12  Aligned_cols=261  Identities=18%  Similarity=0.237  Sum_probs=196.8

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc---CCCceeeccceee----
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQFYGHECRPRAYESCINNVTYAARM---SHNHILKLIGCCL----  132 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~----  132 (353)
                      +|...+.||+|+||   .||++.+   ++..||+|.+............+.+|+.+++.+   .||||++++++|.    
T Consensus         2 ~Y~~~~~lg~G~~g---~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           2 QYECVAEIGEGAYG---KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CcceeeEeccCCCe---EEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            58888999999999   9999987   467899999875543344445667788877766   6999999999985    


Q ss_pred             -eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          133 -ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       133 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                       ....+++||||++ ++|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEE
Confidence             2346899999997 699998875432   35789999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      +|||++......  .......||..|+|||++.+..++.++|||||||++|||++|.+||.......        .....
T Consensus       152 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--------~~~~i  221 (290)
T cd07862         152 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--------QLGKI  221 (290)
T ss_pred             ccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--------HHHHH
Confidence            999998765432  22345578999999999988889999999999999999999999997543211        11111


Q ss_pred             hhcC------ccc-------ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDN------RFT-------EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~------~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....      .++       ............ ......+..+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHhCCCChhhchhhhcccchhccCCCCCCHH-HHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            1000      000       000000000000 001134567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-43  Score=327.19  Aligned_cols=269  Identities=18%  Similarity=0.233  Sum_probs=197.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-----
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-----  135 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----  135 (353)
                      .|...+.||+|+||   .||+|..  ++..||+|++............+.+|+.++++++||||+++++++....     
T Consensus         1 ry~i~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYG---VVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCe---EEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            36778899999999   9999987  7899999998754333445567899999999999999999999986432     


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+||||+. ++|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg  148 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFG  148 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCc
Confidence            4799999996 7899888754     35889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCc--cccccccCCcccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCCh
Q 018633          216 LSISIPEGETH--ITDTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPS  284 (353)
Q Consensus       216 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~  284 (353)
                      +++........  ......||..|+|||++.+  ..++.++|||||||++|||+||+.||........       ...+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  228 (338)
T cd07859         149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS  228 (338)
T ss_pred             cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            98765322211  1234578999999999865  5689999999999999999999999864332110       00011


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHH--HHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIE--KEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........ ....................  ....+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         229 PETISRVR-NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHHhh-hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            11111000 00000000000000000000  0023456789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-43  Score=331.45  Aligned_cols=255  Identities=16%  Similarity=0.202  Sum_probs=201.8

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ...++|...+.||+|+||   .||++..  ++..||+|++..... .......+.+|+.+++.++||||+++++++.+++
T Consensus        40 ~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFG---EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             CCHHHcEEEEEEeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            445679999999999999   9999988  788999999864321 2233456789999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+||||+++|+|.+++...      .++...+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEecc
Confidence            999999999999999988643      4678888899999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccC----CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTG----VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ++...............||+.|+|||++.+.    .++.++|||||||++|||++|..||.....        .......
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i  259 (370)
T cd05596         188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKI  259 (370)
T ss_pred             ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHH
Confidence            9877643332223456799999999998653    378999999999999999999999874321        1111111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCC--CCCHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD--RPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~vl~  344 (353)
                      .........         +  .....+..+.+++.+||+.+|.+  |||+.++++
T Consensus       260 ~~~~~~~~~---------~--~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         260 MDHKNSLTF---------P--DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HcCCCcCCC---------C--CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            111000000         0  00134567889999999999987  999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.6e-44  Score=316.85  Aligned_cols=256  Identities=21%  Similarity=0.359  Sum_probs=208.5

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ...+|+..+.||.|+||   .||+|.+ .+..+++|.+...  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus         4 ~~~~y~~~~~ig~g~~~---~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFG---EVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCc---cEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            34568888999999999   9999998 6788999998766  3445677999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||.+.
T Consensus        79 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~  152 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLAR  152 (261)
T ss_pred             EEEeecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchh
Confidence            99999999999999976543   45789999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ........ .....++..|+|||.+....++.++||||||+++|+|++ |..||.....        .+...........
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~  223 (261)
T cd05148         153 LIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQITAGYRM  223 (261)
T ss_pred             hcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHHhCCcC
Confidence            66433221 223345678999999988889999999999999999998 8888863221        1111111110000


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                                .    .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       224 ----------~----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ----------P----CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----------C----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                      0    0114556788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-43  Score=311.63  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=206.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..+.||+|++|   .||++.+  ++..|++|.+............+.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~~~~~~~l~~g~~~---~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFG---VVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCe---EEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            46778899999999   9999988  789999999876544566778899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||+++..
T Consensus        78 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          78 MEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             EEeCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence            999999999999876532   46889999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......        ....... ...... 
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~~~-  220 (256)
T cd08529         152 SDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKII-RGVFPP-  220 (256)
T ss_pred             cCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH-cCCCCC-
Confidence            44322 223456888999999999888999999999999999999999998743211        1111111 111111 


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                  .+...+..+.+++.+||+.+|++||++.++++
T Consensus       221 ------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         221 ------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ------------CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence                        01145567889999999999999999999886

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.9e-44  Score=312.58  Aligned_cols=275  Identities=19%  Similarity=0.217  Sum_probs=205.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc-eeeccceeeeCC--
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH-ILKLIGCCLETP--  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~--  135 (353)
                      ...|...+.||+|+||   +||+|..  +|+.||+|++.-............+|+.+++.++|+| ||.+++++.+.+  
T Consensus        10 ~~~~~~~eklGeGtyg---~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYG---VVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCce---EEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            3446666779999999   9999999  8999999999766433344566789999999999999 999999998877  


Q ss_pred             ----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          136 ----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       136 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                          .+++|+||+. -+|..++....... ..++...+..++.||+.||+|||   +++|+||||||.||||++.|.+||
T Consensus        87 ~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             cccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEee
Confidence                7899999997 79999998765321 24667889999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCC
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACP  283 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~  283 (353)
                      +|||+|+...-+.. ......+|..|.|||++.+. .|+...||||+|||+.||++++..|....+...+       +.|
T Consensus       162 aDFGlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  162 ADFGLARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP  240 (323)
T ss_pred             eccchHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence            99999987653332 24556789999999999887 5999999999999999999999999865542210       111


Q ss_pred             hHHHHHHHhhcCcccccccchh-hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPII-VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..+.|.....-..+.......- ..+..... +.......+++.+||+++|..|.|+..++..
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111000000000000000000 00000000 0112467899999999999999999998864

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-44  Score=316.73  Aligned_cols=265  Identities=20%  Similarity=0.265  Sum_probs=202.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC--
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP--  135 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--  135 (353)
                      .+-.|...+++|+|+||   .||+|..  ++..||||++..+.      +---+|+.+|+++.|||||++.-+|....  
T Consensus        22 ~~i~~~~~~liG~GsFg---~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFG---VVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             eEEEEEeeEEEeecccc---eEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence            34458888999999999   9999999  77999999987662      11246899999999999999988876432  


Q ss_pred             ---ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEE
Q 018633          136 ---IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKL  211 (353)
Q Consensus       136 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl  211 (353)
                         ...+||||+| .||.+.++.....+ ..++...+.-+..||.+||.|||   +.+|+||||||.|+|+|.+ |.+||
T Consensus        93 d~~~lnlVleymP-~tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen   93 DEVYLNLVLEYMP-ETLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             chhHHHHHHHhch-HHHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEe
Confidence               2458999999 69999998532211 56788888899999999999999   9999999999999999976 89999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCC
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACP  283 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~  283 (353)
                      ||||.|+.+..+..  ..+...|..|+|||.+.+.. |+.+.||||.||++.||+-|++.|.+....+       .++.|
T Consensus       168 cDFGSAK~L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P  245 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP  245 (364)
T ss_pred             ccCCcceeeccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence            99999999866554  45677899999999998754 9999999999999999999999998644322       12233


Q ss_pred             hHHHHHHHhh---cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          284 SNEYLKNYFE---DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       284 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+.+...-.   ...++.+....+..    ......+.+..+|+.++|.++|.+|.|+.+++.
T Consensus       246 t~e~I~~mn~~y~~~~~p~ik~~~~~~----~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  246 TREDIKSMNPNYTEFKFPQIKAHPWHK----VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CHHHHhhcCcccccccCccccccccee----ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            3333322111   11122222211111    111245667889999999999999999998875

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.6e-43  Score=314.31  Aligned_cols=250  Identities=16%  Similarity=0.287  Sum_probs=199.6

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      +|...+.||+|+||   .||.+.+ .+..+|+|.+....   ...+.|.+|+.++.+++||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~G~~~---~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           5 DLTFLKELGTGQFG---VVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HeEEeeEecCcccc---eEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            46777889999999   9999988 44569999887542   23467899999999999999999999999888999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.+||+|||.++...
T Consensus        79 e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          79 EYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             EcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecC
Confidence            9999999999987643    35789999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ...........++..|+|||++.+..++.++||||||+++|+|++ |..||......        ....... ...... 
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~-~~~~~~-  221 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVS-QGLRLY-  221 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHh-cCCCCC-
Confidence            332222222345678999999988889999999999999999999 88887632211        1111111 111000 


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                                  .+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       222 ------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 ------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                        00123567889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-43  Score=316.69  Aligned_cols=257  Identities=23%  Similarity=0.345  Sum_probs=204.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ++|...+.||+|+||   .||+|.+       ++..||+|.+.... .....+.|.+|++++++++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~---~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFG---KVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCc---eEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            457888999999999   9998876       24689999987652 233567899999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCC---------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQ---------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      ...++||||+++++|.+++.....         .....+++..+..++.|++.||.|||   +++++||||||+||+++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcC
Confidence            999999999999999999975431         11135788899999999999999999   999999999999999999


Q ss_pred             CCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCC
Q 018633          206 ENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACP  283 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~  283 (353)
                      ++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......      
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------  231 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------  231 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------
Confidence            99999999999876432221 11233445778999999999999999999999999999999 99998632211      


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                        ..... ...+.....             +...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       232 --~~~~~-~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 --EVIEC-ITQGRLLQR-------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HHHHH-HHcCCcCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              11111 111111110             1145567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-43  Score=329.03  Aligned_cols=252  Identities=14%  Similarity=0.196  Sum_probs=199.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|+..+.||+|+||   .||++..  +++.||||++..... .......+.+|+.++..++||||+++++++.+++..|
T Consensus         1 ~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFG---EVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLY   77 (364)
T ss_pred             CCceEEEEEEecCCE---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEE
Confidence            468889999999999   9999998  788999999965421 2334566889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++.
T Consensus        78 lv~E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             EEECCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccce
Confidence            999999999999998764     35889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCc-------------------------------------cccccccCCccccccccccCCCCccccchhhHHHH
Q 018633          219 SIPEGETH-------------------------------------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFL  261 (353)
Q Consensus       219 ~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  261 (353)
                      ........                                     ......||+.|+|||++....++.++|||||||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            54321100                                     01124689999999999988899999999999999


Q ss_pred             HHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC---
Q 018633          262 FELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS---  338 (353)
Q Consensus       262 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---  338 (353)
                      |||++|..||......        +..............     ...      ...+..+.+++.+|+. +|.+|++   
T Consensus       230 ~el~~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~-----~~~------~~~s~~~~~li~~ll~-~p~~R~~~~~  289 (364)
T cd05599         230 YEMLVGYPPFCSDNPQ--------ETYRKIINWKETLQF-----PDE------VPLSPEAKDLIKRLCC-EAERRLGNNG  289 (364)
T ss_pred             HHhhcCCCCCCCCCHH--------HHHHHHHcCCCccCC-----CCC------CCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence            9999999999743211        111111110000000     000      0234567789999996 9999998   


Q ss_pred             HHHHHH
Q 018633          339 MVDVAK  344 (353)
Q Consensus       339 ~~~vl~  344 (353)
                      +.++++
T Consensus       290 ~~~ll~  295 (364)
T cd05599         290 VNEIKS  295 (364)
T ss_pred             HHHHhc
Confidence            888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.6e-43  Score=313.53  Aligned_cols=262  Identities=19%  Similarity=0.278  Sum_probs=209.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|++|   .||++.+  ++..+|+|.+.... .......++.+|+.+++.++||||+++++++..++..+
T Consensus         2 ~~y~~~~~ig~g~~g---~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFS---EVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN   78 (267)
T ss_pred             chhhhhhhhcccCCe---EEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence            468888999999999   9999997  88999999876432 23345578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      ++|||+++++|.+++....... ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++.
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQK-RLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            9999999999999886432111 46789999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......      ........ ..... 
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~-  225 (267)
T cd08229         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKI-EQCDY-  225 (267)
T ss_pred             ccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhh-hcCCC-
Confidence            6543222 223456888999999998888999999999999999999999998632211      01111110 00000 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                                 ++......+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus       226 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 -----------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -----------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                       00111145678899999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-43  Score=327.83  Aligned_cols=248  Identities=20%  Similarity=0.251  Sum_probs=193.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++.+  +++.||+|++.... .......+.+|+.+++.++|+||+++++++...+..++
T Consensus        74 ~~~~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         74 SELERVNRIGSGAGG---TVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             HHHhhhhhccCCCCe---EEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            446667889999999   9999988  68999999986542 34456778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|.+..         ...+..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       150 v~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        150 LLEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             EEecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999986532         3456777889999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCccccccccCCccccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTG-----VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ..... .......||..|+|||++...     ..+.++|||||||++|||++|+.||.......     ......... .
T Consensus       218 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~-~  290 (353)
T PLN00034        218 LAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAIC-M  290 (353)
T ss_pred             ccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHh-c
Confidence            64322 123345789999999987432     24568999999999999999999987322111     000000000 0


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ...             ...+...+..+.+|+.+||+.||++|||+.++++.
T Consensus       291 ~~~-------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 SQP-------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             cCC-------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000             00011455678899999999999999999999863

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.3e-43  Score=321.71  Aligned_cols=250  Identities=20%  Similarity=0.275  Sum_probs=196.4

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ++||+|+||   .||++.+  ++..||+|++..... .....+.+.+|..++..+ +||||+++++++.+.+..|+||||
T Consensus         1 ~~lG~G~~g---~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~   77 (329)
T cd05588           1 RVIGRGSYA---KVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF   77 (329)
T ss_pred             CeEeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence            469999999   9999988  788999999975422 233456688999999998 699999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          78 VSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence            9999999888654     46899999999999999999999   999999999999999999999999999998653221


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||..|+|||++.+..++.++|+|||||++|+|++|..||+..............+.......... .    
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~----  223 (329)
T cd05588         150 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R----  223 (329)
T ss_pred             C-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C----
Confidence            1 123456789999999999988899999999999999999999999974332221111111222221111110 0    


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC------HHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS------MVDVA  343 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~~vl  343 (353)
                           .    +...+..+.+++.+||+.||.+|||      +.+++
T Consensus       224 -----~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         224 -----I----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             -----C----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence                 0    1134556789999999999999998      55654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-43  Score=324.34  Aligned_cols=264  Identities=19%  Similarity=0.342  Sum_probs=205.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCL  132 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~  132 (353)
                      .++|...+.||+|+||   .||+|..       +++.||+|++.... .....+.+.+|+.++.++ +||||++++++|.
T Consensus         6 ~~~~~i~~~lG~G~fg---~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFG---KVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHHhhhhcccccCcCc---eEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            3468889999999999   8888864       34689999987542 334456788999999999 7999999999886


Q ss_pred             e-CCccEEEEEeccCCChhhhhccCCCCC---------------------------------------------------
Q 018633          133 E-TPIPILVFESVQYGTLWDRILGAPQPH---------------------------------------------------  160 (353)
Q Consensus       133 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  160 (353)
                      . +...+++|||+++++|.+++.......                                                   
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 456889999999999999886432100                                                   


Q ss_pred             -----CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc-cccccccC
Q 018633          161 -----FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGT  234 (353)
Q Consensus       161 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt  234 (353)
                           ...+++..+..++.||+.||.|||   +++|+||||||+||+++.++.++|+|||++..+...... ......++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                 025788999999999999999999   999999999999999999999999999999876433221 12334566


Q ss_pred             CccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHH
Q 018633          235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIE  313 (353)
Q Consensus       235 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (353)
                      ..|+|||++.+..++.++|||||||++|||++ |..||......        +.............             .
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~-------------~  297 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRMR-------------A  297 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCCC-------------C
Confidence            78999999999999999999999999999998 99998632211        11111111111100             0


Q ss_pred             HHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          314 KEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       314 ~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      +...+.++.+++.+||+.+|++|||+.++++.|+++...
T Consensus       298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            113456788999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4e-43  Score=327.67  Aligned_cols=256  Identities=17%  Similarity=0.211  Sum_probs=200.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ...++|...+.||+|+||   .||++.+  +++.+|+|.+.... ........+.+|+.+++.++||||+++++++.+++
T Consensus        40 ~~~~~y~~~~~lG~G~fg---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFG---EVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             CCHHHCeEEEEEEecCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            445789999999999999   9999998  68899999986432 12234456889999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+||||+++|+|.+++...      .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecc
Confidence            999999999999999988643      4788889999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCC----CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGV----FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ++...............||+.|+|||++....    ++.++|||||||++|+|++|..||.....        .......
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i  259 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKI  259 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence            99876433332234567999999999986543    78899999999999999999999974321        1111111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD--RPSMVDVAKK  345 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~vl~~  345 (353)
                      .........         +.  ....+..+.+++..||..+|..  |||+.++++.
T Consensus       260 ~~~~~~~~~---------p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         260 MDHKNSLNF---------PE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HhCCcccCC---------CC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            111100000         00  0134566778999999755543  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-43  Score=329.92  Aligned_cols=265  Identities=19%  Similarity=0.234  Sum_probs=207.5

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CC-----ceeeccceeeeC
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HN-----HILKLIGCCLET  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~~~~~~~~~  134 (353)
                      .|.+.++||+|+||   .|.+|.+  +++.||||++++.   +....+...|+.+|..|+ |.     |+|+++++|...
T Consensus       187 rY~V~e~LGkGtFG---QVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFG---QVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEecccccc---eeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            57778999999999   9999999  8999999999887   667778889999999998 43     799999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC--CceEEe
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE--NVAKLF  212 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~--~~~kl~  212 (353)
                      ++.|||+|.+. -+|+++++.+.-   ..++...++.++.||+.||.+||   ..+|||+||||+||||...  ..+||+
T Consensus       261 ~HlciVfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVI  333 (586)
T KOG0667|consen  261 NHLCIVFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVI  333 (586)
T ss_pred             cceeeeehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEE
Confidence            99999999996 799999987753   67999999999999999999999   9999999999999999754  378999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSN  285 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~  285 (353)
                      |||.|+.....    ..+.+-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|....+.+.       ++.+..
T Consensus       334 DFGSSc~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  334 DFGSSCFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             ecccccccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            99999876432    2266778899999999999999999999999999999999888887665332       222322


Q ss_pred             HHHHHH------hhc-Cccccc----------------------ccchhhh-ccc---hHHHHHHHHHHHHHHHHchhcC
Q 018633          286 EYLKNY------FED-NRFTEI----------------------VDPIIVE-DVL---SIEKEQQLHASAQLSFECIKDS  332 (353)
Q Consensus       286 ~~~~~~------~~~-~~~~~~----------------------~~~~~~~-~~~---~~~~~~~~~~l~~li~~cl~~d  332 (353)
                      ..+...      +.. ...+..                      .+....+ ...   .......-..+.+++.+||.+|
T Consensus       410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d  489 (586)
T KOG0667|consen  410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD  489 (586)
T ss_pred             HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence            222111      111 000000                      0000000 000   1111133467899999999999


Q ss_pred             CCCCCCHHHHHH
Q 018633          333 PADRPSMVDVAK  344 (353)
Q Consensus       333 P~~Rps~~~vl~  344 (353)
                      |..|+|+.++++
T Consensus       490 P~~R~tp~qal~  501 (586)
T KOG0667|consen  490 PAERITPAQALN  501 (586)
T ss_pred             chhcCCHHHHhc
Confidence            999999998875

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-43  Score=313.06  Aligned_cols=249  Identities=19%  Similarity=0.327  Sum_probs=199.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      +|+..+.||+|+||   .||++.+ .+..+|+|.+....   .....|.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~G~~~---~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFG---VVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCc---eEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            47778899999999   9999988 56689999886542   23456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++...
T Consensus        79 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          79 EYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             ecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence            9999999999987643    35789999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ...........++..|+|||.+.+..++.++||||||+++|++++ |..||......        +...........   
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~---  220 (256)
T cd05059         152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAGYRL---  220 (256)
T ss_pred             cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHcCCcC---
Confidence            322211222234457999999998889999999999999999999 78888643221        111111100000   


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                                 ..+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       221 -----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 -----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                       00113456788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-42  Score=309.38  Aligned_cols=257  Identities=22%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             CCCCceeeCCCCCccEEEEEEe--CC--eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC------
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFW--QE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET------  134 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------  134 (353)
                      ...+.||+|+||   .||+|.+  ++  ..||+|.+..........+.|.+|+.+++.++||||+++++++...      
T Consensus         2 ~i~~~ig~G~~g---~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           2 ALGKTLGEGEFG---SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             ccccccCcccCc---eEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            456789999999   9999988  33  2689998876654566778899999999999999999999987532      


Q ss_pred             CccEEEEEeccCCChhhhhccCC-CCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 PIPILVFESVQYGTLWDRILGAP-QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      ...++||||+++|+|.+++.... ......+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECC
Confidence            25789999999999998874321 111145789999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHH
Q 018633          214 FSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       214 fg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ||+++......... .....++..|+|||+.....++.++||||||+++|||++ |..||......        + ....
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~-~~~~  226 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------E-IYDY  226 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------H-HHHH
Confidence            99998764332211 123345678999999998889999999999999999999 78887632211        1 1111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .........             +...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       227 ~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 LRQGNRLKQ-------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111111000             013455678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.9e-43  Score=320.66  Aligned_cols=246  Identities=21%  Similarity=0.289  Sum_probs=193.7

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||++..  +++.||+|++..... .......+.+|+.++.++ +||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   77 (329)
T cd05618           1 RVIGRGSYA---KVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   77 (329)
T ss_pred             CeeeeCCCe---EEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence            469999999   9999988  778999999975421 234456678899988877 799999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|..++...     ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        78 ~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          78 VNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence            9999998888654     35889999999999999999999   999999999999999999999999999998754222


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||..|+|||++.+..++.++|||||||++|+|++|..||...............+.......... .    
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~----  223 (329)
T cd05618         150 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R----  223 (329)
T ss_pred             C-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C----
Confidence            1 123456789999999999988999999999999999999999999964332221111122222221111110 0    


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                           .    +...+..+.+++.+||+.||++|||+
T Consensus       224 -----~----p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 -----I----PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -----C----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                 0    11345567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.1e-43  Score=314.44  Aligned_cols=256  Identities=17%  Similarity=0.318  Sum_probs=200.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCe----EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QER----LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ++|...+.||+|+||   .||+|.+  ++.    .+++|.+.... ......++..|+..++++.||||+++++++. +.
T Consensus         7 ~~~~~~~~lg~G~~~---~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFG---TVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA   81 (279)
T ss_pred             hhceeccccCccCCc---ceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence            357778899999999   9999988  444    47777775431 2344567888999999999999999999875 45


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++++||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCc
Confidence            6789999999999999997654    46889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          216 LSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       216 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +++........ ......++..|+|||.+.+..++.++||||||+++||+++ |..||......         .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---------~~~~~~~  225 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---------EVPDLLE  225 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---------HHHHHHH
Confidence            99766433221 1233456778999999988889999999999999999998 99898643211         1111122


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ......  .+           ..+...+.+++.+||..+|+.|||+.++++.|..+.+
T Consensus       226 ~~~~~~--~~-----------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         226 KGERLA--QP-----------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCcCC--CC-----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            111110  00           0233456789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1e-42  Score=312.53  Aligned_cols=259  Identities=19%  Similarity=0.317  Sum_probs=202.7

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      .+++|+..+.||+|+||   .||+|.+.       +..||+|++.... ......+|.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g---~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFG---MVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCC---eEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            46779999999999999   88888752       4679999886542 3345567999999999999999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCC-----CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQP-----HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN  207 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  207 (353)
                      .+...++||||+++|+|.+++......     ....+++..+..++.|++.||.|||   +.+++|+||||+||++++++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCC
Confidence            999999999999999999998653211     0124578888999999999999999   89999999999999999999


Q ss_pred             ceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChH
Q 018633          208 VAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~  285 (353)
                      .++|+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||.....        .
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~  228 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------E  228 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence            9999999998765432221 1122345778999999988889999999999999999999 6778753211        1


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ... ...........             +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 ~~~-~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         229 QVL-RFVMEGGLLDK-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHH-HHHHcCCcCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111 11111111111             0134457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.2e-43  Score=327.63  Aligned_cols=252  Identities=15%  Similarity=0.164  Sum_probs=197.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .|...+.||+|+||   .||++..  ++..||+|++.... ........+.+|+.++++++||||+++++++.+.+..|+
T Consensus         2 ~f~~~~~LG~G~~g---~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l   78 (381)
T cd05626           2 MFVKIKTLGIGAFG---EVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (381)
T ss_pred             CceEEEEEeecCCE---EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence            47788899999999   9999988  78899999996542 133456678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        79 v~E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          79 VMDYIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            99999999999998764     35788889999999999999999   99999999999999999999999999998754


Q ss_pred             cCCCC----------------------------------------------CccccccccCCccccccccccCCCCcccc
Q 018633          220 IPEGE----------------------------------------------THITDTVMGTWGYCAPEYMRTGVFNEKSD  253 (353)
Q Consensus       220 ~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  253 (353)
                      +....                                              ........||..|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            31100                                              00012357999999999998888999999


Q ss_pred             chhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHH--chhc
Q 018633          254 VFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFE--CIKD  331 (353)
Q Consensus       254 i~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~  331 (353)
                      ||||||++|||++|..||.......        ..............         +.  ....+.++.+|+.+  |+..
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~---------~~--~~~~s~~~~dli~~ll~~~~  291 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTE--------TQLKVINWENTLHI---------PP--QVKLSPEAVDLITKLCCSAE  291 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHH--------HHHHHHccccccCC---------CC--CCCCCHHHHHHHHHHccCcc
Confidence            9999999999999999997432211        11111100000000         00  00244567788887  5566


Q ss_pred             CCCCCCCHHHHHH
Q 018633          332 SPADRPSMVDVAK  344 (353)
Q Consensus       332 dP~~Rps~~~vl~  344 (353)
                      +|..||++.+++.
T Consensus       292 ~~~~R~~~~~~l~  304 (381)
T cd05626         292 ERLGRNGADDIKA  304 (381)
T ss_pred             cccCCCCHHHHhc
Confidence            7777999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1e-43  Score=326.43  Aligned_cols=242  Identities=16%  Similarity=0.189  Sum_probs=194.7

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      +.||+|+||   .||++..  ++..||+|++..... .......+.+|+.++..++||||+++++++...+..|+||||+
T Consensus         1 ~~lG~G~~g---~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            469999999   9999887  789999999875421 2334567789999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      ++|+|..++...     ..+++..+..++.||+.||.|||   + ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          78 NGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            999999888654     35889999999999999999999   7 79999999999999999999999999998754322


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      .. ......||..|+|||++.+..++.++|||||||++|+|++|..||......        .... ....... .    
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~-~i~~~~~-~----  214 (325)
T cd05594         150 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFE-LILMEEI-R----  214 (325)
T ss_pred             Cc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HHHH-HHhcCCC-C----
Confidence            21 223457999999999999889999999999999999999999998632211        1111 1100000 0    


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                           .    +...+..+.+++.+||+.||++|+     ++.++++
T Consensus       215 -----~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         215 -----F----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -----C----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                 0    013445678999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=306.13  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=207.7

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ..+++|+...+||+|.|+   .|+++..  +|+.+|+|+++....+....+.+.+|+++.+.|+|||||++.+.+.....
T Consensus         8 ~f~d~y~l~e~igkG~FS---vVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFS---VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF   84 (355)
T ss_pred             ccchhhhHHHHHccCchH---HHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence            456778888999999999   7777777  88999999987665566788899999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC---CceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl~d  213 (353)
                      .|+|+|+|.|++|..-+-..     .-+++..+-..+.||+.+|.|+|   .++|||||+||+|+|+.+.   --+||+|
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~  156 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLAD  156 (355)
T ss_pred             eEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecc
Confidence            99999999999997655443     35678888899999999999999   9999999999999999532   3579999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||+|..+.  .........||++|||||++...+|+.++|||+.|++||-|+.|..||.....                 
T Consensus       157 FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----------------  217 (355)
T KOG0033|consen  157 FGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------------  217 (355)
T ss_pred             cceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----------------
Confidence            99999886  33345678899999999999999999999999999999999999999974211                 


Q ss_pred             cCcccccccchhhhcc--chHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDV--LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                          ..+++.+..+.+  +...-+..+++..+|+.+||..||++|+|+.|+++
T Consensus       218 ----~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  218 ----HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                112222222211  11111256677889999999999999999998764

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-42  Score=311.37  Aligned_cols=258  Identities=22%  Similarity=0.332  Sum_probs=202.8

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--C---CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc--
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--Q---ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI--  136 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~--  136 (353)
                      |...+.||+|+||   .||+|..  +   +..||+|.+..........+.+.+|+..++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g---~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFG---SVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCc---eEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            4567889999999   8888886  2   3679999987654455667789999999999999999999999876544  


Q ss_pred             ----cEEEEEeccCCChhhhhccCCCC-CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          137 ----PILVFESVQYGTLWDRILGAPQP-HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       137 ----~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                          .++|+||+++|+|..++...... ....+++..+..++.|++.||.|||   +++++||||||+||++++++.+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEE
Confidence                79999999999999888543211 1146889999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHH
Q 018633          212 FDFSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      +|||+++......... .....++..|+|||++....++.++||||||+++|||++ |..||.....        .+...
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~  226 (273)
T cd05035         155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYD  226 (273)
T ss_pred             CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence            9999987664332211 122334678999999988889999999999999999999 8888763221        11111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ... .......             +...+..+.+++.+||+.||++|||+.++++.|.++
T Consensus       227 ~~~-~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         227 YLR-HGNRLKQ-------------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHH-cCCCCCC-------------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111 1111110             114556789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=326.59  Aligned_cols=253  Identities=25%  Similarity=0.342  Sum_probs=213.9

Q ss_pred             CCCCceeeCCCCCccEEEEEEeC------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFWQ------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ...+.||.|.||   .||+|.++      .-.||||..+.+. .+...+.|+.|+.+|++++|||||+++|+|.+. ..|
T Consensus       392 tl~r~iG~GqFG---dVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  392 TLKRLIGEGQFG---DVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             cHHHhhcCCccc---ceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            445789999999   99999982      2368899887753 666789999999999999999999999999755 578


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      ||||+++.|-|..+|..+.    ..++......++.||+.||.|||   ++++|||||..+|||+.++..+||+|||+++
T Consensus       467 ivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             EEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhh
Confidence            9999999999999998876    56889999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      .+............-+..|||||.+....|+.+||||.|||.+||++. |..||+...+.+..                 
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------------  602 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------------  602 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------------
Confidence            987665544444445678999999999999999999999999999876 88999866554421                 


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                          -..-.++. .+.|+.|+..+..|+.+||.++|.+||.+.++...|..++.
T Consensus       603 ----~~iEnGeR-lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 ----GHIENGER-LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ----EEecCCCC-CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                11111111 12233888999999999999999999999999999988875

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.1e-42  Score=306.06  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=196.1

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEecc
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQ  145 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  145 (353)
                      +.||+|+||   .||+|.+  +++.||+|.+.... .......|.+|++++++++||||+++++++......++||||++
T Consensus         1 ~~lg~g~~g---~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFG---EVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCc---cEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            368999999   9999988  78899999876542 34456779999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCC
Q 018633          146 YGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET  225 (353)
Q Consensus       146 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~  225 (353)
                      +++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++........
T Consensus        77 ~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          77 GGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence            999999986543    35789999999999999999999   99999999999999999999999999999875432211


Q ss_pred             cc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          226 HI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       226 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....         .............     
T Consensus       150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---------~~~~~~~~~~~~~-----  215 (252)
T cd05084         150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---------QQTREAIEQGVRL-----  215 (252)
T ss_pred             cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---------HHHHHHHHcCCCC-----
Confidence            11 111223456999999988889999999999999999998 8788753211         1111111111000     


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                          .    .+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       216 ----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         216 ----P----CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ----C----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                0    01134567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4e-43  Score=329.91  Aligned_cols=266  Identities=16%  Similarity=0.266  Sum_probs=207.2

Q ss_pred             HHHHhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeecc
Q 018633           57 IKLATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLI  128 (353)
Q Consensus        57 ~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~  128 (353)
                      +....++|...+.||+|+||   .||+|.+       .+..||+|++.... .....+.+.+|+.++.++. |||||+++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG---~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFG---RVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             ceecHHHeehhhhccCCCce---eEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            33455678888999999999   9999886       23689999997552 2334567899999999998 99999999


Q ss_pred             ceeeeCCccEEEEEeccCCChhhhhccCCCC-------------------------------------------------
Q 018633          129 GCCLETPIPILVFESVQYGTLWDRILGAPQP-------------------------------------------------  159 (353)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------  159 (353)
                      ++|...+..++||||+++|+|.+++......                                                 
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            9999999999999999999999998653210                                                 


Q ss_pred             --------------------------------------------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeec
Q 018633          160 --------------------------------------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN  195 (353)
Q Consensus       160 --------------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~d  195 (353)
                                                                  ....+++..++.++.|++.||.|||   +++++|||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrd  264 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRD  264 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCccc
Confidence                                                        0123677788899999999999999   99999999


Q ss_pred             cCCCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCc
Q 018633          196 FKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDL  273 (353)
Q Consensus       196 lkp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~  273 (353)
                      |||+|||++.++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus       265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         265 LAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             CCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999876533221 11223456788999999988889999999999999999998 8888753


Q ss_pred             cccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          274 VKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      ...        .+........+...         .    .+...+..+.+++.+||..+|+.||++.+|++.|+++.
T Consensus       345 ~~~--------~~~~~~~~~~~~~~---------~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         345 LPM--------NEQFYNAIKRGYRM---------A----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCc--------hHHHHHHHHcCCCC---------C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            211        11111111111000         0    01134567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.4e-42  Score=311.25  Aligned_cols=260  Identities=21%  Similarity=0.322  Sum_probs=204.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +|...+.||+|+||   .||+|...       ...+++|.+.... .......+.+|+.+++.++||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g---~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFG---KVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCc---ceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            46778899999999   88888762       2568888876542 3445678999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCC-------------------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeecc
Q 018633          136 IPILVFESVQYGTLWDRILGAPQ-------------------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF  196 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl  196 (353)
                      ..++|+||+++|+|.+++.....                   .....+++..++.++.|++.||.|||   +++++||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~di  153 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDL  153 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhh
Confidence            99999999999999998764321                   01135788999999999999999999   999999999


Q ss_pred             CCCceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCcc
Q 018633          197 KTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLV  274 (353)
Q Consensus       197 kp~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~  274 (353)
                      ||+|||+++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999998765332221 1223345678999999988889999999999999999999 98888632


Q ss_pred             ccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          275 KDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ..         +.+.........         ..    .+...+..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       234 ~~---------~~~~~~~~~~~~---------~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         234 AP---------ERLFNLLKTGYR---------ME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CH---------HHHHHHHhCCCC---------CC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            11         111222211100         00    011445678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=316.79  Aligned_cols=252  Identities=18%  Similarity=0.262  Sum_probs=200.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +|...++||+|+||   .||++.+  +++.||+|++...... ......+.+|+.++++++||||+++++++.+++..++
T Consensus         1 ~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (285)
T cd05605           1 TFRHYRVLGKGGFG---EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL   77 (285)
T ss_pred             CceEEEEEecCCCe---EEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEE
Confidence            47788899999999   9999887  6889999998654212 2234567889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|.+++.....   ..+++..+..++.|++.||.|||   +++++||||||+||++++++.++|+|||++..
T Consensus        78 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          78 VLTLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             EEeccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            9999999999988865432   35889999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ......  .....|+..|+|||++.+..++.++||||||+++|+|++|..||.......     ....+.......    
T Consensus       152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~----  220 (285)
T cd05605         152 IPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKED----  220 (285)
T ss_pred             cCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhhc----
Confidence            533221  234578999999999988889999999999999999999999997432111     000011100000    


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                                ....+...+..+.+|+.+||+.||++||     ++.++++
T Consensus       221 ----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 ----------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ----------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                      0001114566788999999999999999     7888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.4e-42  Score=305.90  Aligned_cols=248  Identities=18%  Similarity=0.326  Sum_probs=196.0

Q ss_pred             ceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           69 VIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .||+|+||   .||+|.+    .+..||+|.+.... .....+.|.+|+.++++++||||+++++++. .+..++||||+
T Consensus         2 ~ig~G~~g---~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFG---CVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcc---cEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            38999999   8998876    35579999887552 3445677999999999999999999999885 45789999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||++.......
T Consensus        77 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          77 SGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             CCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence            9999999987543    46899999999999999999999   9999999999999999999999999999987654332


Q ss_pred             Cccc--cccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          225 THIT--DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       225 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      ....  ....++..|+|||.+....++.++||||||+++|++++ |..||.....        ... ...........  
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~-~~~~~~~~~~~--  218 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEV-MSFIEQGKRLD--  218 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHH-HHHHHCCCCCC--
Confidence            2111  11223568999999988889999999999999999996 9999863221        111 11111111100  


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                                 .+..++.++.+++.+||..+|++||++.+|.+.|+.++
T Consensus       219 -----------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         219 -----------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             -----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence                       01145667889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-43  Score=310.59  Aligned_cols=252  Identities=18%  Similarity=0.207  Sum_probs=201.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC---hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR---PRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++|...+.||+|++|   .||.+..  +++.||+|.+......   ......+.+|+.++++++||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~~---~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFG---RVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET   78 (263)
T ss_pred             CcccccceecCCCce---EEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence            578999999999999   9999987  7899999988654221   2234678899999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++|+||+++++|.+++...     ..++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            99999999999999988764     35788899999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccc--cccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          217 SISIPEGETHIT--DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       217 a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ++..........  ....|+..|+|||++.+..++.++||||||+++|+|++|..||.......       . .......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~-~~~~~~~  222 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-------A-IFKIATQ  222 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-------H-HHHHhcc
Confidence            876543221111  23467889999999998889999999999999999999999986321110       0 0111000


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ....             ..+...+..+.+++.+||..+|++|||+.++++.
T Consensus       223 ~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 PTNP-------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCC-------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0000             0111445677899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.8e-43  Score=323.44  Aligned_cols=245  Identities=20%  Similarity=0.242  Sum_probs=193.0

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHH---hhcCCCceeeccceeeeCCcc
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYA---ARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l---~~l~H~niv~~~~~~~~~~~~  137 (353)
                      |...+.||+|+||   .||++.+  +++.||+|++.... ......+.+.+|.+++   ..++||||+++++++.+.+..
T Consensus         1 y~i~~~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV   77 (324)
T ss_pred             CeEEEEEeecCCE---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence            4567889999999   9999988  78999999997542 1223445677777665   466799999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+||||+++|+|...+..      ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        78 ~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             EEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCC
Confidence            999999999999887754      35889999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      +...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||......        ......... ..
T Consensus       149 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~-~~  218 (324)
T cd05589         149 KEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVND-EV  218 (324)
T ss_pred             ccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CC
Confidence            6542222 1234567899999999999888999999999999999999999998743211        111111111 00


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                                  .  .+...+..+.+++.+||+.||++||     ++.++++
T Consensus       219 ------------~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 ------------R--YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ------------C--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                        0  0013456678999999999999999     4555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.5e-44  Score=326.77  Aligned_cols=239  Identities=22%  Similarity=0.235  Sum_probs=191.5

Q ss_pred             CceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      +.||+|+||   .||++..     +++.||+|++............+.+|+.++++++||||+++++++.+++..|+|||
T Consensus         2 ~~lg~G~~g---~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFG---KVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCE---EEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            579999999   6665543     67899999997653233345567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      |+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++.....
T Consensus        79 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          79 FLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            99999999988654     45889999999999999999999   99999999999999999999999999999876533


Q ss_pred             CCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccccc
Q 018633          223 GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVD  302 (353)
Q Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
                      ... ......||..|+|||++.+..++.++|||||||++|||++|..||......        ........ ...     
T Consensus       151 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~-~~~-----  215 (318)
T cd05582         151 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILK-AKL-----  215 (318)
T ss_pred             CCC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHc-CCC-----
Confidence            221 234567899999999998888999999999999999999999998743211        11111111 100     


Q ss_pred             chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 018633          303 PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVD  341 (353)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  341 (353)
                           ..    +...+..+.+++.+||+.||++|||+.+
T Consensus       216 -----~~----p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 -----GM----PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                 00    0134456789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-43  Score=322.56  Aligned_cols=242  Identities=19%  Similarity=0.249  Sum_probs=192.6

Q ss_pred             CceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHEC--RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +.||+|+||   .||++..     .++.||+|.+.....  .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g---~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYG---KVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCe---EEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            579999999   7777654     678999999865321  223345678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        79 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          79 LEYLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EeCCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            9999999999998764     35778888899999999999999   999999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.....        ......... ... . 
T Consensus       151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~-~~~-~-  218 (323)
T cd05584         151 IHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILK-GKL-N-  218 (323)
T ss_pred             ccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CCC-C-
Confidence            32221 23345789999999999888899999999999999999999999874221        111111111 110 0 


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                              .+    ...+..+.+++.+||+.+|++||     ++.++++
T Consensus       219 --------~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 --------LP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --------CC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                    00    13345678999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-44  Score=301.10  Aligned_cols=255  Identities=20%  Similarity=0.299  Sum_probs=207.6

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC------ChhHHHHHHHHHHHHhhcC-CCceeecc
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC------RPRAYESCINNVTYAARMS-HNHILKLI  128 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~-H~niv~~~  128 (353)
                      ....++|.+.++||+|..+   .|-++..  +++..|+|++.....      .....+.-.+|+.+|+++. ||+|+++.
T Consensus        13 ~~fy~~y~pkeilgrgvss---~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSS---VVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             hhHHhhcChHHHhcccchh---hhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            3456778999999999999   8888877  888999998854321      1223455678999999997 99999999


Q ss_pred             ceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc
Q 018633          129 GCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV  208 (353)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  208 (353)
                      ++++.+..+++|+|.|+.|.|.|+|.+.     ..+++...+.|+.|+..|+.|||   .++||||||||+|||+|++.+
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~  161 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMN  161 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccc
Confidence            9999999999999999999999999876     57999999999999999999999   999999999999999999999


Q ss_pred             eEEeccCCccccCCCCCccccccccCCcccccccccc------CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT------GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                      ++|+|||+|+.+..+..  ....+||++|+|||.+..      ..|+...|+||+|+|+|.|+.|.+||-.....     
T Consensus       162 i~isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----  234 (411)
T KOG0599|consen  162 IKISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----  234 (411)
T ss_pred             eEEeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----
Confidence            99999999999866543  567899999999998753      34888999999999999999999998632110     


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                          .+......+++. ..         .+.-.+.+....+||.+||+.||.+|.|+++++.
T Consensus       235 ----lMLR~ImeGkyq-F~---------speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  235 ----LMLRMIMEGKYQ-FR---------SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----HHHHHHHhcccc-cC---------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                011111122211 00         1111267778889999999999999999999875

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.5e-43  Score=310.31  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=202.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++|...+.||+|+||   .||+|.+ ....||+|++....   ...+.|.+|+.++++++||||+++++++. ....++|
T Consensus         6 ~~~~~~~~lg~g~~~---~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFG---EVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCC---cEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence            458888999999999   9999988 55679999987542   23457899999999999999999999874 4568999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||.+...
T Consensus        79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             EEcCCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence            999999999999975432   35788999999999999999999   999999999999999999999999999999766


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ............++..|+|||+..+..++.++||||||+++|+|+| |..||.....        .+...........  
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~--  222 (262)
T cd05071         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRM--  222 (262)
T ss_pred             cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCC--
Confidence            4433222233456678999999988889999999999999999999 7778753211        1111111110000  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                                  ..+...+..+.+++.+||+.+|++|||+.++++.|+..+
T Consensus       223 ------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         223 ------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                        001145667889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-43  Score=327.75  Aligned_cols=253  Identities=17%  Similarity=0.199  Sum_probs=196.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++..  +++.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+..|
T Consensus         1 ~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~   77 (377)
T cd05629           1 EDFHTVKVIGKGAFG---EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLY   77 (377)
T ss_pred             CCceEeEEEeecCCE---EEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeE
Confidence            368888999999999   9999988  88999999986432 12344567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||+++
T Consensus        78 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999998754     45788899999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCC------------c----------------------------------cccccccCCccccccccccCCCCccc
Q 018633          219 SIPEGET------------H----------------------------------ITDTVMGTWGYCAPEYMRTGVFNEKS  252 (353)
Q Consensus       219 ~~~~~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~  252 (353)
                      .......            .                                  ......||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            3321000            0                                  00124699999999999888899999


Q ss_pred             cchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcC
Q 018633          253 DVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDS  332 (353)
Q Consensus       253 Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  332 (353)
                      |||||||++|||++|..||......        ...............      ..     ....+..+.+++.+||. +
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~------p~-----~~~~s~~~~dli~~lL~-~  289 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETLYF------PD-----DIHLSVEAEDLIRRLIT-N  289 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCccCC------CC-----CCCCCHHHHHHHHHHhc-C
Confidence            9999999999999999999632211        111111110000000      00     00234567899999997 7


Q ss_pred             CCCC---CCHHHHHHH
Q 018633          333 PADR---PSMVDVAKK  345 (353)
Q Consensus       333 P~~R---ps~~~vl~~  345 (353)
                      |.+|   +|+.+++..
T Consensus       290 ~~~r~~r~~~~~~l~h  305 (377)
T cd05629         290 AENRLGRGGAHEIKSH  305 (377)
T ss_pred             HhhcCCCCCHHHHhcC
Confidence            7765   589888753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-43  Score=322.84  Aligned_cols=242  Identities=18%  Similarity=0.249  Sum_probs=193.9

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ++||+|+||   .||+|.+  +++.||+|++..... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||
T Consensus         1 ~~lG~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~   77 (321)
T cd05591           1 KVLGKGSFG---KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY   77 (321)
T ss_pred             CccccCCCe---EEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence            469999999   9999988  678999999865421 234456678899999876 699999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+.+...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++......
T Consensus        78 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          78 VNGGDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            9999999888754     35788999999999999999999   999999999999999999999999999998754322


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      .. ......||..|+|||++.+..++.++|||||||++|+|++|..||......        ..........        
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~--------  212 (321)
T cd05591         150 GV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDD--------  212 (321)
T ss_pred             Cc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC--------
Confidence            22 233457899999999999888999999999999999999999999743221        1111111110        


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-------CHHHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-------SMVDVAK  344 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~~vl~  344 (353)
                           ..  .+...+..+.+++.+||+.||++||       ++.++++
T Consensus       213 -----~~--~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 -----VL--YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -----CC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                 00  0002345678999999999999999       7777664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-43  Score=322.91  Aligned_cols=237  Identities=20%  Similarity=0.273  Sum_probs=191.2

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ++||+|+||   .||++.+  +++.||+|++..... .....+.+..|..++..+ +||||+++++++...+..|+||||
T Consensus         1 ~~lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey   77 (320)
T cd05590           1 RVLGKGSFG---KVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF   77 (320)
T ss_pred             CeeeeCCCe---EEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence            469999999   9999988  688999999865421 233456778899998877 699999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||+++.....
T Consensus        78 ~~~g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          78 VNGGDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            9999999988765     35889999999999999999999   999999999999999999999999999998754322


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ........ ....   .  
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~-~~~~---~--  214 (320)
T cd05590         150 G-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAIL-NDEV---V--  214 (320)
T ss_pred             C-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHh-cCCC---C--
Confidence            2 123456789999999999988899999999999999999999999974321        11111111 1110   0  


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                               .+...+..+.+++.+||+.||++||++
T Consensus       215 ---------~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 ---------YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ---------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                     001345567899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-42  Score=309.59  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=200.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +.|...+.||+|+||   .||++.+ .+..+|+|.+.....   ..+.|.+|+.++++++||||+++++++. .+..++|
T Consensus         6 ~~~~~~~~ig~g~~~---~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFG---EVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCc---eEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            467888999999999   9999988 667899999876532   3457899999999999999999999875 4568999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++++||||||+||++++++.++|+|||++...
T Consensus        79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             EEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            999999999999876432   35789999999999999999999   999999999999999999999999999999766


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ............++..|+|||+..+..++.++||||||+++|+|++ |..||.....        .+...........  
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~--  222 (260)
T cd05070         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERGYRM--  222 (260)
T ss_pred             cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCC--
Confidence            4333222223345668999999988889999999999999999999 8888863221        1111111110000  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                                  ..+...+..+.+++.+||..+|++|||+.++.+.|++
T Consensus       223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 ------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                        0011445678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.3e-43  Score=325.75  Aligned_cols=261  Identities=16%  Similarity=0.214  Sum_probs=202.8

Q ss_pred             HHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccce
Q 018633           54 AQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGC  130 (353)
Q Consensus        54 ~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~  130 (353)
                      ..++....++|...+.||+|+||   .||++.+  +++.+|+|++..... .......+.+|+.+++.++||||++++++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg---~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  111 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCe---EEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            34455667889999999999999   9999988  788999999864321 22344567899999999999999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                      +.+++..|+||||+++|+|.+++...      .++...+..++.||+.||.|||   +++|+||||||+|||++.++.+|
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ik  182 (371)
T cd05622         112 FQDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLK  182 (371)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEE
Confidence            99999999999999999999988653      4788888999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccC----CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG----VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      |+|||++...............||+.|+|||++...    .++.++|||||||++|||++|..||.....        ..
T Consensus       183 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~  254 (371)
T cd05622         183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VG  254 (371)
T ss_pred             EEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HH
Confidence            999999987644333233456799999999998653    378899999999999999999999974221        11


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD--RPSMVDVAKK  345 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~vl~~  345 (353)
                      ...............+           ....+..+.+++.+||..+|.+  ||++.++++.
T Consensus       255 ~~~~i~~~~~~~~~~~-----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         255 TYSKIMNHKNSLTFPD-----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHcCCCcccCCC-----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1122111111000000           1145667789999999843332  6788888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.5e-43  Score=315.87  Aligned_cols=264  Identities=20%  Similarity=0.314  Sum_probs=206.8

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccc
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIG  129 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~  129 (353)
                      ....++|+..+.||+|+||   .||++.+.       ...+|+|.+.... .......+.+|+.++.++ +||||+++++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g---~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFG---QVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             ccCHhHeEEeeEecccccc---cEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3445678888999999999   89988862       2678999887543 344556789999999999 7999999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCC-----------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCC
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT  198 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  198 (353)
                      ++..++..++||||+++|+|.+++.....           .....+++..++.++.|++.||.|||   +++|+||||||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp  160 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAA  160 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccce
Confidence            99999999999999999999999864320           11146889999999999999999999   99999999999


Q ss_pred             CceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCcccc
Q 018633          199 SCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKD  276 (353)
Q Consensus       199 ~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~  276 (353)
                      +||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++||+++ |..||.....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            9999999999999999999866433221 1122334677999999988889999999999999999998 8888763211


Q ss_pred             ccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                              .+..... .......             .+...+..+.+|+.+||..+|++|||+.++++.|+.+.
T Consensus       241 --------~~~~~~~-~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 --------EELFKLL-KEGYRME-------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --------HHHHHHH-HcCCcCC-------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                    1111111 1111000             00134567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1e-42  Score=316.58  Aligned_cols=259  Identities=16%  Similarity=0.278  Sum_probs=205.4

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecccee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCC  131 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~  131 (353)
                      ..++|...+.||+|+||   .||++.+       .+..||+|.+.... .....+.+.+|+.+++++ +||||+++++++
T Consensus        33 ~~~~~~~~~~ig~G~~g---~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFG---KVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cHHHeEEcceeeccCCe---eEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            34678899999999999   8888764       34579999886542 234457799999999999 799999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                      ...+..++||||+++|+|.+++.....   ..+++.++..++.|++.||.|||   +++++|+||||+|||++.++.+++
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEE
Confidence            999999999999999999999875432   23789999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHH
Q 018633          212 FDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       212 ~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      +|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......        ....
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------~~~~  254 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------SKFY  254 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------HHHH
Confidence            99999876643322 11223345678999999988889999999999999999998 88988643211        1111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .........         ..    +...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus       255 ~~~~~~~~~---------~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         255 KLIKEGYRM---------AQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHcCCcC---------CC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111111000         00    012345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-42  Score=312.48  Aligned_cols=266  Identities=21%  Similarity=0.299  Sum_probs=199.5

Q ss_pred             CCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--Cc
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PI  136 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~  136 (353)
                      ...+.||+|+||   .||.+.+      ++..||+|.+.... .......|.+|+.++++++||||+++++++...  ..
T Consensus         7 ~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           7 KKIRVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             eeceecccCCCc---EEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            778899999999   7766542      57789999987652 334567789999999999999999999988654  35


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++++|.+++...      .+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||+
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccc
Confidence            78999999999999998653      4899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          217 SISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       217 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      +.........  ......++..|+|||.+....++.++||||||+++|+|+||..|+............   ........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~  230 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG---PKQGQMTV  230 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhc---ccccccch
Confidence            8776433221  112234566799999998888999999999999999999999997532211000000   00000000


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      ..+....+......    .+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       231 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         231 VRLIELLERGMRLP----CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhhcCCCCC----CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00000000000000    01145678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=329.61  Aligned_cols=245  Identities=20%  Similarity=0.300  Sum_probs=204.7

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCC-CCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGH-ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      -|...+.||.|+||   .||-+.+  +...||||++.-. ..+...+..++.|++.|.++.|||+|.+-|+|..+...||
T Consensus        27 lf~dLrEIGHGSFG---AVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   27 LFSDLREIGHGSFG---AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHHhcCCccc---eeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence            46677889999999   9999888  8899999998533 1245567889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||||- ||-.|++.-+.    .++.+-.+..|+.+.+.||+|||   +++.||||||..|||+.++|.+||+|||.|..
T Consensus       104 VMEYCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  104 VMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             HHHHHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhh
Confidence            999996 78888887665    57889999999999999999999   99999999999999999999999999998865


Q ss_pred             cCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ..     +.++++||+.|||||++.   .+.|+-++||||||++..||..+++|....+...                  
T Consensus       176 ~~-----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------------------  232 (948)
T KOG0577|consen  176 MA-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------------------  232 (948)
T ss_pred             cC-----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------------------
Confidence            43     357889999999999985   4679999999999999999999999976332211                  


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                         .+..+...+.+......++..+.+++..||+.-|.+|||..+++.
T Consensus       233 ---ALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  233 ---ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ---HHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence               111111122222222378899999999999999999999988765

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-42  Score=304.89  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=205.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      .++|...+.||+|+||   .||++...++.||+|.+....   ...+++.+|+.++++++|+||+++++++.+.+..++|
T Consensus         5 ~~~~~~~~~ig~g~~g---~v~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           5 SKELKLGATIGKGEFG---DVMLGDYRGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhhccceeeeecCCCc---eEEEEEecCcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            3468888999999999   999999999999999997662   2567899999999999999999999999988999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++.....   ..+++..+..++.|++.||.|||   +++++|+||||+||+++.++.++|+|||.+...
T Consensus        79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             EEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccc
Confidence            999999999999876532   35889999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      .....    ...++..|+|||++....++.++||||||+++|++++ |..||.....        .. ............
T Consensus       153 ~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~-~~~~~~~~~~~~  219 (256)
T cd05039         153 SQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KD-VVPHVEKGYRME  219 (256)
T ss_pred             ccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHHhcCCCCC
Confidence            32211    2334567999999988889999999999999999997 8888763211        11 111111110000


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .             +...+..+.+++.+||..+|++|||+.++++.|.++
T Consensus       220 ~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 A-------------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             C-------------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            0             113456788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.4e-43  Score=323.96  Aligned_cols=252  Identities=19%  Similarity=0.255  Sum_probs=196.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhcC-CCceeeccceeeeC
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHEC--RPRAYESCINNVTYAARMS-HNHILKLIGCCLET  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~  134 (353)
                      +|...+.||+|+||   .||++..     ++..||+|++.....  .....+.+.+|+.++.+++ ||||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYG---KVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCE---EEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            47778899999999   6666554     678999999864321  2234566889999999995 99999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      +..++||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeC
Confidence            9999999999999999998754     35889999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      |+++..............||..|+|||++.+. .++.++|||||||++|||+||..||.......    ...........
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILK  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhc
Confidence            99876544333333456799999999998765 47889999999999999999999986432211    01111111110


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                       .      ++.    .    +...+..+.+++.+||+.||++||     ++.++++
T Consensus       226 -~------~~~----~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 -C------DPP----F----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -C------CCC----C----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence             0      000    0    013445678999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.7e-42  Score=323.13  Aligned_cols=201  Identities=16%  Similarity=0.221  Sum_probs=174.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|+..+.||+|+||   .||++..  +++.||+|++..... .......+.+|+.++.+++||||+++++++.+....|
T Consensus         1 ~~y~~~~~LG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFG---EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCE---EEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence            468889999999999   9999988  788999999865321 2334467888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        78 lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            999999999999998764     46889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCC----------------------------------ccccccccCCccccccccccCCCCccccchhhHHHHHHH
Q 018633          219 SIPEGET----------------------------------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL  264 (353)
Q Consensus       219 ~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  264 (353)
                      .......                                  ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el  229 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence            5432110                                  001235799999999999988999999999999999999


Q ss_pred             HhCCCCCCc
Q 018633          265 LTGWDVSDL  273 (353)
Q Consensus       265 ~tg~~p~~~  273 (353)
                      ++|..||..
T Consensus       230 l~G~~Pf~~  238 (363)
T cd05628         230 LIGYPPFCS  238 (363)
T ss_pred             HhCCCCCCC
Confidence            999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.5e-43  Score=320.32  Aligned_cols=241  Identities=20%  Similarity=0.282  Sum_probs=191.1

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ++||+|+||   .||++.+  +++.||+|.+..... .....+.+..|..++..+ +||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~   77 (316)
T cd05592           1 KVLGKGSFG---KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY   77 (316)
T ss_pred             CeeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence            469999999   9999988  678899999875421 223445566777777754 799999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~gg~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          78 LNGGDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            9999999988754     35788999999999999999999   999999999999999999999999999998765332


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||..|+|||++.+..++.++|||||||++|||++|..||.....        .+....... .. .     
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~-~~-~-----  213 (316)
T cd05592         150 E-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILN-DR-P-----  213 (316)
T ss_pred             C-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-CC-C-----
Confidence            2 223456799999999999988899999999999999999999999874321        111111111 00 0     


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV-DVA  343 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~vl  343 (353)
                          ..    +...+..+.+++.+||+.||++||++. +++
T Consensus       214 ----~~----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         214 ----HF----PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ----CC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                00    113445677999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.3e-42  Score=302.54  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=197.5

Q ss_pred             CceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           68 NVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ++||+|+||   .||+|.. ++..+|+|.+.... .......|.+|+.++++++||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g---~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFG---EVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCc---eEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            368999999   9999987 77889999887552 334456789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      ++|.+++....    ..+++..++.++.|++.||.|||   +++++||||+|+||+++.++.++|+|||++.........
T Consensus        77 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          77 GDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            99999886543    35789999999999999999999   999999999999999999999999999998764333222


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPII  305 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (353)
                      ......++..|+|||++.+..++.++||||||+++|++++ |..||......        ..... ........      
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~-~~~~~~~~------  214 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQ-VEKGYRMS------  214 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHH-HHcCCCCC------
Confidence            2223344667999999988889999999999999999998 88898633211        11111 11110000      


Q ss_pred             hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          306 VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       306 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                         .    +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       215 ---~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         215 ---C----PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ---C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence               0    0134567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-42  Score=316.08  Aligned_cols=260  Identities=20%  Similarity=0.253  Sum_probs=201.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCe--EEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QER--LISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETP  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~  135 (353)
                      .++|+..+.||+|+||   .||+|.+  ++.  .+++|.+.... .......+.+|+.++.++ +||||+++++++..++
T Consensus         6 ~~~~~~~~~lg~G~~g---~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             hhhceeeeeecCCCCc---eEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            3568888999999999   9999987  343  46777765432 344567889999999999 8999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          136 IPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                      ..|+||||+++++|.+++......           ....+++..++.++.|++.||.|||   +++++||||||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence            999999999999999998754210           1135789999999999999999999   99999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACP  283 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~  283 (353)
                      .++.++|+|||++.......  ......++..|+|||++.+..++.++||||||+++|||+| |..||......      
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------  230 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------  230 (303)
T ss_pred             CCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------
Confidence            99999999999986432111  1122234567999999988889999999999999999998 99998632211      


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                        +..... .......         .    +...+..+.+|+.+||+.+|++|||+.+++..|.++..
T Consensus       231 --~~~~~~-~~~~~~~---------~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         231 --ELYEKL-PQGYRLE---------K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             --HHHHHH-hcCCcCC---------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              111111 1000000         0    00234567899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-42  Score=325.52  Aligned_cols=269  Identities=19%  Similarity=0.203  Sum_probs=199.8

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-----
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-----  135 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----  135 (353)
                      +|+..+.||+|+||   .||++..  +++.||+|++............+.+|+.+++.++||||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFG---VVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCE---EEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            47888999999999   9999987  7899999998654334455678899999999999999999999998776     


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+|+||+. ++|.+.+...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg  148 (372)
T cd07853          78 EIYVVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFG  148 (372)
T ss_pred             eEEEEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccc
Confidence            7899999997 6888877654     46889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHH
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEY  287 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~  287 (353)
                      +++..............+|..|+|||++.+. .++.++|||||||++|||++|+.||........       ...+....
T Consensus       149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             ceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9976543332223345678899999998764 478999999999999999999999975432110       00000010


Q ss_pred             HHHHhhcCcccccccchh-hhccch--HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          288 LKNYFEDNRFTEIVDPII-VEDVLS--IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +...... ....+..... ......  ......+..+.+|+.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         229 MRSACEG-ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhhHH-HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            0000000 0000000000 000000  000123567889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.1e-42  Score=304.98  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee-eCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL-ETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~~~lv  140 (353)
                      ++|...+.||+|+||   .||++...+..||+|.+...    ...+.|.+|+.++++++|+|++++++++. .++..++|
T Consensus         6 ~~~~~~~~lg~g~~~---~v~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           6 KELKLLQTIGKGEFG---DVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HhCeeeeeecccCCC---eEEEEEEcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            468888999999999   99999999999999998654    23567899999999999999999999765 45678999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++...
T Consensus        79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             EECCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceec
Confidence            999999999999876542   35789999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ....    ....++..|+|||++....++.++|||||||++|+|++ |..||....        ..+..... .......
T Consensus       153 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~~~~  219 (256)
T cd05082         153 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRV-EKGYKMD  219 (256)
T ss_pred             cccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-hcCCCCC
Confidence            3222    23344567999999988889999999999999999998 888876321        11111111 1110000


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                                   .+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       220 -------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         220 -------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                         0113456788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-42  Score=311.12  Aligned_cols=248  Identities=19%  Similarity=0.273  Sum_probs=194.3

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ||+|+||   .||++.+  +++.||+|++..... .....+.+..|+.+++.++||||+++.+++...+..++||||+++
T Consensus         1 lg~G~~g---~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFG---EVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCce---eEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence            6999999   9999887  788999999865421 222346778899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      |+|.+.+....... ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++........ 
T Consensus        78 g~L~~~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          78 GDLRYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             CCHHHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            99988774322111 46889999999999999999999   99999999999999999999999999999876644322 


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIV  306 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (353)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......     ........            ...
T Consensus       153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~------------~~~  215 (280)
T cd05608         153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-----ENKELKQR------------ILN  215 (280)
T ss_pred             cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHh------------hcc
Confidence            2334578999999999999999999999999999999999999987432211     00000000            000


Q ss_pred             hccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          307 EDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       307 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                      ...  ..+...+..+.+++.+||+.||++||     |++++++
T Consensus       216 ~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         216 DSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            000  00114566788999999999999999     6676664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.4e-42  Score=306.25  Aligned_cols=253  Identities=19%  Similarity=0.306  Sum_probs=203.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .+.|...++||+|+||   .||++.. ++..||+|.+....   .....|.+|+.++++++||||+++++++. .+..++
T Consensus         5 ~~~~~~~~~ig~G~~g---~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFG---EVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccc---eEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            3568888999999999   9999988 77899999987652   23467899999999999999999999864 557899


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++.....   ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        78 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence            9999999999998875432   46788999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .............++..|+|||++....++.++||||||+++||+++ |..||......        ...... ......
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~-~~~~~~  222 (260)
T cd05067         152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNL-ERGYRM  222 (260)
T ss_pred             cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHH-HcCCCC
Confidence            64333222233456678999999988889999999999999999999 99998632211        111111 111000


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                      ..             +...+.++.+++.+||+.+|++|||++++++.|+.
T Consensus       223 ~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PR-------------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC-------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            00             01344578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-42  Score=309.08  Aligned_cols=256  Identities=19%  Similarity=0.281  Sum_probs=203.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CC---eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QE---RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      .++|+..+.||+|+||   .||+|..  ++   ..+|+|.+.... .....+.+.+|+.++.+++||||+++.+++...+
T Consensus         4 ~~~~~~~~~lg~g~~g---~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           4 PSHITKQKVIGAGEFG---EVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             hHHceEeeEecCCCCc---cEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            4578889999999999   8888887  23   378999886542 3445678999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++++|.+++....    ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++++|||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCc
Confidence            9999999999999999987543    46789999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccc--cccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          216 LSISIPEGETHIT--DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       216 ~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ++...........  .....+..|+|||++....++.++||||||+++||+++ |..||.....        ........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~  224 (268)
T cd05063         153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAIN  224 (268)
T ss_pred             cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHh
Confidence            9876643222111  11223457999999988889999999999999999998 9999863221        11111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .....+.              +...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       225 ~~~~~~~--------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 DGFRLPA--------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             cCCCCCC--------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1100000              013456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.2e-42  Score=307.35  Aligned_cols=256  Identities=21%  Similarity=0.327  Sum_probs=202.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCe----EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QER----LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +.|...+.||+|+||   .||+|.+  ++.    .||+|.+.... .......+.+|+.++..+.||||+++++++.. .
T Consensus         7 ~~~~~~~~lg~G~~g---~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           7 TELKKVKVLGSGAFG---TVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             hheeeeeecCCCCCc---eEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            457888999999999   9999987  444    48999886542 44556789999999999999999999999875 4


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++++||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCC
Confidence            5789999999999999987643    45889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          216 LSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       216 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +++......... .....++..|+|||...+..++.++|||||||++|||++ |..||.....         ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~~~  225 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLLE  225 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHH
Confidence            998764332211 122334678999999988889999999999999999998 8888763221         11111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......             +...+..+.+++.+||+.||+.|||+.++++.|.++.+
T Consensus       226 ~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         226 KGERLPQ-------------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCCcCCC-------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1111000             01345577899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-42  Score=313.53  Aligned_cols=260  Identities=19%  Similarity=0.280  Sum_probs=201.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CC--eEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QE--RLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~  136 (353)
                      ++|+..++||+|+||   .||+|..  ++  ..+++|.+.... .....+.|.+|+.++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFG---QVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcc---eEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            468888999999999   9999887  33  346888776432 344567799999999999 69999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          137 PILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      .++|+||+++++|.+++......           ....+++..++.++.|++.||.|||   +++++||||||+|||++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~  154 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGE  154 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECC
Confidence            99999999999999998653210           1135788999999999999999999   999999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCCh
Q 018633          206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~  284 (353)
                      ++.+||+|||++.......  .......+..|+|||++....++.++|||||||++|||++ |..||.....        
T Consensus       155 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------  224 (297)
T cd05089         155 NLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------  224 (297)
T ss_pred             CCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence            9999999999986432111  1112223457999999988889999999999999999998 9899863221        


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ............              ...+...+..+.+++.+||+.+|.+|||+.++++.|..+...
T Consensus       225 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         225 AELYEKLPQGYR--------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HHHHHHHhcCCC--------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111111111000              000113456788999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-42  Score=308.92  Aligned_cols=254  Identities=19%  Similarity=0.233  Sum_probs=200.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||+|.+  ++..||+|++...  .......+.+|+.++.+++||||+++++++...+..+
T Consensus         8 ~~~y~~~~~lg~g~~g---~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYG---DVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCe---EEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            3568999999999999   9999997  7889999998655  3344566889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++...     ..+++..+..++.|++.||.|||   +++|+||||+|+||+++.++.++|+|||++.
T Consensus        83 iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~  154 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAA  154 (267)
T ss_pred             EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccce
Confidence            999999999999988654     35788999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ...... .......|+..|+|||.+.   ...++.++|+||||+++|||++|..||..........         .....
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---------~~~~~  224 (267)
T cd06646         155 KITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---------LMSKS  224 (267)
T ss_pred             eecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---------eeecC
Confidence            653322 1123456888999999874   3447889999999999999999999985322111000         00000


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      .   ...+...      .....+..+.+++.+||..+|++|||++++++.|
T Consensus       225 ~---~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 N---FQPPKLK------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             C---CCCCCCc------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0   0000000      0113456788999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=330.31  Aligned_cols=245  Identities=24%  Similarity=0.339  Sum_probs=205.4

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .-+||+|.||   +||-|.+  +...+|||.+...  ..+..+.+..|+.+-++|+|.|||+++|+|.+++++-|.||-+
T Consensus       580 rvVLGKGTYG---~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV  654 (1226)
T KOG4279|consen  580 RVVLGKGTYG---TVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV  654 (1226)
T ss_pred             eEEeecCcee---EEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence            3479999999   9999999  7778999999766  4556677889999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccc--cHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-CCceEEeccCCccccC
Q 018633          145 QYGTLWDRILGAPQPHFEPL--LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIP  221 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~dfg~a~~~~  221 (353)
                      |||||.++++...    .++  .+.++-.+..||+.||.|||   ++.|||||||-+|+|++. .|.+||+|||.++.+.
T Consensus       655 PGGSLSsLLrskW----GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA  727 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKW----GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA  727 (1226)
T ss_pred             CCCcHHHHHHhcc----CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence            9999999998765    455  78888899999999999999   999999999999999974 6899999999998874


Q ss_pred             CCCCccccccccCCccccccccccCC--CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      . -...+.+..||..|||||++..++  |+.++|||||||++.||.||++||......+          ...|.-+-   
T Consensus       728 g-inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----------AAMFkVGm---  793 (1226)
T KOG4279|consen  728 G-INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----------AAMFKVGM---  793 (1226)
T ss_pred             c-CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----------Hhhhhhcc---
Confidence            3 334567889999999999998765  8999999999999999999999997433322          11111111   


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                             -...+..|...+.+...+|.+|+.+||.+|||+.+++.
T Consensus       794 -------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 -------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             -------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                   11122234478889999999999999999999999875

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.6e-42  Score=307.29  Aligned_cols=265  Identities=20%  Similarity=0.297  Sum_probs=209.2

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-C-----CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-Q-----ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ..++|...++||+|+||   .||+|.+ .     +..|++|.+... ......+.+.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~~~i~~g~~g---~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           4 SRDRVTLSDLLQEGTFG---RIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             chhheEEeeeecccCCc---eEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            34678889999999999   9999998 3     578888887644 245556789999999999999999999998876


Q ss_pred             -CCccEEEEEeccCCChhhhhccCCCC---CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          134 -TPIPILVFESVQYGTLWDRILGAPQP---HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       134 -~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                       +...++++||+++++|.+++......   ....+++..++.++.|++.||.|||   +++++|+||||+||+++.++.+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcE
Confidence             46789999999999999998654321   0135889999999999999999999   9999999999999999999999


Q ss_pred             EEeccCCccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHH
Q 018633          210 KLFDFSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  287 (353)
                      ||+|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |..||......        +.
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~  228 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--------EM  228 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--------HH
Confidence            999999998664333221 123345678999999988889999999999999999999 99998642211        11


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                       .........  ...           +..++..+.+++.+||..+|++|||+.++++.|..+.+.+
T Consensus       229 -~~~~~~~~~--~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~  280 (280)
T cd05043         229 -AAYLKDGYR--LAQ-----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL  280 (280)
T ss_pred             -HHHHHcCCC--CCC-----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhcC
Confidence             111111100  000           0134557889999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.7e-43  Score=320.03  Aligned_cols=242  Identities=21%  Similarity=0.271  Sum_probs=194.3

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||++.+  ++..||+|++..... .......+.+|..++..+ +||||+++++++...+..|+||||
T Consensus         1 ~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~   77 (318)
T cd05570           1 KVLGKGSFG---KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY   77 (318)
T ss_pred             CeeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence            469999999   9999988  678999999875421 233456678899999888 699999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||+++.....
T Consensus        78 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          78 VNGGDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence            9999999888754     35899999999999999999999   999999999999999999999999999998653222


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      .. ......||..|+|||++.+..++.++|||||||++|+|++|..||.....        ......... ...  .   
T Consensus       150 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~-~~~--~---  214 (318)
T cd05570         150 GV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILE-DEV--R---  214 (318)
T ss_pred             CC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHc-CCC--C---
Confidence            21 23345689999999999998999999999999999999999999874321        111111111 000  0   


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH-----HHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM-----VDVAK  344 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~~vl~  344 (353)
                               .+...+..+.+++.+||..||++|||+     .++++
T Consensus       215 ---------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 ---------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ---------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                     001345677899999999999999998     76654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.5e-42  Score=307.59  Aligned_cols=263  Identities=23%  Similarity=0.282  Sum_probs=200.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--  133 (353)
                      ..|...+.||+|+||   .||++..      ++..||+|++...  .....+.|.+|+.++++++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFG---SVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCc---eEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            357778899999999   8888763      5789999998765  45667789999999999999999999998754  


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      ....++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~d  151 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGD  151 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECC
Confidence            346889999999999999987543    35789999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCcc--ccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCCh
Q 018633          214 FSLSISIPEGETHI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACPS  284 (353)
Q Consensus       214 fg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~~  284 (353)
                      ||++..........  .....++..|+|||++.+..++.++||||||+++|||++|..++.......       ......
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05081         152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI  231 (284)
T ss_pred             CcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc
Confidence            99998764332211  112223456999999988889999999999999999999877653221100       000000


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ...........             .....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       232 ~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         232 VYHLIELLKNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hHHHHHHHhcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000111000             00000113456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-42  Score=312.32  Aligned_cols=247  Identities=17%  Similarity=0.256  Sum_probs=193.3

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ||+|+||   .||++..  +++.+|+|.+...... ......+..|+.++++++||||+++++++.++...++||||+++
T Consensus         1 lg~G~~g---~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFG---EVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCce---EEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence            6999999   9999887  6899999998653221 22334566799999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      ++|.+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++.......  
T Consensus        78 ~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--  149 (277)
T cd05607          78 GDLKYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--  149 (277)
T ss_pred             CCHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence            999988865432   35788999999999999999999   9999999999999999999999999999987664322  


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIV  306 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (353)
                      ......|+..|+|||++.+..++.++|||||||++|||++|..||.......    ...........             
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~-------------  212 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLE-------------  212 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhc-------------
Confidence            1234568899999999988889999999999999999999999986322111    00011011000             


Q ss_pred             hccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          307 EDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       307 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..... .....+.++.+|+.+||+.||++||++.++++.
T Consensus       213 ~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         213 DEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             ccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            00000 001345678899999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-43  Score=290.48  Aligned_cols=263  Identities=17%  Similarity=0.231  Sum_probs=209.7

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC--
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP--  135 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--  135 (353)
                      ..+.|...+.||.|||+   .||.++.  +++.+|+|++.-.  +.+..+..++|++.-++++|||++++++++..+.  
T Consensus        19 n~~Ryri~~~LgeGGfs---fv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFS---FVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             cCceEEEeeeecCCCce---eeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            34578999999999999   8888887  8999999999776  5678889999999999999999999999987543  


Q ss_pred             ---ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeecCCCceE
Q 018633          136 ---IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       136 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~~k  210 (353)
                         ..||+++|...|||.+.+....... ..+++.+++.|+.++++||.+||   +..  ..||||||.|||+.+.+.++
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceE
Confidence               4899999999999999887543321 47899999999999999999999   555  99999999999999999999


Q ss_pred             EeccCCccccCCCCCcc--------ccccccCCcccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCccccccC
Q 018633          211 LFDFSLSISIPEGETHI--------TDTVMGTWGYCAPEYMRT---GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD  279 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~  279 (353)
                      +.|||.++..+..-...        ......|..|+|||.+.-   ...+.++|||||||+||+|+.|..||+...... 
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-  248 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-  248 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-
Confidence            99999987653221110        112356889999999864   447889999999999999999999998544322 


Q ss_pred             CCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                                     +++.-.+...   ....+....+++.+.+++..|++.||.+||++.+++..+..+.
T Consensus       249 ---------------gSlaLAv~n~---q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 ---------------GSLALAVQNA---QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---------------CeEEEeeecc---ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                           2221111111   1111111147888999999999999999999999999988764

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-42  Score=303.08  Aligned_cols=248  Identities=22%  Similarity=0.355  Sum_probs=197.2

Q ss_pred             CceeeCCCCCccEEEEEEe--CC---eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QE---RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      +.||+|+||   .||+|.+  .+   ..+|+|.+...... ...+.+.+|+.+++++.||||+++++++. .+..++|||
T Consensus         1 ~~ig~G~~g---~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFG---SVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCce---eEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            469999999   9999887  22   68999998766322 45678999999999999999999999875 556899999


Q ss_pred             eccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      |+++|+|.+++...     ..+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||.++....
T Consensus        76 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          76 LAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             eCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            99999999999765     35789999999999999999999   99999999999999999999999999999887644


Q ss_pred             CCCccc--cccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          223 GETHIT--DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       223 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ......  ....++..|+|||.+.+..++.++||||||+++|++++ |..||.....        .+.. ..........
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~-~~~~~~~~~~  218 (257)
T cd05060         148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVI-AMLESGERLP  218 (257)
T ss_pred             CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHH-HHHHcCCcCC
Confidence            332211  11223467999999988889999999999999999998 9999863221        1111 1111111000


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                                   .+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       219 -------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 -------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                         01134567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3e-42  Score=307.87  Aligned_cols=255  Identities=18%  Similarity=0.259  Sum_probs=203.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--C---CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--Q---ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      .+|...+.||+|+||   .||+|.+  +   +..+|+|.+.... .....+.|.+|+.++.+++||||+++++++.+++.
T Consensus         4 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           4 SCIKIEKVIGAGEFG---EVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHeEeeeeecccCCC---ceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            467888999999999   8888876  2   3479999886543 34456789999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++++|.+++....    ..+++.+++.++.|++.||.|||   +++++||||||+|||++.++.++++|||+
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCc
Confidence            999999999999999997653    35788999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccc--ccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          217 SISIPEGETHITD--TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       217 a~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +............  ...++..|+|||++.+..++.++|+||||+++|++++ |..||......        +.......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~  224 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAIEE  224 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------HHHHHHhC
Confidence            8776443222111  1223567999999988889999999999999999887 99998633211        11111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ....+              .+...+..+.+++.+||+.+|.+|||+.++++.|.++
T Consensus       225 ~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 GYRLP--------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCcCC--------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            10000              0013455778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.8e-43  Score=320.46  Aligned_cols=242  Identities=20%  Similarity=0.275  Sum_probs=193.5

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCC-ceeeccceeeeCCccE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHN-HILKLIGCCLETPIPI  138 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~~  138 (353)
                      +|...+.||+|+||   .||+|..  +++.||+|++..... .....+.+..|..++..+.|+ +|+++++++...+..|
T Consensus         1 ~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   77 (324)
T cd05587           1 DFNFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   77 (324)
T ss_pred             CceEEEEEeeccCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence            47778899999999   9999988  677999999865421 234456788999999999865 5888999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.++|+|||++.
T Consensus        78 lv~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          78 FVMEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             EEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            999999999999988754     35788999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... ......||..|+|||++.+..++.++|||||||++|+|+||+.||.....        ......... ... 
T Consensus       150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~-~~~-  218 (324)
T cd05587         150 ENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIME-HNV-  218 (324)
T ss_pred             ecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-CCC-
Confidence            5322221 23345789999999999988899999999999999999999999873221        111111111 100 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                               ..    +...+..+.+++.+||..||.+||+.
T Consensus       219 ---------~~----~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 ---------SY----PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---------CC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                     00    01344567899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.1e-42  Score=324.70  Aligned_cols=251  Identities=14%  Similarity=0.157  Sum_probs=194.7

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .|...+.||+|+||   .||++..  ++..||+|++..... .......+.+|+.++++++|||||++++++.+++..|+
T Consensus         2 ~f~~~~~LG~G~~g---~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l   78 (382)
T cd05625           2 MFVKIKTLGIGAFG---EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF   78 (382)
T ss_pred             CcEEEEEEEeCCCE---EEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence            47888999999999   9999988  788999999865421 23445678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus        79 v~E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          79 VMDYIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999999998764     35788889999999999999999   99999999999999999999999999999753


Q ss_pred             cCCCC----------------------------------------------CccccccccCCccccccccccCCCCcccc
Q 018633          220 IPEGE----------------------------------------------THITDTVMGTWGYCAPEYMRTGVFNEKSD  253 (353)
Q Consensus       220 ~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  253 (353)
                      +....                                              ........||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            31100                                              00012346899999999999889999999


Q ss_pred             chhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCC
Q 018633          254 VFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSP  333 (353)
Q Consensus       254 i~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  333 (353)
                      ||||||++|||++|..||......        +.............         .+  .....+.++.+++.+|+ .+|
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~---------~p--~~~~~s~~~~~li~~l~-~~p  290 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPL--------ETQMKVINWQTSLH---------IP--PQAKLSPEASDLIIKLC-RGP  290 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHH--------HHHHHHHccCCCcC---------CC--CcccCCHHHHHHHHHHc-cCH
Confidence            999999999999999999743211        11111110000000         00  00133456677887765 599


Q ss_pred             CCCCC---HHHHHH
Q 018633          334 ADRPS---MVDVAK  344 (353)
Q Consensus       334 ~~Rps---~~~vl~  344 (353)
                      .+|++   +.+++.
T Consensus       291 ~~R~~~~~~~ei~~  304 (382)
T cd05625         291 EDRLGKNGADEIKA  304 (382)
T ss_pred             hHcCCCCCHHHHhc
Confidence            99997   777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.9e-42  Score=306.94  Aligned_cols=250  Identities=18%  Similarity=0.206  Sum_probs=202.3

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|...+.||+|+||   .||++.+  ++..+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~g---~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCe---EEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            46778899999999   9999888  78999999986442 344567888999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++|+|.+++.....   ..++...++.++.|++.||.|||   +++++|+||||+||+++.++.++++|||.+...
T Consensus        77 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             EeeCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence            999999999998865432   35788999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.....        ........ ......+
T Consensus       151 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~~~  220 (255)
T cd08219         151 TSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVC-QGSYKPL  220 (255)
T ss_pred             ccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHh-cCCCCCC
Confidence            43221 22345688899999999888899999999999999999999999873221        11111111 1111110


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                                   +...+..+.+++.+||+.||++|||+.+++..
T Consensus       221 -------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 -------------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                         01344567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.3e-42  Score=306.37  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=199.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +.|.....||+|++|   .||++.+ .+..+|+|.+....   ...+.+.+|+.++++++|||++++++++. .+..++|
T Consensus         6 ~~~~~~~~ig~g~~~---~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFG---EVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCC---eEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence            457788899999999   9999988 44579999876542   23467899999999999999999999875 4568899


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++.....   ..+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++...
T Consensus        79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             EEcCCCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            999999999999976432   35788999999999999999999   999999999999999999999999999999766


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ............++..|+|||...+..++.++||||||+++|+|+| |..||......        ..... ....... 
T Consensus       153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~-~~~~~~~-  222 (260)
T cd05069         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQ-VERGYRM-  222 (260)
T ss_pred             cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH-HHcCCCC-
Confidence            4333222233446678999999988889999999999999999999 88888632211        11111 1111000 


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                                  ..+...+..+.+++.+||..+|++|||+.++++.|++
T Consensus       223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 ------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                        0011445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.7e-42  Score=307.45  Aligned_cols=258  Identities=21%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +.|+..+.||+|+||   .||+|.+      .+..|++|.+.... .......|.+|+.++++++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g---~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           5 SAVRFMEELGECAFG---KIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhceeeeeccccCCc---ceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            346777899999999   8999875      45789999987542 3445578899999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCC------------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee
Q 018633          136 IPILVFESVQYGTLWDRILGAPQ------------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF  203 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  203 (353)
                      ..|+||||+++++|.+++.....            .....+++..++.++.|++.||.|||   +++++||||||+|||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili  157 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILI  157 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEE
Confidence            99999999999999998853211            00135788899999999999999999   9999999999999999


Q ss_pred             cCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCC
Q 018633          204 NEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLA  281 (353)
Q Consensus       204 ~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~  281 (353)
                      +.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.....     
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----  232 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----  232 (283)
T ss_pred             cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            9999999999999876533221 12233445678999999988889999999999999999998 8888753211     


Q ss_pred             CChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                          ..............             .+..++..+.+++.+||+.||++||++.++.+.|..
T Consensus       233 ----~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ----QEVIEMVRKRQLLP-------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                11111111111100             001345677899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-42  Score=308.30  Aligned_cols=257  Identities=22%  Similarity=0.308  Sum_probs=203.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeC-----CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQ-----ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++|...+.||+|+||   .||+|.+.     ...|++|...... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus         6 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           6 EDITLGRCIGEGQFG---DVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhceeeeeeCCccce---eEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            457788899999999   99999872     2468889886552 24566789999999999999999999999865 55


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCce
Confidence            789999999999999997643    35789999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ++..............++..|+|||.+....++.++||||||+++||+++ |..||.......        .........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~  225 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGE  225 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCC
Confidence            87764432222223334567999999988889999999999999999986 999986432211        111111111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .. .         .    +...+..+.+++.+||..+|++|||+.++++.|.++..+
T Consensus       226 ~~-~---------~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         226 RL-P---------M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             cC-C---------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            10 0         0    013456788999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=308.91  Aligned_cols=296  Identities=22%  Similarity=0.294  Sum_probs=225.2

Q ss_pred             hhhchhHHHHHHHhc--CCCCCCcceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhH
Q 018633           28 MRSGASVLKELIASS--NGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRA  105 (353)
Q Consensus        28 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~  105 (353)
                      ...|.+.+.+++...  +|...-.   ++--=+.........+.||+|.||   .||+|.|.|..||||+|...     .
T Consensus       178 ~~~~~stl~Dll~~~~tSGSGSGl---plLVQRTiarqI~L~e~IGkGRyG---EVwrG~wrGe~VAVKiF~sr-----d  246 (513)
T KOG2052|consen  178 TLAGDSTLKDLLDDLETSGSGSGL---PLLVQRTIARQIVLQEIIGKGRFG---EVWRGRWRGEDVAVKIFSSR-----D  246 (513)
T ss_pred             cccCCccHHHHHHhhccCCCCCCc---hhHhHHhhhheeEEEEEecCcccc---ceeeccccCCceEEEEeccc-----c
Confidence            567777777776432  1211111   111112334456778899999999   99999999999999999654     4


Q ss_pred             HHHHHHHHHHHhh--cCCCceeeccceeeeCC----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHH
Q 018633          106 YESCINNVTYAAR--MSHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA  179 (353)
Q Consensus       106 ~~~~~~E~~~l~~--l~H~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~  179 (353)
                      .+.+.+|.++...  |+|+||+.|++.-..++    .+|||++|.+.|||+|+|...      .++....++++..+|.|
T Consensus       247 E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsG  320 (513)
T KOG2052|consen  247 ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASG  320 (513)
T ss_pred             hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhh
Confidence            5678888888875  68999999999876554    489999999999999999874      68899999999999999


Q ss_pred             HHHHh-----cCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCC---ccccccccCCccccccccccCC----
Q 018633          180 LAYLH-----FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTGV----  247 (353)
Q Consensus       180 L~~LH-----~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----  247 (353)
                      |++||     ++....|.|||||+.|||+.+++.+.|+|+|+|........   ...+..+||.+|||||++....    
T Consensus       321 LaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~  400 (513)
T KOG2052|consen  321 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKH  400 (513)
T ss_pred             HHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhh
Confidence            99999     33466799999999999999999999999999987655432   2347789999999999997543    


Q ss_pred             CC--ccccchhhHHHHHHHHhCC----------CCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHH
Q 018633          248 FN--EKSDVFSFGVFLFELLTGW----------DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKE  315 (353)
Q Consensus       248 ~~--~~~Di~slG~il~el~tg~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (353)
                      |.  ..+||||||.++||+..+.          .||......    .|..+.+...+...++...+++.+..+       
T Consensus       401 Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~----DPs~eeMrkVVCv~~~RP~ipnrW~s~-------  469 (513)
T KOG2052|consen  401 FESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS----DPSFEEMRKVVCVQKLRPNIPNRWKSD-------  469 (513)
T ss_pred             hhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC----CCCHHHHhcceeecccCCCCCcccccC-------
Confidence            22  3699999999999998642          444332222    234444444444444444444444333       


Q ss_pred             HHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          316 QQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       316 ~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .....+.+||..||..+|+.|.|+-.+-+.|.++.+
T Consensus       470 ~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  470 PALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            677889999999999999999999999999998864

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-42  Score=325.89  Aligned_cols=251  Identities=14%  Similarity=0.142  Sum_probs=195.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +|...+.||+|+||   .||++..  +++.||+|++..... .......+.+|+.++++++||||+++++.+.+++.+|+
T Consensus         2 ~y~~~~~lG~G~~g---~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           2 MFVKIKTIGIGAFG---EVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CceEEEEEEeCCCe---EEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            58888999999999   9999988  789999999864321 12345668899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.++|+|||++..
T Consensus        79 v~E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          79 VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            99999999999998764     35788888999999999999999   99999999999999999999999999999753


Q ss_pred             cCCCC------------------------------------------CccccccccCCccccccccccCCCCccccchhh
Q 018633          220 IPEGE------------------------------------------THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF  257 (353)
Q Consensus       220 ~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  257 (353)
                      +....                                          ........||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            31000                                          000123479999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC
Q 018633          258 GVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP  337 (353)
Q Consensus       258 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  337 (353)
                      ||++|||++|..||.......        ..............      ..     ....+..+.+++.+|+ .+|.+|+
T Consensus       231 Gvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~------~~-----~~~~s~~~~~li~~l~-~~p~~R~  290 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAE--------TQLKVINWETTLHI------PS-----QAKLSREASDLILRLC-CGAEDRL  290 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHH--------HHHHHhccCccccC------CC-----CCCCCHHHHHHHHHHh-cCHhhcC
Confidence            999999999999997433211        11111100000000      00     0023456677888876 5999999


Q ss_pred             ---CHHHHHH
Q 018633          338 ---SMVDVAK  344 (353)
Q Consensus       338 ---s~~~vl~  344 (353)
                         |+.++++
T Consensus       291 ~~~t~~ell~  300 (376)
T cd05598         291 GKNGADEIKA  300 (376)
T ss_pred             CCCCHHHHhC
Confidence               8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4e-42  Score=320.17  Aligned_cols=269  Identities=19%  Similarity=0.239  Sum_probs=200.5

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-  135 (353)
                      ...++|...+.||+|+||   .||++.+  ++..||+|++............+.+|+.+++.++||||+++++++.... 
T Consensus        18 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   94 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQG---IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhhceEEEEEeecCCCE---EEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence            345789999999999999   9999987  7899999999765444556678889999999999999999999986543 


Q ss_pred             -----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          136 -----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       136 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                           ..|+||||++ ++|.+.+.       ..++...+..++.|++.||.|||   +++|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          95 LEEFQDVYLVMELMD-ANLCQVIH-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             ccccceeEEEEeCCC-cCHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEE
Confidence                 4699999997 56766663       24678888999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCC
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACP  283 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~  283 (353)
                      |+|||+++......  ......||..|+|||++.+..++.++|||||||++|+|++|..||.......       ....+
T Consensus       164 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         164 ILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             EecCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999987643221  2334578999999999998899999999999999999999999997543211       00111


Q ss_pred             hHHHHH-------HHhhcC-ccc-----ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          284 SNEYLK-------NYFEDN-RFT-----EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       284 ~~~~~~-------~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+..       .+.... ...     +......... ........+..+.+|+.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPS-ESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccc-ccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            111111       011000 000     0000000000 00001123466889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.2e-42  Score=307.79  Aligned_cols=256  Identities=21%  Similarity=0.300  Sum_probs=202.4

Q ss_pred             HHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           56 EIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        56 e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      |++.+++++.....||+|+||   .||+|.+  ++..|++|.+...  .....+.+.+|+.++++++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g---~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYG---IVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE   76 (268)
T ss_pred             CcccccccCCceEEEecCCce---EEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence            345678888888999999999   9999987  6788999988765  45566789999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccc--cHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-CCceE
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPL--LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAK  210 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~k  210 (353)
                      ++..++|+||+++++|.+++....    ..+  +...+..++.|++.||.|||   +++|+||||||+||+++. ++.++
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~  149 (268)
T cd06624          77 NGFFKIFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVK  149 (268)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEE
Confidence            999999999999999999987643    234  77888899999999999999   999999999999999976 67899


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCC--CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      |+|||.+........ ......|+..|+|||++....  ++.++||||||+++|+|++|..||.......     ...+.
T Consensus       150 l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~~  223 (268)
T cd06624         150 ISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMFK  223 (268)
T ss_pred             EecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHhh
Confidence            999999876533222 123345788999999986644  7889999999999999999999986322111     00000


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....  ..             .+..+......+.+++.+||+.+|++|||+.+++.
T Consensus       224 ~~~~--~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         224 VGMF--KI-------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhh--cc-------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0000  00             00001144566889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.9e-43  Score=321.12  Aligned_cols=238  Identities=20%  Similarity=0.248  Sum_probs=188.6

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHH-HHhhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVT-YAARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ++||+|+||   .||++.+  +++.||+|++..... .......+..|.. +++.++||||+++++++.+.+..|+||||
T Consensus         1 ~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFG---KVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence            469999999   9999998  789999999865421 1223345556655 46789999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|..++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++......
T Consensus        78 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          78 VNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            9999999988754     35788999999999999999999   999999999999999999999999999998754222


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        .+........ .. .    
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~-~~-~----  214 (323)
T cd05575         150 S-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNK-PL-R----  214 (323)
T ss_pred             C-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcC-CC-C----
Confidence            2 123445789999999999988899999999999999999999999873221        1111111110 00 0    


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV  340 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  340 (353)
                       +        +...+..+.+++.+||+.||.+||++.
T Consensus       215 -~--------~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 -L--------KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -C--------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             0        013356678999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.7e-42  Score=305.07  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=206.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..++||.|+||   .||.+..  ++..+++|.+.....+......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~ig~g~~g---~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCc---eEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            47888999999999   7777766  788999999876654566777899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++.....   ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        78 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          78 MEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             EEecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            999999999999876532   45789999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....        ..+....... ..+...
T Consensus       152 ~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~-~~~~~~  221 (256)
T cd08221         152 GSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQ-GNYTPV  221 (256)
T ss_pred             ccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHc-CCCCCC
Confidence            44332 2345568899999999988888999999999999999999999986321        1111111111 111110


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                                   +...+..+.+++.+||..+|++|||+.++++.
T Consensus       222 -------------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 -------------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -------------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                         01456678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.3e-42  Score=315.90  Aligned_cols=244  Identities=20%  Similarity=0.281  Sum_probs=192.8

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||++..  +++.||+|++..... .....+.+.+|+.++.++ +||||+++++++.+.+..|+||||
T Consensus         1 ~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (327)
T cd05617           1 RVIGRGSYA---KVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY   77 (327)
T ss_pred             CeeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence            469999999   9999988  778999999975422 233456688999999988 599999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|..++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          78 VNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence            9999999888654     35899999999999999999999   999999999999999999999999999998753222


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|..||........  ................      
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~------  220 (327)
T cd05617         150 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVILEKPI------  220 (327)
T ss_pred             C-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc--cccHHHHHHHHHhCCC------
Confidence            1 123456799999999999988999999999999999999999999964332211  1111111111111100      


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                          .    .+...+..+.+++.+||+.||++||++
T Consensus       221 ----~----~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         221 ----R----IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             ----C----CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                0    011334567899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-42  Score=317.91  Aligned_cols=241  Identities=20%  Similarity=0.273  Sum_probs=191.3

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||+|.+  +++.||+|.+..... .......+..|..++..+ +||||+++++++.+.+..++||||
T Consensus         1 ~~lG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey   77 (316)
T cd05619           1 KMLGKGSFG---KVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY   77 (316)
T ss_pred             CeeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence            469999999   9999998  678999999865421 123345667788888764 899999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++......
T Consensus        78 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          78 LNGGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence            9999999998754     35788899999999999999999   999999999999999999999999999998754222


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      .. ......||..|+|||++.+..++.++|||||||++|||++|..||.....        .+..... ....      +
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i-~~~~------~  213 (316)
T cd05619         150 DA-KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSI-RMDN------P  213 (316)
T ss_pred             CC-ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhCC------C
Confidence            21 23455789999999999988899999999999999999999999874221        1111111 1000      0


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV-DVA  343 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~vl  343 (353)
                      .        .+...+..+.+++.+||+.||++||++. ++.
T Consensus       214 ~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         214 C--------YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             C--------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            0        0013445678999999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-42  Score=310.52  Aligned_cols=259  Identities=20%  Similarity=0.329  Sum_probs=201.6

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      .+++|...+.||+|++|   .||+|.+.       +..||+|.+.... .......|.+|+.++++++|+||+++++++.
T Consensus         4 ~~~~~~~~~~lg~g~~g---~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (277)
T cd05036           4 PRDSITLLRALGHGAFG---EVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSF   79 (277)
T ss_pred             CHHHcEeeeECCCCCCC---cEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            35678999999999999   89988883       4678888876442 3444567999999999999999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCC--CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC---
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQP--HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---  207 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---  207 (353)
                      +.+..++||||+++++|.+++......  ....+++..++.++.||+.||.|||   +++++||||||+||+++.++   
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCc
Confidence            988999999999999999998765321  1135889999999999999999999   99999999999999998654   


Q ss_pred             ceEEeccCCccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChH
Q 018633          208 VAKLFDFSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~  285 (353)
                      .+||+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||......        
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------  228 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------  228 (277)
T ss_pred             ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            58999999987763222111 112233567999999988889999999999999999997 88888632211        


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ............          ..    +...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       229 ~~~~~~~~~~~~----------~~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 EVMEFVTGGGRL----------DP----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHHHcCCcC----------CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111111111100          00    1134567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-42  Score=319.16  Aligned_cols=242  Identities=19%  Similarity=0.259  Sum_probs=194.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPI  138 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~  138 (353)
                      +|...+.||+|+||   .||++..  ++..||+|++..... .....+.+..|..++..+. |++|+++++++...+..+
T Consensus         1 df~~~~~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   77 (323)
T cd05616           1 DFNFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY   77 (323)
T ss_pred             CceEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence            47778899999999   9999988  678999999875421 2234456778888888874 899999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+.+...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        78 lv~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          78 FVMEYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence            999999999999888654     35788999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||+||..||......        ....... .... 
T Consensus       150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~-~~~~-  218 (323)
T cd05616         150 ENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIM-EHNV-  218 (323)
T ss_pred             ecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHH-hCCC-
Confidence            5432221 234567899999999999999999999999999999999999999743211        1111111 1110 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                               ..    +...+.++.+++.+||+.+|++|++.
T Consensus       219 ---------~~----p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ---------AY----PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---------CC----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                     00    01345667899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-42  Score=306.56  Aligned_cols=258  Identities=21%  Similarity=0.336  Sum_probs=204.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++|...+.||+|+||   .||+|.+.       +..||+|.+.... .......+.+|+.++..++||||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFG---MVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCc---eEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4568888999999999   89888872       3679999986542 33445678999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCC-----CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQP-----HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV  208 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  208 (353)
                      ....++||||+++|+|.+++......     ....+++..++.++.|++.||.|||   +++++||||||+||+++.++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCC
Confidence            99999999999999999998654321     1134688899999999999999999   999999999999999999999


Q ss_pred             eEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHH
Q 018633          209 AKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~  286 (353)
                      ++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |..||.....        .+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~  229 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EE  229 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HH
Confidence            99999999876543322 12233456788999999988889999999999999999998 8888753211        11


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      .... ..........             ...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       230 ~~~~-~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         230 VLKF-VIDGGHLDLP-------------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHH-HhcCCCCCCC-------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111 1111111110             133567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-42  Score=312.23  Aligned_cols=257  Identities=17%  Similarity=0.276  Sum_probs=201.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      .|...+.||+|+||   .||+|.+.       +..||+|++.... .....+.|.+|+.++..++||||+++++++...+
T Consensus         6 ~~~~~~~lg~G~~g---~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           6 TVRFMEELGEDRFG---KVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHhCCCCCC---eEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            35667789999999   99999862       4789999987552 3344577899999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCC-----------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          136 IPILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                      ..++++||+++++|.+++.....           .....+++..++.++.|++.||.|||   +++|+||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEec
Confidence            99999999999999998853210           01135788889999999999999999   99999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLAC  282 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~  282 (353)
                      .++.+||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||.....      
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------  232 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  232 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999876533221 11233456778999999988889999999999999999998 7777763211      


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                        .+.... ........             .+..++..+.+++.+||+.+|++|||+.+|+..|+.
T Consensus       233 --~~~~~~-i~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 --QDVIEM-IRNRQVLP-------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHHHH-HHcCCcCC-------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              111111 11111100             011456678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-41  Score=309.01  Aligned_cols=264  Identities=19%  Similarity=0.317  Sum_probs=207.2

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe---------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW---------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLI  128 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~  128 (353)
                      ...++|...+.||+|+||   .||++.+         .+..||+|.+.... .......+.+|+.++..+ +||||++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFG---QVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccHHHeeecceeeccCCc---eEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            345678888999999999   8887764         24579999886542 344567899999999999 799999999


Q ss_pred             ceeeeCCccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccC
Q 018633          129 GCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK  197 (353)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  197 (353)
                      +++......++||||+++|+|.+++......           ....+++..++.++.|++.||.|||   +++++|||||
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlk  164 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLA  164 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccc
Confidence            9999999999999999999999998764221           0135788899999999999999999   9999999999


Q ss_pred             CCceeecCCCceEEeccCCccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccc
Q 018633          198 TSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVK  275 (353)
Q Consensus       198 p~Nill~~~~~~kl~dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~  275 (353)
                      |+||+++.++.++|+|||+++......... .....++..|+|||++.+..++.++||||||+++|++++ |..||... 
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-  243 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-  243 (304)
T ss_pred             cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-
Confidence            999999999999999999997764332211 223345678999999988889999999999999999998 77776522 


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                             +..+........... .             .+..++..+.+++.+||..+|++|||+.++++.|.++..
T Consensus       244 -------~~~~~~~~~~~~~~~-~-------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         244 -------PVEELFKLLKEGHRM-D-------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             -------CHHHHHHHHHcCCcC-C-------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                   122222221111100 0             001455678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-42  Score=314.22  Aligned_cols=263  Identities=20%  Similarity=0.313  Sum_probs=205.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe---------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccce
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW---------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGC  130 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~  130 (353)
                      .++|...+.||+|+||   .||++.+         +...+|+|.+.... .......+.+|+.++.++ +||||++++++
T Consensus        17 ~~~~~i~~~lg~G~~g---~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          17 RDRLVLGKPLGEGCFG---QVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             hHHeEEeeeeccCCCe---eEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3568999999999999   8888875         12469999987542 344556788999999999 79999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      +...+..|+||||+++|+|.+++......           ....+++..++.++.|++.||.|||   +++++||||||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~  169 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR  169 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHH
Confidence            99999999999999999999999764321           0135788999999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDT  277 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~  277 (353)
                      ||+++.++.++|+|||.+.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...   
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~---  246 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---  246 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC---
Confidence            9999999999999999987654322111 112234568999999988889999999999999999998 77887522   


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                           +..+.... .......+             .+...+..+.+++.+||..+|++|||+.++++.|.++...
T Consensus       247 -----~~~~~~~~-~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         247 -----PVEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             -----CHHHHHHH-HHcCCCCC-------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                 11111111 11111000             0113456788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-42  Score=315.40  Aligned_cols=270  Identities=19%  Similarity=0.243  Sum_probs=199.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||+|..  ++..||+|.+.... .......+.+|+.++++++||||+++++++..++..++
T Consensus         6 ~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           6 ETYIKLEKLGEGTYA---TVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CceEEEEEecccCCE---EEEEEEecCCCCeEEEEEeeccc-cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            468888999999999   9999988  78899999986542 22334567889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++ ++|.+.+....    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus        82 v~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          82 VFEYLD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             EEeCCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence            999997 58888876543    35788899999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHH
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNY  291 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~  291 (353)
                      ...... ......+|..|+|||++.+ ..++.++||||||+++|+|+||..||........       ...+....+...
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07872         154 KSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI  232 (309)
T ss_pred             cCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence            533222 1234467889999998865 4588999999999999999999999975432110       001111111110


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....+...-.+..............+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000000000000000000134567789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-42  Score=317.60  Aligned_cols=241  Identities=19%  Similarity=0.238  Sum_probs=191.2

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ++||+|+||   .||++.+  ++..||+|.+..... .......+..|..++... +||||+++++++.+.+..|+||||
T Consensus         1 ~~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   77 (316)
T cd05620           1 KVLGKGSFG---KVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF   77 (316)
T ss_pred             CeeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence            469999999   9999998  788999999865421 123345667788888764 799999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.++|+|||+++.....
T Consensus        78 ~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          78 LNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence            9999999988754     35788999999999999999999   999999999999999999999999999998653222


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||..|+|||++.+..++.++|||||||++|||++|..||......        ...... .... .     
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~-~~~~-~-----  213 (316)
T cd05620         150 D-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESI-RVDT-P-----  213 (316)
T ss_pred             C-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHH-HhCC-C-----
Confidence            2 1234567899999999999889999999999999999999999999743211        111111 1000 0     


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV-DVA  343 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~vl  343 (353)
                          ..    +...+.++.+++.+||+.||++||++. +++
T Consensus       214 ----~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 ----HY----PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                00    012445678999999999999999974 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-41  Score=307.23  Aligned_cols=265  Identities=21%  Similarity=0.277  Sum_probs=203.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeC------------------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQ------------------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHN  122 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~  122 (353)
                      ...|...+.||+|+||   .||++.+.                  +..||+|.+.... .....+.+.+|++++++++||
T Consensus         4 ~~~~~~~~~lg~G~~g---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           4 RQPLNFVEKLGEGQFG---EVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             hhhCcccccccCCCCc---cEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCC
Confidence            3468889999999999   88887762                  2468999987553 345667899999999999999


Q ss_pred             ceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCC------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeecc
Q 018633          123 HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF  196 (353)
Q Consensus       123 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl  196 (353)
                      ||+++++++..++..++||||+++++|.+++.......      ...+++..++.++.|++.||.|||   +++++||||
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dl  156 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDL  156 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCcccccc
Confidence            99999999999999999999999999999987653111      126899999999999999999999   999999999


Q ss_pred             CCCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh--CCCCCCc
Q 018633          197 KTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--GWDVSDL  273 (353)
Q Consensus       197 kp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t--g~~p~~~  273 (353)
                      ||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999876533321 12234456778999999988889999999999999999998  5666653


Q ss_pred             cccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          274 VKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      .....     ........+..........          .+...+.++.+++.+||+.||++|||+.++++.|.
T Consensus       237 ~~~~~-----~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTDQQ-----VIENAGHFFRDDGRQIYLP----------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cChHH-----HHHHHHhccccccccccCC----------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            22111     0001111111000000000          01134567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.2e-42  Score=304.72  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=193.5

Q ss_pred             CceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee-eCCccEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL-ETPIPILVF  141 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~~~lv~  141 (353)
                      +.||+|+||   .||+|.+     ....||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..++|+
T Consensus         1 ~~lg~g~~g---~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFG---CVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCc---eEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            468999999   9998886     23579999885431 3445678899999999999999999999876 455689999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++|+|.+++....    ..+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        77 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          77 PYMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             ecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999999987543    34567778899999999999999   9999999999999999999999999999987653


Q ss_pred             CCCC---ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCC-CCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          222 EGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW-DVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       222 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....   .......++..|+|||.+....++.++||||||+++|||++|. +||....        ..............
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~~~~~~~~  221 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--------SFDITVYLLQGRRL  221 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHhcCCCC
Confidence            3211   0112334567899999998888999999999999999999965 4544211        11111111111000


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                       .             .+...+..+.+++.+||..+|++||++.++++.|+++..
T Consensus       222 -~-------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         222 -L-------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -C-------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             0             001334578899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-41  Score=301.78  Aligned_cols=253  Identities=19%  Similarity=0.297  Sum_probs=202.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .+.|...+.||+|+||   .||++.+ .+..+|+|.+...   ....+.|.+|+.++++++|+||+++++++.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~~---~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFG---EVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccce---EEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            3568888999999999   9999987 6677999987654   3345678999999999999999999999877 77899


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      +|||+++++|.+++.....   ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        78 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceee
Confidence            9999999999999976432   35788899999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .............++..|+|||++....++.++|+||||+++|+++| |..||.......         ...........
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---------~~~~~~~~~~~  222 (260)
T cd05073         152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERGYRM  222 (260)
T ss_pred             ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHhCCCCC
Confidence            64433222333445678999999988889999999999999999999 888886322111         11111111000


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                      .             .+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 ~-------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 P-------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             C-------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0             001445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.3e-42  Score=310.70  Aligned_cols=251  Identities=19%  Similarity=0.274  Sum_probs=199.7

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      |...++||+|+||   .||++.+  +++.||+|.+...... ......+.+|+.++++++|+||+++++.+.+++..++|
T Consensus         2 f~~~~~ig~G~~g---~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           2 FRQYRVLGKGGFG---EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             ceeeEEeecCCCe---EEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            6777899999999   9999998  7889999998654222 23345678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++...
T Consensus        79 ~e~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            999999999998865432   35889999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      .....  .....|+..|+|||++.+..++.++||||||+++|+|++|..||.......     ............  .  
T Consensus       153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~~--~--  221 (285)
T cd05630         153 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKEV--Q--  221 (285)
T ss_pred             CCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhhh--h--
Confidence            33221  234578999999999998889999999999999999999999997432211     000111111000  0  


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                            ..    .+...+..+.+|+.+||+.||++|||     +.++++
T Consensus       222 ------~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 ------EE----YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ------hh----cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                  00    01134556789999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.3e-42  Score=308.34  Aligned_cols=250  Identities=20%  Similarity=0.281  Sum_probs=197.8

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|...++||+|+||   .||+|.+  ++..||+|.+.... .......+.+|+.++.+++||||+++++++...+..++|
T Consensus         2 ~~~~~~~lg~g~~~---~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGG---TVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             cchheeeeccCCCe---EEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            46777899999999   9999987  78899999986542 344557799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|..+         ..+++..+..++.|++.||.|||   +++|+|+||||+|||++.++.++|+|||++...
T Consensus        78 ~e~~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          78 TEFMDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             EecCCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            999999998643         23678888899999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ....   .....||..|+|||++.+..++.++|+||||+++|+|++|..||............. .... ......... 
T Consensus       146 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~-~~~~~~~~~-  219 (279)
T cd06619         146 VNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-QLLQ-CIVDEDPPV-  219 (279)
T ss_pred             cccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH-HHHH-HHhccCCCC-
Confidence            3321   234578899999999998889999999999999999999999987533222111010 1100 000000000 


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                          ..       ....+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ----~~-------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 ----LP-------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ----CC-------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                00       01344567899999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-42  Score=305.93  Aligned_cols=252  Identities=21%  Similarity=0.275  Sum_probs=195.5

Q ss_pred             CceeeCCCCCccEEEEEEe--CC--eEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QE--RLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      ++||+|+||   .||+|.+  ++  ..+++|.+.... .....+.+.+|+.++.++ +||||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g---~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCc---eEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            368999999   9999987  33  356888876431 345567899999999999 79999999999999999999999


Q ss_pred             eccCCChhhhhccCCC-----------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          143 SVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                      |+++|+|.+++.....           .....+++..++.++.|++.||+|||   +++++||||||+|||++.++.+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEE
Confidence            9999999999875421           01135789999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      +|||++......  ........+..|+|||++....++.++||||||+++|||++ |..||.....        ......
T Consensus       154 ~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~  223 (270)
T cd05047         154 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEK  223 (270)
T ss_pred             CCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHH
Confidence            999998533211  11112233567999999988889999999999999999997 9999863211        111111


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      ....... +         .    +...+..+.+++.+||+.+|.+|||+.++++.|.+++
T Consensus       224 ~~~~~~~-~---------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 LPQGYRL-E---------K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HhCCCCC-C---------C----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1110000 0         0    0133456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-41  Score=305.20  Aligned_cols=262  Identities=21%  Similarity=0.267  Sum_probs=202.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      .|...+.||+|+||   .||.+.+      ++..||+|.+.... .......+.+|+.++++++||||+++++++...  
T Consensus         5 ~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCce---eEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            46788899999999   8888763      57889999986542 344567899999999999999999999998765  


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ...++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+||
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCC
Confidence            56889999999999999986543    35789999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCChH
Q 018633          215 SLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACPSN  285 (353)
Q Consensus       215 g~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~  285 (353)
                      |+++........  ......++..|+|||++.+..++.++||||||+++|+|+|+..|........       .......
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05079         154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT  233 (284)
T ss_pred             ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence            998876433221  1223456778999999988889999999999999999999877643211100       0000000


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .... ........             ..+...+..+.+|+.+||+.+|++|||+.++++.|+++
T Consensus       234 ~~~~-~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         234 RLVR-VLEEGKRL-------------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHH-HHHcCccC-------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1110 00000000             00113556789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-42  Score=305.87  Aligned_cols=255  Identities=23%  Similarity=0.345  Sum_probs=204.8

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ..++|...+.||+|+||   .||++.+ .+..||+|.+....   ...+.+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~i~~~ig~g~~~---~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFG---EVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcce---EEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            34678889999999999   9999988 66789999987552   33467899999999999999999999999888999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++.....   ..+++..+..++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++.
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~  151 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLAR  151 (261)
T ss_pred             EEEeccCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccce
Confidence            99999999999999976542   35789999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ..............++..|+|||.+.+..++.++|+||||+++|++++ |+.||.....        .............
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~  223 (261)
T cd05034         152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRM  223 (261)
T ss_pred             eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            764322221222334568999999998889999999999999999999 8888853211        1111111111000


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                      .              .+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       224 ~--------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 P--------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             C--------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0              001235578899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.4e-42  Score=309.02  Aligned_cols=256  Identities=21%  Similarity=0.282  Sum_probs=201.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .++.....||+|+||   .||++..       ++..+|+|.+...  .......|.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFG---KVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCC---eEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            356778899999999   8887753       4668899988765  556677899999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCC----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQP----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                      +..++||||+++++|.+++......          ....+++..++.++.|++.||.|||   +++++||||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence            9999999999999999998754310          0124788999999999999999999   99999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLAC  282 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~  282 (353)
                      +++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.......    
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  232 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----  232 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----
Confidence            999999999999876533221 11223345678999999998889999999999999999998 888875322111    


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                          ..... .......             .+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus       233 ----~~~~~-~~~~~~~-------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 ----AIECI-TQGRELE-------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----HHHHH-HcCccCC-------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                11111 1110000             00134566889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.3e-42  Score=306.50  Aligned_cols=254  Identities=18%  Similarity=0.270  Sum_probs=201.3

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CC---eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QE---RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .|...+.||+|+||   .||+|.+  ++   ..||+|.+.... .......|..|+.++++++||||+++++++.+++..
T Consensus         5 ~~~~~~~lg~g~~g---~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           5 CVKIEEVIGAGEFG---EVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HeEEEeEecCCCCC---eEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            46778899999999   9999887  23   369999987542 345567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++++|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          81 MIITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccc
Confidence            99999999999999987643    35789999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccc--cccc--cCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          218 ISIPEGETHIT--DTVM--GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       218 ~~~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ...........  ....  .+..|+|||.+.+..++.++||||||+++||+++ |..||.....        ........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i~  225 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAIE  225 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHHH
Confidence            76543222111  1111  2357999999998889999999999999999887 9999863221        11111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .....+              .+..++..+.+++.+||..+|++||++.+++..|+++
T Consensus       226 ~~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 QDYRLP--------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCCcCC--------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110000              0114456678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4e-42  Score=327.61  Aligned_cols=264  Identities=18%  Similarity=0.289  Sum_probs=192.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET----  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----  134 (353)
                      ..+|...+.||+|+||   .||+|..  +++.||||++....      ....+|+.+++.++|||||++++++...    
T Consensus        65 ~~~y~~~~~LG~G~fg---~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFG---VVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CCeEEEeEEEEeCCCE---EEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            4579999999999999   9999988  78899999886541      2345799999999999999998886432    


Q ss_pred             ----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ce
Q 018633          135 ----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VA  209 (353)
Q Consensus       135 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~  209 (353)
                          ..+++||||++ ++|.+++....... ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++ .+
T Consensus       136 ~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~-~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        136 NEKNIFLNVVMEFIP-QTVHKYMKHYARNN-HALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             CCCceEEEEEEecCC-ccHHHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCce
Confidence                24679999998 57877765321111 46889999999999999999999   99999999999999998665 69


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CC
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LA  281 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~  281 (353)
                      ||+|||+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|.+||........       ..
T Consensus       211 kL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~  288 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG  288 (440)
T ss_pred             eeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999987643322  2345689999999998764 589999999999999999999999975332110       00


Q ss_pred             CChHHHHHHH---hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          282 CPSNEYLKNY---FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       282 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+..+.....   +....++.....    +.....+...+.++.+|+.+||..||.+|||+.++++
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~----~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPK----DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCch----hHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            1111111100   000011111111    1111111134567889999999999999999999874

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.3e-42  Score=311.61  Aligned_cols=248  Identities=19%  Similarity=0.248  Sum_probs=201.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .+|+..+.||+|++|   .||+|..  +++.|++|.+...  .....+.+.+|+.+++.++||||+++++.+......|+
T Consensus        20 ~~y~~~~~lg~g~~~---~v~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASG---TVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCe---EEEEEEECCCCcEEEEEEEecC--CcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            468888999999999   9999987  7889999998765  33445778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++..      ..+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus        95 v~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~  165 (296)
T cd06654          95 VMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             eecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence            9999999999998864      24688899999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......        ......... ...
T Consensus       166 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--------~~~~~~~~~-~~~  235 (296)
T cd06654         166 ITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIATNG-TPE  235 (296)
T ss_pred             cccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--------hHHHHhcCC-CCC
Confidence            533221 1234468889999999988889999999999999999999999986432111        000011000 000


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .           ..+...+..+.+++.+||..+|++|||+.++++
T Consensus       236 ~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 L-----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             C-----------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            0           001144566889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-42  Score=309.48  Aligned_cols=252  Identities=19%  Similarity=0.251  Sum_probs=198.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeC-
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLET-  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~-  134 (353)
                      .+++.|+..+.||+|+||   .||+|.+  +++.||+|.+...   ......+.+|+.++.++ +||||+++++++... 
T Consensus         3 ~~~~~y~~~~~lg~g~~g---~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           3 DPAGIFELVELVGNGTYG---QVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             ChhhhhhHHHheeecCCe---EEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            456778889999999999   9999988  7889999998654   23446788999999998 699999999998753 


Q ss_pred             -----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          135 -----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       135 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                           ...++||||+++++|.+++.....   ..+++..+..++.|++.||+|||   +++|+|+||||+||+++.++.+
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCE
Confidence                 357899999999999999876432   46889999999999999999999   8999999999999999999999


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                      +|+|||++....... .......|+..|+|||++.     ...++.++|||||||++|||++|..||.......      
T Consensus       151 ~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------  223 (272)
T cd06637         151 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------  223 (272)
T ss_pred             EEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------
Confidence            999999987653322 1234567889999999986     3357889999999999999999999986322111      


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       ... ... ........            ....+..+.+|+.+||..+|.+|||+.++++
T Consensus       224 -~~~-~~~-~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         224 -ALF-LIP-RNPAPRLK------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -HHH-HHh-cCCCCCCC------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             000 000 00000000            0134456789999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.9e-41  Score=305.98  Aligned_cols=259  Identities=22%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++|...+.||+|+||   .||++.+       ++..||+|.+.... .......|.+|+.++++++||||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFG---RVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccc---cEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            4678889999999999   8888775       46789999887542 34455779999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCC-----------------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeecc
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQ-----------------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF  196 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl  196 (353)
                      ++..++|+||+++|+|.+++.....                 .....+++..++.++.|++.||.|||   +++++||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl  156 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDL  156 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccc
Confidence            9999999999999999999874321                 01134788889999999999999999   999999999


Q ss_pred             CCCceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCcc
Q 018633          197 KTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLV  274 (353)
Q Consensus       197 kp~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~  274 (353)
                      ||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998765332211 1222344667999999988889999999999999999998 77787522


Q ss_pred             ccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          275 KDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                      ..        .+.... .........             +...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus       237 ~~--------~~~~~~-~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AH--------EEVIYY-VRDGNVLSC-------------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CH--------HHHHHH-HhcCCCCCC-------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            11        111111 111111100             01345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-42  Score=319.03  Aligned_cols=241  Identities=20%  Similarity=0.256  Sum_probs=188.7

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHH-HHhhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVT-YAARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||++.+  +++.||+|++..... .......+..|.. +++.++||||+++++++...+..|+||||
T Consensus         1 ~~lg~G~fg---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFG---KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence            369999999   9999988  678899999865421 1222334455544 56788999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..++...+..++.||+.||.|||   +++|+||||||+|||++.++.++|+|||+++.....
T Consensus        78 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          78 INGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            9999999988764     35778888899999999999999   999999999999999999999999999998754322


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        .......... ..      
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~-~~------  213 (325)
T cd05602         150 NG-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNK-PL------  213 (325)
T ss_pred             CC-CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhC-Cc------
Confidence            21 23456799999999999988899999999999999999999999873221        1111111110 00      


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                          ..    +...+..+.+++.+||+.||.+||++.+.+
T Consensus       214 ----~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 ----QL----KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ----CC----CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                00    013455678999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.7e-41  Score=307.97  Aligned_cols=263  Identities=20%  Similarity=0.315  Sum_probs=204.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe---------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccce
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW---------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGC  130 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~  130 (353)
                      .++|...+.||+|+||   .||++..         ....+|+|.+.... .......+.+|+.+++++ +||||++++++
T Consensus        11 ~~~~~~~~~lg~G~~g---~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099          11 RDRLVLGKPLGEGCFG---QVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             HHHeeeeeeecCCCcc---cEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            3568888999999999   8888764         34578999887542 344567789999999999 59999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      +...+..++||||+++|+|.+++......           ....+++..+..++.|++.||.|||   +++++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~  163 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR  163 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence            99888999999999999999998754210           0135788999999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDT  277 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~  277 (353)
                      |||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||....  
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--  241 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--  241 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--
Confidence            999999999999999999766432211 1122234467999999988889999999999999999999 788875321  


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                            ....... .........             +...+.++.+++.+||+.+|++|||+.++++.|.++...
T Consensus       242 ------~~~~~~~-~~~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         242 ------VEELFKL-LREGHRMDK-------------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             ------HHHHHHH-HHcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                  1111111 111110000             013455778999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=306.65  Aligned_cols=246  Identities=18%  Similarity=0.295  Sum_probs=210.3

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |++...||.|+||   .||++.+  .|+.+|||++...    ...+++..|+.+|.++..|++|++||.+.....+||||
T Consensus        35 FDi~~KLGEGSYG---SV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYG---SVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcch---HHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            6677789999999   9999998  8999999998755    57889999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      |||..||..+.++..+    .++.+.++..++.+.++||+|||   ..+-||||||..|||++.+|.+||+|||.|-.+.
T Consensus       108 EYCGAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             hhcCCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhh
Confidence            9999999999998766    68999999999999999999999   8889999999999999999999999999997764


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      +. ....++..||+.|||||++..-.|+.++||||||++..||..|++||.........           |       .+
T Consensus       181 DT-MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-----------F-------MI  241 (502)
T KOG0574|consen  181 DT-MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-----------F-------MI  241 (502)
T ss_pred             hh-HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-----------E-------ec
Confidence            33 33467889999999999999999999999999999999999999998743332200           0       00


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .  ..+......+...+.++.+++.+||-..|++|-|+.++++
T Consensus       242 P--T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  242 P--TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             c--CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            0  0001111123478899999999999999999999988775

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=332.03  Aligned_cols=258  Identities=19%  Similarity=0.235  Sum_probs=208.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-CC-eEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceee-e--
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-QE-RLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCL-E--  133 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~-~--  133 (353)
                      ...+.++.++|.+|||+   .||.+.+ .+ ..+|+|++...  .....+...+|+.+|+.|+ |||||.++|... .  
T Consensus        35 g~~~v~V~~vLAEGGFa---~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFA---QVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             CCEEEEEEEEEccCCcE---EEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            34456778899999999   9999999 44 89999998777  6788899999999999998 999999999432 1  


Q ss_pred             -C---CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          134 -T---PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       134 -~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                       +   -.+.|.||||+||+|.|+|...-.   ..|++.++++|+.|+++|+.+||.. ..+|||||||-+||||+.+|..
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~  185 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNY  185 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCE
Confidence             1   246799999999999999986544   3599999999999999999999943 5669999999999999999999


Q ss_pred             EEeccCCccccCCCCCcc--------ccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCcccccc
Q 018633          210 KLFDFSLSISIPEGETHI--------TDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH  278 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~  278 (353)
                      ||||||.++.........        .-...-|+.|+|||++.   +.+.+.|+|||+|||+||-|+....||...... 
T Consensus       186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-  264 (738)
T KOG1989|consen  186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-  264 (738)
T ss_pred             EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-
Confidence            999999886543322111        11235689999999874   566899999999999999999999999733211 


Q ss_pred             CCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                                          .++.    +.+..+..+.++..+.+||..||+.||++||++-+|+..+.++..
T Consensus       265 --------------------aIln----g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 --------------------AILN----GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------------------eEEe----ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                                1111    222211213789999999999999999999999999999987753

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1e-42  Score=319.81  Aligned_cols=241  Identities=20%  Similarity=0.213  Sum_probs=189.9

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHH-HHhhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVT-YAARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ++||+|+||   .||++..  +++.+|+|++..... .......+..|.. +++.++||||+++++++...+..|+||||
T Consensus         1 ~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF   77 (325)
T ss_pred             CceeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence            469999999   9999988  789999999865421 2233455666665 46779999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|...+...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          78 VNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            9999999888654     46889999999999999999999   999999999999999999999999999998654222


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||..|+|||++.+..++.++|||||||++|+|++|..||.....        .+........ ..  ..  
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~-~~--~~--  215 (325)
T cd05604         150 S-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHK-PL--VL--  215 (325)
T ss_pred             C-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcC-Cc--cC--
Confidence            1 123455789999999999998999999999999999999999999864221        1111111110 00  00  


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                            .    +..+..+.+++.+||..+|.+||++.+.+
T Consensus       216 ------~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         216 ------R----PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ------C----CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                  0    03445677899999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.6e-42  Score=317.13  Aligned_cols=271  Identities=17%  Similarity=0.227  Sum_probs=201.0

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      ...++|...+.||+|+||   .||++..  .++.||+|++............+.+|+.+++.++||||+++++++...  
T Consensus        14 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQG---IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhhceeEEEEeeecCCE---EEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            456789999999999999   8998887  788999999976544555667888999999999999999999998643  


Q ss_pred             ----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          135 ----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       135 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                          ...|+||||++ ++|.+.+..       .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~k  159 (355)
T cd07874          91 LEEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_pred             ccccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEE
Confidence                24799999997 577776642       4678888999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCC
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACP  283 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~  283 (353)
                      |+|||+++......  ......||..|+|||++.+..++.++|||||||++|+|++|..||........       ...+
T Consensus       160 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         160 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             EeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999997653321  23445789999999999988899999999999999999999999974332110       0000


Q ss_pred             hHHHH-------HHHhhc-Ccccccccchh-hhcc---chHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          284 SNEYL-------KNYFED-NRFTEIVDPII-VEDV---LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       284 ~~~~~-------~~~~~~-~~~~~~~~~~~-~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..+..       ..+... ........+.. ....   ...........+.+|+.+||..||++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00000       001100 00000000000 0000   000011234567899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-41  Score=317.57  Aligned_cols=269  Identities=16%  Similarity=0.227  Sum_probs=200.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      ...++|...+.||+|+||   .||++..  .++.||||++............+.+|+.+++.++||||+++++++...  
T Consensus        21 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQG---IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             chhcceeEEEEeecCCCe---EEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence            345789999999999999   9999887  788999999976544455667788999999999999999999987643  


Q ss_pred             ----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          135 ----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       135 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                          ...|+||||++ ++|.+.+..       .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875          98 LEEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             ccccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEE
Confidence                35799999997 578777642       4678888999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCC
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACP  283 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~  283 (353)
                      |+|||+++......  ......||..|+|||++.+..++.++|||||||++|+|++|..||........       ...+
T Consensus       167 L~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  244 (364)
T cd07875         167 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  244 (364)
T ss_pred             EEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999997653322  22345789999999999988999999999999999999999999975432110       0011


Q ss_pred             hHHHHHH-------Hhhc-Ccccc-----cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          284 SNEYLKN-------YFED-NRFTE-----IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       284 ~~~~~~~-------~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+...       .... ..+..     ......... ...........+.+|+.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA-DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccc-cccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111100       0000 00000     000000000 00000123456789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.4e-42  Score=315.68  Aligned_cols=263  Identities=18%  Similarity=0.309  Sum_probs=202.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeee
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLE  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~  133 (353)
                      ++|...+.||+|+||   .||+|.+       +++.||||++.... .......+.+|+.++.++ +||||+++++++..
T Consensus         7 ~~~~~~~~lG~G~fg---~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           7 DRLKLGKPLGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hHhcccccccCCccc---eEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            468889999999999   8988863       56789999997542 234456788999999999 68999999998865


Q ss_pred             C-CccEEEEEeccCCChhhhhccCCCCC----------------------------------------------------
Q 018633          134 T-PIPILVFESVQYGTLWDRILGAPQPH----------------------------------------------------  160 (353)
Q Consensus       134 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------------  160 (353)
                      . ...++||||+++|+|.+++.......                                                    
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 46789999999999999886432100                                                    


Q ss_pred             ----------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCC-cccc
Q 018633          161 ----------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITD  229 (353)
Q Consensus       161 ----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~  229 (353)
                                ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++........ ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      023678888999999999999999   99999999999999999999999999999876533221 1122


Q ss_pred             ccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhc
Q 018633          230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVED  308 (353)
Q Consensus       230 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (353)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......       .. ............        
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~-~~~~~~~~~~~~--------  303 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EF-CRRLKEGTRMRA--------  303 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------HH-HHHHhccCCCCC--------
Confidence            3345678999999988889999999999999999997 888876322111       11 111111110000        


Q ss_pred             cchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          309 VLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       309 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                           +...+..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus       304 -----~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         304 -----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 002334678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-42  Score=318.15  Aligned_cols=238  Identities=19%  Similarity=0.248  Sum_probs=187.6

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHH-HHhhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVT-YAARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ++||+|+||   .||++.+  ++..||+|++..... .......+..|.. +++.++||||+++++++.+.+..|+||||
T Consensus         1 ~~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence            469999999   9999998  788999999865421 1223445566654 57889999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|...+...     ..+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        78 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          78 VNGGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            9999998888654     35788889999999999999999   999999999999999999999999999998753222


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|..||.....        ......... ...      
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~-~~~------  213 (321)
T cd05603         150 E-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILH-KPL------  213 (321)
T ss_pred             C-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhc-CCC------
Confidence            2 123455789999999999888899999999999999999999999864221        111111111 000      


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV  340 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  340 (353)
                          ..    +...+..+.+++.+||+.||.+||++.
T Consensus       214 ----~~----~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 ----QL----PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----CC----CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                00    013445678999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.1e-41  Score=300.85  Aligned_cols=255  Identities=18%  Similarity=0.194  Sum_probs=190.9

Q ss_pred             CceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||+|.+    ++..+|+|.+.... .......+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g---~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFG---KVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCc---eEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            358999999   9999976    34679999886653 233445789999999999999999999999988899999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...........++..+..++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            99999999987543211134567788899999999999999   999999999999999999999999999998654332


Q ss_pred             CCc-cccccccCCccccccccccC-------CCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          224 ETH-ITDTVMGTWGYCAPEYMRTG-------VFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       224 ~~~-~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ... ......++..|+|||++...       .++.++||||||+++|||++ |..||.......        ....... 
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~-  224 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--------VLTYTVR-  224 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHhh-
Confidence            211 12234567889999998532       35789999999999999996 999986432211        0000010 


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ........+.+..        ..+..+.+++..|| .+|++|||+.+|+..|.
T Consensus       225 ~~~~~~~~~~~~~--------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         225 EQQLKLPKPRLKL--------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cccCCCCCCccCC--------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0011111111110        23345778999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2e-41  Score=304.86  Aligned_cols=248  Identities=19%  Similarity=0.220  Sum_probs=198.3

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |+..+.||+|+||   .||+|.+  ++..+++|.+...  .....+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus         7 ~~i~~~lg~g~~g---~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFG---KVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCe---EEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence            5667789999999   9999998  6788899988655  4556778999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|..++....    .++++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          82 EFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             EecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9999999988876533    46889999999999999999999   9999999999999999999999999999986653


Q ss_pred             CCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ... .......++..|+|||++.     ...++.++|||||||++|+|++|..||.....        ......... ..
T Consensus       155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~-~~  224 (282)
T cd06643         155 RTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK-SE  224 (282)
T ss_pred             ccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhh-cC
Confidence            221 1233456889999999984     34577899999999999999999999863221        111111111 11


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ......           +...+..+.+++.+||+.+|++|||+.++++
T Consensus       225 ~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 PPTLAQ-----------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCCCCC-----------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            001000           1134567889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.4e-41  Score=305.38  Aligned_cols=262  Identities=19%  Similarity=0.312  Sum_probs=203.2

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      ..++|+..+.||+|+||   .||+|..       .+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~i~~~lg~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           4 SREKITLLRELGQGSFG---MVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cHHHceeeeeecCCCCc---EEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            45679999999999999   8888865       24589999886542 3344557889999999999999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCC-----CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQ-----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN  207 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  207 (353)
                      +.+..++||||+++|+|.+++.....     .....++...+..++.|++.||.|||   +++|+||||||+||+++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCC
Confidence            99999999999999999999975321     01134567788899999999999999   99999999999999999999


Q ss_pred             ceEEeccCCccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChH
Q 018633          208 VAKLFDFSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~  285 (353)
                      .++|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....        .
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~  228 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------E  228 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence            99999999987653322211 122345678999999988889999999999999999998 6778753211        1


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      +...... .......             +...+..+.+++.+||+.+|++|||+.++++.|.+..
T Consensus       229 ~~~~~~~-~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         229 QVLKFVM-DGGYLDQ-------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHHHH-cCCCCCC-------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111111 1111110             0133467889999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.1e-42  Score=303.72  Aligned_cols=250  Identities=19%  Similarity=0.246  Sum_probs=203.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..+.||+|+||   .||.+..  +++.||+|.+...........++.+|+.++++++||||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~g---~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCce---EEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            47778899999999   8888887  788999999875433455667899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+++++|.+.+.....   ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++...
T Consensus        78 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          78 MDYCEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             EecCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            999999999998875432   35788999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..... ......|+..|+|||++.+..++.++|+||||+++++|++|..||.....        ......... +..   
T Consensus       152 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~-~~~---  218 (256)
T cd08218         152 NSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIR-GSY---  218 (256)
T ss_pred             Ccchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhc-CCC---
Confidence            43221 12234578889999999888899999999999999999999999863211        111111111 111   


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                               +. .+...+..+.+++.+||+.+|++||++.+|++
T Consensus       219 ---------~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 ---------PP-VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---------CC-CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                     00 01145667889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.5e-42  Score=340.07  Aligned_cols=264  Identities=20%  Similarity=0.255  Sum_probs=205.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||+|++..... .....++|.+|+.++++++||||+++++++.+++..+
T Consensus         2 grYeIi~~LGkGgfG---~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly   78 (932)
T PRK13184          2 QRYDIIRLIGKGGMG---EVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY   78 (932)
T ss_pred             CCeEEEEEEecCCCE---EEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence            468889999999999   9999988  689999999875432 2345678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCC------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          139 LVFESVQYGTLWDRILGAPQP------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                      +||||+++|+|.+++......      ....+++..++.++.|++.||+|||   +++|+||||||+|||++.++.++|+
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLi  155 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVIL  155 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEE
Confidence            999999999999988642110      0124567788899999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCCCC-----------------CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          213 DFSLSISIPEGE-----------------THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       213 dfg~a~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                      |||+++......                 ........||+.|+|||++.+..++.++|||||||++|||+||..||....
T Consensus       156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            999997652111                 001123569999999999999899999999999999999999999986422


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-SMVDVAKKLRQIYR  351 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~vl~~L~~l~~  351 (353)
                      ...        ..   . ..   ...++....     .....+..+.+++.+||..||++|| ++.++++.|+....
T Consensus       236 ~~k--------i~---~-~~---~i~~P~~~~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        236 GRK--------IS---Y-RD---VILSPIEVA-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhh--------hh---h-hh---hccChhhcc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            111        00   0 00   000000000     0013456678999999999999996 67778888877643

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.9e-41  Score=311.68  Aligned_cols=260  Identities=17%  Similarity=0.206  Sum_probs=195.0

Q ss_pred             CCceeeC--CCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEE
Q 018633           67 KNVIAKD--TSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        67 ~~~lg~G--~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      ..+||+|  +||   +||++..  ++..||+|++..........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         3 ~~~ig~G~~~~~---~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           3 LTVIGRGFEDLM---TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhccccccceE---EEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            4679999  566   8999988  78999999997664445556677889999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      |+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++++||+.......
T Consensus        80 ~~~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          80 FMAYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             ccCCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999865432   35789999999999999999999   99999999999999999999999999986543321


Q ss_pred             CCC------ccccccccCCcccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          223 GET------HITDTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       223 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ...      .......++..|+|||++.+  ..++.++|||||||++|||++|..||.......        ...... .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~-~  224 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--------MLLEKL-N  224 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--------HHHHHh-c
Confidence            111      01122356778999999876  358899999999999999999999997432211        000000 0


Q ss_pred             Cccccccc--------------------------------chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHH
Q 018633          295 NRFTEIVD--------------------------------PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDV  342 (353)
Q Consensus       295 ~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~v  342 (353)
                      ...+...+                                +..............+..+.+++.+||+.||++|||+.++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el  304 (327)
T cd08227         225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL  304 (327)
T ss_pred             CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH
Confidence            00000000                                0000000001112445678999999999999999999999


Q ss_pred             HH
Q 018633          343 AK  344 (353)
Q Consensus       343 l~  344 (353)
                      ++
T Consensus       305 l~  306 (327)
T cd08227         305 LN  306 (327)
T ss_pred             hc
Confidence            86

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.3e-42  Score=308.98  Aligned_cols=261  Identities=21%  Similarity=0.249  Sum_probs=194.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc---CCCceeeccceeeeC---
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM---SHNHILKLIGCCLET---  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~---  134 (353)
                      +|...+.||+|+||   .||++.+  +++.||+|.+............+.+|+.+++.+   +||||+++++++...   
T Consensus         1 ~y~~~~~lg~g~~g---~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYG---TVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCe---EEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            47778899999999   9999988  788999999875432333334566777777765   699999999988642   


Q ss_pred             --CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          135 --PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       135 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                        ...++||||++ ++|.+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        78 ~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~  150 (288)
T cd07863          78 RETKVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLA  150 (288)
T ss_pred             CCceEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEC
Confidence              35789999998 589888865432   35889999999999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |||++.......  ......||..|+|||++.+..++.++|||||||++|+|++|.+||.......        ......
T Consensus       151 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--------~~~~~~  220 (288)
T cd07863         151 DFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--------QLGKIF  220 (288)
T ss_pred             ccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--------HHHHHH
Confidence            999987654322  1234567899999999988889999999999999999999999986432211        000000


Q ss_pred             hc------Ccccc-------cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 ED------NRFTE-------IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~------~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..      ..++.       ...+...... .......+..+.+++.+||+.||++|||+.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHhCCCChhhCcccccccccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00      00000       0000000000 0001134567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.5e-42  Score=307.90  Aligned_cols=271  Identities=16%  Similarity=0.201  Sum_probs=199.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..+.||+|++|   .||+|..  ++..||+|++............+.+|+.++.+++||||+++++++.+++..++|
T Consensus         1 ~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYG---VVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCce---EEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            47778899999999   9999988  788999999865533344456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||++ ++|.+++......  ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++...
T Consensus        78 ~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EecCC-CCHHHHHhcCCCC--CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99997 6898888654321  46889999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHHHHHh
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYLKNYF  292 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~~~  292 (353)
                      .... .......++..|+|||++.+. .++.++||||||+++|+|+||+.||.........       ..+....+....
T Consensus       152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         152 GIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             CCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence            3322 122334568899999988654 4788999999999999999999998743221100       000000000000


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....+....+....... .......+.++.+++.+||..||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         231 SLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000000000000 0001134567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.8e-41  Score=307.14  Aligned_cols=264  Identities=18%  Similarity=0.257  Sum_probs=201.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++.+  ++..+|+|.+.... .......+.+|++++.+++||||+++++++..++..++
T Consensus         1 ~~~~~~~~lg~G~~g---~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGG---VVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCe---EEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            368889999999999   9999988  67888999886542 34456678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      ||||+++++|.+++...     ..+++..+..++.|++.||.|||   + .+++|+||||+|||++.++.++|+|||++.
T Consensus        77 v~ey~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  148 (308)
T ss_pred             EeeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence            99999999999998764     35788999999999999999999   6 589999999999999999999999999986


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc-
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF-  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  297 (353)
                      ......   .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.......     .............. 
T Consensus       149 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~  220 (308)
T cd06615         149 QLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAK  220 (308)
T ss_pred             cccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCcccccccc
Confidence            553221   234578899999999988889999999999999999999999986322111     00000000000000 


Q ss_pred             -------------------cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          298 -------------------TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       298 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                                         .+..+.......+.......+..+.+++.+||..+|++|||+.++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                               000000000000000001245678999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-41  Score=301.88  Aligned_cols=250  Identities=18%  Similarity=0.259  Sum_probs=201.7

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee-CCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-TPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~l  139 (353)
                      +|...+.||+|++|   .||++.+  +++.||+|++..........+.+.+|+.++++++|||++++++.+.. ++..++
T Consensus         1 ~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYG---EVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCe---EEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            47778899999999   9998888  67899999987654445566778999999999999999999998764 446789


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++.....   ..+++.+++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++..
T Consensus        78 v~e~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~  151 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV  151 (257)
T ss_pred             EecccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEE
Confidence            9999999999999876432   45889999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ..... .......++..|+|||++.+..++.++|+||||+++++|++|..||....        .......... .....
T Consensus       152 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~-~~~~~  221 (257)
T cd08223         152 LENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIE-GKLPP  221 (257)
T ss_pred             ecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh-cCCCC
Confidence            64322 22334568889999999998889999999999999999999999986321        1111111111 11100


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                   .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       222 -------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         222 -------------MPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -------------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                         01145567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-41  Score=304.94  Aligned_cols=250  Identities=18%  Similarity=0.212  Sum_probs=200.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +.|...+.||+|+||   .||+|..  ++..+++|.+...  .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        12 ~~y~i~~~lg~g~~g---~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFG---KVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCe---EEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            568888999999999   9999998  6789999998765  56667889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|..++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++..
T Consensus        87 v~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  159 (292)
T cd06644          87 MIEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK  159 (292)
T ss_pred             EEecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence            999999999988776543    35889999999999999999999   99999999999999999999999999998865


Q ss_pred             cCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ..... .......++..|+|||++.     ...++.++|||||||++|+|++|..||.....        ......... 
T Consensus       160 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~-  229 (292)
T cd06644         160 NVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK-  229 (292)
T ss_pred             ccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhc-
Confidence            43221 1123456788999999984     34478899999999999999999999863221        111111111 


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+....           +...+..+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         230 SEPPTLSQ-----------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCccCCC-----------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11100000           1134556889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.7e-42  Score=311.02  Aligned_cols=270  Identities=19%  Similarity=0.252  Sum_probs=199.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +.|...+.||+|+||   .||+|..  ++..||+|.+.... .......+.+|+.++++++||||+++++++...+..++
T Consensus         6 ~~y~~~~~lg~g~~g---~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           6 ETYIKLDKLGEGTYA---TVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cceEEeeEeccCcCE---EEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            458888999999999   9999988  68899999986442 22334567889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++ ++|.+++....    ..+++..+..++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++..
T Consensus        82 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             EEeccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            999997 69988886543    35788999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHH
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNY  291 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~  291 (353)
                      ...... ......++..|+|||++.+. .++.++||||||+++|+|+||..||........       ...+....+...
T Consensus       154 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         154 KSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             cCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence            433221 12334568899999998654 478899999999999999999999874322110       000111111111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....+.....+....+.........+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111100000000000000111134557789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.8e-41  Score=300.30  Aligned_cols=253  Identities=17%  Similarity=0.214  Sum_probs=188.7

Q ss_pred             ceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           69 VIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .||+|+||   .||+|..    ....+|+|.+.... .......|.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         2 ~lg~G~fg---~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFG---KVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCc---eEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            58999999   8888865    34578888775432 3445567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++|+|.+++...........++...+.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9999999997654322134567788899999999999999   9999999999999999999999999999986543221


Q ss_pred             C-ccccccccCCcccccccccc-------CCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          225 T-HITDTVMGTWGYCAPEYMRT-------GVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       225 ~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      . .......++..|+|||++..       ..++.++|||||||++|||++ |..||......        ..........
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~  226 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQ  226 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhcc
Confidence            1 11223345677999998743       346789999999999999999 67777532211        1111111111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                       ...+..+.+        +...+..+.+++..|| .||++|||+.+|++.|
T Consensus       227 -~~~~~~~~~--------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         227 -DIKLPKPQL--------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             -CccCCCCcc--------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence             111111111        1134556677888998 5999999999999887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-41  Score=302.29  Aligned_cols=248  Identities=22%  Similarity=0.411  Sum_probs=198.3

Q ss_pred             CceeeCCCCCccEEEEEEe---C--CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFW---Q--ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      +.||+|++|   .||+|.+   .  ...||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++|+|
T Consensus         1 ~~ig~g~~~---~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFG---VVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcc---cEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            468999999   9999987   2  236899999876422 667889999999999999999999999988 88999999


Q ss_pred             eccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      |+++++|.+++.....   ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.+||+|||++.....
T Consensus        76 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          76 LAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             ecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccc
Confidence            9999999999976532   35789999999999999999999   99999999999999999999999999999987644


Q ss_pred             CCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          223 GETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       223 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ....  ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....        .+...........  
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~--  219 (257)
T cd05040         150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGER--  219 (257)
T ss_pred             cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCCc--
Confidence            2221  1123456788999999988889999999999999999999 9999863221        1111111110000  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ..           .+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 LE-----------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CC-----------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00           00134567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=312.41  Aligned_cols=256  Identities=15%  Similarity=0.147  Sum_probs=196.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++..  +++.||+|++.... ......+.+.+|..++..++|+||+++++++.+++..|
T Consensus         1 ~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFG---EVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY   77 (331)
T ss_pred             CCceEEEEEEecCCe---EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence            368888999999999   9999988  68899999986421 12334566889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++....    ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.++|+|||++.
T Consensus        78 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             EEEecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence            9999999999999987543    45789999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCcccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ..............||+.|+|||++..     ..++.++|||||||++|+|++|+.||.....        .+.......
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~  222 (331)
T cd05597         151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMN  222 (331)
T ss_pred             ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHc
Confidence            654433322334568999999999863     4578899999999999999999999863221        111111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCC--CCCCCHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSP--ADRPSMVDVAKK  345 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP--~~Rps~~~vl~~  345 (353)
                      ......         .+.. ....+..+.+++.+|+..++  ..||++.++++.
T Consensus       223 ~~~~~~---------~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         223 HKEHFQ---------FPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCccc---------CCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            100000         0000 01245667788888775533  347898888753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.8e-42  Score=303.40  Aligned_cols=250  Identities=22%  Similarity=0.384  Sum_probs=199.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      .+|+..+.||+|+||   .||++.+ .+..+|+|.+....   .....|.+|++++++++||||+++++++......++|
T Consensus         4 ~~~~~~~~ig~g~~g---~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFG---LVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccc---eEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            357778899999999   9999988 57889999886542   2245788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++....    ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||.+...
T Consensus        78 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  150 (256)
T cd05112          78 FEFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV  150 (256)
T ss_pred             EEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeec
Confidence            99999999999887543    35788999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ............++..|+|||++.+..++.++||||||+++|||++ |..||.....        ............   
T Consensus       151 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~---  219 (256)
T cd05112         151 LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGFR---  219 (256)
T ss_pred             ccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCCC---
Confidence            4322211222335678999999988889999999999999999998 8888863221        111111111000   


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      ...+           ...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus       220 ~~~~-----------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 LYKP-----------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCC-----------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            0000           02346788999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3e-41  Score=300.75  Aligned_cols=238  Identities=22%  Similarity=0.335  Sum_probs=186.9

Q ss_pred             CceeeCCCCCccEEEEEEeC--------------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           68 NVIAKDTSYNLYTMYKGFWQ--------------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      +.||+|+||   .||+|.+.              ...|++|.+...  .......|.+|+.++..++||||+++++++..
T Consensus         1 ~~lg~G~~~---~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRT---QIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcc---eEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            358999999   99999852              235888887655  34556678999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc-----
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV-----  208 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~-----  208 (353)
                      +...++||||+++|+|..++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.     
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~  148 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECG  148 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCC
Confidence            999999999999999988876543    45889999999999999999999   999999999999999987654     


Q ss_pred             --eEEeccCCccccCCCCCccccccccCCccccccccc-cCCCCccccchhhHHHHHHHH-hCCCCCCccccccCCCCCh
Q 018633          209 --AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR-TGVFNEKSDVFSFGVFLFELL-TGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       209 --~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~-tg~~p~~~~~~~~~~~~~~  284 (353)
                        ++++|||++.....     .....++..|+|||++. +..++.++||||||+++|||+ +|..|+.......      
T Consensus       149 ~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------  217 (262)
T cd05077         149 PFIKLSDPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------  217 (262)
T ss_pred             ceeEeCCCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------
Confidence              89999998865432     12345778899999886 456899999999999999998 5777765321110      


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                        . ..... ... ...        .     .....+.+|+.+||+.||.+||++.++++.+
T Consensus       218 --~-~~~~~-~~~-~~~--------~-----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         218 --K-ERFYE-GQC-MLV--------T-----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --H-HHHHh-cCc-cCC--------C-----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              0 01111 000 000        0     2235678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-41  Score=297.70  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=202.2

Q ss_pred             CceeeCCCCCccEEEEEEeC-----CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFWQ-----ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      +.||+|+||   .||++.+.     +..|++|.+....... ..+.+.+|++.+..++|+||+++++++.+....++|||
T Consensus         1 ~~ig~g~~g---~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFG---EVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCce---EEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            469999999   99999983     8899999997764222 46789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCC----CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          143 SVQYGTLWDRILGAPQP----HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      |+++++|.+++......    ....+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||.+.
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccc
Confidence            99999999999775210    0146899999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          219 SIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       219 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....... .......++..|+|||.+....++.++||||||+++|+|++ |..||.....        ..... ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~-~~~~~~  224 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLE-YLRKGY  224 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHH-HHHcCC
Confidence            7654321 12334557888999999988889999999999999999999 5888874321        11111 111110


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ..             ..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       225 ~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 RL-------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CC-------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            00             001144677889999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.2e-41  Score=305.03  Aligned_cols=264  Identities=19%  Similarity=0.266  Sum_probs=200.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe------------------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW------------------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH  123 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~------------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n  123 (353)
                      ++|+..+.||+|+||   .||++.+                  +...||+|.+.... .......|.+|+.++++++|||
T Consensus         5 ~~~~~~~~lg~G~~g---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           5 KRLTFKEKLGEGQFG---EVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhceeeeeccCCCCC---eEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence            458888999999999   8887643                  23468999886542 3445678999999999999999


Q ss_pred             eeeccceeeeCCccEEEEEeccCCChhhhhccCCCCC------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccC
Q 018633          124 ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK  197 (353)
Q Consensus       124 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  197 (353)
                      |+++++++...+..++||||+++|+|.+++.......      ...+++..++.++.|++.||.|||   +++++|+|||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlk  157 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLA  157 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCC
Confidence            9999999999999999999999999999987643211      124778889999999999999999   9999999999


Q ss_pred             CCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh--CCCCCCcc
Q 018633          198 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--GWDVSDLV  274 (353)
Q Consensus       198 p~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t--g~~p~~~~  274 (353)
                      |+|||++.++.++|+|||+++....... .......++..|+|||....+.++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999876533221 11223344678999999888889999999999999999998  66776532


Q ss_pred             ccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          275 KDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      .....     .......+.........     .     .+..++..+.+++.+||+.||++|||+.+|++.|.
T Consensus       238 ~~~~~-----~~~~~~~~~~~~~~~~~-----~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         238 SDEQV-----IENTGEFFRDQGRQVYL-----P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ChHHH-----HHHHHHHHhhccccccC-----C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            22110     00011111110000000     0     00134567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=304.53  Aligned_cols=256  Identities=20%  Similarity=0.344  Sum_probs=203.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CC----eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QE----RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +.|...+.||+|+||   .||+|.+  ++    ..+|+|.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus         7 ~~~~~~~~ig~g~~g---~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           7 TELEKIKVLGSGAFG---TVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHcEEcceecCCCCc---cEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            457778899999999   9999887  33    368889876552 34456789999999999999999999999987 7


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCc
Confidence            8899999999999999987654    35889999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          216 LSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       216 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .++......... .....++..|+|||.+....++.++|+||||+++||+++ |..||.....        .+. .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~-~~~~~  225 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEI-PDLLE  225 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHH-HHHHh
Confidence            998764332211 112223567999999988889999999999999999999 9999864221        111 11111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ......             .+..++..+.+++.+||..+|+.|||+.++++.|.++.+
T Consensus       226 ~~~~~~-------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         226 KGERLP-------------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCC-------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            111000             001234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-41  Score=303.55  Aligned_cols=252  Identities=18%  Similarity=0.228  Sum_probs=199.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|.+...  .......+.+|+.+++.++||||+++++++...+..+
T Consensus         8 ~~~~~~~~~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYG---DVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCe---EEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            3467778889999999   9999988  7889999998765  3344567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++...     ..+++.+++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++.
T Consensus        83 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEEeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeee
Confidence            999999999999988654     46889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ...... .......|+..|+|||++.   ...++.++|+|||||++|+|++|..||.......        ...... ..
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--------~~~~~~-~~  224 (267)
T cd06645         155 QITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--------ALFLMT-KS  224 (267)
T ss_pred             EccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--------hHHhhh-cc
Confidence            653322 1233457899999999874   4458899999999999999999999985322111        000000 00


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..   ..+.....      ...+..+.+++.+||..+|++|||+.++++
T Consensus       225 ~~---~~~~~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         225 NF---QPPKLKDK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CC---CCCccccc------CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00   00000000      023456789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-41  Score=305.56  Aligned_cols=264  Identities=19%  Similarity=0.270  Sum_probs=199.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeC----------------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCcee
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQ----------------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL  125 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv  125 (353)
                      +.|...+.||+|+||   .||.+...                ...||+|.+.... .....+.|.+|++++++++||||+
T Consensus         5 ~~~~~~~~lg~G~~g---~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQLRLKEKLGEGQFG---EVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhCeehhccCCCCCc---eEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            468888999999999   88877652                2358999987542 345567899999999999999999


Q ss_pred             eccceeeeCCccEEEEEeccCCChhhhhccCCCC-------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCC
Q 018633          126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT  198 (353)
Q Consensus       126 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  198 (353)
                      ++++++...+..++||||+++++|.+++......       ....+++..++.++.|++.||.|||   +++++||||||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp  157 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLAT  157 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccCh
Confidence            9999999999999999999999999988643210       0124688899999999999999999   99999999999


Q ss_pred             CceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh--CCCCCCccc
Q 018633          199 SCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--GWDVSDLVK  275 (353)
Q Consensus       199 ~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t--g~~p~~~~~  275 (353)
                      +||+++.++.+||+|||++........ .......++..|+|||++....++.++||||||+++|+|++  |..||....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            999999999999999999876533221 11223345678999999988889999999999999999998  555655322


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ...     ........+........      ...+    ...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       238 ~~~-----~~~~~~~~~~~~~~~~~------~~~~----~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         238 DEQ-----VIENTGEFFRNQGRQIY------LSQT----PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             hHH-----HHHHHHHhhhhcccccc------CCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            111     00001111110000000      0000    023467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.5e-42  Score=318.86  Aligned_cols=201  Identities=16%  Similarity=0.229  Sum_probs=173.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|+..+.||+|+||   .||++..  +++.||+|++.... ........+.+|+.++..++||||+++++++.+.+..|
T Consensus         1 ~~f~~~~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   77 (360)
T cd05627           1 DDFESLKVIGRGAFG---EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLY   77 (360)
T ss_pred             CCceEEEEEeeCCCE---EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            368888999999999   9999988  78899999986432 12334567888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++.
T Consensus        78 lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             EEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            999999999999998764     35889999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCC----------------------------------ccccccccCCccccccccccCCCCccccchhhHHHHHHH
Q 018633          219 SIPEGET----------------------------------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL  264 (353)
Q Consensus       219 ~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  264 (353)
                      .......                                  .......||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel  229 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence            5432110                                  001235799999999999998999999999999999999


Q ss_pred             HhCCCCCCc
Q 018633          265 LTGWDVSDL  273 (353)
Q Consensus       265 ~tg~~p~~~  273 (353)
                      ++|..||..
T Consensus       230 ~tG~~Pf~~  238 (360)
T cd05627         230 LIGYPPFCS  238 (360)
T ss_pred             ccCCCCCCC
Confidence            999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.9e-42  Score=314.43  Aligned_cols=242  Identities=19%  Similarity=0.261  Sum_probs=193.5

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPI  138 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~  138 (353)
                      +|+..+.||+|+||   .||++..  +++.||+|++..... .....+.+..|..++..+. |++|+++++++.+.+..|
T Consensus         1 ~f~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   77 (323)
T cd05615           1 DFNFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY   77 (323)
T ss_pred             CceEEEEEEecCCe---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence            36677899999999   9999988  788999999875421 2334566788999998886 577888999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++|+|||+++
T Consensus        78 lv~Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615          78 FVMEYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEecccccc
Confidence            999999999999988754     35889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.....        ......... ... 
T Consensus       150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~-~~~-  218 (323)
T cd05615         150 EHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIME-HNV-  218 (323)
T ss_pred             ccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC-
Confidence            5432221 23345689999999999988899999999999999999999999874321        111111111 000 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                               ..    +...+..+.+++.+||+.+|.+|++.
T Consensus       219 ---------~~----p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ---------SY----PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---------CC----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence                     00    01344567899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-41  Score=321.81  Aligned_cols=265  Identities=17%  Similarity=0.207  Sum_probs=198.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ..+|...+.||+|+||   .||++.+  .++.||||....        ..+.+|++++++++|||||++++++..++..+
T Consensus       168 ~~gy~i~~~Lg~G~~G---~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEG---CVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCe---EEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            3468889999999999   9999999  678899996422        34678999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|||++. ++|.+++....    ..+++..++.|+.|++.||.|||   +++|+||||||+|||++.++.++|+|||+++
T Consensus       237 lv~e~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~  308 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAAC  308 (461)
T ss_pred             EEEEccC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence            9999995 79988886543    46899999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc-
Q 018633          219 SIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR-  296 (353)
Q Consensus       219 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  296 (353)
                      ........ ......||..|+|||++.+..++.++|||||||++|||++|..++........ ..+....+........ 
T Consensus       309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~-~~~~~~~l~~~i~~~~~  387 (461)
T PHA03211        309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE-RRPYDAQILRIIRQAQV  387 (461)
T ss_pred             ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc-cCCcHHHHHHHHHhhcc
Confidence            66432221 12345699999999999998999999999999999999998876543322111 1111111221111110 


Q ss_pred             ----ccccccchhhhcc------------c-h--HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          297 ----FTEIVDPIIVEDV------------L-S--IEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       297 ----~~~~~~~~~~~~~------------~-~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                          +.......+....            . .  .........+.+|+.+||+.||.+|||+.|+++.
T Consensus       388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                1100000000000            0 0  0000223467899999999999999999999863

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-41  Score=307.32  Aligned_cols=251  Identities=18%  Similarity=0.266  Sum_probs=197.9

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      |...+.||+|+||   .||++.+  +++.+|+|.+...... ......+.+|+.++++++|+||+.+++++..++..++|
T Consensus         2 ~~~~~~lg~G~~g---~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           2 FRQYRVLGKGGFG---EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             ceEEEEEecCCCe---EEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            6667889999999   9999988  7889999998654222 22345678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+||++++++.++|+|||++...
T Consensus        79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             EEeccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            999999999988865432   36899999999999999999999   999999999999999999999999999998665


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      .....  .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.......     ....+........  ..
T Consensus       153 ~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-----~~~~~~~~~~~~~--~~  223 (285)
T cd05632         153 PEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-----KREEVDRRVLETE--EV  223 (285)
T ss_pred             CCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhhhccc--cc
Confidence            32221  234578999999999988889999999999999999999999987432211     0000100000000  00


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                                  .+...+..+.+|+..||+.||++|||     +.+++.
T Consensus       224 ------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 ------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                        01134556789999999999999999     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-41  Score=319.50  Aligned_cols=261  Identities=20%  Similarity=0.219  Sum_probs=197.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...|...+.||+|+||   .||++..    .+..||+|.+...       ..+.+|+.++++++|||||++++++.....
T Consensus        91 ~~~y~i~~~Lg~G~~g---~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEG---EVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCe---EEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            3569999999999999   8888765    4578999987654       235689999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .|+|||++. ++|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.++|+|||+
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~  231 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGA  231 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcc
Confidence            999999996 7888888433     46899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc-
Q 018633          217 SISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED-  294 (353)
Q Consensus       217 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  294 (353)
                      +......... ......||..|+|||++....++.++|||||||++|||++|..||.......     ....+...... 
T Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~l~~i~~~~  306 (392)
T PHA03207        232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-----SSSQLRSIIRCM  306 (392)
T ss_pred             ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-----cHHHHHHHHHHh
Confidence            8765443221 1234578999999999998899999999999999999999999986543221     00111110000 


Q ss_pred             --Cc--cccc-----------ccchhhhccc--h-HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          295 --NR--FTEI-----------VDPIIVEDVL--S-IEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       295 --~~--~~~~-----------~~~~~~~~~~--~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                        ..  ++.-           ..........  . .........+.+++.+||..||++|||+.+++..
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              00  0000           0000000000  0 0001234567889999999999999999999863

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-41  Score=307.88  Aligned_cols=248  Identities=19%  Similarity=0.243  Sum_probs=201.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .+|...+.||+|+||   .||++..  +++.||+|.+...  .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        19 ~~y~~~~~lg~g~~g---~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASG---TVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCe---EEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            578889999999999   9999987  7899999998765  33445778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++...      .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        94 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          94 VMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             eecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceE
Confidence            99999999999988642      4788899999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ...... ......++..|+|||.+.+..++.++|+||||+++|++++|..||..........        ...... .+.
T Consensus       165 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------~~~~~~-~~~  234 (297)
T cd06656         165 ITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNG-TPE  234 (297)
T ss_pred             ccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------eeccCC-CCC
Confidence            543322 1234568889999999988889999999999999999999999986432211000        000000 000


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                 ...+...+..+.+++.+||..+|++|||+.++++
T Consensus       235 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 -----------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                       0011144566789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.3e-41  Score=299.81  Aligned_cols=248  Identities=20%  Similarity=0.303  Sum_probs=202.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|+..+.||+|+||   .||++.+  ++..+++|.+...    ...+.+.+|++++++++||||+++++++......|+
T Consensus         3 ~~y~~~~~i~~g~~~---~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYG---SVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCe---EEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            578889999999999   9999998  4789999998654    226789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ++||+++++|.+++....    ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~  148 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ  148 (256)
T ss_pred             EEecCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchh
Confidence            999999999999986543    46899999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ...... ......++..|+|||++.+..++.++||||||+++|+|++|..||........        ... ......  
T Consensus       149 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~-~~~~~~--  216 (256)
T cd06612         149 LTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFM-IPNKPP--  216 (256)
T ss_pred             cccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhh-hccCCC--
Confidence            643321 23345578899999999888899999999999999999999999874322110        000 000000  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                             ...  ..+......+.+++.+||+.+|++|||+.++++
T Consensus       217 -------~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         217 -------PTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -------CCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                   000  011145567889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-41  Score=307.23  Aligned_cols=264  Identities=19%  Similarity=0.205  Sum_probs=204.3

Q ss_pred             eecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeec
Q 018633           51 IFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKL  127 (353)
Q Consensus        51 ~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~  127 (353)
                      .+.++++..+.++|...+.||+|+||   .||++..  +++.+|+|.+...   ......+.+|+.++.++ +||||+++
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~---~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~   80 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYG---KVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKF   80 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCc---EEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeee
Confidence            35567777889999999999999999   9999888  7789999987643   22346688899999999 69999999


Q ss_pred             cceee-----eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCcee
Q 018633          128 IGCCL-----ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL  202 (353)
Q Consensus       128 ~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  202 (353)
                      ++++.     .++..++||||+++++|.+++....... ..+++..+..++.|++.||.|||   +++++||||||+||+
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil  156 (286)
T cd06638          81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG-ERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNIL  156 (286)
T ss_pred             eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccC-ccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEE
Confidence            99884     3456899999999999998875321111 45788899999999999999999   999999999999999


Q ss_pred             ecCCCceEEeccCCccccCCCCCccccccccCCcccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCccccc
Q 018633          203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT  277 (353)
Q Consensus       203 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg~~p~~~~~~~  277 (353)
                      ++.++.++|+|||++........ ......|+..|+|||++..     ..++.++|||||||++|+|++|..||......
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~  235 (286)
T cd06638         157 LTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM  235 (286)
T ss_pred             ECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence            99999999999999876643222 2334568899999998753     34788999999999999999999998643211


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .        ..... ..........           +...+..+.+++.+||+.+|++|||+.++++.
T Consensus       236 ~--------~~~~~-~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 R--------ALFKI-PRNPPPTLHQ-----------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             H--------HHhhc-cccCCCcccC-----------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1        00000 0000000000           01234568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1e-41  Score=305.53  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=202.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .+|.....||+|+||   .||++..       ....|++|.+.... .....+.+.+|++++++++||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFG---EVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             Hhceeeeeeccccee---EEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            468888999999999   9999886       34678899886541 223567899999999999999999999999998


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCC----CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPH----FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                      +..++||||+++|+|.+++.......    ...+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEE
Confidence            99999999999999999987553110    025899999999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ++|||++...............++..|+|||.+.+..++.++||||||+++|++++ |..||.....        .....
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~  229 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLN  229 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHH
Confidence            99999986543322222334456778999999988888999999999999999999 7778753211        11111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      . ..........            +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       230 ~-~~~~~~~~~~------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 R-LQAGKLELPV------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             H-HHcCCcCCCC------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1 1111110000            0134567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=298.67  Aligned_cols=247  Identities=22%  Similarity=0.358  Sum_probs=197.3

Q ss_pred             CceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           68 NVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ++||+|+||   .||++.+ .++.||+|.+..... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~g~~g---~v~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFG---DVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCc---eEEEEEEeCCCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            468999999   9999988 589999999876532 24567899999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      ++|.+++....    ..+++..++.++.+++.||.|||   +++++||||+|+||+++.++.++|+|||++.........
T Consensus        77 ~~l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          77 GSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            99999986543    35788899999999999999999   999999999999999999999999999998765422211


Q ss_pred             cc-cccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccch
Q 018633          227 IT-DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPI  304 (353)
Q Consensus       227 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (353)
                      .. ....++..|+|||.+.+..++.++|+||||+++|+|+| |..||.......         .........  ..    
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---------~~~~~~~~~--~~----  214 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---------TRERIESGY--RM----  214 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---------HHHHHhcCC--CC----
Confidence            11 22234567999999988889999999999999999999 777775322111         111111100  00    


Q ss_pred             hhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          305 IVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       305 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                             ..+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus       215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                   001144567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.3e-41  Score=298.08  Aligned_cols=247  Identities=22%  Similarity=0.351  Sum_probs=198.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      ++|...+.||+|+||   .||++...++.||+|.+...    ...+.+.+|+.++++++||||+++++++..+ ..++||
T Consensus         6 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFG---AVLQGEYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCC---ceEecccCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            458888999999999   99999999999999998654    2346789999999999999999999998654 479999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++....
T Consensus        78 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          78 ELMSKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             ECCCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence            99999999999876532   35788999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ...    .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.....        .+. ........... 
T Consensus       152 ~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~-~~~~~~~~~~~-  217 (254)
T cd05083         152 MGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEV-KECVEKGYRME-  217 (254)
T ss_pred             ccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHH-HHHHhCCCCCC-
Confidence            221    12234567999999988889999999999999999998 8888863221        111 11111111000 


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                                  .+...+..+.+++.+||+.+|+.|||+.++++.|++
T Consensus       218 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 ------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                        011445678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-41  Score=301.96  Aligned_cols=236  Identities=20%  Similarity=0.300  Sum_probs=185.2

Q ss_pred             ceeeCCCCCccEEEEEEe--------------------------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC
Q 018633           69 VIAKDTSYNLYTMYKGFW--------------------------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHN  122 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~--------------------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~  122 (353)
                      .||+|+||   .||+|.+                          ....|++|.+...  .......|.+|+.+++.++||
T Consensus         2 ~lG~G~~~---~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRT---NIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCccccc---ceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCC
Confidence            58999999   8888874                          1235888888654  344556789999999999999


Q ss_pred             ceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCcee
Q 018633          123 HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL  202 (353)
Q Consensus       123 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  202 (353)
                      ||++++++|.+.+..++||||+++|+|..++....    ..+++..+..++.|++.||.|||   +++|+||||||+|||
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nil  149 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNIL  149 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEE
Confidence            99999999999999999999999999998886543    45788999999999999999999   999999999999999


Q ss_pred             ecCCC-------ceEEeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHH-hCCCCCCc
Q 018633          203 FNEEN-------VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELL-TGWDVSDL  273 (353)
Q Consensus       203 l~~~~-------~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~-tg~~p~~~  273 (353)
                      ++..+       .++++|||++......     ....++..|+|||.+.+ ..++.++||||||+++||++ +|..||..
T Consensus       150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         150 LARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             EeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence            97543       4799999987544221     22356788999998865 45889999999999999995 68888763


Q ss_pred             cccccCCCCChHHHHHHHhhc-CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          274 VKDTHDLACPSNEYLKNYFED-NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      .....         ....... ...+            .    .....+.+++.+||+.+|++|||+.++++.|
T Consensus       225 ~~~~~---------~~~~~~~~~~~~------------~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         225 RTPSE---------KERFYEKKHRLP------------E----PSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             cChHH---------HHHHHHhccCCC------------C----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            22111         0111110 0000            0    1234578999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-41  Score=305.50  Aligned_cols=259  Identities=20%  Similarity=0.262  Sum_probs=203.8

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecc
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLI  128 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~  128 (353)
                      .++.++....+.|+..+.||+|+||   .||+|.+  .++.+|+|.+...   ......+..|+.++.++ +||||++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~---~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~   79 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYG---QVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYY   79 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCe---EEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence            4566777788899999999999999   9999998  7789999988554   33456788999999999 699999999


Q ss_pred             ceeee------CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCcee
Q 018633          129 GCCLE------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL  202 (353)
Q Consensus       129 ~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  202 (353)
                      +++..      .+..|++|||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++++|+||+|+||+
T Consensus        80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nil  153 (282)
T cd06636          80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVL  153 (282)
T ss_pred             eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEE
Confidence            99853      4568999999999999998876432   35788889999999999999999   999999999999999


Q ss_pred             ecCCCceEEeccCCccccCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccc
Q 018633          203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT  277 (353)
Q Consensus       203 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~  277 (353)
                      ++.++.++|+|||++........ ......|+..|+|||.+.     ...++.++|+||||+++|+|++|..||......
T Consensus       154 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~  232 (282)
T cd06636         154 LTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM  232 (282)
T ss_pred             ECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence            99999999999999876532221 223456889999999875     345788999999999999999999998633211


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..        .... ....     ...       ......+..+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~--------~~~~-~~~~-----~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         233 RA--------LFLI-PRNP-----PPK-------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hh--------hhhH-hhCC-----CCC-------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            10        0000 0000     000       001145567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=316.51  Aligned_cols=261  Identities=20%  Similarity=0.260  Sum_probs=209.0

Q ss_pred             cCCCCceeeCCCCCccEEEEEEeCC-eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFWQE-RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      ....+.||+|.||   .|..+...+ ..||||+++... ......+|.+|+++|.+|+|||||.++|+|..++.+++|+|
T Consensus       540 L~~~ekiGeGqFG---EVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  540 LRFKEKIGEGQFG---EVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             eehhhhhcCcccc---eeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            3446789999999   999999955 999999998875 44556899999999999999999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      ||++|+|.+++..+..+   .+.-.....|+.||+.|++||.   +.++||||+.++|+|+|.++++||+|||+++.+-.
T Consensus       616 YmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccccc
Confidence            99999999999887532   2344556779999999999999   99999999999999999999999999999987655


Q ss_pred             CCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh--CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          223 GETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       223 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ++... ....+-+..|||||.+..+.++++||+|+||+++||+++  ...||....+.+     ..+....++.+.... 
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vven~~~~~~~~~~~-  763 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVENAGEFFRDQGRQ-  763 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHHhhhhhcCCCCcc-
Confidence            55433 334455789999999999999999999999999999876  567776433322     001111112111110 


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                              .+. ..|.-++..+.+++..||..+-.+|||++++...|.+.
T Consensus       764 --------~~l-~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 --------VVL-SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             --------eec-cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                    111 11226788899999999999999999999999888764

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=303.70  Aligned_cols=252  Identities=18%  Similarity=0.238  Sum_probs=202.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  ++..+|+|.+...  .....+.|.+|+.++++++||||+++++++..++..+
T Consensus         4 ~~~~~i~~~l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFG---KVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCc---eEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            4568888899999999   9999988  6889999998765  5566678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++....    ..+++..+..++.|++.||.|||   +++|+|+||+|+||+++.++.++|+|||++.
T Consensus        79 lv~e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          79 ILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             EEeeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccch
Confidence            9999999999999887643    46889999999999999999999   9999999999999999999999999999886


Q ss_pred             ccCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ....... ......++..|+|||.+.     ...++.++|+||||+++|+|++|..||......        ....... 
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-  221 (280)
T cd06611         152 KNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKIL-  221 (280)
T ss_pred             hhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHh-
Confidence            6533221 223456888999999875     344778999999999999999999998643211        1111111 


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ....+.+.           .+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       222 ~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         222 KSEPPTLD-----------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCCCCCcC-----------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11100000           011345678899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.7e-42  Score=315.12  Aligned_cols=255  Identities=16%  Similarity=0.156  Sum_probs=197.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++..  +++.||+|.+.... ........+.+|..++..++|+||+++++++.+.+..|
T Consensus         1 d~y~i~~~lG~G~fg---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFG---EVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            468888999999999   9999988  77899999986531 12334456888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++....    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus        78 lv~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence            9999999999999997643    35788899999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCcccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ..............||+.|+|||++.+     ..++.++||||||+++|+|++|+.||.....        .+.......
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~  222 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMN  222 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHc
Confidence            764433322334579999999999865     4578899999999999999999999863221        111111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCC--CCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD--RPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~vl~  344 (353)
                      .....         ..+.. ....+..+.+++.+|+..++..  |+++.++++
T Consensus       223 ~~~~~---------~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         223 HEERF---------QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             CCCcc---------cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            10000         00000 0134567788999999866544  457877764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=300.48  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=203.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++..  ++..+++|.+...  .....+.+.+|+.++++++||||+++++++...+..|+
T Consensus         3 ~~~~~~~~l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYG---DVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCce---EEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            568888999999999   9999988  6788999998765  33466789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      +|||+++++|.+++....    ..++...+..++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||.+..
T Consensus        78 ~~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  150 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQ  150 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchh
Confidence            999999999999887653    35889999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccC---CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTG---VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ...... ......++..|+|||.+...   .++.++|+||||+++|+|+||..||.......        .... .....
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~-~~~~~  220 (262)
T cd06613         151 LTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFL-ISKSN  220 (262)
T ss_pred             hhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHH-HHhcc
Confidence            543221 22345678899999998776   78899999999999999999999986432111        0000 00000


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.   ....      ......+..+.+++.+||..+|.+|||+.+++.
T Consensus       221 ~~---~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         221 FP---PPKL------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CC---Cccc------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00   0000      011245677899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.5e-42  Score=341.07  Aligned_cols=258  Identities=19%  Similarity=0.252  Sum_probs=200.5

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      ...++|...+.||+|+||   .||++.+  .+..||+|.+............|..|+.++.+|+|||||+++++|.+.  
T Consensus        10 ~~l~~YeIl~kLG~GgFG---tVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFG---EVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCe---EEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            445689999999999999   9999998  778999999876544556678899999999999999999999988643  


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC----CCCeEeeccCCCceeecC-----
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF----PRPIVFRNFKTSCILFNE-----  205 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~iiH~dlkp~Nill~~-----  205 (353)
                      ..+||||||+++|+|.++|...... ...+++..++.|+.||+.||.|||+..    .++||||||||+||||+.     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            5689999999999999988653211 146899999999999999999999321    146999999999999964     


Q ss_pred             ------------CCceEEeccCCccccCCCCCccccccccCCcccccccccc--CCCCccccchhhHHHHHHHHhCCCCC
Q 018633          206 ------------ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       206 ------------~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~p~  271 (353)
                                  .+.+||+|||++.......  ......||+.|+|||++..  ..++.++|||||||++|+|+||..||
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                        3458999999997654322  2344578999999999864  34889999999999999999999999


Q ss_pred             CccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          272 DLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ......       ...........   .+         +   ....+..+.+||..||..+|.+|||+.+++.
T Consensus       244 ~~~~~~-------~qli~~lk~~p---~l---------p---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        244 HKANNF-------SQLISELKRGP---DL---------P---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcCCcH-------HHHHHHHhcCC---CC---------C---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            743211       11111111100   00         0   0134567889999999999999999999984

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.8e-41  Score=301.21  Aligned_cols=247  Identities=19%  Similarity=0.292  Sum_probs=201.8

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      .|+..+.||+|+||   .||+|.+  ++..||+|.+.... .......+.+|+.+++++.||||+++++++.+++..++|
T Consensus         5 ~y~~~~~lg~g~~~---~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           5 LFTKLERIGKGSFG---EVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             hhhhhhhcccCCCe---EEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            47777889999999   9999988  68899999886542 345567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++..      .++++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++...
T Consensus        81 ~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~  151 (277)
T cd06640          81 MEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             EecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence            999999999998864      34788889999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..... ......++..|+|||++.+..++.++|+||||+++|||++|..||.......        ... ......    
T Consensus       152 ~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~-~~~~~~----  217 (277)
T cd06640         152 TDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLF-LIPKNN----  217 (277)
T ss_pred             cCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhh-hhhcCC----
Confidence            43322 2334467888999999988889999999999999999999999986332111        000 000000    


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                               .+......+..+.+++.+||+.+|++||++.++++.
T Consensus       218 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 ---------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                     011112456778899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3e-41  Score=310.96  Aligned_cols=256  Identities=16%  Similarity=0.152  Sum_probs=197.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++.+  +++.+|+|++.... ........+.+|+.++..++|+||+++++++.+.+..|
T Consensus         1 ~~y~~~~~lG~G~fg---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFG---EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCe---EEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEE
Confidence            368888999999999   9999988  67889999986431 12233455888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++....    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++.
T Consensus        78 lv~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~  150 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL  150 (332)
T ss_pred             EEEeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence            9999999999999997643    35788899999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ..............||+.|+|||++.     ...++.++|||||||++|||++|+.||.....        .+.......
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~  222 (332)
T cd05623         151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMN  222 (332)
T ss_pred             ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhC
Confidence            65433332234467999999999986     34588999999999999999999999973221        111111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD--RPSMVDVAKK  345 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~vl~~  345 (353)
                      .....         ..+. .....+..+.+|+.+|+..+|+.  |+++.++++.
T Consensus       223 ~~~~~---------~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         223 HKERF---------QFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCccc---------cCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            10000         0000 00134567788999988654444  6888888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.3e-42  Score=304.40  Aligned_cols=251  Identities=27%  Similarity=0.402  Sum_probs=199.5

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |...+.||+|+||   .||++..  +++.+|+|++..............+|+.++++++||||+++++++.+....++||
T Consensus         1 y~~~~~lg~G~~g---~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFG---TVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSE---EEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCE---EEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccc
Confidence            4556789999999   9999999  6778999999887433333444567999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|.+++...     ..+++..++.++.|++.||.+||   +++++|+||||+||+++.++.++|+|||.+....
T Consensus        78 ~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             ccccccccccccccc-----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            999988999999733     46899999999999999999999   8999999999999999999999999999987542


Q ss_pred             CCCCccccccccCCccccccccc-cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMR-TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      . .........++..|+|||++. +..++.++||||+|+++|+|++|..||.......        ...          .
T Consensus       150 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--------~~~----------~  210 (260)
T PF00069_consen  150 E-NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--------QLE----------I  210 (260)
T ss_dssp             S-TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--------HHH----------H
T ss_pred             c-cccccccccccccccccccccccccccccccccccccccccccccccccccccchh--------hhh----------h
Confidence            1 222344567889999999998 7789999999999999999999999987431100        000          0


Q ss_pred             ccchhhhccchHH--HHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          301 VDPIIVEDVLSIE--KEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +............  .......+.+++.+||+.||++|||+.++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  211 IEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000000  0011378899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.1e-41  Score=304.24  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCe----EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QER----LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +.|...+.||+|+||   .||+|.+  ++.    .||+|.+.... .......+.+|+.+++.++||||++++|+|... 
T Consensus         7 ~~~~~~~~lg~G~~g---~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           7 TELKRVKVLGSGAFG---TVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhceeccccccCCCc---cEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            457788899999999   9999987  443    57888876542 334445789999999999999999999998754 


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++++||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccc
Confidence            4679999999999999987653    35788999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          216 LSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       216 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +++........ ......++..|+|||++.+..++.++||||||+++||+++ |..||....        ... ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--------~~~-~~~~~~  225 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--------TRE-IPDLLE  225 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHH-HHHHHH
Confidence            99876433221 1223345678999999988889999999999999999998 888876321        111 111221


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......             +..++..+.+++.+||..+|++||++.++++.|.++.+
T Consensus       226 ~~~~~~~-------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         226 KGERLPQ-------------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCCCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1110000             01234567899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.6e-41  Score=304.29  Aligned_cols=248  Identities=19%  Similarity=0.259  Sum_probs=201.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .+|+..+.||.|++|   .||+|..  +++.|++|.+...  .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        19 ~~y~~~~~lg~g~~g---~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASG---TVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCe---EEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence            358888999999999   9999987  7899999998755  34456778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+||+++++|..++..      ..+++.++..++.|++.||.|||   +++++||||||+||+++.++.++|+|||++..
T Consensus        94 v~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~  164 (296)
T cd06655          94 VMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ  164 (296)
T ss_pred             EEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence            9999999999998864      34789999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ...... ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......        ....... .....
T Consensus       165 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--------~~~~~~~-~~~~~  234 (296)
T cd06655         165 ITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIAT-NGTPE  234 (296)
T ss_pred             cccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh-cCCcc
Confidence            543322 1234468889999999988889999999999999999999999986432211        1111110 00000


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..           .+...+..+.+++.+||..||++|||+.++++
T Consensus       235 ~~-----------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 LQ-----------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cC-----------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            00           01134556789999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-41  Score=306.40  Aligned_cols=260  Identities=20%  Similarity=0.247  Sum_probs=203.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++.+  ++..||+|++.... .....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus         5 ~~~~~~~~ig~g~~g---~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGG---SVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCe---EEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            457778899999999   9999998  58899999886542 34456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++...     ..+++..+..++.+++.||.|||+  .++++||||+|+||+++.++.++|+|||++..
T Consensus        81 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          81 CMEFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             EEecCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999999888654     357899999999999999999992  26899999999999999999999999998765


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      .....   .....|+..|+|||++.+..++.++|||||||++|++++|..||.................          +
T Consensus       154 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----------~  220 (284)
T cd06620         154 LINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----------D  220 (284)
T ss_pred             hhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH----------H
Confidence            42221   2345789999999999888899999999999999999999999985433211000000000          0


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..........+.......+..+.+|+.+||+.||++|||+.++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         221 LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             HHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111111111111111355678899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.5e-41  Score=299.60  Aligned_cols=249  Identities=22%  Similarity=0.288  Sum_probs=202.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|...+.||+|+||   .||++..  ++..+|+|.+............+.+|+.++++++||||+++++.+..++..++|
T Consensus         1 ~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFG---IVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCce---EEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            47788899999999   8998887  788999999876644555678899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEEeccCCccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSIS  219 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~dfg~a~~  219 (353)
                      |||+++++|.+++.....   ..+++..+..++.+++.||.|||   +++++|+||+|+||+++.+ +.++|+|||.+..
T Consensus        78 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             EecCCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            999999999999976432   35789999999999999999999   9999999999999999855 4679999999877


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ......  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......        ........ .....
T Consensus       152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~-~~~~~  220 (256)
T cd08220         152 LSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMS-GTFAP  220 (256)
T ss_pred             cCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHh-cCCCC
Confidence            643321  23456788999999998888899999999999999999999998632211        11111111 11111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +             +...+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ~-------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 I-------------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             C-------------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0             0134567889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=302.52  Aligned_cols=248  Identities=21%  Similarity=0.275  Sum_probs=202.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||.|++|   .||+|.+  ++..||+|.+.... .......+.+|+.+++.++||||+++++++.++...++
T Consensus         1 ~~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFG---EVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCe---EEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            357788899999999   9999998  78999999987553 34455678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+||+++++|.+++...      ++++..++.++.|++.||.|||   +++++|+||+|+||++++++.++|+|||+++.
T Consensus        77 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  147 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQ  147 (274)
T ss_pred             EEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccccccee
Confidence            99999999999998753      5789999999999999999999   99999999999999999999999999999977


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ..... .......++..|+|||++.+..++.++||||||+++|+|+||..||.......        ... .......+.
T Consensus       148 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~-~~~~~~~~~  217 (274)
T cd06609         148 LTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLF-LIPKNNPPS  217 (274)
T ss_pred             ecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHH-HhhhcCCCC
Confidence            65432 22334568889999999988889999999999999999999999986432111        000 000110100


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.            ....+..+.+++.+||..+|++|||++++++
T Consensus       218 ~~------------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LE------------GNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             Cc------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            00            0014567889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.8e-41  Score=304.51  Aligned_cols=245  Identities=21%  Similarity=0.309  Sum_probs=198.8

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |+..+.||+|+||   .||+|.+  ++..||+|.+.... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus         6 y~~~~~l~~g~~~---~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           6 FTKLERIGKGSFG---EVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHhcCCCCe---eEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            5556779999999   9999987  67899999886542 2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|.+++..      ..+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.++++|||++....
T Consensus        82 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          82 EYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcccccccccc
Confidence            99999999998854      35788999999999999999999   9999999999999999999999999999987664


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      .... ......|+..|+|||++.+..++.++|+||||+++|||++|..|+.......        .. ........    
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~-~~~~~~~~----  218 (277)
T cd06642         153 DTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VL-FLIPKNSP----  218 (277)
T ss_pred             Ccch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HH-hhhhcCCC----
Confidence            3221 2234567889999999988889999999999999999999999976322111        00 00111100    


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       +.        .....+..+.+++.+||+.+|++|||+.++++
T Consensus       219 -~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         219 -PT--------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -CC--------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             00        01134567889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-41  Score=304.94  Aligned_cols=268  Identities=16%  Similarity=0.169  Sum_probs=197.9

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|...+.||+|+||   .||++.+  ++..||+|.+............+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~~~~~l~~g~~~---~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYG---TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCe---EEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            36777899999999   9999998  788999999865432333446678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||++ ++|.+++....    ..+++..++.++.||+.||.|||   +++++||||||+||+++.++.++|+|||++...
T Consensus        78 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          78 FEYCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             EecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            99997 68888776543    45899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCC--------CCChHHHHHHH
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL--------ACPSNEYLKNY  291 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~  291 (353)
                      ..... ......++..|+|||++.+.. ++.++|||||||++|+|+||..|+.........        ..+....+...
T Consensus       150 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         150 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence            43221 123345788999999987644 789999999999999999999886532221100        00000000000


Q ss_pred             hhcCcccccccchhhhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ......... . ....... .......+..+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         229 SKLPDYKPY-P-MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhccccccc-C-CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000000000 0 0000000 0001134577889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-42  Score=309.36  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=214.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++.+-|+..+.||+|-|+   .|-.+.+  +|..||||++.+.....-....+.+|++.|+-++|||||++|.+......
T Consensus        15 kIAGLYDLekTlG~GHFA---VVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFA---VVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             ceeeeehhhhhhcCCcee---hhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            445668889999999999   8888877  99999999998775555566778999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec-CCCceEEeccC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN-EENVAKLFDFS  215 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~dfg  215 (353)
                      +|||+|+-.+|+|++++..+.    ..+.+.-+.+++.||+.|+.|+|   ...+|||||||+|+.+. .-|-+||.|||
T Consensus        92 lyLiLELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeecc
Confidence            999999999999999998876    56889999999999999999999   99999999999998865 56889999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ++-.+.++..  .++.+|+..|-|||++.+..|+ ++.||||||||||-|+.|+.||+.+++.+-+              
T Consensus       165 FSNkf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL--------------  228 (864)
T KOG4717|consen  165 FSNKFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL--------------  228 (864)
T ss_pred             ccccCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh--------------
Confidence            9988765543  5788999999999999999987 6899999999999999999999966654411              


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                         .-++|-..    .  .|...+.++.+||..||..||.+|-|.++|+.
T Consensus       229 ---TmImDCKY----t--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  229 ---TMIMDCKY----T--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ---hhhhcccc----c--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence               12222111    1  12277889999999999999999999998864

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.8e-41  Score=303.38  Aligned_cols=271  Identities=18%  Similarity=0.207  Sum_probs=202.7

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|...+.||+|++|   .||+|.+  ++..||+|++............+.+|+.++++++||||+++++++..++..++|
T Consensus         1 ~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHG---IVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCc---EEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            36778899999999   9999998  788999999976644455567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+ +++|.+++....    ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||.+...
T Consensus        78 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          78 MEYM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             eccc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            9999 899999987544    46899999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHHh
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNYF  292 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~  292 (353)
                      ............|+..|+|||.+.+. .++.++||||+|+++|+|++|.+||........       ...+....+....
T Consensus       150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence            54332223345688899999998654 468999999999999999999777753322110       0000000000000


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .-..+..+..+.................+.+++.+||+.+|++|||+++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000000000000000000000134578899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.1e-41  Score=348.33  Aligned_cols=269  Identities=26%  Similarity=0.373  Sum_probs=212.2

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccc
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIG  129 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~  129 (353)
                      ++++++   ...|...++||+|+||   .||+|.+  ++..||||++....  .    ....|++.+++++|||||+++|
T Consensus       683 ~~~~~~---~~~~~~~~~ig~G~~g---~Vy~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~l~~l~HpnIv~~~~  750 (968)
T PLN00113        683 ITINDI---LSSLKEENVISRGKKG---ASYKGKSIKNGMQFVVKEINDVN--S----IPSSEIADMGKLQHPNIVKLIG  750 (968)
T ss_pred             hhHHHH---HhhCCcccEEccCCCe---eEEEEEECCCCcEEEEEEccCCc--c----ccHHHHHHHhhCCCCCcceEEE
Confidence            444444   3457788999999999   9999997  78999999986542  1    1234688899999999999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                      +|.+.+..++||||+++|+|.++++        .++|..+..++.|++.||+|||+.++.+|+||||||+||+++.++.+
T Consensus       751 ~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~  822 (968)
T PLN00113        751 LCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP  822 (968)
T ss_pred             EEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCce
Confidence            9999999999999999999999984        36889999999999999999997667799999999999999998888


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ++. ||.+.....     .....||..|+|||++.+..++.++|||||||++|||+||+.||+.....   .....+|..
T Consensus       823 ~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~  893 (968)
T PLN00113        823 HLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWAR  893 (968)
T ss_pred             EEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---CCcHHHHHH
Confidence            776 665433211     12336789999999999889999999999999999999999998532221   233444554


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ...........+++.+......  ......++.+++.+||+.||++||||.++++.|+++.+
T Consensus       894 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        894 YCYSDCHLDMWIDPSIRGDVSV--NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             HhcCccchhheeCccccCCCCc--cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            4444444445555555433222  12456678899999999999999999999999998865

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-41  Score=299.84  Aligned_cols=249  Identities=18%  Similarity=0.270  Sum_probs=199.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh-------hHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP-------RAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      +|.....||+|++|   .||+|..  +++.+|+|.+.......       ...+.+.+|+.++++++||||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~---~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (267)
T cd06628           1 KWIKGALIGSGSFG---SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD   77 (267)
T ss_pred             CccccceeecCCCe---EEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Confidence            36677899999999   9999987  67899999886543221       233568899999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..++|+||+++++|.+++...     ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.++|+|
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~d  149 (267)
T cd06628          78 ADHLNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISD  149 (267)
T ss_pred             CCccEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecc
Confidence            99999999999999999999764     35788899999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCc-----cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          214 FSLSISIPEGETH-----ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       214 fg~a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      ||.++........     ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......        ..
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~  221 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--------AI  221 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--------HH
Confidence            9998766422111     1123457889999999988889999999999999999999999987422111        11


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... ..     .+.        .+...+..+.+++.+||+.||.+||++.++++
T Consensus       222 ~~~~~-~~-----~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         222 FKIGE-NA-----SPE--------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHhc-cC-----CCc--------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            10000 00     000        01144567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.6e-41  Score=300.33  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=203.7

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--C
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--T  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~  134 (353)
                      .|...+.||+|+||   .||++.+      ++..+|+|.+...... ...+.|.+|+.+++.++||||+++++++..  .
T Consensus         5 ~~~~~~~ig~g~~~---~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           5 HLKFIKQLGEGHFG---KVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hchhheeeccCCCe---eEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            35667889999999   9999986      3679999999766322 356789999999999999999999999877  5


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ...++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+||
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df  153 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDF  153 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence            57899999999999999997653    35889999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC--C----CChHH
Q 018633          215 SLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL--A----CPSNE  286 (353)
Q Consensus       215 g~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~--~----~~~~~  286 (353)
                      |.+.........  ......++..|+|||.+.+..++.++||||||+++|||+||..|+.........  .    .....
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            999876532211  111234456799999998888999999999999999999999987643221100  0    00011


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      .+.......             .....+..++.++.+++.+||+.+|++|||+.+|++.|+++
T Consensus       234 ~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEG-------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcC-------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111100             00000113456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=319.20  Aligned_cols=247  Identities=24%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             CCceeeCCCCCccEEEEEEe---CC--eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFW---QE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      .++||+|.||   .|++|.|   .|  -.||||.+..+.... ...+|++|+.+|.+|+|||+|++||+..+ ....+||
T Consensus       115 ~e~LG~GsFg---vV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  115 YELLGEGSFG---VVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHhcCccee---eEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            4579999999   9999999   23  468999998774333 78899999999999999999999999887 6778999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      |+++.|||.+.|++...   ..|.......++.|||.|+.||.   ++++|||||..+|+|+...-.+||+|||+.+.+.
T Consensus       190 ELaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            99999999999988322   57888888999999999999999   9999999999999999999999999999999886


Q ss_pred             CCCCcc--ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          222 EGETHI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       222 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ..+...  .....-.+.|.|||.+....|+.+||||+|||++|||+| |..||....        ..+.+.......++ 
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~iD~~erL-  334 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKNIDAGERL-  334 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHhccccccC-
Confidence            654332  123344578999999999999999999999999999999 667876332        22222222211111 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                                   ..++.|++.+.+++..||..+|++|||+..|.+.+
T Consensus       335 -------------pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 -------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             -------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                         12237899999999999999999999999997554

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-41  Score=310.61  Aligned_cols=265  Identities=17%  Similarity=0.201  Sum_probs=196.1

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC---
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET---  134 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~---  134 (353)
                      ..++|...+.||+|+||   .||++.+  ++..||+|++............+.+|+.++++++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          13 VPERYQNLTPVGSGAYG---SVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhheecccCCCe---EEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            45779999999999999   9999987  778999999876533344556788999999999999999999988643   


Q ss_pred             ---CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          135 ---PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       135 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                         ...|++++++ +++|.+++..      ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEE
Confidence               3468999998 6899887753      35889999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCC
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACP  283 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~  283 (353)
                      +|||+++.....    .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.........       ..+
T Consensus       160 ~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07878         160 LDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP  235 (343)
T ss_pred             cCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999998765332    234568999999999876 46889999999999999999999998643221100       000


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHH----HHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIE----KEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .......... ......... + ...+...    .......+.+|+.+||..||++|||+.++++
T Consensus       236 ~~~~~~~~~~-~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         236 SPEVLKKISS-EHARKYIQS-L-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CHHHHHhcch-hhHHHHhhc-c-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000 000000000 0 0000000    0012345779999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-41  Score=300.70  Aligned_cols=239  Identities=21%  Similarity=0.347  Sum_probs=186.8

Q ss_pred             CceeeCCCCCccEEEEEEe--C-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           68 NVIAKDTSYNLYTMYKGFW--Q-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      +.||+|+||   .||+|..  .       ...|++|.+...  .....+.+.+|+.+++.++||||+++++++..++..+
T Consensus         1 ~~lg~G~~~---~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFT---KIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccch---hheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            368999999   8888876  2       234888887554  3455678899999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc--------eE
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV--------AK  210 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--------~k  210 (353)
                      +||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.        ++
T Consensus        76 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~  148 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIK  148 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEE
Confidence            9999999999999997654    35788999999999999999999   999999999999999987664        69


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCC-CCCCccccccCCCCChHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGW-DVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~  288 (353)
                      ++|||++.....     .....++..|+|||++.+. .++.++||||||+++|+|++|. .|+......        .. 
T Consensus       149 l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------~~-  214 (258)
T cd05078         149 LSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------KK-  214 (258)
T ss_pred             ecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------HH-
Confidence            999998865432     2234678889999999764 4789999999999999999995 444321110        00 


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ...... . .         ..+.    .....+.+++.+||+.+|++|||++++++.|+
T Consensus       215 ~~~~~~-~-~---------~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         215 LQFYED-R-H---------QLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHc-c-c---------cCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            001110 0 0         0000    22356789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-41  Score=310.60  Aligned_cols=262  Identities=19%  Similarity=0.298  Sum_probs=203.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe---------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccce
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW---------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGC  130 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~  130 (353)
                      ..+|...+.||+|+||   .||++.+         ....||+|.+.... .....+.+.+|+.++.++ +||||++++++
T Consensus        11 ~~~~~i~~~ig~G~~g---~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100          11 RTRLTLGKPLGEGCFG---QVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             HhHeeecceeccccCC---cEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3468889999999999   7777764         22468999876542 344567899999999999 79999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      |...+..++++||+++|+|.+++......           ....+++..++.++.|++.||.|||   +++++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence            99999999999999999999998753210           1135788899999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDT  277 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~  277 (353)
                      |||++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||....  
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--  241 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--  241 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence            9999999999999999987654322111 122234567999999988889999999999999999998 778875321  


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                            ......... .......             +...+..+.+++.+||+.+|++|||+.++++.|.++..
T Consensus       242 ------~~~~~~~~~-~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         242 ------VEELFKLLK-EGHRMDK-------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ------HHHHHHHHH-cCCCCCC-------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                  112211111 1110000             01345678899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-40  Score=305.35  Aligned_cols=198  Identities=20%  Similarity=0.257  Sum_probs=160.5

Q ss_pred             CCceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--CCccEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--TPIPILV  140 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv  140 (353)
                      ...||+|+||   .||+|..    ++..||+|.+....    ....+.+|+.++++++||||+++++++..  +...|+|
T Consensus         6 ~~~lG~G~~g---~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYG---HVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCe---EEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            4579999999   9999985    45789999986542    23457889999999999999999999864  4568899


Q ss_pred             EEeccCCChhhhhccCCC----CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee----cCCCceEEe
Q 018633          141 FESVQYGTLWDRILGAPQ----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLF  212 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~  212 (353)
                      |||+. ++|.+++.....    .....++...+..++.||+.||.|||   +++|+||||||+|||+    +.++.+||+
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            99996 688887653221    11135889999999999999999999   9999999999999999    456789999


Q ss_pred             ccCCccccCCCCC--ccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          213 DFSLSISIPEGET--HITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       213 dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                      |||+++.......  .......||+.|+|||++.+. .++.++||||+||++|+|++|.+||....
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            9999977643221  112346789999999998764 58899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.6e-41  Score=302.26  Aligned_cols=271  Identities=18%  Similarity=0.221  Sum_probs=201.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|+....||+|++|   .||++.+  +++.||+|++..........+.+.+|+.++++++||||+++++++......++
T Consensus         1 ~~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYG---VVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCe---EEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            468888999999999   9999998  68999999986543333445678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|..++...     ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++..
T Consensus        78 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (286)
T cd07847          78 VFEYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARI  149 (286)
T ss_pred             EEeccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECcccccee
Confidence            99999988887766543     35889999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCC------CChHHHHHHHh
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA------CPSNEYLKNYF  292 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~  292 (353)
                      ...... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||..........      ..........+
T Consensus       150 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         150 LTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             cCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            644321 1233457888999999876 457899999999999999999999987433211000      00000000001


Q ss_pred             hcCcccc-cccchhhhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTE-IVDPIIVEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....+.. ...+....... .......+..+.+++.+||+.+|++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000 00000000000 0001134577889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-40  Score=295.76  Aligned_cols=253  Identities=17%  Similarity=0.207  Sum_probs=187.5

Q ss_pred             ceeeCCCCCccEEEEEEe-CC---eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           69 VIAKDTSYNLYTMYKGFW-QE---RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .||+|+||   .||+|.. ++   ..+++|.+.... .....+.|.+|+.+++.++||||+++++.|.+....++||||+
T Consensus         2 ~lg~G~~g---~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFG---KVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCc---eEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            58999999   9999876 32   345666665432 3445678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++|+|.+++...... ...++...++.++.|++.||.|||   +++++||||||+|||++.++.++|+|||++.......
T Consensus        78 ~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          78 ELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             CCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence            999999998764321 134667778899999999999999   9999999999999999999999999999875432211


Q ss_pred             -CccccccccCCcccccccccc-------CCCCccccchhhHHHHHHHHhC-CCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          225 -THITDTVMGTWGYCAPEYMRT-------GVFNEKSDVFSFGVFLFELLTG-WDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       225 -~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                       ........++..|+|||++..       ..++.++||||||+++|||+++ ..||.....        .+........ 
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~-  224 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKD-  224 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhh-
Confidence             112234567889999998743       2357899999999999999975 567653221        1111111111 


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ......++.+..        .....+.+++..|| .+|++|||+.+|++.|.
T Consensus       225 ~~~~~~~~~~~~--------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 QQVKLFKPQLEL--------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccccCCCccCC--------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111122221111        23456778999999 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-41  Score=311.88  Aligned_cols=192  Identities=19%  Similarity=0.270  Sum_probs=165.5

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ....+|...+.||+|+||   .||+|..  ++..||+|.....        ....|+.++++++||||+++++++...+.
T Consensus        63 ~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  131 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEG---RVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI  131 (357)
T ss_pred             hhhcCcEEEEEecCCCCe---EEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence            334679999999999999   9999998  6678999975433        23568999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++|+|++. ++|.+++....    ..+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.++|+|||+
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcc
Confidence            999999996 78988886543    46899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCC
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~  271 (353)
                      ++......  ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       204 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        204 AQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            86532221  123456899999999999889999999999999999999976654

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.4e-41  Score=298.68  Aligned_cols=250  Identities=18%  Similarity=0.217  Sum_probs=194.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC---ChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC---RPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      .+|...+.||+|+||   .||++..  ++..|++|++.....   .......+.+|+.++++++||||+++++++.+.  
T Consensus         2 ~~~~~~~~lg~g~~g---~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFG---RVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE   78 (266)
T ss_pred             CCccccceecCCCCE---EEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence            478999999999999   9999987  688999998864321   233456789999999999999999999998753  


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ...++++||+++++|.+++...     ..+++...+.++.|++.||.|||   +.+++||||+|+||+++.++.++|+||
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~df  150 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDF  150 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccC
Confidence            5678999999999999998754     35788889999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCC--ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          215 SLSISIPEGET--HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       215 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |++........  .......++..|+|||++.+..++.++|||||||++|+|++|..||......        .......
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~  222 (266)
T cd06651         151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIA  222 (266)
T ss_pred             CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHh
Confidence            99876532111  1112345788999999998888999999999999999999999998632111        1111110


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....     .        +..+......+.+++ +||..+|++|||+.++++
T Consensus       223 ~~~~-----~--------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         223 TQPT-----N--------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             cCCC-----C--------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            0000     0        001113445566677 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-42  Score=316.07  Aligned_cols=241  Identities=21%  Similarity=0.254  Sum_probs=187.0

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc---CCCceeeccceeeeCCccEEEEEe
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM---SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ||+|+||   .||++.+  ++..||+|++..... .......+..|..++...   .||||+++++++.+.+..|+||||
T Consensus         1 lG~G~~g---~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~   77 (330)
T cd05586           1 IGKGTFG---QVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY   77 (330)
T ss_pred             CCCCCce---EEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence            6999999   9999988  689999999864321 122334566677777766   699999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.++|+|||++......
T Consensus        78 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          78 MSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD  149 (330)
T ss_pred             CCCChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence            9999999888754     46889999999999999999999   999999999999999999999999999998754322


Q ss_pred             CCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVD  302 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
                      .. ......||..|+|||++.+. .++.++|||||||++|+|++|..||.....        .+...... .... .+  
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~-~~~~-~~--  216 (330)
T cd05586         150 NK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIA-FGKV-RF--  216 (330)
T ss_pred             CC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHH-cCCC-CC--
Confidence            21 23456799999999998754 488999999999999999999999864221        11111111 1110 00  


Q ss_pred             chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC----HHHHHH
Q 018633          303 PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS----MVDVAK  344 (353)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~vl~  344 (353)
                         ..       ...+..+.+++.+||+.||.+||+    +.++++
T Consensus       217 ---~~-------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 ---PK-------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ---CC-------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence               00       023456778999999999999995    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.6e-41  Score=302.51  Aligned_cols=263  Identities=20%  Similarity=0.210  Sum_probs=204.6

Q ss_pred             eecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeec
Q 018633           51 IFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKL  127 (353)
Q Consensus        51 ~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~  127 (353)
                      .+.+.++.+++++|...+.||+|+||   .||++..  +++.+|+|.+...   ......+.+|+.++.++ +|||++++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~---~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~   84 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYG---KVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKF   84 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCe---EEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            45667788889999999999999999   9999988  7889999998654   22345678899999999 79999999


Q ss_pred             cceeeeC-----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCcee
Q 018633          128 IGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL  202 (353)
Q Consensus       128 ~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  202 (353)
                      ++++...     +..++||||+++++|.+++...... ...+++..++.++.|++.||.|||   +++++|+||||+||+
T Consensus        85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nil  160 (291)
T cd06639          85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNIL  160 (291)
T ss_pred             EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEE
Confidence            9998753     3589999999999999987642111 146789999999999999999999   999999999999999


Q ss_pred             ecCCCceEEeccCCccccCCCCCccccccccCCccccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCccccc
Q 018633          203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-----VFNEKSDVFSFGVFLFELLTGWDVSDLVKDT  277 (353)
Q Consensus       203 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~tg~~p~~~~~~~  277 (353)
                      ++.++.++|+|||++........ ......|+..|+|||++...     .++.++|||||||++|+|++|+.||......
T Consensus       161 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         161 LTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             EcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            99999999999999876543221 12345678899999998643     2688999999999999999999998643211


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .        ...... ......+.+           +......+.+++.+||+.+|++|||+.++++
T Consensus       240 ~--------~~~~~~-~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 K--------TLFKIP-RNPPPTLLH-----------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             H--------HHHHHh-cCCCCCCCc-----------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1        011110 011111100           1134456889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.8e-41  Score=300.92  Aligned_cols=253  Identities=21%  Similarity=0.252  Sum_probs=202.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|+..+.||+|++|   .||++.+  +++.+|+|.+.... .......+.+|+.++++++||||+++++++...+..++
T Consensus         1 ~~~~~~~~ig~g~~~---~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (265)
T cd06605           1 DDLEYLGELGAGNSG---VVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI   76 (265)
T ss_pred             CcchHHHHhcCCCCe---EEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence            357777889999999   9999988  58899999987653 23556778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      |+||+++++|.+++....    ..++...+..++.|++.||.|||   + .+++|+||||+||+++.++.++|+|||.+.
T Consensus        77 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~  149 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG  149 (265)
T ss_pred             EEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence            999999999999987653    46788999999999999999999   8 999999999999999999999999999986


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .......   ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......   .............    
T Consensus       150 ~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~----  219 (265)
T cd06605         150 QLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNE----  219 (265)
T ss_pred             hhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcC----
Confidence            6532211   22667889999999988889999999999999999999999987432211   0011111111110    


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                               ..+.......+..+.+++.+||..+|++|||+.+++.
T Consensus       220 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         220 ---------PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---------CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                     0000011125667889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-40  Score=296.13  Aligned_cols=237  Identities=22%  Similarity=0.366  Sum_probs=187.4

Q ss_pred             CceeeCCCCCccEEEEEEeC--C----------eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           68 NVIAKDTSYNLYTMYKGFWQ--E----------RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~--~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +.||+|+||   .||+|.+.  +          ..|++|.+....   .....|.+|+.++++++||||+++++++.. +
T Consensus         1 ~~lg~G~~~---~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFT---NIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             Ccccccccc---eEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            368999999   99999983  3          247778765542   226789999999999999999999999988 7


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-------c
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-------V  208 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-------~  208 (353)
                      ..++||||+++|+|.+++....    ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++       .
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~  146 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPF  146 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCcee
Confidence            7899999999999999997654    35788999999999999999999   99999999999999999887       7


Q ss_pred             eEEeccCCccccCCCCCccccccccCCccccccccccC--CCCccccchhhHHHHHHHHhC-CCCCCccccccCCCCChH
Q 018633          209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG--VFNEKSDVFSFGVFLFELLTG-WDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg-~~p~~~~~~~~~~~~~~~  285 (353)
                      ++|+|||++.....     .....++..|+|||++...  .++.++||||||+++|+|++| ..|+.......       
T Consensus       147 ~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------  214 (259)
T cd05037         147 IKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------  214 (259)
T ss_pred             EEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------
Confidence            99999999876533     2234566789999999876  689999999999999999994 66665322110       


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                       . ...+.....       .    +.    .....+.+++.+||..+|.+|||+.++++.|+
T Consensus       215 -~-~~~~~~~~~-------~----~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         215 -K-ERFYQDQHR-------L----PM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -H-HHHHhcCCC-------C----CC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             1 111111000       0    00    11257789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.2e-41  Score=300.02  Aligned_cols=255  Identities=18%  Similarity=0.297  Sum_probs=200.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEecCCC--------CChhHHHHHHHHHHHHhh-cCCCceeeccce
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQFYGHE--------CRPRAYESCINNVTYAAR-MSHNHILKLIGC  130 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~H~niv~~~~~  130 (353)
                      +|+..+.||+|+||   .||++.+   .+..+|+|.+....        ........+.+|+.++.+ ++||||++++++
T Consensus         1 ~y~~~~~ig~G~~~---~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~   77 (269)
T cd08528           1 EYAVLEHLGSGAFG---CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT   77 (269)
T ss_pred             CchhhhhhcCCCCc---eEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence            47788899999999   9999988   35889999875332        123345667889988875 789999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCce
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~  209 (353)
                      +..++..++||||+++++|.+++...... ...+++..++.++.|++.||.|||   + .+++|+||+|+||+++.++.+
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          78 FLENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             EccCCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcE
Confidence            99999999999999999999887542111 146889999999999999999999   6 679999999999999999999


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      +|+|||.+.......  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......        ....
T Consensus       154 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~  223 (269)
T cd08528         154 TITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLAT  223 (269)
T ss_pred             EEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHH
Confidence            999999987654332  234556888999999999888999999999999999999999998632111        1111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      .. ........            .....+..+.+++.+||+.||++|||+.++.++|+
T Consensus       224 ~~-~~~~~~~~------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 KI-VEAVYEPL------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HH-hhccCCcC------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11 11111100            00134567889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.3e-41  Score=299.27  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=199.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCC----ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHEC----RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .|...+.||+|+||   .||+|.. +++.+|+|.+.....    .......+.+|+.++++++|+||+++++++.+.+..
T Consensus         1 ~~~~~~~ig~g~~~---~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (265)
T cd06631           1 EWTKGEVLGKGAYG---TVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI   77 (265)
T ss_pred             CccccceEeccCCe---EEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence            37778899999999   9999988 788999998864421    223346688999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++|+||+++++|.+++...     .++++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++
T Consensus        78 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          78 SIFMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             EEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            9999999999999998754     35788999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCC-----CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          218 ISIPEGE-----THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       218 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .......     ........|+..|+|||++.+..++.++|+||||+++|+|++|..||.......        ......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~  221 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYIG  221 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--------HHHHhh
Confidence            7643211     111233568889999999988889999999999999999999999986432111        000000


Q ss_pred             hc-CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 ED-NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .. ...+.         .    +...+..+.+++.+||+.+|++|||+.++++
T Consensus       222 ~~~~~~~~---------~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         222 AHRGLMPR---------L----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hccCCCCC---------C----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00 00000         0    1134567789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.3e-41  Score=301.82  Aligned_cols=252  Identities=18%  Similarity=0.252  Sum_probs=198.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|+..+.||+|+||   .||++.+  ++..||+|.+.... .......+.+|+.++++++||||+++++++...+..++
T Consensus         1 ~~~~~~~~ig~g~~g---~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYG---SVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCe---EEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            357788899999999   9999998  68999999886542 34456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      ||||+++++|..++.....  ...+++..+..++.|++.||.|||   + .+++|+||||+||+++.++.++|+|||++.
T Consensus        77 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  151 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG  151 (286)
T ss_pred             EEeecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence            9999999999888865321  136899999999999999999999   5 599999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCC------CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGV------FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ......   .....++..|+|||++.+..      ++.++|+|||||++|+|++|..||.......     ........ 
T Consensus       152 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-  222 (286)
T cd06622         152 NLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFAQLSAI-  222 (286)
T ss_pred             cccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHHHHHHH-
Confidence            653221   23446788999999985443      5789999999999999999999986321110     00000000 


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ......             ..+...+..+.+++.+||..+|++||++.+++.
T Consensus       223 ~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         223 VDGDPP-------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hhcCCC-------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            000000             011145677889999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=308.41  Aligned_cols=253  Identities=21%  Similarity=0.266  Sum_probs=210.2

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcC-CCceeeccceeeeC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMS-HNHILKLIGCCLET  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~  134 (353)
                      .....|...+.||+|.||   .||++..  +|+.+|+|.+.+.... ....+.+.+|+.+|++++ |||||.+++++++.
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg---~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFG---VVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             cccccEEehhhhCCCCce---EEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            445568888999999999   9999998  7999999999776432 234578999999999999 99999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC----CceE
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE----NVAK  210 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~----~~~k  210 (353)
                      ...++|||+|.||.|.+.+...      .+++..+..++.|++.++.|||   +.+|+||||||+|+|+...    +.+|
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEE
Confidence            9999999999999999999764      2789999999999999999999   9999999999999999643    4799


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ++|||++.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......        ... 
T Consensus       180 ~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~~-  248 (382)
T KOG0032|consen  180 LIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IFL-  248 (382)
T ss_pred             EeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HHH-
Confidence            999999988765  334667899999999999999999999999999999999999999998544322        000 


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....+.+          ++....-+..+....+++..|+..||..|+|+.++++
T Consensus       249 ~i~~~~~----------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  249 AILRGDF----------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHcCCC----------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1111111          1111111256778889999999999999999999986

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.7e-41  Score=301.67  Aligned_cols=266  Identities=17%  Similarity=0.209  Sum_probs=199.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..+.||.|++|   .||++..  ++..||+|++............+.+|++++++++||||+++++++.+++..++|
T Consensus         1 ~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYG---VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCce---EEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            57888999999999   9999988  788999999875533344456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+. ++|.+++.....   ..+++..++.++.|++.||+|||   +++++|+||+|+||+++.++.++|+|||++...
T Consensus        78 ~e~~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          78 FEFLH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             eeccc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            99996 689888865432   46789999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHHHHHh
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYLKNYF  292 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~~~  292 (353)
                      ..... ......++..|+|||++.+.. ++.++||||||+++|+|+||..||.........       ..+....+....
T Consensus       151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         151 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             ccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence            33221 123345678899999887644 688999999999999999999998643221100       000000000000


Q ss_pred             h----cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 E----DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .    ...+..........     .....+..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSK-----VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHHhhcccccccCHHH-----HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0    00010100000000     01134456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=303.02  Aligned_cols=269  Identities=20%  Similarity=0.252  Sum_probs=202.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|+..+.||+|++|   .||++.+  ++..||+|++..........+.+.+|++++++++|+||+++++++..++..++
T Consensus         1 ~~y~~~~~i~~g~~~---~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYG---VVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCe---eEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            368888999999999   9999988  67899999987654445556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++++.+..+....     ..+++..+..++.|++.||.|||   .++++|+||+|+||+++.++.++|+|||++..
T Consensus        78 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~  149 (288)
T cd07833          78 VFEYVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARA  149 (288)
T ss_pred             EEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence            99999976665554432     35789999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCC------CChHHHHHHHh
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA------CPSNEYLKNYF  292 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~  292 (353)
                      .............++..|+|||++.+. .++.++||||||+++|+|++|..||..........      ..........+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             cCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            654433223445678889999999887 78999999999999999999999987432211000      00000000000


Q ss_pred             h-cC-----cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 E-DN-----RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      . ..     .+....+...   .....+...+..+.+++.+||..+|++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPES---LERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccCccccccccCCCCCcHH---HHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0 00     0000000000   000011123678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-41  Score=298.89  Aligned_cols=252  Identities=20%  Similarity=0.256  Sum_probs=204.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      +.|...+.||+|.-|   +||.+..  ++...|+|++.+.... .....+...|-+||+.++||.++.+|+.++.+...|
T Consensus        77 ~~f~llk~LG~GdiG---~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIG---TVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             HHHHHHHHcCCCCce---eEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            456667789999999   9999999  5589999999876532 445567788999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|||||+||+|..+.+.+.+   ..+++..++.++.+++.||+|||   -.|||.|||||+||||-++|++-|+||.++.
T Consensus       154 l~meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EEEecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccc
Confidence            99999999999998887765   57899999999999999999999   9999999999999999999999999998864


Q ss_pred             ccCCC----------------------------------C---------------------CccccccccCCcccccccc
Q 018633          219 SIPEG----------------------------------E---------------------THITDTVMGTWGYCAPEYM  243 (353)
Q Consensus       219 ~~~~~----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~  243 (353)
                      .....                                  .                     ....+..+||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            33110                                  0                     0112346799999999999


Q ss_pred             ccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHH
Q 018633          244 RTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQ  323 (353)
Q Consensus       244 ~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  323 (353)
                      .+...+.++|.|+|||++|||+.|..||.......                     .+.+++..+...+.....+..+.+
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------------Tl~NIv~~~l~Fp~~~~vs~~akD  366 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------------TLRNIVGQPLKFPEEPEVSSAAKD  366 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------------hHHHHhcCCCcCCCCCcchhHHHH
Confidence            99999999999999999999999999998543322                     111222222111111155677899


Q ss_pred             HHHHchhcCCCCCCC----HHHHH
Q 018633          324 LSFECIKDSPADRPS----MVDVA  343 (353)
Q Consensus       324 li~~cl~~dP~~Rps----~~~vl  343 (353)
                      ||.+.|..||.+|.-    +.||-
T Consensus       367 LIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  367 LIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHHHHhccChhhhhccccchHHhh
Confidence            999999999999987    55553

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.2e-40  Score=294.69  Aligned_cols=258  Identities=21%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC---
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP---  135 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---  135 (353)
                      |...++||+|+||   .||+|.+     ++..||+|.+..........+++.+|+.++++++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g---~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFG---SVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCC---CEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            4567789999999   7777765     4689999999766545566778999999999999999999999886532   


Q ss_pred             ---ccEEEEEeccCCChhhhhccCC-CCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          136 ---IPILVFESVQYGTLWDRILGAP-QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       136 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                         ..++++||+++|+|.+++.... ......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+++
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEE
Confidence               2478999999999988775322 111135788899999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHH
Q 018633          212 FDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      +|||+++........ ......++..|++||.+....++.++||||||+++|+|++ |..||.....        .. ..
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~-~~  225 (273)
T cd05074         155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SE-IY  225 (273)
T ss_pred             CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HH-HH
Confidence            999998765432211 1123345678999999988889999999999999999999 7788753211        11 11


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ...........             +...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       226 ~~~~~~~~~~~-------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         226 NYLIKGNRLKQ-------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHcCCcCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111110000             013456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2e-40  Score=303.29  Aligned_cols=198  Identities=20%  Similarity=0.257  Sum_probs=159.9

Q ss_pred             CCceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--CCccEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--TPIPILV  140 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv  140 (353)
                      ...||+|+||   .||+|..    ++..||+|.+...    .....+.+|+.++++++||||+++++++..  +...++|
T Consensus         6 g~~lG~G~~g---~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYG---HVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCe---eEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            3579999999   9999986    4478999988654    223457889999999999999999999854  4568899


Q ss_pred             EEeccCCChhhhhccCCC----CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee----cCCCceEEe
Q 018633          141 FESVQYGTLWDRILGAPQ----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLF  212 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~  212 (353)
                      +||++ ++|.+++.....    .....+++..++.++.|++.||.|||   +++|+||||||+|||+    +.++.+||+
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence            99997 588777653211    11135788999999999999999999   9999999999999999    566789999


Q ss_pred             ccCCccccCCCCCc--cccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          213 DFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       213 dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                      |||+++........  ......||..|+|||++.+. .++.++|||||||++|||+||..||....
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            99999876433221  12345688999999998764 58899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-40  Score=295.71  Aligned_cols=254  Identities=16%  Similarity=0.226  Sum_probs=197.8

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC--------ChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC--------RPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      +|...+.||+|+||   .||+|..  +++.||+|.+.....        .....+.+.+|+.++++++||||+++++++.
T Consensus         2 ~~~~~~~lg~g~~~---~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   78 (272)
T cd06629           2 KWVKGELIGKGTYG---RVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET   78 (272)
T ss_pred             ceeecceecccCce---EEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec
Confidence            46778899999999   9999987  788999998753211        1112356888999999999999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                      ..+..++||||+++++|.+++...     ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.++++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~  150 (272)
T cd06629          79 TEEYLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKIS  150 (272)
T ss_pred             cCCceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEe
Confidence            999999999999999999998765     35788899999999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCCCCC-ccccccccCCccccccccccCC--CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          213 DFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       213 dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      |||++........ .......|+..|+|||.+....  ++.++|+||||+++|++++|..||......        ....
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~  222 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------AAMF  222 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--------HHHH
Confidence            9999876532211 1123456788999999987654  889999999999999999999998632211        1111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........ .....        ......+..+.+++.+||..+|+.|||+.++++
T Consensus       223 ~~~~~~~~-~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         223 KLGNKRSA-PPIPP--------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HhhccccC-CcCCc--------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11111000 00000        001134677889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-40  Score=301.39  Aligned_cols=247  Identities=16%  Similarity=0.248  Sum_probs=197.8

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |.....||+|+||   .||++..  ++..||+|.+...  .....+.+.+|+.++++++||||+++++.+...+..++||
T Consensus        24 ~~~~~~lg~g~~g---~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          24 LDSFIKIGEGSTG---IVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HhhhhcccCCCCe---EEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            4444669999999   9999887  7889999998655  4455677899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|.+++..      ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++....
T Consensus        99 e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658          99 EFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             eCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            99999999988754      34788899999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      .... ......|+..|+|||.+.+..++.++||||||+++|||++|..||......        ...... ..     ..
T Consensus       170 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~-~~-----~~  234 (292)
T cd06658         170 KEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAMRRI-RD-----NL  234 (292)
T ss_pred             cccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-Hh-----cC
Confidence            3221 223456889999999998888999999999999999999999998632211        111110 00     00


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ......      ....+..+.+++.+||..||++|||+.++++.
T Consensus       235 ~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 PPRVKD------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCcccc------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111000      01345567889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.4e-41  Score=299.33  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             CceeeCCCCCccEEEEEEeCC--------eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           68 NVIAKDTSYNLYTMYKGFWQE--------RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +.||+|+||   .||+|.+..        ..+|+|.+.... .......|.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~lg~g~~g---~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFG---EVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             Cccccccce---eEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            469999999   899888722        578999876542 23456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCC--CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-----ceEEe
Q 018633          140 VFESVQYGTLWDRILGAPQP--HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-----VAKLF  212 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-----~~kl~  212 (353)
                      ||||+++++|.+++......  ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++     .++++
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEEC
Confidence            99999999999998753211  1134788999999999999999999   99999999999999999877     89999


Q ss_pred             ccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHH
Q 018633          213 DFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       213 dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      |||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......        +... 
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~-  224 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQ-  224 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHH-
Confidence            99998765432211 1223345678999999998899999999999999999998 99888632211        1111 


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ........             ..+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus       225 ~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         225 HVTAGGRL-------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHhcCCcc-------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11110000             001145567889999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=317.73  Aligned_cols=249  Identities=18%  Similarity=0.250  Sum_probs=205.5

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      -|.+...||.|+||   .||++..  ++-..|.|++...  +....+.|+-|++||+.+.||+||++++.|...+.+||+
T Consensus        33 ~WeIiGELGDGAFG---KVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFG---KVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccch---hhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence            35566679999999   9999998  4555677888766  678889999999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      .|||.||-....+....    ..|.+.++.-+++|++.||.|||   +++|||||||+.|||+.-+|.++|+|||.+...
T Consensus       108 iEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             EeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccc
Confidence            99999999988887765    57899999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .. ......++.||++|||||+..     +.+|+.++||||||++|.||..+.+|........        .+.. ....
T Consensus       181 ~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--------VllK-iaKS  250 (1187)
T KOG0579|consen  181 KS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLK-IAKS  250 (1187)
T ss_pred             hh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--------HHHH-Hhhc
Confidence            22 222346789999999999864     4579999999999999999999999966322211        1111 1112


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+.++.           |..++..+.+++.+||..||..||++.++++
T Consensus       251 ePPTLlq-----------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  251 EPPTLLQ-----------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CCCcccC-----------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            2222222           2278889999999999999999999999875

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=301.58  Aligned_cols=270  Identities=20%  Similarity=0.283  Sum_probs=209.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhh--cCCCceeeccceeeeCC---
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAAR--MSHNHILKLIGCCLETP---  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~~---  135 (353)
                      ..+.....++|+|.||   .||+|+++++.||||++.     ....+.|.+|-+|.+-  +.|+||++|+++-....   
T Consensus       209 l~pl~l~eli~~Grfg---~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFG---CVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccc---eeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            3445556789999999   999999999999999994     4577889999888875  57999999999966544   


Q ss_pred             -ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC------CCCeEeeccCCCceeecCCCc
Q 018633          136 -IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF------PRPIVFRNFKTSCILFNEENV  208 (353)
Q Consensus       136 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~iiH~dlkp~Nill~~~~~  208 (353)
                       .++||+||.+.|||.++|..+      .++|....+++.-|++||+|||+..      ..+|+|||||++|||+.++++
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence             799999999999999999875      5899999999999999999999532      457999999999999999999


Q ss_pred             eEEeccCCccccCCCCCc-cccccccCCccccccccccCC-CC-----ccccchhhHHHHHHHHhCCCCCCc--------
Q 018633          209 AKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGV-FN-----EKSDVFSFGVFLFELLTGWDVSDL--------  273 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Di~slG~il~el~tg~~p~~~--------  273 (353)
                      +.|+|||+|..+..+... .....+||.+|||||++.+.. +.     .+.||||+|.+||||+++..-++.        
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            999999999888654322 233478999999999997643 22     468999999999999997654431        


Q ss_pred             cccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          274 VKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .........|..+.++...-..+....+...+...       .....+.+.+..||..||+.|.|+.-|.+++.++..
T Consensus       435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            11222223344444444443332222222222222       445678899999999999999999999999988754

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-40  Score=292.12  Aligned_cols=248  Identities=18%  Similarity=0.280  Sum_probs=200.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC---CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE---CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      +|...+.||+|++|   .||+|..  ++..|++|.+....   ......+.+.+|+.+++.++||||+++++++..++..
T Consensus         1 ~~~~~~~ig~g~~~---~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFG---SVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL   77 (258)
T ss_pred             CccccceeeecCCc---eEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeE
Confidence            36777899999999   9999998  68899999886542   1234567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++|+||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++
T Consensus        78 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             EEEEEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence            9999999999999998754     35788899999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .......  ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||.....        ............
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~  219 (258)
T cd06632         150 KQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKE  219 (258)
T ss_pred             eeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhccc
Confidence            7654332  234456888999999987766 89999999999999999999999864321        111111111011


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+             +......+.+++.+||+.+|++|||+.+++.
T Consensus       220 ~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 LPPI-------------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCCc-------------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1110             1134566788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.4e-40  Score=293.35  Aligned_cols=255  Identities=18%  Similarity=0.229  Sum_probs=204.3

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--CCccE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--TPIPI  138 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~  138 (353)
                      +|+..+.||+|+||   .||++.+  ++..+|+|.+..........+.+.+|+.++++++||||+++++++..  ....+
T Consensus         1 ~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFG---TVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCe---EEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            47778899999999   9999887  77899999987655556667889999999999999999999998764  45678


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC--CCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF--PRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      ++|||+++++|.+++...... ...+++..++.++.|++.||.|||..+  +.+++|+||+|+||+++.++.++|+|||+
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence            999999999999998654211 146889999999999999999999443  57899999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      +......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....         ...........
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~  226 (265)
T cd08217         157 AKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---------LQLASKIKEGK  226 (265)
T ss_pred             cccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---------HHHHHHHhcCC
Confidence            8876443321 2345688999999999888899999999999999999999999874321         11111111111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...             .+...+..+.+++.+||+.+|++|||+.+|++
T Consensus       227 ~~~-------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         227 FRR-------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CCC-------------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            111             11145677889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-40  Score=295.44  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=199.4

Q ss_pred             CCCCceeeCCCCCccEEEEEEeCC------eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFWQE------RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      +..+.||.|+||   .||++.+..      ..||+|.+.... .......+.+|+.++..++|+||+++++++.+.+..+
T Consensus         2 ~~~~~lg~g~~g---~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        2 TLGKKLGEGAFG---EVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             cccceeccCCCc---ceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            456789999999   999998833      889999996652 2225678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      ++|||+++++|.+++.....   ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCce
Confidence            99999999999999876532   12899999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ..............++..|+|||.+.+..++.++||||||+++++|++ |..||.....        ....... .....
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~-~~~~~  222 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYL-KKGYR  222 (258)
T ss_pred             ecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-hcCCC
Confidence            765442222222336788999999988889999999999999999998 7777763211        1111111 11111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      ...             +...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       223 ~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 LPK-------------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCC-------------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            100             013456788999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-40  Score=296.50  Aligned_cols=250  Identities=17%  Similarity=0.189  Sum_probs=196.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC---ChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC---RPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      .+|...+.||+|+||   .||.|.+  ++..||+|.+.....   .....+.+.+|+.++++++||||+++++++.+.  
T Consensus         2 ~~~~~~~~l~~g~~g---~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFG---RVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME   78 (265)
T ss_pred             CcceEeeEEecCCce---EEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence            468889999999999   9999987  688999998854321   233456789999999999999999999988753  


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ..+++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+||
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Df  150 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDF  150 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcC
Confidence            4678999999999999988754     34788889999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          215 SLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       215 g~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |++.........  ......|+..|+|||++.+..++.++||||||+++|+|++|..||......        .......
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~  222 (265)
T cd06652         151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIA  222 (265)
T ss_pred             ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--------HHHHHHh
Confidence            998765322111  122346888999999998888999999999999999999999998632111        0111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....             .+..+......+.+++.+|| .+|++|||++++++
T Consensus       223 ~~~~-------------~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~  260 (265)
T cd06652         223 TQPT-------------NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR  260 (265)
T ss_pred             cCCC-------------CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence            0000             00111245567788999999 49999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.7e-41  Score=300.68  Aligned_cols=252  Identities=20%  Similarity=0.240  Sum_probs=194.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHH-HhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTY-AARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|+..+.||+|+||   .||++.+  ++..||+|.+....... ....+..|+.+ ++.++||||+++++++..++..|
T Consensus         1 ~~~~~~~~ig~g~~g---~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYG---VVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCe---EEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            468888999999999   9999998  68999999987653222 33455666665 56678999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC-CeEeeccCCCceeecCCCceEEeccCCc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      +||||++ |+|.+++....... ..+++..++.++.|++.||.|||   ++ +++||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            9999997 78888876532211 46899999999999999999999   76 9999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCcccccccccc----CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      .......  ......|+..|+|||.+.+    ..++.++|+||||+++|+|++|..||......       .+.......
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~  222 (283)
T cd06617         152 GYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVE  222 (283)
T ss_pred             ccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHh
Confidence            7653221  1233467889999998865    34688999999999999999999998632111       011111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .. ....            .....+..+.+++.+||..+|++|||+.++++
T Consensus       223 ~~-~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 EP-SPQL------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cC-CCCC------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10 0000            01135667889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-40  Score=296.78  Aligned_cols=253  Identities=18%  Similarity=0.280  Sum_probs=200.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC----hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR----PRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      +|+..+.||+|++|   .||++..  ++..||+|.+......    ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~lg~g~~~---~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFS---SCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH   77 (268)
T ss_pred             CccccceecCcCce---EEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence            47888999999999   9999887  7899999998644211    2245788999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ceEEeccC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFS  215 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~dfg  215 (353)
                      .++|+||+++++|.+++...     .++++..++.++.|++.||.|||   +++++|+||+|+||+++.++ .++|+|||
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence            99999999999999998754     35788999999999999999999   99999999999999998776 58999999


Q ss_pred             CccccCCCCCc---cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          216 LSISIPEGETH---ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       216 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      .+.........   ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.......     .........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~  224 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-----HLALIFKIA  224 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-----hHHHHHHHh
Confidence            98766432111   1223467889999999988889999999999999999999999986322111     001111100


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...             .....+...+..+.+++.+||..+|++|||+.++++
T Consensus       225 ~~~-------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SAT-------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ccC-------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            000             001111245677889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.2e-40  Score=293.36  Aligned_cols=257  Identities=20%  Similarity=0.326  Sum_probs=204.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|+..+.||.|+||   .||+|..  ++..+++|++....... ....+.+|+..++.++|+||+++++.+..++..++
T Consensus         1 ~~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATA---VVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCe---EEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            468889999999999   9999987  77899999987553233 56789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+|++++++|.+++......  ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++..
T Consensus        77 v~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~  151 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPR--GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSAS  151 (267)
T ss_pred             EEeccCCCcHHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence            99999999999998754211  35789999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCCCCc---cccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          220 IPEGETH---ITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       220 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .......   ......|+..|+|||++... .++.++|+||||+++|+|++|..||.......        ........ 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~-  222 (267)
T cd06610         152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQN-  222 (267)
T ss_pred             hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcC-
Confidence            6543322   12344688899999998776 68999999999999999999999986332211        11111111 


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..     +......   .....+..+.+++.+||..||++|||+.++++
T Consensus       223 ~~-----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 DP-----PSLETGA---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CC-----CCcCCcc---ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00     0000000   01145677889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.9e-41  Score=297.82  Aligned_cols=250  Identities=23%  Similarity=0.283  Sum_probs=201.8

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|...+.||+|+||   .||++.+  ++..+|+|.+..........+.+.+|+.++++++|+||+++++.+..++..++|
T Consensus         1 ~~~~~~~l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFG---KIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcc---eEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            47778899999999   9999998  678999999876543445567788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ceEEeccCCccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSIS  219 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~dfg~a~~  219 (353)
                      +||+++++|.+++.....   ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++ .++|+|||.+..
T Consensus        78 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          78 MEYCDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             EecCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence            999999999999876432   35789999999999999999999   99999999999999999885 469999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ...... ......|+..|+|||++....++.++|+||||+++|++++|..||....        ..+....... ..+..
T Consensus       152 ~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~  221 (257)
T cd08225         152 LNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQ-GYFAP  221 (257)
T ss_pred             ccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhc-ccCCC
Confidence            643222 2234468889999999988889999999999999999999999986322        1112211111 11111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .             ....+..+.+++.+||..+|++|||+.++++
T Consensus       222 ~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 I-------------SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             C-------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0             0134457889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.6e-40  Score=292.22  Aligned_cols=252  Identities=20%  Similarity=0.313  Sum_probs=201.9

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|...+.||+|+||   .||+|..  ++..|++|.+..........+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~G~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFG---KVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCc---EEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            37778899999999   9999987  788999999877654445778899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        78 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          78 MEYCSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             EecCCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence            9999999999998764     34788889999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCCccc---cccccCCccccccccccCC---CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          221 PEGETHIT---DTVMGTWGYCAPEYMRTGV---FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       221 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ........   ....++..|+|||++.+..   ++.++||||||+++|++++|..||.......       ..... ...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-------~~~~~-~~~  221 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-------QIMFH-VGA  221 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-------HHHHH-Hhc
Confidence            44332211   1346788999999998766   8899999999999999999999986432110       00000 000


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....     +    +.  ....+..+.+++.+||+.+|++|||+.+++.
T Consensus       222 ~~~~~-----~----~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 GHKPP-----I----PD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCC-----C----Cc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000     0    00  0023566789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=300.79  Aligned_cols=267  Identities=18%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|++|   .||+|..  +++.||+|.+.... .......+.+|+.++++++||||+++++++.+++..++
T Consensus         5 ~~y~~~~~lg~g~~~---~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           5 ETYKKLDKLGEGSYA---TVYKGRSKLTGQLVALKEIRLEH-EEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             cceeEEEEEeecCCe---EEEEEEEcCCCcEEEEEEEeccc-ccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            568888999999999   9999988  68899999986542 12223457789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++ ++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||+++.
T Consensus        81 v~e~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          81 VFEYLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             EEecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence            999998 59999887654    35788999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCcccccc--------CCCCChHHHHHH
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH--------DLACPSNEYLKN  290 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~  290 (353)
                      ...... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.......        ....+....+..
T Consensus       153 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07844         153 KSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG  231 (291)
T ss_pred             cCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence            432211 1122346788999999875 458899999999999999999999986433110        000000000000


Q ss_pred             HhhcCcccc-----cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDNRFTE-----IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .........     .....+......   ......+.+++.+||+.+|++|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPR---LDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcC---CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000000000     000000000000   011256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-40  Score=300.02  Aligned_cols=250  Identities=19%  Similarity=0.257  Sum_probs=202.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++..  ++..||+|.+...  .....+.+.+|+.++++++||||+++++++...+..|
T Consensus        18 ~~~~~~~~~lg~g~~g---~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASG---TVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCe---EEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            3678889999999999   9999986  7789999998654  3344577899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|+||+++++|.+++...      .+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++.
T Consensus        93 lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             EEEecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence            999999999999988653      4678889999999999999999   9999999999999999999999999999887


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... ......|+..|+|||.+....++.++|+||||+++|++++|..||..........        ....... .
T Consensus       164 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--------~~~~~~~-~  233 (293)
T cd06647         164 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNGT-P  233 (293)
T ss_pred             ccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--------ehhcCCC-C
Confidence            6543322 2234568889999999988889999999999999999999999997433211000        0000000 0


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .         .  ..+...+..+.+++.+||..+|++||++.+++..
T Consensus       234 ~---------~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 E---------L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             C---------C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0         0  0111345678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-40  Score=299.20  Aligned_cols=271  Identities=20%  Similarity=0.268  Sum_probs=200.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|+..+.||+|+||   .||++.+  +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++
T Consensus         1 ~~y~~~~~lg~g~~~---~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYG---MVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCe---EEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            368888999999999   9999998  68899999986654344456678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+||+++++|..+....     ..+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++..
T Consensus        78 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~  149 (286)
T cd07846          78 VFEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFART  149 (286)
T ss_pred             EEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence            99999988887766543     34789999999999999999999   89999999999999999999999999999877


Q ss_pred             cCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCC------CChHHHHHHHh
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA------CPSNEYLKNYF  292 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~  292 (353)
                      ...... ......++..|+|||++.+. .++.++||||||+++|+|++|..||..........      ..........+
T Consensus       150 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         150 LAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             ccCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            543322 22345678899999998753 47889999999999999999998886332111000      00000000000


Q ss_pred             hcCcc-cccccchhhhcc-chHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRF-TEIVDPIIVEDV-LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... .....+...... .....+..+..+.+++.+||+.+|++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000 000000000000 00001134677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-41  Score=310.00  Aligned_cols=252  Identities=18%  Similarity=0.249  Sum_probs=201.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~l  139 (353)
                      ..|+..+.||+||.+   .||++.. +.+.+|+|++....-.......|.+|+..|.+|+ |.+||++++|-..++.+|+
T Consensus       361 ~~Yeilk~iG~GGSS---kV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  361 REYEILKQIGSGGSS---KVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             chhhHHHhhcCCCcc---eeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            468888999999999   9999998 6788888888666556778889999999999997 9999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||-+ .+|..+|.....    .++.-.++.+..||+.++.++|   .+||||.||||.|.|+- .|.+||+|||.|..
T Consensus       438 vmE~Gd-~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  438 VMECGD-IDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             Eeeccc-ccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            999875 799999987653    3343378889999999999999   99999999999999876 57899999999998


Q ss_pred             cCCCCCc-cccccccCCccccccccccCC-----------CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          220 IPEGETH-ITDTVMGTWGYCAPEYMRTGV-----------FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       220 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      +..+.+. .....+||+.||+||.+....           .+.+|||||+|||||+|+.|+.||.......         
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~---------  579 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI---------  579 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH---------
Confidence            8765543 346679999999999985432           5678999999999999999999987332111         


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                             .++..+.++...-.++...   ...++.+++..||..||.+|||..++++
T Consensus       580 -------aKl~aI~~P~~~Iefp~~~---~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 -------AKLHAITDPNHEIEFPDIP---ENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -------HHHHhhcCCCccccccCCC---CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                   1233334432211111111   1122889999999999999999999885

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-41  Score=298.79  Aligned_cols=255  Identities=22%  Similarity=0.258  Sum_probs=200.2

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~  135 (353)
                      +.+++|...+.||+|++|   .||+|.+  +++.+++|.+...   ....+.+.+|+.+++++ .||||+++++++....
T Consensus         3 ~~~~~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           3 DPTGIFELVEVIGEGTYG---KVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             CchhheeheeeecCCCCe---EEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            467889999999999999   9999998  6788999998765   23456789999999999 6999999999997654


Q ss_pred             ------ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          136 ------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       136 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                            ..++||||+++++|.+++....... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~  152 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEV  152 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeE
Confidence                  4899999999999999886532111 46889999999999999999999   9999999999999999999999


Q ss_pred             EEeccCCccccCCCCCccccccccCCcccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                      +|+|||.+....... .......|+..|+|||++..     ..++.++||||||+++|+|++|..||.......      
T Consensus       153 ~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------  225 (275)
T cd06608         153 KLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------  225 (275)
T ss_pred             EECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------
Confidence            999999987653322 22344568889999998753     236788999999999999999999986322111      


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                        ....... .....+           ..+...+..+.+++.+||..||++|||+.++++
T Consensus       226 --~~~~~~~-~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         226 --ALFKIPR-NPPPTL-----------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --HHHHhhc-cCCCCC-----------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              1111110 000000           011135677889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8e-41  Score=304.52  Aligned_cols=255  Identities=17%  Similarity=0.176  Sum_probs=199.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++..  .++.|++|.+..... .......+.+|+.+++.++||||+++++.+..++..+
T Consensus         1 ~~y~~~~~l~~g~~~---~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   77 (305)
T cd05609           1 EDFETIKLISNGAYG---AVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLC   77 (305)
T ss_pred             CCceEeeEeecCCCe---eEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEE
Confidence            468888999999999   9999988  678999999875532 1334567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++...     ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.++|+|||+++
T Consensus        78 lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          78 MVMEYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             EEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            999999999999998664     35788999999999999999999   9999999999999999999999999999886


Q ss_pred             ccCCCCC--------------ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          219 SIPEGET--------------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       219 ~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                      .......              .......++..|+|||.+....++.++|+||||+++||+++|..||.....        
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------  221 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------  221 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence            4211100              011224578889999999888899999999999999999999999863211        


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      .+....... ....   .+.        .....+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       222 ~~~~~~~~~-~~~~---~~~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         222 EELFGQVIS-DDIE---WPE--------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHHHHHh-cccC---CCC--------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            111111111 0000   000        00134566789999999999999999766665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-40  Score=301.39  Aligned_cols=246  Identities=17%  Similarity=0.244  Sum_probs=196.9

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |.....||+|+||   .||++..  +++.||+|.+...  .....+.+.+|+.++..++||||+++++++..++..++|+
T Consensus        23 ~~~~~~ig~g~~g---~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTG---IVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCce---eEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            3334579999999   9999987  7899999998654  3344567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|.+++..      ..+++..++.++.|++.||.|||   +++++||||+|+||+++.++.++|+|||++....
T Consensus        98 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659          98 EFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             ecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            99999999887754      34788999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      .... ......|+..|+|||++.+..++.++||||||+++|||++|..||......        ...... ........ 
T Consensus       169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~-~~~~~~~~-  237 (297)
T cd06659         169 KDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRL-RDSPPPKL-  237 (297)
T ss_pred             cccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-hccCCCCc-
Confidence            3221 223456889999999998888999999999999999999999998632211        111111 11000000 


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                          .      .....+..+.+++.+||+.+|++|||+.++++
T Consensus       238 ----~------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         238 ----K------NAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             ----c------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                0      00133456789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=304.59  Aligned_cols=252  Identities=18%  Similarity=0.238  Sum_probs=200.8

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +|...+.||+|++|   .||++..  ++..+|+|.+...... ....+.+.+|+.++..++||||+++++.+.++...|+
T Consensus         2 ~y~~~~~ig~g~~g---~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           2 HFKKIKLLGKGDVG---RVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             ceEEeeeecCCccE---EEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            57888999999999   9999988  5899999999765322 2356678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+.+++|.+++.....   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++..
T Consensus        79 v~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            9999999999999875432   46889999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCCCc----------------------------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCC
Q 018633          220 IPEGETH----------------------------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       220 ~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~  271 (353)
                      .......                            ..+...||..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4322110                            112346788999999998888999999999999999999999998


Q ss_pred             CccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC----HHHHHH
Q 018633          272 DLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS----MVDVAK  344 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~vl~  344 (353)
                      .......        ....... ...            ........+..+.+++.+||..+|++|||    +.+++.
T Consensus       233 ~~~~~~~--------~~~~~~~-~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         233 KGSNRDE--------TFSNILK-KEV------------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCchHH--------HHHHHhc-CCc------------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            6432211        1111110 000            00000025677899999999999999999    666554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.2e-41  Score=321.26  Aligned_cols=271  Identities=14%  Similarity=0.218  Sum_probs=194.5

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC------Cceee
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSH------NHILK  126 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~  126 (353)
                      +++...+++|...+.||+|+||   .||++.+  +++.||||++...   ......+..|+.++..++|      .++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg---~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFG---KVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCE---EEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            3444556789999999999999   9999988  7889999998653   2334456677777777765      45888


Q ss_pred             ccceeeeC-CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeec
Q 018633          127 LIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFN  204 (353)
Q Consensus       127 ~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~  204 (353)
                      +++++... .+.|+|||++ +++|.+++...     ..+++..+..|+.||+.||.|||   + .+||||||||+|||++
T Consensus       196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~  266 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILME  266 (467)
T ss_pred             eEEEEEcCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEe
Confidence            98888754 5789999998 68898888754     36889999999999999999999   7 5999999999999998


Q ss_pred             CCC----------------ceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCC
Q 018633          205 EEN----------------VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW  268 (353)
Q Consensus       205 ~~~----------------~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~  268 (353)
                      .++                .+||+|||.+.....    ......||..|+|||++.+..++.++|||||||++|||++|+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~  342 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK  342 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence            765                499999998754321    233567999999999999999999999999999999999999


Q ss_pred             CCCCccccccC-------CCCChHHHHH--------HHhhc-Ccccccccchhhhc---cchHHHHHHHHHHHHHHHHch
Q 018633          269 DVSDLVKDTHD-------LACPSNEYLK--------NYFED-NRFTEIVDPIIVED---VLSIEKEQQLHASAQLSFECI  329 (353)
Q Consensus       269 ~p~~~~~~~~~-------~~~~~~~~~~--------~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl  329 (353)
                      .||........       .......|..        .++.. ..+....++.....   ............+.+||.+||
T Consensus       343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  422 (467)
T PTZ00284        343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL  422 (467)
T ss_pred             CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence            99975432110       0001111110        00000 00000000000000   000000012355789999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 018633          330 KDSPADRPSMVDVAK  344 (353)
Q Consensus       330 ~~dP~~Rps~~~vl~  344 (353)
                      .+||++|||+.++++
T Consensus       423 ~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        423 HYDRQKRLNARQMTT  437 (467)
T ss_pred             CcChhhCCCHHHHhc
Confidence            999999999999986

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-40  Score=301.18  Aligned_cols=247  Identities=21%  Similarity=0.297  Sum_probs=197.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ..|...+.||+|+||   .||+|..  +++.||+|++.... ........+.+|+.+++.++||||++++++|.+.+..+
T Consensus        15 ~~y~~~~~lg~g~~g---~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          15 KLFTDLREIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             hhhhhheeecCCCCe---EEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            348888899999999   9999988  78999999886432 23445567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|+||++ |+|.+.+....    ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        92 lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          92 LVMEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcce
Confidence            9999997 68877775433    45889999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....     ....++..|+|||++.   ...++.++||||||+++|||+||..||.......        ...... ..
T Consensus       164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~~~~-~~  229 (307)
T cd06607         164 LVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIA-QN  229 (307)
T ss_pred             ecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHHHHh-cC
Confidence            54322     2346788899999874   3568899999999999999999999986332111        000000 00


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..            +......++..+.+++.+||+.+|++|||+.+++..
T Consensus       230 ~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         230 DS------------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CC------------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00            000111456678999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-40  Score=295.06  Aligned_cols=261  Identities=20%  Similarity=0.219  Sum_probs=200.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--Ccc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PIP  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~  137 (353)
                      ++|...+.||.|++|   .||++.+  +++.+|+|.+.... .......+.+|++++++++||||++++++|...  +.+
T Consensus         1 ~~~~~~~~lg~g~~~---~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGG---SVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCce---EEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            467788899999999   9999998  78899999987543 234567799999999999999999999998653  468


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++..... ....++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence            999999999999887653221 1145788899999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      .......   .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......   ....+. .........
T Consensus       153 ~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~-~~~~~~~~~  225 (287)
T cd06621         153 GELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIEL-LSYIVNMPN  225 (287)
T ss_pred             ccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHH-HHHHhcCCc
Confidence            6543222   123457788999999988889999999999999999999999987543211   011111 111111111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+.+.     ...  ....+..+.+++.+||..+|++|||+.++++
T Consensus       226 ~~~~~~-----~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 PELKDE-----PGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhhccC-----CCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            111000     000  0134567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=296.29  Aligned_cols=247  Identities=19%  Similarity=0.330  Sum_probs=198.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC---CCceeeccceeeeCCcc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS---HNHILKLIGCCLETPIP  137 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~  137 (353)
                      .|+..+.||+|+||   .||+|.+  ++..||+|.+.... .......+.+|+.++++++   |||++++++++..++..
T Consensus         2 ~y~~~~~l~~g~~g---~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYG---AVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCc---eEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            47778899999999   9999998  78899999986542 3345567889999999997   99999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++...      .+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++
T Consensus        78 ~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVA  148 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCce
Confidence            9999999999999988642      5789999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ........ ......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.......        ... ......
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~-~~~~~~  218 (277)
T cd06917         149 ALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMM-LIPKSK  218 (277)
T ss_pred             eecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hhh-ccccCC
Confidence            77654332 23345688899999988654 47899999999999999999999986432211        000 000000


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+     .+...       ..+..+.+++.+||+.||++||++.+++.
T Consensus       219 ~~-----~~~~~-------~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         219 PP-----RLEDN-------GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CC-----CCCcc-------cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            00     00000       24567889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-40  Score=294.04  Aligned_cols=252  Identities=19%  Similarity=0.256  Sum_probs=206.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|++|   .||++..  +++.|++|++..... ......+.+|+..+.+++||||+++++++...+..++
T Consensus         1 ~~~~~~~~i~~g~~~---~v~~~~~~~~~~~~~vk~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06623           1 SDLERVKVLGQGSSG---VVYKVRHKPTGKIYALKKIHVDGD-EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI   76 (264)
T ss_pred             CcceeeeeeeecCCe---EEEEEEEcCCCcEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence            368888999999999   9999988  589999999876632 2556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      |+||+++++|.+++...     ..++...++.++.|++.||.|||   + .+++|+||+|+||+++.++.++|+|||.+.
T Consensus        77 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~  148 (264)
T cd06623          77 VLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISK  148 (264)
T ss_pred             EEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccce
Confidence            99999999999999765     35889999999999999999999   8 999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......     ...+...... .... 
T Consensus       149 ~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~-~~~~-  220 (264)
T cd06623         149 VLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAIC-DGPP-  220 (264)
T ss_pred             ecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHh-cCCC-
Confidence            76433321 23456788999999998888999999999999999999999998754320     1111111111 1100 


Q ss_pred             ccccchhhhccchHHHHH-HHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQ-QLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                                 ... +.. .+..+.+++.+||..+|++|||+.++++.
T Consensus       221 -----------~~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 -----------PSL-PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -----------CCC-CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                       000 112 56788999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-41  Score=310.08  Aligned_cols=252  Identities=21%  Similarity=0.236  Sum_probs=218.4

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ..-.++|.....||+|.|+   .|..+.+  ++..||+|.+.+........+.+.+|+.+|..++|||||+++.+.....
T Consensus        52 ~~~vg~y~i~~tig~g~f~---~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFA---KVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccceeeeeeeccceeE---EEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            3556789999999999999   9999998  8999999999888777777778999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      .+|+||||+.+|.+.+++..+.     .+.+..+..++.|+.+|++|||   ++.|+|||||++|||++.+.++||+|||
T Consensus       129 ~lylV~eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfg  200 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFG  200 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccc
Confidence            9999999999999999998874     4566888899999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ++..+....  ...+.+|++.|.|||++.+..|. +.+|+||+|+++|-|+.|..||+.                     
T Consensus       201 fS~~~~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG---------------------  257 (596)
T KOG0586|consen  201 FSTFFDYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG---------------------  257 (596)
T ss_pred             cceeecccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC---------------------
Confidence            999886433  36788999999999999988765 789999999999999999999983                     


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..+.++-++.+.+.+.-+.  -.+.++.+++.++|-.+|..|++++++.+.
T Consensus       258 ~~lk~Lr~rvl~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  258 QNLKELRPRVLRGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             cccccccchheeeeecccc--eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            3333444444444433222  455677789999999999999999998763

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.4e-40  Score=297.54  Aligned_cols=272  Identities=18%  Similarity=0.218  Sum_probs=197.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ++++|...+.||+|+||   .||+|..  ++..||+|.+.... .......+.+|+.+++.++|+||+++++++..++..
T Consensus         3 ~~~~y~~~~~ig~g~~~---~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   78 (291)
T cd07870           3 AATSYLNLEKLGEGSYA---TVYKGISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL   78 (291)
T ss_pred             ccceeEEEEEEEecCCE---EEEEEEEcCCCcEEEEEEecccC-cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence            45679999999999999   9999987  78899999986542 223334678899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+|+||++ ++|.+.+....    ..+++..+..++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  150 (291)
T cd07870          79 TFVFEYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLA  150 (291)
T ss_pred             EEEEeccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccc
Confidence            99999996 78877775443    34678888899999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC--------CCCChHHHH
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD--------LACPSNEYL  288 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~--------~~~~~~~~~  288 (353)
                      +....... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||........        ...+.....
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  229 (291)
T cd07870         151 RAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW  229 (291)
T ss_pred             cccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence            76433221 12334578899999998754 478899999999999999999999874332110        000000000


Q ss_pred             HHHhhcCcccccccchh-hhccchH-HHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPII-VEDVLSI-EKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ................. ....... ........+.+++.+|+..||.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000000000 0000000 00012456789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-40  Score=299.74  Aligned_cols=244  Identities=17%  Similarity=0.250  Sum_probs=198.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|++|   .||++.+  +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus         1 ~~y~~~~~ig~g~~~---~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (290)
T cd05580           1 DDFEFIKTLGTGSFG---RVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLY   77 (290)
T ss_pred             CceEEEEEeecCCCe---EEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEE
Confidence            368888999999999   9999988  689999999865421 2344577899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++...     ..++...+..++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++.
T Consensus        78 ~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          78 LVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             EEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            999999999999998765     36889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .....    .....|+..|+|||.+.+...+.++||||||+++|+|++|..||.....        ........ .... 
T Consensus       150 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~-  215 (290)
T cd05580         150 RVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKIL-EGKV-  215 (290)
T ss_pred             ccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCCc-
Confidence            76433    2345688999999999888889999999999999999999999863221        11111111 1110 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVA  343 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl  343 (353)
                      .             .+...+..+.+++.+||..+|.+||     ++.+++
T Consensus       216 ~-------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         216 R-------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             c-------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            0             0013356678999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.5e-40  Score=297.34  Aligned_cols=267  Identities=19%  Similarity=0.189  Sum_probs=199.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC---hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR---PRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      +|+..+.||+|++|   .||+|.+  +++.||+|.+......   ......+..|+.++++++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~g~~~---~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYA---VVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNI   77 (298)
T ss_pred             Cceeeeeeeecccc---EEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEE
Confidence            36777889999999   9999998  6889999999765322   33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+ +|+|.+++....    ..+++..++.++.||+.||.|||   +++++|+||+|+||+++.++.++|+|||++
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             EEEEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceee
Confidence            9999999 899999987643    26889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHHH
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYLK  289 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~  289 (353)
                      ........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.........       ..+...++.
T Consensus       150 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         150 RSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            77644322 1233456788999998854 45789999999999999999997776533221100       000000000


Q ss_pred             HHhhcCcccccccchhhhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..   ................ .......+..+.+++.+||+.+|++|||+.+++.
T Consensus       229 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         229 GV---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hc---ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00   0000000000000000 0001134677899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-39  Score=291.46  Aligned_cols=246  Identities=20%  Similarity=0.306  Sum_probs=199.5

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |...+.||+|+||   .||+|.+  ++..||+|.+.... .......+.+|+.++.+++||||+++++++..++..++||
T Consensus         6 ~~~~~~ig~G~~~---~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           6 FTKLEKIGKGSFG---EVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             hhhheeEeecCCe---EEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            6777889999999   9999987  67899999876442 2345567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|.+++..      ..+++..+..++.|++.|+.|||   +++++|+||+|+||+++.++.++++|||++....
T Consensus        82 e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          82 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            99999999988864      34789999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......        ..... ........  
T Consensus       153 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~-~~~~~~~~--  220 (277)
T cd06641         153 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFL-IPKNNPPT--  220 (277)
T ss_pred             cchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHH-HhcCCCCC--
Confidence            3221 233456788999999998888899999999999999999999998632111        11111 11111100  


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                                 .+...+..+.+++.+||+.+|+.||++.++++.
T Consensus       221 -----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 -----------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -----------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                       011345667899999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-41  Score=313.66  Aligned_cols=244  Identities=20%  Similarity=0.282  Sum_probs=196.1

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEe--cCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc--cEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQF--YGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI--PILV  140 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~--~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~--~~lv  140 (353)
                      ..+||+|+|-   +||+|.+  +|..||--.+  .....++...++|..|+++|+.|+|||||++|+++.+...  ..+|
T Consensus        45 ~evLGrGafK---tVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   45 DEVLGRGAFK---TVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             hhhcccccce---eeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            4579999999   9999999  6666764322  2222356777999999999999999999999999987654  6789


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEEeccCCccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSIS  219 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~dfg~a~~  219 (353)
                      +|.+..|+|..+.++..     .+....+..|++||++||.|||+. ..+|||||||.+||+|+.+ |.+||+|+|+|+.
T Consensus       122 TEL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            99999999999998874     578889999999999999999976 7799999999999999865 8999999999988


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      .....   .....||+.|||||++. ..|+..+||||||+.++||+|+.+||.-...       ..+..+....+ ..+.
T Consensus       196 ~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SG-iKP~  263 (632)
T KOG0584|consen  196 LRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSG-IKPA  263 (632)
T ss_pred             hhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcC-CCHH
Confidence            75432   33579999999999997 7899999999999999999999999874322       22222332221 1111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+.+            -...++.++|.+||.. .++|||+.|+++
T Consensus       264 sl~k------------V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  264 ALSK------------VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             Hhhc------------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1111            1234678999999999 899999999986

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.7e-40  Score=297.61  Aligned_cols=268  Identities=19%  Similarity=0.243  Sum_probs=200.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--Ccc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PIP  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~  137 (353)
                      ++|+..+.||+|+||   .||+|.+  +++.+|+|.+............+.+|+.++.+++||||+++++++...  +..
T Consensus         5 ~~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYG---VVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCe---EEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            568888999999999   9999998  688999999975533333445678899999999999999999998877  889


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+||||++ ++|.+++....    ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~  153 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLA  153 (293)
T ss_pred             EEEehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCce
Confidence            99999997 59998887643    35899999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHH
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLK  289 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~  289 (353)
                      ........ ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........       ...+....+.
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         154 REYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            77644321 123345788899999987544 68899999999999999999999874322110       0001111111


Q ss_pred             HHhhc-----CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFED-----NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+..-     ..+.......+....+..   ..+..+.+++.+||+.+|++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPAL---SLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             Hhhccchhcccccccccchhhhcccccc---CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000     000000000011111100   13567889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-39  Score=294.34  Aligned_cols=247  Identities=17%  Similarity=0.232  Sum_probs=198.6

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      .|...+.||+|++|   .||++..  +++.+++|++...  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        20 ~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTG---IVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCe---EEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            35556799999999   9999987  7789999988654  344556789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+++++|.+++..      ..+++..+..++.|++.||+|||   +++++||||+|+||+++.++.++|+|||.+...
T Consensus        95 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          95 MEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             EeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            999999999998875      24788899999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.....        ......... ......
T Consensus       166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~-~~~~~~  235 (285)
T cd06648         166 SKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRD-NLPPKL  235 (285)
T ss_pred             ccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHh-cCCCCC
Confidence            33221 22345688999999999888899999999999999999999999863211        111111111 100000


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..           ....+..+.+++.+||+.+|++|||+.++++
T Consensus       236 ~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 KN-----------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cc-----------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            00           0124567899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=295.62  Aligned_cols=269  Identities=17%  Similarity=0.203  Sum_probs=198.5

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |+..+.||.|++|   .||+|.+  ++..||+|++............+.+|+.+++.++|||++++++++.+.+..++||
T Consensus         1 y~~~~~l~~g~~~---~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYG---VVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCe---EEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            5667889999999   9999987  7899999998765333444567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||++ ++|.+++.....   ..+++..++.++.|++.||.|||   +++++||||+|+||+++.++.++|+|||++....
T Consensus        78 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          78 EFLD-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             eccC-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            9995 799998876532   35889999999999999999999   8999999999999999999999999999987653


Q ss_pred             CCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHHhh
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNYFE  293 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~  293 (353)
                      .... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||........       ...+....+.....
T Consensus       151 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         151 VPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             CCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            3221 12233567889999988664 478899999999999999999999864322110       00000000000000


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+........... ........+..+.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         230 LPDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             chhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000000000 00011134467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.1e-40  Score=300.94  Aligned_cols=262  Identities=19%  Similarity=0.236  Sum_probs=194.1

Q ss_pred             eeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccCCCh
Q 018633           70 IAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTL  149 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL  149 (353)
                      +|.|+++   .|+++..+++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..+++|||+++|+|
T Consensus        10 ~~~~~~v---~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          10 FEDLMIV---HLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             hcCCceE---EEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3444544   5666666899999999976644566778899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCC----
Q 018633          150 WDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET----  225 (353)
Q Consensus       150 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~----  225 (353)
                      .+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++++|||.+........    
T Consensus        87 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          87 EDLLKTHFP---EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999876432   35788899999999999999999   99999999999999999999999999998865532211    


Q ss_pred             --ccccccccCCccccccccccC--CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH----HHhhcCc-
Q 018633          226 --HITDTVMGTWGYCAPEYMRTG--VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK----NYFEDNR-  296 (353)
Q Consensus       226 --~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~-  296 (353)
                        .......++..|+|||++...  .++.++|+|||||++|||++|..||.........    .+...    ....... 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML----LEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccCccccccCch
Confidence              112334567789999998763  4889999999999999999999999753321100    00000    0000000 


Q ss_pred             ------ccc----cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 ------FTE----IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ------~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                            ...    ..+...............+..+.+++.+||..||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                  000    001111111111122355678899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.3e-40  Score=298.42  Aligned_cols=270  Identities=19%  Similarity=0.202  Sum_probs=199.7

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-  135 (353)
                      ...++|+..+.||+|+||   .||+|.+  +++.||+|.+............+.+|+.++++++||||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~~lg~g~~g---~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYG---QVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhheeeeecccCCE---EEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            456789999999999999   9999998  6889999998765333444567788999999999999999999987654 


Q ss_pred             ---------ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC
Q 018633          136 ---------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE  206 (353)
Q Consensus       136 ---------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  206 (353)
                               ..++|+||+++ +|.+.+....    ..+++..++.++.|++.||.|||   +.+|+|+||+|+||+++++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~  152 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNK  152 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence                     78999999984 7777776542    46889999999999999999999   9999999999999999999


Q ss_pred             CceEEeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChH
Q 018633          207 NVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~  285 (353)
                      +.+||+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......     ..
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-----~~  227 (302)
T cd07864         153 GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-----QL  227 (302)
T ss_pred             CcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-----HH
Confidence            999999999987764433222223356778999998865 347889999999999999999999987433211     00


Q ss_pred             HHHHHHhhcC---cccccc--------cchhh-hccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EYLKNYFEDN---RFTEIV--------DPIIV-EDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~~~~~~~~~---~~~~~~--------~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+.......   .++.+.        +.... ...........+..+.+++.+||+.+|++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0001100000   000000        00000 00000000123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-40  Score=294.17  Aligned_cols=248  Identities=19%  Similarity=0.230  Sum_probs=201.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +|...+.||+|+||   .||++.+  ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.++...++
T Consensus         1 ~y~~~~~i~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFG---KVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL   77 (258)
T ss_pred             CceEEEEeccCCCc---eEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence            47778899999999   9999988  589999999975432 23556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+||+++++|.+++...     .++++..+..++.|++.||.|||   +++++|+||+|+||++++++.++|+|||.+..
T Consensus        78 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          78 VVDLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             EEeCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            99999999999998764     35789999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      .....  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......      ..........  .  
T Consensus       150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~--~--  217 (258)
T cd05578         150 VTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET--A--  217 (258)
T ss_pred             cCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc--c--
Confidence            64332  2334567889999999988889999999999999999999999987433210      1111111110  0  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH--HHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM--VDVA  343 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~~vl  343 (353)
                                ....+...+..+.+++.+||+.||.+||++  .+++
T Consensus       218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                      000111345778899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-39  Score=302.24  Aligned_cols=270  Identities=17%  Similarity=0.232  Sum_probs=201.3

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      ...+.|...+.||+|+||   .||++..  +++.||+|.+............+.+|+.++++++||||+++++++...  
T Consensus        13 ~~~~~y~~~~~lg~g~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQG---IVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS   89 (353)
T ss_pred             hhhcceEEEEEeccCCCE---EEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence            345779999999999999   9999988  789999999875443455567788999999999999999999988643  


Q ss_pred             ----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          135 ----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       135 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                          ...|+||||+. ++|.+.+..       .++...+..++.|++.||.|||   +++++||||||+||+++.++.++
T Consensus        90 ~~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          90 LEEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             ccccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence                35799999996 688887753       2678888999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCC
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACP  283 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~  283 (353)
                      |+|||++.......  ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......       ....+
T Consensus       159 L~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         159 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             EccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999997654322  1234467889999999998889999999999999999999999986433211       00111


Q ss_pred             hHHHHHH-------HhhcC------cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          284 SNEYLKN-------YFEDN------RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       284 ~~~~~~~-------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..++...       .....      .+....................+..+.+++.+||+.||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111110       00000      0001111111000000001134567889999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1e-39  Score=298.84  Aligned_cols=247  Identities=21%  Similarity=0.307  Sum_probs=196.9

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .|...+.||+|+||   .||++.+  ++..||+|++.... ........+.+|+.++++++|||++++++++.+++..++
T Consensus        26 ~f~~~~~lg~G~~~---~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          26 LFTDLREIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhheeccCCCe---EEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            37778899999999   9999987  78899999986432 234455678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++ |+|.+.+....    .++++..+..++.|++.||.|||   +++++||||+|+||+++.++.++|+|||++..
T Consensus       103 v~e~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         103 VMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             EEeCCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence            999997 68888776443    46889999999999999999999   99999999999999999999999999998865


Q ss_pred             cCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ...     .....|+..|+|||++.   ...++.++||||||+++|+|++|..||.....        ............
T Consensus       175 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~  241 (317)
T cd06635         175 ASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNES  241 (317)
T ss_pred             cCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhccC
Confidence            432     22446788999999974   45688999999999999999999999863211        111111111110


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                                   ........+..+.+++.+||+.+|.+|||+.++++.+
T Consensus       242 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         242 -------------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -------------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                         0000114456788999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-39  Score=294.19  Aligned_cols=267  Identities=16%  Similarity=0.150  Sum_probs=197.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCc--
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPI--  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~--  136 (353)
                      ++|+..+.||+|+||   .||+|.+  +++.||+|++............+.+|+.++++++ ||||+++++++...+.  
T Consensus         1 ~~y~~~~~lg~g~~g---~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYG---KVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCe---EEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            468889999999999   9999998  7899999988655333334567889999999996 6999999999887665  


Q ss_pred             ---cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-CCceEEe
Q 018633          137 ---PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLF  212 (353)
Q Consensus       137 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~  212 (353)
                         .|+||||++ ++|.+++..........+++..++.++.||+.||.|||   +++++||||+|+||+++. ++.++|+
T Consensus        78 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          78 KPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             CceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEe
Confidence               799999998 58988876543221146899999999999999999999   999999999999999998 8899999


Q ss_pred             ccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      |||++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......        .....
T Consensus       154 dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~  224 (295)
T cd07837         154 DLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--------QLLHI  224 (295)
T ss_pred             ecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHH
Confidence            9999876533211 1223356788999998865 457899999999999999999999987432211        11111


Q ss_pred             hhc---C---ccccc---ccch----hhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FED---N---RFTEI---VDPI----IVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~---~---~~~~~---~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +..   .   .+...   .+..    ..........+..+..+.+++.+||..||++|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            100   0   00000   0000    0000000011135677899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-39  Score=291.69  Aligned_cols=265  Identities=22%  Similarity=0.265  Sum_probs=194.4

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeC--CccE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLET--PIPI  138 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~~~~  138 (353)
                      |...+.||+|+||   .||++..  ++..||+|++........ .....+|+.++.++. ||||+++++++.+.  +..+
T Consensus         1 y~~~~~lg~g~~~---~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFS---EVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccc---eEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            4567789999999   9999988  789999999875432222 234467899999986 99999999999887  8899


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||++ ++|.+.+....    ..+++..++.++.|++.||.|||   +++++||||+|+||+++. +.++|+|||++.
T Consensus        77 lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          77 LVFELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEEecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccc
Confidence            9999997 68888886543    46899999999999999999999   999999999999999999 999999999987


Q ss_pred             ccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCChHHHHHH
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACPSNEYLKN  290 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~~~~~  290 (353)
                      .......  .....++..|+|||++.. ..++.++|||||||++|||++|..||.......       ....+...+ ..
T Consensus       148 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  224 (282)
T cd07831         148 GIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LK  224 (282)
T ss_pred             ccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HH
Confidence            6643222  223457889999997654 457889999999999999999999996433211       001111111 11


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+..........+..............+..+.+++.+||+.+|++|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            111111000000000000000111245788999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-39  Score=291.81  Aligned_cols=270  Identities=16%  Similarity=0.216  Sum_probs=200.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..+.||.|++|   .||+|.+  ++..||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYA---TVYKGRNRTTGEIVALKEIHLDA-EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCce---EEEEEEECCCCeEEEEEEecccc-cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            47888999999999   9999998  78999999987553 223346678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||++ ++|.+++......  ..+++..+..++.|++.||.|||   +++++||||+|+||++++++.++|+|||++...
T Consensus        77 ~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          77 FEYMD-KDLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             EecCC-ccHHHHHHhcCCC--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            99998 5888888654321  35899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHHh
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNYF  292 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~  292 (353)
                      ..... ......++..|+|||++.+. .++.++||||||+++|+|++|..||........       ...+....+....
T Consensus       151 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         151 GIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             cCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            33221 12334568889999998654 478899999999999999999999874332110       0001111111110


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....+............ .......+..+.+++.+||+.||.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         230 QLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000000000000 0011134677889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=296.38  Aligned_cols=274  Identities=18%  Similarity=0.249  Sum_probs=198.4

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe----CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--Cc
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW----QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PI  136 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~  136 (353)
                      |...+.||+|++|   .||+|.+    .+..||+|.+.... ......+.+.+|+.++.+++||||+++++++.+.  ..
T Consensus         2 y~~~~~ig~g~~g---~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           2 YEIEGCIGRGTYG---RVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             ceEEEEeccCCcE---EEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            6777889999999   9999998    46899999997642 1233456778899999999999999999999987  78


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC----CCceEEe
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE----ENVAKLF  212 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kl~  212 (353)
                      .++||||++ ++|.+++..........++...++.++.|++.||.|||   +++++||||||+||+++.    ++.+||+
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence            999999997 57777765433222136889999999999999999999   999999999999999999    8999999


Q ss_pred             ccCCccccCCCCC--ccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh-HHHH
Q 018633          213 DFSLSISIPEGET--HITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS-NEYL  288 (353)
Q Consensus       213 dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~  288 (353)
                      |||++........  .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+. ....
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999876543221  112345678899999988764 47899999999999999999999997544332111110 0000


Q ss_pred             HHHhh---------------cCcccccccchhhh-----ccchHHHH--HHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFE---------------DNRFTEIVDPIIVE-----DVLSIEKE--QQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~---------------~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+.               ...+....+.....     ........  .....+.+++.+||++||++|||+.++++
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000               00000000000000     00000011  23457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-40  Score=319.45  Aligned_cols=274  Identities=15%  Similarity=0.161  Sum_probs=189.3

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEe--------------c-CCCCChhHHHHHHHHHHHHhhcC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQF--------------Y-GHECRPRAYESCINNVTYAARMS  120 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~--------------~-~~~~~~~~~~~~~~E~~~l~~l~  120 (353)
                      ...++|...+.||+|+||   .||++..   .+..+++|.+              . ...........+.+|+.+|.+++
T Consensus       145 ~~~~~Y~ii~~LG~G~fG---~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~  221 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFG---KIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN  221 (501)
T ss_pred             hhhhccEEEeEecCCCCc---ceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence            345789999999999999   8887765   2222222211              0 00012334567889999999999


Q ss_pred             CCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCc
Q 018633          121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC  200 (353)
Q Consensus       121 H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  200 (353)
                      |||||++++++...+..|+|+|++. ++|.+++...............+..++.||+.||.|||   +++|+||||||+|
T Consensus       222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~N  297 (501)
T PHA03210        222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLEN  297 (501)
T ss_pred             CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence            9999999999999999999999996 67877775432111122345667889999999999999   9999999999999


Q ss_pred             eeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC
Q 018633          201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL  280 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~  280 (353)
                      ||++.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++.......  
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~--  375 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK--  375 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC--
Confidence            999999999999999998765443333345679999999999999899999999999999999999876433211110  


Q ss_pred             CCChHHHHHHHhh-----cCcccc-------cccchhh----hccchH-HHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          281 ACPSNEYLKNYFE-----DNRFTE-------IVDPIIV----EDVLSI-EKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       281 ~~~~~~~~~~~~~-----~~~~~~-------~~~~~~~----~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                         ..........     ...++.       .++....    ...+.. .....+..+.+++.+||++||.+|||+.|++
T Consensus       376 ---~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL  452 (501)
T PHA03210        376 ---PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL  452 (501)
T ss_pred             ---HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence               0000000000     000000       0000000    000000 0002234577889999999999999999998


Q ss_pred             H
Q 018633          344 K  344 (353)
Q Consensus       344 ~  344 (353)
                      .
T Consensus       453 ~  453 (501)
T PHA03210        453 A  453 (501)
T ss_pred             h
Confidence            6

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=293.86  Aligned_cols=252  Identities=19%  Similarity=0.263  Sum_probs=204.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ..+++|+..+.||+|++|   .||++.+  .+..+++|++....  . ..+.+.+|+..++.++|+||+++++++...+.
T Consensus        16 ~~~~~~~~~~~l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~--~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          16 DPRELYKNLEKIGEGASG---EVYKATDRATGKEVAIKKMRLRK--Q-NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             CccccchHhHhccCCCCe---EEEEEEEccCCcEEEEEEEecCc--h-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            345678888999999999   9999998  58899999997652  2 56778999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++|+||+++++|.+++....    ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccch
Confidence            999999999999999998753    36889999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      +........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......        ....... ..
T Consensus       163 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--------~~~~~~~-~~  232 (286)
T cd06614         163 AAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--------ALFLITT-KG  232 (286)
T ss_pred             hhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh-cC
Confidence            765533221 2234457889999999988889999999999999999999999986322111        1111000 00


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....           ......+..+.+++.+||+.+|..|||+.+++.
T Consensus       233 ~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         233 IPPL-----------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCC-----------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0000           001135567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=337.88  Aligned_cols=254  Identities=18%  Similarity=0.243  Sum_probs=209.4

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ..+-+|.....||.|.||   .||.+.+  +|...|+|-+............+.+|..++..+.|||+|++||+-.+++.
T Consensus      1232 nV~~rWqrg~~Ig~G~fG---~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFG---KVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             cceeeeccccccCCccee---eeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence            445678888999999999   9999998  89999999987776566667788999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .+|.||||++|+|.+++...     ...++.....+..|++.|+.|||   .+|||||||||.||+++.+|.+|++|||.
T Consensus      1309 v~IFMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccc
Confidence            99999999999999998765     34566677778999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCC---ccccccccCCccccccccccCC---CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          217 SISIPEGET---HITDTVMGTWGYCAPEYMRTGV---FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       217 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      |..+.....   ...+...||+.|||||++.+..   -..+.||||+||++.||+||+.||.......            
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~------------ 1448 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW------------ 1448 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh------------
Confidence            987754421   1235678999999999997644   4568999999999999999999987433211            


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                              .++-....+..+.. |...+.+-.+++..||..||..|.++.++++
T Consensus      1449 --------aIMy~V~~gh~Pq~-P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1449 --------AIMYHVAAGHKPQI-PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             --------HHHhHHhccCCCCC-chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                    12222222222222 2257777889999999999999999988775

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.3e-40  Score=297.84  Aligned_cols=257  Identities=19%  Similarity=0.210  Sum_probs=194.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~l  139 (353)
                      +|.....||+|+||   .||++.+  ++..||+|.+.... .......+.+|+.++.++. ||||+++++++..++..++
T Consensus         5 ~~~~~~~lg~G~~g---~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           5 DLKDLGEIGRGAFG---TVNKMLHKPSGTIMAVKRIRSTV-DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HhHHHHHhCCCCce---EEEEEEECCCCCEEEEEEehhcc-ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            35556789999999   9999988  78999999987543 2345667899999999997 9999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      +|||++ ++|.++...........+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.++|+|||++..
T Consensus        81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            999986 566554321100001468899999999999999999992  25999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccC---CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTG---VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ......  .....|+..|+|||++...   .++.++||||||+++|+|++|..||.....       ..+....... ..
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~-~~  227 (288)
T cd06616         158 LVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVK-GD  227 (288)
T ss_pred             hccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcC-CC
Confidence            543221  2334678899999998766   588999999999999999999999863221       0011111110 00


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .     +.+....    ....+..+.+|+.+||+.+|++|||+.+|++.
T Consensus       228 ~-----~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 P-----PILSNSE----EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             C-----CcCCCcC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0     0111110    01456778999999999999999999998863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4e-39  Score=283.96  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |+..+.||+|++|   .||++.+  ++..+++|++....  ......+.+|+..+++++||||+++++++..+...++++
T Consensus         2 y~~~~~l~~g~~~---~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           2 FEILEKIGKGGFG---EVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             ceeeeeeccCCce---EEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            6778899999999   9999998  58899999997762  346678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||+++++|.+++....    ..+++..+..++.|++.||.|||   .++++|+||+|+||+++.++.++|+|||.+....
T Consensus        77 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          77 EFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             ecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence            9999999999987653    36899999999999999999999   9999999999999999999999999999987765


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      ....  .....++..|+|||.+....++.++|+||||+++|+|++|..||......        ...... .........
T Consensus       150 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~-~~~~~~~~~  218 (253)
T cd05122         150 DTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------KALFKI-ATNGPPGLR  218 (253)
T ss_pred             cccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------HHHHHH-HhcCCCCcC
Confidence            4332  34556888999999998888999999999999999999999998633211        111110 001111110


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .           ....+..+.+++.+||+.||++|||+.++++
T Consensus       219 ~-----------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 N-----------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             c-----------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0           0023567889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.4e-39  Score=286.71  Aligned_cols=250  Identities=18%  Similarity=0.278  Sum_probs=204.3

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..+.||+|+||   .||++..  ++..+|+|.+............+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~~~~~i~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYG---SVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCce---eEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            47778899999999   9999887  788999999876554556667889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+++++|.+++....... ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            99999999999886532111 45788999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ...   ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......        . .........+..+
T Consensus       154 ~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~-~~~~~~~~~~~~~  221 (256)
T cd08530         154 KKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------D-LRYKVQRGKYPPI  221 (256)
T ss_pred             ccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------H-HHHHHhcCCCCCC
Confidence            443   223456788999999998888999999999999999999999998633211        1 1111111111111


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                   +...+..+.+++.+||+.+|++|||+.++++
T Consensus       222 -------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         222 -------------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -------------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                         1145667899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=292.60  Aligned_cols=265  Identities=18%  Similarity=0.196  Sum_probs=198.9

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--CccEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PIPIL  139 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~l  139 (353)
                      |...+.||+|++|   .||+|.+  ++..+|+|++............+.+|+.++++++|||++++++++...  +..++
T Consensus         1 y~~~~~l~~g~~~---~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYG---QVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCe---EEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            4567789999999   9999998  579999999976643344556788999999999999999999999887  78999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+||++ ++|.+++....    ..+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++..
T Consensus        78 v~e~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~  149 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARP  149 (287)
T ss_pred             Eecccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceee
Confidence            999997 58988886543    36889999999999999999999   89999999999999999999999999999877


Q ss_pred             cCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc---C
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED---N  295 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  295 (353)
                      .............++..|+|||.+.+ ..++.++||||||+++|||++|..||........     ..........   .
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-----~~~~~~~~~~~~~~  224 (287)
T cd07840         150 YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-----LEKIFELCGSPTDE  224 (287)
T ss_pred             ccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCchh
Confidence            65433222233456788999998765 4578999999999999999999999864332110     0000000000   0


Q ss_pred             ccccccc----------chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVD----------PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .++...+          ..............++..+.+++.+||+.+|.+|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000000          000000000011112678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-39  Score=297.18  Aligned_cols=271  Identities=18%  Similarity=0.228  Sum_probs=197.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--Cc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PI  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~  136 (353)
                      .++|...+.||+|+||   .||+|.+  ++..||+|.+............+.+|+.++++++|+||+++++++...  +.
T Consensus         6 ~~~y~~~~~ig~g~~~---~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYG---IVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCE---EEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            4679999999999999   9999998  689999999865532333344567899999999999999999998755  46


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+. ++|.+++....    ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||.
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~  154 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGL  154 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccce
Confidence            899999997 58888887543    46889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHH
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYL  288 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~  288 (353)
                      +........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........       ...+....+
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         155 ARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            877643321 1223345778999999865 4578999999999999999999999864322110       000000000


Q ss_pred             HHHhhcCcc-cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRF-TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .. +..... ....-+..............+..+.+++.+||++||++|||+.+++.
T Consensus       234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         234 PG-FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hh-hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00 000000 00000000000000000123567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-39  Score=290.03  Aligned_cols=243  Identities=21%  Similarity=0.254  Sum_probs=195.2

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ||.|++|   .||++..  ++..+|+|.+..... .....+.+.+|+.+++.++||||+++++++.+++..++|+||+++
T Consensus         1 lg~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFG---RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCce---EEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence            6899999   9999999  489999999875432 234557799999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      ++|.+++...     ..++...+..++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 ~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          78 GELWTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             CcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            9999999764     35788999999999999999999   9999999999999999999999999999987764432  


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIV  306 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (353)
                      ......++..|+|||.+....++.++|+||||+++|+|++|..||......      ..............         
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~---------  212 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKGNGK---------  212 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhccCCC---------
Confidence            223456788999999998888999999999999999999999998743320      11111111100000         


Q ss_pred             hccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          307 EDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       307 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                      ..    .+...+..+.+++.+||..+|++||+     +.++++
T Consensus       213 ~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LE----FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CC----CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            00    01123567899999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.1e-39  Score=295.12  Aligned_cols=268  Identities=19%  Similarity=0.207  Sum_probs=193.6

Q ss_pred             CceeeC--CCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKD--TSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G--~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ..||+|  +||   .||.+.+  +++.||+|.+..........+.+.+|+.+++.++||||++++++|..++..++|+||
T Consensus         4 ~~ig~g~~~~~---~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLT---SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCce---eEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            356776  777   9999988  899999999876544555667899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++++|.+++.....   ..+++..+..++.|++.||+|||   +++++||||||+||+++.++.++++||+.+......
T Consensus        81 ~~~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          81 MAYGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ccCCCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence            999999998876532   35788999999999999999999   999999999999999999999999999754332111


Q ss_pred             CCc------cccccccCCccccccccccC--CCCccccchhhHHHHHHHHhCCCCCCccccccCC--------CCChH--
Q 018633          224 ETH------ITDTVMGTWGYCAPEYMRTG--VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL--------ACPSN--  285 (353)
Q Consensus       224 ~~~------~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~--------~~~~~--  285 (353)
                      ...      ......++..|+|||++.+.  .++.++|||||||++|+|++|..||.........        ..+..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            100      01122345679999998764  4789999999999999999999998643211100        00000  


Q ss_pred             ---HHHHHH------hhcCccccccc-----chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 ---EYLKNY------FEDNRFTEIVD-----PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ---~~~~~~------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                         ......      +..........     ...............+..+.+|+.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               000000      00000000000     000001111222356778999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=290.32  Aligned_cols=269  Identities=19%  Similarity=0.205  Sum_probs=202.0

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |...+.||+|++|   .||++..  ++..+++|.+............+.+|+.++++++||||+++++++..++..++|+
T Consensus         1 y~~~~~i~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYG---VVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCc---eEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            4567789999999   9999988  7889999998766444455678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||++ ++|.+++....    ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          78 EFMD-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             eccC-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            9997 58888887643    46889999999999999999999   9999999999999999999999999999987765


Q ss_pred             CCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHHhh
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNYFE  293 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~  293 (353)
                      ... .......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||........       ...+....+.....
T Consensus       150 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         150 SPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             CCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            433 112334577889999998776 688999999999999999999999864332110       00000000000000


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........-+..............+..+.+++.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000000000000000001112256788999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-39  Score=287.87  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=206.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|...+.||+|++|   .||++.+  ++..+++|++............+.+|+++++.++|||++++++.+...+..++|
T Consensus         1 ~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFG---KVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCe---EEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            47778899999999   9999998  589999999987654556778899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+++++|.+++....... ..+++..+..++.+++.||.|||   +++++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             EEecCCCcHHHHHHHhhccC-CCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence            99999999999987643111 46899999999999999999999   899999999999999999999999999998776


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      .... .......|+..|+|||.+....++.++|+||+|+++++|++|..||.....        .+...... ......+
T Consensus       154 ~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~~~  223 (258)
T cd08215         154 SSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKIL-KGQYPPI  223 (258)
T ss_pred             ccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHh-cCCCCCC
Confidence            4432 223445788899999999888899999999999999999999999863221        11111111 1111110


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                   +...+..+.+++.+||..+|++|||+.++++
T Consensus       224 -------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 -------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                         0134567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.2e-39  Score=282.79  Aligned_cols=251  Identities=21%  Similarity=0.270  Sum_probs=205.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--CccE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PIPI  138 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~  138 (353)
                      +|...+.||+|++|   .||+|..  ++..|++|++..........+.+.+|+.++++++||||+++++.+...  +..+
T Consensus         1 ~~~~~~~i~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFG---SVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCce---EEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            47778899999999   9999998  589999999876644456678899999999999999999999999988  8899


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|+||+++++|.+++...     ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus        78 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~  149 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAK  149 (260)
T ss_pred             EEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEE
Confidence            999999999999998765     36889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ........ ......++..|+|||.+....++.++||||||+++++|++|..||......       .............
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~  222 (260)
T cd06606         150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-------MAALYKIGSSGEP  222 (260)
T ss_pred             ecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHhccccCCC
Confidence            76543321 123456788999999998888999999999999999999999998744311       1111111100011


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..             .+...+..+.+++.+||..+|++|||+.+++.
T Consensus       223 ~~-------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 PE-------------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cC-------------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            00             11134677889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=312.37  Aligned_cols=252  Identities=21%  Similarity=0.356  Sum_probs=208.5

Q ss_pred             CCCceeeCCCCCccEEEEEEe--CC----eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           66 QKNVIAKDTSYNLYTMYKGFW--QE----RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        66 ~~~~lg~G~~g~~~~v~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ...+||+|+||   +||+|.|  .+    -+||+|++.... ..+...++++|+-+|.+++|||+++++|+|.... +.|
T Consensus       700 k~kvLGsgAfG---tV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  700 KDKVLGSGAFG---TVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhceeccccce---eEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            35689999999   9999999  43    368888886553 5666788999999999999999999999998765 889


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |++|+|.|+|.++++.+.    .++.....+.|+.|||+||.|||   .++++||||..+|||+.+...+|+.|||+++.
T Consensus       775 vtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            999999999999999876    57889999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCCccc-cccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          220 IPEGETHIT-DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       220 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ...+..... ....-.+.|||-|.+....|+.++|||||||++||++| |..|++.....+         +..+++.+. 
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------I~dlle~ge-  917 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------IPDLLEKGE-  917 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------hhHHHhccc-
Confidence            865543321 22233568999999999999999999999999999999 888987432211         222222211 


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                                 . ...|+.++-.+..++.+||..|++.||+++++...+.++.+
T Consensus       918 -----------R-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  918 -----------R-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             -----------c-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                       1 11223778889999999999999999999999999887764

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.8e-39  Score=291.19  Aligned_cols=264  Identities=18%  Similarity=0.203  Sum_probs=196.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|++|   .||+|.+  +++.||+|.+..........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYG---VVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCE---EEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            468888999999999   9999988  68899999986553333445678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-CCceEEeccCCcc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSI  218 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~dfg~a~  218 (353)
                      ||||++ ++|.+++.....   ..+++..+..++.||+.||.|||   +++++|+||+|+||+++. ++.+||+|||++.
T Consensus        79 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         79 VFEYLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             EEeccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccccccc
Confidence            999996 688888765432   23578888899999999999999   999999999999999985 5578999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc--C
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED--N  295 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  295 (353)
                      ....... ......++..|+|||++.+. .++.++||||||+++|+|+||..||.......        .....+..  .
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--------~~~~~~~~~~~  222 (294)
T PLN00009        152 AFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--------ELFKIFRILGT  222 (294)
T ss_pred             ccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhCC
Confidence            6533211 12334568899999988664 57899999999999999999999986432211        01111000  0


Q ss_pred             ----------ccccccc--chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 ----------RFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ----------~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                .......  +...........+..+..+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      0000000  000000000001134566889999999999999999999886

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-39  Score=298.18  Aligned_cols=273  Identities=16%  Similarity=0.210  Sum_probs=198.6

Q ss_pred             ecHHHHHHHh----hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCcee
Q 018633           52 FSAQEIKLAT----NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL  125 (353)
Q Consensus        52 ~~~~e~~~~~----~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv  125 (353)
                      |+.+|+.+++    ++|...+.||+|+||   .||+|.+  ++..||+|++............+.+|+.++++++||||+
T Consensus         1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g---~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv   77 (342)
T cd07879           1 FYREEVNKTVWELPERYTSLKQVGSGAYG---SVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVI   77 (342)
T ss_pred             CchhhhhhhhhccccceEEEEEeeecCCe---EEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCcc
Confidence            3455666554    789999999999999   9999987  789999999876433344456788999999999999999


Q ss_pred             eccceeeeCC------ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          126 KLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       126 ~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      ++++++....      ..++|+||+. .+|.+.+.       ..+++..+..++.|++.||.|||   +++++||||||+
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~  146 (342)
T cd07879          78 GLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPG  146 (342)
T ss_pred             chhheecccccCCCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHH
Confidence            9999987543      3589999996 57766542       24788999999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCcccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH  278 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~  278 (353)
                      ||+++.++.++|+|||+++.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus       147 NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~  222 (342)
T cd07879         147 NLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD  222 (342)
T ss_pred             HEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999998764321    223467888999999876 458899999999999999999999997432111


Q ss_pred             C-------CCCChHHHHHHHhhcCcccccc---cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          279 D-------LACPSNEYLKNYFEDNRFTEIV---DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       279 ~-------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .       ...+...+.... .........   .......... ..+..+..+.+++.+||+.||++|||+.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         223 QLTQILKVTGVPGPEFVQKL-EDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHHHhcCCCCHHHHHHh-cccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0       000000000000 000000000   0000000000 00123456889999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-39  Score=295.84  Aligned_cols=269  Identities=16%  Similarity=0.205  Sum_probs=195.7

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc-
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI-  136 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-  136 (353)
                      ..++|...+.||+|+||   .||++..  +++.||+|.+............+.+|+.++++++||||+++++++...+. 
T Consensus        10 ~~~~y~~~~~lg~g~~~---~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865          10 EVSKYEKLAKIGQGTFG---EVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             hhhheEEEEEeecCCCE---EEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            34568899999999999   9999998  78999999986543233334566789999999999999999999876543 


Q ss_pred             -------cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          137 -------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       137 -------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                             .++||||+. ++|.+.+....    ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          87 YNRYKGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGIL  158 (310)
T ss_pred             ccCCCceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcE
Confidence                   499999997 68888776543    35889999999999999999999   9999999999999999999999


Q ss_pred             EEeccCCccccCCCCCc---cccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChH
Q 018633          210 KLFDFSLSISIPEGETH---ITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~  285 (353)
                      +|+|||++.........   ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.......     ..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-----~~  233 (310)
T cd07865         159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-----QL  233 (310)
T ss_pred             EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HH
Confidence            99999998765432211   123345778899999886644 7889999999999999999999986433211     00


Q ss_pred             HHHHHHhh---cCcccc-----cccchh-hhccchHHH-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EYLKNYFE---DNRFTE-----IVDPII-VEDVLSIEK-----EQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~~~~~~~---~~~~~~-----~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........   ...++.     ..+... .........     ......+.+++.+||..||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000000   000000     000000 000000000     012345679999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.9e-39  Score=297.17  Aligned_cols=271  Identities=17%  Similarity=0.232  Sum_probs=200.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee----C
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE----T  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~  134 (353)
                      .++|+..+.||+|++|   .||++..  ++..||+|++............+.+|+.++++++||||+++++++..    .
T Consensus         4 ~~~y~~~~~lg~g~~g---~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYG---VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhceeeeeeeecCCCe---EEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            4679999999999999   9999987  78999999987654344556778899999999999999999998763    3


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ...++||||+. ++|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~df  151 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDF  151 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccc
Confidence            46799999996 6898888654     35899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCc---cccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCC
Q 018633          215 SLSISIPEGETH---ITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACP  283 (353)
Q Consensus       215 g~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~  283 (353)
                      |++.........   ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........       ...+
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~  231 (334)
T cd07855         152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP  231 (334)
T ss_pred             ccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence            998765432211   1123468889999999865 4588999999999999999999999964332110       0001


Q ss_pred             hHHHHHHHhhcCcccccccchh-hhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPII-VEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ......... ........+..- ..... .......+..+.+++.+||+.+|++|||+.+++.
T Consensus       232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         232 SEEVLNRIG-SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhHhhhhhc-hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000000000 000000000000 00000 0001134678899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=298.25  Aligned_cols=271  Identities=18%  Similarity=0.225  Sum_probs=197.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC---
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET---  134 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~---  134 (353)
                      .+++|...+.||+|+||   .||+|.+  ++..||+|++.... .......+.+|+.++++++||||+++++++...   
T Consensus         3 ~~~~y~i~~~lg~G~~g---~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           3 VGPRYQNLSYIGEGAYG---MVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE   78 (336)
T ss_pred             cccceEEEEEEEecCCe---EEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence            35689999999999999   9999987  78999999986432 234556788999999999999999999987644   


Q ss_pred             --CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          135 --PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       135 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                        ...++|+||++ ++|.+.+..      ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++|+
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~  148 (336)
T cd07849          79 SFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKIC  148 (336)
T ss_pred             ccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEC
Confidence              35799999997 688877754      35889999999999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCCCCCc--cccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCC
Q 018633          213 DFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LAC  282 (353)
Q Consensus       213 dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~  282 (353)
                      |||++.........  ......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||........       ...
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~  228 (336)
T cd07849         149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT  228 (336)
T ss_pred             cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99998765332211  1123567889999998754 4588999999999999999999999864321110       000


Q ss_pred             ChHHHHHHHhhcCcccccccch-hhhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPI-IVEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      +..+.+..... .......... .....+ .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       229 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         229 PSQEDLNCIIS-LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCHHHHHHhhc-hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000000 0000000000 000000 00011345678899999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=305.58  Aligned_cols=274  Identities=20%  Similarity=0.259  Sum_probs=207.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-----
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-----  135 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----  135 (353)
                      .|...+.||+||||   .||+|.+  +|+.||||.+.... .....+.+.+|+++|++++|||||+++++-.+..     
T Consensus        14 ~W~~~e~LG~Ga~g---~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   14 LWEMDERLGKGAFG---NVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             ceeehhhhcCCccc---eeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            46677889999999   9999998  89999999997653 5667788999999999999999999999866543     


Q ss_pred             -ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec--CCC--ceE
Q 018633          136 -IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN--EEN--VAK  210 (353)
Q Consensus       136 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~--~~~--~~k  210 (353)
                       ...+|||||.+|||...|.+..+.  ..|++...+.++.+++.||.|||   .++|+||||||.||++-  .+|  ..|
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEe
Confidence             578999999999999999876543  47999999999999999999999   99999999999999983  323  569


Q ss_pred             EeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      |+|||.|+.++++.  ...+.+||..|++||++.. ..|+..+|.|||||++|+++||..||-......+.    .+..+
T Consensus       165 LtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~----~~~~~  238 (732)
T KOG4250|consen  165 LTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN----KEIMW  238 (732)
T ss_pred             eecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc----chhhh
Confidence            99999999986554  4677899999999999984 78999999999999999999999999744332210    11111


Q ss_pred             HHhhcCccccc--cc-----chhh-hcc--chHHHHHHHHHHHHHHHHchhcCCCCCC--CHHHHHHHHHHHHH
Q 018633          290 NYFEDNRFTEI--VD-----PIIV-EDV--LSIEKEQQLHASAQLSFECIKDSPADRP--SMVDVAKKLRQIYR  351 (353)
Q Consensus       290 ~~~~~~~~~~~--~~-----~~~~-~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rp--s~~~vl~~L~~l~~  351 (353)
                      .......-..+  .+     +.-. ...  +..........+-.++..+|..+|.+|.  .+.+....+..++.
T Consensus       239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            11111000000  00     0000 000  1111113344556677788999999998  77777777766653

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=278.62  Aligned_cols=245  Identities=20%  Similarity=0.265  Sum_probs=195.5

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEEEEEec
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      ..||.|+.|   .|++...  ++...|||.+.... +.....+++..++++.+-. +|.||+.+|+|..+...++.||.|
T Consensus        98 ~dlGsGtcG---~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   98 GDLGSGTCG---QVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             HhhcCCCcc---ceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            348999999   9999999  67999999987653 5566677888888887766 899999999999999999999998


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      . ..+..+++...    .++++..+-++...++.||.||-.  .++|+|||+||+|||+|+.|++|++|||.+-.+.++.
T Consensus       174 s-~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  174 S-TCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             H-HHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            5 56666666554    578888888999999999999996  8899999999999999999999999999987664433


Q ss_pred             CccccccccCCcccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          225 THITDTVMGTWGYCAPEYMRT---GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       225 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                        ......|.+.|||||.+.-   ..|+.++||||||++++||.||+.||.......       +.+.....+ ..    
T Consensus       247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-------e~ltkvln~-eP----  312 (391)
T KOG0983|consen  247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-------EVLTKVLNE-EP----  312 (391)
T ss_pred             --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-------HHHHHHHhc-CC----
Confidence              2445578899999999864   358899999999999999999999998644332       111111111 00    


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       +.+.+.      ...+..+.+++..||..|+.+||...++++
T Consensus       313 -P~L~~~------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  313 -PLLPGH------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -CCCCcc------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence             111111      136778899999999999999999998875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.6e-39  Score=289.06  Aligned_cols=245  Identities=20%  Similarity=0.203  Sum_probs=194.5

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ||+|+||   .||++.+  ++..+++|.+..... .....+.+.+|+.++++++||||+++++.+..+...|+|+||+++
T Consensus         1 lg~g~~~---~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYG---RVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCce---EEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence            6899999   9999998  589999999865521 234567889999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCC-
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-  225 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-  225 (353)
                      ++|.+++...     ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        78 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          78 GDLASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            9999998764     35789999999999999999999   99999999999999999999999999999876533211 


Q ss_pred             ------ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          226 ------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       226 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                            .......++..|+|||......++.++|+||||+++|++++|..||.....        ......... ...  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~--  218 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILN-GKI--  218 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-CCc--
Confidence                  122345678889999999888899999999999999999999999863321        111111110 000  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                                ........+..+.+++.+||+.+|++|||+..+.+.|
T Consensus       219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 ----------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ----------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                      0000001256788999999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-39  Score=296.80  Aligned_cols=271  Identities=16%  Similarity=0.207  Sum_probs=199.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET----  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----  134 (353)
                      .+.|...+.||+|+||   .||++..  ++..||+|.+............+.+|+.+++.++||||+++++++...    
T Consensus         4 ~~~y~~~~~lg~G~~~---~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKYVPIKPIGRGAYG---IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccceeEEEEeccCCCe---EEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            4568889999999999   9999987  789999999875433444556778999999999999999999988644    


Q ss_pred             -CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                       ...|+|+||+. ++|.+++...     ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~D  151 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICD  151 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECc
Confidence             34799999996 7898888654     35889999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~  285 (353)
                      ||++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|..||........       ...+..
T Consensus       152 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (337)
T cd07858         152 FGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE  230 (337)
T ss_pred             CccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99987764332 12234567889999998865 4588999999999999999999999864321100       000000


Q ss_pred             HHHHHHhhcCcccccccchhhhc--cchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVED--VLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      +.. ...................  ......+..+..+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         231 EDL-GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHh-hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000 0000000000000000000  0000111456778999999999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=286.48  Aligned_cols=250  Identities=17%  Similarity=0.184  Sum_probs=196.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC---CChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE---CRPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      .+|...+.||+|+||   .||++.+  ++..||+|.+....   ........+.+|+.++++++||||+++++++.+.  
T Consensus         2 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFG---EVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE   78 (264)
T ss_pred             CceeeeeeEccCCCe---EEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence            468889999999999   9999987  78899999875321   1234556889999999999999999999998764  


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ..+++|+||+++++|.+++...     ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+||
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~df  150 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDF  150 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcc
Confidence            4578999999999999988754     34788889999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCC--ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          215 SLSISIPEGET--HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       215 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |+++.......  .......++..|+|||++.+..++.++|+||||+++|+|++|..||......        .......
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~  222 (264)
T cd06653         151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIA  222 (264)
T ss_pred             ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHH
Confidence            99876532111  1112346888999999998888999999999999999999999998632111        0111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....             .+..+...+..+.+++.+||. +|..|||+.+++.
T Consensus       223 ~~~~-------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 TQPT-------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cCCC-------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0000             001112456778899999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-39  Score=283.59  Aligned_cols=248  Identities=22%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..+.||+|++|   .||++..  .+..|++|.+..........+.+.+|++++.+++|||++++++++.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFG---VVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCe---EEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            47778899999999   9999987  678999999987754446678899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++...     ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.++|+|||.+...
T Consensus        78 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          78 LEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             EecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence            9999999999998765     36889999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ...... .....++..|+|||...+..++.++||||||+++|+|++|..||......        ....... ......+
T Consensus       150 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--------~~~~~~~-~~~~~~~  219 (254)
T cd06627         150 NDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--------AALFRIV-QDDHPPL  219 (254)
T ss_pred             CCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHh-ccCCCCC
Confidence            543321 23456788999999998777899999999999999999999998632211        1111111 0110000


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                   +...+..+.+++.+||..+|++|||+.+++.
T Consensus       220 -------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 -------------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -------------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                         1134567789999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=295.28  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=206.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      +.|...++||+||||   .||-++-  +|+-+|.|++.+.... .......++|-.+|.+++.+.||.+--.|.+.+.+|
T Consensus       185 n~F~~~RvlGkGGFG---EV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFG---EVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             cceeeeEEEeccccc---ceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            678899999999999   7777666  8999999988655322 223455789999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|+..|.||+|.-+|...++   ..+++..++.++.+|+.||.+||   ..+||.||+||+|||+|+.|+++|+|+|+|.
T Consensus       262 lVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             EEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEE
Confidence            99999999999999987765   46899999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .+..+..  ....+||.+|||||++.+..|+...|.|||||++|||+.|+.||.......                  -.
T Consensus       336 ei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------------k~  395 (591)
T KOG0986|consen  336 EIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------------KR  395 (591)
T ss_pred             ecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------------hH
Confidence            9876654  344589999999999999999999999999999999999999997443221                  01


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                      +-+|..+..+.... +...+++..+|....|..||++|.-.
T Consensus       396 eEvdrr~~~~~~ey-~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  396 EEVDRRTLEDPEEY-SDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHHHHhcchhhc-ccccCHHHHHHHHHHHccCHHHhccC
Confidence            12333333322221 23778888899999999999999743

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.6e-39  Score=289.57  Aligned_cols=245  Identities=19%  Similarity=0.256  Sum_probs=191.9

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ||+|+||   .||++..  +++.+|+|.+...... ......+.+|+.++++++||||+++++++...+..|+||||+++
T Consensus         1 lg~g~~g---~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFG---EVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCce---eEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence            6899999   9998877  7889999998654211 22345678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      ++|.+++.....   ..+++..++.++.|++.||.|||   +++++||||+|+||+++.++.++|+|||.+.......  
T Consensus        78 ~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  149 (277)
T cd05577          78 GDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--  149 (277)
T ss_pred             CcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--
Confidence            999998876532   35889999999999999999999   9999999999999999999999999999987653321  


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIV  306 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (353)
                      ......++..|+|||++.+..++.++||||||+++|+|++|..||.......     ....+..    .....       
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~----~~~~~-------  213 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-----EKEELKR----RTLEM-------  213 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-----cHHHHHh----ccccc-------
Confidence            1234467789999999988889999999999999999999999986433211     0000000    00000       


Q ss_pred             hccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          307 EDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       307 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                         ....+...+..+.+++.+||+.+|++||     ++.+++.
T Consensus       214 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 ---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence               0000113456778999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.5e-39  Score=292.86  Aligned_cols=247  Identities=20%  Similarity=0.290  Sum_probs=195.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      +.|+..+.||+|+||   .||+|..  ++..+|+|.+.... .......++.+|+.+++.++|+|++++++++......+
T Consensus        15 ~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          15 KLFSDLREIGHGSFG---AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             HHHHHHHheeeCCCE---EEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence            347777889999999   9999998  77889999886431 23345567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+. |+|.+.+....    .++++..+..++.|++.||.|||   +++++||||+|+||+++.++.++|+|||++.
T Consensus        92 lv~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  163 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (308)
T ss_pred             EEEEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccce
Confidence            9999997 68888775443    45788999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .....     ....++..|+|||.+.   ...++.++|||||||++|+|++|..||......        ....... ..
T Consensus       164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~-~~  229 (308)
T cd06634         164 IMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIA-QN  229 (308)
T ss_pred             eecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHh-hc
Confidence            65322     2346788999999974   345788999999999999999999997532111        0111111 11


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..+            .......+..+.+++.+||..+|++||++.+++..
T Consensus       230 ~~~------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         230 ESP------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CCC------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            100            00111456678899999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-38  Score=288.82  Aligned_cols=243  Identities=17%  Similarity=0.248  Sum_probs=195.0

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      ...||+|+||   .||++..  ++..||+|++...  .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        25 ~~~lg~g~~g---~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTG---IVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCe---EEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            3579999999   9999988  7899999998654  3455677999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++++|.+++..      ..+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++.......
T Consensus       100 ~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657         100 EGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            99999987754      24788899999999999999999   9999999999999999999999999999886654322


Q ss_pred             CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccch
Q 018633          225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPI  304 (353)
Q Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (353)
                      . ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......        ..... .... .+.    .
T Consensus       171 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~~-~~~~-~~~----~  235 (292)
T cd06657         171 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKM-IRDN-LPP----K  235 (292)
T ss_pred             c-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhh-CCc----c
Confidence            1 123456888999999998888899999999999999999999998632111        11111 1000 000    0


Q ss_pred             hhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          305 IVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       305 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +..      ....+..+.+++.+||..+|.+||++.++++
T Consensus       236 ~~~------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         236 LKN------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCC------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            000      0033456778999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=287.21  Aligned_cols=267  Identities=18%  Similarity=0.232  Sum_probs=197.0

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv  140 (353)
                      |...+.||+|++|   .||+|..  +++.|++|++...... .......+|+..+.+++ ||||+++++++..++..++|
T Consensus         1 y~~~~~ig~g~~g---~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFG---SVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCce---EEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            5567889999999   9999998  6789999998655322 22334567999999999 99999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+ +|+|.+.+.....   ..+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             EecC-CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence            9999 7899998876532   36789999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHH-HHHHH
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNE-YLKNY  291 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~-~~~~~  291 (353)
                      .....  .....++..|+|||++.. ..++.++|+||||+++++|++|..||........       ...+... |....
T Consensus       150 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07830         150 RSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY  227 (283)
T ss_pred             cCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence            43222  233467889999998754 4578999999999999999999999864432110       0001110 11110


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .........+.......... .....+..+.+++.+||+.+|++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         228 KLASKLGFRFPQFAPTSLHQ-LIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhccccccccccccccHHH-HcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00001110100000000000 00122467889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.9e-39  Score=289.09  Aligned_cols=242  Identities=17%  Similarity=0.221  Sum_probs=186.0

Q ss_pred             ceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChh-HHHHHHHHHHHHh---hcCCCceeeccceeeeCCccEEEEE
Q 018633           69 VIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPR-AYESCINNVTYAA---RMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~---~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      +||+|+||   .||++..  +++.+|+|.+........ ....+.+|..++.   ...||||+.+++++...+..++|||
T Consensus         1 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   77 (279)
T cd05633           1 IIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD   77 (279)
T ss_pred             CcccCCCe---EEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence            48999999   9999888  688999998865432212 2233445544444   3469999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      |+++|+|.+++...     ..+++..+..++.|++.||.|||   +++++||||||+|||+++++.++|+|||++.....
T Consensus        78 ~~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          78 LMNGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             cCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            99999999888754     35899999999999999999999   99999999999999999999999999999865533


Q ss_pred             CCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          223 GETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      ..   .....|+..|+|||.+.. ..++.++|||||||++|+|++|..||.......      ..........      .
T Consensus       150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~------~  214 (279)
T cd05633         150 KK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHEIDRMTLT------V  214 (279)
T ss_pred             cC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC------HHHHHHHhhc------C
Confidence            22   223468999999999864 558899999999999999999999987432211      0111111000      0


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                      ..        ..+...+..+.+++.+||+.||++||     |+.++++
T Consensus       215 ~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         215 NV--------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             Cc--------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            00        01114566788999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=284.35  Aligned_cols=260  Identities=18%  Similarity=0.243  Sum_probs=196.7

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc---CCCceeeccceeeeCCc--
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM---SHNHILKLIGCCLETPI--  136 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~~~~--  136 (353)
                      |+..+.||+|+||   .||+|.+  +++.+|+|.+............+.+|+.++.++   .||||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~---~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYG---TVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCce---EEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            5567889999999   9999998  589999999975543333445677888887766   59999999999987776  


Q ss_pred             ---cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          137 ---PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       137 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                         .+++|||++ ++|.+++.....   ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|
T Consensus        78 ~~~~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~d  150 (287)
T cd07838          78 ELKLTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIAD  150 (287)
T ss_pred             CceeEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEec
Confidence               899999997 589888865432   35889999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||.+........  .....++..|+|||++.+..++.++|+||||+++|+|++|..||.......        .......
T Consensus       151 fg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--------~~~~~~~  220 (287)
T cd07838         151 FGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--------QLDKIFD  220 (287)
T ss_pred             cCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--------HHHHHHH
Confidence            999877643321  223457888999999998889999999999999999999998887433211        1111111


Q ss_pred             cCc------ccc-------cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNR------FTE-------IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~------~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...      +..       .......... .......+..+.+++.+||+.||++||++.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HcCCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000      000       0000000000 1111245677889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-38  Score=291.42  Aligned_cols=244  Identities=20%  Similarity=0.300  Sum_probs=193.8

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      |...+.||+|+||   .||+|.+  ++..|++|++..... .......+.+|+.+++.++|||++++++++.+....|+|
T Consensus        23 ~~~~~~lg~g~~g---~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          23 FVGLHEIGHGSFG---AVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             hhcceeeccCCCe---EEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            5666779999999   9999987  788999999864421 334456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||++ |+|.+++....    .++++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++...
T Consensus       100 ~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         100 MEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             EecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            99996 68888776543    46889999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ..     .....|+..|+|||++.   ...++.++||||||+++|+|++|..||.......        ....... ...
T Consensus       172 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~-~~~  237 (313)
T cd06633         172 SP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQ-NDS  237 (313)
T ss_pred             CC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHh-cCC
Confidence            21     23456888999999984   3568889999999999999999999986432111        1111110 011


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +...            ....+..+.+++.+||+.+|.+||++.+++.
T Consensus       238 ~~~~------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         238 PTLQ------------SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CCCC------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1100            0133456789999999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.2e-38  Score=287.16  Aligned_cols=253  Identities=20%  Similarity=0.262  Sum_probs=195.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPI  136 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~  136 (353)
                      ..++|...+.||+|+||   .||++.+  +++.||||.+.... .......+..|+.++.+.. ||||+++++++.+...
T Consensus        13 ~~~~~~~~~~lg~g~~~---~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          13 DLNDLENLGEIGSGTCG---QVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             CcchheeeeEeeccCCe---EEEEEEECCCCeEEEEEEEeccC-ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            34678889999999999   9999999  48999999987543 2234456777887777775 9999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      .|+||||++ ++|.+++....    ..+++..+..++.|++.||.|||   + ++|+||||+|+||++++++.++|+|||
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence            999999986 57777765533    36889999999999999999999   6 599999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCC----CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGV----FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ++........  .....++..|+|||.+.+..    ++.++||||||+++|+|++|..||......       .+.....
T Consensus       161 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~  231 (296)
T cd06618         161 ISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKI  231 (296)
T ss_pred             cchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHH
Confidence            9876533222  22335778899999987543    788999999999999999999998632111       1111111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .... ......           ....+.++.+++.+||..||++|||+.+++..
T Consensus       232 ~~~~-~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         232 LQEE-PPSLPP-----------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             hcCC-CCCCCC-----------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111 000000           00245678899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1e-38  Score=294.67  Aligned_cols=273  Identities=19%  Similarity=0.250  Sum_probs=199.8

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeC-
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLET-  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~-  134 (353)
                      ...++|...+.||+|+||   .||+|.+  ++..+|+|++............+.+|+.+++++ +||||++++++|... 
T Consensus         4 ~~~~~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852           4 HILRKYEILQKLGKGAYG---IVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             hhhhHHHHhHhhcCCCCe---eEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence            356678889999999999   9999988  688999999865433445556788999999999 999999999998643 


Q ss_pred             -CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                       ...|+||||++ ++|.+++...      .+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          81 DKDIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             CceEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEee
Confidence             36899999997 6998887653      4678888899999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCc----cccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CC
Q 018633          214 FSLSISIPEGETH----ITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LA  281 (353)
Q Consensus       214 fg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~  281 (353)
                      ||++.........    ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........       ..
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~  230 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG  230 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9998766433221    2233568889999998765 4578899999999999999999999864322110       00


Q ss_pred             CChHHHHHHHhhcCcccccccchhhhccc--hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVL--SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .+....+.... ......+++........  .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         231 PPSAEDIESIK-SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHH-hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000000000 00000001100000000  00011246778999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-38  Score=290.80  Aligned_cols=268  Identities=15%  Similarity=0.193  Sum_probs=195.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC---
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP---  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---  135 (353)
                      .++|...+.||+|+||   .||++.+  +++.+|+|++............+.+|+.++++++||||+++++++....   
T Consensus         7 ~~~y~~~~~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFG---EVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCE---EEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            5789999999999999   9999998  6889999998655333333456789999999999999999999876443   


Q ss_pred             -----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          136 -----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       136 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                           .+++|+||+. ++|.+.+....    ..+++..+..++.|++.||.|||   +++++|+||||+||++++++.++
T Consensus        84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~  155 (311)
T cd07866          84 KRKRGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILK  155 (311)
T ss_pred             cccCceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence                 4699999997 57777776543    46899999999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCcc----------ccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC
Q 018633          211 LFDFSLSISIPEGETHI----------TDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD  279 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~  279 (353)
                      |+|||++..........          .....++..|+|||.+.+. .++.++||||||+++|+|++|.+||........
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~  235 (311)
T cd07866         156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ  235 (311)
T ss_pred             ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999987654322111          1233567889999988654 478999999999999999999999864332110


Q ss_pred             CCCChHHHHHHHhhc---------CcccccccchhhhccchH---HHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          280 LACPSNEYLKNYFED---------NRFTEIVDPIIVEDVLSI---EKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       280 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                           ..........         ...+...+.......+..   ........+.+++.+||+.||++|||+.+++.
T Consensus       236 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         236 -----LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             -----HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                 0000000000         000010000000000000   00123467889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-38  Score=287.71  Aligned_cols=257  Identities=13%  Similarity=0.089  Sum_probs=183.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--C---CeEEEEEEecCCCCChhH---------HHHHHHHHHHHhhcCCCceeec
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--Q---ERLISVLQFYGHECRPRA---------YESCINNVTYAARMSHNHILKL  127 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~---~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~~  127 (353)
                      +.|...++||+|+||   .||+|.+  +   +..+|+|+..........         ......+...+..+.|+||+++
T Consensus        12 ~~y~i~~~LG~G~fG---~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882         12 KEWKIDKLIGCGGFG---CVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             CceEEeeEEecCCCc---eEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            578899999999999   9999988  2   345666654322111000         0112334445566789999999


Q ss_pred             cceeeeCC----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee
Q 018633          128 IGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF  203 (353)
Q Consensus       128 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  203 (353)
                      ++++....    ..++++|++. .++.+.+...     ...++..+..++.|++.||.|||   +++|+||||||+|||+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill  159 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV  159 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            99876543    3467888775 4676666543     23567788899999999999999   9999999999999999


Q ss_pred             cCCCceEEeccCCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccc
Q 018633          204 NEENVAKLFDFSLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT  277 (353)
Q Consensus       204 ~~~~~~kl~dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~  277 (353)
                      +.++.++|+|||+|+.+......      ......||+.|+|||+..+..++.++|||||||++|||++|..||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999999999876432211      122346999999999999889999999999999999999999999754221


Q ss_pred             cCCCC-ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          278 HDLAC-PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       278 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      ..... ...++..... .            +..   .....+..+.+++..||+.+|++||++.++.+.|
T Consensus       240 ~~~~~~~~~~~~~~~~-~------------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        240 GNLIHAAKCDFIKRLH-E------------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHhHHHHHHHhh-h------------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            10000 0001111110 0            000   0013456788999999999999999999998876

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.1e-39  Score=294.60  Aligned_cols=272  Identities=19%  Similarity=0.201  Sum_probs=201.0

Q ss_pred             HHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           56 EIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        56 e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ++..++++|+..+.||.|+||   .||++..  +++.||+|++..........+.+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g---~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   80 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFG---LVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS   80 (328)
T ss_pred             ceeccccceEEEEeecccCCe---EEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence            344678899999999999999   9999987  78899999886543344456778899999999999999999999875


Q ss_pred             -CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          134 -TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       134 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                       ....++|+||+. ++|.+++..      .+++...+..++.|++.||.|||   +++++||||+|+||+++.++.++|+
T Consensus        81 ~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          81 PLEDIYFVTELLG-TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             CCCcEEEEeehhc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeC
Confidence             567899999994 789888764      24678888899999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCCh
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACPS  284 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~~  284 (353)
                      |||.+......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......       ....+.
T Consensus       151 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  226 (328)
T cd07856         151 DFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP  226 (328)
T ss_pred             ccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998754321    223456788999998766 568899999999999999999999986432210       000111


Q ss_pred             HHHHHHHhhcCcccccccchhh-hccch-HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIV-EDVLS-IEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .++......... .+....... ...+. ...+..+..+.+++.+||+.+|++|||+.+++..
T Consensus       227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         227 DDVINTICSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHHhccchhh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111111111100 000000000 00000 0001245788999999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.4e-39  Score=289.98  Aligned_cols=255  Identities=19%  Similarity=0.224  Sum_probs=198.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhcC-CCceeeccceeeeC
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHEC--RPRAYESCINNVTYAARMS-HNHILKLIGCCLET  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~  134 (353)
                      +|...+.||+|++|   .||++..     ++..||+|.+.....  .....+.+.+|+.++.+++ ||||+++++++..+
T Consensus         1 ~~~~~~~ig~G~~~---~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYG---KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCc---eEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            36677889999999   7877764     567899998864321  2234567889999999994 99999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ...++||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+||
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEEC
Confidence            9999999999999999988654     35788899999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCC--CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |++...............|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.......    ..........
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~  225 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQSEISRRIL  225 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHHHHHHHHH
Confidence            998776444333333456888999999987655  7889999999999999999999986322110    0111111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ..             ..  ..+...+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       226 ~~-------------~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         226 KS-------------KP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             cc-------------CC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            00             00  001134556789999999999999999888877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.4e-38  Score=281.08  Aligned_cols=250  Identities=18%  Similarity=0.187  Sum_probs=192.0

Q ss_pred             cHHHHHHHhhCcCCCCce--eeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeec
Q 018633           53 SAQEIKLATNSYDQKNVI--AKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKL  127 (353)
Q Consensus        53 ~~~e~~~~~~~~~~~~~l--g~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~  127 (353)
                      +..++....++|...+.+  |+|+||   .||++..  ++..+|+|.+......  ..     |+.....+ +||||+++
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g---~v~~~~~~~~~~~~~~k~~~~~~~~--~~-----e~~~~~~~~~h~~iv~~   74 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFG---KVSVLKHKPTQKLFVQKIIKAKNFN--AI-----EPMVHQLMKDNPNFIKL   74 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCce---EEEEEEEcCCCcEEEEEEEehhhcc--hh-----hHHHHHHhhcCCCEEEE
Confidence            344555666777777776  999999   8888887  7888999998654211  11     22222222 69999999


Q ss_pred             cceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC
Q 018633          128 IGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN  207 (353)
Q Consensus       128 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  207 (353)
                      ++++...+..|+||||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++
T Consensus        75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         75 YYSVTTLKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             EEEEecCCeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCC
Confidence            99999999999999999999999998764     36899999999999999999999   99999999999999999998


Q ss_pred             -ceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          208 -VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       208 -~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                       .++|+|||++......     ....++..|+|||++.+..++.++||||||+++|+|++|..||.......   .....
T Consensus       147 ~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~  218 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLES  218 (267)
T ss_pred             CeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHH
Confidence             9999999998765322     23457889999999998889999999999999999999999987332211   01111


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-HHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-MVDVAK  344 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~vl~  344 (353)
                      +....  ..            ..  ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus       219 ~~~~~--~~------------~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        219 LLKRQ--QK------------KL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHhh--cc------------cC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11100  00            00  001145667889999999999999996 588774

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=310.37  Aligned_cols=266  Identities=21%  Similarity=0.316  Sum_probs=211.4

Q ss_pred             HHHHhhCcCCCCceeeCCCCCccEEEEEEeC---------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceee
Q 018633           57 IKLATNSYDQKNVIAKDTSYNLYTMYKGFWQ---------ERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILK  126 (353)
Q Consensus        57 ~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~  126 (353)
                      ++...++....+.||.|.||   .|++|...         ...||||.++..... ...+.+..|+.+|..+. ||||+.
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG---~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~  366 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFG---QVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVN  366 (609)
T ss_pred             eeechhhccccceeeccccc---ceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhh
Confidence            33344445556699999999   99998751         467999999877544 67788999999999996 999999


Q ss_pred             ccceeeeCCccEEEEEeccCCChhhhhccCC---------CCCCc--cccHHHHHHHHHHHHHHHHHHhcCCCCCeEeec
Q 018633          127 LIGCCLETPIPILVFESVQYGTLWDRILGAP---------QPHFE--PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN  195 (353)
Q Consensus       127 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~d  195 (353)
                      ++|+|.+++..++|+||+..|+|.++++...         .....  .+.....+.++.|||.|++||+   +.++||||
T Consensus       367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRD  443 (609)
T KOG0200|consen  367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRD  443 (609)
T ss_pred             heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchh
Confidence            9999999999999999999999999998776         11111  3888899999999999999999   99999999


Q ss_pred             cCCCceeecCCCceEEeccCCccccCCCCCcccccccc--CCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCC
Q 018633          196 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG--TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSD  272 (353)
Q Consensus       196 lkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~  272 (353)
                      |.++|||+..+..+||+|||+|+..............|  +..|||||.+....|+.+|||||||++|||++| |..|+.
T Consensus       444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            99999999999999999999998765444332222222  456999999999999999999999999999999 667765


Q ss_pred             ccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          273 LVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      .        .+....+.+....+.-             ...|..++.++.++|..||+.+|++||++.++.+.++..+
T Consensus       524 ~--------~~~~~~l~~~l~~G~r-------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  524 G--------IPPTEELLEFLKEGNR-------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             C--------CCcHHHHHHHHhcCCC-------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            3        1111111222222221             1122267888999999999999999999999999998854

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=281.37  Aligned_cols=244  Identities=20%  Similarity=0.157  Sum_probs=188.2

Q ss_pred             CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHH-hhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYA-ARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l-~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||++..  +++.||+|.+..... .......+..|..++ ....||||+++++++..++..|+|+||
T Consensus         2 ~~l~~g~~~---~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (260)
T cd05611           2 KPISKGAFG---SVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY   78 (260)
T ss_pred             ccCCcCCCe---eEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence            468999999   9999988  788999999865421 122233445555444 455799999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++++|.+++...     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..... 
T Consensus        79 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          79 LNGGDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             cCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence            9999999998754     35789999999999999999999   99999999999999999999999999998875432 


Q ss_pred             CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                          .....++..|+|||.+.+..++.++||||||+++|+|++|..||.....        ....... ......     
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~~-----  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNI-LSRRIN-----  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH-HhcccC-----
Confidence                2234678899999999888889999999999999999999999863221        1111111 111000     


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                           .........+..+.+++.+||+.+|++|||+.++.+.|
T Consensus       212 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         212 -----WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             -----CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence                 00000113556788999999999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-38  Score=290.36  Aligned_cols=270  Identities=19%  Similarity=0.213  Sum_probs=202.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-----
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-----  135 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----  135 (353)
                      +|...+.||+|++|   .||++..  ++..||+|++..........+.+.+|+.+++.++||||+++++++...+     
T Consensus         1 ~y~i~~~ig~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYG---VVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCe---EEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            47788899999999   9999998  5899999998765433556678999999999999999999999998765     


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+||||++ ++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg  148 (330)
T cd07834          78 DVYIVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFG  148 (330)
T ss_pred             ceEEEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccC
Confidence            7899999997 6898888654     36889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCC--ccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChH
Q 018633          216 LSISIPEGET--HITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSN  285 (353)
Q Consensus       216 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~  285 (353)
                      ++........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........       ...+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  228 (330)
T cd07834         149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE  228 (330)
T ss_pred             ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence            9887644321  112344678899999999887 789999999999999999999999875432110       000000


Q ss_pred             HHHHHHhhcCcccccccchhhhccc--hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVL--SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..+. ..........+.........  .......+..+.+++.+||+.+|++|||+.+++..
T Consensus       229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         229 EDLK-FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hHhh-hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0000 00000000000000000000  00011345778999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-38  Score=284.05  Aligned_cols=249  Identities=18%  Similarity=0.232  Sum_probs=201.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCcc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIP  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~  137 (353)
                      ++|...+.||+|+||   .||++..  ++..||+|++..... .....+.+.+|+.++.+++ ||||+++++++.+++..
T Consensus         1 ~~y~~~~~lg~g~~~---~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   77 (280)
T cd05581           1 DDFKFGKIIGEGSFS---TVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL   77 (280)
T ss_pred             CCceEeeeecCCCce---EEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence            367888899999999   9999998  789999999865321 3344577889999999999 99999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.++++|||++
T Consensus        78 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          78 YFVLEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             EEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccc
Confidence            9999999999999999765     36899999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCC-------------------ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc
Q 018633          218 ISIPEGET-------------------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH  278 (353)
Q Consensus       218 ~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~  278 (353)
                      ........                   .......++..|+|||+.....++.++|+||||++++++++|..||...... 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-  228 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-  228 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-
Confidence            76543221                   1123346788999999998888999999999999999999999998743211 


Q ss_pred             CCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH----HHHHH
Q 018633          279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM----VDVAK  344 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~~vl~  344 (353)
                             ........ ...          ..    +...+..+.+++.+||+.+|++|||+    .++++
T Consensus       229 -------~~~~~~~~-~~~----------~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 -------LTFQKILK-LEY----------SF----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -------HHHHHHHh-cCC----------CC----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                   11111110 000          00    01335667899999999999999999    76654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-38  Score=287.60  Aligned_cols=252  Identities=18%  Similarity=0.249  Sum_probs=194.2

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeC
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHEC--RPRAYESCINNVTYAARM-SHNHILKLIGCCLET  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~  134 (353)
                      +|+..+.||+|+||   .||.+..     ++..||+|.+.....  .....+.+.+|+.++.++ +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g---~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYG---KVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcc---eEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            47778899999999   7776665     678999999865321  223456788999999999 599999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      +..++|+||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+++||||+|+|||++.++.++|+||
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeC
Confidence            9999999999999999998764     35788899999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccC--CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTG--VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |++...............|+..|+|||.+...  .++.++||||||+++|+|++|..||.......    ..........
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~  225 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN----SQAEISRRIL  225 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc----cHHHHHHHhh
Confidence            99877644332223345688899999998653  46789999999999999999999986322111    1111111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                      ....           .    .+......+.+++.+||+.+|++||     ++.+++.
T Consensus       226 ~~~~-----------~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         226 KSEP-----------P----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ccCC-----------C----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            0000           0    0113455678999999999999997     5666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-38  Score=291.87  Aligned_cols=269  Identities=17%  Similarity=0.158  Sum_probs=200.7

Q ss_pred             eecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeecc
Q 018633           51 IFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLI  128 (353)
Q Consensus        51 ~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~  128 (353)
                      .....++...+++|...+.||+|+||   .||++..  ++..||+|++..........+.+.+|+.++.+++||||++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g---~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~   82 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYG---SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL   82 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCe---EEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence            34456677788999999999999999   9999986  789999999976533444556788999999999999999999


Q ss_pred             ceeeeC------CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCcee
Q 018633          129 GCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL  202 (353)
Q Consensus       129 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  202 (353)
                      +++...      ...+++++++ +++|.+++..      ..+++..++.++.|++.||.|||   +++|+||||||+||+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl  152 (345)
T cd07877          83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLA  152 (345)
T ss_pred             eeeeecccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEE
Confidence            988643      3467888887 6899887754      34788999999999999999999   999999999999999


Q ss_pred             ecCCCceEEeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCC
Q 018633          203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA  281 (353)
Q Consensus       203 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~  281 (353)
                      ++.++.++|+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......   
T Consensus       153 l~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---  225 (345)
T cd07877         153 VNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---  225 (345)
T ss_pred             EcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            999999999999998764321    234467889999998866 468889999999999999999999986422111   


Q ss_pred             CChHHHHHHHhhc--Ccccccc----cc---hhh---hccch----HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          282 CPSNEYLKNYFED--NRFTEIV----DP---IIV---EDVLS----IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       282 ~~~~~~~~~~~~~--~~~~~~~----~~---~~~---~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                           ........  .....+.    +.   ...   ...+.    ......+..+.+++.+||+.||.+|||+.+++.
T Consensus       226 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         226 -----QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             -----HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                 00000000  0000000    00   000   00000    000023456789999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.9e-38  Score=283.92  Aligned_cols=242  Identities=17%  Similarity=0.212  Sum_probs=186.2

Q ss_pred             ceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHH---HhhcCCCceeeccceeeeCCccEEEEE
Q 018633           69 VIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTY---AARMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~---l~~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      +||+|+||   .||++..  +++.||+|.+...... ......+..|..+   +....||||+.+++++...+..++|||
T Consensus         1 ~ig~g~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD   77 (278)
T ss_pred             CcccCCCe---EEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence            48999999   9998887  6889999998654322 1222234444443   444579999999999999999999999


Q ss_pred             eccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      |+++|+|.+++...     ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          78 LMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            99999999888654     46899999999999999999999   99999999999999999999999999999876533


Q ss_pred             CCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          223 GETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      ..   .....|+..|+|||++.++ .++.++||||+|+++|+|++|..||........      ..........      
T Consensus       150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~------  214 (278)
T cd05606         150 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEIDRMTLTM------  214 (278)
T ss_pred             cC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch------HHHHHHhhcc------
Confidence            22   2345689999999998754 589999999999999999999999874322110      0000000000      


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                      ...        .+...+..+.+++.+||..+|++||     ++.++++
T Consensus       215 ~~~--------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         215 AVE--------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCC--------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            000        0113456788999999999999999     9988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=283.37  Aligned_cols=268  Identities=20%  Similarity=0.241  Sum_probs=200.4

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |+....||+|++|   .||+|..  +++.+|+|.+..........+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus         1 y~~~~~ig~g~~~---~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYG---VVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcc---eEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            4556789999999   9999999  5899999999776433445677889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||++ ++|.+++....    ..+++..+..++.|++.||.|||   +++|+||||+|+||++++++.++|+|||.+....
T Consensus        78 e~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          78 EYCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             cCcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            9998 69999997653    35889999999999999999999   9999999999999999999999999999987764


Q ss_pred             CCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHHhh
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNYFE  293 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~  293 (353)
                      .... ......++..|+|||.+.+. .++.++||||||+++||+++|..||........       ...+....+.....
T Consensus       150 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         150 IPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             CCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            3322 12234456789999998766 789999999999999999999999864332110       00000111100000


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+............. ...+..+..+.+++.+||..+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         229 LPDYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000000000000 000123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-38  Score=291.73  Aligned_cols=267  Identities=15%  Similarity=0.175  Sum_probs=197.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-  135 (353)
                      ...++|...+.||+|+||   .||++..  ++..||+|++............+.+|+.++++++||||+++++++..+. 
T Consensus        12 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYG---TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             ccccceEEEEEeeecCCe---EEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            456789999999999999   9999987  7899999998654334445667889999999999999999999987654 


Q ss_pred             -----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          136 -----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       136 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                           ..++||||+ +++|.+++..      ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.++
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence                 358999999 6799888754      35789999999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCC
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LAC  282 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~  282 (353)
                      |+|||++......    .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||........       ...
T Consensus       159 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07880         159 ILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT  234 (343)
T ss_pred             EeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999998765322    223457889999999876 3588999999999999999999999874322110       000


Q ss_pred             ChHHHHHHHhhcCcccccc---cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIV---DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....+..... ........   ........ .......+..+.+++.+|+..||++|||+.+++.
T Consensus       235 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         235 PSKEFVQKLQ-SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCHHHHHhhc-chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0001100000 00000000   00000000 0001134556889999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.8e-38  Score=280.95  Aligned_cols=251  Identities=18%  Similarity=0.204  Sum_probs=193.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecC---CCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYG---HECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~---~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .|...+.||+|+||   .||++.+  .+..+++|.+..   ..........+..|+.++++++||||+++++++.+....
T Consensus         1 ~y~i~~~ig~g~~g---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFG---TVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAF   77 (260)
T ss_pred             CceeeeeecCCCCc---eEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCce
Confidence            36778899999999   9998888  344455555432   222333445677899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++|+||+++++|.+++....... ..+++..++.++.|++.||.|||   +++++|+||+|+||+++. +.++|+|||++
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCce
Confidence            99999999999998886432111 46899999999999999999999   999999999999999975 56999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....        ........ ....
T Consensus       153 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~-~~~~  222 (260)
T cd08222         153 RLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIV-EGPT  222 (260)
T ss_pred             eecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHH-cCCC
Confidence            7654322 223345678899999999888889999999999999999999999863211        11111111 1111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.             .+...+..+.+++.+||..+|++||++.++++
T Consensus       223 ~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 PS-------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CC-------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            00             11255677889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=271.01  Aligned_cols=265  Identities=20%  Similarity=0.242  Sum_probs=205.0

Q ss_pred             cHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccc
Q 018633           53 SAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIG  129 (353)
Q Consensus        53 ~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~  129 (353)
                      .+.|+-+.|+     ++||+|+|+   .|-.+..  ++..+|||++.+.  ....+.+..+|++++.+.+ |+||+++++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAya---sVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLie  143 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYA---SVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIE  143 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccce---eeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHH
Confidence            4667777775     469999999   8877776  9999999999888  5667788999999999997 999999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC--
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN--  207 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~--  207 (353)
                      +|+++..+|||||-|.||+|..++...     ..+++.++.+++.+|+.||.|||   .+||.||||||+|||..+..  
T Consensus       144 fFEdd~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  144 FFEDDTRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             HhcccceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCc
Confidence            999999999999999999999999876     46899999999999999999999   99999999999999986554  


Q ss_pred             -ceEEeccCCccccCCCC------CccccccccCCccccccccc---c--CCCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          208 -VAKLFDFSLSISIPEGE------THITDTVMGTWGYCAPEYMR---T--GVFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       208 -~~kl~dfg~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                       -+||+||.+........      +....+.+|+..|||||+..   +  ..|+.+.|.||||+|+|-|+.|.+||...-
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence             47999998765432111      11124568999999999863   2  348899999999999999999999998654


Q ss_pred             ccc---CCCCChHHHHHHHhhcCcccccccchhhhccc--hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          276 DTH---DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVL--SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       276 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+   +-+..-..-...+|         ..+..+.+.  ...-...+.+..++++..|..||.+|.++.+++.
T Consensus       296 g~dCGWdrGe~Cr~CQ~~LF---------esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  296 GADCGWDRGEVCRVCQNKLF---------ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCcCCccCCCccHHHHHHHH---------HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            322   11111111111111         111111111  1112266778889999999999999999988875

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.2e-39  Score=275.01  Aligned_cols=280  Identities=18%  Similarity=0.211  Sum_probs=208.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe----C--CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW----Q--ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~----~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      .....|+....||+|.||   .||++..    +  ...+|+|+++.............+|+.+++.++||||+.+..++.
T Consensus        21 e~l~~ye~ig~Ig~GTYG---~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl   97 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYG---KVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL   97 (438)
T ss_pred             HHHHHhhccceecccccc---eeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence            445568888999999999   9999965    2  237899999766434455567889999999999999999999998


Q ss_pred             e-CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC----C
Q 018633          133 E-TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE----N  207 (353)
Q Consensus       133 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~----~  207 (353)
                      + +...++++||.+ -+|...++.+..+....++...+..|+.||+.|+.|||   ++=|+||||||.|||+..+    |
T Consensus        98 ~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG  173 (438)
T KOG0666|consen   98 SHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERG  173 (438)
T ss_pred             ccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccC
Confidence            7 778999999998 59999998776554467889999999999999999999   9999999999999999877    8


Q ss_pred             ceEEeccCCccccCCCCCc--cccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCC-CC
Q 018633          208 VAKLFDFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA-CP  283 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~-~~  283 (353)
                      .+||+|||+++.+...-..  .....+-|+.|.|||.+.+.. ||.+.||||.|||+.||+|-.+.|...+...... +-
T Consensus       174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf  253 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF  253 (438)
T ss_pred             eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence            9999999999988543322  234567789999999999866 9999999999999999999988887654432222 11


Q ss_pred             hHHHHHHHhhc------Cccccc---------ccchhhhccchH-HH------HHHHHHHHHHHHHchhcCCCCCCCHHH
Q 018633          284 SNEYLKNYFED------NRFTEI---------VDPIIVEDVLSI-EK------EQQLHASAQLSFECIKDSPADRPSMVD  341 (353)
Q Consensus       284 ~~~~~~~~~~~------~~~~~~---------~~~~~~~~~~~~-~~------~~~~~~l~~li~~cl~~dP~~Rps~~~  341 (353)
                      ....+...++-      ..++.+         +...-....... ..      ...+....+|+.++|.+||-.|.|+.+
T Consensus       254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q  333 (438)
T KOG0666|consen  254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ  333 (438)
T ss_pred             hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence            22222222221      111110         000000000000 00      011233679999999999999999999


Q ss_pred             HHHH
Q 018633          342 VAKK  345 (353)
Q Consensus       342 vl~~  345 (353)
                      +++.
T Consensus       334 Aleh  337 (438)
T KOG0666|consen  334 ALEH  337 (438)
T ss_pred             Hhcc
Confidence            8764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-38  Score=313.76  Aligned_cols=255  Identities=20%  Similarity=0.296  Sum_probs=192.8

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC-
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET-  134 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-  134 (353)
                      .+..++|++..+||+||||   .||++++  +|+.+|||++.... +........+|+.+|++|+|||||+++..+.+. 
T Consensus       475 SRY~~DFEEL~lLGkGGFG---~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFG---SVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST  550 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCc---eEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence            4667789999999999999   9999998  99999999998775 556667789999999999999999998876430 


Q ss_pred             --------------------------------------------------------------------------------
Q 018633          135 --------------------------------------------------------------------------------  134 (353)
Q Consensus       135 --------------------------------------------------------------------------------  134 (353)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHH
Q 018633          135 --------------------------------------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI  176 (353)
Q Consensus       135 --------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i  176 (353)
                                                            -.+||-||||+..+|.+++..+...    -.....++++++|
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI  706 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI  706 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence                                                  0137889999977777776654210    0366788999999


Q ss_pred             HHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC----------------CC-CCccccccccCCcccc
Q 018633          177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP----------------EG-ETHITDTVMGTWGYCA  239 (353)
Q Consensus       177 ~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~----------------~~-~~~~~~~~~gt~~y~a  239 (353)
                      +.||.|+|   +.+||||||||.||+++++..+||+|||+|+...                .+ .....+..+||.-|+|
T Consensus       707 lEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  707 LEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence            99999999   9999999999999999999999999999998721                00 0112345689999999


Q ss_pred             ccccccCC---CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHH
Q 018633          240 PEYMRTGV---FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQ  316 (353)
Q Consensus       240 PE~~~~~~---~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (353)
                      ||++.+..   |+.|+|+||||++++||+.   ||....+-        .......+.+.++..  +.+        ...
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--------a~iL~~LR~g~iP~~--~~f--------~~~  842 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--------ASILTNLRKGSIPEP--ADF--------FDP  842 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH--------HHHHHhcccCCCCCC--ccc--------ccc
Confidence            99997654   9999999999999999996   34422110        111111223333322  000        002


Q ss_pred             HHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          317 QLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       317 ~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....-..+|.++++.||++||||.+++.
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            2333457999999999999999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=282.66  Aligned_cols=276  Identities=17%  Similarity=0.248  Sum_probs=209.4

Q ss_pred             ceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC--CCc--
Q 018633           50 RIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS--HNH--  123 (353)
Q Consensus        50 ~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--H~n--  123 (353)
                      -+|...+..  ++.|.....+|+|.||   .|..+.+  ++..||+|+++..   ....+..+-|+++|.++.  -|+  
T Consensus        79 ~v~~~gD~l--~~Ry~i~~~lGeGtFG---kV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~  150 (415)
T KOG0671|consen   79 YVYQVGDIL--TNRYEIVDLLGEGTFG---KVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGK  150 (415)
T ss_pred             EEEEecccc--ccceehhhhhcCCccc---ceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCc
Confidence            344444433  7789999999999999   8888887  6789999999876   567777888999999994  233  


Q ss_pred             --eeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCce
Q 018633          124 --ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI  201 (353)
Q Consensus       124 --iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  201 (353)
                        +|.+.++|.-.++.|||+|.+ |-|+.++|..+.-   .+++..+++.++.|++.+++|||   +.+++|-||||+||
T Consensus       151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENI  223 (415)
T KOG0671|consen  151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENI  223 (415)
T ss_pred             eEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheE
Confidence              888999999999999999999 4699999987643   78999999999999999999999   99999999999999


Q ss_pred             eecC--------------------CCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHH
Q 018633          202 LFNE--------------------ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFL  261 (353)
Q Consensus       202 ll~~--------------------~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  261 (353)
                      |+.+                    +..++|+|||.|+.....    ....+.|.+|.|||++.+-.++.++||||+||||
T Consensus       224 Lfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL  299 (415)
T KOG0671|consen  224 LFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL  299 (415)
T ss_pred             EEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence            9821                    346899999998765332    2566789999999999999999999999999999


Q ss_pred             HHHHhCCCCCCccccccCC-------CCChHHH-----HHHHhhcCccc--ccccch----hhhccchH-----HHHHHH
Q 018633          262 FELLTGWDVSDLVKDTHDL-------ACPSNEY-----LKNYFEDNRFT--EIVDPI----IVEDVLSI-----EKEQQL  318 (353)
Q Consensus       262 ~el~tg~~p~~~~~~~~~~-------~~~~~~~-----~~~~~~~~~~~--~~~~~~----~~~~~~~~-----~~~~~~  318 (353)
                      +|++||...|+..++.+.+       ++.....     ...++..+++.  +...+.    ......+.     ......
T Consensus       300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~  379 (415)
T KOG0671|consen  300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH  379 (415)
T ss_pred             EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence            9999999999876643311       1111111     11122222111  100000    00000000     012455


Q ss_pred             HHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          319 HASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       319 ~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+|.+|+.+||.+||.+|+|+.|++.
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhc
Confidence            77999999999999999999999875

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=270.41  Aligned_cols=253  Identities=20%  Similarity=0.267  Sum_probs=200.5

Q ss_pred             HHhhCcCCC-CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeC
Q 018633           59 LATNSYDQK-NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLET  134 (353)
Q Consensus        59 ~~~~~~~~~-~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~  134 (353)
                      ..|++|+.. .+||-|-.|   .|..+..  +++.+|+|++...       ....+|++.--..+ |||||.+++++.+.
T Consensus        58 ~itedY~is~qvLG~GinG---kV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGING---KVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             cchhhheehhhhhccccCC---ceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            356777754 689999999   8777777  8999999998654       45667887766554 99999999998753


Q ss_pred             ----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---CC
Q 018633          135 ----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---EN  207 (353)
Q Consensus       135 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~  207 (353)
                          ..+.+|||.|+||.|.+.+.+.++   ..+++.++-.|+.||+.|+.|||   +.+|.||||||+|+|...   +-
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCc
Confidence                346799999999999999988875   67999999999999999999999   999999999999999964   44


Q ss_pred             ceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          208 VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      .+||+|||+|+.....  ....+.+-|+.|.|||++-...|+...|+||+||++|-|+.|.+||.+.....     ....
T Consensus       202 ~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----ispg  274 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPG  274 (400)
T ss_pred             ceEecccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----CChh
Confidence            7899999999876432  22456788999999999988889999999999999999999999998554321     1111


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ++.....+.+          .++...-.+.++...++|+.+|+.+|.+|.|+.++++
T Consensus       275 Mk~rI~~gqy----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  275 MKRRIRTGQY----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHhHhhccCc----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            2211111111          1122222377888999999999999999999999875

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-38  Score=290.13  Aligned_cols=267  Identities=18%  Similarity=0.227  Sum_probs=199.2

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|++|   .||+|.+  ++..||+|++............+.+|+.+++++.||||+++++++...+.
T Consensus        12 ~~~~~y~~~~~ig~g~~g---~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYG---QVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             cccCceEEEEEeccCCce---EEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            456789999999999999   9999998  68899999987554344556778899999999999999999998876554


Q ss_pred             ------cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          137 ------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       137 ------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                            .++|+||+ +++|.+++..      ..+++..++.++.|++.||.|||   +.+|+||||+|+||+++.++.++
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEE
Confidence                  89999999 5799988864      35889999999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCC
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LAC  282 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~  282 (353)
                      |+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|++++|..||........       ...
T Consensus       159 L~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         159 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             Ecccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            9999998765332    234467888999999865 3578999999999999999999999864322110       000


Q ss_pred             ChHHHHHHHhhcCcccccccch---hhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPI---IVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +...++... ........+...   ....... .....+..+.+++.+||+.+|++|||+.+|++
T Consensus       235 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         235 PDEELLQKI-SSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCHHHHhhc-cchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000110000 000000000000   0000000 00124678899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-37  Score=288.02  Aligned_cols=266  Identities=15%  Similarity=0.190  Sum_probs=192.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC-----
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET-----  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----  134 (353)
                      ++|...+.||.|+||   .||+|..  ++..||+|++...  .....+.+.+|+.++++++||||+++++++...     
T Consensus         5 ~~y~~~~~Lg~g~~g---~vy~~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           5 SRYMDLRPLGCGSNG---LVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             cceEEEEEecCCCCE---EEEEEEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            578889999999999   9999988  6889999998665  345567789999999999999999999887654     


Q ss_pred             ---------CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          135 ---------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       135 ---------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                               ...|+||||++ ++|.+++..      ..+++..++.++.|++.||.|||   +.+++||||||+||+++.
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~  149 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINT  149 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcC
Confidence                     24789999997 689888754      35788999999999999999999   999999999999999974


Q ss_pred             -CCceEEeccCCccccCCCCCc--cccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCC-
Q 018633          206 -ENVAKLFDFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-  280 (353)
Q Consensus       206 -~~~~kl~dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-  280 (353)
                       ++.++++|||.+.........  ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... 
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~  229 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ  229 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence             567899999998765322111  1123357888999998754 45788999999999999999999999643321100 


Q ss_pred             ------CCChHHHHHHHhhcCccccccc-chhhhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          281 ------ACPSNEYLKNYFEDNRFTEIVD-PIIVEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       281 ------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                            .............  ....... .......+ .......+.++.+++.+||+.||++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         230 LILESVPVVREEDRNELLN--VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHhcCCCChHHhhhhhh--hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                  0000000000000  0000000 00000000 0001134567889999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.8e-37  Score=285.76  Aligned_cols=268  Identities=19%  Similarity=0.205  Sum_probs=193.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--C--CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeC---
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--Q--ERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLET---  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~---  134 (353)
                      +|...+.||+|+||   .||++..  .  +..||+|++............+.+|+.++.++. ||||+++++.+...   
T Consensus         1 ~y~~~~~lg~G~~g---~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYG---IVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCe---EEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            36777889999999   9999988  3  679999998754333444667889999999995 99999999975432   


Q ss_pred             -CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                       ...++++||+. ++|.+.+...     ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~D  148 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICD  148 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCc
Confidence             35788899986 7898888654     46889999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCc---cccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCC
Q 018633          214 FSLSISIPEGETH---ITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LAC  282 (353)
Q Consensus       214 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~  282 (353)
                      ||+++........   ......||..|+|||++.+ ..++.++||||||+++|+|++|..||........       ...
T Consensus       149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  228 (332)
T cd07857         149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT  228 (332)
T ss_pred             CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence            9999765432211   1233568899999998765 4588999999999999999999999864331110       000


Q ss_pred             ChHHHHHHHhhcCccccc---ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEI---VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.......... ......   ....-....... ....+..+.+++.+||+.||.+|||+.+++.
T Consensus       229 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         229 PDEETLSRIGS-PKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCHHHHHhhhh-hhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00111100000 000000   000000000000 0023467889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=276.32  Aligned_cols=253  Identities=20%  Similarity=0.195  Sum_probs=191.6

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEe
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ...||.|+||   +|+|-.+  .|+..|||++.... ....+.+++.|.++..+- +.||||++||.+..++..|+.||+
T Consensus        69 lg~iG~G~fG---~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   69 LGEIGNGAFG---TVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHHhcCCcch---hhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            4469999999   8888887  89999999997664 346677888888776665 599999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      |. -||..+.+.-..-....+++...-+|....+.||.||-.  ...|||||+||+|||++..|.+||||||.+-.+..+
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            96 787654432111111468888888999999999999986  678999999999999999999999999998665322


Q ss_pred             CCccccccccCCccccccccccC--CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          224 ETHITDTVMGTWGYCAPEYMRTG--VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                        ...+...|...|||||.+...  .|+.+|||||||++|||+.||..|+..-..       .-+.+..... +..+.+.
T Consensus       222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~-gdpp~l~  291 (361)
T KOG1006|consen  222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVI-GDPPILL  291 (361)
T ss_pred             --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHc-CCCCeec
Confidence              223455788899999998643  489999999999999999999999762111       0011111111 1111111


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .     +.   .....+.++..++.-||..|-++||+..++.+
T Consensus       292 ~-----~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  292 F-----DK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             C-----cc---cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1     10   01157788999999999999999999998765

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=273.63  Aligned_cols=237  Identities=22%  Similarity=0.271  Sum_probs=192.0

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccC
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      ||+|+||   .||++..  +++.+|+|.+..... .......+.+|+.++++++||||+++++.+..++..++||||+++
T Consensus         1 lg~G~~~---~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFG---KVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCce---EEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence            6899999   9999988  588999999876532 233566889999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      ++|.+++...     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        78 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~  148 (250)
T cd05123          78 GELFSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-S  148 (250)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-C
Confidence            9999998765     35789999999999999999999   9999999999999999999999999999987654332 1


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIV  306 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (353)
                      ......++..|+|||...+...+.++|+||||+++|++++|..||.....        ......... ..+         
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~---------  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-DPL---------  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-CCC---------
Confidence            23445678899999999888889999999999999999999999864321        111111111 000         


Q ss_pred             hccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 018633          307 EDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVD  341 (353)
Q Consensus       307 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  341 (353)
                       .    .+...+..+.+++.+||..||++|||+.+
T Consensus       211 -~----~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 -R----FPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -C----CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence             0    00023567789999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-37  Score=285.04  Aligned_cols=265  Identities=17%  Similarity=0.191  Sum_probs=194.3

Q ss_pred             hCcC-CCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChh------------HHHHHHHHHHHHhhcCCCceee
Q 018633           62 NSYD-QKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPR------------AYESCINNVTYAARMSHNHILK  126 (353)
Q Consensus        62 ~~~~-~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~H~niv~  126 (353)
                      ++|. ..+.||+|+||   .||++.+  .++.||+|++........            ....+.+|+.++++++||||++
T Consensus         8 ~ry~~~~~~ig~G~~g---~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYG---KVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             cchhhhhhcccCCCce---eEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            4454 35779999999   9999987  788999999865422110            1125789999999999999999


Q ss_pred             ccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC
Q 018633          127 LIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE  206 (353)
Q Consensus       127 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  206 (353)
                      +++++...+..++||||++ |+|.+++...     ..+++.....++.|++.||.|||   +++++|+||+|+||+++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSK  155 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCC
Confidence            9999999999999999997 7999988654     35789999999999999999999   9999999999999999999


Q ss_pred             CceEEeccCCccccCCCC-------------CccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCC
Q 018633          207 NVAKLFDFSLSISIPEGE-------------THITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSD  272 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~  272 (353)
                      +.++|+|||.+.......             ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999987654110             1111233467889999998764 47899999999999999999999987


Q ss_pred             ccccccCCCCChHHHHHHHhhcCc---cccc--------ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 018633          273 LVKDTHDLACPSNEYLKNYFEDNR---FTEI--------VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVD  341 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  341 (353)
                      .......     ............   ++..        .......... ......+..+.+++.+||+.+|++|||+.+
T Consensus       236 ~~~~~~~-----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        236 GENEIDQ-----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             CCCHHHH-----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            4432110     000000000000   0000        0000000000 001134567889999999999999999999


Q ss_pred             HHH
Q 018633          342 VAK  344 (353)
Q Consensus       342 vl~  344 (353)
                      ++.
T Consensus       310 ~l~  312 (335)
T PTZ00024        310 ALK  312 (335)
T ss_pred             Hhc
Confidence            985

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=272.81  Aligned_cols=241  Identities=20%  Similarity=0.228  Sum_probs=199.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|+-.++||+|.||   .|-.+.-  +++.+|+|++++... .......-+.|-++|...+||.+..+.-.|...+++|
T Consensus       168 ~dFdfLKvLGkGTFG---KVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFG---KVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             chhhHHHHhcCCccc---eEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            678889999999999   8877776  899999999987643 3344455678999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+.||.|.-+|...     ..+++...+.+-..|+.||.|||   +++||.||||.+|.|+|.+|++||+|||+++
T Consensus       245 FVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccch
Confidence            999999999999888765     46889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .--.. .....+.+||+.|+|||++....|+.+.|.|.+|+++|||+.|+.||.......                    
T Consensus       317 E~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------------------  375 (516)
T KOG0690|consen  317 EEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------------------  375 (516)
T ss_pred             hcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--------------------
Confidence            64322 223578899999999999999999999999999999999999999997332211                    


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP  337 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  337 (353)
                       ++.-++..+...  |...+.+...|+...|..||.+|.
T Consensus       376 -LFeLIl~ed~kF--Pr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  376 -LFELILMEDLKF--PRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -HHHHHHhhhccC--CccCCHHHHHHHHHHhhcChHhhc
Confidence             111111111111  114556677899999999999996

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=311.85  Aligned_cols=260  Identities=18%  Similarity=0.198  Sum_probs=207.8

Q ss_pred             cHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcCCCceeeccc
Q 018633           53 SAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMSHNHILKLIG  129 (353)
Q Consensus        53 ~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~~~~  129 (353)
                      ...+++...++|.+.++||+|+||   .|.....  +++.+|+|++++...- .....-|..|-.+|..-..+-||.++-
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFG---EV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy  142 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFG---EVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY  142 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccc---eeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence            345555667899999999999999   7777777  8899999999875432 233455788999999999999999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                      .|.+++++|+||||++||+|..+|...     .++|+..++.++..|+.||.-||   +.|+|||||||+|||+|..|++
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHi  214 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHI  214 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcE
Confidence            999999999999999999999999765     46899999999999999999999   9999999999999999999999


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccc----c-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR----T-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                      ||+|||.+.....+........+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||....-..      
T Consensus       215 kLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve------  288 (1317)
T KOG0612|consen  215 KLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE------  288 (1317)
T ss_pred             eeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH------
Confidence            99999988777666666677889999999999985    2 569999999999999999999999997322111      


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC---HHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS---MVDVA  343 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~~vl  343 (353)
                                 .+..+++..-.-.+|  .....+....+||.+.+ .+|+.|..   +.++.
T Consensus       289 -----------TY~KIm~hk~~l~FP--~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  289 -----------TYGKIMNHKESLSFP--DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK  336 (1317)
T ss_pred             -----------HHHHHhchhhhcCCC--cccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence                       111111111111111  11146677788888766 57788877   66654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=285.85  Aligned_cols=244  Identities=22%  Similarity=0.248  Sum_probs=199.3

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .++||+|.||   +||-|++  +|+.||||++.+..-.......+.+|+.||.++.||.||.+--.|++.+..++|||-+
T Consensus       569 devLGSGQFG---~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl  645 (888)
T KOG4236|consen  569 DEVLGSGQFG---TVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL  645 (888)
T ss_pred             HhhccCCcce---eeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence            5789999999   9999998  8999999999876655666688999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC---CceEEeccCCccccC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFDFSLSISIP  221 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl~dfg~a~~~~  221 (353)
                      . |+..+.+.....   ..+++.....++.||+.||.|||   .++|+|+||||+|||+.+.   ..+||+|||+|+.+.
T Consensus       646 ~-GDMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  646 H-GDMLEMILSSEK---GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             c-chHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            6 666666654433   57888888899999999999999   9999999999999999654   579999999999986


Q ss_pred             CCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      +...  ..+.+||+.|+|||++....|+..-|+||+|+|+|--++|..||...++..       +.+    +...+.-  
T Consensus       719 EksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-------dQI----QNAaFMy--  783 (888)
T KOG4236|consen  719 EKSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-------DQI----QNAAFMY--  783 (888)
T ss_pred             hhhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-------HHh----hcccccc--
Confidence            5443  467889999999999999999999999999999999999999998443322       111    1111100  


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                              ++..-.+.+....+||...|+..-.+|-|....+
T Consensus       784 --------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  784 --------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             --------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence                    0111115566778899999999888898876544

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=294.03  Aligned_cols=257  Identities=20%  Similarity=0.243  Sum_probs=210.7

Q ss_pred             HHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccce
Q 018633           54 AQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGC  130 (353)
Q Consensus        54 ~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~  130 (353)
                      ++.+..-++.|....+||+|.+|   .||++..  +++.+|+|+....   ....++...|.++|+... |||++.++|+
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtyg---kv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~   84 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYG---KVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGA   84 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccce---eEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEE
Confidence            34444557789999999999999   8888877  8899999998765   345567788999999886 9999999999


Q ss_pred             eee-----CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          131 CLE-----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       131 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      +..     ++.+|||||||.+||..|+++...+   ..+.|..+..|++.++.||.+||   .+.++|||||-.|||+..
T Consensus        85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~  158 (953)
T KOG0587|consen   85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTE  158 (953)
T ss_pred             EEEecCCCCCeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEec
Confidence            873     4679999999999999999987663   67899999999999999999999   999999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCccccccccCCccccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCccccccCC
Q 018633          206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-----VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL  280 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~  280 (353)
                      ++.+|++|||++..+... ....++..||+.|||||++...     .|+..+|+||||++..||..|.+|+.......  
T Consensus       159 e~~VKLvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--  235 (953)
T KOG0587|consen  159 NAEVKLVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--  235 (953)
T ss_pred             cCcEEEeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--
Confidence            999999999999887543 3346788999999999998643     37789999999999999999999976433221  


Q ss_pred             CCChHHHHHHHhhcCcccccccchhhhccch-HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          281 ACPSNEYLKNYFEDNRFTEIVDPIIVEDVLS-IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                               .+|.          +.+.+.+. ..+...+.++.++|..||..|-+.||++.++++
T Consensus       236 ---------aLF~----------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  236 ---------ALFL----------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---------hhcc----------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                     1111          11111111 123488999999999999999999999998874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=247.32  Aligned_cols=262  Identities=18%  Similarity=0.194  Sum_probs=201.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +|+..+.||+|.||   +||+|.+  +++.||+|.+.-+..........++|+-+++.+.|.|||+++++...+..+-+|
T Consensus         3 ~ydkmekigegtyg---tvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYG---TVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcce---eeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            46667789999999   9999998  789999999987765666677889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +|||. .+|..+...-.    ..++.+....++.|+++||.|+|   +++++|||+||.|.||+.+|.+|++|||+++.+
T Consensus        80 fe~cd-qdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   80 FEFCD-QDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             HHHhh-HHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence            99996 68888876654    46888999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh-----
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE-----  293 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-----  293 (353)
                      .-.-. ......-|..|.+|.++.+.. |++..|+||-|||+.|+.. |++.|......+        .++..+.     
T Consensus       152 gipvr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--------qlkrif~~lg~p  222 (292)
T KOG0662|consen  152 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--------QLKRIFRLLGTP  222 (292)
T ss_pred             CCceE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--------HHHHHHHHhCCC
Confidence            54332 234456688999999998765 8999999999999999987 555555433222        1111111     


Q ss_pred             -cCcccc---cccchhhhccchH-----HHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 -DNRFTE---IVDPIIVEDVLSI-----EKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 -~~~~~~---~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       ...++.   +.|-...+.++..     .-+.....-.+|+.+.+.-+|..|.++++.++
T Consensus       223 ~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  223 TEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence             011111   1111111111110     00133344568999999999999999998765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.2e-37  Score=268.85  Aligned_cols=218  Identities=19%  Similarity=0.200  Sum_probs=174.5

Q ss_pred             CCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccCCChh
Q 018633           73 DTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLW  150 (353)
Q Consensus        73 G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~  150 (353)
                      |.+|   .||++.+  +++.+|+|++...       ..+.+|...+....||||+++++++.+.+..++||||+++|+|.
T Consensus         4 g~~~---~v~~~~~~~~~~~~~~K~i~~~-------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVID---KVLLVMDTRTQQTFILKGLRKS-------SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccc---eEEEEEEccCCcEEEEEeecch-------hhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            6778   8999888  8899999998654       12344555566677999999999999999999999999999999


Q ss_pred             hhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCccccc
Q 018633          151 DRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT  230 (353)
Q Consensus       151 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~  230 (353)
                      +++...     ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.++++|||.+......    ...
T Consensus        74 ~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~  141 (237)
T cd05576          74 SHISKF-----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDG  141 (237)
T ss_pred             HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----ccc
Confidence            988754     35889999999999999999999   999999999999999999999999999987654322    123


Q ss_pred             cccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccc
Q 018633          231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVL  310 (353)
Q Consensus       231 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (353)
                      ..++..|+|||.+....++.++|+||+|+++|||++|..|+.......             ....   .+       .. 
T Consensus       142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~---~~-------~~-  197 (237)
T cd05576         142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHT---TL-------NI-  197 (237)
T ss_pred             CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------cccc---cc-------CC-
Confidence            345677999999988889999999999999999999998765211100             0000   00       00 


Q ss_pred             hHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          311 SIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       311 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                         +...+..+.+++.+||+.||++|||+
T Consensus       198 ---~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         198 ---PEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ---cccCCHHHHHHHHHHccCCHHHhcCC
Confidence               11345667899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-36  Score=303.58  Aligned_cols=146  Identities=20%  Similarity=0.168  Sum_probs=130.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||+|++.... ........+.+|+.++..++||||+++++++...+..|
T Consensus         4 ~~y~i~~~LG~G~fg---~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           4 EEFVIVKPISRGAFG---KVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             CCEEEEEEEecCCCe---EEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            568888999999999   9999999  58999999986542 23444577899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++...     ..+++..++.|+.||+.||.|||   .++|+||||||+|||++.++.++|+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999998654     35788889999999999999999   8999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-39  Score=267.03  Aligned_cols=272  Identities=15%  Similarity=0.221  Sum_probs=199.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC-----
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET-----  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----  134 (353)
                      +.|.....+|+|.||   .||++..  +++.||+|++.........-...++|+++|..+.|+|++.+++.|...     
T Consensus        17 ~~yek~~kigqGtfg---eVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFG---EVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             hHHHHHHhcCCchHH---HHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            346667789999999   8888877  788899988765443445556778999999999999999999998642     


Q ss_pred             ---CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          135 ---PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       135 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                         ..+|+||.+|+ -+|..++....    ..++..++.+++.++..||.|+|   +..|+|||+||.|+||+.+|.+||
T Consensus        94 r~r~t~ylVf~~ce-hDLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilkl  165 (376)
T KOG0669|consen   94 RDRATFYLVFDFCE-HDLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKL  165 (376)
T ss_pred             cccceeeeeHHHhh-hhHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEe
Confidence               34899999998 58988887654    57899999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCcc---ccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCC------C
Q 018633          212 FDFSLSISIPEGETHI---TDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL------A  281 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~------~  281 (353)
                      +|||+++.+.......   ....+-|..|++||.+.+.. |+++.|||.-||++.||+||.+.++...+...+      +
T Consensus       166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc  245 (376)
T KOG0669|consen  166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC  245 (376)
T ss_pred             eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence            9999998775443221   23455689999999998755 999999999999999999999998865543311      1


Q ss_pred             CChHHHHHHHhhcCcccccc--cchhhhccchHH----HHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          282 CPSNEYLKNYFEDNRFTEIV--DPIIVEDVLSIE----KEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ......+|.....-.+...+  .+.-.+......    +-......++|+.+++..||.+||++++++.
T Consensus       246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            11111111111100000000  000000000000    0011236679999999999999999998875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-37  Score=272.67  Aligned_cols=281  Identities=21%  Similarity=0.255  Sum_probs=207.2

Q ss_pred             hhHHHHHHHhcCCCCCCcceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-C----Chh
Q 018633           32 ASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-C----RPR  104 (353)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~----~~~  104 (353)
                      ..-..++....++....+.     +-....+.|-..++||+|||+   .||++.+  ..+.||||+-.... +    ...
T Consensus       438 nlHiRELKRi~NEdnSQFk-----DHptLn~RYLlLhLLGrGGFS---EVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeN  509 (775)
T KOG1151|consen  438 NLHIRELKRIHNEDNSQFK-----DHPTLNDRYLLLHLLGRGGFS---EVYKAFDLTEQRYVAVKIHQLNKNWRDEKKEN  509 (775)
T ss_pred             HHHHHHHHhhcccchhhhc-----cCcchHHHHHHHHHhccccHH---HHHHhcccchhheeeEeeehhccchhhHhhhh
Confidence            3344555555444433222     222445667788899999999   8889988  77889999864332 1    223


Q ss_pred             HHHHHHHHHHHHhhcCCCceeeccceee-eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHH
Q 018633          105 AYESCINNVTYAARMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL  183 (353)
Q Consensus       105 ~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L  183 (353)
                      ..+...+|.+|-+.|.||.||++|+++. +.+.+|-|+|||+|.+|.-+|+.+     ..+++.+++.|+.||+.||.||
T Consensus       510 YhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YL  584 (775)
T KOG1151|consen  510 YHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYL  584 (775)
T ss_pred             HHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHH
Confidence            3455789999999999999999999987 556799999999999998888776     4689999999999999999999


Q ss_pred             hcCCCCCeEeeccCCCceeecC---CCceEEeccCCccccCCCCCc------cccccccCCccccccccccC----CCCc
Q 018633          184 HFGFPRPIVFRNFKTSCILFNE---ENVAKLFDFSLSISIPEGETH------ITDTVMGTWGYCAPEYMRTG----VFNE  250 (353)
Q Consensus       184 H~~~~~~iiH~dlkp~Nill~~---~~~~kl~dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~  250 (353)
                      ..- +.+|||-||||.|||+-+   .|.+||.|||+++....+...      .+....||..|++||++.-+    ..+.
T Consensus       585 NEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsn  663 (775)
T KOG1151|consen  585 NEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISN  663 (775)
T ss_pred             hcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccc
Confidence            854 779999999999999853   478999999999987544322      23456899999999998644    3788


Q ss_pred             cccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchh
Q 018633          251 KSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIK  330 (353)
Q Consensus       251 ~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  330 (353)
                      ++||||+|||+|+++.|+.||.......           .....+.+.....      +..+..+..+.+..++|.+||.
T Consensus       664 KVDVWSvGVIFyQClYGrKPFGhnqsQQ-----------dILqeNTIlkAtE------VqFP~KPvVsseAkaFIRRCLa  726 (775)
T KOG1151|consen  664 KVDVWSVGVIFYQCLYGRKPFGHNQSQQ-----------DILQENTILKATE------VQFPPKPVVSSEAKAFIRRCLA  726 (775)
T ss_pred             ceeeEeeehhhhhhhccCCCCCCchhHH-----------HHHhhhchhccee------ccCCCCCccCHHHHHHHHHHHH
Confidence            9999999999999999999997433222           1111111111100      0001111455667789999999


Q ss_pred             cCCCCCCCHHHHH
Q 018633          331 DSPADRPSMVDVA  343 (353)
Q Consensus       331 ~dP~~Rps~~~vl  343 (353)
                      +.-++|....++.
T Consensus       727 YRKeDR~DV~qLA  739 (775)
T KOG1151|consen  727 YRKEDRIDVQQLA  739 (775)
T ss_pred             hhhhhhhhHHHHc
Confidence            9999998877664

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=283.29  Aligned_cols=238  Identities=22%  Similarity=0.271  Sum_probs=191.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~  137 (353)
                      ++.|.....+|.|+|+   .|-.+..  +++..++|++....      ..-.+|+.++... +||||+++.+++.++.+.
T Consensus       321 ~~~y~~~~~~~~gs~s---~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFS---AVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             chhhccccccCCCCcc---ceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCcee
Confidence            4567777779999999   8888888  88899999997651      2234566566655 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee-cCCCceEEeccCC
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF-NEENVAKLFDFSL  216 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill-~~~~~~kl~dfg~  216 (353)
                      |+|||.+.++-|.+.+....      .....+..|+.+|+.|+.|||   ++|||||||||+|||+ ++.++++|+|||.
T Consensus       392 ~~v~e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             eeeehhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEech
Confidence            99999999998888776643      233777789999999999999   9999999999999999 6899999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ++.....    ..+.+-|..|.|||++....|+.++|+||||++||+|++|+.||.......                  
T Consensus       463 a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------------------  520 (612)
T KOG0603|consen  463 WSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------------------  520 (612)
T ss_pred             hhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------------------
Confidence            9877544    234456788999999998899999999999999999999999987433221                  


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                        ++...+..+...    ...+....+|+.+||+.||.+||++.++..
T Consensus       521 --ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  521 --EIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --HHHHhhcCCccc----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              111111111111    267788899999999999999999998864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=278.80  Aligned_cols=241  Identities=17%  Similarity=0.223  Sum_probs=198.1

Q ss_pred             cCCCCceeeCCCCCccEEEEEEeCCeE--EEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFWQERL--ISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~~~~~--vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      +.....||-||||   .|-....+++.  .|+|++++... .....+....|-++|...+.|.||++|-.|.+....|+.
T Consensus       422 l~~iaTLGvGgFG---RVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  422 LKRIATLGVGGFG---RVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhcccCccc---eEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            4445569999999   87777774444  78888876553 345567788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      ||-|-||.|...|++.     ..++..+...++.+++.|++|||   +++||.|||||+|.++|.+|.+||.|||+|+.+
T Consensus       499 mEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  499 MEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             HHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999877     46888899999999999999999   999999999999999999999999999999998


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..+..  +.+.+||+.|.|||++.+...+.++|.||||+++|||++|.+||.......                     .
T Consensus       571 ~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---------------------t  627 (732)
T KOG0614|consen  571 GSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---------------------T  627 (732)
T ss_pred             ccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---------------------H
Confidence            65543  678899999999999999999999999999999999999999998433211                     1


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS  338 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  338 (353)
                      +..++.+--....|........+||.+....+|.+|..
T Consensus       628 Yn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  628 YNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             HHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            11111111111112245566678999999999999975

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.6e-35  Score=286.00  Aligned_cols=265  Identities=18%  Similarity=0.109  Sum_probs=171.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--C----CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccce---
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--Q----ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGC---  130 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~---  130 (353)
                      ..++|...+.||+|+||   .||+|.+  +    +..||+|++...    ...+.+..|  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG---~VYka~~~~~~~~~~~~vAvK~~~~~----~~~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFG---VVYKASLVNKQSKKEGKYVLKKATEY----GAVEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCe---EEEEEEEcCCccccCcEEEEEEeccc----chhHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            56789999999999999   9999998  4    689999987643    112222222  1222233333333322   


Q ss_pred             ---eeeCCccEEEEEeccCCChhhhhccCCCCC---------------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 018633          131 ---CLETPIPILVFESVQYGTLWDRILGAPQPH---------------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV  192 (353)
Q Consensus       131 ---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii  192 (353)
                         +..+...++|+||+++++|.+++.......               ........+..++.|++.||.|||   +++|+
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIi  277 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIV  277 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEE
Confidence               235567899999999999999887543110               001123345679999999999999   99999


Q ss_pred             eeccCCCceeecC-CCceEEeccCCccccCCCCCccccccccCCccccccccccCC----------------------CC
Q 018633          193 FRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV----------------------FN  249 (353)
Q Consensus       193 H~dlkp~Nill~~-~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~  249 (353)
                      ||||||+|||++. ++.+||+|||+|+..............+++.|+|||.+....                      ++
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            9999999999985 578999999999876544333345667899999999663221                      33


Q ss_pred             ccccchhhHHHHHHHHhCCCCCCccccc-----cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHH
Q 018633          250 EKSDVFSFGVFLFELLTGWDVSDLVKDT-----HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQL  324 (353)
Q Consensus       250 ~~~Di~slG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  324 (353)
                      .++|||||||++|||+++..+++.....     .........|... ....     ..+.+.....  ..........+|
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~--~~d~~~~~~~dL  429 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPR-----ASPDLRRGFE--VLDLDGGAGWEL  429 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccc-----cchhhhhhhh--hccccchHHHHH
Confidence            4569999999999999976654321000     0000001111000 0000     0000000000  000112345689


Q ss_pred             HHHchhcCCCCCCCHHHHHH
Q 018633          325 SFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       325 i~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.+||+.||++|||+.++++
T Consensus       430 i~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHHccCCcccCCCHHHHhC
Confidence            99999999999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5e-35  Score=256.05  Aligned_cols=238  Identities=23%  Similarity=0.279  Sum_probs=191.0

Q ss_pred             CCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccCCChhh
Q 018633           74 TSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD  151 (353)
Q Consensus        74 ~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  151 (353)
                      +||   .||+|.+  +++.+|+|++........ .+.+.+|+..+++++|+||+++++++......++++||+++++|.+
T Consensus         1 ~~g---~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFG---KVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             Cce---EEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            578   9999999  479999999976632211 6789999999999999999999999999999999999999889999


Q ss_pred             hhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCcccccc
Q 018633          152 RILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV  231 (353)
Q Consensus       152 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~  231 (353)
                      ++....     .++...++.++.+++.++.|||   ..+++|+||+|+||+++.++.++++|||.+.......  .....
T Consensus        77 ~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  146 (244)
T smart00220       77 LLKKRG-----RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTF  146 (244)
T ss_pred             HHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccc
Confidence            887642     3788999999999999999999   8999999999999999999999999999987764432  23345


Q ss_pred             ccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccch
Q 018633          232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLS  311 (353)
Q Consensus       232 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (353)
                      .++..|++||......++.++||||||++++++++|..||......        ................          
T Consensus       147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~~----------  208 (244)
T smart00220      147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--------LELFKKIGKPKPPFPP----------  208 (244)
T ss_pred             cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHhccCCCCcc----------
Confidence            6788999999998888999999999999999999999998642111        1111111111110000          


Q ss_pred             HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          312 IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       312 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       .....+..+.+++.+||..+|++||++.++++
T Consensus       209 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      209 -PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             -ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence             00015567889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=285.02  Aligned_cols=247  Identities=20%  Similarity=0.295  Sum_probs=190.9

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  141 (353)
                      -|...+++|.|+.|  +.||+|.+.++.||||++...     ...-..+|+..|+.-+ |||||++|+.-.+..+.||..
T Consensus       510 ~~~~~eilG~Gs~G--t~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  510 FFSPKEILGYGSNG--TVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eeccHHHcccCCCC--cEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            35666789999999  358999999999999998544     4556689999999886 999999999988999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---C--CceEEeccCC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---E--NVAKLFDFSL  216 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~--~~~kl~dfg~  216 (353)
                      |.|. .||.+++..... ..........+.++.|++.||++||   +.+||||||||.||||+.   +  ..++|+|||+
T Consensus       583 ELC~-~sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             hHhh-hhHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence            9997 799999987411 1011111445678999999999999   999999999999999976   2  4789999999


Q ss_pred             ccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhC-CCCCCccccccCCCCChHHHHHHHhh
Q 018633          217 SISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG-WDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       217 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ++....+...  ......||-+|+|||++....-+.++||||+||++|..++| ..||.....-+          .+...
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~  727 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILT  727 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhc
Confidence            9988765533  24567899999999999988888999999999999999996 78886332211          00000


Q ss_pred             c-CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 D-NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      . ..+..         ..+. . ++  +..+||.+|++++|..||||.+|+.
T Consensus       728 ~~~~L~~---------L~~~-~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  728 GNYTLVH---------LEPL-P-DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             Cccceee---------eccC-c-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0 00000         0000 0 22  6679999999999999999999974

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-36  Score=264.18  Aligned_cols=248  Identities=19%  Similarity=0.238  Sum_probs=198.6

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-hhHHHHHHHHHHHHhhcC-CCceeeccce
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-PRAYESCINNVTYAARMS-HNHILKLIGC  130 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~~~~~  130 (353)
                      .+..+++ +|.-..+||+|+||   .|..+..  +...+|||+++++... ....+--+.|-++|+-.. -|.++++..+
T Consensus       343 ~d~i~~t-DFnFl~VlGKGSFG---KVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  343 RDRIKAT-DFNFLMVLGKGSFG---KVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             ccceeec-ccceEEEeccCccc---eeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            3333444 47778899999999   9999988  6678999999876532 223343466777777664 7899999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                      |.+-+.+|+||||+.||+|--.++.-     ..+.+..+..++..||-||-|||   +++||.||||.+||++|.+|++|
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiK  490 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIK  490 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceE
Confidence            99999999999999999998888765     45778888999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      |+|||+++.---+.. .+.+.+||+.|+|||.+...+|+..+|.||||++||||+.|++||+...+..        ... 
T Consensus       491 i~DFGmcKEni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~-  560 (683)
T KOG0696|consen  491 IADFGMCKENIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQ-  560 (683)
T ss_pred             eeecccccccccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHH-
Confidence            999999876433322 3567899999999999999999999999999999999999999998544322        111 


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS  338 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  338 (353)
                              .+.+..    .  ..|...+.+..++....|...|.+|..
T Consensus       561 --------aI~ehn----v--syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  561 --------AIMEHN----V--SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --------HHHHcc----C--cCcccccHHHHHHHHHHhhcCCccccC
Confidence                    111111    1  112266777788899999999999963

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=259.32  Aligned_cols=268  Identities=19%  Similarity=0.283  Sum_probs=212.5

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeec
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKL  127 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~  127 (353)
                      +|+......+....++-+|.||   .||.|.|       +.+.|-+|.++... ++-....++.|.-.+..+.|||+..+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFG---ri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V  352 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFG---RIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSV  352 (563)
T ss_pred             HhhhhhhhheechhhhhcCchh---heeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccce
Confidence            3444555677788889999999   9999977       23456677776553 55567789999999999999999999


Q ss_pred             cceeeeC-CccEEEEEeccCCChhhhhc-----cCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCce
Q 018633          128 IGCCLET-PIPILVFESVQYGTLWDRIL-----GAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI  201 (353)
Q Consensus       128 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  201 (353)
                      .+++.++ ..+++++.++.-|+|..++.     +...  .+.+.-.+...++.|++.|++|||   +++|||.||..+|.
T Consensus       353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~--aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNC  427 (563)
T KOG1024|consen  353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSY--AQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNC  427 (563)
T ss_pred             eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCcc--ccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcc
Confidence            9998754 57889999999999999998     2222  256777788899999999999999   99999999999999


Q ss_pred             eecCCCceEEeccCCccccCCCCCccc-cccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccC
Q 018633          202 LFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHD  279 (353)
Q Consensus       202 ll~~~~~~kl~dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~  279 (353)
                      +||+.-++||+|=.+++.+-+.+.+.. .....+..||+||.+....|+.++|+||||+++|||+| |+.|+......+ 
T Consensus       428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-  506 (563)
T KOG1024|consen  428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-  506 (563)
T ss_pred             eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence            999999999999999987765554332 23345678999999999999999999999999999999 777865322211 


Q ss_pred             CCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                              +..+..+             ......|-+++.++..+|.-||..+|++|||+++++..|.++...|
T Consensus       507 --------m~~ylkd-------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  507 --------MEHYLKD-------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             --------HHHHHhc-------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence                    1111111             1111222288999999999999999999999999999999887653

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.5e-34  Score=271.58  Aligned_cols=263  Identities=16%  Similarity=0.200  Sum_probs=180.9

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe------------------CCeEEEEEEecCCCCChhHHHH-------------
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW------------------QERLISVLQFYGHECRPRAYES-------------  108 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~------------------~~~~vavK~~~~~~~~~~~~~~-------------  108 (353)
                      ..++|...++||+|+||   .||+|.+                  .++.||||++...  .....++             
T Consensus       143 ~~d~F~i~~~LG~GgFG---~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~--~~~~~~~fl~e~~~~~~~~e  217 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFG---ITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMD--RQGVRQDFLKTGTLAKGSAE  217 (507)
T ss_pred             cccCceEeeEeecCCCe---EEEEEEecccccchhhhhccccccccCceEEEEEeccc--chhhHHHHHhhhhhhhcccc
Confidence            46789999999999999   9999864                  3467999998654  2222333             


Q ss_pred             -HHHHHHHHhhcCCCce-----eeccceeee--------CCccEEEEEeccCCChhhhhccCCCCC--------------
Q 018633          109 -CINNVTYAARMSHNHI-----LKLIGCCLE--------TPIPILVFESVQYGTLWDRILGAPQPH--------------  160 (353)
Q Consensus       109 -~~~E~~~l~~l~H~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------  160 (353)
                       +..|+..+.+++|.++     ++++++|..        .+..++||||+++++|.+++.......              
T Consensus       218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l  297 (507)
T PLN03224        218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI  297 (507)
T ss_pred             hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence             3447777777776654     677887753        356899999999999999887532110              


Q ss_pred             -----CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCC
Q 018633          161 -----FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW  235 (353)
Q Consensus       161 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~  235 (353)
                           ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++...............+|+
T Consensus       298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp  374 (507)
T PLN03224        298 PDNMPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDP  374 (507)
T ss_pred             hhhcccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCc
Confidence                 023456778899999999999999   999999999999999999999999999998765433222122234578


Q ss_pred             ccccccccccCC--------------------CC--ccccchhhHHHHHHHHhCCC-CCCccccccCC----CCChHHHH
Q 018633          236 GYCAPEYMRTGV--------------------FN--EKSDVFSFGVFLFELLTGWD-VSDLVKDTHDL----ACPSNEYL  288 (353)
Q Consensus       236 ~y~aPE~~~~~~--------------------~~--~~~Di~slG~il~el~tg~~-p~~~~~~~~~~----~~~~~~~~  288 (353)
                      .|+|||.+....                    ++  .+.||||+||++++|++|.. |+.........    ......| 
T Consensus       375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~-  453 (507)
T PLN03224        375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW-  453 (507)
T ss_pred             ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH-
Confidence            999999875322                    11  24799999999999999875 55422111100    0000000 


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCC---CCCCCHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSP---ADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~~vl~  344 (353)
                       .......+          +..  .....+....+|+.++|..+|   .+|+|+.++++
T Consensus       454 -r~~~~~~~----------~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        454 -RMYKGQKY----------DFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -HhhcccCC----------Ccc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             00000000          000  011345677899999999766   68999999875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=253.58  Aligned_cols=271  Identities=17%  Similarity=0.208  Sum_probs=206.3

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-----
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-----  135 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-----  135 (353)
                      +....+-||-|+||   .||...+  +|+.||.|++.+...+....+.+.+|+++|..++|.|++..+++.....     
T Consensus        54 Di~PDRPIGYGAFG---VVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFG---VVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCccccccee---EEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            45677899999999   9999888  8999999999887667777889999999999999999999999865432     


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+++|+|. .+|...+-..     ++++...+.-+++||++||.|||   +.+|+||||||.|.|+++|..+||+|||
T Consensus       131 EiYV~TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  131 ELYVLTELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHHHHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccc
Confidence            4678999996 6887776543     67889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCChHHH
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACPSNEY  287 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~~  287 (353)
                      +++....++.......+-|..|.|||.+.+.. |+.+.||||+|||+.||+.++..|+......       -++.+..+.
T Consensus       202 LARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  202 LARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             cccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            99887554443334455678899999999865 9999999999999999999988887554422       233444444


Q ss_pred             HHHHhhcCcccccccchhhhccc----hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVL----SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ++...++.+..-+....-.++..    ...+.....+...+..+++.+||+.|.+-.+.+..
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            44443332211111111001100    00111333455678889999999999998876643

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=237.38  Aligned_cols=202  Identities=18%  Similarity=0.194  Sum_probs=163.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEE--eCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGF--WQERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~  138 (353)
                      +.......||+|++|   .|-+-.  .+|...|+|.+.... +.+...+.++|+.+..+. .+|.+|.|||........|
T Consensus        46 d~L~~i~elGrGayG---~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYG---VVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             hhhhhhhhhcCCccc---hhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            334445669999999   554444  499999999997664 455667788899887765 5999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      |.||.|. -||..+..+--... ..+++..+-+|+..++.||.|||+  ...+||||+||+||||+.+|++|+||||.+-
T Consensus       122 IcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  122 ICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999996 68866554321111 578899999999999999999996  6789999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCcccccccccc----CCCCccccchhhHHHHHHHHhCCCCCCc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTGWDVSDL  273 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el~tg~~p~~~  273 (353)
                      .+.++-  ..+...|...|||||.+..    ..|+.+|||||||+++.||.+++.|++.
T Consensus       198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            664322  1233567788999998853    3599999999999999999999999873

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=250.01  Aligned_cols=251  Identities=20%  Similarity=0.269  Sum_probs=199.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh-hHHHHHHHHHHHHhhcC-CCceeeccceeeeCCc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP-RAYESCINNVTYAARMS-HNHILKLIGCCLETPI  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~  136 (353)
                      .++|...++||+|+|+   .|..+.+  +.+.+|+|++++...+. ...+=...|-.+..+.+ ||.+|-+..+|.+...
T Consensus       249 l~df~ll~vigrgsya---kvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYA---KVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             cccceeeeeecCcchh---hhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            4679999999999999   8887777  88999999987654332 23334466777777764 9999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      +++|.||++||+|--++...     ..+|++.++.+...|+.||.|||   ++|||.||||.+|+|+|..|++||.|+|.
T Consensus       326 lffvieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             EEEEEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccch
Confidence            99999999999998888765     47999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .+..-.+ ...+.+.+||+.|.|||.+.+..|....|.|+||++++||+.|+.||+...... .......++-+.     
T Consensus       398 cke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n-~d~ntedylfqv-----  470 (593)
T KOG0695|consen  398 CKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN-PDMNTEDYLFQV-----  470 (593)
T ss_pred             hhcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC-cccchhHHHHHH-----
Confidence            8764332 233678999999999999999999999999999999999999999998654221 112222222111     


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS  338 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  338 (353)
                         ++.+.++-      |...+.....++..-|+.||.+|..
T Consensus       471 ---ilekqiri------prslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  471 ---ILEKQIRI------PRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ---Hhhhcccc------cceeehhhHHHHHHhhcCCcHHhcC
Confidence               12211111      1144555667888899999999853

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-33  Score=259.31  Aligned_cols=204  Identities=15%  Similarity=0.171  Sum_probs=172.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .-|...+.||-|+||   .|..+.-  +...+|.|.+.+.+ ...........|-+||+....+-||+||-.|.+.+.+|
T Consensus       629 SmFvkik~iGvGAFG---eV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFG---EVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             cceEEEeeecccccc---eeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            457788899999999   6665544  67788988886553 23344556788999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||+|++||++-.+|...     .-|++..++.++.++.+|+++.|   ..|+|||||||+|||||.+|++||.|||+++
T Consensus       706 FVMdYIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             EEEeccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccc
Confidence            999999999999999876     46889999999999999999999   9999999999999999999999999999976


Q ss_pred             ccCCC---------CC--------------------------------ccccccccCCccccccccccCCCCccccchhh
Q 018633          219 SIPEG---------ET--------------------------------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF  257 (353)
Q Consensus       219 ~~~~~---------~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  257 (353)
                      -+...         ..                                ......+||..|+|||++....|+..+|.||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            44210         00                                00123569999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCcccc
Q 018633          258 GVFLFELLTGWDVSDLVKD  276 (353)
Q Consensus       258 G~il~el~tg~~p~~~~~~  276 (353)
                      |||||||+.|+.||.....
T Consensus       858 gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCC
Confidence            9999999999999975433

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.5e-33  Score=255.81  Aligned_cols=268  Identities=19%  Similarity=0.211  Sum_probs=202.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC------CCceeeccceeee
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS------HNHILKLIGCCLE  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~~~~~~~~  133 (353)
                      +.|.+....|+|-|+   +|..|.+  .+..||||++.+.   ......=+.|+++|++|+      --|+++++-.|..
T Consensus       432 ~RY~V~~~~GkGvFs---~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFS---TVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             ceeEEEeccccceee---eeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            346666778999999   9999998  7889999999876   455666788999999996      2379999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEEe
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLF  212 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~  212 (353)
                      .+++|||+|.+. .+|.++|+..+..  ..|....+..++.|+..||..|-   ..+|+|.||||+|||+++. ..+|||
T Consensus       506 knHLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  506 KNHLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             cceeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeec
Confidence            999999999996 7999999876543  56888899999999999999999   9999999999999999865 567999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSN  285 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~  285 (353)
                      |||.|........   ..+.-+..|.|||++.+-+|+...|+||+||+||||+||+..|.....-+-+       +...+
T Consensus       580 DfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  580 DFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             cCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            9999977654432   2344567899999999999999999999999999999999888754321100       00011


Q ss_pred             H------HHHHHhhcC-cc----------------ccccc------chhhh-ccchHHHHHHHHHHHHHHHHchhcCCCC
Q 018633          286 E------YLKNYFEDN-RF----------------TEIVD------PIIVE-DVLSIEKEQQLHASAQLSFECIKDSPAD  335 (353)
Q Consensus       286 ~------~~~~~~~~~-~~----------------~~~~~------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~  335 (353)
                      .      +...-|... ++                ...+.      ..+.. ...+.........+.+|+.+||..||+.
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence            1      111111100 00                00000      11111 1112222367788999999999999999


Q ss_pred             CCCHHHHHH
Q 018633          336 RPSMVDVAK  344 (353)
Q Consensus       336 Rps~~~vl~  344 (353)
                      |.|..++++
T Consensus       737 Rit~nqAL~  745 (752)
T KOG0670|consen  737 RITVNQALK  745 (752)
T ss_pred             cCCHHHHhc
Confidence            999998875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.9e-33  Score=231.52  Aligned_cols=263  Identities=14%  Similarity=0.200  Sum_probs=195.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeC--C
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLET--P  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~--~  135 (353)
                      .++|+..+.+|+|.++   .||.|..  ++..++||+++..     ....+.+|+.+|..|+ ||||++++++..+.  .
T Consensus        37 ~ddYeivrk~GRGKYS---EVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYS---EVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             cchHHHHHHHcCccHh---hHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            4678889999999999   9999997  8889999998544     5677899999999998 99999999998765  4


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEEecc
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDF  214 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~df  214 (353)
                      .+.+|+||+.+.+...+.        ..++...+..++.+++.||.|+|   +.||+|||+||.|++||.. -.++|+|+
T Consensus       109 tpaLiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             CchhHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeec
Confidence            678999999887765544        46778889999999999999999   9999999999999999965 46899999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCcccc-ccCCCC----ChHHHH
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKD-THDLAC----PSNEYL  288 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~-~~~~~~----~~~~~~  288 (353)
                      |+|-..-++..  .+..+.+..|--||.+..- .|+..-|+|||||++..|+..+.||....+ .+.+..    .....+
T Consensus       178 GLAEFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  178 GLAEFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             chHhhcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence            99977644432  3455667788999998764 488999999999999999999999875432 111100    000111


Q ss_pred             HHHhhc------Ccccccccchhhh----ccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFED------NRFTEIVDPIIVE----DVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~------~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+...      ..+..++......    -.+.....-.+++..+|+.+.|.+|..+|||+.|++.
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            111111      1111211111111    0111111123477889999999999999999999874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-32  Score=246.71  Aligned_cols=130  Identities=15%  Similarity=0.222  Sum_probs=113.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-----C---Cceeecccee
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-----H---NHILKLIGCC  131 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~~~~~~  131 (353)
                      +.|...++||.|-|+   +||.+.+  ..+.||+|+.+..   ....+..+.|+++|++++     |   .+||+|++.|
T Consensus        78 gRY~v~rKLGWGHFS---TVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFS---TVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceEEEEEeccccccc---eeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            567789999999999   9999999  7889999998765   566778899999999985     3   3599999999


Q ss_pred             ee----CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee
Q 018633          132 LE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF  203 (353)
Q Consensus       132 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  203 (353)
                      ..    +.+.|+|+|++ |.+|..++....-   ..++...+.+|+.||+.||.|||.  ..+|||-||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            74    45899999999 5799999986643   678999999999999999999997  5699999999999999

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=241.57  Aligned_cols=265  Identities=19%  Similarity=0.232  Sum_probs=196.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC----
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP----  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----  135 (353)
                      ..|.....+|.|.-    .|..+.+  .++.||+|+...........++..+|...+..+.|+||++++.++....    
T Consensus        17 ~Ry~nL~p~~~g~~----~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ----IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeecccCCCCc----eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34555666776664    3555555  8999999998766555666778899999999999999999999997543    


Q ss_pred             --ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          136 --IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       136 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                        ..|+|||+|. ++|...+.-       .++-.++..|+.|++.|+.|||   +.+|+||||||+||++..+..+||.|
T Consensus        93 ~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   93 FQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             HHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeecc
Confidence              5799999996 799888762       3567788899999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCChHH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACPSNE  286 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~  286 (353)
                      ||+|+.....  ...+..+.|..|.|||++.+..+...+||||+||++.||++|...|......+       .++.+...
T Consensus       162 fg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  162 FGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             chhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            9999775433  23456778999999999999889999999999999999999998876432211       22223222


Q ss_pred             HHHHHhhc-------------CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          287 YLKNYFED-------------NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       287 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.......             -.+.+.+....-...... ++..+....+++.+||-.||++|.|+++++.
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~-~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG-SKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccC-CccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            22222110             011111111111000000 0133455779999999999999999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=3.1e-31  Score=226.48  Aligned_cols=210  Identities=26%  Similarity=0.417  Sum_probs=181.2

Q ss_pred             eeeCCCCCccEEEEEEeC--CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccCC
Q 018633           70 IAKDTSYNLYTMYKGFWQ--ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYG  147 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  147 (353)
                      ||+|++|   .||++...  ++.+++|++....... ..+.+.+|+..++.++|++|+++++++......++++|+++++
T Consensus         1 l~~g~~~---~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFG---TVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCce---EEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            6899999   99999994  8999999997663111 4577999999999999999999999999989999999999999


Q ss_pred             ChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-CCceEEeccCCccccCCCCCc
Q 018633          148 TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       148 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      +|.+++....    ..++...+..++.+++.+|.+||   +.+++|+||+|.||+++. ++.++|+|||.+........ 
T Consensus        77 ~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-  148 (215)
T cd00180          77 SLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-  148 (215)
T ss_pred             cHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence            9999987542    25788999999999999999999   899999999999999999 89999999999876643321 


Q ss_pred             cccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchh
Q 018633          227 ITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPII  305 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (353)
                      ......+...|++||.+... .++.++|+|++|++++++                                         
T Consensus       149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------  187 (215)
T cd00180         149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------  187 (215)
T ss_pred             hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence            12334567889999999877 788999999999999998                                         


Q ss_pred             hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          306 VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       306 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                                   ..+.+++.+|++.+|++||++.++++.
T Consensus       188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                         345689999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=231.95  Aligned_cols=264  Identities=18%  Similarity=0.207  Sum_probs=195.3

Q ss_pred             ecHHHHHHH--hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceee
Q 018633           52 FSAQEIKLA--TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILK  126 (353)
Q Consensus        52 ~~~~e~~~~--~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~  126 (353)
                      ++..||.+.  .+.|++.+.||.|.||   .+-.+.+  ....+|+|.+...   .....+|.+|+..--.|. |.||+.
T Consensus        12 I~~~el~kv~l~d~y~I~k~lgeG~Fg---kIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~   85 (378)
T KOG1345|consen   12 IPMEELKKVDLEDVYTINKQLGEGRFG---KILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIID   85 (378)
T ss_pred             cccccccccchhhhhhHHHHhccccee---eEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhH
Confidence            334444443  4679999999999999   9999998  6788999988765   456788999998888887 999999


Q ss_pred             ccce-eeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec-
Q 018633          127 LIGC-CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN-  204 (353)
Q Consensus       127 ~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-  204 (353)
                      -|++ |...+.+++++||+|.|+|.+-+...      .+.+.....++.|+++|+.|||   ++++||||||.+||||- 
T Consensus        86 tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~  156 (378)
T KOG1345|consen   86 TYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFD  156 (378)
T ss_pred             HHHHHhhcCceEEEeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEec
Confidence            8876 56677888999999999998877653      4677888899999999999999   99999999999999984 


Q ss_pred             -CCCceEEeccCCccccCCCCCccccccccCCccccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCcccccc
Q 018633          205 -EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-----VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH  278 (353)
Q Consensus       205 -~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~tg~~p~~~~~~~~  278 (353)
                       +...+||+|||.++..+..    ......+..|.+||.+...     ...+.+|+|.||+++|.++||..||+-+...+
T Consensus       157 ~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d  232 (378)
T KOG1345|consen  157 ADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD  232 (378)
T ss_pred             CCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence             3358999999998665321    2233345679999987532     25678999999999999999999998433322


Q ss_pred             CCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                         .+..+|.  .|.+...+     .+...+.     ..+..+..+..+-|.++|++|=-..++.+....+
T Consensus       233 ---~~Y~~~~--~w~~rk~~-----~~P~~F~-----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~  288 (378)
T KOG1345|consen  233 ---KPYWEWE--QWLKRKNP-----ALPKKFN-----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL  288 (378)
T ss_pred             ---chHHHHH--HHhcccCc-----cCchhhc-----ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence               2222221  22222222     1111111     4556677888899999999995555555544433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-33  Score=257.88  Aligned_cols=252  Identities=19%  Similarity=0.222  Sum_probs=203.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|.....||+|.||   .|||+++  ++...|+|+++..  ......-..+|+-+++..+|||||.++|.+...+..|
T Consensus        14 ~ddyellqrvgsgTyg---dvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYG---DVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             ccchhheeeecCCccc---chhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            4678888999999999   9999999  8999999999876  3445566778999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      ++||||.+|+|.+..+..     .++++.++...++..++||.|||   +.+=+|||||-.|||+.+.|.+|++|||.+-
T Consensus        89 icMEycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsa  160 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSA  160 (829)
T ss_pred             EEEEecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchh
Confidence            999999999999877655     57899999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      .+...- .......||+.|||||+..   .+.|...+|||++|++..|+..-++|........         ........
T Consensus       161 qitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr---------~l~LmTkS  230 (829)
T KOG0576|consen  161 QITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR---------ALFLMTKS  230 (829)
T ss_pred             hhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH---------HHHHhhcc
Confidence            654321 2245678999999999863   4669999999999999999988877744222111         01111111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                          .+++...++     +......+.+++..|+..+|.+|||+..++.
T Consensus       231 ----~~qpp~lkD-----k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 ----GFQPPTLKD-----KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ----CCCCCcccC-----CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                111111111     1267788899999999999999999987764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=250.04  Aligned_cols=197  Identities=19%  Similarity=0.272  Sum_probs=169.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC------ChhHHHHHHHHHHHHhhcC---CCceeeccce
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC------RPRAYESCINNVTYAARMS---HNHILKLIGC  130 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---H~niv~~~~~  130 (353)
                      ..|+....+|.|+||   .|+.+.+  +...|+||.+.+...      .....-..--|+.||+.++   |+||++++++
T Consensus       561 s~yttlq~lG~GAyG---kV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYG---KVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             ccceeeeeccccccc---eEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            358888999999999   9999999  677899999876531      1111223456999999998   9999999999


Q ss_pred             eeeCCccEEEEEec-cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          131 CLETPIPILVFESV-QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       131 ~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                      |++++.+||+||-. ++-+|.+++...     ..+++..+..|+.|++.|+.+||   +.+|||||||-+|+.++++|.+
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeE
Confidence            99999999999976 455889998776     46899999999999999999999   9999999999999999999999


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCC
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSD  272 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~  272 (353)
                      ||+|||.|.....+.   -....||..|.|||++.+..| +...|||++|++||.++....||.
T Consensus       710 klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999987765443   346789999999999998886 467999999999999999888875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.3e-30  Score=223.32  Aligned_cols=199  Identities=27%  Similarity=0.339  Sum_probs=171.0

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |...+.||+|++|   .||++..  ++..+++|.+...... ...+.+.+|+..+.+++|+|++++++++......++++
T Consensus         1 ~~~~~~i~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFG---KVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCe---EEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            4566789999999   9999998  4789999999766322 25678999999999999999999999999889999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      |++++++|.+++.....    .+++..+..++.+++.++.+||   ..+++|+|++|.||+++.++.++|+|||.+....
T Consensus        77 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       77 EYCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             eccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            99999899999876531    1788899999999999999999   8999999999999999999999999999988765


Q ss_pred             CCCCccccccccCCcccccccc-ccCCCCccccchhhHHHHHHHHhCCCCCCc
Q 018633          222 EGETHITDTVMGTWGYCAPEYM-RTGVFNEKSDVFSFGVFLFELLTGWDVSDL  273 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~tg~~p~~~  273 (353)
                      ...........++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4321122345677889999998 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=9.3e-30  Score=226.64  Aligned_cols=268  Identities=23%  Similarity=0.280  Sum_probs=195.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCL  132 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~  132 (353)
                      ...+.|...+.||.|.|+   +||++.+     ..+.||+|.+...    ....+..+|++.|..+. +.||+++.+++.
T Consensus        33 ~~~~~~~~v~kigeGsFs---sv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFS---SVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhccccccchh---hhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            445678899999999999   8888887     3678999998654    34466889999999997 999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEE
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKL  211 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl  211 (353)
                      .++..++|+||++.....++..        .++...+..+++.++.||.++|   .+|||||||||+|+|.+.. +.-.|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceE
Confidence            9999999999999988888874        4678889999999999999999   9999999999999999854 56789


Q ss_pred             eccCCccccCCCC-------------------------------------------CccccccccCCccccccccccCC-
Q 018633          212 FDFSLSISIPEGE-------------------------------------------THITDTVMGTWGYCAPEYMRTGV-  247 (353)
Q Consensus       212 ~dfg~a~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~-  247 (353)
                      +|||+|.......                                           ........||++|.|||++...+ 
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            9999986211000                                           00011246999999999987654 


Q ss_pred             CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChH------HHHH--H------HhhcCccccccc----------c
Q 018633          248 FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN------EYLK--N------YFEDNRFTEIVD----------P  303 (353)
Q Consensus       248 ~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~------~~~~--~------~~~~~~~~~~~~----------~  303 (353)
                      .++++||||.|+|+.-+++++.||..............      ..-+  .      .++..+++.+..          .
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~  334 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE  334 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence            78899999999999999999999976554331110000      0000  0      011011001000          0


Q ss_pred             hhhh-cc----chHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          304 IIVE-DV----LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       304 ~~~~-~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+.+ +.    ........+..+.+|+.+|+..||.+|.|++++++
T Consensus       335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            0000 00    01111234457899999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.5e-30  Score=263.52  Aligned_cols=196  Identities=19%  Similarity=0.234  Sum_probs=140.4

Q ss_pred             hhcCC-Cceeecccee-------eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC
Q 018633          117 ARMSH-NHILKLIGCC-------LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP  188 (353)
Q Consensus       117 ~~l~H-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  188 (353)
                      +.++| +||++++++|       .....++.++|++. ++|.+++....    ..+++.+++.++.||+.||.|||   +
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~   98 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH---S   98 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH---h
Confidence            45566 6888899987       23345778899884 79999997543    46899999999999999999999   9


Q ss_pred             CCeEeeccCCCceeecC-------------------CCceEEeccCCccccCCCC---------------CccccccccC
Q 018633          189 RPIVFRNFKTSCILFNE-------------------ENVAKLFDFSLSISIPEGE---------------THITDTVMGT  234 (353)
Q Consensus       189 ~~iiH~dlkp~Nill~~-------------------~~~~kl~dfg~a~~~~~~~---------------~~~~~~~~gt  234 (353)
                      ++|+||||||+|||++.                   ++.+|++|||+++......               ........||
T Consensus        99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181         99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence            99999999999999954                   4456666777665421100               0001124578


Q ss_pred             CccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHH
Q 018633          235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEK  314 (353)
Q Consensus       235 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (353)
                      +.|+|||++.+..++.++|||||||++|||++|..|+....          ........ .    ...+.        ..
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~-~----~~~~~--------~~  235 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRH-R----VLPPQ--------IL  235 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHH-h----hcChh--------hh
Confidence            89999999999999999999999999999999887754211          00000000 0    00000        00


Q ss_pred             HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          315 EQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       315 ~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       .......+++.+||..+|.+|||+.++++
T Consensus       236 -~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        236 -LNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             -hcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence             12234567888999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.3e-28  Score=205.90  Aligned_cols=169  Identities=19%  Similarity=0.186  Sum_probs=126.8

Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      |||.+++....    ..+++..++.|+.|++.||.|||   +++      ||+|||++.++.+++  ||++......   
T Consensus         1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---   62 (176)
T smart00750        1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE---   62 (176)
T ss_pred             CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc---
Confidence            68999987643    46899999999999999999999   666      999999999999999  9998765332   


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhh
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIV  306 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (353)
                         ...||+.|+|||++.+..++.++|||||||++|||+||..||.......       ..............      .
T Consensus        63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~~------~  126 (176)
T smart00750       63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-------AILEILLNGMPADD------P  126 (176)
T ss_pred             ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-------HHHHHHHHHhccCC------c
Confidence               1258899999999999999999999999999999999999986322111       11111111100000      0


Q ss_pred             hccchHHHHHHHH--HHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          307 EDVLSIEKEQQLH--ASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       307 ~~~~~~~~~~~~~--~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ....  .+.....  .+.+++.+||+.+|++|||+.++++.+..+..
T Consensus       127 ~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      127 RDRS--NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             cccc--cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            0000  0112333  68999999999999999999999999877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=212.28  Aligned_cols=246  Identities=18%  Similarity=0.253  Sum_probs=194.1

Q ss_pred             ceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccCCC
Q 018633           69 VIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGT  148 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gs  148 (353)
                      +|.....|   ..|+|.|.|..+++|++....++....+.|..|+-.|+.+.||||+.++|.|...+.+.++..|||.||
T Consensus       197 kl~e~hsg---elwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  197 KLAESHSG---ELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhccCCCc---ccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            46777788   999999999999999999888888888999999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe--ccCCccccCCCCCc
Q 018633          149 LWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF--DFSLSISIPEGETH  226 (353)
Q Consensus       149 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~--dfg~a~~~~~~~~~  226 (353)
                      |+..++...+   ...+-.++.+++.++++|++|||+- ..-|..-.|.+..+++|++.+++|+  |--++..       
T Consensus       274 lynvlhe~t~---vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq-------  342 (448)
T KOG0195|consen  274 LYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------  342 (448)
T ss_pred             HHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence            9999987653   4567889999999999999999963 2334445788999999999887765  4332211       


Q ss_pred             cccccccCCccccccccccCCC---CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccc
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVF---NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP  303 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
                       .....-.+.||+||.+...+-   -.++|+|||++++|||.|+..||......+                     .--+
T Consensus       343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---------------------cgmk  400 (448)
T KOG0195|consen  343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---------------------CGMK  400 (448)
T ss_pred             -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---------------------hhhh
Confidence             112234678999999976553   357999999999999999999987433322                     1111


Q ss_pred             hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       304 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      +..+......|+..+..+..|+.-|.+.||.+||.+..++-.|+++.
T Consensus       401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            11111112222256677889999999999999999999999998864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.3e-26  Score=212.31  Aligned_cols=168  Identities=15%  Similarity=0.104  Sum_probs=130.7

Q ss_pred             HHHHHhhCcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEecCCCC---ChhHHHHHHHHHHHHhhcCCCceee-cc
Q 018633           56 EIKLATNSYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQFYGHEC---RPRAYESCINNVTYAARMSHNHILK-LI  128 (353)
Q Consensus        56 e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~-~~  128 (353)
                      .+....++|...+.||+|+||   .||+|.+   ++..||||++.....   .....+.|.+|+++|++++|+|++. ++
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg---~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFS---TVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             ccccccCCceEccEEeecCcE---EEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            344566789999999999999   9999987   567789998753311   2334667999999999999999985 44


Q ss_pred             ceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeecc-CCCceeecCCC
Q 018633          129 GCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF-KTSCILFNEEN  207 (353)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl-kp~Nill~~~~  207 (353)
                      ++    +..|+||||++|++|.. +..        ..   ...++.+++.||.|||   +++|+|||| ||+|||++.++
T Consensus        89 ~~----~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~  149 (365)
T PRK09188         89 AT----GKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDG  149 (365)
T ss_pred             Ec----CCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCC
Confidence            32    45799999999999963 211        11   1367889999999999   999999999 99999999999


Q ss_pred             ceEEeccCCccccCCCCCcc-------ccccccCCcccccccccc
Q 018633          208 VAKLFDFSLSISIPEGETHI-------TDTVMGTWGYCAPEYMRT  245 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  245 (353)
                      .++|+|||+|+.+.......       ..+..+++.|+|||.+..
T Consensus       150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999999998765432111       135678888999999854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.9e-26  Score=222.36  Aligned_cols=255  Identities=15%  Similarity=0.191  Sum_probs=188.3

Q ss_pred             CCCCceeeCCCCCccEEEEEEe--CCeEEEEEEec----CCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFY----GHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ...+++|.|++|   .|+....  .....+.|.+.    ...........+..|+-+-..+.|||++..+..+.+.....
T Consensus       321 ~~~~~~g~ga~g---~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~  397 (601)
T KOG0590|consen  321 KPGRVLGSGAYG---SVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL  397 (601)
T ss_pred             CccceeeecccC---ceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence            357889999999   5555544  33333333332    22212222233677888888999999999988887766655


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      -+||||++ +|..++...     ..+....+-.++.|++.|+.|||   +.||.|||+||+|+++..+|.+||+|||.+.
T Consensus       398 ~~mE~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~  468 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAAS  468 (601)
T ss_pred             hhhhcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcce
Confidence            56999998 999998765     25778888899999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCC---ccccccccCCccccccccccCCCCc-cccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          219 SIPEGET---HITDTVMGTWGYCAPEYMRTGVFNE-KSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       219 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .+..+..   ......+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......++.-          . .
T Consensus       469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------~-~  537 (601)
T KOG0590|consen  469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------K-T  537 (601)
T ss_pred             eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------h-h
Confidence            7654332   3456678999999999999999885 6999999999999999999998655443211          0 0


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .   ......-....+.......+.....++.++|+.+|..|.|+.+|++.
T Consensus       538 ~---~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  538 N---NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             h---ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0   00000000011111122566777889999999999999999999863

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-24  Score=188.29  Aligned_cols=264  Identities=13%  Similarity=0.123  Sum_probs=207.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~  135 (353)
                      ...-+|.+.+.||.|+||   .++.|.+  ++..||||.-...    ....++..|.+..+.|. .++|..+|-+-..+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG---~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFG---VLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             EecccceeccccccCcce---eeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            344579999999999999   9999998  9999999976443    34456777888888886 789999888888888


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-----ceE
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-----VAK  210 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-----~~k  210 (353)
                      +..||+|++ |.||.|+..-..    ..|+..++.-++.|++.-++|+|   ++.+|.|||||+|.||...+     .+.
T Consensus        98 ~NiLVidLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~Ih  169 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIH  169 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEE
Confidence            889999999 689999886554    57999999999999999999999   99999999999999997543     589


Q ss_pred             EeccCCccccCCCCCcc------ccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          211 LFDFSLSISIPEGETHI------TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                      ++|||+|+...+..+..      .....||..||+--.-.+...+..-|+=|||-+++..+.|..||+......      
T Consensus       170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t------  243 (449)
T KOG1165|consen  170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT------  243 (449)
T ss_pred             EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc------
Confidence            99999999987655432      245679999999999989899999999999999999999999998655433      


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                              ...++..+-+........... ...+.++..-+.-.-+.+-.+-|..+-+...+..+++-
T Consensus       244 --------nK~kYeKIGe~Kr~T~i~~Lc-~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  244 --------NKEKYEKIGETKRSTPIEVLC-EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             --------hHHHHHHhccccccCCHHHHH-hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence                    012222333322222221111 24566777777777778888889988887777777653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-25  Score=185.24  Aligned_cols=269  Identities=16%  Similarity=0.154  Sum_probs=204.4

Q ss_pred             cHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC-Cceeeccc
Q 018633           53 SAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSH-NHILKLIG  129 (353)
Q Consensus        53 ~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~  129 (353)
                      |..++ ...++|...+.||+|+||   .+|.|..  .|..||||.-....    ...++..|.++...|+| ..|..+..
T Consensus         7 s~~~~-iv~gky~lvrkiGsGSFG---dIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~   78 (341)
T KOG1163|consen    7 SLEEL-IVGGKYKLVRKIGSGSFG---DIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRH   78 (341)
T ss_pred             chhhh-eeccceEEEEeecCCchh---heeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhh
Confidence            33444 344679999999999999   9999998  89999999876552    33457789999999985 56777777


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---C
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---E  206 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~  206 (353)
                      +..+.....+||+++ |.||.+++.--.    ..++..+++-++-|++.-++|+|   .++.|||||||+|.|..-   .
T Consensus        79 y~~e~~ynvlVMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~  150 (341)
T KOG1163|consen   79 YGTEKDYNVLVMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHC  150 (341)
T ss_pred             hccccccceeeeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeecccccc
Confidence            778888899999999 689999876433    46889999999999999999999   999999999999999853   3


Q ss_pred             CceEEeccCCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC
Q 018633          207 NVAKLFDFSLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL  280 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~  280 (353)
                      ..+.++|||+|+.+.+..+.      ......||..|.+--...+...+..-|+=|+|-+|...-.|..||+......  
T Consensus       151 ~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t--  228 (341)
T KOG1163|consen  151 NKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT--  228 (341)
T ss_pred             ceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh--
Confidence            56899999999887544322      1245679999998887777778889999999999999999999998543322  


Q ss_pred             CCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          281 ACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                                  ...+...+....+.-...... ...+.++...+.-|-..--++-|...-+-+.+.-|++.
T Consensus       229 ------------k~QKyEkI~EkK~s~~ie~LC-~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  229 ------------KKQKYEKISEKKMSTPIEVLC-KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             ------------HHHHHHHHHHhhcCCCHHHHh-CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence                        111222222222222221111 15567788888899999999999988777766666554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.2e-23  Score=191.37  Aligned_cols=262  Identities=24%  Similarity=0.313  Sum_probs=197.4

Q ss_pred             cCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChh-HHHHHHHHHHHHhhcCCC-ceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPR-AYESCINNVTYAARMSHN-HILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~~lv~  141 (353)
                      |.....||.|+||   .||++... ..+++|.+........ ....|.+|+.+++.+.|+ +|+++++++......++++
T Consensus         2 ~~~~~~l~~g~~~---~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFG---EVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCe---EEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            5566789999999   99999987 8889998877654433 578899999999999988 7999999997777789999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ceEEeccCCcccc
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISI  220 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~dfg~a~~~  220 (353)
                      +++.++++.+++......  ..++......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.+...
T Consensus        78 ~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             ecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence            999999999776654211  15788899999999999999999   99999999999999999988 7999999998765


Q ss_pred             CCCCCc-----cccccccCCcccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          221 PEGETH-----ITDTVMGTWGYCAPEYMRT---GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       221 ~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ......     ......||..|+|||.+..   ..++...|+||+|++++++++|..||......     ..........
T Consensus       153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~  227 (384)
T COG0515         153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKII  227 (384)
T ss_pred             CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHH
Confidence            443321     2356789999999999987   57889999999999999999999996543321     0011111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...... ...........    ......+.+++..|+..+|..|.+..+...
T Consensus       228 ~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         228 LELPTP-SLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HhcCCc-ccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            111111 00000000000    133456788999999999999999887655

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.7e-24  Score=196.03  Aligned_cols=259  Identities=16%  Similarity=0.118  Sum_probs=192.1

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEeCC---eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC----Cceeecccee-eeC
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFWQE---RLISVLQFYGHECRPRAYESCINNVTYAARMSH----NHILKLIGCC-LET  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~~~~~~-~~~  134 (353)
                      .|...+.||+|+||   .||.+....   ..+|+|......  ......+..|+.++..+..    +++..+++.. ..+
T Consensus        19 ~~~i~~~iG~G~fG---~V~~v~~~~~~~~~~a~K~e~~~~--~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFG---AVYLVSDKSEKNKEYAKKLEKKEL--GSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCc---eEEEEEecCCCCeeEEEEEEEecc--cCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            79999999999999   999999832   467888765542  1212267788999999873    5888888888 477


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-----Cce
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-----NVA  209 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-----~~~  209 (353)
                      ...++||+.+ |.||.++......   ..++..+.+.|+.|++.+|.+||   +.|++||||||.|+++...     -.+
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~---~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPP---GRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCC---CCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceE
Confidence            7889999998 6899998765542   57899999999999999999999   9999999999999999755     358


Q ss_pred             EEeccCCcc--ccCCCCC----cc---ccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC
Q 018633          210 KLFDFSLSI--SIPEGET----HI---TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL  280 (353)
Q Consensus       210 kl~dfg~a~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~  280 (353)
                      .|.|||+++  .......    ..   .....||..|+++.+..+...+.+.|+||++-++.+++.|..||........ 
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-  245 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-  245 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence            999999998  3221111    01   1235599999999999999999999999999999999999999865443221 


Q ss_pred             CCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          281 ACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                          ..........    .....     .    ....+..+..+...+-..+..++|....+...|.++..
T Consensus       246 ----~~~~~~~~~~----~~~~~-----~----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  246 ----KSKFEKDPRK----LLTDR-----F----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             ----HHHHHHHhhh----hcccc-----c----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence                0111111000    00000     0    00233455566666666899999999999998877754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.2e-23  Score=175.98  Aligned_cols=140  Identities=11%  Similarity=0.084  Sum_probs=108.0

Q ss_pred             CCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhH-------H-----------------HHHHHHHHHHhhcCC
Q 018633           67 KNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRA-------Y-----------------ESCINNVTYAARMSH  121 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~-------~-----------------~~~~~E~~~l~~l~H  121 (353)
                      ...||+|++|   .||+|.. +|+.||+|++.........       .                 ....+|+..+.++.+
T Consensus         2 ~~~ig~G~~~---~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05147           2 NGCISTGKEA---NVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT   78 (190)
T ss_pred             CCccccccce---EEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence            4579999999   9999998 7999999999765321111       1                 122459999999988


Q ss_pred             CceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHH-hcCCCCCeEeeccCCCc
Q 018633          122 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL-HFGFPRPIVFRNFKTSC  200 (353)
Q Consensus       122 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~dlkp~N  200 (353)
                      +++.....+. . ...+|||||++++++.......     ..++...+..++.|++.+|.++ |   +.+|+||||||+|
T Consensus        79 ~~v~~p~~~~-~-~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~N  148 (190)
T cd05147          79 AGIPCPEPIL-L-KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYN  148 (190)
T ss_pred             CCCCCCcEEE-e-cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHH
Confidence            8774433322 2 2348999999987775543322     3578889999999999999999 7   8899999999999


Q ss_pred             eeecCCCceEEeccCCcccc
Q 018633          201 ILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~  220 (353)
                      ||++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 478999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=2.9e-23  Score=193.84  Aligned_cols=217  Identities=27%  Similarity=0.406  Sum_probs=161.8

Q ss_pred             HhhcCCCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCe-Eee
Q 018633          116 AARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI-VFR  194 (353)
Q Consensus       116 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-iH~  194 (353)
                      |+.+.|.|+.+++|.+.+++..++|.+||..|+|.|.+....    ..+++.....++++++.||.|||   ...| .|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLH---NSPIGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHh---cCcceeee
Confidence            467889999999999999999999999999999999998754    57889999999999999999999   4444 999


Q ss_pred             ccCCCceeecCCCceEEeccCCccccCCC-CCccccccccCCccccccccccCC-------CCccccchhhHHHHHHHHh
Q 018633          195 NFKTSCILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTWGYCAPEYMRTGV-------FNEKSDVFSFGVFLFELLT  266 (353)
Q Consensus       195 dlkp~Nill~~~~~~kl~dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~el~t  266 (353)
                      .+++.|.++|..+.+|++|||+....... .........-..-|.|||.+....       .+.+.||||||++++|+++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            99999999999999999999998665321 111111222345699999987631       4678999999999999999


Q ss_pred             CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          267 GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       267 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      ...||+........    .+.+.......  .....+.+.    ...  .....+..++.+||..+|+.||++..+-..+
T Consensus       154 r~~~~~~~~~~~~~----~eii~~~~~~~--~~~~rP~i~----~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~  221 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDP----DEIILRVKKGG--SNPFRPSIE----LLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKL  221 (484)
T ss_pred             ccCccccccccCCh----HHHHHHHHhcC--CCCcCcchh----hhh--hcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence            99999864443311    11111111101  111111111    110  3334688999999999999999999998888


Q ss_pred             HHHHH
Q 018633          347 RQIYR  351 (353)
Q Consensus       347 ~~l~~  351 (353)
                      +.+..
T Consensus       222 ~~~~~  226 (484)
T KOG1023|consen  222 LTINK  226 (484)
T ss_pred             hhhcc
Confidence            76643

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=1.3e-23  Score=179.64  Aligned_cols=173  Identities=12%  Similarity=0.069  Sum_probs=133.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChh-HHHH------HHHHHHHHhhcCCCceeeccceeee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPR-AYES------CINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++|...+++|.|+||   .||....++..+|+|.+........ ....      +.+|+..+.++.||+|..+.+++..
T Consensus        30 ~~~y~~~~~l~~~~f~---~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         30 SYNIKTIKVFRNIDDT---KVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hCceEEEEEecCCCce---EEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            5789999999999999   8888666778999999976543222 2223      6799999999999999999888653


Q ss_pred             C--------CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          134 T--------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       134 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      .        +..++||||++|.+|.++..         ++.    ....+++.+|..+|   ..+++|||++|+||+++.
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~  170 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSK  170 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeC
Confidence            3        35789999999999977631         222    24569999999999   999999999999999998


Q ss_pred             CCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh
Q 018633          206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT  266 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  266 (353)
                      ++ ++|+|||..........             ...+.....+..++|+||||+++.....
T Consensus       171 ~g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             CC-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence            88 99999998765422111             0113344456779999999998776543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-23  Score=205.01  Aligned_cols=250  Identities=21%  Similarity=0.225  Sum_probs=178.9

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHEC--RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++.-.+.||++.|=   +|.++++....|+||++-+...  +.....+-+.|++ ...++|||.+++.-+-..+...|+|
T Consensus        24 e~~~~~~LGstRFl---Kv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFL---KVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhh---hhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            67777889999988   9999999777799999976642  2223333344555 5566899999999988888888999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      =+|.. -+|+|.+...+     -+...+..-|+.|++.||..+|   ..+|+|||||.+||||.+=..+.|+||..-+..
T Consensus       100 Rqyvk-hnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHh-hhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCc
Confidence            99996 69999997653     4566777789999999999999   999999999999999998888999999865432


Q ss_pred             --CCCCCcccc----ccccCCccccccccccC----------C-CCccccchhhHHHHHHHHh-CCCCCCccccccCCCC
Q 018633          221 --PEGETHITD----TVMGTWGYCAPEYMRTG----------V-FNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLAC  282 (353)
Q Consensus       221 --~~~~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~  282 (353)
                        +.+.+..-.    +...-..|.|||.+...          . .+++-||||+||++.||++ |++||...        
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------  242 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------  242 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------
Confidence              222221111    11122359999988541          1 6788999999999999998 57777621        


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                             +++...+-.......+...       -....+.+|+..|++.||+.|.|+++.++.-+
T Consensus       243 -------QL~aYr~~~~~~~e~~Le~-------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  243 -------QLLAYRSGNADDPEQLLEK-------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             -------HHHhHhccCccCHHHHHHh-------CcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence                   1111111000000111111       11235778999999999999999999998743

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=4e-22  Score=168.72  Aligned_cols=141  Identities=13%  Similarity=0.122  Sum_probs=109.9

Q ss_pred             CCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhH------------------------HHHHHHHHHHHhhcCC
Q 018633           67 KNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRA------------------------YESCINNVTYAARMSH  121 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~H  121 (353)
                      ...||+|++|   .||+|.. +|+.||||++.........                        ...+..|...+.++.|
T Consensus         2 ~~~ig~G~~~---~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05145           2 NGCISTGKEA---NVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE   78 (190)
T ss_pred             CceeecCCCc---EEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4579999999   9999988 6999999998765321100                        1234679999999999


Q ss_pred             CceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCc
Q 018633          122 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSC  200 (353)
Q Consensus       122 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~N  200 (353)
                      +++.....+...  ..++||||++++++.......     ..++......++.|++.++.++|   + .+|+||||||+|
T Consensus        79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~N  148 (190)
T cd05145          79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYN  148 (190)
T ss_pred             CCCCCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhh
Confidence            987554444332  248999999987654332221     34677888999999999999999   7 999999999999


Q ss_pred             eeecCCCceEEeccCCccccC
Q 018633          201 ILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~  221 (353)
                      |+++ ++.++|+|||++....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEEE-CCCEEEEEcccceecC
Confidence            9999 7899999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=9e-22  Score=164.99  Aligned_cols=191  Identities=13%  Similarity=0.012  Sum_probs=141.0

Q ss_pred             cCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCC--hhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECR--PRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv  140 (353)
                      +.+...|++|+||   +|+.....+..++.+.+......  .-....|.+|+++|++|. |+++++++++    +..+++
T Consensus         4 ~~~~~~l~~~~f~---~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lv   76 (218)
T PRK12274          4 PAVNEPLKSDTFG---RILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLD   76 (218)
T ss_pred             cccceeecCCCcc---eEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEE
Confidence            4456789999999   88877778888888887665321  112336889999999996 5889999886    346899


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeecc-CCCceeecCCCceEEeccCCccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF-KTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl-kp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||+.|.+|.+.+..            ....++.|++.+|.++|   ++||+|||| ||+|||++.++.++|+|||++..
T Consensus        77 meyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         77 RSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            999998888653311            11357789999999999   999999999 79999999999999999999986


Q ss_pred             cCCCCCc----c--------ccccccCCcccccccccc-CCCC-ccccchhhHHHHHHHHhCCCCCCcccc
Q 018633          220 IPEGETH----I--------TDTVMGTWGYCAPEYMRT-GVFN-EKSDVFSFGVFLFELLTGWDVSDLVKD  276 (353)
Q Consensus       220 ~~~~~~~----~--------~~~~~gt~~y~aPE~~~~-~~~~-~~~Di~slG~il~el~tg~~p~~~~~~  276 (353)
                      .......    .        ......++.|++|+.-.- ...+ ...+.++.|.-+|.++||..++-...+
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            5432210    0        111235667777775432 1334 456777999999999999888654443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.5e-23  Score=193.60  Aligned_cols=229  Identities=21%  Similarity=0.210  Sum_probs=179.4

Q ss_pred             ceeeCCCCCccEEEEEE--eCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEEEEEecc
Q 018633           69 VIAKDTSYNLYTMYKGF--WQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVFESVQ  145 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~  145 (353)
                      ++|+|.||.++.|-+..  +.+..+|.|+..+.....+.......|..++..++ ||.+|++.-.+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999555554433  37788888887665433333335567888888888 9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCC
Q 018633          146 YGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET  225 (353)
Q Consensus       146 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~  225 (353)
                      +|.|...+...     ..+.......+...++-|++++|   +.+++|||+|++||+++.+|++++.|||+++..-....
T Consensus        81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            99998877665     35677777888999999999999   99999999999999999999999999999987644332


Q ss_pred             ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchh
Q 018633          226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPII  305 (353)
Q Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (353)
                           .+||..|||||+..  .....+|.||||++++||+||..||..                         +++..++
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------------~~~~~Il  200 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------------DTMKRIL  200 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------------HHHHHHh
Confidence                 28999999999997  567889999999999999999999873                         1111111


Q ss_pred             hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          306 VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       306 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                      ...  ...+........+++..++..+|..|.-.
T Consensus       201 ~~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  201 KAE--LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhc--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            101  11122666677788888999999988744

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=3.3e-21  Score=164.25  Aligned_cols=137  Identities=13%  Similarity=0.069  Sum_probs=106.1

Q ss_pred             cCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-----CCCceeeccceeeeCC---
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARM-----SHNHILKLIGCCLETP---  135 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~~~~~~~~~~---  135 (353)
                      .+....||+|+||   .||....+... +||++...  .....+.+.+|+.+++.+     .||||++++|++.++.   
T Consensus         4 L~~~~~LG~G~~~---~Vy~hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          4 LSEQSPLGTGRHR---KCYAHPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cCCcceecCCCce---EEEECCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            4556789999999   88863224444 68888654  233557799999999999     5799999999998763   


Q ss_pred             c-cEEEEEe--ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHH-HHHhcCCCCCeEeeccCCCceeecC----CC
Q 018633          136 I-PILVFES--VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL-AYLHFGFPRPIVFRNFKTSCILFNE----EN  207 (353)
Q Consensus       136 ~-~~lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~iiH~dlkp~Nill~~----~~  207 (353)
                      . +.+|+||  +++|||.+++.+.      .+++.  ..++.+++.++ .|||   +++|+||||||+|||++.    ++
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCC
Confidence            3 3478999  6679999999653      24444  35678888888 9999   999999999999999974    34


Q ss_pred             ceEEeccCCc
Q 018633          208 VAKLFDFSLS  217 (353)
Q Consensus       208 ~~kl~dfg~a  217 (353)
                      .++|+||+.+
T Consensus       147 ~~~LiDg~G~  156 (210)
T PRK10345        147 IPVVCDNIGE  156 (210)
T ss_pred             cEEEEECCCC
Confidence            7999995433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=4e-20  Score=159.21  Aligned_cols=136  Identities=17%  Similarity=0.166  Sum_probs=115.0

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChh------HHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPR------AYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      +.||+|++|   .||+|.+.+..|++|+.........      ....+.+|+.++..+.|+||.....++...+..++||
T Consensus         2 ~~l~~G~~~---~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEA---EIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceE---EEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            579999999   9999999889999998754322111      2346789999999999999888877777778889999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||++|++|.+++...        .. .+..++.+++.+|.++|   +.+++|+|++|.|||++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999988542        12 77889999999999999   99999999999999999 78899999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=1.3e-20  Score=165.92  Aligned_cols=234  Identities=18%  Similarity=0.206  Sum_probs=149.6

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCC----------Cceeeccce
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSH----------NHILKLIGC  130 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H----------~niv~~~~~  130 (353)
                      ......||.|+++   .||.+.+  +++.+|+|++.... ......+.+.+|.-....+.+          -.++..++.
T Consensus        14 l~~~~~i~~g~~~---~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   14 LVRGRIIGKGGFS---IVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEETTE---EEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEccccccCCce---EEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            4456789999999   9999999  78999999985443 234456777777755555332          122222332


Q ss_pred             ee---------eCC--------ccEEEEEeccCCChhhhhc---cCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC
Q 018633          131 CL---------ETP--------IPILVFESVQYGTLWDRIL---GAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP  190 (353)
Q Consensus       131 ~~---------~~~--------~~~lv~e~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  190 (353)
                      ..         ...        ..+++|+-+. ++|.+++.   ..... ...+....++.+..|+++.+++||   +.|
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh---~~G  165 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLH---SYG  165 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHh---hcc
Confidence            21         111        2367888885 78877654   22211 134555566778899999999999   999


Q ss_pred             eEeeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccC--------CCCccccchhhHHHHH
Q 018633          191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG--------VFNEKSDVFSFGVFLF  262 (353)
Q Consensus       191 iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Di~slG~il~  262 (353)
                      ++|+||+|+|++++.+|.+.|+||+.........   . ....+..|.+||.....        .++.+.|.|+||+++|
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE---E-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeecCcee---e-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            9999999999999999999999998765542211   1 13345679999977442        4788999999999999


Q ss_pred             HHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCC
Q 018633          263 ELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR  336 (353)
Q Consensus       263 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  336 (353)
                      .|++|..||...........             .+             .... +.++.+..||..+|+.+|.+|
T Consensus       242 ~lWC~~lPf~~~~~~~~~~~-------------~f-------------~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPEW-------------DF-------------SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSGG-------------GG-------------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCccccccc-------------cc-------------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999985433221000             00             0111 567788899999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.3e-20  Score=167.30  Aligned_cols=196  Identities=17%  Similarity=0.234  Sum_probs=138.3

Q ss_pred             CCCceeeccceeee---------------------------CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHH
Q 018633          120 SHNHILKLIGCCLE---------------------------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI  172 (353)
Q Consensus       120 ~H~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  172 (353)
                      .|||||.+.++|.+                           +..+|+||.-.+ .+|..++-..      ..+.....-+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHHH
Confidence            49999999999865                           124689998886 6999988654      3456667778


Q ss_pred             HHHHHHHHHHHhcCCCCCeEeeccCCCceee--cCC--CceEEeccCCccccCCCC-----CccccccccCCcccccccc
Q 018633          173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILF--NEE--NVAKLFDFSLSISIPEGE-----THITDTVMGTWGYCAPEYM  243 (353)
Q Consensus       173 ~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill--~~~--~~~kl~dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~  243 (353)
                      +.|+++|+.|||   .++|.|||+|++|||+  |++  ..+.|+|||++-.-....     ....-...|....||||+.
T Consensus       347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            999999999999   9999999999999998  334  357899999864322110     1111234567778999998


Q ss_pred             ccCC-----C-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHH
Q 018633          244 RTGV-----F-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQ  317 (353)
Q Consensus       244 ~~~~-----~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (353)
                      ...+     . -.++|.|+.|.+.||+++...||.......   .....     ++...+             +..+..+
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~~r~-----Yqe~qL-------------Palp~~v  482 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LDTRT-----YQESQL-------------PALPSRV  482 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---echhh-----hhhhhC-------------CCCcccC
Confidence            6533     1 248999999999999999999997522211   00000     111111             1112255


Q ss_pred             HHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          318 LHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       318 ~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      +..+.+|+...|+.||++|+|+.-....|
T Consensus       483 pp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  483 PPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             ChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            66678899999999999999976555444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=6.7e-20  Score=182.77  Aligned_cols=201  Identities=16%  Similarity=0.142  Sum_probs=158.7

Q ss_pred             HHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC---CCceeeccc
Q 018633           54 AQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMS---HNHILKLIG  129 (353)
Q Consensus        54 ~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~  129 (353)
                      ..+++.....|.+.+.||+|+||   .||+|.. +++.||+|+-....+..-..     -..++.+|+   -+.|..+..
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~---~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~  761 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYG---SVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISS  761 (974)
T ss_pred             cceeeecceeEEEEeeeccccce---EEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHH
Confidence            34555666789999999999999   9999998 89999999976654322211     122334443   345667777


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec-----
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN-----  204 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-----  204 (353)
                      ++.-.+.-+||+||.+.|||.+++...     ..+++.-...++.||+.-+..||   ..+|||+||||+|.||.     
T Consensus       762 a~~~~~~S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~  833 (974)
T KOG1166|consen  762 AHVFQNASVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICA  833 (974)
T ss_pred             HHccCCcceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCC
Confidence            777777888999999999999999844     56889999999999999999999   99999999999999993     


Q ss_pred             --CCCceEEeccCCccccCCC-CCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCC
Q 018633          205 --EENVAKLFDFSLSISIPEG-ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDV  270 (353)
Q Consensus       205 --~~~~~kl~dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p  270 (353)
                        ....++|+|||.+.-...- +...-....+|-.+-++|...+.+++..+|.|.|+.+++.|+.|++-
T Consensus       834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence              2346899999988543211 11223456778889999999999999999999999999999998543

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.3e-19  Score=156.59  Aligned_cols=146  Identities=14%  Similarity=0.096  Sum_probs=111.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEE-e--CCeEEEEEEecCCCCCh--------------------h--HHHHHHHHH
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGF-W--QERLISVLQFYGHECRP--------------------R--AYESCINNV  113 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~-~--~~~~vavK~~~~~~~~~--------------------~--~~~~~~~E~  113 (353)
                      +...-|...+.||+|++|   .||+|. .  +++.||+|++.......                    .  ....+.+|+
T Consensus        25 ~~~~~~~i~~~Lg~G~~g---~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  101 (237)
T smart00090       25 NRGILSAIGGCISTGKEA---NVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF  101 (237)
T ss_pred             hcCchHHhCCeeccCcce---eEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence            333457788899999999   999998 3  89999999987542110                    0  113457899


Q ss_pred             HHHhhcCCCc--eeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC-
Q 018633          114 TYAARMSHNH--ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP-  190 (353)
Q Consensus       114 ~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-  190 (353)
                      ..+.++.+.+  +.++++.    ...++||||+++++|.......     ..+.......++.|++.+|.+||   .++ 
T Consensus       102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~g~  169 (237)
T smart00090      102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY---KEGE  169 (237)
T ss_pred             HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH---hcCC
Confidence            9999998633  3333432    2358999999988887654322     23455667889999999999999   999 


Q ss_pred             eEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          191 IVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       191 iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      ++||||||+||+++ ++.++|+|||.+...
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999999999 889999999988654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.7e-19  Score=152.63  Aligned_cols=132  Identities=20%  Similarity=0.188  Sum_probs=108.8

Q ss_pred             ceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCC------hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEE
Q 018633           69 VIAKDTSYNLYTMYKGFWQERLISVLQFYGHECR------PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE  142 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  142 (353)
                      .||+|++|   .||+|.+++..|++|........      .....++.+|++++..++|+++.....++...+..++|||
T Consensus         1 ~ig~G~~~---~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEA---IIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceE---EEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence            48999999   99999999999999986543211      1123567899999999999887666656666777899999


Q ss_pred             eccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          143 SVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       143 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |++|++|.+++....     .       .++.+++.+|.+||   +.+++|+|++|.||+++ ++.++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~-----~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN-----D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH-----H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988775421     1       78999999999999   99999999999999999 78999999998755

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=2.5e-19  Score=174.88  Aligned_cols=140  Identities=16%  Similarity=0.121  Sum_probs=114.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCC------hhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECR------PRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ...|...+.||+|+||   .||+|.+.+..+++|+.......      ....+.+.+|++++..++|++++....++.+.
T Consensus       332 ~~~~~~~~~iG~G~~g---~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        332 KRRKIPDHLIGKGAEA---DIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccCccceeccCCcE---EEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            4455678899999999   99999996666666654322111      12245688999999999999999888777777


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      ...++||||+++++|.+++.             ....++.+++.+|.+||   +.+++||||||+|||+ .++.++|+||
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeC
Confidence            78899999999999988763             34578999999999999   9999999999999999 5788999999


Q ss_pred             CCcccc
Q 018633          215 SLSISI  220 (353)
Q Consensus       215 g~a~~~  220 (353)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            998653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=7.3e-19  Score=149.84  Aligned_cols=147  Identities=10%  Similarity=0.039  Sum_probs=112.4

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCCh--------------------hHHHHHHHHH
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRP--------------------RAYESCINNV  113 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~  113 (353)
                      .++......|...+.||+|+||   .||++.+ +++.||||++.......                    .....+..|.
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g---~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   84 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKES---DVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF   84 (198)
T ss_pred             HHHHHcCchhhcCCccccCcce---EEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence            4454555558888999999999   9999988 79999999876432110                    0112367899


Q ss_pred             HHHhhcCCCc--eeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018633          114 TYAARMSHNH--ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI  191 (353)
Q Consensus       114 ~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  191 (353)
                      .++.++.|++  +...++    ....++||||+++++|......           .....++.+++.++.++|   ..++
T Consensus        85 ~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi  146 (198)
T cd05144          85 AALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGI  146 (198)
T ss_pred             HHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCC
Confidence            9999998874  333333    2345899999999988664321           233568899999999999   8999


Q ss_pred             EeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          192 VFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       192 iH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      +||||+|+||+++.++.++|+|||.+.....
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999999999866543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=4.5e-20  Score=169.78  Aligned_cols=123  Identities=28%  Similarity=0.406  Sum_probs=106.4

Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      .+||.|++|...+|.++|......  ...++...+.++.|++.|+.|      ++.+|+|+||.||++..+..+||.|||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence            478999999999999999755432  456778889999999999988      689999999999999989999999999


Q ss_pred             CccccCCCC-----CccccccccCCccccccccccCCCCccccchhhHHHHHHHHh
Q 018633          216 LSISIPEGE-----THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT  266 (353)
Q Consensus       216 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  266 (353)
                      +........     ........||..||+||.+.+..|+.++||||||++|+|+++
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            987765544     112345689999999999999999999999999999999998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=5.8e-19  Score=173.50  Aligned_cols=206  Identities=21%  Similarity=0.266  Sum_probs=142.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ..+|+..+.|-.|+||   .||...+  +.+.+|+ +++++.       .+.+.  ++.....|.+|             
T Consensus        82 e~df~~IklisngAyg---avylvrh~~trqrfa~-kiNkq~-------lilRn--ilt~a~npfvv-------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYG---AVYLVRHKETRQRFAM-KINKQN-------LILRN--ILTFAGNPFVV-------------  135 (1205)
T ss_pred             ccccceeEeeccCCCC---ceeeeeccccccchhh-cccccc-------hhhhc--cccccCCccee-------------
Confidence            4689999999999999   8888776  5777888 444431       11111  22222333333             


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                              |+=...++..     .+++.        +++.+++|||   +.+|+|||+||+|.||..-|++|+.|||+++
T Consensus       136 --------gDc~tllk~~-----g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk  191 (1205)
T KOG0606|consen  136 --------GDCATLLKNI-----GPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSK  191 (1205)
T ss_pred             --------chhhhhcccC-----CCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhh
Confidence                    3333333322     23443        2388999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCc--------------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          219 SIPEGETH--------------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       219 ~~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                      ........              .....+||+.|.|||++....|...+|.|++|+|+||.+-|..||+......      
T Consensus       192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------  265 (1205)
T KOG0606|consen  192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------  265 (1205)
T ss_pred             hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------
Confidence            65322111              1234689999999999999999999999999999999999999998432211      


Q ss_pred             HHHHHHHhh-cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC
Q 018633          285 NEYLKNYFE-DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP  337 (353)
Q Consensus       285 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  337 (353)
                        .+..+.. ...+++- |            ...+.+..+++.+.|..+|..|.
T Consensus       266 --lfg~visd~i~wpE~-d------------ea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  266 --LFGQVISDDIEWPEE-D------------EALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --HHhhhhhhhcccccc-C------------cCCCHHHHHHHHHHHHhChHhhc
Confidence              1111111 1111111 1            14456778899999999999996

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=4.7e-19  Score=172.95  Aligned_cols=259  Identities=18%  Similarity=0.185  Sum_probs=188.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~l  139 (353)
                      ...|...+.||+|+|+.+-...........+|+|.+...............|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            345777788999999944433333346667777777655323444455556888888887 9999999999999999999


Q ss_pred             EEEeccCCChhhhh-ccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ceEEeccCCc
Q 018633          140 VFESVQYGTLWDRI-LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLS  217 (353)
Q Consensus       140 v~e~~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~dfg~a  217 (353)
                      +++|..++++.+.+ ....    ...+....-.++.|+..++.|+|.  ..++.|+|+||+|.+++..+ ..+++|||+|
T Consensus        99 ~~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhh
Confidence            99999999998888 3322    234556667889999999999996  67899999999999999999 9999999999


Q ss_pred             cccCC--CCCcccccccc-CCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          218 ISIPE--GETHITDTVMG-TWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       218 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ..+..  +........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++.......              
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------  238 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------  238 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence            88765  23333455678 9999999999874 456789999999999999999999875443321              


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                        .+............  ...........+++.+++..+|+.|.+.+++.
T Consensus       239 --~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  239 --RYSSWKSNKGRFTQ--LPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             --cceeeccccccccc--CccccCChhhhhcccccccCCchhcccccccc
Confidence              11111111100000  00013344556788889999999999887654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=3.3e-17  Score=138.24  Aligned_cols=138  Identities=14%  Similarity=0.119  Sum_probs=97.9

Q ss_pred             CCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHH----------------------HHHHHHHhhcCCCc
Q 018633           67 KNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESC----------------------INNVTYAARMSHNH  123 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~----------------------~~E~~~l~~l~H~n  123 (353)
                      .+.||+|+||   .||++.. +++.||||++............+                      ..|...+.++.+..
T Consensus         2 ~~~lg~G~~g---~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   78 (187)
T cd05119           2 GGPIGTGKEA---DVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG   78 (187)
T ss_pred             Ccccccccce---eEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence            4679999999   9999988 69999999987643222222211                      34566666665432


Q ss_pred             --eeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCc
Q 018633          124 --ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSC  200 (353)
Q Consensus       124 --iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~N  200 (353)
                        +.+.+++    ...++||||++++++........     .. ...+..++.+++.++.++|   . ++|+|+||||+|
T Consensus        79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~N  145 (187)
T cd05119          79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RL-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYN  145 (187)
T ss_pred             CCCCceEec----CCCEEEEEEeCCCCccChhhhhh-----hh-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhh
Confidence              3333332    24689999999865432211110     01 1567789999999999999   7 999999999999


Q ss_pred             eeecCCCceEEeccCCccccC
Q 018633          201 ILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~  221 (353)
                      |+++ ++.++++|||.+....
T Consensus       146 ili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         146 ILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             EEEE-CCcEEEEECccccccc
Confidence            9999 8899999999986553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=7.3e-17  Score=141.05  Aligned_cols=138  Identities=12%  Similarity=0.054  Sum_probs=105.9

Q ss_pred             CCcee-eCCCCCccEEEEEEeCCeEEEEEEecCCCC-----------ChhHHHHHHHHHHHHhhcCCCce--eeccceee
Q 018633           67 KNVIA-KDTSYNLYTMYKGFWQERLISVLQFYGHEC-----------RPRAYESCINNVTYAARMSHNHI--LKLIGCCL  132 (353)
Q Consensus        67 ~~~lg-~G~~g~~~~v~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~H~ni--v~~~~~~~  132 (353)
                      ..+|| .||.|   +||.....+..+++|.+.....           .......+.+|+.++.+++|++|  +..+++..
T Consensus        36 ~~~lg~~~g~g---tv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         36 ARVVGSAKGRG---TTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             CceeecCCCCc---cEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            45788 89999   7777777788999998854210           11234568899999999998885  66777654


Q ss_pred             eCC----ccEEEEEeccC-CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC
Q 018633          133 ETP----IPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN  207 (353)
Q Consensus       133 ~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  207 (353)
                      ...    ..++|||++++ .+|.+++...      +++..    .+.+++.+|.+||   ++||+||||||.|||++.++
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCC
Confidence            332    23599999997 6888887542      23433    3678999999999   99999999999999999888


Q ss_pred             ceEEeccCCcccc
Q 018633          208 VAKLFDFSLSISI  220 (353)
Q Consensus       208 ~~kl~dfg~a~~~  220 (353)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999988653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.5e-16  Score=128.82  Aligned_cols=135  Identities=13%  Similarity=0.053  Sum_probs=112.4

Q ss_pred             CCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC--CceeeccceeeeCCccEEEEEe
Q 018633           66 QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSH--NHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        66 ~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.+.||+|.++   .||++...+..+++|......  .  ...+.+|+.++..++|  .++++++++....+..++++||
T Consensus         2 ~~~~i~~g~~~---~v~~~~~~~~~~~iK~~~~~~--~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTN---RVYLLGTKDEDYVLKINPSRE--K--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceeccccccc---ceEEEEecCCeEEEEecCCCC--c--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            34679999999   999999977899999986652  1  5678899999999986  5899999988887889999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ++++++..+            +......++.+++.+|.+||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus        75 ~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            998777543            3455667899999999999933225799999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=1.2e-15  Score=132.91  Aligned_cols=203  Identities=19%  Similarity=0.236  Sum_probs=139.4

Q ss_pred             HHHhhcCCCceeeccceeeeC-----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC
Q 018633          114 TYAARMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP  188 (353)
Q Consensus       114 ~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  188 (353)
                      .-|-++-|-|||+++.++.+.     ....++.|||..|+|.++|++..... ..+......+|+.||+.||.|||+. +
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            445666799999999998753     35789999999999999998764322 4667777789999999999999965 8


Q ss_pred             CCeEeeccCCCceeecCCCceEEeccCCcccc---CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHH
Q 018633          189 RPIVFRNFKTSCILFNEENVAKLFDFSLSISI---PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELL  265 (353)
Q Consensus       189 ~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  265 (353)
                      ..|+|+++..+-|++..+|-+|+.--.-....   ............+-++|.|||.-.....+.++|||+||....+|.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            89999999999999998888887632211110   000111112234567899999987777788999999999999998


Q ss_pred             hCCCCCC-ccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          266 TGWDVSD-LVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       266 tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+..-.. ......                  ..+.+...+.+.....        =+.++.+|++..|..||+|++++-
T Consensus       277 ilEiq~tnseS~~~------------------~ee~ia~~i~~len~l--------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVE------------------VEENIANVIIGLENGL--------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceee------------------hhhhhhhheeeccCcc--------ccCcCcccccCCCCCCcchhhhhc
Confidence            8743211 100000                  0011111111111110        125778999999999999998753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=5.5e-14  Score=133.31  Aligned_cols=160  Identities=10%  Similarity=0.062  Sum_probs=108.3

Q ss_pred             CcceecHHHHHHHh------------hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChh----------
Q 018633           48 PYRIFSAQEIKLAT------------NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPR----------  104 (353)
Q Consensus        48 ~~~~~~~~e~~~~~------------~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~----------  104 (353)
                      ..+.+++++++...            ..|+ .+.||+|++|   .||+|.. +|+.||||+........-          
T Consensus        92 ~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSig---QVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~  167 (437)
T TIGR01982        92 RVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIA---QVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRL  167 (437)
T ss_pred             CCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-Ccceeeeehh---heEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHH
Confidence            34556666665543            2233 4679999999   9999999 899999999865521000          


Q ss_pred             ------------------HH----------HHHHHHHHHHhhcC----CCceeeccceee-eCCccEEEEEeccCCChhh
Q 018633          105 ------------------AY----------ESCINNVTYAARMS----HNHILKLIGCCL-ETPIPILVFESVQYGTLWD  151 (353)
Q Consensus       105 ------------------~~----------~~~~~E~~~l~~l~----H~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~  151 (353)
                                        ..          -+|.+|++.+.++.    |.+-+.+-.++. .....+|||||++|++|.+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~  247 (437)
T TIGR01982       168 ARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSD  247 (437)
T ss_pred             HHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCccccc
Confidence                              00          02455666666653    333333333332 2345789999999999988


Q ss_pred             hhccCCCCCCccccHHHHHHHHHHHHH-HHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          152 RILGAPQPHFEPLLLKHRLKIAMDIVH-ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       152 ~l~~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      .......    ..   ....++..++. .+..+|   ..|++|+|++|.||+++.++.++++|||++..+.
T Consensus       248 ~~~~~~~----~~---~~~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       248 IAALDEA----GL---DRKALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHhc----CC---CHHHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7643211    11   23346666665 467889   8999999999999999999999999999987764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=9.9e-15  Score=137.08  Aligned_cols=246  Identities=17%  Similarity=0.167  Sum_probs=180.0

Q ss_pred             cCCCCceee--CCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCc
Q 018633           64 YDQKNVIAK--DTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPI  136 (353)
Q Consensus        64 ~~~~~~lg~--G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~  136 (353)
                      |.....+|.  |++|   .||.+..    .+..+|+|+-+.....+....+=.+|+...+++. |+|.++.+..+...+.
T Consensus       116 ~~~~~~~g~~~g~~~---s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKG---SVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             cccccccccCCCCCc---eeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            556677999  9999   8888766    6778899885444333344444467777777776 9999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHH----HHHHHhcCCCCCeEeeccCCCceeecCC-CceEE
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH----ALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKL  211 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl  211 (353)
                      .++-+|+|. .+|..+.....    ..++....+.++.+...    ||..+|   +.+++|-|+||.||++..+ ..+++
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             ceeeecccc-chhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeec
Confidence            999999995 78877766543    34677888888888888    999999   9999999999999999999 88999


Q ss_pred             eccCCccccCCCCCccc----cccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          212 FDFSLSISIPEGETHIT----DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      +|||+...+........    ....|...|++||... +.++..+|+||+|.++.+..++..++.......         
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---------  334 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS---------  334 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC---------
Confidence            99999887765442211    1225677899999985 567889999999999999999877654322111         


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                          |...+-..+-+..+         .....++...+..+++.+|-.|+++..+.
T Consensus       335 ----W~~~r~~~ip~e~~---------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  335 ----WSQLRQGYIPLEFC---------EGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             ----ccccccccCchhhh---------cCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence                00000000000000         02234445588899999999999987654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=1.8e-12  Score=123.36  Aligned_cols=164  Identities=20%  Similarity=0.169  Sum_probs=125.2

Q ss_pred             CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccH
Q 018633           87 QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL  166 (353)
Q Consensus        87 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~  166 (353)
                      ++..|.|......  +....+...+-++-|+.++||||+++++.++..+..|||+|-+.  .|...+..        +..
T Consensus        36 ~~~~vsVF~~~~~--~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~  103 (690)
T KOG1243|consen   36 DGGPVSVFVYKRS--NGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK  103 (690)
T ss_pred             cCCceEEEEEeCC--CchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence            7888888888766  33445556778899999999999999999999999999999984  77777754        345


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccC
Q 018633          167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG  246 (353)
Q Consensus       167 ~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  246 (353)
                      ....-.+.||+.||.|||+  +.+++|++|.-..|+++..|..||++|-++........ ......--..|..|+.....
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            5556678999999999986  78999999999999999999999999987654422211 01111112235666654322


Q ss_pred             CCCccccchhhHHHHHHHHhC
Q 018633          247 VFNEKSDVFSFGVFLFELLTG  267 (353)
Q Consensus       247 ~~~~~~Di~slG~il~el~tg  267 (353)
                      .  ...|.|-|||+++|++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  346999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=5.3e-13  Score=110.55  Aligned_cols=127  Identities=13%  Similarity=0.049  Sum_probs=95.2

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCcee-eccceeeeCCccEEEEEeccC
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL-KLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      +.|+.|.++   .||+....+..+++|......   .....+.+|+.++..+.+.+++ +++.+.  ....++||||++|
T Consensus         4 ~~l~~G~~~---~vy~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           4 SPLKGGMTN---KNYRVEVANKKYVVRIPGNGT---ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eecCCcccC---ceEEEEECCeEEEEEeCCCCc---ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            457889999   888888888999999875542   1223467899999998765544 444443  3345899999999


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC-----eEeeccCCCceeecCCCceEEeccCCccc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP-----IVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      .++.+..          .   ....++.+++.+|+.||   ..+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        76 ~~l~~~~----------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTED----------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Ccccccc----------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            8875430          0   01245678999999999   666     59999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.45  E-value=9.6e-13  Score=110.42  Aligned_cols=137  Identities=9%  Similarity=0.052  Sum_probs=97.4

Q ss_pred             CceeeCCCCCccEEEEEEeC--------CeEEEEEEecCCCCC--------------------hhHHHHHH----HHHHH
Q 018633           68 NVIAKDTSYNLYTMYKGFWQ--------ERLISVLQFYGHECR--------------------PRAYESCI----NNVTY  115 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~--------~~~vavK~~~~~~~~--------------------~~~~~~~~----~E~~~  115 (353)
                      ..||.|--+   .||.|...        +..+|||+.......                    ......+.    +|++.
T Consensus         3 g~i~~GKEa---~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~   79 (197)
T cd05146           3 GCISTGKES---VVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHN   79 (197)
T ss_pred             CccccCcce---EEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHH
Confidence            468889999   89998763        378999988532210                    01122333    89999


Q ss_pred             HhhcCC--CceeeccceeeeCCccEEEEEeccCCChhh-hhccCCCCCCccccHHHHHHHHHHHHHHHHHH-hcCCCCCe
Q 018633          116 AARMSH--NHILKLIGCCLETPIPILVFESVQYGTLWD-RILGAPQPHFEPLLLKHRLKIAMDIVHALAYL-HFGFPRPI  191 (353)
Q Consensus       116 l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~i  191 (353)
                      |.++..  -++.+++++    ...+|||||+.+..+.. .+.+      ..++......+..+++.+|..| |   ..++
T Consensus        80 L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~gl  146 (197)
T cd05146          80 LKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNL  146 (197)
T ss_pred             HHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            999863  455666654    45679999997543322 2222      1234455667889999999999 8   8999


Q ss_pred             EeeccCCCceeecCCCceEEeccCCccccC
Q 018633          192 VFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       192 iH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      +|+||++.|||++ ++.+.|+|||.+....
T Consensus       147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         147 VHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             ecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999999997 4679999999886653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=8.4e-14  Score=130.86  Aligned_cols=263  Identities=17%  Similarity=0.120  Sum_probs=181.5

Q ss_pred             CcceecHHH-HHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCcee
Q 018633           48 PYRIFSAQE-IKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHIL  125 (353)
Q Consensus        48 ~~~~~~~~e-~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv  125 (353)
                      +..+|.-.+ ....+..|.....||.|.|+.++.|-+--.++..+++|...+..........-+.|+-+...+. |.+++
T Consensus       250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence            334444445 3445667888999999999944443322127889999988777544444444466777777765 99999


Q ss_pred             eccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       126 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      ..+..+......|+-.|||.++++.....-.     ..+....++.+..|++.++.++|   ++.++|+|+||+||++..
T Consensus       330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~  401 (524)
T KOG0601|consen  330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISN  401 (524)
T ss_pred             CCCCCccccccccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeecc
Confidence            9999888888888999999998886655221     45777888999999999999999   999999999999999988


Q ss_pred             C-CceEEeccCCccccCCCCCccccccccCCcc-ccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCC
Q 018633          206 E-NVAKLFDFSLSISIPEGETHITDTVMGTWGY-CAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACP  283 (353)
Q Consensus       206 ~-~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~  283 (353)
                      + +..+++|||+++.+.-..   ......+..| .+|.......+..+.|++|||..+.+.+++........        
T Consensus       402 ~~~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------  470 (524)
T KOG0601|consen  402 DGFFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------  470 (524)
T ss_pred             chhhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------
Confidence            6 778999999886432111   1111223334 35556666778899999999999999999864422100        


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                                  .+..+....+. ..+     .....+..+...+...++..||++.++....+
T Consensus       471 ------------~~~~i~~~~~p-~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  471 ------------QSLTIRSGDTP-NLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------------cceeeeccccc-CCC-----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                        00011111000 000     22255566777889999999999888765544

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=7e-13  Score=127.46  Aligned_cols=160  Identities=11%  Similarity=0.083  Sum_probs=100.1

Q ss_pred             CcceecHHHHHHHh------------hCcCCCCceeeCCCCCccEEEEEEe-C-CeEEEEEEecCCCCC-----------
Q 018633           48 PYRIFSAQEIKLAT------------NSYDQKNVIAKDTSYNLYTMYKGFW-Q-ERLISVLQFYGHECR-----------  102 (353)
Q Consensus        48 ~~~~~~~~e~~~~~------------~~~~~~~~lg~G~~g~~~~v~~~~~-~-~~~vavK~~~~~~~~-----------  102 (353)
                      ..+.++++++++..            ..|+. +.||+|++|   .||++.. + |+.||||+..+....           
T Consensus        94 ~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSia---QVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~  169 (537)
T PRK04750         94 RVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIA---QVHFARLKDNGREVVVKVLRPDILPVIDADLALMYR  169 (537)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCcc---EEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHH
Confidence            34556666555442            35666 789999999   9999998 4 899999999755200           


Q ss_pred             ----------------h-----hHHHH------HHHHHHHHhhcC----CCceeeccceeee-CCccEEEEEeccCCChh
Q 018633          103 ----------------P-----RAYES------CINNVTYAARMS----HNHILKLIGCCLE-TPIPILVFESVQYGTLW  150 (353)
Q Consensus       103 ----------------~-----~~~~~------~~~E~~~l~~l~----H~niv~~~~~~~~-~~~~~lv~e~~~~gsL~  150 (353)
                                      .     ...+.      |.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+++.
T Consensus       170 ~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~  249 (537)
T PRK04750        170 LARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVS  249 (537)
T ss_pred             HHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHH
Confidence                            0     01111      334444444442    3333433333322 34567999999999997


Q ss_pred             hhh--ccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC----ceEEeccCCccccCC
Q 018633          151 DRI--LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN----VAKLFDFSLSISIPE  222 (353)
Q Consensus       151 ~~l--~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~dfg~a~~~~~  222 (353)
                      +.-  .... .....+....+..++.|+       .   ..|++|+|++|.||+++.++    .+++.|||++..++.
T Consensus       250 d~~~l~~~g-~d~~~la~~~v~~~~~Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        250 DVAALRAAG-TDMKLLAERGVEVFFTQV-------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hHHHHHhcC-CCHHHHHHHHHHHHHHHH-------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            742  2211 000123333333333333       3   67999999999999999887    999999999877643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.8e-11  Score=99.54  Aligned_cols=133  Identities=18%  Similarity=0.180  Sum_probs=99.0

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCC-hh-----HHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECR-PR-----AYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~-~~-----~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      ..+++|+-+   .++.+.+-|..+++|.-.+.... +.     ..++-.+|++++.++.--.|...+=+..+.+...|+|
T Consensus         2 ~~i~~GAEa---~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEA---IIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcce---eEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence            357899999   99999887767777754333222 11     1245678999999987544444444445667778999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||++|..|.+.+...            ...++..+-.-+.-||   ..+|+|+||.++||++.+.. +.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999988888777543            2356777778888999   99999999999999998654 99999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.33  E-value=1.8e-11  Score=99.20  Aligned_cols=145  Identities=17%  Similarity=0.143  Sum_probs=107.3

Q ss_pred             CCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCC------hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           66 QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECR------PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        66 ~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ...+|-||+-+   .|+++.+.|+..+||.-......      .-...+..+|++.|.++.--.|.-..=++.+...-.|
T Consensus        11 ~l~likQGAEA---rv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEA---RVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeecccee---eEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence            56789999999   99999999999888865433221      1123567789999999875555444444556667789


Q ss_pred             EEEeccC-CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC---ceEEeccC
Q 018633          140 VFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFS  215 (353)
Q Consensus       140 v~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl~dfg  215 (353)
                      +|||+++ .++.+++......   .........++..|-..+.-||   .++++|+||..+||++..++   .+.++|||
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             EEEeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeec
Confidence            9999985 3778887765432   1222223678889999999999   99999999999999996554   45899999


Q ss_pred             Cccc
Q 018633          216 LSIS  219 (353)
Q Consensus       216 ~a~~  219 (353)
                      ++..
T Consensus       162 ls~~  165 (229)
T KOG3087|consen  162 LSSV  165 (229)
T ss_pred             chhc
Confidence            9754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.32  E-value=2.3e-13  Score=134.62  Aligned_cols=249  Identities=17%  Similarity=0.146  Sum_probs=167.9

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ..+.|...+-+-+|.++   .++...-  .+...+++....... .....+....+-.++-...||-++...-.+.....
T Consensus       802 S~d~~~i~~p~qS~sp~---ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPS---SSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             CCccceecccccCCCCc---ccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            34566666677888888   7666554  343333333322110 11123334444444444566888877766667778


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++|++|..+++|...|+...     ..+..-....+..+..+++|||   ...+.|+|++|.|+|+..++..+++|||.
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccc
Confidence            899999999999999887764     3444445566778889999999   77799999999999999999999999984


Q ss_pred             ccccCCC-------------------------C-----CccccccccCCccccccccccCCCCccccchhhHHHHHHHHh
Q 018633          217 SISIPEG-------------------------E-----THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT  266 (353)
Q Consensus       217 a~~~~~~-------------------------~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  266 (353)
                      ......-                         .     ........||+.|.+||...+......+|.|++|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            3221100                         0     001223568999999999999999999999999999999999


Q ss_pred             CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchH-HHHHHHHHHHHHHHHchhcCCCCCCCHH
Q 018633          267 GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSI-EKEQQLHASAQLSFECIKDSPADRPSMV  340 (353)
Q Consensus       267 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~  340 (353)
                      |.+||.......                     +++.++..+.+.. .+...+....+++...+..+|..|..+.
T Consensus      1031 g~pp~na~tpq~---------------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQ---------------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhh---------------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999987432221                     2222222222211 1224455566788888889999987664

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.4e-10  Score=100.30  Aligned_cols=142  Identities=18%  Similarity=0.208  Sum_probs=106.7

Q ss_pred             CceeeCCCCCccEEEEEEeC-CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC--ceeeccceeeeC---CccEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFWQ-ERLISVLQFYGHECRPRAYESCINNVTYAARMSHN--HILKLIGCCLET---PIPILVF  141 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~~~---~~~~lv~  141 (353)
                      +.|+.|.++   .||+.... |..+++|........ .....+.+|+.++..+++.  ++.+++.+....   +..++||
T Consensus         4 ~~l~~G~~n---~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSN---LTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccc---eEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            468889999   88888874 488999987654211 2345788999999999863  456677776653   3678999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF----------------------------------  187 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  187 (353)
                      ||++|.++.+.+..      ..++......++.+++.+|..||+..                                  
T Consensus        80 e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          80 ERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999888776532      13566777788888888888888321                                  


Q ss_pred             -------------------CCCeEeeccCCCceeecC--CCceEEeccCCccc
Q 018633          188 -------------------PRPIVFRNFKTSCILFNE--ENVAKLFDFSLSIS  219 (353)
Q Consensus       188 -------------------~~~iiH~dlkp~Nill~~--~~~~kl~dfg~a~~  219 (353)
                                         ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               245799999999999998  56689999997754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=5.9e-10  Score=103.43  Aligned_cols=215  Identities=14%  Similarity=0.122  Sum_probs=146.6

Q ss_pred             EEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee----CCccEEEEEeccC-CChhhh
Q 018633           80 TMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE----TPIPILVFESVQY-GTLWDR  152 (353)
Q Consensus        80 ~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~~  152 (353)
                      +.|++..  +|..+++|++....  .........-++.++++.|+|+|++.+++..    +...++|++|.|+ ++|.++
T Consensus       291 Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  291 TTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             eeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            5677776  89999999994431  1111122334678999999999999999873    4468999999886 477775


Q ss_pred             hccCCCCC----------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          153 ILGAPQPH----------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       153 l~~~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      ........          ....++..+|.++.|+..||.++|   +.|+.-+-|.|.+||++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            54332211          135678899999999999999999   89998899999999999999999998887766543


Q ss_pred             CCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccccc
Q 018633          223 GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVD  302 (353)
Q Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
                      +...               -+   .--.+-|.=.||.+++.|.||..--......                        .
T Consensus       446 d~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~------------------------~  483 (655)
T KOG3741|consen  446 DPTE---------------PL---ESQQQNDLRDLGLLLLALATGTENSNRTDST------------------------Q  483 (655)
T ss_pred             CCCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccccccccch------------------------H
Confidence            3310               00   0124568889999999999985431100000                        0


Q ss_pred             chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          303 PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      ....    ......++.++.+++.-....++++ -+..+++..+
T Consensus       484 ~s~~----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  484 SSHL----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             HHHH----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            0000    0011256677777777777777776 5666666554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.19  E-value=3.4e-10  Score=100.26  Aligned_cols=142  Identities=9%  Similarity=0.034  Sum_probs=101.5

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHH----------HHHHHHHHHhhcCCCce--eeccceeee--
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYE----------SCINNVTYAARMSHNHI--LKLIGCCLE--  133 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~----------~~~~E~~~l~~l~H~ni--v~~~~~~~~--  133 (353)
                      +++-.....   .|++..+.|+.+.||........ ...+          .+.+|...+.++..-+|  ...+++.+.  
T Consensus        28 e~v~~~~~r---rvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~  103 (268)
T PRK15123         28 EVFRELEGR---RTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS  103 (268)
T ss_pred             cEEecCCCc---eEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC
Confidence            445544444   67788889999999987544211 1111          47899999998864343  334445432  


Q ss_pred             ---CCccEEEEEeccCC-ChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC----
Q 018633          134 ---TPIPILVFESVQYG-TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE----  205 (353)
Q Consensus       134 ---~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~----  205 (353)
                         ....+||+|++++. +|.+++.....   .+.+......++.+++..+.-||   ..||+|+|++++|||++.    
T Consensus       104 ~~~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~  177 (268)
T PRK15123        104 NPATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPG  177 (268)
T ss_pred             CCccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccC
Confidence               23468999999875 78888753211   23456677789999999999999   999999999999999975    


Q ss_pred             ---CCceEEeccCCccc
Q 018633          206 ---ENVAKLFDFSLSIS  219 (353)
Q Consensus       206 ---~~~~kl~dfg~a~~  219 (353)
                         ++.+.++||+.+..
T Consensus       178 ~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        178 REEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCceEEEEECCcccc
Confidence               46789999997743

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=9.2e-10  Score=92.07  Aligned_cols=126  Identities=14%  Similarity=0.138  Sum_probs=81.0

Q ss_pred             EEEEEEe-CCeEEEEEEecCCCCC------------------------hhHHHHHHHHHHHHhhcCCC--ceeeccceee
Q 018633           80 TMYKGFW-QERLISVLQFYGHECR------------------------PRAYESCINNVTYAARMSHN--HILKLIGCCL  132 (353)
Q Consensus        80 ~v~~~~~-~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~  132 (353)
                      .||.|.. ++..+|+|.......+                        .-......+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3788888 8889999998543211                        00123457899999999855  455666442 


Q ss_pred             eCCccEEEEEecc--CCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHH-HhcCCCCCeEeeccCCCceeecCCCce
Q 018633          133 ETPIPILVFESVQ--YGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAY-LHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       133 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                         ..+|||||++  |..+.. +...      .++......++.+++..+.. +|   ..||+|+||.+.|||++.+ .+
T Consensus        80 ---~~~ivME~I~~~G~~~~~-l~~~------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPR-LKDV------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGC-HHHC------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CE
T ss_pred             ---CCEEEEEecCCCccchhh-HHhc------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eE
Confidence               3469999998  545543 3322      12233445677778775555 58   8999999999999999877 89


Q ss_pred             EEeccCCcccc
Q 018633          210 KLFDFSLSISI  220 (353)
Q Consensus       210 kl~dfg~a~~~  220 (353)
                      .++|||.+...
T Consensus       146 ~iIDf~qav~~  156 (188)
T PF01163_consen  146 YIIDFGQAVDS  156 (188)
T ss_dssp             EE--GTTEEET
T ss_pred             EEEecCcceec
Confidence            99999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.12  E-value=8.2e-09  Score=93.84  Aligned_cols=271  Identities=14%  Similarity=0.098  Sum_probs=160.7

Q ss_pred             CCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecccee------eeCC-c
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCC------LETP-I  136 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~------~~~~-~  136 (353)
                      ...+.||+|+.+   .+|.----+. .+.|+....  .+....+.   +..|... .||-+-.-+.+=      -+.. .
T Consensus        14 ~~gr~LgqGgea---~ly~l~e~~d-~VAKIYh~P--ppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEA---DLYTLGEVRD-QVAKIYHAP--PPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccc---eeeecchhhc-hhheeecCC--CchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            456789999999   5553222111 244666544  22222222   2223333 355433211111      0122 2


Q ss_pred             cEEEEEeccCC-Chhhhhc-cCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          137 PILVFESVQYG-TLWDRIL-GAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       137 ~~lv~e~~~~g-sL~~~l~-~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      .-+.|..+++. .+..++. .....++..+.|...++.++.++.+.+-||   ..|.+-+|+.++|+|+++++.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence            45777777653 2222222 112223356789999999999999999999   999999999999999999999999974


Q ss_pred             CCccccCCCCCccccccccCCcccccccccc-----CCCCccccchhhHHHHHHHHhC-CCCCCccccccCCCCChHHHH
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTG-WDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      ..-...  ......-..+|...|.+||.-.-     ..-+..+|.|.||+++++++.| +.||...........+....+
T Consensus       162 Dsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         162 DSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             cceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            422121  11122345678899999997652     2356789999999999999886 899986544333333322111


Q ss_pred             HHHhhcCcccccccch--hhhccchHHHHHHHHHHHHHHHHchhc--CCCCCCCHHHHHHHHHHHHHhC
Q 018633          289 KNYFEDNRFTEIVDPI--IVEDVLSIEKEQQLHASAQLSFECIKD--SPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                      .    .+.+....+..  .........-.-.+..+..|..+|+..  +|.-|||++.-+..|..+.++|
T Consensus       240 a----~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         240 A----HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             h----cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            1    11111111110  000000001113445666777888854  3568999999999999988775

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=7.7e-09  Score=89.35  Aligned_cols=137  Identities=15%  Similarity=0.096  Sum_probs=98.1

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCC--------------------hhHHHHHHHHHHHHhhcCCC
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECR--------------------PRAYESCINNVTYAARMSHN  122 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~H~  122 (353)
                      ....+.||-|--+   .||.|.. .|.++|||.-....++                    .-......+|+++|.+|...
T Consensus        93 e~iG~~IGvGKEs---dVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          93 EAIGTKIGVGKES---DVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             HhhccccccCccc---eEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            3456789999999   9999999 7999999976433211                    11233467899999999754


Q ss_pred             --ceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCc
Q 018633          123 --HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC  200 (353)
Q Consensus       123 --niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  200 (353)
                        .+.+.+++    +.-.+||||++|-.|...-          +.....-.++..|+.-+.-+-   ..|+||+|+++-|
T Consensus       170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefN  232 (304)
T COG0478         170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFN  232 (304)
T ss_pred             CCCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchhe
Confidence              56666664    3456999999976664422          122333345555655555555   6899999999999


Q ss_pred             eeecCCCceEEeccCCcccc
Q 018633          201 ILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~  220 (353)
                      |+++++|.+.++||-.+...
T Consensus       233 IlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEEecCCCEEEEeCcccccC
Confidence            99999999999999766443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=4e-10  Score=107.97  Aligned_cols=150  Identities=19%  Similarity=0.262  Sum_probs=99.7

Q ss_pred             HHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc--------cccccccCCccccccccc
Q 018633          173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--------ITDTVMGTWGYCAPEYMR  244 (353)
Q Consensus       173 ~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~  244 (353)
                      +.+++.||.|+|.  +.++||++|.|++|.++.++..|++.|+.+.........        ......-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455599999996  778999999999999999999999999987554331110        011122345799999999


Q ss_pred             cCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHH
Q 018633          245 TGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQ  323 (353)
Q Consensus       245 ~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  323 (353)
                      ....+.++|+||+|+++|.+.. |+..+........     ...     ...    ..+.....     .....+.++.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~-----~~~----~~~~~~~~-----~s~~~p~el~~  243 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSF-----SRN----LLNAGAFG-----YSNNLPSELRE  243 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhh-----hhc----cccccccc-----ccccCcHHHHH
Confidence            8888899999999999999994 5444432211110     000     000    00000000     00145667778


Q ss_pred             HHHHchhcCCCCCCCHHHHH
Q 018633          324 LSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       324 li~~cl~~dP~~Rps~~~vl  343 (353)
                      =+.+++..++.-||++..+.
T Consensus       244 ~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  244 SLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHHHHhcCCcccCcchhhhh
Confidence            88899999999999776554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=1.1e-08  Score=87.55  Aligned_cols=126  Identities=15%  Similarity=0.098  Sum_probs=90.4

Q ss_pred             CCeEEEEEEecCCCCC-----hhHHHHHHHHHHHHhhcCCC--ceeeccceeeeCC----ccEEEEEeccCC-Chhhhhc
Q 018633           87 QERLISVLQFYGHECR-----PRAYESCINNVTYAARMSHN--HILKLIGCCLETP----IPILVFESVQYG-TLWDRIL  154 (353)
Q Consensus        87 ~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~  154 (353)
                      .++.+.+|........     .-....+.+|...+..|..-  .+.+.+++.....    ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            4555666654322111     12334678888888888633  3455566655432    357999999874 7888887


Q ss_pred             cCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC---ceEEeccCCcccc
Q 018633          155 GAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISI  220 (353)
Q Consensus       155 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl~dfg~a~~~  220 (353)
                      ...     ..+......++.+++..+.-||   .+||+|+|+++.|||++.++   .+.++||+.++..
T Consensus       111 ~~~-----~~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWE-----QLDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhc-----ccchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            532     2455667789999999999999   99999999999999999887   8999999977553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.77  E-value=1.7e-07  Score=80.35  Aligned_cols=157  Identities=13%  Similarity=0.095  Sum_probs=106.5

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHH----------------------
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYES----------------------  108 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~----------------------  108 (353)
                      .+...+....+........|.++.|.--.||+|.. ++..+|+|++....+.-.....                      
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            46667777777777888888888886668999987 7999999999765322111110                      


Q ss_pred             HHHHHHHHhhcC--CCceeeccceeeeCCccEEEEEeccCCC-hhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhc
Q 018633          109 CINNVTYAARMS--HNHILKLIGCCLETPIPILVFESVQYGT-LWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF  185 (353)
Q Consensus       109 ~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~  185 (353)
                      ...|+.-|.++.  +-.+.+.+++.    ...|||||+.... -.-.|.+      .++.......+..++++.+.-|-.
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH
Confidence            134666666654  33344444432    3469999996431 1112222      123333566778888888888872


Q ss_pred             CCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       186 ~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                        ..++||+||+.=|||+. ++.+.++|||.|....
T Consensus       185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             --hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence              38999999999999999 8899999999886653

>PRK09902 hypothetical protein; Provisional

Probab=98.76  E-value=2.2e-07  Score=78.38  Aligned_cols=149  Identities=13%  Similarity=0.062  Sum_probs=107.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCC---C-hhHHHHHHHHHHHHhhcCCCc--eeeccceee-e
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHEC---R-PRAYESCINNVTYAARMSHNH--ILKLIGCCL-E  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~---~-~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~-~  133 (353)
                      ...+-+.=--|+||.+   -|+.-...|..+-+|+-.+...   . +-....|.+|+..+.+|..-+  +.+.. ++. .
T Consensus        17 ~~~wve~pN~~rgG~S---gV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~   92 (216)
T PRK09902         17 EGDWVEEPNYRRNGMS---GVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAV   92 (216)
T ss_pred             CCceecCCCcCCCCcc---eEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeee
Confidence            3344444445889998   8888777777888888753321   1 445678999999999997433  44444 322 1


Q ss_pred             C----CccEEEEEeccC-CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc
Q 018633          134 T----PIPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV  208 (353)
Q Consensus       134 ~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  208 (353)
                      .    -..+||+|-+++ -||.+++....-   .+.+...+..++.+++..+.-||   +.|+.|+|+.+.||+++.++.
T Consensus        93 k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902         93 KIEGEWRALLVTEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             ccCCceEEEEEEEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCC
Confidence            1    135799997753 478887755321   34577778899999999999999   999999999999999987677


Q ss_pred             --eEEeccCCccc
Q 018633          209 --AKLFDFSLSIS  219 (353)
Q Consensus       209 --~kl~dfg~a~~  219 (353)
                        +.++||--++.
T Consensus       167 ~~v~lIDlEk~r~  179 (216)
T PRK09902        167 AEAGFLDLEKSRR  179 (216)
T ss_pred             eeEEEEEhhccch
Confidence              89999986644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.56  E-value=1.1e-06  Score=76.35  Aligned_cols=133  Identities=8%  Similarity=-0.047  Sum_probs=82.8

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc--eeeccceeeeCCccEEEEEecc
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH--ILKLIGCCLETPIPILVFESVQ  145 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~  145 (353)
                      ..||+|..+   .||+.  .+..+++|......    ......+|.+++..+..-+  +.+.+++....+...+|||+++
T Consensus         7 ~~i~~G~t~---~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNG---ESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCc---ceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            468999999   77773  24456778775431    2345688999999987443  4667777777777889999999


Q ss_pred             CCC-hhhhhccCCCCCCccccHHHHHHHHHHHHHHH---------------------------------------HHHhc
Q 018633          146 YGT-LWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL---------------------------------------AYLHF  185 (353)
Q Consensus       146 ~gs-L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L---------------------------------------~~LH~  185 (353)
                      |.+ +...+...         ......++..++..+                                       .+|..
T Consensus        78 G~~~~~~~~~~~---------~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~  148 (226)
T TIGR02172        78 GKRSFSRIISDN---------PSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE  148 (226)
T ss_pred             CccchhhhhcCC---------HHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh
Confidence            753 21111100         000011111111111                                       11110


Q ss_pred             -CCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          186 -GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       186 -~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                       .....++|+|+.|.||+++.++ +.|+||+.+..
T Consensus       149 ~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       149 VPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence             1144578999999999999888 99999997743

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.54  E-value=1.4e-08  Score=96.65  Aligned_cols=181  Identities=17%  Similarity=0.078  Sum_probs=131.6

Q ss_pred             CceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc-eeeccceeeeCCccEEEEEecc
Q 018633           68 NVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH-ILKLIGCCLETPIPILVFESVQ  145 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~  145 (353)
                      +-+++|+.+   .++|.+. ..+....+.+...       ....-++++|.+++||| .+..++-+..++..+++++++.
T Consensus       248 h~fvK~alt---knpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  248 HNFVKGALT---KNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             HHHHHHHhc---CCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            447888888   8888877 2333334443222       33445778899999999 7777888877888999999998


Q ss_pred             CC-ChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          146 YG-TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       146 ~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      .+ +-...+....    ..+...+...+.+.-+++++++|   +-.=+|+|    ||+..+ +..+..||+....+....
T Consensus       318 ~~rs~~~~~~~se----~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  318 TGRSSALEMTVSE----IALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             CCccccccCChhh----Hhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc
Confidence            76 3322222111    23444555667778889999999   55557888    777654 678999999887765433


Q ss_pred             CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 018633          225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSD  272 (353)
Q Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~  272 (353)
                        ..++..+|..++|||+...+.+....|+||+|.-..++.-|.+|-.
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              3567789999999999999999999999999988778887877743

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.48  E-value=2.2e-06  Score=72.75  Aligned_cols=137  Identities=12%  Similarity=0.034  Sum_probs=90.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHH---------HHHHHHHhhcCC---Cceeecc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESC---------INNVTYAARMSH---NHILKLI  128 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~~~  128 (353)
                      .++|...+++-.....   .|.+-..++...++|......  ....+.|         .+++..+.+++.   -....++
T Consensus        30 ~~~~~~~kv~k~~~r~---~ValIei~~~kyIlK~pr~~~--~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRN---YVALIEIDGKKYILKEPREEN--RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             hCCceEEEeecCCCcc---EEEEEEECCcEEEEeccchhh--hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            3567777777776666   677777799999999887653  2222222         234444444432   2333333


Q ss_pred             ceeeeC-----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee
Q 018633          129 GCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF  203 (353)
Q Consensus       129 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  203 (353)
                      .+....     ...++||||++|..|.+...         ++.    .++..++.++.-||   ..|+.|+|..|.|+++
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv  168 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLV  168 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEE
Confidence            333322     24568999999988866532         222    24566778899999   9999999999999999


Q ss_pred             cCCCceEEeccCCccc
Q 018633          204 NEENVAKLFDFSLSIS  219 (353)
Q Consensus       204 ~~~~~~kl~dfg~a~~  219 (353)
                      ..++ ++++||+..+.
T Consensus       169 ~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  169 SNNG-IRIIDTQGKRM  183 (229)
T ss_pred             ECCc-EEEEECccccc
Confidence            8554 99999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=1.9e-06  Score=82.84  Aligned_cols=160  Identities=14%  Similarity=0.071  Sum_probs=98.5

Q ss_pred             CcceecHHHHHHHh------------hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChh----------
Q 018633           48 PYRIFSAQEIKLAT------------NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPR----------  104 (353)
Q Consensus        48 ~~~~~~~~e~~~~~------------~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~----------  104 (353)
                      ..+.|++++.....            .+|+ ..-|+.++-|   .||+|.+ +|+.||||+...+....-          
T Consensus       100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIa---QVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~  175 (517)
T COG0661         100 RVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIA---QVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRL  175 (517)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHh---hheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHH
Confidence            34556666555442            3343 3578999999   9999999 699999999865531000          


Q ss_pred             ------------------HHH----------HHHHHHHHHhhcC-----CCceeeccceee-eCCccEEEEEeccCCChh
Q 018633          105 ------------------AYE----------SCINNVTYAARMS-----HNHILKLIGCCL-ETPIPILVFESVQYGTLW  150 (353)
Q Consensus       105 ------------------~~~----------~~~~E~~~l~~l~-----H~niv~~~~~~~-~~~~~~lv~e~~~~gsL~  150 (353)
                                        ..+          .+.+|+.-+.+++     .|+ +.+-.++. -.....|+|||++|-.+.
T Consensus       176 a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~  254 (517)
T COG0661         176 ARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKIS  254 (517)
T ss_pred             HHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecc
Confidence                              000          1334555555443     233 33333332 234567999999998888


Q ss_pred             hhhccCCCCCCccccHHHHHHHHHHHHHH-HHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCC
Q 018633          151 DRILGAPQPHFEPLLLKHRLKIAMDIVHA-LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       151 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~  222 (353)
                      +...-..    ...+..   .++..++.+ +..+-   ..|+.|.|..|.||+++.+|.+.+.|||+...+.+
T Consensus       255 d~~~l~~----~g~d~k---~ia~~~~~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         255 DIAALKS----AGIDRK---ELAELLVRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cHHHHHh----cCCCHH---HHHHHHHHHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            8742221    122322   222222222 12222   56899999999999999999999999999876643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=2.9e-06  Score=69.02  Aligned_cols=129  Identities=12%  Similarity=0.096  Sum_probs=89.1

Q ss_pred             CCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceee-ccceeeeCCccEEEEEe
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILK-LIGCCLETPIPILVFES  143 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-~~~~~~~~~~~~lv~e~  143 (353)
                      .....||+|.+|   .||+|.|.+..+|+|+-..+    .....+..|+++|..++-.++.+ +|.+-.+    .+.|||
T Consensus        25 ~v~~~L~KG~~s---~Vyl~~~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTS---VVYLGEWRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhccccc---EEEEeeccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            346779999999   99999999999999997665    44577899999999998766543 4444222    255999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCC-CceeecCCCceEEeccCCccc
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT-SCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp-~Nill~~~~~~kl~dfg~a~~  219 (353)
                      +.|-+|.+.....        +..+    +..++..-.-|-   ..||-|+.|.- ...++-.++.+.|+||..|+.
T Consensus        94 i~G~~L~~~~~~~--------~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG--------DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc--------cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9987886654321        2222    233334433333   67888888864 334444455899999998863

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.33  E-value=6.4e-06  Score=72.37  Aligned_cols=68  Identities=7%  Similarity=-0.132  Sum_probs=48.8

Q ss_pred             EEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEEEEEeccCCChhhh
Q 018633           80 TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVFESVQYGTLWDR  152 (353)
Q Consensus        80 ~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  152 (353)
                      .||+....+..+++|......     .....+|++++..+. +--+.+++++...++..++|||+++|.+|...
T Consensus        14 ~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          14 TVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             eEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            778877766778888775441     345677898988885 43455677777666678999999998777543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.27  E-value=7.3e-06  Score=71.07  Aligned_cols=143  Identities=13%  Similarity=0.156  Sum_probs=82.4

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc--eeeccceeee---CCccEEEEE
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH--ILKLIGCCLE---TPIPILVFE  142 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~---~~~~~lv~e  142 (353)
                      +.|+.|..+   .||+....+..+++|.....    .....+.+|..++..+....  +.+++.++..   ....+++|+
T Consensus         3 ~~l~~G~~n---~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    3 RPLSGGFSN---RVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEESSSS---EEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             ccCCCCCee---eEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            468899999   99999996689999986433    45667788999998886332  4556654432   334689999


Q ss_pred             eccCCChhh----------------hh---ccCCCCCCccccHHH---------HHHH------------HHHHHH-HHH
Q 018633          143 SVQYGTLWD----------------RI---LGAPQPHFEPLLLKH---------RLKI------------AMDIVH-ALA  181 (353)
Q Consensus       143 ~~~~gsL~~----------------~l---~~~~~~~~~~l~~~~---------~~~i------------~~~i~~-~L~  181 (353)
                      ++++.++..                .+   +...... ..+....         ....            ...+.. .+.
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPF-SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC-CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             Eeccccccccccccccccccccchhhhhhcccccccc-cccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            999877766                11   1110000 0011000         0000            111222 223


Q ss_pred             HHhc----CCCCCeEeeccCCCceeec-CCCceEEeccCCcc
Q 018633          182 YLHF----GFPRPIVFRNFKTSCILFN-EENVAKLFDFSLSI  218 (353)
Q Consensus       182 ~LH~----~~~~~iiH~dlkp~Nill~-~~~~~kl~dfg~a~  218 (353)
                      .++.    .....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3331    1256799999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.26  E-value=5.7e-06  Score=69.49  Aligned_cols=105  Identities=21%  Similarity=0.226  Sum_probs=81.4

Q ss_pred             HHHHHHHhhcCC-CceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC
Q 018633          110 INNVTYAARMSH-NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP  188 (353)
Q Consensus       110 ~~E~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  188 (353)
                      .+|.-++..+++ +++.+++|+|-.    ++|.||.+.+++.+.-...  ..+...+|..+.+|+.+++..+.+|++...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            357888999986 699999999932    4799999877664321000  011245899999999999999999995544


Q ss_pred             CCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          189 RPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       189 ~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      ..+.-.|++|+|+-+++++.+|++|.......
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            66888999999999999999999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.24  E-value=1.9e-05  Score=81.39  Aligned_cols=79  Identities=6%  Similarity=0.027  Sum_probs=54.4

Q ss_pred             CCceeeCCCCCccEEEEEEeCC----eEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCce--eeccceeeeC---Cc
Q 018633           67 KNVIAKDTSYNLYTMYKGFWQE----RLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHI--LKLIGCCLET---PI  136 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~~~~~~~~~---~~  136 (353)
                      ...++.|.+.   .+|.-...+    ..+++|+..... .......+.+|+++++.+. |+++  .+++.+|.+.   +.
T Consensus        43 v~~l~gG~sn---~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSN---PTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcC---ceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            4567888888   666665532    467777764432 1223456889999999996 6665  7777877654   46


Q ss_pred             cEEEEEeccCCCh
Q 018633          137 PILVFESVQYGTL  149 (353)
Q Consensus       137 ~~lv~e~~~~gsL  149 (353)
                      .|+||||++|..+
T Consensus       119 ~flVME~v~G~~~  131 (822)
T PLN02876        119 AFYIMEYLEGRIF  131 (822)
T ss_pred             ceEEEEecCCccc
Confidence            7899999987554

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.18  E-value=3e-05  Score=65.52  Aligned_cols=136  Identities=18%  Similarity=0.187  Sum_probs=93.1

Q ss_pred             CCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCC--------------CChhHHHHHHHHHHHHhhcC------CCce
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHE--------------CRPRAYESCINNVTYAARMS------HNHI  124 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------H~ni  124 (353)
                      +....||+|+.-   .||.-- .+...+||+.....              .......+..+|+.....+.      +.+|
T Consensus         4 ~~~~~i~~G~~R---~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i   79 (199)
T PF10707_consen    4 SESDLIAQGGER---DCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHI   79 (199)
T ss_pred             CCCcccccCCCc---eEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccc
Confidence            345689999998   776543 45556678876653              01223566777887777776      7889


Q ss_pred             eeccceeeeCCccEEEEEeccC------CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCC
Q 018633          125 LKLIGCCLETPIPILVFESVQY------GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT  198 (353)
Q Consensus       125 v~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  198 (353)
                      .+++|+..++--.-+|+|.+.+      .||.+++...      .++. ...+.+.++   ..||-   ++.|+.+|++|
T Consensus        80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~  146 (199)
T PF10707_consen   80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNP  146 (199)
T ss_pred             ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHHHH---HHHHH---HcCCeecCCCc
Confidence            9999999998888899998643      2677777543      3444 344444444   44555   77899999999


Q ss_pred             CceeecCC--C--ceEEec-cCCc
Q 018633          199 SCILFNEE--N--VAKLFD-FSLS  217 (353)
Q Consensus       199 ~Nill~~~--~--~~kl~d-fg~a  217 (353)
                      .||++...  +  .+.|+| ||..
T Consensus       147 ~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ccEEEEecCCCceEEEEEeCCCCc
Confidence            99999533  2  577776 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.15  E-value=1.7e-05  Score=76.18  Aligned_cols=162  Identities=12%  Similarity=0.015  Sum_probs=99.1

Q ss_pred             CCcceecHHHHHHHh------------hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChh---------
Q 018633           47 YPYRIFSAQEIKLAT------------NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPR---------  104 (353)
Q Consensus        47 ~~~~~~~~~e~~~~~------------~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~---------  104 (353)
                      ...+.++++|+.+..            ..|+ ...||..+.|   .||++.. +|+.||||+-.++....-         
T Consensus       135 D~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASla---QVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~  210 (538)
T KOG1235|consen  135 DQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLA---QVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRL  210 (538)
T ss_pred             ccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchh---heEEEEecCCCEEEEEecCcChHHHHHHHHHHHHH
Confidence            345667888877663            2333 3568999999   9999999 899999999865531110         


Q ss_pred             --------------------HHH------HHHHHHHHHhhc----CCCc---eeeccceeee-CCccEEEEEeccCCChh
Q 018633          105 --------------------AYE------SCINNVTYAARM----SHNH---ILKLIGCCLE-TPIPILVFESVQYGTLW  150 (353)
Q Consensus       105 --------------------~~~------~~~~E~~~l~~l----~H~n---iv~~~~~~~~-~~~~~lv~e~~~~gsL~  150 (353)
                                          ..+      +|.+|++-..++    .|-+   =|.+-.++.+ .....|+||||+|..+.
T Consensus       211 ~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~  290 (538)
T KOG1235|consen  211 LAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKIN  290 (538)
T ss_pred             HHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCC
Confidence                                000      133444433333    3444   1223333322 23567999999998877


Q ss_pred             hhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC----CCceEEeccCCccccC
Q 018633          151 DRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE----ENVAKLFDFSLSISIP  221 (353)
Q Consensus       151 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~----~~~~kl~dfg~a~~~~  221 (353)
                      |.-.-..    ..++...+..-+.+...-+-+     ..|++|+|-.|.||++..    ++.+.+-|||+...+.
T Consensus       291 Dl~~i~~----~gi~~~~i~~~l~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  291 DLDAIDK----RGISPHDILNKLVEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CHHHHHH----cCCCHHHHHHHHHHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            6532111    124444333333333222222     568999999999999983    6788999999987653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.10  E-value=9.9e-06  Score=82.62  Aligned_cols=197  Identities=16%  Similarity=0.207  Sum_probs=134.7

Q ss_pred             HHHHHHHHHHhhcCCCceeeccceeeeCCc----cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHH
Q 018633          107 ESCINNVTYAARMSHNHILKLIGCCLETPI----PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAY  182 (353)
Q Consensus       107 ~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~  182 (353)
                      ....-|...+.++.|+|++.++.+......    ..+..|++..-++.+.+..-     ...+....+.+..++..||.|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHH
Confidence            334557788889999999999998765432    33456888888888877654     467888999999999999999


Q ss_pred             HhcCCCCCeEeeccCCC---ceeecCCCceEEe--ccCCccccCCCCCccccccccCCccccccccccCCCC--ccccch
Q 018633          183 LHFGFPRPIVFRNFKTS---CILFNEENVAKLF--DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFN--EKSDVF  255 (353)
Q Consensus       183 LH~~~~~~iiH~dlkp~---Nill~~~~~~kl~--dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di~  255 (353)
                      +|   +....|.-+..+   +-..+..+....+  ||+.+........  ......+..+.+||......+.  ...|+|
T Consensus       302 ~h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  302 LH---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HH---HhccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHH
Confidence            99   666666655554   4444556666666  8887766543322  2222334557788877665544  447999


Q ss_pred             hhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCC
Q 018633          256 SFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD  335 (353)
Q Consensus       256 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  335 (353)
                      .+|.....+..|..+-.......                    .+++.            .......+...+|+..++++
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~~~--------------------~~l~~------------~~~~~~~d~~~~~~~~~~~~  424 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAVPV--------------------SLLDV------------LSTSELLDALPKCLDEDSEE  424 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccchh--------------------hhhcc------------ccchhhhhhhhhhcchhhhh
Confidence            99999999999866532111100                    01110            11114567788999999999


Q ss_pred             CCCHHHHHHH
Q 018633          336 RPSMVDVAKK  345 (353)
Q Consensus       336 Rps~~~vl~~  345 (353)
                      |+++.+++..
T Consensus       425 Rl~~~~ll~~  434 (1351)
T KOG1035|consen  425 RLSALELLTH  434 (1351)
T ss_pred             ccchhhhhhc
Confidence            9999988764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.09  E-value=3.3e-05  Score=64.88  Aligned_cols=127  Identities=21%  Similarity=0.211  Sum_probs=92.5

Q ss_pred             hCcCCCCceeeCCC-CCccEEEEEEeCCeEEEEEEecCCC---C-------C---------hhHHHHHHHHHHHHhhcC-
Q 018633           62 NSYDQKNVIAKDTS-YNLYTMYKGFWQERLISVLQFYGHE---C-------R---------PRAYESCINNVTYAARMS-  120 (353)
Q Consensus        62 ~~~~~~~~lg~G~~-g~~~~v~~~~~~~~~vavK~~~~~~---~-------~---------~~~~~~~~~E~~~l~~l~-  120 (353)
                      .+++-.+.||.|.. |   .||+...+|+.+|+|.+..-.   .       .         ......|..|++...+|+ 
T Consensus        37 ~~I~flefLg~g~~~~---~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDG---YVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CcEeeeeecCCCCcee---EEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            66777889999999 9   999999999999999932110   0       0         023456889999999986 


Q ss_pred             --CCce--eeccceeeeC------------------CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHH
Q 018633          121 --HNHI--LKLIGCCLET------------------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH  178 (353)
Q Consensus       121 --H~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~  178 (353)
                        +.++  |+++|+..-.                  ....||.||.+...              .+..    .-+.+|.+
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~----~~~~~~~~  175 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQI----RDIPQMLR  175 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccch----hHHHHHHH
Confidence              4456  9999997321                  12357888776433              1122    23567778


Q ss_pred             HHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       179 ~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      -|..+|   ..+|+-+|+++.|..     .-+|+|||.+
T Consensus       176 dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            888999   999999999999986     3489999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.07  E-value=4.7e-05  Score=66.48  Aligned_cols=32  Identities=13%  Similarity=0.238  Sum_probs=26.5

Q ss_pred             CCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          188 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ...++|+|+.|.||+++.....-|+||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            44589999999999998766567999997743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.92  E-value=0.00019  Score=65.02  Aligned_cols=76  Identities=7%  Similarity=0.014  Sum_probs=54.4

Q ss_pred             CCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC---Cceeeccceeee---CCccEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSH---NHILKLIGCCLE---TPIPILV  140 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~~~~~~~~---~~~~~lv  140 (353)
                      ...||.|..+   .||.-...+..+++|..+..    .....|.+|+..|+.|.-   ..+.+++++|..   .+..+||
T Consensus        19 ~~~i~~G~~~---~vy~~~~~~~~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         19 VECISEQPYA---ALWALYDSQGNPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeecCCccce---eEEEEEcCCCCEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            4568999999   88887764445666664321    123578899999998863   357778877754   3668999


Q ss_pred             EEeccCCCh
Q 018633          141 FESVQYGTL  149 (353)
Q Consensus       141 ~e~~~~gsL  149 (353)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.84  E-value=0.00019  Score=65.00  Aligned_cols=144  Identities=15%  Similarity=0.100  Sum_probs=81.9

Q ss_pred             CCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc--eeecccee------eeCCccE
Q 018633           67 KNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH--ILKLIGCC------LETPIPI  138 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~------~~~~~~~  138 (353)
                      ...|..|...   .+|+...++..+++|+....     .......|++++..+.+.+  +.+++...      ...+..+
T Consensus        19 i~~i~~G~~n---~~y~v~~~~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIEN---TNYFVTTDSGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCcccc---ceEEEEeCCCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            4456667667   77777666667888887532     2345667888888875332  44444321      2234568


Q ss_pred             EEEEeccCCChhh--------------hhccCC----CC--CCccccHHHHH----------HHHHHHHHHHHHHhc---
Q 018633          139 LVFESVQYGTLWD--------------RILGAP----QP--HFEPLLLKHRL----------KIAMDIVHALAYLHF---  185 (353)
Q Consensus       139 lv~e~~~~gsL~~--------------~l~~~~----~~--~~~~l~~~~~~----------~i~~~i~~~L~~LH~---  185 (353)
                      +|+++++|.++..              .++...    ..  ......|....          .....+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999866532              011000    00  00001111110          011112333444431   


Q ss_pred             -CCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          186 -GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       186 -~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                       ....+++|+|+.|.|||++.++.+.|.||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence             124579999999999999988777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.83  E-value=0.00015  Score=64.22  Aligned_cols=139  Identities=11%  Similarity=0.000  Sum_probs=75.8

Q ss_pred             eeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCce-eeccceeeeCCccEEEEEeccCCC
Q 018633           70 IAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHI-LKLIGCCLETPIPILVFESVQYGT  148 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~gs  148 (353)
                      +..|-.+   .+|+...++..+++|......  ....-...+|..+++.+...++ .+++..+.    -++|+||++|.+
T Consensus         4 ~~~G~tn---~~y~~~~~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTN---RSWRIEHPGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcC---CeEEEEeCCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            3446666   777777777788888754331  1110134678888988874333 33343322    368999999866


Q ss_pred             hhhh-----------------hccCCCCCCccccHH-HHHHHHHHH---------HHHHHHHhc-----CCCCCeEeecc
Q 018633          149 LWDR-----------------ILGAPQPHFEPLLLK-HRLKIAMDI---------VHALAYLHF-----GFPRPIVFRNF  196 (353)
Q Consensus       149 L~~~-----------------l~~~~~~~~~~l~~~-~~~~i~~~i---------~~~L~~LH~-----~~~~~iiH~dl  196 (353)
                      +...                 ++...... .+++.. ....+..++         ..-+..+-.     .....++|+|+
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFG-YPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5421                 11111100 111111 111111111         111111110     11346899999


Q ss_pred             CCCceeecCCCceEEeccCCccc
Q 018633          197 KTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       197 kp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      .|.||+++.++ +.|+||..+..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999877 78999997743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.81  E-value=0.00067  Score=62.11  Aligned_cols=161  Identities=13%  Similarity=0.113  Sum_probs=82.6

Q ss_pred             eecHHHHHHHhhCcCC-----CCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc--
Q 018633           51 IFSAQEIKLATNSYDQ-----KNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH--  123 (353)
Q Consensus        51 ~~~~~e~~~~~~~~~~-----~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--  123 (353)
                      .+|.+++......|..     .+.++.|...   .+|....++..+++|++...  ..   +....|+.++..|...+  
T Consensus         6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n---~~y~v~t~~g~~vLK~~~~~--~~---~~l~~~~~~l~~L~~~glp   77 (319)
T PRK05231          6 DVSDDELAAFLAPYDLGELLSLKGIAEGIEN---SNFFLTTTQGEYVLTLFERL--TA---EDLPFFLGLMQHLAARGVP   77 (319)
T ss_pred             cCCHHHHHHHHHhcCCchhhccchhcccccc---ceEEEEeCCCcEEEEEeccC--Ch---HHhHHHHHHHHHHHHCCCC
Confidence            3456666665555643     2345556656   77777765557888987521  22   23334455555553211  


Q ss_pred             eeeccce------eeeCCccEEEEEeccCCChhh--------------hhccCCC----C--CCccccH-HHHHH-----
Q 018633          124 ILKLIGC------CLETPIPILVFESVQYGTLWD--------------RILGAPQ----P--HFEPLLL-KHRLK-----  171 (353)
Q Consensus       124 iv~~~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~--~~~~l~~-~~~~~-----  171 (353)
                      +.+++..      ....+..++++||++|..+..              .++....    .  ....+.+ .....     
T Consensus        78 vP~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~  157 (319)
T PRK05231         78 VPAPVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPF  157 (319)
T ss_pred             CCcceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhc
Confidence            2233321      122456789999999764421              0111100    0  0001111 11110     


Q ss_pred             -------HHHH-HHHHHHHHhc----CCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          172 -------IAMD-IVHALAYLHF----GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       172 -------i~~~-i~~~L~~LH~----~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                             .+.+ +...+..+..    ....++||+|+.|.||+++.+...-|+||+.+..
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        158 LADEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cChhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                   1111 1111222221    1256899999999999999766568999997643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.75  E-value=0.00067  Score=60.72  Aligned_cols=79  Identities=6%  Similarity=-0.066  Sum_probs=46.6

Q ss_pred             CCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           66 QKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        66 ~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      ..+.++.|+.|..+.|+.... +|+..++|.-..    ........+|+++|+.+...--+..-.+.... .-+++|+++
T Consensus        12 ~~~~~~~~~~g~~~~v~~i~~~~g~~~VlR~p~~----~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~~-~~~~~y~~i   86 (276)
T cd05152          12 KPETLSLNESGLDFQVVFAKDTDGVPWVLRIPRR----PDVSERAAAEKRVLALVRKHLPVQVPDWRVHT-PELIAYPKL   86 (276)
T ss_pred             CCCcceecCCcceeEEEEEEcCCCCeEEEEecCC----HHHHHHHHHHHHHHHHHHhcCCCCCCceeeec-CceEEEecc
Confidence            345567777776667887655 577888887643    23446678999999998621002222221111 224677777


Q ss_pred             cCCCh
Q 018633          145 QYGTL  149 (353)
Q Consensus       145 ~~gsL  149 (353)
                      +|.++
T Consensus        87 ~G~p~   91 (276)
T cd05152          87 PGVPA   91 (276)
T ss_pred             CCCcc
Confidence            76544

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.66  E-value=0.00054  Score=59.67  Aligned_cols=71  Identities=13%  Similarity=0.030  Sum_probs=43.9

Q ss_pred             ceeeCCCCCccEEEEEEeC---CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc-eeeccceeeeCCccEEEEEec
Q 018633           69 VIAKDTSYNLYTMYKGFWQ---ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH-ILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .|..|-..   .+|+....   +..+++|......  .. .-.-.+|+.++..+...+ ..++++.+. +   .+||||+
T Consensus         5 ~l~gG~tN---~~~~v~~~~~~~~~~vlR~~~~~~--~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i   74 (235)
T cd05157           5 RFTGGITN---KLVKVSNKEDNQDAVLVRVYGNKT--EL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFI   74 (235)
T ss_pred             EcCCcccc---eEEEEEcCCCCCCeEEEEEccCCc--cc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEee
Confidence            46667777   77777664   5788888765431  11 112246888888886333 344444432 1   3799999


Q ss_pred             cCCCh
Q 018633          145 QYGTL  149 (353)
Q Consensus       145 ~~gsL  149 (353)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.62  E-value=0.0014  Score=59.65  Aligned_cols=160  Identities=14%  Similarity=0.116  Sum_probs=87.1

Q ss_pred             ecHHHHHHHhhCcCC-----CCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc--e
Q 018633           52 FSAQEIKLATNSYDQ-----KNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH--I  124 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~-----~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--i  124 (353)
                      .+.++|......|..     ...++.|...   .+|+...++..+++|+.....    ..+....|++++..|...+  +
T Consensus         7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n---~~y~v~t~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pv   79 (307)
T TIGR00938         7 VSDEEMSSFLDGYDLGELLSLKGIAEGVEN---SNYLLTTDVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPV   79 (307)
T ss_pred             CCHHHHHHHHHhcCCCCceeccccCCcccc---ceEEEEeCCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCC
Confidence            344566555555543     3446666656   677766655567788764421    1234456677777774222  3


Q ss_pred             eecccee------eeCCccEEEEEeccCCChhh--------------hhccCCCC---CC-c---cccHHHHH-------
Q 018633          125 LKLIGCC------LETPIPILVFESVQYGTLWD--------------RILGAPQP---HF-E---PLLLKHRL-------  170 (353)
Q Consensus       125 v~~~~~~------~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~---~~-~---~l~~~~~~-------  170 (353)
                      .+++...      ...+..+++++|++|.++..              .++.....   .. .   .-.|....       
T Consensus        80 p~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (307)
T TIGR00938        80 PKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAA  159 (307)
T ss_pred             CccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcc
Confidence            4444322      12356789999998755421              11111000   00 0   00111100       


Q ss_pred             -----HHHHHHHHHHHHHhc----CCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          171 -----KIAMDIVHALAYLHF----GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       171 -----~i~~~i~~~L~~LH~----~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                           .....+...++++..    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       160 ~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       160 PQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                 011123334555531    125789999999999999988877899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.55  E-value=2.4e-05  Score=81.88  Aligned_cols=190  Identities=11%  Similarity=-0.035  Sum_probs=128.0

Q ss_pred             EEEEEEe---CCeEEEEEEecCCC---CChhHHHHHHHHHHHHhhcCCCceeeccceeee--CCccEEEEEeccCCChhh
Q 018633           80 TMYKGFW---QERLISVLQFYGHE---CRPRAYESCINNVTYAARMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWD  151 (353)
Q Consensus        80 ~v~~~~~---~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~  151 (353)
                      .-++|+|   .-.+..+++.....   ......+....|..-++...|+++...+.=...  ....+.+++|+.+|.+.+
T Consensus      1241 ~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~ 1320 (2724)
T KOG1826|consen 1241 FHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFS 1320 (2724)
T ss_pred             eeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHH
Confidence            4557777   22334455543221   122333445566666677789998877665543  345789999999999999


Q ss_pred             hhccCCCCCCccccHHHHHHHHHHHHHHHHHHhc--CCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCcccc
Q 018633          152 RILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF--GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD  229 (353)
Q Consensus       152 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~--~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~  229 (353)
                      .+.+..... .++...-......+...+..-+|+  ..++..+|+++|+-|.+|..+..++++++|+.+.. .......+
T Consensus      1321 iIikg~ee~-~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~G 1398 (2724)
T KOG1826|consen 1321 IIIKGLEES-PDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFG 1398 (2724)
T ss_pred             HHHhccccC-CcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhh
Confidence            887654321 233333333333333566666553  22445789999999999999999999999999832 22222345


Q ss_pred             ccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCC
Q 018633          230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       230 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~  271 (353)
                      ...+++.|++|+....-.++.++|+|..|+.+|+...|..+|
T Consensus      1399 l~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1399 LELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            567788899999998888998899999999999988876654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.45  E-value=0.00024  Score=63.53  Aligned_cols=136  Identities=12%  Similarity=0.055  Sum_probs=90.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCCh--------------------hHHHHHHHHHHHHhhcC-
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRP--------------------RAYESCINNVTYAARMS-  120 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~-  120 (353)
                      -++..+.||-|--+   .||.+.+ .|++.++|.-.....+-                    -.+-...+|+..|+.|. 
T Consensus        93 v~svGnqIGVGKES---DIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e  169 (465)
T KOG2268|consen   93 VESVGNQIGVGKES---DIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE  169 (465)
T ss_pred             hhhhcccccccccc---ceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence            45677889999999   9999988 68888877543221110                    01123467888888886 


Q ss_pred             CCc-eeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          121 HNH-ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       121 H~n-iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      |.. +.+.++    .+.-++|||++.+-+|...-+-.        ...++..   .+..-+--|-   .+|+||+|..-=
T Consensus       170 ~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~---~lm~~Iv~la---~~GlIHgDFNEF  231 (465)
T KOG2268|consen  170 RGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE--------DPPTLYD---DLMGLIVRLA---NHGLIHGDFNEF  231 (465)
T ss_pred             cCCCCCCccc----ccceeeHHHhhcccceeeeeecC--------ChHHHHH---HHHHHHHHHH---HcCceecccchh
Confidence            322 333343    34567999999998887653221        2223222   2222333344   789999999999


Q ss_pred             ceeecCCCceEEeccCCccc
Q 018633          200 CILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||++++++.++++||-....
T Consensus       232 Nimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  232 NIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eeEEecCCCEEEeechHhhc
Confidence            99999999999999965433

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.45  E-value=0.0027  Score=59.55  Aligned_cols=76  Identities=9%  Similarity=0.034  Sum_probs=52.1

Q ss_pred             CceeeCCCCCccEEEEEEe-CC-eEEEEEEecCCCC-----ChhHHHHHHHHHHHHhhcC---CCceeeccceeeeCCcc
Q 018633           68 NVIAKDTSYNLYTMYKGFW-QE-RLISVLQFYGHEC-----RPRAYESCINNVTYAARMS---HNHILKLIGCCLETPIP  137 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~-~~-~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~  137 (353)
                      +.||-|.+.   .||+... +| +.|+||......-     .+-..+++..|.+.|..+.   ..++.+++.+  +....
T Consensus        32 ~elggGn~N---~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~  106 (401)
T PRK09550         32 REIGDGNLN---LVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA  106 (401)
T ss_pred             eEcCCCceE---EEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence            457888888   8999888 44 4899998542210     1224567778888888864   3457777776  34557


Q ss_pred             EEEEEeccCCC
Q 018633          138 ILVFESVQYGT  148 (353)
Q Consensus       138 ~lv~e~~~~gs  148 (353)
                      ++|||++++..
T Consensus       107 ~lVME~L~~~~  117 (401)
T PRK09550        107 VTVMEDLSDHK  117 (401)
T ss_pred             EEEEecCCCcc
Confidence            89999998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.27  E-value=0.002  Score=58.52  Aligned_cols=31  Identities=19%  Similarity=0.313  Sum_probs=27.2

Q ss_pred             CCCeEeeccCCCceeecCC----CceEEeccCCcc
Q 018633          188 PRPIVFRNFKTSCILFNEE----NVAKLFDFSLSI  218 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~----~~~kl~dfg~a~  218 (353)
                      ...++|+|+.|.|||++.+    +.+.++||..|.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            5678999999999999874    789999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.25  E-value=0.013  Score=53.18  Aligned_cols=130  Identities=15%  Similarity=0.124  Sum_probs=80.6

Q ss_pred             EEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC--CceeeccceeeeCC--ccEEEEEeccCCChhhhhcc
Q 018633           80 TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSH--NHILKLIGCCLETP--IPILVFESVQYGTLWDRILG  155 (353)
Q Consensus        80 ~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~  155 (353)
                      ..|....+++..++. ...............+|+.+++.+.-  .-+...++.|.++.  ..+.||++++|..+.+.+..
T Consensus        40 ~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~  118 (321)
T COG3173          40 DTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP  118 (321)
T ss_pred             ceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence            444444457777777 33211123344556778888887753  22344577777665  78999999987544433221


Q ss_pred             CCCCCCccccHHHHHHHH-HHHHHHHHHHhcCC-----------------------------------------------
Q 018633          156 APQPHFEPLLLKHRLKIA-MDIVHALAYLHFGF-----------------------------------------------  187 (353)
Q Consensus       156 ~~~~~~~~l~~~~~~~i~-~~i~~~L~~LH~~~-----------------------------------------------  187 (353)
                      ..      ..    ..++ ..+++.|.-||+--                                               
T Consensus       119 ~~------~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~  188 (321)
T COG3173         119 ES------LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE  188 (321)
T ss_pred             cc------ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence            11      11    1222 25555566666110                                               


Q ss_pred             --------CCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          188 --------PRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       188 --------~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                              ...++|+|+.+.||+++..+-+-|.||+.+...
T Consensus       189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                    336899999999999998888999999998664

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.94  E-value=0.0076  Score=55.12  Aligned_cols=140  Identities=13%  Similarity=0.119  Sum_probs=89.5

Q ss_pred             CCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCC----------------------hhH-HHH-HHHHHHHHhhcCC
Q 018633           67 KNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECR----------------------PRA-YES-CINNVTYAARMSH  121 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~----------------------~~~-~~~-~~~E~~~l~~l~H  121 (353)
                      .-.|..|--+   -||.+.. +|..+|||+++.....                      +.. ..- ...|++-|.++..
T Consensus       149 nGCiSTGKEA---NVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  149 NGCISTGKEA---NVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ccccccCccc---eeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3456667777   8999888 8889999998533211                      111 111 2357777777765


Q ss_pred             CceeeccceeeeCCccEEEEEeccCCCh-hhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCc
Q 018633          122 NHILKLIGCCLETPIPILVFESVQYGTL-WDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC  200 (353)
Q Consensus       122 ~niv~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  200 (353)
                      ..|. +-.-..-. .-.|||+|+....- .-.|+.      ..++...+..+-.+++.-+.-|..  ..++||.||+--|
T Consensus       226 aGIP-~PePIlLk-~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIP-CPEPILLK-NHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFN  295 (520)
T ss_pred             cCCC-CCCceeee-cceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHH--Hhceeccchhhhh
Confidence            4432 11111111 23589999842111 112222      356666777888888888888875  6689999999999


Q ss_pred             eeecCCCceEEeccCCcccc
Q 018633          201 ILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~  220 (353)
                      +|+- +|.+.++|.+.+...
T Consensus       296 ~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  296 LLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             heEE-CCEEEEEEccccccC
Confidence            9875 678999999877554

>PLN02236 choline kinase

Probab=96.91  E-value=0.0089  Score=55.33  Aligned_cols=137  Identities=13%  Similarity=0.117  Sum_probs=75.8

Q ss_pred             CCCCCccEEEEEEeC------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCce-eeccceeeeCCccEEEEEecc
Q 018633           73 DTSYNLYTMYKGFWQ------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHI-LKLIGCCLETPIPILVFESVQ  145 (353)
Q Consensus        73 G~~g~~~~v~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~  145 (353)
                      |-.-   .+|+..+.      ++.+++|.....  .....++ .+|..++..+..-++ .++++.+..+    .|.+|++
T Consensus        47 GlTN---~~y~v~~~~~~~~~~~~~v~Ri~g~~--t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         47 AMTN---EVFQIKWPTKEGNLGRKVLVRIYGEG--VELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             cccc---eeEEEEeCCCCCCCCCeEEEEEccCC--CCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            5445   77877652      357888877554  2222222 578888888864333 3455655332    5899998


Q ss_pred             CCChhhh-----------------hccCCCCC-CccccHHHHHHHHHHH-----------------HHHHHHH----hc-
Q 018633          146 YGTLWDR-----------------ILGAPQPH-FEPLLLKHRLKIAMDI-----------------VHALAYL----HF-  185 (353)
Q Consensus       146 ~gsL~~~-----------------l~~~~~~~-~~~l~~~~~~~i~~~i-----------------~~~L~~L----H~-  185 (353)
                      +.+|...                 ++....+. .....+.++..+..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7676421                 11111000 0112233333332211                 1111112    11 


Q ss_pred             CCCCCeEeeccCCCceeecC-CCceEEeccCCccc
Q 018633          186 GFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSIS  219 (353)
Q Consensus       186 ~~~~~iiH~dlkp~Nill~~-~~~~kl~dfg~a~~  219 (353)
                      .....++|+|+++.||+++. ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            11457899999999999976 46799999988743

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.90  E-value=0.014  Score=54.79  Aligned_cols=74  Identities=8%  Similarity=-0.002  Sum_probs=47.7

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCC-----ChhHHHHHHHHHHHHhhcC---CCceeeccceeeeCCccEE
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHEC-----RPRAYESCINNVTYAARMS---HNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~l  139 (353)
                      +.||-|...   .||+....++.++||.-.....     .+-...+-..|.+.|..+.   ..++.+++.++.  +..++
T Consensus        38 ~eiggGn~N---~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         38 KEVGDGNLN---FVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEcCCCcee---eEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            446666666   8888777667799998762211     1113344445566676654   357888888876  44578


Q ss_pred             EEEeccC
Q 018633          140 VFESVQY  146 (353)
Q Consensus       140 v~e~~~~  146 (353)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999976

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.81  E-value=0.006  Score=51.85  Aligned_cols=139  Identities=14%  Similarity=0.095  Sum_probs=83.5

Q ss_pred             eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHH
Q 018633           89 RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKH  168 (353)
Q Consensus        89 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~  168 (353)
                      ....+|++....+.- ...-|.++.++++++.  .|+++..  .+.-.+-++.|+|-....              .+   
T Consensus        86 G~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i--------------~~---  143 (308)
T PF07387_consen   86 GPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI--------------NF---  143 (308)
T ss_pred             chhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc--------------ch---
Confidence            344566665442211 2345688899999885  4666662  123345689999843111              11   


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccCCC
Q 018633          169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF  248 (353)
Q Consensus       169 ~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  248 (353)
                       ..++..=+.+|.-.|++ +.+.+|+|..|+||+-|..|.+||.|=+.-..   .          +..|.--|+   ...
T Consensus       144 -~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---~----------~V~~vN~~Y---~~l  205 (308)
T PF07387_consen  144 -SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---N----------QVNMVNIEY---ESL  205 (308)
T ss_pred             -hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh---h----------eeeEEeeec---ccc
Confidence             12222224678888965 78899999999999999999999999774311   0          111222111   234


Q ss_pred             CccccchhhHHHHHHHHhC
Q 018633          249 NEKSDVFSFGVFLFELLTG  267 (353)
Q Consensus       249 ~~~~Di~slG~il~el~tg  267 (353)
                      ++++.+=+|=..++++...
T Consensus       206 T~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  206 TQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             ChHHHHHHHHHHHHHHHHH
Confidence            5666666666666666553

The function of this family is unknown.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.69  E-value=0.012  Score=52.79  Aligned_cols=72  Identities=10%  Similarity=-0.030  Sum_probs=46.5

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC---CCceeeccceeeeCCccEEEEEec
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS---HNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      +.|+-|...   .+|+...+++.+.||.-..     .....|..|++-|+.|.   --.+.+++++....+..+||+||+
T Consensus        23 ~~v~GG~i~---~a~~~~~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   23 EPVSGGDIN---EAYRLDTDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEE--SSSS---EEEEEETTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             EecCCCChh---heEEEECCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            457766666   8888888888999998652     23467888999888884   345778888887777789999999


Q ss_pred             cCC
Q 018633          145 QYG  147 (353)
Q Consensus       145 ~~g  147 (353)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            866

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.61  E-value=0.022  Score=52.53  Aligned_cols=74  Identities=14%  Similarity=0.118  Sum_probs=45.7

Q ss_pred             ceeeCCCCCccEEEEEEeCC--eEEEEEEecCCC-----CChhHHHHHHHHHHHHhhcC--CC-ceeeccceeeeCCccE
Q 018633           69 VIAKDTSYNLYTMYKGFWQE--RLISVLQFYGHE-----CRPRAYESCINNVTYAARMS--HN-HILKLIGCCLETPIPI  138 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~~~--~~vavK~~~~~~-----~~~~~~~~~~~E~~~l~~l~--H~-niv~~~~~~~~~~~~~  138 (353)
                      .||-|...   .||++...+  +.|+||.-....     ..+-..++..-|...|....  -| .+.++|.+  +.....
T Consensus         2 EigdGnlN---~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~   76 (370)
T TIGR01767         2 EVGDGNLN---LVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAV   76 (370)
T ss_pred             cCCCCceE---EEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccce
Confidence            35666666   889888743  589998864221     11333445566777787654  34 45555554  455566


Q ss_pred             EEEEeccCC
Q 018633          139 LVFESVQYG  147 (353)
Q Consensus       139 lv~e~~~~g  147 (353)
                      +|||+++..
T Consensus        77 ~vMEdL~~~   85 (370)
T TIGR01767        77 TVMEDLSHH   85 (370)
T ss_pred             ehHhhCccc
Confidence            899998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.61  E-value=0.0049  Score=58.58  Aligned_cols=49  Identities=14%  Similarity=0.199  Sum_probs=38.6

Q ss_pred             HHHHHHHHHHhhcCCCceeeccceeeeC-CccEEEEEeccCCChhhhhccC
Q 018633          107 ESCINNVTYAARMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGA  156 (353)
Q Consensus       107 ~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~  156 (353)
                      ...+..+.+++.+.|+|...++++.... ....+|+|++. .||++.+...
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence            4456667889999999999999887643 35778999995 7999988654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.60  E-value=0.022  Score=51.74  Aligned_cols=29  Identities=21%  Similarity=0.397  Sum_probs=25.3

Q ss_pred             CCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          188 PRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ..+++|+|+.+.||+++. +.+.|+||+.+
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            468999999999999987 66889999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.27  E-value=0.015  Score=49.73  Aligned_cols=31  Identities=23%  Similarity=0.335  Sum_probs=21.6

Q ss_pred             CCeEeeccCCCceee-cCCCceEEeccCCccc
Q 018633          189 RPIVFRNFKTSCILF-NEENVAKLFDFSLSIS  219 (353)
Q Consensus       189 ~~iiH~dlkp~Nill-~~~~~~kl~dfg~a~~  219 (353)
                      ..++|+|+.|.|||+ +.++.++++||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            467899999999999 7889999999988743

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.11  E-value=0.075  Score=48.37  Aligned_cols=32  Identities=16%  Similarity=0.238  Sum_probs=28.2

Q ss_pred             CCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          188 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ..+++|+|+.+.|+|++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999998999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.95  E-value=0.054  Score=49.86  Aligned_cols=30  Identities=17%  Similarity=0.305  Sum_probs=25.5

Q ss_pred             CeEeeccCCCceeecC-CCceEEeccCCccc
Q 018633          190 PIVFRNFKTSCILFNE-ENVAKLFDFSLSIS  219 (353)
Q Consensus       190 ~iiH~dlkp~Nill~~-~~~~kl~dfg~a~~  219 (353)
                      -++|.|+.+.|||++. ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4799999999999974 57899999998744

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.51  E-value=0.49  Score=43.40  Aligned_cols=135  Identities=16%  Similarity=0.199  Sum_probs=73.6

Q ss_pred             EEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC---Cceee---ccce----eeeCCccEEEEEeccCCCh
Q 018633           80 TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSH---NHILK---LIGC----CLETPIPILVFESVQYGTL  149 (353)
Q Consensus        80 ~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~---~~~~----~~~~~~~~lv~e~~~~gsL  149 (353)
                      .+|+....+...++|+....    ....+..-|...|..|.-   +=.++   .=|-    .......+-+++|++|..+
T Consensus        40 ~~f~~~~~~g~~iLki~~~~----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~  115 (331)
T COG2334          40 SNFRVQTEDGRYILKIYRPG----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPL  115 (331)
T ss_pred             ceEEEEecCCCeEEEEecCC----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCc
Confidence            68888885555588887654    233444556666666642   21122   1111    1111367789999998777


Q ss_pred             hh---------------hhc----cCC--CCC-CccccHH----HH---------HHHHHHHHHHHHHHhcC----CCCC
Q 018633          150 WD---------------RIL----GAP--QPH-FEPLLLK----HR---------LKIAMDIVHALAYLHFG----FPRP  190 (353)
Q Consensus       150 ~~---------------~l~----~~~--~~~-~~~l~~~----~~---------~~i~~~i~~~L~~LH~~----~~~~  190 (353)
                      ..               .|+    ...  .++ .....|.    ..         .....++...+..+...    ....
T Consensus       116 ~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~  195 (331)
T COG2334         116 ERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPAL  195 (331)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcc
Confidence            62               011    110  000 0122222    00         11233444444444411    1223


Q ss_pred             ---eEeeccCCCceeecCCCc-eEEeccCCcc
Q 018633          191 ---IVFRNFKTSCILFNEENV-AKLFDFSLSI  218 (353)
Q Consensus       191 ---iiH~dlkp~Nill~~~~~-~kl~dfg~a~  218 (353)
                         +||+|+.|.|||++.+.. +.+.||+-+.
T Consensus       196 ~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         196 GDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               999999999999998874 8999999764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.47  E-value=1.6  Score=40.12  Aligned_cols=96  Identities=9%  Similarity=0.108  Sum_probs=53.5

Q ss_pred             CCcceecHHHHHHHhhCcCCC-----CceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC
Q 018633           47 YPYRIFSAQEIKLATNSYDQK-----NVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMS  120 (353)
Q Consensus        47 ~~~~~~~~~e~~~~~~~~~~~-----~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~  120 (353)
                      .+...++.+.+..+...+...     ..|+++ -.   .||+... ++..+++|......   ........|++.+..|.
T Consensus         6 ~~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~-eN---~vy~v~~~~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~   78 (325)
T PRK11768          6 FPFQTLTPDLILDALESLGLRVDGRLLALNSY-EN---RVYQFGDEDGRRVVAKFYRPER---WSDAQILEEHAFALELA   78 (325)
T ss_pred             CCCCCCChHHHHHHHHHcCCCCccceEeeccc-cc---eEEEEecCCCCEEEEEEcCccc---CCHHHHHHHHHHHHHHH
Confidence            345556777776666555321     223322 23   6887776 56778888875431   23455666777777664


Q ss_pred             CCc--eeecc---c--eeeeCCccEEEEEeccCCCh
Q 018633          121 HNH--ILKLI---G--CCLETPIPILVFESVQYGTL  149 (353)
Q Consensus       121 H~n--iv~~~---~--~~~~~~~~~lv~e~~~~gsL  149 (353)
                      -..  ++...   |  ...-++..+.|+++++|...
T Consensus        79 ~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         79 EAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             HCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            211  22221   1  11224567789999987543

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.45  E-value=0.52  Score=40.68  Aligned_cols=70  Identities=11%  Similarity=0.002  Sum_probs=51.0

Q ss_pred             CCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC---ceeeccceeeeCCccEEEEEeccCCChh
Q 018633           76 YNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHN---HILKLIGCCLETPIPILVFESVQYGTLW  150 (353)
Q Consensus        76 g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~~~~~~~~~~~~~lv~e~~~~gsL~  150 (353)
                      |.+...|...+....+-||+-     .......|..|+.-|..+.--   ++.+++.+-...++.|+|+||++-|.+.
T Consensus        27 G~inea~~v~dg~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccccceeEeecCCcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            333356666667778888874     234567788999888877644   4666777777888999999999987765

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.45  E-value=0.039  Score=50.56  Aligned_cols=71  Identities=24%  Similarity=0.212  Sum_probs=53.3

Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|++|++. |++|.. +        ....+++++.++.+.+.-++-+..  .-..-|||+.-.||||+ +|++.|+||-
T Consensus       300 y~yl~~kdh-gt~is~-i--------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         300 YLYLHFKDH-GTPISI-I--------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             EEEEEEecC-Cceeee-e--------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEee
Confidence            355667765 455532 2        223577888888888777776663  55788999999999999 9999999999


Q ss_pred             Cccc
Q 018633          216 LSIS  219 (353)
Q Consensus       216 ~a~~  219 (353)
                      +++.
T Consensus       367 lsRl  370 (488)
T COG5072         367 LSRL  370 (488)
T ss_pred             eeec
Confidence            9984

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.43  E-value=0.055  Score=50.61  Aligned_cols=74  Identities=8%  Similarity=-0.067  Sum_probs=47.9

Q ss_pred             CceeeCCCCCccEEEEEEeC--CeEEEEEEecCCC----CChhHHHHHHHHHHHHhhcC--CC-ceeeccceeeeCCccE
Q 018633           68 NVIAKDTSYNLYTMYKGFWQ--ERLISVLQFYGHE----CRPRAYESCINNVTYAARMS--HN-HILKLIGCCLETPIPI  138 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~--~~~vavK~~~~~~----~~~~~~~~~~~E~~~l~~l~--H~-niv~~~~~~~~~~~~~  138 (353)
                      ..||-|.-.   .||++.+.  ++.|+||.-....    ..+-..++..-|.+.|+...  -| .+.++|.+  +.....
T Consensus        35 ~eigdGnlN---~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~  109 (409)
T PRK12396         35 KEIGDGNLN---YVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNC  109 (409)
T ss_pred             eEcCCCceE---EEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhh
Confidence            456766666   89999873  6789998764221    12334566667788888764  34 45556665  445556


Q ss_pred             EEEEeccC
Q 018633          139 LVFESVQY  146 (353)
Q Consensus       139 lv~e~~~~  146 (353)
                      +|||+++.
T Consensus       110 ~vMEdL~~  117 (409)
T PRK12396        110 CVMEDLSD  117 (409)
T ss_pred             HHHHhCcc
Confidence            89999864

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=93.73  E-value=0.25  Score=43.46  Aligned_cols=72  Identities=10%  Similarity=-0.069  Sum_probs=49.7

Q ss_pred             eeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHH---HHHhhcCCCceeeccceeeeCCccEEEEEec-
Q 018633           70 IAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNV---TYAARMSHNHILKLIGCCLETPIPILVFESV-  144 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~---~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~-  144 (353)
                      +..|..+   .|+.+.. +|..+++|......       .+..|.   ..|+..+-...|++++.-.  ..-.+++|.+ 
T Consensus        10 ~~~g~~s---~V~pv~~~dG~~avLKl~~p~~-------~~~~E~~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~   77 (253)
T PF04655_consen   10 PAHGSSS---LVVPVRRADGTPAVLKLAPPHA-------EAEHEARGEAALRWWNGRGAVRLLAADP--ERGALLLERLD   77 (253)
T ss_pred             CCCCcce---EEEEEEcCCCCeEEEEecCCcc-------cchhhhhHHhHhheeCCCCceeeecccc--ccchhhhhhcc
Confidence            4456666   8999977 88999999986541       122233   4577778788899999743  3445888988 


Q ss_pred             cCCChhhhh
Q 018633          145 QYGTLWDRI  153 (353)
Q Consensus       145 ~~gsL~~~l  153 (353)
                      ++.+|.+..
T Consensus        78 ~g~~L~~~~   86 (253)
T PF04655_consen   78 PGRSLASLP   86 (253)
T ss_pred             CCCchhhcc
Confidence            555776554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PTZ00384 choline kinase; Provisional

Probab=93.72  E-value=0.46  Score=44.65  Aligned_cols=29  Identities=14%  Similarity=0.059  Sum_probs=24.0

Q ss_pred             CCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          189 RPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       189 ~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      ...+|.|+-+.|||.++ ..+.++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            56799999999998764 459999998764

>PHA03111 Ser/Thr kinase; Provisional

Probab=93.58  E-value=0.09  Score=47.57  Aligned_cols=38  Identities=13%  Similarity=0.055  Sum_probs=26.6

Q ss_pred             HHHHHHHHHHHHHHHHH-hcCCCCCeEeeccCCCceeec
Q 018633          167 KHRLKIAMDIVHALAYL-HFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       167 ~~~~~i~~~i~~~L~~L-H~~~~~~iiH~dlkp~Nill~  204 (353)
                      +-+..+..||+.-.-.+ ...+..+.+|-||||+|||+-
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            34556777886655344 334456799999999999984

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	353
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-29
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-28
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-27
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-15
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-15
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-05
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-05
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-04
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-04
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 146/295 (49%), Gaps = 8/295 (2%)
Query: 52  FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCIN 111
           FS +E+++A++++  KN++ +        +YKG   +  +  ++    E           
Sbjct: 28  FSLRELQVASDNFSNKNILGRG---GFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 112 NVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 171
            V   +   H ++L+L G C+     +LV+  +  G++   +   P+    PL    R +
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQR 143
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           IA+     LAYLH      I+ R+ K + IL +EE  A + DF L+  +   + H+   V
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY 291
            GT G+ APEY+ TG  +EK+DVF +GV L EL+TG    DL +  +D      +++K  
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
            ++ +   +VD     D+    K++++    Q++  C + SP +RP M +V + L
Sbjct: 264 LKEKKLEALVDV----DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 145/295 (49%), Gaps = 8/295 (2%)
Query: 52  FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCIN 111
           FS +E+++A++++  KN++ +        +YKG   +  +  ++    E           
Sbjct: 20  FSLRELQVASDNFXNKNILGRG---GFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 112 NVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 171
            V   +   H ++L+L G C+     +LV+  +  G++   +   P+    PL    R +
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQR 135
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           IA+     LAYLH      I+ R+ K + IL +EE  A + DF L+  +   + H+   V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY 291
            G  G+ APEY+ TG  +EK+DVF +GV L EL+TG    DL +  +D      +++K  
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
            ++ +   +VD     D+    K++++    Q++  C + SP +RP M +V + L
Sbjct: 256 LKEKKLEALVDV----DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 144/302 (47%), Gaps = 25/302 (8%)
Query: 56  EIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTY 115
           +++ ATN++D K +I          +YKG  ++     L+       P + +      T 
Sbjct: 33  DLEEATNNFDHKFLIGHGV---FGKVYKGVLRDGAKVALK----RRTPESSQGIEEFETE 85
Query: 116 AARMS---HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
              +S   H H++ LIG C E    IL+++ ++ G L   + G+  P    +  + RL+I
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEI 144
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE-GETHITDTV 231
            +     L YLH    R I+ R+ K+  IL +E  V K+ DF +S    E G+TH+   V
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD--VSDLVKDTHDLACPSNEYLK 289
            GT GY  PEY   G   EKSDV+SFGV LFE+L      V  L ++  +LA    E+  
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA----EWAV 257
Query: 290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
               + +  +IVDP + + +    + + L      + +C+  S  DRPSM DV  KL   
Sbjct: 258 ESHNNGQLEQIVDPNLADKI----RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
Query: 350 YR 351
            R
Sbjct: 314 LR 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 92/302 (30%), Positives = 143/302 (47%), Gaps = 25/302 (8%)
Query: 56  EIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTY 115
           +++ ATN++D K +I          +YKG  ++     L+       P + +      T 
Sbjct: 33  DLEEATNNFDHKFLIGHGV---FGKVYKGVLRDGAKVALK----RRTPESSQGIEEFETE 85
Query: 116 AARMS---HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
              +S   H H++ LIG C E    IL+++ ++ G L   + G+  P    +  + RL+I
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEI 144
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE-GETHITDTV 231
            +     L YLH    R I+ R+ K+  IL +E  V K+ DF +S    E  +TH+   V
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD--VSDLVKDTHDLACPSNEYLK 289
            GT GY  PEY   G   EKSDV+SFGV LFE+L      V  L ++  +LA    E+  
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA----EWAV 257
Query: 290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
               + +  +IVDP + + +    + + L      + +C+  S  DRPSM DV  KL   
Sbjct: 258 ESHNNGQLEQIVDPNLADKI----RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
Query: 350 YR 351
            R
Sbjct: 314 LR 315

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 68  NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKL 127
           N+  K  + +  T+++  W    ++V      +         +  V    R+ H +I+  
Sbjct: 40  NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 128 IGCCLETPIPILVFESVQYGTLWDRIL---GAPQPHFEPLLLKHRLKIAMDIVHALAYLH 184
           +G   + P   +V E +  G+L+ R+L   GA     E L  + RL +A D+   + YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGA----REQLDERRRLSMAYDVAKGMNYLH 154
Query: 185 FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR 244
              P PIV RN K+  +L +++   K+ DF LS  +       + +  GT  + APE +R
Sbjct: 155 NRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 245 TGVFNEKSDVFSFGVFLFELLT 266
               NEKSDV+SFGV L+EL T
Sbjct: 213 DEPSNEKSDVYSFGVILWELAT 234

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 124/271 (45%), Gaps = 35/271 (12%)
Query: 83  KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
           K  W+ + +++ Q      R    ++ I  +   +R++H +I+KL G CL  P+  LV E
Sbjct: 27  KAKWRAKDVAIKQIESESER----KAFIVELRQLSRVNHPNIVKLYGACL-NPV-CLVME 80
Query: 143 SVQYGTLWDRILGA-PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT-SC 200
             + G+L++ + GA P P++      H +   +     +AYLH   P+ ++ R+ K  + 
Sbjct: 81  YAEGGSLYNVLHGAEPLPYY---TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 137
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVF 260
           +L     V K+ DF  +  I   +TH+T+   G+  + APE      ++EK DVFS+G+ 
Sbjct: 138 LLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGII 193
Query: 261 LFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHA 320
           L+E++T        K   ++  P+   +       R      P+I      IE       
Sbjct: 194 LWEVIT------RRKPFDEIGGPAFRIMWAVHNGTR-----PPLIKNLPKPIE------- 235
Query: 321 SAQLSFECIKDSPADRPSMVDVAKKLRQIYR 351
              L   C    P+ RPSM ++ K +  + R
Sbjct: 236 --SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 124/271 (45%), Gaps = 35/271 (12%)
Query: 83  KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFE 142
           K  W+ + +++ Q      R    ++ I  +   +R++H +I+KL G CL  P+  LV E
Sbjct: 26  KAKWRAKDVAIKQIESESER----KAFIVELRQLSRVNHPNIVKLYGACL-NPV-CLVME 79
Query: 143 SVQYGTLWDRILGA-PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT-SC 200
             + G+L++ + GA P P++      H +   +     +AYLH   P+ ++ R+ K  + 
Sbjct: 80  YAEGGSLYNVLHGAEPLPYY---TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVF 260
           +L     V K+ DF  +  I   +TH+T+   G+  + APE      ++EK DVFS+G+ 
Sbjct: 137 LLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGII 192
Query: 261 LFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHA 320
           L+E++T        K   ++  P+   +       R      P+I      IE       
Sbjct: 193 LWEVIT------RRKPFDEIGGPAFRIMWAVHNGTR-----PPLIKNLPKPIE------- 234
Query: 321 SAQLSFECIKDSPADRPSMVDVAKKLRQIYR 351
              L   C    P+ RPSM ++ K +  + R
Sbjct: 235 --SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 68  NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKL 127
           N+  K  + +  T+++  W    ++V      +         +  V    R+ H +I+  
Sbjct: 40  NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 128 IGCCLETPIPILVFESVQYGTLWDRIL---GAPQPHFEPLLLKHRLKIAMDIVHALAYLH 184
           +G   + P   +V E +  G+L+ R+L   GA     E L  + RL +A D+   + YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGA----REQLDERRRLSMAYDVAKGMNYLH 154
Query: 185 FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR 244
              P PIV R+ K+  +L +++   K+ DF LS  +       +    GT  + APE +R
Sbjct: 155 NRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKASXFLXSKXAAGTPEWMAPEVLR 212
Query: 245 TGVFNEKSDVFSFGVFLFELLT 266
               NEKSDV+SFGV L+EL T
Sbjct: 213 DEPSNEKSDVYSFGVILWELAT 234

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 26/237 (10%)
Query: 49  YRIFSAQEIKLATNSYDQKNVIA---KDTSYNLYTMYKGFWQ------ERLISVLQFYGH 99
           +  FS  E+K  TN++D++ +     K        +YKG+        ++L +++     
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL---GA 156
           E + +  +     +   A+  H ++++L+G   +     LV+  +  G+L DR+    G 
Sbjct: 72  ELKQQFDQE----IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
           P     PL    R KIA    + + +LH       + R+ K++ IL +E   AK+ DF L
Sbjct: 128 P-----PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 217 SISIPE-GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSD 272
           + +  +  +T +   ++GT  Y APE +R G    KSD++SFGV L E++TG    D
Sbjct: 180 ARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 26/237 (10%)
Query: 49  YRIFSAQEIKLATNSYDQKNVIA---KDTSYNLYTMYKGFWQ------ERLISVLQFYGH 99
           +  FS  E+K  TN++D++ +     K        +YKG+        ++L +++     
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL---GA 156
           E + +  +     +   A+  H ++++L+G   +     LV+  +  G+L DR+    G 
Sbjct: 72  ELKQQFDQE----IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
           P     PL    R KIA    + + +LH       + R+ K++ IL +E   AK+ DF L
Sbjct: 128 P-----PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 217 SISIPE-GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSD 272
           + +  +  +T +   ++GT  Y APE +R G    KSD++SFGV L E++TG    D
Sbjct: 180 ARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 112/237 (47%), Gaps = 26/237 (10%)
Query: 49  YRIFSAQEIKLATNSYDQKNVIA---KDTSYNLYTMYKGFWQ------ERLISVLQFYGH 99
           +  FS  E+K  TN++D++ +     K        +YKG+        ++L +++     
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 62
Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL---GA 156
           E + +  +     +   A+  H ++++L+G   +     LV+     G+L DR+    G 
Sbjct: 63  ELKQQFDQE----IKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT 118
Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
           P     PL    R KIA    + + +LH       + R+ K++ IL +E   AK+ DF L
Sbjct: 119 P-----PLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGL 170
Query: 217 SISIPEGETHITDT-VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSD 272
           + +  +    +  + ++GT  Y APE +R G    KSD++SFGV L E++TG    D
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 113/237 (47%), Gaps = 26/237 (10%)
Query: 49  YRIFSAQEIKLATNSYDQKNVIA---KDTSYNLYTMYKGFWQ------ERLISVLQFYGH 99
           +  FS  E+K  TN++D++ +     K        +YKG+        ++L +++     
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 65
Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL---GA 156
           E + +  +     +   A+  H ++++L+G   +     LV+  +  G+L DR+    G 
Sbjct: 66  ELKQQFDQE----IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 121
Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
           P     PL    R KIA    + + +LH       + R+ K++ IL +E   AK+ DF L
Sbjct: 122 P-----PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGL 173
Query: 217 SISIPE-GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSD 272
           + +  +  +  +   ++GT  Y APE +R G    KSD++SFGV L E++TG    D
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 81  MYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI 138
           +Y+ FW   E  +   +    E   +  E+        A + H +I+ L G CL+ P   
Sbjct: 23  VYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LV E  + G L +R+L   +    P +L   +  A+ I   + YLH     PI+ R+ K+
Sbjct: 83  LVMEFARGGPL-NRVLSGKR--IPPDIL---VNWAVQIARGMNYLHDEAIVPIIHRDLKS 136
Query: 199 SCILFNEE--------NVAKLFDFSLSISIPEGETHITD--TVMGTWGYCAPEYMRTGVF 248
           S IL  ++         + K+ DF L+      E H T   +  G + + APE +R  +F
Sbjct: 137 SNILILQKVENGDLSNKILKITDFGLA-----REWHRTTKMSAAGAYAWMAPEVIRASMF 191
Query: 249 NEKSDVFSFGVFLFELLTG 267
           ++ SDV+S+GV L+ELLTG
Sbjct: 192 SKGSDVWSYGVLLWELLTG 210

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 116 AARMSHNHILKLIGCC-LETP---IPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRL 170
           AA ++H  I+ +      ETP   +P +V E V   TL D +      H E P+  K  +
Sbjct: 66  AAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAI 119
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           ++  D   AL + H      I+ R+ K + I+ +  N  K+ DF ++ +I +    +T T
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 231 --VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             V+GT  Y +PE  R    + +SDV+S G  L+E+LTG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 193
           P+P +V E V   TL D +      H E P+  K  +++  D   AL + H      I+ 
Sbjct: 89  PLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIADACQALNFSHQNG---IIH 139
Query: 194 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--VMGTWGYCAPEYMRTGVFNEK 251
           R+ K + I+ +  N  K+ DF ++ +I +    +T T  V+GT  Y +PE  R    + +
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 252 SDVFSFGVFLFELLTG 267
           SDV+S G  L+E+LTG
Sbjct: 200 SDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 193
           P+P +V E V   TL D +      H E P+  K  +++  D   AL + H      I+ 
Sbjct: 89  PLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIADACQALNFSHQNG---IIH 139
Query: 194 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--VMGTWGYCAPEYMRTGVFNEK 251
           R+ K + I+ +  N  K+ DF ++ +I +    +T T  V+GT  Y +PE  R    + +
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 252 SDVFSFGVFLFELLTG 267
           SDV+S G  L+E+LTG
Sbjct: 200 SDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 193
           P+P +V E V   TL D +      H E P+  K  +++  D   AL + H      I+ 
Sbjct: 89  PLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIADACQALNFSHQNG---IIH 139
Query: 194 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--VMGTWGYCAPEYMRTGVFNEK 251
           R+ K + I+ +  N  K+ DF ++ +I +    +T T  V+GT  Y +PE  R    + +
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 252 SDVFSFGVFLFELLTG 267
           SDV+S G  L+E+LTG
Sbjct: 200 SDVYSLGCVLYEVLTG 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 193
           P+P +V E V   TL D +      H E P+  K  +++  D   AL + H      I+ 
Sbjct: 106 PLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIADACQALNFSHQNG---IIH 156
Query: 194 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--VMGTWGYCAPEYMRTGVFNEK 251
           R+ K + I+ +  N  K+ DF ++ +I +    +T T  V+GT  Y +PE  R    + +
Sbjct: 157 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 216
Query: 252 SDVFSFGVFLFELLTG 267
           SDV+S G  L+E+LTG
Sbjct: 217 SDVYSLGCVLYEVLTG 232

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 69/136 (50%), Gaps = 12/136 (8%)
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 193
           P+P +V E V   TL D +      H E P+  K  +++  D   AL + H      I+ 
Sbjct: 89  PLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIADACQALNFSHQNG---IIH 139
Query: 194 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--VMGTWGYCAPEYMRTGVFNEK 251
           R+ K + IL +  N  K+ DF ++ +I +    +  T  V+GT  Y +PE  R    + +
Sbjct: 140 RDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 252 SDVFSFGVFLFELLTG 267
           SDV+S G  L+E+LTG
Sbjct: 200 SDVYSLGCVLYEVLTG 215

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +P A +  I  V     + H ++++L G  L  P+  +V E    G+L DR L   Q HF
Sbjct: 55  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHF 112
Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
              LL    + A+ +   + YL     +  + R+     +L    ++ K+ DF L  ++P
Sbjct: 113 ---LLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 166
Query: 222 EGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + H  + +     + +CAPE ++T  F+  SD + FGV L+E+ T
Sbjct: 167 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +P A +  I  V     + H ++++L G  L  P+  +V E    G+L DR L   Q HF
Sbjct: 55  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHF 112
Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
              LL    + A+ +   + YL     +  + R+     +L    ++ K+ DF L  ++P
Sbjct: 113 ---LLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 166
Query: 222 EGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + H  + +     + +CAPE ++T  F+  SD + FGV L+E+ T
Sbjct: 167 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +P A +  I  V     + H ++++L G  L  P+  +V E    G+L DR L   Q HF
Sbjct: 51  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHF 108
Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
              LL    + A+ +   + YL     +  + R+     +L    ++ K+ DF L  ++P
Sbjct: 109 ---LLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162
Query: 222 EGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + H  + +     + +CAPE ++T  F+  SD + FGV L+E+ T
Sbjct: 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +P A +  I  V     + H ++++L G  L  P+  +V E    G+L DR L   Q HF
Sbjct: 51  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHF 108
Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
              LL    + A+ +   + YL     +  + R+     +L    ++ K+ DF L  ++P
Sbjct: 109 ---LLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162
Query: 222 EGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + H  + +     + +CAPE ++T  F+  SD + FGV L+E+ T
Sbjct: 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +P A +  I  V     + H ++++L G  L  P+  +V E    G+L DR L   Q HF
Sbjct: 61  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHF 118
Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
              LL    + A+ +   + YL     +  + R+     +L    ++ K+ DF L  ++P
Sbjct: 119 ---LLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
Query: 222 EGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + H  + +     + +CAPE ++T  F+  SD + FGV L+E+ T
Sbjct: 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +P A +  I  V     + H ++++L G  L  P+  +V E    G+L DR L   Q HF
Sbjct: 61  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHF 118
Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
              LL    + A+ +   + YL     +  + R+     +L    ++ K+ DF L  ++P
Sbjct: 119 ---LLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
Query: 222 EGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + H  + +     + +CAPE ++T  F+  SD + FGV L+E+ T
Sbjct: 173 QNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +P A +  I  V     + H ++++L G  L  P+  +V E    G+L DR L   Q HF
Sbjct: 51  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHF 108
Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
              LL    + A+ +   + YL     +  + R+     +L    ++ K+ DF L  ++P
Sbjct: 109 ---LLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162
Query: 222 EGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + H  + +     + +CAPE ++T  F+  SD + FGV L+E+ T
Sbjct: 163 QNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL--VFESVQYGTLWDRILGAP 157
           +C P+        +     + H HI+K  GCC +     L  V E V  G+L D +   P
Sbjct: 54  DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---P 110
Query: 158 QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS 217
           +     + L   L  A  I   +AYLH    +  + RN     +L + + + K+ DF L+
Sbjct: 111 R---HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLA 164
Query: 218 ISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVS 271
            ++PEG  +  + +       + APE ++   F   SDV+SFGV L+ELLT  D S
Sbjct: 165 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 220

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL--VFESVQYGTLWDRILGAP 157
           +C P+        +     + H HI+K  GCC +     L  V E V  G+L D +   P
Sbjct: 54  DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---P 110
Query: 158 QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS 217
           +     + L   L  A  I   +AYLH    +  + RN     +L + + + K+ DF L+
Sbjct: 111 R---HSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLA 164
Query: 218 ISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVS 271
            ++PEG  +  + +       + APE ++   F   SDV+SFGV L+ELLT  D S
Sbjct: 165 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 220

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 129/292 (44%), Gaps = 30/292 (10%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 13  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L A +  FE   +K  + IA      + YLH 
Sbjct: 72  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHASETKFE---MKKLIDIARQTARGMDYLH- 125
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+N  K+ DF L ++      +H  + + G+  + APE +R
Sbjct: 126 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 245 ---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV 301
              +  ++ +SDV++FG+ L+EL+TG               P      N    ++  E+V
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTG-------------QLP----YSNINNRDQIIEMV 226
Query: 302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
               +   LS  +        +L  EC+K    +RPS   +  ++ ++ R L
Sbjct: 227 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 278

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 128/292 (43%), Gaps = 30/292 (10%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L A +  FE   +K  + IA      + YLH 
Sbjct: 84  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHASETKFE---MKKLIDIARQTARGMDYLH- 137
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE-GETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+N  K+ DF L+        +H  + + G+  + APE +R
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 245 ---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV 301
              +  ++ +SDV++FG+ L+EL+TG               P      N    ++  E+V
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTG-------------QLP----YSNINNRDQIIEMV 238
Query: 302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
               +   LS  +        +L  EC+K    +RPS   +  ++ ++ R L
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 290

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G     P   +V +  +  +L+   L A +  FE   +K  + IA      + YLH 
Sbjct: 84  LFMGYST-APQLAIVTQWCEGSSLYHH-LHASETKFE---MKKLIDIARQTARGMDYLH- 137
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE-GETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+N  K+ DF L+        +H  + + G+  + APE +R
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 245 ---TGVFNEKSDVFSFGVFLFELLTG 267
              +  ++ +SDV++FG+ L+EL+TG
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTG 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 119 MSHNHILKLIGCCLETPIPIL--VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H HI+K  GCC +     L  V E V  G+L D +   P+     + L   L  A  I
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PR---HSIGLAQLLLFAQQI 143
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGT 234
              +AYLH    +  + R+     +L + + + K+ DF L+ ++PEG     + +     
Sbjct: 144 CEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP 200
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVS 271
             + APE ++   F   SDV+SFGV L+ELLT  D S
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 103 PRAYESCIN----NVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ 158
           PR  E  +      V  ++++SH +I+ +I    E     LV E ++  TL + I    +
Sbjct: 48  PREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----E 103
Query: 159 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
            H  PL +   +     I+  + + H      IV R+ K   IL +     K+FDF ++ 
Sbjct: 104 SHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
Query: 219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           ++ E     T+ V+GT  Y +PE  +    +E +D++S G+ L+E+L G
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  I       ++SH  +++L G CLE     LVFE +++G L D  L   +  F    L
Sbjct: 45  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETL 103
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              L + +D+   +AYL       ++ R+      L  E  V K+ DF ++  + + +  
Sbjct: 104 ---LGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
            +        + +PE      ++ KSDV+SFGV ++E+ +   +                
Sbjct: 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--------------- 202
Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
                +E+   +E+V+ I     L   +    H   Q+   C K+ P DRP+   + ++L
Sbjct: 203 -----YENRSNSEVVEDISTGFRLYKPRLASTHV-YQIMNHCWKERPEDRPAFSRLLRQL 256
Query: 347 RQIYRS 352
            +I  S
Sbjct: 257 AEIAES 262

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  I       ++SH  +++L G CLE     LVFE +++G L D  L   +  F    L
Sbjct: 47  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETL 105
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              L + +D+   +AYL       ++ R+      L  E  V K+ DF ++  + + +  
Sbjct: 106 ---LGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 159
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
            +        + +PE      ++ KSDV+SFGV ++E+ +   +                
Sbjct: 160 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--------------- 204
Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
                +E+   +E+V+ I     L   +    H   Q+   C K+ P DRP+   + ++L
Sbjct: 205 -----YENRSNSEVVEDISTGFRLYKPRLASTHV-YQIMNHCWKERPEDRPAFSRLLRQL 258
Query: 347 RQIYRS 352
            +I  S
Sbjct: 259 AEIAES 264

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 15/174 (8%)
Query: 101 CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI--LVFESVQYGTLWDRILGAPQ 158
           C P+        +     + H HI+K  GCC +       LV E V  G+L D +     
Sbjct: 50  CGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCV 109
Query: 159 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
              + LL   ++   M  +HA  Y+H    R +  RN     +L + + + K+ DF L+ 
Sbjct: 110 GLAQLLLFAQQICEGMAYLHAQHYIH----RALAARN-----VLLDNDRLVKIGDFGLAK 160
Query: 219 SIPEGETHI---TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD 269
           ++PEG  +     D     + Y APE ++   F   SDV+SFGV L+ELLT  D
Sbjct: 161 AVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCD 213

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 15/174 (8%)
Query: 101 CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI--LVFESVQYGTLWDRILGAPQ 158
           C P+        +     + H HI+K  GCC +       LV E V  G+L D +     
Sbjct: 49  CGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCV 108
Query: 159 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
              + LL   ++   M  +HA  Y+H    R +  RN     +L + + + K+ DF L+ 
Sbjct: 109 GLAQLLLFAQQICEGMAYLHAQHYIH----RALAARN-----VLLDNDRLVKIGDFGLAK 159
Query: 219 SIPEGETHI---TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD 269
           ++PEG  +     D     + Y APE ++   F   SDV+SFGV L+ELLT  D
Sbjct: 160 AVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCD 212

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 15/156 (9%)
Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           R+SH +I+KL     ETP  I LV E V  G L+DRI+   + ++        +K    I
Sbjct: 104 RLSHPNIIKL-KEIFETPTEISLVLELVTGGELFDRIV--EKGYYSERDAADAVK---QI 157
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNE---ENVAKLFDFSLSISIPEGETHITDTVMG 233
           + A+AYLH      IV R+ K   +L+     +   K+ DF LS  I E +  +  TV G
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS-KIVEHQV-LMKTVCG 212
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD 269
           T GYCAPE +R   +  + D++S G+  + LL G++
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 28/243 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I       ++SH  +++L G CLE     LVFE +++G L D  L   +  F    L   
Sbjct: 70  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETL--- 125
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L + +D+   +AYL       ++ R+      L  E  V K+ DF ++  + + +   + 
Sbjct: 126 LGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 182
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK 289
                  + +PE      ++ KSDV+SFGV ++E+ +   +                   
Sbjct: 183 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP------------------ 224
Query: 290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
             +E+   +E+V+ I     L   +    H   Q+   C K+ P DRP+   + ++L +I
Sbjct: 225 --YENRSNSEVVEDISTGFRLYKPRLASTHV-YQIMNHCWKERPEDRPAFSRLLRQLAEI 281
Query: 350 YRS 352
             S
Sbjct: 282 AES 284

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  I       ++SH  +++L G CLE     LVFE +++G L D  L   +  F    L
Sbjct: 50  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETL 108
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              L + +D+   +AYL       ++ R+      L  E  V K+ DF ++  + + +  
Sbjct: 109 ---LGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
            +        + +PE      ++ KSDV+SFGV ++E+ +   +                
Sbjct: 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--------------- 207
Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
                +E+   +E+V+ I     L   +    H   Q+   C ++ P DRP+   + ++L
Sbjct: 208 -----YENRSNSEVVEDISTGFRLYKPRLASTHV-YQIMNHCWRERPEDRPAFSRLLRQL 261
Query: 347 RQIYRS 352
            +I  S
Sbjct: 262 AEIAES 267

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 28/246 (11%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  I       ++SH  +++L G CLE     LVFE +++G L D  L   +  F    L
Sbjct: 47  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETL 105
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              L + +D+   +AYL       ++ R+      L  E  V K+ DF ++  + + +  
Sbjct: 106 ---LGMCLDVCEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 159
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
            +        + +PE      ++ KSDV+SFGV ++E+ +   +                
Sbjct: 160 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--------------- 204
Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
                +E+   +E+V+ I     L   +    H   Q+   C K+ P DRP+   + ++L
Sbjct: 205 -----YENRSNSEVVEDISTGFRLYKPRLASTHV-YQIMNHCWKERPEDRPAFSRLLRQL 258
Query: 347 RQIYRS 352
             I  S
Sbjct: 259 AAIAAS 264

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 18/158 (11%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + ++H +I+KL G  +  P P +V E V  G L+ R+L    P    +    +L++ +DI
Sbjct: 78  SNLNHPNIVKLYGL-MHNP-PRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDI 131
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFN--EENV---AKLFDFSLSISIPEGETHITDTV 231
              + Y+    P PIV R+ ++  I     +EN    AK+ DFSLS    +   H    +
Sbjct: 132 ALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSVSGL 186
Query: 232 MGTWGYCAPEYM--RTGVFNEKSDVFSFGVFLFELLTG 267
           +G + + APE +      + EK+D +SF + L+ +LTG
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 103/246 (41%), Gaps = 28/246 (11%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  I       ++SH  +++L G CLE     LV E +++G L D  L   +  F    L
Sbjct: 48  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD-YLRTQRGLFAAETL 106
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              L + +D+   +AYL       ++ R+      L  E  V K+ DF ++  + + +  
Sbjct: 107 ---LGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
            +        + +PE      ++ KSDV+SFGV ++E+ +   +                
Sbjct: 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--------------- 205
Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
                +E+   +E+V+ I     L   +    H   Q+   C ++ P DRP+   + ++L
Sbjct: 206 -----YENRSNSEVVEDISTGFRLYKPRLASTHV-YQIMNHCWRERPEDRPAFSRLLRQL 259
Query: 347 RQIYRS 352
            +I  S
Sbjct: 260 AEIAES 265

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 18/158 (11%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + ++H +I+KL G  +  P P +V E V  G L+ R+L    P    +    +L++ +DI
Sbjct: 78  SNLNHPNIVKLYGL-MHNP-PRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDI 131
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFN--EENV---AKLFDFSLSISIPEGETHITDTV 231
              + Y+    P PIV R+ ++  I     +EN    AK+ DF LS    +   H    +
Sbjct: 132 ALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGL 186
Query: 232 MGTWGYCAPEYM--RTGVFNEKSDVFSFGVFLFELLTG 267
           +G + + APE +      + EK+D +SF + L+ +LTG
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLL 165
           ++ +   +   ++ H+++++L+G  +E    + +V E +  G+L D +    +       
Sbjct: 50  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 109
Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
           L   LK ++D+  A+ YL        V R+     +L +E+NVAK+ DF L+    +  +
Sbjct: 110 L---LKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEAS 159
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
              DT      + APE +R   F+ KSDV+SFG+ L+E+
Sbjct: 160 STQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 48  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKY---LRL 103
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 104 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT 160
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 161 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 220
Query: 277 THDLACP 283
            + + CP
Sbjct: 221 GYRMPCP 227

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 62  NSYDQKNVIAKDTSYNLYT-MYKGFWQERLISVLQFYGHECRPRAYES---CINNVTYAA 117
             YD K+VI +  S  +   +++    E  + +++       P   E         T+  
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 118 RM--SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
           R    H HI+ LI     +    LVF+ ++ G L+D +          L  K    I   
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-----LSEKETRSIMRS 208
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++ A+++LH      IV R+ K   IL ++    +L DF  S  +  GE      + GT 
Sbjct: 209 LLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTP 263
Query: 236 GYCAPEYMRTGV------FNEKSDVFSFGVFLFELLTG 267
           GY APE ++  +      + ++ D+++ GV LF LL G
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLL 165
           ++ +   +   ++ H+++++L+G  +E    + +V E +  G+L D +    +       
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118
Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
           L   LK ++D+  A+ YL        V R+     +L +E+NVAK+ DF L+    +  +
Sbjct: 119 L---LKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEAS 168
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
              DT      + APE +R   F+ KSDV+SFG+ L+E+
Sbjct: 169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 35/248 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  +        + H ++++L+G C   P   +V E + YG L D +    +     ++L
Sbjct: 73  EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVL 132
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET- 225
              L +A  I  A+ YL     +  + R+      L  E +V K+ DF LS  +  G+T 
Sbjct: 133 ---LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLS-RLMTGDTY 185
Query: 226 --HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACP 283
             H        W   APE +    F+ KSDV++FGV L+E+ T                 
Sbjct: 186 TAHAGAKFPIKW--TAPESLAYNTFSIKSDVWAFGVLLWEIAT----------------- 226
Query: 284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASA-QLSFECIKDSPADRPSMVDV 342
              Y  + +     +++ D  ++E    +E+ +       +L   C K SPADRPS  + 
Sbjct: 227 ---YGMSPYPGIDLSQVYD--LLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAET 281
Query: 343 AKKLRQIY 350
            +    ++
Sbjct: 282 HQAFETMF 289

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLL 165
           ++ +   +   ++ H+++++L+G  +E    + +V E +  G+L D +    +       
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103
Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
           L   LK ++D+  A+ YL        V R+     +L +E+NVAK+ DF L+    +  +
Sbjct: 104 L---LKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEAS 153
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
              DT      + APE +R   F+ KSDV+SFG+ L+E+
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VIEYMSKGSLLDFLKGEMGKY---LRL 113
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 114 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT 170
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 171 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 277 THDLACP 283
            + + CP
Sbjct: 231 GYRMPCP 237

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++ H+++++L+G  +E    + +V E +  G+L D +    +       L   LK ++D+
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDV 298
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
             A+ YL        V R+     +L +E+NVAK+ DF L+    +  +   DT      
Sbjct: 299 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVK 351
Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
           + APE +R   F+ KSDV+SFG+ L+E+
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN     A ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 55  EICIN-----AMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 110 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKY---LRL 279
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 280 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 277 THDLACP 283
            + + CP
Sbjct: 397 GYRMPCP 403

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 18/158 (11%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + ++H +I+KL G  +  P P +V E V  G L+ R+L    P    +    +L++ +DI
Sbjct: 78  SNLNHPNIVKLYGL-MHNP-PRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDI 131
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFN--EENV---AKLFDFSLSISIPEGETHITDTV 231
              + Y+    P PIV R+ ++  I     +EN    AK+ DF  S    +   H    +
Sbjct: 132 ALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSVSGL 186
Query: 232 MGTWGYCAPEYM--RTGVFNEKSDVFSFGVFLFELLTG 267
           +G + + APE +      + EK+D +SF + L+ +LTG
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VIEYMSKGSLLDFLKGEMGKY---LRL 113
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 114 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 171 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 277 THDLACP 283
            + + CP
Sbjct: 231 GYRMPCP 237

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKY---LRL 279
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 280 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 277 THDLACP 283
            + + CP
Sbjct: 397 GYRMPCP 403

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 12/150 (8%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           ++H  I+++ G   +     ++ + ++ G L+  +L   Q    P+   +    A ++  
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFY----AAEVCL 117
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYC 238
           AL YLH    + I++R+ K   IL ++    K+ DF  +  +P+    +T  + GT  Y 
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYI 170
Query: 239 APEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           APE + T  +N+  D +SFG+ ++E+L G+
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 51  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKY---LRL 106
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 107 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 163
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 164 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 223
Query: 277 THDLACP 283
            + + CP
Sbjct: 224 GYRMPCP 230

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 69  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 124
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGT 234
              + YL  G  R  + RN  T  IL   EN  K+ DF L+  +P+ + +  + +     
Sbjct: 125 CKGMEYL--GTKR-YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 232
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 233 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 290

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 96  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 149
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L ++      +H  + + G+  + APE +R
Sbjct: 150 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 245 TGVFNE---KSDVFSFGVFLFELLTG 267
               N    +SDV++FG+ L+EL+TG
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTG 233

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 96  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 149
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE-GETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L+        +H  + + G+  + APE +R
Sbjct: 150 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 245 TGVFNE---KSDVFSFGVFLFELLTG 267
               N    +SDV++FG+ L+EL+TG
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTG 233

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VGEYMSKGSLLDFLKGETGKY---LRL 279
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 280 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 277 THDLACP 283
            + + CP
Sbjct: 397 GYRMPCP 403

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 36  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 95  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 148
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L ++      +H  + + G+  + APE +R
Sbjct: 149 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 245 TGVFNE---KSDVFSFGVFLFELLTG 267
               N    +SDV++FG+ L+EL+TG
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTG 232

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 60  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 115
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + RN + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 116 EGMAFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 173 TAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 9/111 (8%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L ++H  F   +V+R+ K + IL +E    ++ D  L+    + + H +   +
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 350
Query: 233 GTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDV--SDLVKDTHDL 280
           GT GY APE ++ GV ++  +D FS G  LF+LL G         KD H++
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 9/111 (8%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L ++H  F   +V+R+ K + IL +E    ++ D  L+    + + H +   +
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 351
Query: 233 GTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDV--SDLVKDTHDL 280
           GT GY APE ++ GV ++  +D FS G  LF+LL G         KD H++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI  +V E +  G+L D + G    +   L L
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY---LRL 362
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 363 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
Query: 277 THDLACP 283
            + + CP
Sbjct: 480 GYRMPCP 486

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 29  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 88  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 141
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE-GETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L+        +H  + + G+  + APE +R
Sbjct: 142 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 245 TGVFNE---KSDVFSFGVFLFELLTG 267
               N    +SDV++FG+ L+EL+TG
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTG 225

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L ++H  F   +V+R+ K + IL +E    ++ D  L+    + + H +   +
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 351
Query: 233 GTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++ GV ++  +D FS G  LF+LL G
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L ++H  F   +V+R+ K + IL +E    ++ D  L+    + + H +   +
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 351
Query: 233 GTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++ GV ++  +D FS G  LF+LL G
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 53  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 107
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 108 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 156
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 110 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 110 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 110 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 110 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 110 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 81/190 (42%), Gaps = 23/190 (12%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLL 165
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   P L
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL 113
Query: 166 LKHRLKIA--MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           +    +IA  M  V  + Y+H         R+ + + IL  E  V K+ DF L+  I + 
Sbjct: 114 VDMSAQIASGMAYVERMNYVH---------RDLRAANILVGENLVCKVADFGLARLIEDN 164
Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDL 273
           E            + APE    G F  KSDV+SFG+ L EL T            +V D 
Sbjct: 165 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 224
Query: 274 VKDTHDLACP 283
           V+  + + CP
Sbjct: 225 VERGYRMPCP 234

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 109 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 157
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEP 163
           E CIN +     ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-E 222
               H+L   +  +H +   H         R+ K   +L +E +  K+ DF L+      
Sbjct: 110 FF--HQLMAGVVYLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
               + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLK 167
           + H HI++  G C E    ++VFE +++G L +R L +  P  +           PL L 
Sbjct: 71  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 168 HRLKIAMDIVHALAY---LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
             L +A  +   + Y   LHF      V R+  T   L  +  V K+ DF +S  I   +
Sbjct: 130 QLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 183
Query: 225 TH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + +    M    +  PE +    F  +SDV+SFGV L+E+ T
Sbjct: 184 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKY---LRL 113
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 114 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 171 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 277 THDLACP 283
            + + CP
Sbjct: 231 GYRMPCP 237

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 49  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKY---LRL 104
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 105 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 161
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 162 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 221
Query: 277 THDLACP 283
            + + CP
Sbjct: 222 GYRMPCP 228

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 68  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 121
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE-GETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L+        +H  + + G+  + APE +R
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 245 ---TGVFNEKSDVFSFGVFLFELLTG 267
                 ++ +SDV++FG+ L+EL+TG
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 73  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 126
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L ++      +H  + + G+  + APE +R
Sbjct: 127 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 245 ---TGVFNEKSDVFSFGVFLFELLTG 267
                 ++ +SDV++FG+ L+EL+TG
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTG 210

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLK 167
           + H HI++  G C E    ++VFE +++G L +R L +  P  +           PL L 
Sbjct: 77  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 168 HRLKIAMDIVHALAY---LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
             L +A  +   + Y   LHF      V R+  T   L  +  V K+ DF +S  I   +
Sbjct: 136 QLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189
Query: 225 TH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + +    M    +  PE +    F  +SDV+SFGV L+E+ T
Sbjct: 190 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 73  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 126
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L ++      +H  + + G+  + APE +R
Sbjct: 127 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 245 TGVFNE---KSDVFSFGVFLFELLTG 267
               N    +SDV++FG+ L+EL+TG
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTG 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 70  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 123
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L ++      +H  + + G+  + APE +R
Sbjct: 124 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 245 ---TGVFNEKSDVFSFGVFLFELLTG 267
                 ++ +SDV++FG+ L+EL+TG
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTG 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 81/190 (42%), Gaps = 23/190 (12%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLL 165
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   P L
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL 113
Query: 166 LKHRLKIA--MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           +    +IA  M  V  + Y+H         R+ + + IL  E  V K+ DF L+  I + 
Sbjct: 114 VDMSAQIASGMAYVERMNYVH---------RDLRAANILVGENLVCKVADFGLARLIEDN 164
Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDL 273
           E            + APE    G F  KSDV+SFG+ L EL T            +V D 
Sbjct: 165 EWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 224
Query: 274 VKDTHDLACP 283
           V+  + + CP
Sbjct: 225 VERGYRMPCP 234

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 47  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKY---LRL 102
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 103 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 159
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 160 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 219
Query: 277 THDLACP 283
            + + CP
Sbjct: 220 GYRMPCP 226

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G   +  + I V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 68  LFMGYSTKPQLAI-VTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 121
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L ++      +H  + + G+  + APE +R
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 245 ---TGVFNEKSDVFSFGVFLFELLTG 267
                 ++ +SDV++FG+ L+EL+TG
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLK 167
           + H HI++  G C E    ++VFE +++G L +R L +  P  +           PL L 
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 168 HRLKIAMDIVHALAY---LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
             L +A  +   + Y   LHF      V R+  T   L  +  V K+ DF +S  I   +
Sbjct: 159 QLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 225 TH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + +    M    +  PE +    F  +SDV+SFGV L+E+ T
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G L D + G    +   L L
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VMEYMSKGCLLDFLKGEMGKY---LRL 113
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 114 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 171 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 277 THDLACP 283
            + + CP
Sbjct: 231 GYRMPCP 237

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VCEYMSKGSLLDFLKGEMGKY---LRL 113
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 114 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 171 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 277 THDLACP 283
            + + CP
Sbjct: 231 GYRMPCP 237

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 225 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKY---LRL 280
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L   I + E  
Sbjct: 281 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYT 337
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 338 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 397
Query: 277 THDLACP 283
            + + CP
Sbjct: 398 GYRMPCP 404

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 58  EAFLQEAQVMKKIRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKY---LRL 113
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 114 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 171 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 277 THDLACP 283
            + + CP
Sbjct: 231 GYRMPCP 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFWQE-----RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W       ++   ++       P+A    ++     A M H H+++L+G CL +
Sbjct: 30  TVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-S 88
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
           P   LV + + +G L + +      H + +  +  L   + I   + YL     R +V R
Sbjct: 89  PTIQLVTQLMPHGCLLEYV----HEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHR 141
Query: 195 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW--GYCAPEYMRTGVFNEKS 252
           +     +L    N  K+ DF L+  + EG+    +   G     + A E +    F  +S
Sbjct: 142 DLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 200
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 201 DVWSYGVTIWELMT 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 119
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 120 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 65  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 120
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 121 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 178 TAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 13/189 (6%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 236 VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + RN     
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRNLAARN 348
Query: 201 ILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
            L  E ++ K+ DF LS  +  G+T   H        W   APE +    F+ KSDV++F
Sbjct: 349 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW--TAPESLAYNKFSIKSDVWAF 405
Query: 258 GVFLFELLT 266
           GV L+E+ T
Sbjct: 406 GVLLWEIAT 414

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 119
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 120 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 66  QKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL 125
           Q  V  +  S +  T+YKG W    ++V         P+  ++  N V    +  H +IL
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 185
             +G     P   +V +  +  +L+   L   +  FE + L   + IA      + YLH 
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKL---IDIARQTAQGMDYLH- 121
Query: 186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGTWGYCAPEYMR 244
              + I+ R+ K++ I  +E+   K+ DF L ++      +H  + + G+  + APE +R
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 245 ---TGVFNEKSDVFSFGVFLFELLTG 267
                 ++ +SDV++FG+ L+EL+TG
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 70  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 125
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 126 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 66  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 121
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 122 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 179 TAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 72  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 127
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 128 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 185 TAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 88  IEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 141
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 142 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 201 LLWEIAT 207

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 59  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 114
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 115 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 172 TAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 119
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 120 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 13/189 (6%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 275 VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 333
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + RN     
Sbjct: 334 TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRNLAARN 387
Query: 201 ILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
            L  E ++ K+ DF LS  +  G+T   H        W   APE +    F+ KSDV++F
Sbjct: 388 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW--TAPESLAYNKFSIKSDVWAF 444
Query: 258 GVFLFELLT 266
           GV L+E+ T
Sbjct: 445 GVLLWEIAT 453

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFWQE-----RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W       ++   ++       P+A    ++     A M H H+++L+G CL +
Sbjct: 53  TVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-S 111
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
           P   LV + + +G L + +      H + +  +  L   + I   + YL     R +V R
Sbjct: 112 PTIQLVTQLMPHGCLLEYV----HEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHR 164
Query: 195 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW--GYCAPEYMRTGVFNEKS 252
           +     +L    N  K+ DF L+  + EG+    +   G     + A E +    F  +S
Sbjct: 165 DLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 223
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 224 DVWSYGVTIWELMT 237

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 73  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 128
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 129 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 186 TAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 88  IEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 141
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 142 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 201 LLWEIAT 207

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G L D + G    +   L L
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGCLLDFLKGEMGKY---LRL 113
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 114 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 171 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 277 THDLACP 283
            + + CP
Sbjct: 231 GYRMPCP 237

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 93  IEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 146
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 147 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 206 LLWEIAT 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 17/187 (9%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +   L L
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKY---LRL 113
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+   + IL  E  V K+ DF L+  I + E  
Sbjct: 114 PQLVDMAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL T            +V D V+ 
Sbjct: 171 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 277 THDLACP 283
            + + CP
Sbjct: 231 GYRMPCP 237

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 119
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 120 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 13/189 (6%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 27  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 86  IEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 139
Query: 201 ILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
            L  E ++ K+ DF LS  +  G+T   H        W   APE +    F+ KSDV++F
Sbjct: 140 CLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKW--TAPESLAYNKFSIKSDVWAF 196
Query: 258 GVFLFELLT 266
           GV L+E+ T
Sbjct: 197 GVLLWEIAT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 70  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 125
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 126 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 69  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 124
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 125 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 13/189 (6%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 30  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 88
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 89  IEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 142
Query: 201 ILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
            L  E ++ K+ DF LS  +  G+T   H        W   APE +    F+ KSDV++F
Sbjct: 143 CLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKW--TAPESLAYNKFSIKSDVWAF 199
Query: 258 GVFLFELLT 266
           GV L+E+ T
Sbjct: 200 GVLLWEIAT 208

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I+  E ++ G+L D +     P    L +   L +A  I 
Sbjct: 74  QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIA 129
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +A++     R  + R+ + + IL ++    K+ DF L+  I + E    +       +
Sbjct: 130 EGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L E++T
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 13/163 (7%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL---GAPQPHFEP 163
           E+ +        + H+ ++KL     + PI I+  E +  G+L D +    G+ QP    
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQP---- 282
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +  +  I   +A++     R  + R+ + + IL +   V K+ DF L+  I + 
Sbjct: 283 --LPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337
Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           E    +       + APE +  G F  KSDV+SFG+ L E++T
Sbjct: 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/250 (22%), Positives = 107/250 (42%), Gaps = 42/250 (16%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    ++V E + +G L       R      P   P 
Sbjct: 69  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 128
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L+  +++A +I   +AYL+    +  V RN      +   +   K+ DF ++  I E +
Sbjct: 129 TLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 185
Query: 225 THITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD 279
            +      G  G     + APE ++ GVF   SD++SFGV L      W+++ L +  + 
Sbjct: 186 YYRK----GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLAEQPYQ 235
Query: 280 LACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP 337
               SNE +  +  D  + +  D  P  V D++ +               C + +P  RP
Sbjct: 236 GL--SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---------------CWQFNPNMRP 278
Query: 338 SMVDVAKKLR 347
           + +++   L+
Sbjct: 279 TFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/250 (22%), Positives = 107/250 (42%), Gaps = 42/250 (16%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    ++V E + +G L       R      P   P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L+  +++A +I   +AYL+    +  V RN      +   +   K+ DF ++  I E +
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
Query: 225 THITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD 279
            +      G  G     + APE ++ GVF   SD++SFGV L      W+++ L +  + 
Sbjct: 185 YYRK----GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLAEQPYQ 234
Query: 280 LACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP 337
               SNE +  +  D  + +  D  P  V D++ +               C + +P  RP
Sbjct: 235 GL--SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---------------CWQFNPNMRP 277
Query: 338 SMVDVAKKLR 347
           + +++   L+
Sbjct: 278 TFLEIVNLLK 287

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 19/159 (11%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEPLLLKHRLKIAMD 175
           ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  +     H+L   + 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVV 118
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-EGETHITDTVMGT 234
            +H +   H         R+ K   +L +E +  K+ DF L+          + + + GT
Sbjct: 119 YLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 235 WGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
             Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 141
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 142 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 201 LLWEIAT 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 19/159 (11%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEPLLLKHRLKIAMD 175
           ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  +     H+L   + 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVV 119
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-EGETHITDTVMGT 234
            +H +   H         R+ K   +L +E +  K+ DF L+          + + + GT
Sbjct: 120 YLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170
Query: 235 WGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
             Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 30  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 88
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 89  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 142
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 143 CLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 201
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 202 LLWEIAT 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 39/208 (18%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF--------------- 161
           A   + +I+KL+G C       L+FE + YG L +  L +  PH                
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 162 -----EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
                 PL    +L IA  +   +AYL     R  V R+  T   L  E  V K+ DF L
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 217 SISIPEGETHITD---TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL--------- 264
           S +I   + +  D    +   W    PE +    +  +SDV+++GV L+E+         
Sbjct: 221 SRNIYSADYYKADGNDAIPIRW--MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 265 -LTGWDVSDLVKDTHDLACPSNEYLKNY 291
            +   +V   V+D + LACP N  L+ Y
Sbjct: 279 GMAHEEVIYYVRDGNILACPENCPLELY 306

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 31  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 143
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 144 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 202
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 203 LLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 42  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 100
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 101 TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 154
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 155 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 213
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 214 LLWEIAT 220

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 13/189 (6%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 27  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 86  TEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 139
Query: 201 ILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
            L  E ++ K+ DF LS  +  G+T   H        W   APE +    F+ KSDV++F
Sbjct: 140 CLVGENHLVKVADFGLS-RLMTGDTFTAHAGAKFPIKW--TAPESLAYNKFSIKSDVWAF 196
Query: 258 GVFLFELLT 266
           GV L+E+ T
Sbjct: 197 GVLLWEIAT 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 146
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 147 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 206 LLWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 146
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 147 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 206 LLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 31  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 143
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 144 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 202
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 203 LLWEIAT 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 13/189 (6%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 27  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 86  TEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 139
Query: 201 ILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
            L  E ++ K+ DF LS  +  G+T   H        W   APE +    F+ KSDV++F
Sbjct: 140 CLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKW--TAPESLAYNKFSIKSDVWAF 196
Query: 258 GVFLFELLT 266
           GV L+E+ T
Sbjct: 197 GVLLWEIAT 205

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QAHAERIDHIKLLQYTSQI 126
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 127 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 234
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 235 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 31  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 143
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 144 CLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 202
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 203 LLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 141
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 142 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 201 LLWEIAT 207

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 22/177 (12%)
Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMDIV 177
           SH +I++LIG C +     +V E VQ G      R  GA       L +K  L++  D  
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR------LRVKTLLQMVGDAA 223
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-WG 236
             + YL     +  + R+      L  E+NV K+ DF +S    +G    +  +      
Sbjct: 224 AGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK 280
Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACP 283
           + APE +  G ++ +SDV+SFG+ L+E           L+     + V+    L CP
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP 337

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 146
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 147 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 206 LLWEIAT 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 19/159 (11%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEPLLLKHRLKIAMD 175
           ++H +++K  G   E  I  L  E    G L+DRI   +G P+P  +     H+L   + 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF--HQLMAGVV 118
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP-EGETHITDTVMGT 234
            +H +   H         R+ K   +L +E +  K+ DF L+          + + + GT
Sbjct: 119 YLHGIGITH---------RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 235 WGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG---WD 269
             Y APE ++   F+ E  DV+S G+ L  +L G   WD
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 33  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 92  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 145
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 146 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 205 LLWEIAT 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 126
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 127 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 234
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 235 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 67  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 122
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 123 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 230
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 231 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 74  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 129
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 130 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 237
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 238 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 295

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 123
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 124 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 231
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 141
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMG-TWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 142 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 201 LLWEIAT 207

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 73  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 128
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 129 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 236
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 237 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 294

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 75  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 130
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 131 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 238
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 239 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 296

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 9/187 (4%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 29  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 141
Query: 201 ILFNEENVAKLFDFSLSISIPEGETHITDT-VMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E ++ K+ DF LS  +  G+T+           + APE +    F+ KSDV++FGV
Sbjct: 142 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 260 FLFELLT 266
            L+E+ T
Sbjct: 201 LLWEIAT 207

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 17/194 (8%)
Query: 80  TMYKGFWQERL-ISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI 138
           T+YKG W   + + +L+    +  P  +++  N V    +  H +IL  +G   +  + I
Sbjct: 51  TVYKGKWHGDVAVKILKVV--DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAI 108
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
            V +  +  +L+   L   +  F+   L   + IA      + YLH    + I+ R+ K+
Sbjct: 109 -VTQWCEGSSLYKH-LHVQETKFQMFQL---IDIARQTAQGMDYLH---AKNIIHRDMKS 160
Query: 199 SCILFNEENVAKLFDFSLSI--SIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSD 253
           + I  +E    K+ DF L+   S   G   +     G+  + APE +R      F+ +SD
Sbjct: 161 NNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT-GSVLWMAPEVIRMQDNNPFSFQSD 219
Query: 254 VFSFGVFLFELLTG 267
           V+S+G+ L+EL+TG
Sbjct: 220 VYSYGIVLYELMTG 233

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 141
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 142 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 249
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 250 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 13/189 (6%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV 140
           +Y+G W++  ++V      E      E  +        + H ++++L+G C   P   ++
Sbjct: 34  VYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
            E + YG L D +    +     ++L   L +A  I  A+ YL     +  + R+     
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 146
Query: 201 ILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
            L  E ++ K+ DF LS  +  G+T   H        W   APE +    F+ KSDV++F
Sbjct: 147 CLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKW--TAPESLAYNKFSIKSDVWAF 203
Query: 258 GVFLFELLT 266
           GV L+E+ T
Sbjct: 204 GVLLWEIAT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 66  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 121
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 122 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 229
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 230 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 287

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 123
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 124 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 231
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 154
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 155 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 262
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 263 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 141
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 142 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 249
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 250 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 72  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 127
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 128 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 235
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 236 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 293

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 13/163 (7%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL---GAPQPHFEP 163
           E+ +        + H+ ++KL     + PI I+  E +  G+L D +    G+ QP    
Sbjct: 55  EAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQP---- 109
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +  +  I   +A++     R  + R+ + + IL +   V K+ DF L+  I + 
Sbjct: 110 --LPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 164
Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           E    +       + APE +  G F  KSDV+SFG+ L E++T
Sbjct: 165 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L D +    Q H E +     L+    I
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQI 123
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 124 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 231
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 107/251 (42%), Gaps = 44/251 (17%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    ++V E + +G L       R      P   P 
Sbjct: 65  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 124
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L+  +++A +I   +AYL+    +  V R+      +   +   K+ DF ++  I E  
Sbjct: 125 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-- 179
Query: 225 THITDTVM-GTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH 278
              TD    G  G     + APE ++ GVF   SD++SFGV L      W+++ L +  +
Sbjct: 180 ---TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLAEQPY 230
Query: 279 DLACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR 336
                SNE +  +  D  + +  D  P  V D++ +               C + +P  R
Sbjct: 231 QGL--SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---------------CWQFNPKMR 273
Query: 337 PSMVDVAKKLR 347
           P+ +++   L+
Sbjct: 274 PTFLEIVNLLK 284

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 74  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E +      G W 
Sbjct: 133 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E           + G +V+ +++    + CP+
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 243
Query: 285 N 285
Sbjct: 244 G 244

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 22/177 (12%)
Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMDIV 177
           SH +I++LIG C +     +V E VQ G      R  GA       L +K  L++  D  
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR------LRVKTLLQMVGDAA 223
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-WG 236
             + YL     +  + R+      L  E+NV K+ DF +S    +G    +  +      
Sbjct: 224 AGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACP 283
           + APE +  G ++ +SDV+SFG+ L+E           L+     + V+    L CP
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP 337

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 85/180 (47%), Gaps = 23/180 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 64  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E +      G W 
Sbjct: 123 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E  +          G +V+ +++    + CP+
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 233

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 153 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDX 205
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 266 KEGHRMDKPSN 276

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 62  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 120
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E +      G W 
Sbjct: 121 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 171
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E           + G +V+ +++    + CP+
Sbjct: 172 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 231
Query: 285 N 285
Sbjct: 232 G 232

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 84  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 142
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E +      G W 
Sbjct: 143 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E           + G +V+ +++    + CP+
Sbjct: 194 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 253
Query: 285 N 285
Sbjct: 254 G 254

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 84  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 142
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E +      G W 
Sbjct: 143 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E           + G +V+ +++    + CP+
Sbjct: 194 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 253
Query: 285 N 285
Sbjct: 254 G 254

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/250 (21%), Positives = 107/250 (42%), Gaps = 42/250 (16%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    ++V E + +G L       R      P   P 
Sbjct: 67  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 126
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L+  +++A +I   +AYL+    +  V R+      +   +   K+ DF ++  I E +
Sbjct: 127 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 183
Query: 225 THITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD 279
            +      G  G     + APE ++ GVF   SD++SFGV L      W+++ L +  + 
Sbjct: 184 YYRK----GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLAEQPYQ 233
Query: 280 LACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP 337
               SNE +  +  D  + +  D  P  V D++ +               C + +P  RP
Sbjct: 234 GL--SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---------------CWQFNPKMRP 276
Query: 338 SMVDVAKKLR 347
           + +++   L+
Sbjct: 277 TFLEIVNLLK 286

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 31  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 90
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 91  TVQ-LIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 142
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 143 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 201
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 202 DVWSYGVTVWELMT 215

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 107/251 (42%), Gaps = 44/251 (17%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    ++V E + +G L       R      P   P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L+  +++A +I   +AYL+    +  V R+      +   +   K+ DF ++  I E  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-- 182
Query: 225 THITDTVM-GTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH 278
              TD    G  G     + APE ++ GVF   SD++SFGV L      W+++ L +  +
Sbjct: 183 ---TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLAEQPY 233
Query: 279 DLACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR 336
                SNE +  +  D  + +  D  P  V D++ +               C + +P  R
Sbjct: 234 QGL--SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---------------CWQFNPKMR 276
Query: 337 PSMVDVAKKLR 347
           P+ +++   L+
Sbjct: 277 PTFLEIVNLLK 287

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 68  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 126
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E +      G W 
Sbjct: 127 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 177
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E           + G +V+ +++    + CP+
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 237
Query: 285 N 285
Sbjct: 238 G 238

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 82  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 140
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E +      G W 
Sbjct: 141 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 191
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E           + G +V+ +++    + CP+
Sbjct: 192 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 251
Query: 285 N 285
Sbjct: 252 G 252

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 18/160 (11%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLW--------DRILGAPQPHFEPLLLKHRL 170
           + H HI+K  G C+E    I+VFE +++G L         D +L A       L     L
Sbjct: 72  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 171 KIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH- 226
            IA  I   + YL   HF      V R+  T   L  E  + K+ DF +S  +   + + 
Sbjct: 132 HIAQQIAAGMVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 185
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           +    M    +  PE +    F  +SDV+S GV L+E+ T
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 37  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 96
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 97  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 148
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 149 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 207
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 208 DVWSYGVTVWELMT 221

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 107/251 (42%), Gaps = 44/251 (17%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    ++V E + +G L       R      P   P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L+  +++A +I   +AYL+    +  V R+      +   +   K+ DF ++  I E  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-- 182
Query: 225 THITDTVM-GTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH 278
              TD    G  G     + APE ++ GVF   SD++SFGV L      W+++ L +  +
Sbjct: 183 ---TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLAEQPY 233
Query: 279 DLACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR 336
                SNE +  +  D  + +  D  P  V D++ +               C + +P  R
Sbjct: 234 QGL--SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---------------CWQFNPNMR 276
Query: 337 PSMVDVAKKLR 347
           P+ +++   L+
Sbjct: 277 PTFLEIVNLLK 287

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ--PHFEPLLLKHRLKIAMD 175
           ++ + +I++LIG C    + +LV E    G L   ++G  +  P      L H++ + M 
Sbjct: 392 QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
            +    ++H         RN     +L    + AK+ DF LS ++   +++ T    G W
Sbjct: 451 YLEEKNFVH---------RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 236 --GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKDTHDLACP 283
              + APE +    F+ +SDV+S+GV ++E L+          G +V   ++    + CP
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 561

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 83  KGFWQERLISVLQFYGHECRPRAY-----------ESCINNVTYAARMSHNHILKLIGCC 131
           KG + E ++   +  G EC  +             ES +  V    ++ H +I+KL    
Sbjct: 36  KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95
Query: 132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 191
            +     LV E    G L+D I+   +  F  +      +I   ++  + Y+H      I
Sbjct: 96  EDKGYFYLVGEVYTGGELFDEII--SRKRFSEV---DAARIIRQVLSGITYMH---KNKI 147
Query: 192 VFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF 248
           V R+ K   +L    +++   ++ DF LS    E    + D + GT  Y APE +  G +
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-GTAYYIAPEVLH-GTY 204
Query: 249 NEKSDVFSFGVFLFELLTG 267
           +EK DV+S GV L+ LL+G
Sbjct: 205 DEKCDVWSTGVILYILLSG 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 33  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 92
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 93  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 144
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 145 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 203
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 204 DVWSYGVTVWELMT 217

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 30  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 90  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 141
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 200
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 201 DVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 32  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 91
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 92  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 143
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 144 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 202
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 203 DVWSYGVTVWELMT 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 34  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 93
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 94  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 145
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 146 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 204
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 205 DVWSYGVTVWELMT 218

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 31  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 90
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 91  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 142
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 143 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 201
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 202 DVWSYGVTVWELMT 215

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 87/194 (44%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W       ++   ++       P+A +  ++     A +   ++ +L+G CL +
Sbjct: 32  TVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTS 91
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  LV + + YG L D +    + +   L  +  L   M I   ++YL       +V R
Sbjct: 92  TVQ-LVTQLMPYGCLLDHV----RENRGRLGSQDLLNWCMQIAKGMSYLE---DVRLVHR 143
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L    N  K+ DF L+  + I E E H  D       + A E +    F  +S
Sbjct: 144 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVPIKWMALESILRRRFTHQS 202
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 203 DVWSYGVTVWELMT 216

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 205
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 266 KEGHRMDKPSN 276

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L +A+D +H+L          I++R+ K   IL +EE   KL DF LS    + E     
Sbjct: 135 LALALDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 184
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +  GT  Y APE +      + +D +SFGV +FE+LTG
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L +A+D +H+L          I++R+ K   IL +EE   KL DF LS    + E     
Sbjct: 136 LALALDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 185
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +  GT  Y APE +      + +D +SFGV +FE+LTG
Sbjct: 186 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L +A+D +H+L          I++R+ K   IL +EE   KL DF LS    + E     
Sbjct: 135 LALALDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 184
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +  GT  Y APE +      + +D +SFGV +FE+LTG
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 84/180 (46%), Gaps = 24/180 (13%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ--PHFEPLLLKHRLKIAMD 175
           ++ + +I++LIG C    + +LV E    G L   ++G  +  P      L H++ + M 
Sbjct: 66  QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
            +    ++H    R +  RN     +L    + AK+ DF LS ++   +++ T    G W
Sbjct: 125 YLEEKNFVH----RDLAARN-----VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 236 --GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKDTHDLACP 283
              + APE +    F+ +SDV+S+GV ++E L+          G +V   ++    + CP
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 235

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 83  KGFWQERLISVLQFYGHECRPRAY-----------ESCINNVTYAARMSHNHILKLIGCC 131
           KG + E ++   +  G EC  +             ES +  V    ++ H +I+KL    
Sbjct: 59  KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 118
Query: 132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 191
            +     LV E    G L+D I+   +  F  +      +I   ++  + Y+H      I
Sbjct: 119 EDKGYFYLVGEVYTGGELFDEII--SRKRFSEV---DAARIIRQVLSGITYMH---KNKI 170
Query: 192 VFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF 248
           V R+ K   +L    +++   ++ DF LS    E    + D + GT  Y APE +  G +
Sbjct: 171 VHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-GTAYYIAPEVLH-GTY 227
Query: 249 NEKSDVFSFGVFLFELLTG 267
           +EK DV+S GV L+ LL+G
Sbjct: 228 DEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 83  KGFWQERLISVLQFYGHECRPRAY-----------ESCINNVTYAARMSHNHILKLIGCC 131
           KG + E ++   +  G EC  +             ES +  V    ++ H +I+KL    
Sbjct: 60  KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 119
Query: 132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 191
            +     LV E    G L+D I+   +  F  +      +I   ++  + Y+H      I
Sbjct: 120 EDKGYFYLVGEVYTGGELFDEII--SRKRFSEV---DAARIIRQVLSGITYMH---KNKI 171
Query: 192 VFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF 248
           V R+ K   +L    +++   ++ DF LS    E    + D + GT  Y APE +  G +
Sbjct: 172 VHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-GTAYYIAPEVLH-GTY 228
Query: 249 NEKSDVFSFGVFLFELLTG 267
           +EK DV+S GV L+ LL+G
Sbjct: 229 DEKCDVWSTGVILYILLSG 247

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 17/189 (8%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           ES +       ++ H+ +++L     E PI I V E +  G+L D +          L L
Sbjct: 49  ESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKDG---EGRALKL 104
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
            + + +A  +   +AY+        + R+ +++ IL     + K+ DF L+  I + E  
Sbjct: 105 PNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXT 161
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                     + APE    G F  KSDV+SFG+ L EL+T            +V + V+ 
Sbjct: 162 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 221
Query: 277 THDLACPSN 285
            + + CP +
Sbjct: 222 GYRMPCPQD 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/250 (21%), Positives = 107/250 (42%), Gaps = 42/250 (16%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    ++V E + +G L       R      P   P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L+  +++A +I   +AYL+    +  V R+      +   +   K+ DF ++  I E +
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
Query: 225 THITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD 279
            +      G  G     + APE ++ GVF   SD++SFGV L      W+++ L +  + 
Sbjct: 185 YYRK----GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLAEQPYQ 234
Query: 280 LACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP 337
               SNE +  +  D  + +  D  P  V D++ +               C + +P  RP
Sbjct: 235 GL--SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---------------CWQFNPKMRP 277
Query: 338 SMVDVAKKLR 347
           + +++   L+
Sbjct: 278 TFLEIVNLLK 287

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 194
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 254
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 255 KEGHRMDKPSN 265

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 101 CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-- 158
            + +   + +  V    ++ H +I+KL     ++    +V E    G L+D I+   +  
Sbjct: 60  AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 159 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLFDFS 215
            H    ++K        +   + Y+H      IV R+ K   IL   +      K+ DF 
Sbjct: 120 EHDAARIIKQ-------VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           LS    +  T + D + GT  Y APE +R G ++EK DV+S GV L+ LL+G
Sbjct: 170 LSTCFQQN-TKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL------------GAPQPHFEPLLL 166
           + H HI+K  G C +    I+VFE +++G L ++ L            G P+     L L
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 167 KHRLKIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
              L IA  I   + YL   HF      V R+  T   L     + K+ DF +S  +   
Sbjct: 133 SQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 224 ETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + + +    M    +  PE +    F  +SDV+SFGV L+E+ T
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 24  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 84  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 135
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 194
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 195 DVWSYGVTVWELMT 208

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 198
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 258
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 259 KEGHRMDKPSN 269

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 205
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 266 KEGHRMDKPSN 276

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 197
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 257
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 258 KEGHRMDKPSN 268

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 27  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 86
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 87  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAEGMNYLE---DRRLVHR 138
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 139 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 197
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 198 DVWSYGVTVWELMT 211

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    +++ E +  G L       R   A  P   P 
Sbjct: 66  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E +
Sbjct: 126 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 182
Query: 225 THITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 183 YYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 30  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 90  TVQ-LITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 141
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 200
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 201 DVWSYGVTVWELMT 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 76/161 (47%), Gaps = 30/161 (18%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK------- 171
           + H +I+KL     +     LV E  + G L+D I+             HR+K       
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-------------HRMKFNEVDAA 139
Query: 172 -IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHI 227
            I   ++  + YLH      IV R+ K   +L     ++ + K+ DF LS ++ E +  +
Sbjct: 140 VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKM 195
Query: 228 TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            +  +GT  Y APE +R   ++EK DV+S GV LF LL G+
Sbjct: 196 KER-LGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGY 234

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 84/181 (46%), Gaps = 23/181 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 68  QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 126
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E        G W 
Sbjct: 127 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP 177
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E           + G +V+ +++    + CP+
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 237
Query: 285 N 285
Sbjct: 238 G 238

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 32  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 91
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 92  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 143
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 144 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 202
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 203 DVWSYGVTVWELMT 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 37  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 96
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 97  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 148
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 149 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 207
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 208 DVWSYGVTVWELMT 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 55  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 114
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 115 TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 166
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 167 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 225
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 226 DVWSYGVTVWELMT 239

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 36  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 95
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 96  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 147
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 148 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 206
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 207 DVWSYGVTVWELMT 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    +++ E +  G L       R   A  P   P 
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E +
Sbjct: 136 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 225 THITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 193 YYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 40  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 99
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 100 TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 151
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 152 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 210
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 211 DVWSYGVTVWELMT 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 37  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 96
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 97  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 148
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 149 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 207
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 208 DVWSYGVTVWELMT 221

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 190
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 251 KEGHRMDKPSN 261

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 30  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 90  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 141
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 200
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 201 DVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 33  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 92
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 93  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 144
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 145 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 203
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 204 DVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 33  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 92
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 93  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 144
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 145 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 203
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 204 DVWSYGVTVWELMT 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 15/153 (9%)
Query: 119 MSHNH-ILKLIGCCLETPIPIL-VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI-AMD 175
           ++ NH  L  + CC +TP  +  V E V  G L   I  + +        + R +  A +
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAE 132
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMGT 234
           I+ AL +LH    + I++R+ K   +L + E   KL DF +    I  G T  T T  GT
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGT 187
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             Y APE ++  ++    D ++ GV L+E+L G
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 205
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 266 KEGHRMDKPSN 276

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 95  QFYGHECRPR----AYESCINN-VTYAARMSHNHILKLIGCCLETPIPI-LVFESVQYGT 148
           + +  +C P+      ES I N +    ++ H +I+ L     E+P  + LV + V  G 
Sbjct: 48  KLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDI-YESPNHLYLVMQLVSGGE 106
Query: 149 LWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NE 205
           L+DRI+   +  F     K    +   ++ A+ YLH      IV R+ K   +L+   +E
Sbjct: 107 LFDRIV---EKGF--YTEKDASTLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDE 158
Query: 206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELL 265
           E+   + DF LS    EG+  +  T  GT GY APE +    +++  D +S GV  + LL
Sbjct: 159 ESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 216
Query: 266 TGW 268
            G+
Sbjct: 217 CGY 219

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 30  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 90  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 141
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 200
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 201 DVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 33  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 92
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 93  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 144
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 145 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 203
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 204 DVWSYGVTVWELMT 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 30  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 90  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 141
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 200
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 201 DVWSYGVTVWELMT 214

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 72/149 (48%), Gaps = 8/149 (5%)
Query: 119 MSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           + H+ +++L      E PI I+  E +  G+L D +          +LL   +  +  I 
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIIT-EYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQIA 120
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +AY+     +  + R+ + + +L +E  + K+ DF L+  I + E    +       +
Sbjct: 121 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 177
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KSDV+SFG+ L+E++T
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 6/123 (4%)
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGET 225
           +H    + +I  AL YLH    R I++R+ K   +L + E   KL D+ +    +  G+T
Sbjct: 153 EHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN 285
             T T  GT  Y APE +R   +    D ++ GV +FE++ G    D+V  + +    + 
Sbjct: 210 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 267
Query: 286 EYL 288
           +YL
Sbjct: 268 DYL 270

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 113/253 (44%), Gaps = 34/253 (13%)
Query: 55  QEIKLATNSYDQKNVIAKDT---SYNLYTMYKGFWQ------ERLISVLQFYGHECRPRA 105
           +EI+      D+K +  +D    S N  T+ KG++Q         + +L+   ++  P  
Sbjct: 356 EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PAL 413
Query: 106 YESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL 165
            +  +       ++ + +I+++IG C E    +LV E  + G L   +        + ++
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 472
Query: 166 -LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L H++ + M  +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E
Sbjct: 473 ELVHQVSMGMKYLEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADE 523
Query: 225 THITDTVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSD 272
            +      G W   + APE +    F+ KSDV+SFGV ++E  +          G +V+ 
Sbjct: 524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 583
Query: 273 LVKDTHDLACPSN 285
           +++    + CP+ 
Sbjct: 584 MLEKGERMGCPAG 596

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 23/181 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 176
           ++ + +I+++IG C E    +LV E  + G L   +        + ++ L H++ + M  
Sbjct: 427 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 485
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW- 235
           +    ++H    R +  RN     +L   ++ AK+ DF LS ++   E +      G W 
Sbjct: 486 LEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 536
Query: 236 -GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKDTHDLACPS 284
             + APE +    F+ KSDV+SFGV ++E  +          G +V+ +++    + CP+
Sbjct: 537 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 596
Query: 285 N 285
Sbjct: 597 G 597

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/250 (21%), Positives = 106/250 (42%), Gaps = 42/250 (16%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPL 164
           +N  +     + +H+++L+G   +    ++V E + +G L       R      P   P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 165 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
            L+  +++A +I   +AYL+    +  V R+      +   +   K+ DF ++  I E  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA 184
Query: 225 THITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD 279
            +      G  G     + APE ++ GVF   SD++SFGV L      W+++ L +  + 
Sbjct: 185 YYRK----GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL------WEITSLAEQPYQ 234
Query: 280 LACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP 337
               SNE +  +  D  + +  D  P  V D++ +               C + +P  RP
Sbjct: 235 GL--SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---------------CWQFNPKMRP 277
Query: 338 SMVDVAKKLR 347
           + +++   L+
Sbjct: 278 TFLEIVNLLK 287

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            L  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I     HI  
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 246
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   ++  +SDV+SFGV L+E+ T       G  V +   L+
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 275 KDTHDLACPSN 285
           K+ H +  PSN
Sbjct: 307 KEGHRMDKPSN 317

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 25/199 (12%)
Query: 83  KGFWQERLISVLQFYGHECRPRAY-----------ESCINNVTYAARMSHNHILKLIGCC 131
           KG + E ++   +  G EC  +             ES +  V    ++ H +I+KL    
Sbjct: 42  KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 101
Query: 132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 191
            +     LV E    G L+D I+   +  F  +      +I   ++  + Y+H      I
Sbjct: 102 EDKGYFYLVGEVYTGGELFDEII--SRKRFSEV---DAARIIRQVLSGITYMH---KNKI 153
Query: 192 VFRNFKTSCILFNEENV---AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF 248
           V R+ K   +L   ++     ++ DF LS    E    + D + GT  Y APE +  G +
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-GTAYYIAPEVLH-GTY 210
Query: 249 NEKSDVFSFGVFLFELLTG 267
           +EK DV+S GV L+ LL+G
Sbjct: 211 DEKCDVWSTGVILYILLSG 229

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 23/238 (9%)
Query: 119 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + H++I+K  G C         L+ E + YG+L + +    Q H E +     L+    I
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL----QKHKERIDHIKLLQYTSQI 126
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGT 234
              + YL  G  R  + R+  T  IL   EN  K+ DF L+  +P+ +    + +     
Sbjct: 127 CKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED 294
             + APE +    F+  SDV+SFGV L+EL T  + S           P  E+++    D
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS---------KSPPAEFMRMIGND 234
Query: 295 NRFTEIVDPII--VEDVLSIEKEQQLHASAQLSF-ECIKDSPADRPSMVDVAKKLRQI 349
            +   IV  +I  +++   + +         +   EC  ++   RPS  D+A ++ QI
Sbjct: 235 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLK 171
           +T  ++   +++ K  G  L+     ++ E +  G+  D +   P   F+   +LK  LK
Sbjct: 72  ITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK 131
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
             +D +H+   +H         R+ K + +L +E+   KL DF ++  + + +    +T 
Sbjct: 132 -GLDYLHSEKKIH---------RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTF 180
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 181 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 22/170 (12%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H +I++L     E     LVF+ V  G L++ I+   +  +      H ++    I+
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQ---QIL 138
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGT 234
            ++AY H      IV RN K   +L   +      KL DF L+I + + E        GT
Sbjct: 139 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGT 193
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSDLVKDTHDL 280
            GY +PE ++   +++  D+++ GV L+ LL G    WD     +D H L
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-----EDQHRL 238

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 114
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P       DT+ 
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DTLC 168
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDE---QRTATY 117
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P       DT+ 
Sbjct: 118 ITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR---DTLC 171
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 48/269 (17%)
Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLW-----DRILGAP 157
           P      ++      +++H H++KL G C +    +L+ E  +YG+L       R +G  
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 158 --------------QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF 203
                          P    L +   +  A  I   + YL       +V R+     IL 
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILV 183
Query: 204 NEENVAKLFDFSLSISIPEGETHITDT---VMGTWGYCAPEYMRTGVFNEKSDVFSFGVF 260
            E    K+ DF LS  + E ++++  +   +   W   A E +   ++  +SDV+SFGV 
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKW--MAIESLFDHIYTTQSDVWSFGVL 241
Query: 261 LFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHA 320
           L+E++T      L  + +    P  E L N  +     E  D    E             
Sbjct: 242 LWEIVT------LGGNPYPGIPP--ERLFNLLKTGHRMERPDNCSEE------------- 280
Query: 321 SAQLSFECIKDSPADRPSMVDVAKKLRQI 349
             +L  +C K  P  RP   D++K L ++
Sbjct: 281 MYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H +I++L     E     LVF+ V  G L++ I+   +  +      H ++    I+
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQ---QIL 114
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGT 234
            ++AY H      IV RN K   +L   +      KL DF L+I + + E        GT
Sbjct: 115 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGT 169
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WD 269
            GY +PE ++   +++  D+++ GV L+ LL G    WD
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 208

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H +I++L     E     LVF+ V  G L++ I+   +  +      H ++    I+
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQ---QIL 115
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGT 234
            ++AY H      IV RN K   +L   +      KL DF L+I + + E        GT
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGT 170
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WD 269
            GY +PE ++   +++  D+++ GV L+ LL G    WD
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE 162
            + +E   N ++    + H +I+KL     +     LV E  + G L           FE
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-----------FE 135
Query: 163 PLLLKHRL------KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLFD 213
            ++ +H+        I   I+  + YLH      IV R+ K   IL   +N     K+ D
Sbjct: 136 QIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           F LS S    +  + D  +GT  Y APE ++   +NEK DV+S GV ++ LL G+
Sbjct: 193 FGLS-SFFSKDYKLRDR-LGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGY 244

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 128
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE- 184
Query: 224 ETHITDTVM-GTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               TD    G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 185 ----TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 13/100 (13%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H++  +H         R+ K   +L ++    KL DF   + + E      DT 
Sbjct: 185 LALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA 235
Query: 232 MGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE +++    G +  + D +S GVFLFE+L G
Sbjct: 236 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 61  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 119
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 120 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE- 175
Query: 224 ETHITDTV-MGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               TD    G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 176 ----TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   +        P+A +  ++     A + + H+ +L+G CL +
Sbjct: 64  TVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 123
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 124 TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 175
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF L+  +   E E H     +    + A E +   ++  +S
Sbjct: 176 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 234
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 235 DVWSYGVTVWELMT 248

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H +I++L     E     LVF+ V  G L++ I+   +  +      H ++    I+
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQ---QIL 115
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGT 234
            ++AY H      IV RN K   +L   +      KL DF L+I + + E        GT
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGT 170
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WD 269
            GY +PE ++   +++  D+++ GV L+ LL G    WD
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP--------LLLKHRLK 171
           H +++ L+G C +   P++V  E  ++G L    L + +  F P        L L+H + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDT 230
            +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +   ++    
Sbjct: 149 YSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                 + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 131/292 (44%), Gaps = 32/292 (10%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP--- 137
           +++G W    ++V  F   + +    E+ I N      + H++IL  I   + +      
Sbjct: 24  VWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVL---LRHDNILGFIASDMTSRNSSTQ 80
Query: 138 -ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLH---FGFP-RP-I 191
             L+    ++G+L+D +    +   EP L    L++A+     LA+LH   FG   +P I
Sbjct: 81  LWLITHYHEHGSLYDFL---QRQTLEPHLA---LRLAVSAACGLAHLHVEIFGTQGKPAI 134
Query: 192 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI---TDTVMGTWGYCAPEYM----R 244
             R+FK+  +L        + D  L++   +G  ++    +  +GT  Y APE +    R
Sbjct: 135 AHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIR 194
Query: 245 TGVFN--EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN--YFEDNRFTEI 300
           T  F   + +D+++FG+ L+E+     V+ +V+D      P  + + N   FED +    
Sbjct: 195 TDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRP---PFYDVVPNDPSFEDMKKVVC 251
Query: 301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
           VD         +  +  L   AQ+  EC   +P+ R + + + K L++I  S
Sbjct: 252 VDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKISNS 303

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 168
           H +I+ L+G C       L  E   +G L D     R+L    P F         L  + 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL-ETDPAFAIANSTASTLSSQQ 140
Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            L  A D+   + YL     +  + RN     IL  E  VAK+ DF LS     G+    
Sbjct: 141 LLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLS----RGQEVYV 193
Query: 229 DTVMGTWG--YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              MG     + A E +   V+   SDV+S+GV L+E+++
Sbjct: 194 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 108 SCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
           + +  V    ++ H +I+KL     ++    +V E    G L+D I+   +  F      
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSE---H 121
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLFDFSLSISIPEGE 224
              +I   +   + Y+H      IV R+ K   IL   +      K+ DF LS    +  
Sbjct: 122 DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T + D + GT  Y APE +R G ++EK DV+S GV L+ LL+G
Sbjct: 178 TKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L + +D +H+L          I++R+ K   IL +EE   KL DF LS    + E     
Sbjct: 139 LALGLDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY- 188
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +  GT  Y APE +     +  +D +S+GV +FE+LTG
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 108 SCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
           + +  V    ++ H +I+KL     ++    +V E    G L+D I+   +  F      
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSE---H 121
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLFDFSLSISIPEGE 224
              +I   +   + Y+H      IV R+ K   IL   +      K+ DF LS    +  
Sbjct: 122 DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T + D + GT  Y APE +R G ++EK DV+S GV L+ LL+G
Sbjct: 178 TKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 127
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 224 ETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 185 DYYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 30/221 (13%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LV E +  G L D +    Q H   L     L  +  I   + YL     R  V R+   
Sbjct: 90  LVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 142
Query: 199 SCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFS 256
             IL   E   K+ DF L+  +P  + +  + +       + APE +   +F+ +SDV+S
Sbjct: 143 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 202
Query: 257 FGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQ 316
           FGV L+EL T  D S           PS E+L+    +        P +   +  +E+ Q
Sbjct: 203 FGVVLYELFTYCDKS---------CSPSAEFLRMMGSERDV-----PALSRLLELLEEGQ 248
Query: 317 QLHASAQLSFE-------CIKDSPADRPSMVDVAKKLRQIY 350
           +L A      E       C   SP DRPS   +  +L  ++
Sbjct: 249 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 289

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 34  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 93
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 94  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 145
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF  +  +   E E H     +    + A E +   ++  +S
Sbjct: 146 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 204
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 205 DVWSYGVTVWELMT 218

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 128
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 185
Query: 224 ETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 186 DYYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMG 233
           +I  AL +LH    + I++R+ K   I+ N +   KL DF L   SI +G   +T T  G
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCG 183
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y APE +     N   D +S G  ++++LTG
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 67  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 125
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 126 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 182
Query: 224 ETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 183 DYYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 32  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 91
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 92  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 143
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF  +  +   E E H     +    + A E +   ++  +S
Sbjct: 144 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 202
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 203 DVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 32  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 91
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 92  TVQ-LIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 143
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF  +  +   E E H     +    + A E +   ++  +S
Sbjct: 144 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 202
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 203 DVWSYGVTVWELMT 216

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I   L  LH      IV+R+ K   IL ++    ++ D  L++ +PEG+T      +
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 346
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++   +    D ++ G  L+E++ G
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 121
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 122 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 178
Query: 224 ETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 179 DYYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 127
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 224 ETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 185 DYYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 68/279 (24%)
Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLW-----DRILGAP 157
           P      ++      +++H H++KL G C +    +L+ E  +YG+L       R +G  
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 158 --------------QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF 203
                          P    L +   +  A  I   + YL       +V R+     IL 
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILV 183
Query: 204 NEENVAKLFDFSLSISIPEGETHITDT---VMGTWGYCAPEYMRTGVFNEKSDVFSFGVF 260
            E    K+ DF LS  + E ++ +  +   +   W   A E +   ++  +SDV+SFGV 
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKW--MAIESLFDHIYTTQSDVWSFGVL 241
Query: 261 LFELLT-GWD---------VSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVL 310
           L+E++T G +         + +L+K  H +  P N   + Y                   
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY------------------- 282
Query: 311 SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
                       +L  +C K  P  RP   D++K L ++
Sbjct: 283 ------------RLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I   L  LH      IV+R+ K   IL ++    ++ D  L++ +PEG+T      +
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 346
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT GY APE ++   +    D ++ G  L+E++ G
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L +LH    + IV+R+ K   IL +++   K+ DF +      G+   T+   
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFC 179
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +    +N   D +SFGV L+E+L G
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I+  L +LH    + IV+R+ K   IL +++   K+ DF +      G+   T+   
Sbjct: 125 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFC 180
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +    +N   D +SFGV L+E+L G
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 215

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 20/182 (10%)
Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----PLLLKHRLKIAM 174
            H +I+ L+G C      +++ E   YG L + +    +   +     PL L+  L  + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMG 233
            +   +A+L     +  + R+     +L    +VAK+ DF L+  I     +I       
Sbjct: 168 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFE-----------LLTGWDVSDLVKDTHDLAC 282
              + APE +   V+  +SDV+S+G+ L+E           +L       LVKD + +A 
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 284
Query: 283 PS 284
           P+
Sbjct: 285 PA 286

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 68/279 (24%)
Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLW-----DRILGAP 157
           P      ++      +++H H++KL G C +    +L+ E  +YG+L       R +G  
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 158 --------------QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF 203
                          P    L +   +  A  I   + YL       +V R+     IL 
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILV 183
Query: 204 NEENVAKLFDFSLSISIPEGETHITDT---VMGTWGYCAPEYMRTGVFNEKSDVFSFGVF 260
            E    K+ DF LS  + E ++ +  +   +   W   A E +   ++  +SDV+SFGV 
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKW--MAIESLFDHIYTTQSDVWSFGVL 241
Query: 261 LFELLT-GWD---------VSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVL 310
           L+E++T G +         + +L+K  H +  P N   + Y                   
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY------------------- 282
Query: 311 SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
                       +L  +C K  P  RP   D++K L ++
Sbjct: 283 ------------RLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 90/221 (40%), Gaps = 30/221 (13%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LV E +  G L D +    Q H   L     L  +  I   + YL     R  V R+   
Sbjct: 91  LVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 143
Query: 199 SCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFS 256
             IL   E   K+ DF L+  +P  + +  + +       + APE +   +F+ +SDV+S
Sbjct: 144 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 203
Query: 257 FGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQ 316
           FGV L+EL T  D S           PS E+L+         E   P +   +  +E+ Q
Sbjct: 204 FGVVLYELFTYCDKS---------CSPSAEFLRMM-----GCERDVPALCRLLELLEEGQ 249
Query: 317 QLHASAQLSFE-------CIKDSPADRPSMVDVAKKLRQIY 350
           +L A      E       C   SP DRPS   +  +L  ++
Sbjct: 250 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 290

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 134
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 224 ETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 192 DYYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 98  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 156
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+      +  E+   K+ DF ++  I E 
Sbjct: 157 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 213
Query: 224 ETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 214 DYYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 35/204 (17%)
Query: 115 YAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR--LKI 172
           YAA +   + +K +    +     +  E  + GTL+D I      H E L  +     ++
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI------HSENLNQQRDEYWRL 121
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL--------------SI 218
              I+ AL+Y+H    + I+ R+ K   I  +E    K+ DF L              S 
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 219 SIPEGETHITDTVMGTWGYCAPEYMR-TGVFNEKSDVFSFGVFLFELL----TGWDVSDL 273
           ++P    ++T + +GT  Y A E +  TG +NEK D++S G+  FE++    TG +  ++
Sbjct: 179 NLPGSSDNLT-SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 274 VKDTHDLACPSNEYLKNYFEDNRF 297
           +K    L   S E+  + F+DN+ 
Sbjct: 238 LK---KLRSVSIEFPPD-FDDNKM 257

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 18/174 (10%)
Query: 104 RAYESCINNVTYAARMSHNHILKLIGCCLET-----PIPILVFESVQYGTL-----WDRI 153
           R  E  ++        SH ++++L+G C+E      P P+++   ++YG L     + R+
Sbjct: 78  REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137
Query: 154 LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD 213
              P+ H     L+  LK  +DI   + YL     R  + R+      +  ++    + D
Sbjct: 138 ETGPK-HIP---LQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVAD 190
Query: 214 FSLSISIPEGETHITDTVMGT-WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           F LS  I  G+ +    +      + A E +   V+  KSDV++FGV ++E+ T
Sbjct: 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 6/117 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
           + +I  AL YLH    R I++R+ K   +L + E   KL D+ +    +  G+T  T   
Sbjct: 127 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXF 181
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL 288
            GT  Y APE +R   +    D ++ GV +FE++ G    D+V  + +    + +YL
Sbjct: 182 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 238

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 90/221 (40%), Gaps = 30/221 (13%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LV E +  G L D +    Q H   L     L  +  I   + YL     R  V R+   
Sbjct: 103 LVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 155
Query: 199 SCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFS 256
             IL   E   K+ DF L+  +P  + +  + +       + APE +   +F+ +SDV+S
Sbjct: 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 215
Query: 257 FGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQ 316
           FGV L+EL T  D S           PS E+L+         E   P +   +  +E+ Q
Sbjct: 216 FGVVLYELFTYCDKS---------CSPSAEFLRMM-----GCERDVPALSRLLELLEEGQ 261
Query: 317 QLHASAQLSFE-------CIKDSPADRPSMVDVAKKLRQIY 350
           +L A      E       C   SP DRPS   +  +L  ++
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 37  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 96
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 97  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 148
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF  +  +   E E H     +    + A E +   ++  +S
Sbjct: 149 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 207
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 208 DVWSYGVTVWELMT 221

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LV E +  G L D +    Q H   L     L  +  I   + YL     R  V R+   
Sbjct: 87  LVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 139
Query: 199 SCILFNEENVAKLFDFSLSISIP--EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFS 256
             IL   E   K+ DF L+  +P  +    + +       + APE +   +F+ +SDV+S
Sbjct: 140 RNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 199
Query: 257 FGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQ 316
           FGV L+EL T  D S           PS E+L+         E   P +   +  +E+ Q
Sbjct: 200 FGVVLYELFTYCDKS---------CSPSAEFLRMM-----GCERDVPALCRLLELLEEGQ 245
Query: 317 QLHASAQLSFE-------CIKDSPADRPSMVDVAKKLRQIY 350
           +L A      E       C   SP DRPS   +  +L  ++
Sbjct: 246 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 286

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 32  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 91
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 92  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 143
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF  +  +   E E H     +    + A E +   ++  +S
Sbjct: 144 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 202
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 203 DVWSYGVTVWELMT 216

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 46/188 (24%)
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT- 228
           L I + I  A+ +LH    + ++ R+ K S I F  ++V K+ DF L  ++ + E   T 
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 229 ----------DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELL----TGWDVSDLV 274
                        +GT  Y +PE +    ++ K D+FS G+ LFELL    T  +   ++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII 283
Query: 275 KDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPA 334
            D  +L  P                         +L  +K  Q H   Q   + +  SP 
Sbjct: 284 TDVRNLKFP-------------------------LLFTQKYPQEHMMVQ---DMLSPSPT 315
Query: 335 DRPSMVDV 342
           +RP   D+
Sbjct: 316 ERPEATDI 323

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 20/181 (11%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----PLLLKHRLKIAMD 175
           H +I+ L+G C      +++ E   YG L + +    +   +     PL L+  L  +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGT 234
           +   +A+L     +  + R+     +L    +VAK+ DF L+  I     +I        
Sbjct: 161 VAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFE-----------LLTGWDVSDLVKDTHDLACP 283
             + APE +   V+  +SDV+S+G+ L+E           +L       LVKD + +A P
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 277
Query: 284 S 284
           +
Sbjct: 278 A 278

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP--------LLLKHRLK 171
           H +++ L+G C +   P++V  E  ++G L    L + +  F P        L L+H + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDT 230
            +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +   ++    
Sbjct: 149 YSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 205
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                 + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 80  TMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T+YKG W     + ++   ++       P+A +  ++     A + + H+ +L+G CL +
Sbjct: 30  TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  L+ + + +G L D +    + H + +  ++ L   + I   + YL     R +V R
Sbjct: 90  TVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 141
Query: 195 NFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           +     +L       K+ DF  +  +   E E H     +    + A E +   ++  +S
Sbjct: 142 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMALESILHRIYTHQS 200
Query: 253 DVFSFGVFLFELLT 266
           DV+S+GV ++EL+T
Sbjct: 201 DVWSYGVTVWELMT 214

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 6/117 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
           + +I  AL YLH    R I++R+ K   +L + E   KL D+ +    +  G+T  T   
Sbjct: 112 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXF 166
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL 288
            GT  Y APE +R   +    D ++ GV +FE++ G    D+V  + +    + +YL
Sbjct: 167 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 223

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 94/242 (38%), Gaps = 35/242 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E     V   A M H +I++      E     +V +  + G L+ RI       F+    
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE--- 124
Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              L   + I  AL ++H    R I+ R+ K+  I   ++   +L DF ++  +      
Sbjct: 125 DQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIA-RVLNSTVE 180
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
           +    +GT  Y +PE      +N KSD+++ G  L+EL T                    
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT-------------------- 220
Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHAS---AQLSFECIKDSPADRPSMVDVA 343
            LK+ FE      +V  II      +     LH S     L  +  K +P DRPS+  + 
Sbjct: 221 -LKHAFEAGSMKNLVLKIISGSFPPVS----LHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 344 KK 345
           +K
Sbjct: 276 EK 277

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 16/158 (10%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP----------LLLKHR 169
           H +++ L+G C +   P++V  E  ++G L    L + +  F P          L L+H 
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKPEDLYKDFLTLEHL 150
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-T 228
           +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +    +  
Sbjct: 151 IXYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                   + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
           + +I  AL YLH    R I++R+ K   +L + E   KL D+ +    +  G+T  T   
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXF 170
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY---- 287
            GT  Y APE +R   +    D ++ GV +FE++ G    D+V  + +    + +Y    
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230
Query: 288 -LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSP 333
            L+      R   +    +++  L+ + +++L    Q  F  I+  P
Sbjct: 231 ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 72/149 (48%), Gaps = 8/149 (5%)
Query: 119 MSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           + H+ +++L      E PI I+  E +  G+L D +          +LL   +  +  I 
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIIT-EFMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQIA 119
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
             +AY+     +  + R+ + + +L +E  + K+ DF L+  I + E    +       +
Sbjct: 120 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 176
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            APE +  G F  KS+V+SFG+ L+E++T
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 21/191 (10%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H ++LK IG   +      + E ++ GTL   I+ +    +       R+  A DI  
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYP---WSQRVSFAKDIAS 119
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS------ISIPEGETHITD--- 229
            +AYLH      I+ R+  +   L  E     + DF L+       + PEG   +     
Sbjct: 120 GMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 230 ----TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVS-DLVKDTHDLACPS 284
               TV+G   + APE +    ++EK DVFSFG+ L E++   +   D +  T D     
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236
Query: 285 NEYLKNYFEDN 295
             +L  Y   N
Sbjct: 237 RGFLDRYCPPN 247

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 24/167 (14%)
Query: 120 SHNHILKLIGCC-LETPIPILVFESVQYGTLW------------DRILGAPQPHFEP--- 163
           SH +I+ L+G C L  PI  L+FE   YG L             D I    Q   E    
Sbjct: 107 SHENIVNLLGACTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 164 ---LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
              L  +  L  A  +   + +L F   +  V R+     +L     V K+ DF L+  I
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 221 PEGETHIT-DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                ++          + APE +  G++  KSDV+S+G+ L+E+ +
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 14/107 (13%)
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT- 228
           L I + I  A+ +LH    + ++ R+ K S I F  ++V K+ DF L  ++ + E   T 
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 229 ----------DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELL 265
                        +GT  Y +PE +    ++ K D+FS G+ LFELL
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 25/201 (12%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAY-----------ESCINNVTYAARMSHNHILKLIG 129
           + KG + E ++   +  G EC  +             ES +  V    ++ H +I KL  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR 189
              +     LV E    G L+D I+   +  F  +      +I   ++  + Y H     
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEII--SRKRFSEV---DAARIIRQVLSGITYXH---KN 145
Query: 190 PIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG 246
            IV R+ K   +L    +++   ++ DF LS    E      D + GT  Y APE +  G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKXKDKI-GTAYYIAPEVLH-G 202
Query: 247 VFNEKSDVFSFGVFLFELLTG 267
            ++EK DV+S GV L+ LL+G
Sbjct: 203 TYDEKCDVWSTGVILYILLSG 223

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H++ ++H         R+ K   +L ++    KL DF   + + +      DT 
Sbjct: 179 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 232 MGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE +++    G +  + D +S GVFL+E+L G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE------P 163
           +N  +     + +H+++L+G   +    +++ E +  G L    L + +P  E      P
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPEMENNPVLAP 121
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +++A +I   +AYL+       V R+         E+   K+ DF ++  I E 
Sbjct: 122 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYET 178
Query: 224 ETHITDTVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           + +      G  G     + +PE ++ GVF   SDV+SFGV L+E+ T
Sbjct: 179 DYYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +             +     
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATY 139
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P       D + 
Sbjct: 140 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLC 193
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 168
           H +I+ L+G C       L  E   +G L D     R+L    P F         L  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL-ETDPAFAIANSTASTLSSQQ 143
Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            L  A D+   + YL     +  + R+     IL  E  VAK+ DF LS     G+    
Sbjct: 144 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYV 196
Query: 229 DTVMGTWG--YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              MG     + A E +   V+   SDV+S+GV L+E+++
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H++ ++H         R+ K   +L ++    KL DF   + + +      DT 
Sbjct: 184 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 234
Query: 232 MGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE +++    G +  + D +S GVFL+E+L G
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H++ ++H         R+ K   +L ++    KL DF   + + +      DT 
Sbjct: 184 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 234
Query: 232 MGTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE +++    G +  + D +S GVFL+E+L G
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 18/163 (11%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL--GAPQPHFEPLLLKH 168
           N +    ++ H +I+ L      T    LV + V  G L+DRIL  G        L+++ 
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ 114
Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLF-DFSLSISIPEGET 225
                  ++ A+ YLH      IV R+ K   +L+   EEN   +  DF LS     G  
Sbjct: 115 -------VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            I  T  GT GY APE +    +++  D +S GV  + LL G+
Sbjct: 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY 204

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H++I++L     E     LVF+ V  G L++ I+   + ++      H ++    I+ 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA--REYYSEADASHCIQ---QILE 114
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFDFSLSISIPEGETHITDTVMGTW 235
           A+ + H      +V R+ K   +L   +      KL DF L+I + +G+        GT 
Sbjct: 115 AVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGDQQAWFGFAGTP 170
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSDLVKDTHDL 280
           GY +PE +R   + +  D+++ GV L+ LL G    WD     +D H L
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWD-----EDQHKL 214

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 168
           H +I+ L+G C       L  E   +G L D     R+L    P F         L  + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL-ETDPAFAIANSTASTLSSQQ 133
Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            L  A D+   + YL     +  + R+     IL  E  VAK+ DF LS     G+    
Sbjct: 134 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYV 186
Query: 229 DTVMGTWG--YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              MG     + A E +   V+   SDV+S+GV L+E+++
Sbjct: 187 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV  L +LH    R I++R+ K   +L +++   ++ D  L++ +  G+T  T    GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           G+ APE +    ++   D F+ GV L+E++ 
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV  L +LH    R I++R+ K   +L +++   ++ D  L++ +  G+T  T    GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           G+ APE +    ++   D F+ GV L+E++ 
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV  L +LH    R I++R+ K   +L +++   ++ D  L++ +  G+T  T    GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           G+ APE +    ++   D F+ GV L+E++ 
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 130
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T+ 
Sbjct: 131 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 184
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 219

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV  L +LH    R I++R+ K   +L +++   ++ D  L++ +  G+T  T    GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           G+ APE +    ++   D F+ GV L+E++ 
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 112 NVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 171
            V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +    
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTAT 115
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
              ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P       D +
Sbjct: 116 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDL 169
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 116
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T+ 
Sbjct: 117 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 170
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 144
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 145 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 143
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 144 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 80  TMYKGFWQERLISV-----LQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T++KG W     S+     ++    +   +++++  +++     + H HI++L+G C  +
Sbjct: 46  TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS 105
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  LV + +  G+L D +    + H   L  +  L   + I   + YL       +V R
Sbjct: 106 SLQ-LVTQYLPLGSLLDHV----RQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHR 157
Query: 195 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-WGYCAPEYMRTGVFNEKSD 253
           N     +L    +  ++ DF ++  +P  +  +  +   T   + A E +  G +  +SD
Sbjct: 158 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSD 217
Query: 254 VFSFGVFLFELLT 266
           V+S+GV ++EL+T
Sbjct: 218 VWSYGVTVWELMT 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 144
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 145 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 81  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 136
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 137 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H +I++L     E     LVF+ V  G L++ I+   + ++      H +     I+ 
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA--REYYSEADASHCIH---QILE 141
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++ ++H      IV R+ K   +L   +      KL DF L+I + +GE        GT 
Sbjct: 142 SVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGEQQAWFGFAGTP 197
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSDLVKDTHDL 280
           GY +PE +R   + +  D+++ GV L+ LL G    WD     +D H L
Sbjct: 198 GYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWD-----EDQHKL 241

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 102/253 (40%), Gaps = 60/253 (23%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            + SH++I++L G   +    +++ E ++ G L D+ L      F  L L   L+     
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-- 234
           +  LA +++      V R+     IL N   V K+ DF LS  + E +   T T  G   
Sbjct: 160 MKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLS-RVLEDDPEATYTTSGGKI 212
Query: 235 -WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-----GWDVS--DLVKDTHD------- 279
              + APE +    F   SDV+SFG+ ++E++T      W++S  +++K  +D       
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272
Query: 280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM 339
           + CPS  Y                                   QL  +C +   A RP  
Sbjct: 273 MDCPSAIY-----------------------------------QLMMQCWQQERARRPKF 297
Query: 340 VDVAKKLRQIYRS 352
            D+   L ++ R+
Sbjct: 298 ADIVSILDKLIRA 310

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 118
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T+ 
Sbjct: 119 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 172
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 142
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 143 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 107 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 162
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 163 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 220 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 139
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 140 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +   ++
Sbjct: 140 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 228 -TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                     + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 141
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 142 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMG 233
           +I  AL +LH    + I++R+ K   I+ N +   KL DF L   SI +G   +T    G
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCG 183
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y APE +     N   D +S G  ++++LTG
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDE---QRTATY 117
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T+ 
Sbjct: 118 ITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR---TTLC 171
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H +I++L     E     L+F+ V  G L++ I+   + ++      H ++    I+ 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQ---QILE 121
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFDFSLSISIPEGETHITDTVMGTW 235
           A+ + H      +V RN K   +L   +      KL DF L+I + EGE        GT 
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTP 177
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSDLVKDTHDL 280
           GY +PE +R   + +  D+++ GV L+ LL G    WD     +D H L
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-----EDQHRL 221

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +             +     
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATY 139
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T+ 
Sbjct: 140 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 193
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +   ++
Sbjct: 140 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 228 -TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                     + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 80  TMYKGFWQERLISV-----LQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           T++KG W     S+     ++    +   +++++  +++     + H HI++L+G C  +
Sbjct: 28  TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS 87
Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
            +  LV + +  G+L D +    + H   L  +  L   + I   + YL       +V R
Sbjct: 88  SLQ-LVTQYLPLGSLLDHV----RQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHR 139
Query: 195 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-WGYCAPEYMRTGVFNEKSD 253
           N     +L    +  ++ DF ++  +P  +  +  +   T   + A E +  G +  +SD
Sbjct: 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSD 199
Query: 254 VFSFGVFLFELLT 266
           V+S+GV ++EL+T
Sbjct: 200 VWSYGVTVWELMT 212

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +  +
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKN 215
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 276 HRMDKPAN 283

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 11/157 (7%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +   
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTA 114
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
               ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 168
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 108 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 163
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E +      G     
Sbjct: 164 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 221 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM------DIVHALAYLHFGFPRPIV 192
           +V E ++ G L+D+++G             RLK A        ++ A+ YLH      I+
Sbjct: 90  IVLELMEGGELFDKVVG-----------NKRLKEATCKLYFYQMLLAVQYLH---ENGII 135
Query: 193 FRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM---RTG 246
            R+ K   +L +   E+ + K+ DF  S  +  GET +  T+ GT  Y APE +    T 
Sbjct: 136 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTA 193
Query: 247 VFNEKSDVFSFGVFLFELLTGW 268
            +N   D +S GV LF  L+G+
Sbjct: 194 GYNRAVDCWSLGVILFICLSGY 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM------DIVHALAYLHFGFPRPIV 192
           +V E ++ G L+D+++G             RLK A        ++ A+ YLH      I+
Sbjct: 91  IVLELMEGGELFDKVVG-----------NKRLKEATCKLYFYQMLLAVQYLH---ENGII 136
Query: 193 FRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM---RTG 246
            R+ K   +L +   E+ + K+ DF  S  +  GET +  T+ GT  Y APE +    T 
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 247 VFNEKSDVFSFGVFLFELLTGW 268
            +N   D +S GV LF  L+G+
Sbjct: 195 GYNRAVDCWSLGVILFICLSGY 216

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 113
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T+ 
Sbjct: 114 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 167
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM------DIVHALAYLHFGFPRPIV 192
           +V E ++ G L+D+++G             RLK A        ++ A+ YLH      I+
Sbjct: 91  IVLELMEGGELFDKVVG-----------NKRLKEATCKLYFYQMLLAVQYLH---ENGII 136
Query: 193 FRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM---RTG 246
            R+ K   +L +   E+ + K+ DF  S  +  GET +  T+ GT  Y APE +    T 
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 247 VFNEKSDVFSFGVFLFELLTGW 268
            +N   D +S GV LF  L+G+
Sbjct: 195 GYNRAVDCWSLGVILFICLSGY 216

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKEAPEDLYKDFLTLE 150
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +   ++
Sbjct: 151 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
Query: 228 -TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                     + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 208 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM------DIVHALAYLHFGFPRPIV 192
           +V E ++ G L+D+++G             RLK A        ++ A+ YLH      I+
Sbjct: 91  IVLELMEGGELFDKVVG-----------NKRLKEATCKLYFYQMLLAVQYLH---ENGII 136
Query: 193 FRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM---RTG 246
            R+ K   +L +   E+ + K+ DF  S  +  GET +  T+ GT  Y APE +    T 
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 247 VFNEKSDVFSFGVFLFELLTGW 268
            +N   D +S GV LF  L+G+
Sbjct: 195 GYNRAVDCWSLGVILFICLSGY 216

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 11/157 (7%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +   
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTA 110
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
               ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T
Sbjct: 111 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 164
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 201

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 11/151 (7%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 143
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT---W 235
            + YL     +  V R+      + +E+   K+ DF L+  + + E        G     
Sbjct: 144 GMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +    +
Sbjct: 140 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 228 -TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                     + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 11/157 (7%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +   
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTA 115
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
               ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T
Sbjct: 116 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 169
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 40/248 (16%)
Query: 104 RAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP 163
           R     ++  +   +  H +I++L G      + ++V E ++ G+L D  L      F  
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTI 150
Query: 164 LLLKHRLK---IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
           + L   L+     M  +  L Y+H         R+     +L +   V K+ DF LS  +
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVH---------RDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 221 PEGETHITDTVMGTWG--YCAPEYMRTGVFNEKSDVFSFGVFLFELL----------TGW 268
            +       T  G     + APE +    F+  SDV+SFGV ++E+L          T  
Sbjct: 202 EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261
Query: 269 DVSDLVKDTHDL----ACPS-------NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQ 317
           DV   V++ + L     CP        + + K+  +  RF++IV    V D L I   + 
Sbjct: 262 DVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS---VLDAL-IRSPES 317
Query: 318 LHASAQLS 325
           L A+A +S
Sbjct: 318 LRATATVS 325

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 11/157 (7%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +   
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTA 108
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
               ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T
Sbjct: 109 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 162
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 199

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  LAYL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 118 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 172
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y APE ++   ++ +SD++S G+ L EL  G
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP-----------LLLKH 168
           H +++ L+G C +   P++V  E  ++G L    L + +  F P           L L+H
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI- 227
            +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +    + 
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 228 TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                    + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM------DIVHALAYLHFGFPRPIV 192
           +V E ++ G L+D+++G             RLK A        ++ A+ YLH      I+
Sbjct: 97  IVLELMEGGELFDKVVG-----------NKRLKEATCKLYFYQMLLAVQYLH---ENGII 142
Query: 193 FRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM---RTG 246
            R+ K   +L +   E+ + K+ DF  S  +  GET +  T+ GT  Y APE +    T 
Sbjct: 143 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTA 200
Query: 247 VFNEKSDVFSFGVFLFELLTGW 268
            +N   D +S GV LF  L+G+
Sbjct: 201 GYNRAVDCWSLGVILFICLSGY 222

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +   ++
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 228 -TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                     + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 78/191 (40%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +I  
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI----NNIDX 212
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 275 KDTHDLACPSN 285
           K+ H +  P+N
Sbjct: 273 KEGHRMDKPAN 283

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +    +
Sbjct: 140 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 228 -TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                     + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 118
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T+ 
Sbjct: 119 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 172
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +     +EK D++S GV  +E L G
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVG 207

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLE 185
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +   ++
Sbjct: 186 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 242
Query: 228 -TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                     + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 243 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H +I++L     E     LVF+ V  G L++ I+   + ++      H ++    I+ 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA--REYYSEADASHCIQ---QILE 114
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++ + H      IV R+ K   +L   ++     KL DF L+I + +G+        GT 
Sbjct: 115 SVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV-QGDQQAWFGFAGTP 170
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSDLVKDTHDL 280
           GY +PE +R   + +  D+++ GV L+ LL G    WD     +D H L
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD-----EDQHRL 214

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 78/191 (40%), Gaps = 33/191 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +I  
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI----NNIDX 212
Query: 230 TVMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LV 274
               T G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 275 KDTHDLACPSN 285
           K+ H +  P+N
Sbjct: 273 KEGHRMDKPAN 283

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    ++ +G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +     ++ SD+++ G  +++L+ G
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I +    +
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 228 -TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                     + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 167 KHRLKIAM-DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
           +H ++I + +IV AL +LH      I++R+ K   IL +      L DF LS      ET
Sbjct: 158 EHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 226 HITDTVMGTWGYCAPEYMRTG--VFNEKSDVFSFGVFLFELLTG 267
                  GT  Y AP+ +R G    ++  D +S GV ++ELLTG
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H +I++L     E     LVF+ V  G L++ I+   + ++      H ++    I+ 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA--REYYSEADASHCIQ---QILE 114
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++ + H      IV R+ K   +L   ++     KL DF L+I + +G+        GT 
Sbjct: 115 SVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV-QGDQQAWFGFAGTP 170
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSDLVKDTHDL 280
           GY +PE +R   + +  D+++ GV L+ LL G    WD     +D H L
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD-----EDQHRL 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 215
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 276 HRMDKPAN 283

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I        +SH  +++L G C +     ++ E +  G L +  L   +  F+   L   
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQL--- 107
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L++  D+  A+ YL     +  + R+      L N++ V K+ DF LS  + + E   + 
Sbjct: 108 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR 164
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                  +  PE +    F+ KSD+++FGV ++E+ +
Sbjct: 165 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 40/248 (16%)
Query: 104 RAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP 163
           R     ++  +   +  H +I++L G      + ++V E ++ G+L D  L      F  
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTI 150
Query: 164 LLLKHRLK---IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
           + L   L+     M  +  L Y+H         R+     +L +   V K+ DF LS  +
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVH---------RDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 221 PEGETHITDTVMGTWG--YCAPEYMRTGVFNEKSDVFSFGVFLFELL----------TGW 268
            +       T  G     + APE +    F+  SDV+SFGV ++E+L          T  
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261
Query: 269 DVSDLVKDTHDL----ACPS-------NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQ 317
           DV   V++ + L     CP        + + K+  +  RF++IV    V D L I   + 
Sbjct: 262 DVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS---VLDAL-IRSPES 317
Query: 318 LHASAQLS 325
           L A+A +S
Sbjct: 318 LRATATVS 325

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 149 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 204
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 264
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 265 HRMDKPAN 272

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 118
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P      TD + 
Sbjct: 119 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TD-LC 172
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 152 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 207
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 267
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 268 HRMDKPAN 275

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 1/74 (1%)
Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNE 250
           ++ R+ K + +  + +   KL DF L+  I   +T    T +GT  Y +PE M    +NE
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE 195
Query: 251 KSDVFSFGVFLFEL 264
           KSD++S G  L+EL
Sbjct: 196 KSDIWSLGCLLYEL 209

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
           ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P        T+ GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGT 174
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             Y  PE +   + +EK D++S GV  +E L G
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   ++    L+ E    GT++  +    +  F+    +     
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 113
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         + 
Sbjct: 114 ITELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALC 167
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 147 VSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDI-NNIDYYKK 202
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 262
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 263 HRMDKPAN 270

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 261
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 322 HRMDKPAN 329

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 22/162 (13%)
Query: 121 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEP------------LLLK 167
           H +++ L+G C +   P++V  E  ++G L    L + +  F P            L L+
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI---PEGE 224
           H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I   P+  
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXV 205
Query: 225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                 +   W   APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 206 RKGDARLPLKW--MAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 215
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 276 HRMDKPAN 283

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 114
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P   +  TD + 
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTD-LC 168
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 113
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P      TD + 
Sbjct: 114 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TD-LC 167
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 113
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P   +  TD + 
Sbjct: 114 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTD-LC 167
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 114
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S   P        T+ 
Sbjct: 115 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR---TTLS 168
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           + H +I++L     E     L+F+ V  G L++ I+   + ++      H ++    I+ 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQ---QILE 132
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFDFSLSISIPEGETHITDTVMGTW 235
           A+ + H      +V R+ K   +L   +      KL DF L+I + EGE        GT 
Sbjct: 133 AVLHCH---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTP 188
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSDLVKDTHDL 280
           GY +PE +R   + +  D+++ GV L+ LL G    WD     +D H L
Sbjct: 189 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-----EDQHRL 232

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  +I+  L YLH       + R+ K + +L +E    KL DF ++  + + +    +T 
Sbjct: 109 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTF 164
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 215
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 276 HRMDKPAN 283

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM------DIVHALAYLHFGFPRPIV 192
           +V E ++ G L+D+++G             RLK A        ++ A+ YLH      I+
Sbjct: 230 IVLELMEGGELFDKVVG-----------NKRLKEATCKLYFYQMLLAVQYLH---ENGII 275
Query: 193 FRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM---RTG 246
            R+ K   +L +   E+ + K+ DF  S  +  GET +  T+ GT  Y APE +    T 
Sbjct: 276 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTA 333
Query: 247 VFNEKSDVFSFGVFLFELLTGW 268
            +N   D +S GV LF  L+G+
Sbjct: 334 GYNRAVDCWSLGVILFICLSGY 355

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I        +SH  +++L G C +     ++ E +  G L +  L   +  F+   L   
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQL--- 102
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L++  D+  A+ YL     +  + R+      L N++ V K+ DF LS  + + E   + 
Sbjct: 103 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                  +  PE +    F+ KSD+++FGV ++E+ +
Sbjct: 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 58/119 (48%), Gaps = 23/119 (19%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL--------------SISIP 221
           I+ AL+Y+H    + I+ RN K   I  +E    K+ DF L              S ++P
Sbjct: 125 ILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 222 EGETHITDTVMGTWGYCAPEYMR-TGVFNEKSDVFSFGVFLFELL----TGWDVSDLVK 275
               ++T + +GT  Y A E +  TG +NEK D +S G+  FE +    TG +  +++K
Sbjct: 182 GSSDNLT-SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILK 239

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 115
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ +F  S+  P        T+ 
Sbjct: 116 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLC 169
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
           H HI+KL    + TP  I +V E V  G L+D I    +     L  K   ++   I+  
Sbjct: 75  HPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGR-----LDEKESRRLFQQILSG 128
Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCA 239
           + Y H      +V R+ K   +L +    AK+ DF LS  + +GE        G+  Y A
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSCGSPNYAA 183
Query: 240 PEYMRTGVF-NEKSDVFSFGVFLFELLTG 267
           PE +   ++   + D++S GV L+ LL G
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I        +SH  +++L G C +     ++ E +  G L +  L   +  F+   L   
Sbjct: 51  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQL--- 106
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L++  D+  A+ YL     +  + R+      L N++ V K+ DF LS  + + E   + 
Sbjct: 107 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 163
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                  +  PE +    F+ KSD+++FGV ++E+ +
Sbjct: 164 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM------DIVHALAYLHFGFPRPIV 192
           +V E ++ G L+D+++G             RLK A        ++ A+ YLH      I+
Sbjct: 216 IVLELMEGGELFDKVVG-----------NKRLKEATCKLYFYQMLLAVQYLH---ENGII 261
Query: 193 FRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM---RTG 246
            R+ K   +L +   E+ + K+ DF  S  +  GET +  T+ GT  Y APE +    T 
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTA 319
Query: 247 VFNEKSDVFSFGVFLFELLTGW 268
            +N   D +S GV LF  L+G+
Sbjct: 320 GYNRAVDCWSLGVILFICLSGY 341

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 145
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG-- 236
            + +L     +  V R+      + +E+   K+ DF L+  + + E    D+V    G  
Sbjct: 146 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF---DSVHNKTGAK 199
Query: 237 ----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 115
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         + 
Sbjct: 116 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLC 169
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 144
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG-- 236
            + +L     +  V R+      + +E+   K+ DF L+  + + E    D+V    G  
Sbjct: 145 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 198
Query: 237 ----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 142
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG-- 236
            + +L     +  V R+      + +E+   K+ DF L+  + + E    D+V    G  
Sbjct: 143 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 196
Query: 237 ----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 23/163 (14%)
Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL---GAPQPHFEP 163
           E+ +        + H+ ++KL     + PI I+  E +  G+L D +    G+ QP    
Sbjct: 222 EAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQP---- 276
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
             L   +  +  I   +A++     R  + R+ + + IL +   V K+ DF L+      
Sbjct: 277 --LPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA------ 325
Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
              +       W   APE +  G F  KSDV+SFG+ L E++T
Sbjct: 326 --RVGAKFPIKW--TAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I        +SH  +++L G C +     ++ E +  G L +  L   +  F+   L   
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQL--- 122
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L++  D+  A+ YL     +  + R+      L N++ V K+ DF LS  + + E   + 
Sbjct: 123 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV 179
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                  +  PE +    F+ KSD+++FGV ++E+ +
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I        +SH  +++L G C +     ++ E +  G L +  L   +  F+   L   
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQL--- 107
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L++  D+  A+ YL     +  + R+      L N++ V K+ DF LS  + + E   + 
Sbjct: 108 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 164
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                  +  PE +    F+ KSD+++FGV ++E+ +
Sbjct: 165 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 145
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG-- 236
            + +L     +  V R+      + +E+   K+ DF L+  + + E    D+V    G  
Sbjct: 146 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 199
Query: 237 ----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           EP+ ++  +  +  +   + +L     R  + R+     IL +E NV K+ DF L+  I 
Sbjct: 194 EPITMEDLISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 250
Query: 222 EGETHI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           +   ++   DT +    + APE +   +++ KSDV+S+GV L+E+ +
Sbjct: 251 KNPDYVRKGDTRL-PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 116
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ +F  S+  P        T+ 
Sbjct: 117 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLC 170
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 13/165 (7%)
Query: 104 RAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF-- 161
           +A   CI  +    +++H +++K     +E     +V E    G L   I      HF  
Sbjct: 74  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKK 128
Query: 162 EPLLLKHRL--KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
           +  L+  R   K  + +  AL ++H    R ++ R+ K + +      V KL D  L   
Sbjct: 129 QKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
               +T    +++GT  Y +PE +    +N KSD++S G  L+E+
Sbjct: 186 F-SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++ E    G L + +     P  E            +  K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV ++ DF L+  I     +   
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDI-NNIDYYKK 215
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 276 HRMDKPAN 283

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 35/204 (17%)
Query: 115 YAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR--LKI 172
           YAA +   + +K +    +     +  E  +  TL+D I      H E L  +     ++
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI------HSENLNQQRDEYWRL 121
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL--------------SI 218
              I+ AL+Y+H    + I+ R+ K   I  +E    K+ DF L              S 
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 219 SIPEGETHITDTVMGTWGYCAPEYMR-TGVFNEKSDVFSFGVFLFELL----TGWDVSDL 273
           ++P    ++T + +GT  Y A E +  TG +NEK D++S G+  FE++    TG +  ++
Sbjct: 179 NLPGSSDNLT-SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 274 VKDTHDLACPSNEYLKNYFEDNRF 297
           +K    L   S E+  + F+DN+ 
Sbjct: 238 LK---KLRSVSIEFPPD-FDDNKM 257

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T    T 
Sbjct: 114 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTF 168
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 204

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I        +SH  +++L G C +     ++ E +  G L +  L   +  F+   L   
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQL--- 113
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L++  D+  A+ YL     +  + R+      L N++ V K+ DF LS  + + E   + 
Sbjct: 114 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 170
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                  +  PE +    F+ KSD+++FGV ++E+ +
Sbjct: 171 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 94  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 149
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG-- 236
            + +L     +  V R+      + +E+   K+ DF L+  + + E    D+V    G  
Sbjct: 150 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 203
Query: 237 ----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T    T 
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTF 165
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    ++ +G
Sbjct: 141 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 144
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG-- 236
            + +L     +  V R+      + +E+   K+ DF L+  + + E    D+V    G  
Sbjct: 145 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 198
Query: 237 ----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 116
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         + 
Sbjct: 117 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALC 170
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T    T 
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTF 165
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 120 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           SH ++L L+G CL +   P++V   +++G L + I         P + K  +   + +  
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTV-KDLIGFGLQVAK 203
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG-- 236
            + +L     +  V R+      + +E+   K+ DF L+  + + E    D+V    G  
Sbjct: 204 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHNKTGAK 257
Query: 237 ----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
               + A E ++T  F  KSDV+SFGV L+EL+T
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  +I+  L YLH       + R+ K + +L +E    KL DF ++  + + +    +T 
Sbjct: 129 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTF 184
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 185 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 220

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    ++ +G
Sbjct: 137 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 11/153 (7%)
Query: 121 HNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           H +I+K  G C E       L+ E +  G+L + +   P+ +   + LK +LK A+ I  
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PK-NKNKINLKQQLKYAVQICK 137
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTWG 236
            + YL     R  V R+     +L   E+  K+ DF L+ +I   +   T  D       
Sbjct: 138 GMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF 194
Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD 269
           + APE +    F   SDV+SFGV L ELLT  D
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 11/157 (7%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +   
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTA 114
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
               ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XX 168
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 12/151 (7%)
Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
            H +I+KL     +     LV E +  G L++RI    + HF      +   I   +V A
Sbjct: 64  GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASY---IMRKLVSA 118
Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTWG 236
           ++++H      +V R+ K   +LF +EN     K+ DF  +   P  +     T   T  
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLH 174
Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           Y APE +    ++E  D++S GV L+ +L+G
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 11/155 (7%)
Query: 113 VTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 172
           V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +     
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTATY 113
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         + 
Sbjct: 114 ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELC 167
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           I        +SH  +++L G C +     ++ E +  G L +  L   +  F+   L   
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQL--- 122
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L++  D+  A+ YL     +  + R+      L N++ V K+ DF LS  + + E   + 
Sbjct: 123 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                  +  PE +    F+ KSD+++FGV ++E+ +
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 11/157 (7%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +   
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTA 111
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
               ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AA 165
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 11/153 (7%)
Query: 121 HNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 178
           H +I+K  G C E       L+ E +  G+L + +   P+ +   + LK +LK A+ I  
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PK-NKNKINLKQQLKYAVQICK 125
Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTWG 236
            + YL     R  V R+     +L   E+  K+ DF L+ +I   +   T  D       
Sbjct: 126 GMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF 182
Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD 269
           + APE +    F   SDV+SFGV L ELLT  D
Sbjct: 183 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 215

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 11/157 (7%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +   
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTA 111
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
               ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XX 165
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 37/192 (19%)
Query: 172 IAMDIVHALAYLHFGFP-------RP-IVFRNFKTSCILFNEENVAKLFDFSLSISI--- 220
           +A  +   L+YLH   P       +P I  R+FK+  +L   +  A L DF L++     
Sbjct: 117 VAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPG 176
Query: 221 -PEGETHITDTVMGTWGYCAPEYMRTGVFNEKS-----DVFSFGVFLFELLTGWDVSDLV 274
            P G+TH     +GT  Y APE +   +  ++      D+++ G+ L+EL++    +D  
Sbjct: 177 KPPGDTH---GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGP 233
Query: 275 KDTHDLACPSNEYLKNYFEDNRFTEIV---------------DPIIVEDVLSIEKEQQLH 319
            D + L  P  E +  +       E+V                P + +  ++IE+     
Sbjct: 234 VDEYML--PFEEEIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHD 291
Query: 320 ASAQLSFECIKD 331
           A A+LS  C+++
Sbjct: 292 AEARLSAGCVEE 303

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 11/157 (7%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             V   + + H +IL+L G   +     L+ E    GT++  +    +  F+    +   
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDE---QRTA 111
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
               ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TX 165
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y  PE +   + +EK D++S GV  +E L G
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 116 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 117 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 115 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 172 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 118 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG----ETHI 227
           I  +++  L YLH       + R+ K   IL  E+   ++ DF +S  +  G       +
Sbjct: 126 ILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 228 TDTVMGTWGYCAPEYM-RTGVFNEKSDVFSFGVFLFELLTG 267
             T +GT  + APE M +   ++ K+D++SFG+   EL TG
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 33/194 (17%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLW-------DRILG---APQPHFE-------- 162
           H +I+ L+G C      +++ E   YG L        + +LG   AP    E        
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 163 PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 222
           PL L+  L  +  +   +A+L     +  + R+     +L    +VAK+ DF L+  I  
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 223 GETHIT-DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFE-----------LLTGWDV 270
              +I          + APE +   V+  +SDV+S+G+ L+E           +L     
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 270
Query: 271 SDLVKDTHDLACPS 284
             LVKD + +A P+
Sbjct: 271 YKLVKDGYQMAQPA 284

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG----ETHI 227
           I  +++  L YLH       + R+ K   IL  E+   ++ DF +S  +  G       +
Sbjct: 121 ILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 177
Query: 228 TDTVMGTWGYCAPEYM-RTGVFNEKSDVFSFGVFLFELLTG 267
             T +GT  + APE M +   ++ K+D++SFG+   EL TG
Sbjct: 178 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 122 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 141 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 143 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 145 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
           ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P         + GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLXGT 174
Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             Y  PE +   + +EK D++S GV  +E L G
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 14/164 (8%)
Query: 108 SCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
           + ++ V    ++ H +I+KL     +     LV E  + G L+D I+   +  F  +   
Sbjct: 50  ALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII--LRQKFSEV--- 104
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGE 224
               I   ++    YLH      IV R+ K   +L   ++   + K+ DF LS     G 
Sbjct: 105 DAAVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG 161
Query: 225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
                  +GT  Y APE +R   ++EK DV+S GV L+ LL G+
Sbjct: 162 K--MKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGY 202

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    +  +G
Sbjct: 137 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  Y +PE +      + SD+++ G  +++L+ G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 1/74 (1%)
Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNE 250
           ++ R+ K + +  + +   KL DF L+  I   +T      +GT  Y +PE M    +NE
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE 195
Query: 251 KSDVFSFGVFLFEL 264
           KSD++S G  L+EL
Sbjct: 196 KSDIWSLGCLLYEL 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 72  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTAL 126
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 127 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 183
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 75  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTAL 129
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 130 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 127 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 181
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 67  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTAL 121
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 122 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 135 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 189
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 70  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTAL 124
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 98  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTAL 152
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 153 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 209
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 210 ESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 76/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++      G L + +     P  E            +  K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 215
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 276 HRMDKPAN 283

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 70  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTAL 124
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 73  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTAL 127
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 128 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 184
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 170 KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 224
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 11/190 (5%)
Query: 77  NLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI 136
            +YT +KG   E++   ++    +C     E  ++       + H HI+KLIG   E P 
Sbjct: 27  GVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 83
Query: 137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 196
            I + E   YG L    L   +   + L L   +  ++ I  A+AYL        V R+ 
Sbjct: 84  WI-IMELYPYGEL-GHYLERNKNSLKVLTL---VLYSLQICKAMAYLE---SINCVHRDI 135
Query: 197 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFS 256
               IL       KL DF LS  I + + +          + +PE +    F   SDV+ 
Sbjct: 136 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 195
Query: 257 FGVFLFELLT 266
           F V ++E+L+
Sbjct: 196 FAVCMWEILS 205

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDT 230
           +  + + AL +LH      ++ RN K+  IL   +   KL DF     I PE       T
Sbjct: 122 VCRECLQALEFLH---SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--ST 176
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           ++GT  + APE +    +  K D++S G+   E++ G
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 11/190 (5%)
Query: 77  NLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI 136
            +YT +KG   E++   ++    +C     E  ++       + H HI+KLIG   E P 
Sbjct: 43  GVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 99
Query: 137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 196
            I + E   YG L    L   +   + L L   +  ++ I  A+AYL        V R+ 
Sbjct: 100 WI-IMELYPYGEL-GHYLERNKNSLKVLTL---VLYSLQICKAMAYLE---SINCVHRDI 151
Query: 197 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFS 256
               IL       KL DF LS  I + + +          + +PE +    F   SDV+ 
Sbjct: 152 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 211
Query: 257 FGVFLFELLT 266
           F V ++E+L+
Sbjct: 212 FAVCMWEILS 221

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE++  K+ DF L+      +  +T  V   W
Sbjct: 140 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDEMTGYVATRW 193
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 194 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 64/148 (43%), Gaps = 8/148 (5%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           +  H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  + 
Sbjct: 447 QFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKFSLDLASLILYAYQLS 501
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
            ALAYL     +  V R+     +L +  +  KL DF LS  + +   +          +
Sbjct: 502 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELL 265
            APE +    F   SDV+ FGV ++E+L
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE++  K+ DF L+      +  +T  V   W
Sbjct: 136 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDEMTGYVATRW 189
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 190 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 106 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 165
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I   G       
Sbjct: 166 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRAGYYRKGGC 222
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 223 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 26/170 (15%)
Query: 108 SCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
           + ++ V    ++ H +I+KL     +     LV E  + G L+D I+           L+
Sbjct: 67  ALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-----------LR 115
Query: 168 HRLK------IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSI 218
            +        I   ++    YLH      IV R+ K   +L   ++   + K+ DF LS 
Sbjct: 116 QKFSEVDAAVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA 172
Query: 219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
               G        +GT  Y APE +R   ++EK DV+S GV L+ LL G+
Sbjct: 173 HFEVGGK--MKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGY 219

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 11/190 (5%)
Query: 77  NLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI 136
            +YT +KG   E++   ++    +C     E  ++       + H HI+KLIG   E P 
Sbjct: 31  GVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 87
Query: 137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 196
            I + E   YG L    L   +   + L L   +  ++ I  A+AYL        V R+ 
Sbjct: 88  WI-IMELYPYGEL-GHYLERNKNSLKVLTL---VLYSLQICKAMAYLE---SINCVHRDI 139
Query: 197 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFS 256
               IL       KL DF LS  I + + +          + +PE +    F   SDV+ 
Sbjct: 140 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 199
Query: 257 FGVFLFELLT 266
           F V ++E+L+
Sbjct: 200 FAVCMWEILS 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  +I+  L YLH       + R+ K + +L +E    KL DF ++  + + +    +  
Sbjct: 124 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNXF 179
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 42/246 (17%)
Query: 121 HNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGA---PQPHFEPLLLKHRLK 171
           H H+ KL+G  L +      PIP+++   +++G L   +L +     P   PL  +  ++
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL--QTLVR 141
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH---IT 228
             +DI   + YL     R  + R+      +  E+    + DF LS  I  G+ +     
Sbjct: 142 FMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL 288
             +   W   A E +   ++   SDV++FGV ++E++T        +     A   N  +
Sbjct: 199 SKLPVKW--LALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENAEI 248
Query: 289 KNYF-EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR 347
            NY    NR  +   P  +E+V              L ++C    P  RPS   +  +L 
Sbjct: 249 YNYLIGGNRLKQ--PPECMEEVYD------------LMYQCWSADPKQRPSFTCLRMELE 294
Query: 348 QIYRSL 353
            I   L
Sbjct: 295 NILGHL 300

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 26/186 (13%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWD------RILGAPQPHF----EPLLLKHRL 170
           H +I+ L+G C      +++ E   YG L +      R+L    P F      L  +  L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL-ETDPAFAIANSTLSTRDLL 167
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-D 229
             +  +   +A+L     +  + R+     +L    +VAK+ DF L+  I     +I   
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFE-----------LLTGWDVSDLVKDTH 278
                  + APE +   V+  +SDV+S+G+ L+E           +L       LVKD +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284
Query: 279 DLACPS 284
            +A P+
Sbjct: 285 QMAQPA 290

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  +I+  L YLH       + R+ K + +L +E    KL DF ++  + + +    +  
Sbjct: 109 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNXF 164
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++ ALAYLH    + ++ R+ K+  IL   +   KL DF     I + +      ++GT 
Sbjct: 150 VLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKXLVGTP 205
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            + APE +   ++  + D++S G+ + E++ G
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 162
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 76/188 (40%), Gaps = 27/188 (14%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C +     ++      G L + +     P  E            +  K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +     +   + YL     +  + R+     +L  E NV K+ DF L+  I     +   
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKK 215
Query: 230 TVMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GWDVSD---LVKDT 277
           T  G     + APE +   V+  +SDV+SFGV ++E+ T       G  V +   L+K+ 
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 278 HDLACPSN 285
           H +  P+N
Sbjct: 276 HRMDKPAN 283

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I   G       
Sbjct: 189 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++++H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 89  SKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 149 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 162
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 162
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 162
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + ++
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 162
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR- 169
           N +    ++ H +I+ L           L+ + V  G L+DRI+       E      R 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 117
Query: 170 -LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGET 225
             ++   ++ A+ YLH      IV R+ K   +L+   +E++   + DF LS    E   
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPG 172
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            +  T  GT GY APE +    +++  D +S GV  + LL G+
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
           H HI+KL    + TP    +V E V  G L+D I      H     ++ R ++   I+ A
Sbjct: 70  HPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEAR-RLFQQILSA 123
Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCA 239
           + Y H      +V R+ K   +L +    AK+ DF LS  + +GE     T  G+  Y A
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAA 178
Query: 240 PEYMRTGVF-NEKSDVFSFGVFLFELLTG 267
           PE +   ++   + D++S GV L+ LL G
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR- 169
           N +    ++ H +I+ L           L+ + V  G L+DRI+       E      R 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 117
Query: 170 -LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGET 225
             ++   ++ A+ YLH      IV R+ K   +L+   +E++   + DF LS    E   
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPG 172
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            +  T  GT GY APE +    +++  D +S GV  + LL G+
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
             +T  ++    +I +  G  L++    ++ E +  G+  D  L  P P  E  +     
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD--LLKPGPLEETYIAT--- 120
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
            I  +I+  L YLH       + R+ K + +L +E+   KL DF ++  + + +    + 
Sbjct: 121 -ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNX 175
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 176 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 212

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T      
Sbjct: 116 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 170
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 139 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRW 192
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 193 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR- 169
           N +    ++ H +I+ L           L+ + V  G L+DRI+       E      R 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 117
Query: 170 -LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGET 225
             ++   ++ A+ YLH      IV R+ K   +L+   +E++   + DF LS    E   
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPG 172
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            +  T  GT GY APE +    +++  D +S GV  + LL G+
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 139 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRW 192
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 193 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 64/148 (43%), Gaps = 8/148 (5%)
Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           +  H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  + 
Sbjct: 447 QFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKFSLDLASLILYAYQLS 501
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY 237
            ALAYL     +  V R+     +L +  +  KL DF LS  + +   +          +
Sbjct: 502 TALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 238 CAPEYMRTGVFNEKSDVFSFGVFLFELL 265
            APE +    F   SDV+ FGV ++E+L
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T      
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR- 169
           N +    ++ H +I+ L           L+ + V  G L+DRI+       E      R 
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERD 117
Query: 170 -LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGET 225
             ++   ++ A+ YLH      IV R+ K   +L+   +E++   + DF LS    E   
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPG 172
Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            +  T  GT GY APE +    +++  D +S GV  + LL G+
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 5/96 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    + +V+R+ K   ++ +++   K+ DF L    I +G T    T 
Sbjct: 254 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTF 309
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 5/96 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    + +V+R+ K   ++ +++   K+ DF L    I +G T    T 
Sbjct: 257 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTF 312
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 348

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T      
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T      
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 145 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRW 198
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 199 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+++ ++  L YL       I+ R+ K S IL N     KL DF +S  + +    + + 
Sbjct: 111 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---EMANE 165
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++++H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 103 SKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 163 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 26/187 (13%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 169
           H +I+ L+G C      +++ E   YG L + +     P  E            L  +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT- 228
           L  +  +   +A+L     +  + R+     +L    +VAK+ DF L+  I     +I  
Sbjct: 169 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFE-----------LLTGWDVSDLVKDT 277
                   + APE +   V+  +SDV+S+G+ L+E           +L       LVKD 
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 285
Query: 278 HDLACPS 284
           + +A P+
Sbjct: 286 YQMAQPA 292

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGXVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           KI +  V AL +L       I+ R+ K S IL +     KL DF +S  + +      D 
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 231 VMGTWGYCAPEYM-----RTGVFNEKSDVFSFGVFLFELLTG 267
             G   Y APE +     R G ++ +SDV+S G+ L+EL TG
Sbjct: 187 --GCRPYMAPERIDPSASRQG-YDVRSDVWSLGITLYELATG 225

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE++  K+ DF L         H  D + G  
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLC-------RHTDDEMTGYV 183
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 62/145 (42%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 70  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTAL 124
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +              + AP
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP 181
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTADEMTGYV 190
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
           H HI+KLIG   E P+ I + E    G L   +    Q     L L   +  A  +  AL
Sbjct: 70  HPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTAL 124
Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAP 240
           AYL     +  V R+     +L +  +  KL DF LS  + +   +          + AP
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 241 EYMRTGVFNEKSDVFSFGVFLFELL 265
           E +    F   SDV+ FGV ++E+L
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTADEMTGYV 190
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTADEMTGYV 190
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I    +  L YLHF      + R+ K   IL N E  AKL DF ++  + +      + V
Sbjct: 130 ILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXV 185
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   +N  +D++S G+   E+  G
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 115 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 174
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 175 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 231
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 232 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 89  SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 149 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMAQDIYRASYYRKGGC 205
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 95  SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 154
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 155 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 211
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 212 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH-FEP--LLLKHRLKIA 173
           ++ +H +I++ IG  L++ +P  +   +  G      L   +P   +P  L +   L +A
Sbjct: 88  SKFNHQNIVRCIGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 174 MDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITD 229
            DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +    
Sbjct: 147 RDIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 139 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 192
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 193 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 133 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 186
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 187 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 145 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 198
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 199 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF--EPLLLKHRLKIAMDI 176
           + H HI++L+       +  +VFE +    L   I+      F     +  H ++    I
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR---QI 141
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILF-NEENVA--KLFDFSLSISIPEGETHITDTVMG 233
           + AL Y H      I+ R+ K  C+L  ++EN A  KL  F ++I + E    +    +G
Sbjct: 142 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVG 197
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  + APE ++   + +  DV+  GV LF LL+G
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 146 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 199
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 200 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 140 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 193
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 194 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 146 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 199
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 200 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 139 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 192
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 193 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 144 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 197
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 198 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 194
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 195 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 146 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 199
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 200 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 89  SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 149 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 105 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 164
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 165 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 221
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 222 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 136 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 189
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 190 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH-FEP--LLLKHRLKIA 173
           ++ +H +I++ IG  L++ +P  +   +  G      L   +P   +P  L +   L +A
Sbjct: 103 SKFNHQNIVRCIGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 174 MDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITD 229
            DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +    
Sbjct: 162 RDIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF--EPLLLKHRLKIAMDI 176
           + H HI++L+       +  +VFE +    L   I+      F     +  H ++    I
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR---QI 139
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILF-NEENVA--KLFDFSLSISIPEGETHITDTVMG 233
           + AL Y H      I+ R+ K  C+L  ++EN A  KL  F ++I + E    +    +G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVG 195
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  + APE ++   + +  DV+  GV LF LL+G
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L Y+H      I+ R+ K S +  NE++  ++ DF L+    + +  +T  V   W
Sbjct: 140 LLRGLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRW 193
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELL G
Sbjct: 194 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 136 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 189
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 190 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 136 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 189
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 190 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 154 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 207
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 208 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 140 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 193
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 194 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 140 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 193
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 194 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 154 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 207
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 208 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L Y+H      I+ R+ K S +  NE++  ++ DF L+    + +  +T  V   W
Sbjct: 140 LLRGLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRW 193
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELL G
Sbjct: 194 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 131 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 184
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 185 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMAGFV 183
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 157 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 210
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 211 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 153 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 206
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 207 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 154 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMXGXV 203
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 15/155 (9%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM---D 175
           + H +I++ +G   E     +  E V  G+L   +     P     L  +   I      
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP-----LKDNEQTIGFYTKQ 130
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGT 234
           I+  L YLH      IV R+ K   +L N    V K+ DF  S  +  G    T+T  GT
Sbjct: 131 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGT 186
Query: 235 WGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTG 267
             Y APE +  G   + + +D++S G  + E+ TG
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMAGFV 183
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 183
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 184 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDT 230
           +  + + AL +LH      ++ R+ K+  IL   +   KL DF     I PE       T
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--ST 175
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           ++GT  + APE +    +  K D++S G+   E++ G
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 1/74 (1%)
Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNE 250
           ++ R+ K + +  + +   KL DF L+  +   E    + V GT  Y +PE M    +NE
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRMSYNE 195
Query: 251 KSDVFSFGVFLFEL 264
           KSD++S G  L+EL
Sbjct: 196 KSDIWSLGCLLYEL 209

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 183
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 184 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 153 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 206
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 207 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 103 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 163 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 183
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 184 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 157 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMXGYV 206
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 131 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 184
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 185 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/96 (25%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+YLH    + ++ R+ K+  IL   +   KL DF     + + E      +
Sbjct: 146 VCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKXL 201
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 202 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 132 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 185
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 186 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 88  SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 148 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/211 (21%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 64  YDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH 123
           + Q N + K    +   ++KG WQ   I V      +   R               SH +
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 124 ILKLIGCCLETPI--PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALA 181
           +L ++G C   P   P L+   + YG+L++ +        +       +K A+D+   +A
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD---QSQAVKFALDMARGMA 125
Query: 182 YLHFGFPRPIVFRN-FKTSCILFNEENVAK--LFDFSLSISIPEGETHITDTVMGTWGYC 238
           +LH     P++ R+   +  ++ +E+  A+  + D   S   P G  +          + 
Sbjct: 126 FLHTL--EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-GRMYAP-------AWV 175
Query: 239 APEYMRT---GVFNEKSDVFSFGVFLFELLT 266
           APE ++          +D++SF V L+EL+T
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 14/101 (13%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           IA+D VH L Y+H         R+ K   IL +     +L DF   + + E  T  +   
Sbjct: 186 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 232 MGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE ++      G +  + D +S GV ++E+L G
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
           H HI+KL    + TP    +V E V  G L+D I      H     ++ R ++   I+ A
Sbjct: 70  HPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEAR-RLFQQILSA 123
Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCA 239
           + Y H      +V R+ K   +L +    AK+ DF LS  + +GE  + D+  G+  Y A
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRDSC-GSPNYAA 178
Query: 240 PEYMRTGVF-NEKSDVFSFGVFLFELLTG 267
           PE +   ++   + D++S GV L+ LL G
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           KIA+ IV AL +LH      ++ R+ K S +L N     K+ DF +S  + +      D 
Sbjct: 157 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 231 VMGTWGYCAPEYMRTGV----FNEKSDVFSFGVFLFEL 264
             G   Y APE +   +    ++ KSD++S G+ + EL
Sbjct: 215 --GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 9/156 (5%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA-PQP-HFEPLLLKHRLKIAM 174
           ++ +H +I++ IG  L++    ++ E +  G L   +    P+P     L +   L +A 
Sbjct: 80  SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 139
Query: 175 DIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDT 230
           DI     YL   HF   R I  RN   +C       VAK+ DF ++  I     +     
Sbjct: 140 DIACGCQYLEENHF-IHRDIAARNCLLTCP--GPGRVAKIGDFGMARDIYRASYYRKGGC 196
Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            M    +  PE    G+F  K+D +SFGV L+E+ +
Sbjct: 197 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I  AL YLH      IV+R+ K   IL + +    L DF L     E  +  T T  
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFC 200
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +    ++   D +  G  L+E+L G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 14/100 (14%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A +I   L +LH    R I++R+ K   ++ + E   K+ DF +       + H+ D V 
Sbjct: 126 AAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMC------KEHMMDGVT 176
Query: 233 -----GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
                GT  Y APE +    + +  D +++GV L+E+L G
Sbjct: 177 TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGM 123
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 124 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 175
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMAGFV 179
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWD------RILGAPQPHF----EPLLLKHRL 170
           H +I+ L+G C      +++ E   YG L +      R+L    P F         +  L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL-ETDPAFAIANSTASTRDLL 167
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-D 229
             +  +   +A+L     +  + R+     +L    +VAK+ DF L+  I     +I   
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFE-----------LLTGWDVSDLVKDTH 278
                  + APE +   V+  +SDV+S+G+ L+E           +L       LVKD +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284
Query: 279 DLACPS 284
            +A P+
Sbjct: 285 QMAQPA 290

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 8/96 (8%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTV 231
           DI  AL YLH      I+ R+ K   I+     +  + K+ D   +  + +GE  +    
Sbjct: 130 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEF 184
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y APE +    +    D +SFG   FE +TG
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 8/96 (8%)
Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFN---EENVAKLFDFSLSISIPEGETHITDTV 231
           DI  AL YLH      I+ R+ K   I+     +  + K+ D   +  + +GE  +    
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEF 183
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y APE +    +    D +SFG   FE +TG
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 15/155 (9%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM---D 175
           + H +I++ +G   E     +  E V  G+L   +     P     L  +   I      
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP-----LKDNEQTIGFYTKQ 116
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGT 234
           I+  L YLH      IV R+ K   +L N    V K+ DF  S  +  G    T+T  GT
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGT 172
Query: 235 WGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTG 267
             Y APE +  G   + + +D++S G  + E+ TG
Sbjct: 173 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 25/186 (13%)
Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            +  H +++ L G        ++V E ++ G L D  L      F  + L   L+    I
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLR---GI 154
Query: 177 VHALAYL-HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
              + YL   G+    V R+     IL N   V K+ DF LS  I +    +  T  G  
Sbjct: 155 AAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI 210
Query: 236 G--YCAPEYMRTGVFNEKSDVFSFGVFLFELLT-----GWDVS--DLVKDTHD------- 279
              + APE ++   F   SDV+S+G+ ++E+++      WD+S  D++K   +       
Sbjct: 211 PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAP 270
Query: 280 LACPSN 285
           + CP+ 
Sbjct: 271 MDCPAG 276

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   GF    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 153 LR---GIASGMKYLSDMGF----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 204
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 153 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 204
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/96 (26%), Positives = 46/96 (47%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +  + + AL +LH      ++ R+ K+  IL   +   KL DF     I   ++  ++ V
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV 177
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  + APE +    +  K D++S G+   E++ G
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 30/222 (13%)
Query: 118 RMSHNHILKLIGCC-LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++SH  ++K  G C  E PI I V E +  G L    L   + H + L     L++  D+
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYI-VTEYISNGCL----LNYLRSHGKGLEPSQLLEMCYDV 113
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
              +A+L        + R+      L + +   K+ DF ++  + + +   +        
Sbjct: 114 CEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR 296
           + APE      ++ KSDV++FG+ +      W+V  L K  +DL   S   LK     ++
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILM------WEVFSLGKMPYDLYTNSEVVLKV----SQ 220
Query: 297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS 338
              +  P +  D +            Q+ + C  + P  RP+
Sbjct: 221 GHRLYRPHLASDTI-----------YQIMYSCWHELPEKRPT 251

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           L L+H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I + 
Sbjct: 195 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 224 ETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             ++          + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ D+ L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           L L+H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I + 
Sbjct: 197 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 224 ETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             ++          + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 123
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 124 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 175
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           L L+H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I + 
Sbjct: 188 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 224 ETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             ++          + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           L L+H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I + 
Sbjct: 190 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 224 ETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             ++          + APE +   V+  +SDV+SFGV L+E+ +
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF--EPLLLKHRLKIAMDI 176
           + H HI++L+       +  +VFE +    L   I+      F     +  H ++    I
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR---QI 139
Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILF-NEENVA--KLFDFSLSISIPEGETHITDTVMG 233
           + AL Y H      I+ R+ K   +L  ++EN A  KL DF ++I + E    +    +G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL-VAGGRVG 195
Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  + APE ++   + +  DV+  GV LF LL+G
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 140
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 141 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 192
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L Y+H      I+ R+ K S +  NE+   ++ DF L+    + +  +T  V   W
Sbjct: 132 LLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA---RQADEEMTGYVATRW 185
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELL G
Sbjct: 186 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV    YLH      ++ R+ K   +  NE+   K+ DF L+  + E +     T+ GT 
Sbjct: 130 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTP 185
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN 295
            Y APE +     + + DV+S G  ++ LL G       K   + +C    YL+    + 
Sbjct: 186 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKNEY 238
Query: 296 RFTEIVDPI 304
              + ++P+
Sbjct: 239 SIPKHINPV 247

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    + +V+R+ K   ++ +++   K+ DF L    I +G T      
Sbjct: 116 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXF 171
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 172 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 207

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    + +V+R+ K   ++ +++   K+ DF L    I +G T      
Sbjct: 115 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXF 170
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 231
             +IV AL YLH    + +V+R+ K   ++ +++   K+ DF L    I +G T      
Sbjct: 114 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXF 169
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 205

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 153 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 204
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV    YLH      ++ R+ K   +  NE+   K+ DF L+  + E +     T+ GT 
Sbjct: 126 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTP 181
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN 295
            Y APE +     + + DV+S G  ++ LL G       K   + +C    YL+    + 
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKNEY 234
Query: 296 RFTEIVDPI 304
              + ++P+
Sbjct: 235 SIPKHINPV 243

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 150
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 151 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 202
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 11/129 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV    YLH      ++ R+ K   +  NE+   K+ DF L+  + E +     T+ GT 
Sbjct: 126 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTP 181
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN 295
            Y APE +     + + DV+S G  ++ LL G       K   + +C    YL+    + 
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKNEY 234
Query: 296 RFTEIVDPI 304
              + ++P+
Sbjct: 235 SIPKHINPV 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 153 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 204
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 153 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 204
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 119 MSHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++H ++L LIG  L    +P ++   + +G L   I     P   P + K  +   + + 
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTV-KDLISFGLQVA 134
Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-----THITDTVM 232
             + YL     +  V R+      + +E    K+ DF L+  I + E      H    + 
Sbjct: 135 RGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
             W   A E ++T  F  KSDV+SFGV L+ELLT
Sbjct: 192 VKW--TALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 38/85 (44%), Gaps = 3/85 (3%)
Query: 183 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEY 242
           LH+   R ++ R+ K   +L   +   K+ DF  S+  P         + GT  Y  PE 
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---XMCGTLDYLPPEM 183
Query: 243 MRTGVFNEKSDVFSFGVFLFELLTG 267
           +     +EK D++  GV  +E L G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETH 226
           H +  A +I   L +L     + I++R+ K   ++ + E   K+ DF +   +I +G T 
Sbjct: 122 HAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT- 177
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            T    GT  Y APE +    + +  D ++FGV L+E+L G
Sbjct: 178 -TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF LS  + E +    
Sbjct: 153 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 204
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           KIA+ IV AL +LH      ++ R+ K S +L N     K+ DF +S  + +      D 
Sbjct: 113 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 231 VMGTWGYCAPEYMRTGV----FNEKSDVFSFGVFLFEL 264
             G   Y APE +   +    ++ KSD++S G+ + EL
Sbjct: 171 --GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 38/85 (44%), Gaps = 3/85 (3%)
Query: 183 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEY 242
           LH+   R ++ R+ K   +L   +   K+ DF  S+  P         + GT  Y  PE 
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---XMCGTLDYLPPEM 184
Query: 243 MRTGVFNEKSDVFSFGVFLFELLTG 267
           +     +EK D++  GV  +E L G
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +  + + AL +LH      ++ R+ K+  IL   +   KL DF     I   ++  +  V
Sbjct: 122 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV 178
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  + APE +    +  K D++S G+   E++ G
Sbjct: 179 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/96 (23%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+ LH    + ++ R+ K+  IL   +   KL DF     + + E      +
Sbjct: 252 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXL 307
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 14/96 (14%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 233
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+        H  D + G  
Sbjct: 163 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGYV 212
Query: 234 -TWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            T  Y APE M   + +N   D++S G  + ELLTG
Sbjct: 213 ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +  + + AL +LH      ++ R+ K+  IL   +   KL DF     I   ++  +  V
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV 177
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  + APE +    +  K D++S G+   E++ G
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETH 226
           H +  A +I   L +L     + I++R+ K   ++ + E   K+ DF +   +I +G T 
Sbjct: 443 HAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT- 498
Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            T    GT  Y APE +    + +  D ++FGV L+E+L G
Sbjct: 499 -TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/96 (23%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+ LH    + ++ R+ K+  IL   +   KL DF     + + E      +
Sbjct: 130 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXL 185
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/96 (23%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+ LH    + ++ R+ K+  IL   +   KL DF     + + E      +
Sbjct: 132 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXL 187
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/96 (23%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+ LH    + ++ R+ K+  IL   +   KL DF     + + E      +
Sbjct: 175 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXL 230
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L+    I   + YL        V R+     IL N   V K+ DF LS  + E +     
Sbjct: 153 LR---GIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 205
Query: 230 TVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
           T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/96 (23%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+ LH    + ++ R+ K+  IL   +   KL DF     + + E      +
Sbjct: 121 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXL 176
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/96 (23%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           + + ++ AL+ LH    + ++ R+ K+  IL   +   KL DF     + + E      +
Sbjct: 125 VCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXL 180
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +    +  + D++S G+ + E++ G
Sbjct: 181 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 41/237 (17%)
Query: 111 NNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
           N V    ++ H  IL+L     ++    LV E    G + +R L      F     +H +
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFM 118
Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS--ISIPEGETHIT 228
                I+  + YLH      I+ R+   S +L       K+ DF L+  + +P  E H T
Sbjct: 119 H---QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-EKHYT 171
Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG---WDVSDLVKDTHDLACPSN 285
             + GT  Y +PE         +SDV+S G   + LL G   +D +D VK+T +    ++
Sbjct: 172 --LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLNKVVLAD 228
Query: 286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDV 342
             + ++                  LSIE +  +H       + ++ +PADR S+  V
Sbjct: 229 YEMPSF------------------LSIEAKDLIH-------QLLRRNPADRLSLSSV 260

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 48/254 (18%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           ++  +   +  H +I+ L G   +    +++ E ++ G+L D  L      F  + L   
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGM 121
Query: 170 LK---IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
           L+     M  +  ++Y+H    R +  RN     IL N   V K+ DF +S  + E +  
Sbjct: 122 LRGIGSGMKYLSDMSYVH----RDLAARN-----ILVNSNLVCKVSDFGMS-RVLEDDPE 171
Query: 227 ITDTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG-----WDVSDLVKDTH 278
              T  G      + APE +    F   SDV+S+G+ ++E+++      WD+S+      
Sbjct: 172 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------ 225
Query: 279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS 338
                  + +K   E  R    +D  I            LH   QL  +C +   +DRP 
Sbjct: 226 ------QDVIKAIEEGYRLPPPMDCPIA-----------LH---QLMLDCWQKERSDRPK 265
Query: 339 MVDVAKKLRQIYRS 352
              +   L ++ R+
Sbjct: 266 FGQIVNMLDKLIRN 279

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 48/254 (18%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           ++  +   +  H +I+ L G   +    +++ E ++ G+L D  L      F  + L   
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGM 115
Query: 170 LK---IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
           L+     M  +  ++Y+H    R +  RN     IL N   V K+ DF +S  + E +  
Sbjct: 116 LRGIGSGMKYLSDMSYVH----RDLAARN-----ILVNSNLVCKVSDFGMS-RVLEDDPE 165
Query: 227 ITDTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG-----WDVSDLVKDTH 278
              T  G      + APE +    F   SDV+S+G+ ++E+++      WD+S+      
Sbjct: 166 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------ 219
Query: 279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS 338
                  + +K   E  R    +D  I            LH   QL  +C +   +DRP 
Sbjct: 220 ------QDVIKAIEEGYRLPPPMDCPIA-----------LH---QLMLDCWQKERSDRPK 259
Query: 339 MVDVAKKLRQIYRS 352
              +   L ++ R+
Sbjct: 260 FGQIVNMLDKLIRN 273

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 86/219 (39%), Gaps = 44/219 (20%)
Query: 88  ERLISVLQFYGHECR-----PRAYESCI------------------NNVTYAARMSHNHI 124
           E +I   +F G  CR     P   ESC+                  +  +   +  H +I
Sbjct: 21  EEVIGAGEF-GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 125 LKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLH 184
           ++L G    + +P+++          D  L      F  + L   L+     +  LA + 
Sbjct: 80  IRLEGVVTNS-MPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS 138
Query: 185 FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG------YC 238
           +      V R+     IL N   V K+ DF LS  + E  +  T+T   + G      + 
Sbjct: 139 Y------VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTET--SSLGGKIPIRWT 190
Query: 239 APEYMRTGVFNEKSDVFSFGVFLFELLTG-----WDVSD 272
           APE +    F   SD +S+G+ ++E+++      WD+S+
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN 229

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 38/295 (12%)
Query: 81  MYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP--- 137
           ++ G W+   ++V  F+  E      E+ I        M H +IL  I   ++       
Sbjct: 53  VWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVL---MRHENILGFIAADIKGTGSWTQ 109
Query: 138 -ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF------GFPRP 190
             L+ +  + G+L+D +          L  K  LK+A   V  L +LH       G P  
Sbjct: 110 LYLITDYHENGSLYDYLKSTT------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP-A 162
Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI---TDTVMGTWGYCAPEYMRTGV 247
           I  R+ K+  IL  +     + D  L++        +    +T +GT  Y  PE +   +
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 248 FNEK------SDVFSFGVFLFEL----LTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF 297
                     +D++SFG+ L+E+    ++G  V +     HDL  PS+      +ED R 
Sbjct: 223 NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV-PSDPS----YEDMRE 277
Query: 298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
              +  +          ++ L    +L  EC   +PA R + + V K L ++  S
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+  F L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 13/134 (9%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           +V E ++ G L D+IL   Q  F     +    +   I   + YLH    + +V R+ K 
Sbjct: 93  VVTELMKGGELLDKIL--RQKFFSE---REASAVLFTITKTVEYLH---AQGVVHRDLKP 144
Query: 199 SCILFNEEN----VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDV 254
           S IL+ +E+      ++ DF  +  +   E  +  T   T  + APE +    ++   D+
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYTANFVAPEVLERQGYDAACDI 203
Query: 255 FSFGVFLFELLTGW 268
           +S GV L+ +LTG+
Sbjct: 204 WSLGVLLYTMLTGY 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 165 LLKHRLKIAMDIVHALAY-----LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
           L+KH  K+  D +  L Y     L +     I+ R+ K   +  NE+   K+ DF L+  
Sbjct: 119 LMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-- 175
Query: 220 IPEGETHITDTVMGTWGYCAPE----YMRTGVFNEKSDVFSFGVFLFELLT------GWD 269
             + ++ +   V+  W Y APE    +MR   + +  D++S G  + E++T      G D
Sbjct: 176 -RQADSEMXGXVVTRW-YRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSD 230
Query: 270 VSDLVKDTHDL-ACPSNEYL--------KNY------FEDNRFTEIV---DPIIV---ED 308
             D +K+   +   P  E++        KNY       E   F  I+    P+ V   E 
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 309 VLSIEKEQQLHASAQLS---FECIKDSPADRPSMVDVAKKLRQIYRSL 353
           +L ++ EQ++ A   L+   FE + D+  D P +         + R+L
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFESLHDT-EDEPQVQKYDDSFDDVDRTL 337

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 45/96 (46%), Gaps = 6/96 (6%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  ++  AL Y H    + ++ R+ K   +L   +   K+ DF  S+  P        T+
Sbjct: 128 IMEELADALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR---KTM 181
Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  Y  PE +   + NEK D++  GV  +ELL G
Sbjct: 182 CGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ D  L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF L+  + E +    
Sbjct: 153 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLA-RVLEDDPEAA 204
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A  IV    YLH      +++R+ K   ++ +++   K+ DF L+  + +G T     + 
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV-KGRTW---XLC 199
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           GT  Y APE + +  +N+  D ++ GV ++E+  G+
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 108 SCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
           + I  ++    + H++I+KL          +LVFE +       ++L   +   E +  K
Sbjct: 46  TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK 103
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
             L   + +++ +AY H    R ++ R+ K   +L N E   K+ DF L+ +        
Sbjct: 104 SFL---LQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 228 TDTVMGTWGYCAPE-YMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  V+  W Y AP+  M +  ++   D++S G    E++ G
Sbjct: 158 THEVVTLW-YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 78/190 (41%), Gaps = 27/190 (14%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I+ L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 71  LGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGM 129
Query: 170 LK---IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
           L+     M  +  + Y+H         R+     IL N   V K+ DF LS  + E +  
Sbjct: 130 LRGISAGMKYLSDMGYVH---------RDLAARNILINSNLVCKVSDFGLS-RVLEDDPE 179
Query: 227 ITDTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFEL----------LTGWDVSDL 273
              T  G      + APE +    F   SDV+S+G+ ++E+          +T  DV   
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKA 239
Query: 274 VKDTHDLACP 283
           V++ + L  P
Sbjct: 240 VEEGYRLPSP 249

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 108 SCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
           + I  ++    + H++I+KL          +LVFE +       ++L   +   E +  K
Sbjct: 46  TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK 103
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
             L   + +++ +AY H    R ++ R+ K   +L N E   K+ DF L+ +        
Sbjct: 104 SFL---LQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 228 TDTVMGTWGYCAPE-YMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  V+  W Y AP+  M +  ++   D++S G    E++ G
Sbjct: 158 THEVVTLW-YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ D  L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ D  L+      +  +T  V   W
Sbjct: 134 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLA---RHTDDEMTGYVATRW 187
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE M   + +N+  D++S G  + ELLTG
Sbjct: 188 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 11/129 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV    YLH      ++ R+ K   +  NE+   K+ DF L+  + E +      + GT 
Sbjct: 148 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTP 203
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN 295
            Y APE +     + + DV+S G  ++ LL G       K   + +C    YL+    + 
Sbjct: 204 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKNEY 256
Query: 296 RFTEIVDPI 304
              + ++P+
Sbjct: 257 SIPKHINPV 265

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 11/129 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV    YLH      ++ R+ K   +  NE+   K+ DF L+  + E +      + GT 
Sbjct: 150 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTP 205
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN 295
            Y APE +     + + DV+S G  ++ LL G       K   + +C    YL+    + 
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKNEY 258
Query: 296 RFTEIVDPI 304
              + ++P+
Sbjct: 259 SIPKHINPV 267

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 13/161 (8%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           +   +   +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGM 152
Query: 170 LKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
           L+    I   + YL   G+    V R+     IL N   V K+ DF L   + E +    
Sbjct: 153 LR---GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLG-RVLEDDPEAA 204
Query: 229 DTVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
            T  G      + +PE +    F   SDV+S+G+ L+E+++
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A  IV    YLH      +++R+ K   +L +++   K+ DF  +  + +G T     + 
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTW---XLC 200
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           GT  Y APE + +  +N+  D ++ GV ++E+  G+
Sbjct: 201 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 236

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A  IV    YLH      +++R+ K   +L +++   K+ DF  +  + +G T     + 
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTW---XLC 199
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           GT  Y APE + +  +N+  D ++ GV ++E+  G+
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A  IV    YLH      +++R+ K   +L +++   K+ DF  +  + +G T     + 
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTW---XLC 199
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           GT  Y APE + +  +N+  D ++ GV ++E+  G+
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
           A  IV    YLH      +++R+ K   +L +++   K+ DF  +  + +G T     + 
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTW---XLC 199
Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           GT  Y APE + +  +N+  D ++ GV ++E+  G+
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 11/129 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV    YLH      ++ R+ K   +  NE+   K+ DF L+  + E +      + GT 
Sbjct: 124 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTP 179
Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN 295
            Y APE +     + + DV+S G  ++ LL G       K   + +C    YL+    + 
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKNEY 232
Query: 296 RFTEIVDPI 304
              + ++P+
Sbjct: 233 SIPKHINPV 241

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 108 SCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
           + I  ++    + H++I+KL          +LVFE +       ++L   +   E +  K
Sbjct: 46  TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAK 103
Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 227
             L   + +++ +AY H    R ++ R+ K   +L N E   K+ DF L+ +        
Sbjct: 104 SFL---LQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 228 TDTVMGTWGYCAPE-YMRTGVFNEKSDVFSFGVFLFELLTG 267
           T  ++  W Y AP+  M +  ++   D++S G    E++ G
Sbjct: 158 THEIVTLW-YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 14/101 (13%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H L Y+H         R+ K   +L +     +L DF   + + +  T  +   
Sbjct: 186 LAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA 236
Query: 232 MGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE ++      G +  + D +S GV ++E+L G
Sbjct: 237 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L Y+H      +V R+ K   +  NE+   K+ DF L+      +  +T  V+  W
Sbjct: 135 MLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRW 188
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE + + + +N+  D++S G  + E+LTG
Sbjct: 189 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L Y+H      +V R+ K   +  NE+   K+ DF L+      +  +T  V+  W
Sbjct: 153 MLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRW 206
Query: 236 GYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
            Y APE + + + +N+  D++S G  + E+LTG
Sbjct: 207 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 14/101 (13%)
Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +A+D +H L Y+H         R+ K   +L +     +L DF   + + +  T  +   
Sbjct: 202 LAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA 252
Query: 232 MGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y +PE ++      G +  + D +S GV ++E+L G
Sbjct: 253 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 13/134 (9%)
Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           +V E  + G L D+IL   Q  F     +    +   I   + YLH    + +V R+ K 
Sbjct: 93  VVTELXKGGELLDKIL--RQKFFSE---REASAVLFTITKTVEYLH---AQGVVHRDLKP 144
Query: 199 SCILFNEEN----VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDV 254
           S IL+ +E+      ++ DF  +  +   E  +  T   T  + APE +    ++   D+
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQL-RAENGLLXTPCYTANFVAPEVLERQGYDAACDI 203
Query: 255 FSFGVFLFELLTGW 268
           +S GV L+  LTG+
Sbjct: 204 WSLGVLLYTXLTGY 217

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 42/251 (16%)
Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR 169
           ++  +   +  H +I+ L G   +    +++ E ++ G+L D  L      F  + L   
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGM 136
Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L+    I   + YL        V R+     IL N   V K+ DF +S  + E +     
Sbjct: 137 LR---GIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMS-RVLEDDPEAAY 189
Query: 230 TVMGT---WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG-----WDVSDLVKDTHDLA 281
           T  G      + APE +    F   SDV+S+G+ ++E+++      WD+S+         
Sbjct: 190 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------- 240
Query: 282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVD 341
               + +K   E  R    +D  I            LH   QL  +C +   +DRP    
Sbjct: 241 ---QDVIKAIEEGYRLPPPMDCPIA-----------LH---QLMLDCWQKERSDRPKFGQ 283
Query: 342 VAKKLRQIYRS 352
           +   L ++ R+
Sbjct: 284 IVNMLDKLIRN 294

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	353
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-65
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-60
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-59
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-33
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-31
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-30
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-28
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-19
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-18
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-17
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-17
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-17
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-17
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-16
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-16
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-16
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-15
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-15
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-15
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-15
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-14
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-14
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-14
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-14
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-14
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-14
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-14
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-13
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-13
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-13
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-13
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-13
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-12
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-12
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-12
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-11
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-11
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-11
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-11
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-11
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-11
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-11
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-10
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-10
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-10
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-10
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-10
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-10
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-10
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-10
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-09
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-08
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-08
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-08
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-07
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-07
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-07
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-07
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-07
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-07
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-07
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-07
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-07
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-06
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-06
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-06
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-06
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-06
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-06
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-06
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-06
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-04
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-04
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-04
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-04
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-04
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-04
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  208 bits (531), Expect = 4e-65
 Identities = 88/321 (27%), Positives = 150/321 (46%), Gaps = 21/321 (6%)

Query: 30  SGASVLKELIASSNGKYYPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQE- 88
              + + + ++SS    +        +++ ATN++D K +I     +    +YKG  ++ 
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHG-VFG--KVYKGVLRDG 63

Query: 89  RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGT 148
             +++ +        +  E     +   +   H H++ LIG C E    IL+++ ++ G 
Sbjct: 64  AKVALKR--RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 149 LWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV 208
           L   + G+  P    +  + RL+I +     L YLH      I+ R+ K+  IL +E  V
Sbjct: 122 LKRHLYGSDLPT-MSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV 177

Query: 209 AKLFDFSLSISIPEG-ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            K+ DF +S    E  +TH++  V GT GY  PEY   G   EKSDV+SFGV LFE+L  
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

Query: 268 WDVSD--LVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLS 325
                  L ++  +LA    E+      + +  +IVDP + + +    + + L      +
Sbjct: 238 RSAIVQSLPREMVNLA----EWAVESHNNGQLEQIVDPNLADKI----RPESLRKFGDTA 289

Query: 326 FECIKDSPADRPSMVDVAKKL 346
            +C+  S  DRPSM DV  KL
Sbjct: 290 VKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  194 bits (496), Expect = 4e-60
 Identities = 70/317 (22%), Positives = 136/317 (42%), Gaps = 36/317 (11%)

Query: 50  RIFSAQEIKLATNSYDQKNVIAKDTSYNLY------TMYKGFWQERLISVLQFYGHECRP 103
             FS  E+K  TN++D++ +       N         +YKG+     ++V +        
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGG---NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDI- 68

Query: 104 RAYESC------INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAP 157
               +          +   A+  H ++++L+G   +     LV+  +  G+L DR+    
Sbjct: 69  ---TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125

Query: 158 QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS 217
                PL    R KIA    + + +LH       + R+ K++ IL +E   AK+ DF L+
Sbjct: 126 GT--PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 218 ISIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKD 276
            +  +   T +T  ++GT  Y APE +  G    KSD++SFGV L E++TG    D  ++
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 277 THDLACPSNEYLKNYFEDNR-FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD 335
              L     +  +   ++ +   + +D       ++      + A   ++ +C+ +    
Sbjct: 240 PQLLL----DIKEEIEDEEKTIEDYIDK-----KMNDADSTSVEAMYSVASQCLHEKKNK 290

Query: 336 RPSMVDVAKKLRQIYRS 352
           RP +  V + L+++  S
Sbjct: 291 RPDIKKVQQLLQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  192 bits (491), Expect = 3e-59
 Identities = 85/301 (28%), Positives = 150/301 (49%), Gaps = 16/301 (5%)

Query: 50  RIFSAQEIKLATNSYDQKNVIAKDTSYNLY-TMYKGFWQE-RLISV--LQFYGHECRPRA 105
           + FS +E+++A++++  KN++ +      +  +YKG   +  L++V  L+    +     
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGG----FGKVYKGRLADGTLVAVKRLKEERTQGGELQ 73

Query: 106 YESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL 165
           +      V   +   H ++L+L G C+     +LV+  +  G++   +   P     PL 
Sbjct: 74  F---QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLD 129

Query: 166 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
              R +IA+     LAYLH      I+ R+ K + IL +EE  A + DF L+  +   +T
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189

Query: 226 HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN 285
           H+T  V GT G+ APEY+ TG  +EK+DVF +GV L EL+TG    DL +  +D      
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249

Query: 286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK 345
           +++K   ++ +   +VD  +  +    E EQ +  +      C + SP +RP M +V + 
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL----CTQSSPMERPKMSEVVRM 305

Query: 346 L 346
           L
Sbjct: 306 L 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  152 bits (387), Expect = 7e-44
 Identities = 61/323 (18%), Positives = 114/323 (35%), Gaps = 39/323 (12%)

Query: 52  FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCIN 111
              + +   +       V A+   +    ++K       ++V  F   +   +       
Sbjct: 14  LGTENLYFQSMPLQLLEVKAR-GRFG--CVWKAQLLNEYVAVKIFPIQD---KQSWQNEY 67

Query: 112 NVTYAARMSHNHILKLIGCCLETPIP----ILVFESVQYGTLWDRILGAPQPHFEPLLLK 167
            V     M H +IL+ IG             L+    + G+L D +          +   
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWN 121

Query: 168 HRLKIAMDIVHALAYLH------FGFPRP-IVFRNFKTSCILFNEENVAKLFDFSLSISI 220
               IA  +   LAYLH          +P I  R+ K+  +L      A + DF L++  
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181

Query: 221 PEGETHI-TDTVMGTWGYCAPEYMRTGV-----FNEKSDVFSFGVFLFELLTGWDVSDLV 274
             G++   T   +GT  Y APE +   +        + D+++ G+ L+EL +    +D  
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 275 KDTHDLACPSNEYLKNYFEDNRFTEIV-----DPIIVEDVLSIEKEQQLHASAQLSFECI 329
            D + L  P  E +  +       E+V      P++ +     +K   +    +   EC 
Sbjct: 242 VDEYML--PFEEEIGQHPSLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECW 296

Query: 330 KDSPADRPSMVDVAKKLRQIYRS 352
                 R S   V +++ Q+ R 
Sbjct: 297 DHDAEARLSAGCVGERITQMQRL 319

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  134 bits (340), Expect = 1e-37
 Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 40/277 (14%)

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL 139
            ++KG WQ   I V      +   R               SH ++L ++G C   P P  
Sbjct: 25  ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84

Query: 140 --VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 197
             +   + YG+L++ +    +     +     +K A+D+   +A+LH      I      
Sbjct: 85  TLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALN 140

Query: 198 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDV 254
           +  ++ +E+  A++    +  S            M    + APE ++          +D+
Sbjct: 141 SRSVMIDEDMTARISMADVKFSFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADM 194

Query: 255 FSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDV-LSIE 313
           +SF V L+EL+T                      +  F D    EI   + +E +  +I 
Sbjct: 195 WSFAVLLWELVTR---------------------EVPFADLSNMEIGMKVALEGLRPTIP 233

Query: 314 KEQQLHAS-AQLSFECIKDSPADRPSMVDVAKKLRQI 349
               +    ++L   C+ + PA RP    +   L ++
Sbjct: 234 PG--ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  132 bits (334), Expect = 3e-36
 Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 29/276 (10%)

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL 139
           T+++  W    ++V      +         +  V    R+ H +I+  +G   + P   +
Sbjct: 52  TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111

Query: 140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           V E +  G+L+  +L         L  + RL +A D+   + YLH     PIV RN K+ 
Sbjct: 112 VTEYLSRGSLYR-LLHKSGARE-QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSP 168

Query: 200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
            +L +++   K+ DF LS            +  GT  + APE +R    NEKSDV+SFGV
Sbjct: 169 NLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227

Query: 260 FLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDV-LSIEKEQQL 318
            L+EL T                      +  + +    ++V  +  +   L I +   L
Sbjct: 228 ILWELATL---------------------QQPWGNLNPAQVVAAVGFKCKRLEIPRN--L 264

Query: 319 HAS-AQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
           +   A +   C  + P  RPS   +   LR + +S 
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  127 bits (322), Expect = 1e-34
 Identities = 64/276 (23%), Positives = 119/276 (43%), Gaps = 39/276 (14%)

Query: 82  YKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF 141
            K  W+ + +++ Q      R    ++ I  +   +R++H +I+KL G CL      LV 
Sbjct: 25  CKAKWRAKDVAIKQIESESER----KAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVM 78

Query: 142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 201
           E  + G+L++ + GA           H +   +     +AYLH   P+ ++ R+ K   +
Sbjct: 79  EYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136

Query: 202 LFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVF 260
           L      V K+ DF  +  I   +TH+T+   G+  + APE      ++EK DVFS+G+ 
Sbjct: 137 LLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEKCDVFSWGII 192

Query: 261 LFELLTG---WDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQ 317
           L+E++T    +D         ++  P+   +       R      P +++++        
Sbjct: 193 LWEVITRRKPFD---------EIGGPAFRIMWAVHNGTR------PPLIKNLPK------ 231

Query: 318 LHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
                 L   C    P+ RPSM ++ K +  + R  
Sbjct: 232 --PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  124 bits (313), Expect = 1e-33
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 44/280 (15%)

Query: 82  YKGFWQERLISV--LQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL 139
           Y+ FW    ++V   +    E   +  E+        A + H +I+ L G CL+ P   L
Sbjct: 24  YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83

Query: 140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           V E  + G L   +        + +     +  A+ I   + YLH     PI+ R+ K+S
Sbjct: 84  VMEFARGGPLNRVL------SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137

Query: 200 CILFNEE--------NVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEK 251
            IL  ++         + K+ DF L+            +  G + + APE +R  +F++ 
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKG 194

Query: 252 SDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDV-L 310
           SDV+S+GV L+ELLTG                     +  F       +   + +  + L
Sbjct: 195 SDVWSYGVLLWELLTG---------------------EVPFRGIDGLAVAYGVAMNKLAL 233

Query: 311 SIEKEQQLHAS-AQLSFECIKDSPADRPSMVDVAKKLRQI 349
            I          A+L  +C    P  RPS  ++  +L  I
Sbjct: 234 PIPST--CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  125 bits (316), Expect = 2e-33
 Identities = 57/295 (19%), Positives = 109/295 (36%), Gaps = 38/295 (12%)

Query: 82  YKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI--- 138
           + G W+   ++V  F+  E      E+ I        M H +IL  I   ++        
Sbjct: 54  WMGKWRGEKVAVKVFFTTEEASWFRETEIYQT---VLMRHENILGFIAADIKGTGSWTQL 110

Query: 139 -LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-----PIV 192
            L+ +  + G+L+D +          L  K  LK+A   V  L +LH           I 
Sbjct: 111 YLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164

Query: 193 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM---GTWGYCAPE------YM 243
            R+ K+  IL  +     + D  L++        +        GT  Y  PE        
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224

Query: 244 RTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP 303
                   +D++SFG+ L+E+        +V+   +   P ++ +     D  + ++ + 
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVE---EYQLPYHDLV---PSDPSYEDMREI 278

Query: 304 IIVEDV-----LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
           + ++ +          ++ L    +L  EC   +PA R + + V K L ++  S 
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  123 bits (311), Expect = 1e-32
 Identities = 57/334 (17%), Positives = 109/334 (32%), Gaps = 48/334 (14%)

Query: 52  FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCIN 111
            +A E  L  ++     +I +   Y    +YKG   ER ++V  F          ++ IN
Sbjct: 3   AAASEPSLDLDNLKLLELIGRG-RYG--AVYKGSLDERPVAVKVF-----SFANRQNFIN 54

Query: 112 --NVTYAARMSHNHILKLIGCCLETPIPI-----LVFESVQYGTLWDRILGAPQPHFEPL 164
             N+     M H++I + I               LV E    G+L   +           
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTS 108

Query: 165 LLKHRLKIAMDIVHALAYLHFGFPR------PIVFRNFKTSCILFNEENVAKLFDFSLS- 217
                 ++A  +   LAYLH   PR       I  R+  +  +L   +    + DF LS 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 218 ------ISIPEGETHITDTVMGTWGYCAPEYMRTGV-------FNEKSDVFSFGVFLFEL 264
                 +  P  E +   + +GT  Y APE +   V         ++ D+++ G+  +E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 265 LTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVD-----PIIVEDVLSIEKEQQLH 319
                     +   +        + N+        +V      P   E          + 
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS--LAVR 286

Query: 320 ASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
           +  +   +C       R +     +++ ++    
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  120 bits (302), Expect = 2e-31
 Identities = 53/300 (17%), Positives = 115/300 (38%), Gaps = 46/300 (15%)

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI- 138
            +++G W+   ++V  F   E R    E+ I        + H +IL  I    +      
Sbjct: 57  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQT---VMLRHENILGFIAADNKDNGTWT 113

Query: 139 ---LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-----P 190
              LV +  ++G+L+D +      +   + ++  +K+A+     LA+LH           
Sbjct: 114 QLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167

Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD---TVMGTWGYCAPEYMRTGV 247
           I  R+ K+  IL  +     + D  L++        I       +GT  Y APE +   +
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227

Query: 248 ------FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE----DNRF 297
                   +++D+++ G+  +E+     +  + +          +Y   Y++    D   
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE----------DYQLPYYDLVPSDPSV 277

Query: 298 TEIVDPIIVEDV-----LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
            E+   +  + +        +  + L   A++  EC   + A R + + + K L Q+ + 
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  116 bits (292), Expect = 3e-30
 Identities = 53/249 (21%), Positives = 88/249 (35%), Gaps = 40/249 (16%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
            + H ++LK IG   +      + E ++ GTL   I    +          R+  A DI 
Sbjct: 63  CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIA 118

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD-------- 229
             +AYLH      I+ R+  +   L  E     + DF L+  + + +T            
Sbjct: 119 SGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 230 -----TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS 284
                TV+G   + APE +    ++EK DVFSFG+ L E++        V    D    +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR------VNADPDYLPRT 229

Query: 285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK 344
            ++  N                 +           +   ++  C    P  RPS V +  
Sbjct: 230 MDFGLNVRGFLD------RYCPPNCPP--------SFFPITVRCCDLDPEKRPSFVKLEH 275

Query: 345 KLRQIYRSL 353
            L  +   L
Sbjct: 276 WLETLRMHL 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  115 bits (290), Expect = 4e-30
 Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 52/286 (18%)

Query: 82  YKGFWQER-------LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET 134
           +KG   +         + +    G       ++     V   + ++H +I+KL G     
Sbjct: 36  HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95

Query: 135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
           P   +V E V  G L+ R+L        P+    +L++ +DI   + Y+      PIV R
Sbjct: 96  PR--MVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHR 148

Query: 195 NFKTSCILFNEEN-----VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPE--YMRTGV 247
           + ++  I     +      AK+ DF LS    +   H    ++G + + APE        
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQWMAPETIGAEEES 204

Query: 248 FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVD----P 303
           + EK+D +SF + L+ +LTG               P +EY  +Y +      I +    P
Sbjct: 205 YTEKADTYSFAMILYTILTG-------------EGPFDEY--SYGKIKFINMIREEGLRP 249

Query: 304 IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
            I ED               +   C    P  RP    + K+L ++
Sbjct: 250 TIPEDCPP--------RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  113 bits (286), Expect = 2e-29
 Identities = 58/291 (19%), Positives = 113/291 (38%), Gaps = 38/291 (13%)

Query: 82  YKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI--- 138
           ++G WQ   ++V  F   + +    E+ + N      + H +IL  I   + +       
Sbjct: 25  WRGSWQGENVAVKIFSSRDEKSWFRETELYNT---VMLRHENILGFIASDMTSRHSSTQL 81

Query: 139 -LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLH-----FGFPRPIV 192
            L+    + G+L+D +          L     L+I + I   LA+LH           I 
Sbjct: 82  WLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135

Query: 193 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM---GTWGYCAPE------YM 243
            R+ K+  IL  +     + D  L++   +    +        GT  Y APE       +
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195

Query: 244 RTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP 303
                 ++ D+++FG+ L+E+      + +V+   D   P  + + N   D  F ++   
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE---DYKPPFYDVVPN---DPSFEDMRKV 249

Query: 304 IIVEDV-LSIEKEQQLHAS----AQLSFECIKDSPADRPSMVDVAKKLRQI 349
           + V+    +I        +    A+L  EC   +P+ R + + + K L +I
Sbjct: 250 VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  109 bits (275), Expect = 6e-28
 Identities = 54/241 (22%), Positives = 107/241 (44%), Gaps = 35/241 (14%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           +  H +IL  +G      + I V +  +  +L+   L A +  FE   +K  + IA    
Sbjct: 76  KTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYH-HLHASETKFE---MKKLIDIARQTA 130

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGTWG 236
             + YLH    + I+ R+ K++ I  +E+N  K+ DF L+        +H  + + G+  
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187

Query: 237 YCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE 293
           + APE +R   +  ++ +SDV++FG+ L+EL+TG               P       Y  
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG-------------QLP-------YSN 227

Query: 294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSF---ECIKDSPADRPSMVDVAKKLRQIY 350
            N   +I++ +    +     + + +   ++     EC+K    +RPS   +  ++ ++ 
Sbjct: 228 INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

Query: 351 R 351
           R
Sbjct: 288 R 288

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (272), Expect = 3e-27
 Identities = 45/283 (15%), Positives = 97/283 (34%), Gaps = 43/283 (15%)

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL 139
            +Y G W    +++             ++    V    +  H +++  +G C+  P   +
Sbjct: 48  QVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106

Query: 140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           +    +  TL+  +  A       L +    +IA +IV  + YLH    + I+ ++ K+ 
Sbjct: 107 ITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSK 159

Query: 200 CILFNEENVAKLFDFSLSISIPEGETHITDTVM----GTWGYCAPEYMRTGV-------- 247
            + ++   V  + DF L       +    +  +    G   + APE +R           
Sbjct: 160 NVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218

Query: 248 -FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIV 306
            F++ SDVF+ G   +EL                  P        F+      I+  +  
Sbjct: 219 PFSKHSDVFALGTIWYELHAR-------------EWP--------FKTQPAEAIIWQMGT 257

Query: 307 EDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
               ++ +       + +   C      +RP+   +   L ++
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 40/190 (21%), Positives = 76/190 (40%), Gaps = 39/190 (20%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           A + + H+ +L+G CL + + + + + + +G L D  +   + +     L   L   + I
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY-VREHKDNIGSQYL---LNWCVQI 126

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     +L       K+ DF L+  +   E      
Sbjct: 127 AKGMNYLEDRRLVH----RDLAARN-----VLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVK 275
             G      W   A E +   ++  +SDV+S+GV ++EL+T            ++S +++
Sbjct: 178 --GGKVPIKW--MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

Query: 276 DTHDLACPSN 285
               L  P  
Sbjct: 234 KGERLPQPPI 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 61/257 (23%), Positives = 101/257 (39%), Gaps = 49/257 (19%)

Query: 117 ARMSHNHILKLIGCCLETPI-PI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM 174
             + H++I+K  G C       + L+ E + YG+L D +    Q H E +     L+   
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTS 121

Query: 175 DIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            I   + YL      H    R +  RN     IL   EN  K+ DF L+  +P+ +    
Sbjct: 122 QICKGMEYLGTKRYIH----RDLATRN-----ILVENENRVKIGDFGLTKVLPQDKEFFK 172

Query: 229 DTVMGT----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS 284
               G     W   APE +    F+  SDV+SFGV L+EL T  + S            +
Sbjct: 173 VKEPGESPIFW--YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230

Query: 285 NEYLKNYFEDNRFTEIVDPIIVEDVLS-IEKEQQLHASA-------QLSFECIKDSPADR 336
           ++                 +IV  ++  ++   +L            +  EC  ++   R
Sbjct: 231 DKQ--------------GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276

Query: 337 PSMVDVAKKLRQIYRSL 353
           PS  D+A ++ QI  ++
Sbjct: 277 PSFRDLALRVDQIRDNM 293

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 60/257 (23%), Positives = 94/257 (36%), Gaps = 71/257 (27%)

Query: 118 RMSHNHILKLIG-CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           + SH +I++LIG C  + PI I V E VQ G     +    +     L +K  L++  D 
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYI-VMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDA 222

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN      L  E+NV K+ DF +S    +G       
Sbjct: 223 AAGMEYLESKCCIH----RDLAARN-----CLVTEKNVLKISDFGMSREEADGVY----A 269

Query: 231 VMGTWGYC-----APEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVK 275
             G          APE +  G ++ +SDV+SFG+ L+E  +               + V+
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

Query: 276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD 335
               L CP                   P              +    +L  +C    P  
Sbjct: 330 KGGRLPCPELC----------------P------------DAVF---RLMEQCWAYEPGQ 358

Query: 336 RPSMVDVAKKLRQIYRS 352
           RPS   + ++L+ I + 
Sbjct: 359 RPSFSTIYQELQSIRKR 375

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 61/257 (23%), Positives = 101/257 (39%), Gaps = 49/257 (19%)

Query: 117 ARMSHNHILKLIGCCLETPI-PI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM 174
             + H++I+K  G C       + L+ E + YG+L D +    Q H E +     L+   
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTS 152

Query: 175 DIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            I   + YL      H    R +  RN     IL   EN  K+ DF L+  +P+ + +  
Sbjct: 153 QICKGMEYLGTKRYIH----RDLATRN-----ILVENENRVKIGDFGLTKVLPQDKEYYK 203

Query: 229 DTVMGT----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS 284
               G     W   APE +    F+  SDV+SFGV L+EL T  + S            +
Sbjct: 204 VKEPGESPIFW--YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261

Query: 285 NEYLKNYFEDNRFTEIVDPIIVEDVLS-IEKEQQLHASA-------QLSFECIKDSPADR 336
           ++                 +IV  ++  ++   +L            +  EC  ++   R
Sbjct: 262 DKQ--------------GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307

Query: 337 PSMVDVAKKLRQIYRSL 353
           PS  D+A ++ QI   +
Sbjct: 308 PSFRDLALRVDQIRDQM 324

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 84.2 bits (209), Expect = 9e-19
 Identities = 53/261 (20%), Positives = 94/261 (36%), Gaps = 75/261 (28%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            ++ + +I++LIG C    + + V E    G L  + L   +       +    ++   +
Sbjct: 65  HQLDNPYIVRLIGVCQAEALML-VMEMAGGGPL-HKFLVGKREEIPVSNV---AELLHQV 119

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     +L    + AK+ DF LS ++   +++ T  
Sbjct: 120 SMGMKYLEEKNFVH----RDLAARN-----VLLVNRHYAKISDFGLSKALGADDSYYTAR 170

Query: 231 VMGT----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
             G     W   APE +    F+ +SDV+S+GV ++E L+          G +V   ++ 
Sbjct: 171 SAGKWPLKW--YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

Query: 277 THDL----ACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDS 332
              +     CP   Y                                    L  +C    
Sbjct: 229 GKRMECPPECPPELY-----------------------------------ALMSDCWIYK 253

Query: 333 PADRPSMVDVAKKLRQIYRSL 353
             DRP  + V +++R  Y SL
Sbjct: 254 WEDRPDFLTVEQRMRACYYSL 274

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 8/152 (5%)

Query: 116 AARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
           ++++SH +I+ +I    E     LV E ++  TL + I         PL +   +     
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQ 119

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  + + H      IV R+ K   IL +     K+FDF ++ ++ E     T+ V+GT 
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            Y +PE  +    +E +D++S G+ L+E+L G
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 39/190 (20%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
             + H HI++L+G C  + + + V + +  G+L D  +   +    P LL   L   + I
Sbjct: 70  GSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDH-VRQHRGALGPQLL---LNWGVQI 124

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     +L    +  ++ DF ++  +P  +  +  +
Sbjct: 125 AKGMYYLEEHGMVH----RNLAARN-----VLLKSPSQVQVADFGVADLLPPDDKQLLYS 175

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVK 275
                    W   A E +  G +  +SDV+S+GV ++EL+T            +V DL++
Sbjct: 176 --EAKTPIKW--MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

Query: 276 DTHDLACPSN 285
               LA P  
Sbjct: 232 KGERLAQPQI 241

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 37/189 (19%)

Query: 119 MSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++H ++L LIG  L    +P ++   + +G L   I    +       +K  +   + + 
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVA 134

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
             + YL      H    R +  RN      + +E    K+ DF L+  I + E +     
Sbjct: 135 RGMEYLAEQKFVH----RDLAARN-----CMLDESFTVKVADFGLARDILDREYYSVQQH 185

Query: 232 MGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                   W   A E ++T  F  KSDV+SFGV L+ELLT           +D++  +  
Sbjct: 186 RHARLPVKW--TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

Query: 277 THDLACPSN 285
              L  P  
Sbjct: 244 GRRLPQPEY 252

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
             + H ++++L G  L  P+ + V E    G+L DR L   Q HF    L    + A+ +
Sbjct: 76  HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR-LRKHQGHFLLGTL---SRYAVQV 130

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     +L    ++ K+ DF L  ++P+ + H    
Sbjct: 131 AEGMGYLESKRFIH----RDLAARN-----LLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181

Query: 231 VMGTWGY--CAPEYMRTGVFNEKSDVFSFGVFLFELLT 266
                 +  CAPE ++T  F+  SD + FGV L+E+ T
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 51/259 (19%), Positives = 92/259 (35%), Gaps = 72/259 (27%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            ++ + +I+++IG C      + V E  + G L   +          +  K+ +++   +
Sbjct: 73  QQLDNPYIVRMIGICEAESWML-VMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQV 126

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     +L   ++ AK+ DF LS ++   E +    
Sbjct: 127 SMGMKYLEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQ 177

Query: 231 VMGTW--GYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKDTH 278
             G W   + APE +    F+ KSDV+SFGV ++E  +          G +V+ +++   
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237

Query: 279 DL----ACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPA 334
            +     CP   Y                                    L   C      
Sbjct: 238 RMGCPAGCPREMY-----------------------------------DLMNLCWTYDVE 262

Query: 335 DRPSMVDVAKKLRQIYRSL 353
           +RP    V  +LR  Y  +
Sbjct: 263 NRPGFAAVELRLRNYYYDV 281

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 51/257 (19%), Positives = 93/257 (36%), Gaps = 68/257 (26%)

Query: 119 MSHNHILKLIGCCLETPIPIL-VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
            SH ++L L+G CL +    L V   +++G L    +     +     +K  +   + + 
Sbjct: 83  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHN---PTVKDLIGFGLQVA 138

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
             + YL      H    R +  RN      + +E+   K+ DF L+  + + E +     
Sbjct: 139 KGMKYLASKKFVH----RDLAARN-----CMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189

Query: 232 MGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
            G      W   A E ++T  F  KSDV+SFGV L+EL+T           +D++  +  
Sbjct: 190 TGAKLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

Query: 277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR 336
              L  P                                  L+   ++  +C       R
Sbjct: 248 GRRLLQPEY----------------------------CPDPLY---EVMLKCWHPKAEMR 276

Query: 337 PSMVDVAKKLRQIYRSL 353
           PS  ++  ++  I+ + 
Sbjct: 277 PSFSELVSRISAIFSTF 293

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 50/257 (19%), Positives = 91/257 (35%), Gaps = 68/257 (26%)

Query: 119 MSHNHILKLIGCCLETPIPIL-VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
            SH ++L L+G CL +    L V   +++G L    +     +     L   +   + + 
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDL---IGFGLQVA 202

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
             + +L      H    R +  RN      + +E+   K+ DF L+  + + E       
Sbjct: 203 KGMKFLASKKFVH----RDLAARN-----CMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253

Query: 232 MGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
            G      W   A E ++T  F  KSDV+SFGV L+EL+T           +D++  +  
Sbjct: 254 TGAKLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311

Query: 277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR 336
              L  P                                  L+   ++  +C       R
Sbjct: 312 GRRLLQPEY----------------------------CPDPLY---EVMLKCWHPKAEMR 340

Query: 337 PSMVDVAKKLRQIYRSL 353
           PS  ++  ++  I+ + 
Sbjct: 341 PSFSELVSRISAIFSTF 357

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 45/197 (22%), Positives = 84/197 (42%), Gaps = 44/197 (22%)

Query: 118 RMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGA-PQPHFEPLLLKHRLK 171
             SH ++++L+G C+E      P P+++   ++YG L   +L +  +   + + L+  LK
Sbjct: 92  DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151

Query: 172 IAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 225
             +DI   + YL      H    R +  RN      +  ++    + DF LS  I  G+ 
Sbjct: 152 FMVDIALGMEYLSNRNFLH----RDLAARN-----CMLRDDMTVCVADFGLSKKIYSGDY 202

Query: 226 HITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GW 268
           +    +       +      A E +   V+  KSDV++FGV ++E+ T            
Sbjct: 203 YRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256

Query: 269 DVSDLVKDTHDLACPSN 285
           ++ D +   H L  P +
Sbjct: 257 EMYDYLLHGHRLKQPED 273

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 14/158 (8%)

Query: 116 AARMSHNHILKL--IGC--CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 171
           AA ++H  I+ +   G       P+P +V E V   TL D +         P+  K  ++
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIE 120

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT- 230
           +  D   AL + H      I+ R+ K + I+ +  N  K+ DF ++ +I +    +T T 
Sbjct: 121 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 231 -VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            V+GT  Y +PE  R    + +SDV+S G  L+E+LTG
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 83.2 bits (206), Expect = 4e-18
 Identities = 44/203 (21%), Positives = 81/203 (39%), Gaps = 48/203 (23%)

Query: 116 AARMS---HNHILKLIGCCLE------TPIPILVFESVQYGTLWDRILGA-PQPHFEPLL 165
           AA M    H H+ KL+G  L        PIP+++   +++G L   +L +    +   L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135

Query: 166 LKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
           L+  ++  +DI   + YL      H    R +  RN      +  E+    + DF LS  
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIH----RDLAARN-----CMLAEDMTVCVADFGLSRK 186

Query: 220 IPEGETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT------ 266
           I  G+ +            +      A E +   ++   SDV++FGV ++E++T      
Sbjct: 187 IYSGDYYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

Query: 267 ----GWDVSDLVKDTHDLACPSN 285
                 ++ + +   + L  P  
Sbjct: 241 AGIENAEIYNYLIGGNRLKQPPE 263

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 82.7 bits (205), Expect = 5e-18
 Identities = 47/196 (23%), Positives = 78/196 (39%), Gaps = 43/196 (21%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPLLLKHRLKI 172
             + +H+++L+G   +    +++ E +  G L       R   A  P   P  L   +++
Sbjct: 84  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 173 AMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
           A +I   +AYL      H    R +  RN      +  E+   K+ DF ++  I E + +
Sbjct: 144 AGEIADGMAYLNANKFVH----RDLAARN-----CMVAEDFTVKIGDFGMTRDIYETDYY 194

Query: 227 ITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWD 269
                       M      +PE ++ GVF   SDV+SFGV L+E+ T             
Sbjct: 195 RKGGKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248

Query: 270 VSDLVKDTHDLACPSN 285
           V   V +   L  P N
Sbjct: 249 VLRFVMEGGLLDKPDN 264

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 82.4 bits (204), Expect = 6e-18
 Identities = 40/190 (21%), Positives = 76/190 (40%), Gaps = 39/190 (20%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           A + + H+ +L+G CL + + + + + + +G L D  +   + +     L   L   + I
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY-VREHKDNIGSQYL---LNWCVQI 126

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     +L       K+ DF L+  +   E      
Sbjct: 127 AKGMNYLEDRRLVH----RDLAARN-----VLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVK 275
             G      W   A E +   ++  +SDV+S+GV ++EL+T            ++S +++
Sbjct: 178 --GGKVPIKW--MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

Query: 276 DTHDLACPSN 285
               L  P  
Sbjct: 234 KGERLPQPPI 243

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.5 bits (202), Expect = 6e-18
 Identities = 51/189 (26%), Positives = 73/189 (38%), Gaps = 40/189 (21%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           +  H HI+KLIG   E P+ I + E    G L    L   +   +   L   +  A  + 
Sbjct: 72  QFDHPHIVKLIGVITENPVWI-IMELCTLGEL-RSFLQVRKYSLDLASL---ILYAYQLS 126

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
            ALAYL      H    R I  RN     +L +  +  KL DF LS  + +   +     
Sbjct: 127 TALAYLESKRFVH----RDIAARN-----VLVSSNDCVKLGDFGLSRYMEDSTYYKAS-- 175

Query: 232 MGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
                   W   APE +    F   SDV+ FGV ++E+L             DV   +++
Sbjct: 176 -KGKLPIKW--MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232

Query: 277 THDLACPSN 285
              L  P N
Sbjct: 233 GERLPMPPN 241

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 46/193 (23%), Positives = 71/193 (36%), Gaps = 37/193 (19%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMD 175
           + +H +I++ IG  L++    ++ E +  G L    R           L +   L +A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189

Query: 176 IVHALAYL------HFGFPRPIVFRNFKTSCIL--FNEENVAKLFDFSLSISIPEGETHI 227
           I     YL      H    R I  RN    C+L       VAK+ DF ++  I       
Sbjct: 190 IACGCQYLEENHFIH----RDIAARN----CLLTCPGPGRVAKIGDFGMARDIYRAGY-- 239

Query: 228 TDTVMGTWGY-----CAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSD 272
                G           PE    G+F  K+D +SFGV L+E+ +            +V +
Sbjct: 240 --YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297

Query: 273 LVKDTHDLACPSN 285
            V     +  P N
Sbjct: 298 FVTSGGRMDPPKN 310

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 33/156 (21%), Positives = 57/156 (36%), Gaps = 16/156 (10%)

Query: 116 AARMSHNHILKL--IGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 173
           A R+   H++ +   G         +    +    L   +         PL     + I 
Sbjct: 88  AGRLQEPHVVPIHDFGE--IDGQLYVDMRLINGVDLAAMLR-----RQGPLAPPRAVAIV 140

Query: 174 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--V 231
             I  AL   H         R+ K   IL + ++ A L DF ++ +    +  +T     
Sbjct: 141 RQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNT 195

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  Y APE         ++D+++    L+E LTG
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 61/256 (23%), Positives = 93/256 (36%), Gaps = 50/256 (19%)

Query: 117 ARMSHNHILKLIGCCLETPI-PI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM 174
             +  + I+K  G         + LV E +  G L D  L   +   +   L   L  + 
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF-LQRHRARLDASRL---LLYSS 134

Query: 175 DIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            I   + YL      H    R +  RN     IL   E   K+ DF L+  +P  + +  
Sbjct: 135 QICKGMEYLGSRRCVH----RDLAARN-----ILVESEAHVKIADFGLAKLLPLDKDYYV 185

Query: 229 DTVMGT----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS 284
               G     W   APE +   +F+ +SDV+SFGV L+EL T  D S             
Sbjct: 186 VREPGQSPIFW--YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------- 230

Query: 285 NEYLKNYFEDNRFTEIVDPIIVEDVLS-IEKEQQLHASA-------QLSFECIKDSPADR 336
                +           D   +  +L  +E+ Q+L A         +L   C   SP DR
Sbjct: 231 --CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 288

Query: 337 PSMVDVAKKLRQIYRS 352
           PS   +  +L  ++  
Sbjct: 289 PSFSALGPQLDMLWSG 304

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 37/159 (23%), Positives = 63/159 (39%), Gaps = 26/159 (16%)

Query: 116 AARMSHNHILKLI-----GCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
            A + H  I+++            P+  +V E V   +L              L +   +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAI 185

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              ++I+ AL+YLH      +V+ + K   I+  EE + KL D           + I   
Sbjct: 186 AYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAV-------SRINSF 234

Query: 231 --VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + GT G+ APE +RTG     +D+++ G  L  L   
Sbjct: 235 GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLD 272

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 46/193 (23%), Positives = 71/193 (36%), Gaps = 37/193 (19%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMD 175
           + +H +I++ IG  L++    ++ E +  G L    R           L +   L +A D
Sbjct: 89  KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148

Query: 176 IVHALAYL------HFGFPRPIVFRNFKTSCIL--FNEENVAKLFDFSLSISIPEGETHI 227
           I     YL      H    R I  RN    C+L       VAK+ DF ++  I       
Sbjct: 149 IACGCQYLEENHFIH----RDIAARN----CLLTCPGPGRVAKIGDFGMARDIYRASY-- 198

Query: 228 TDTVMGTWGY-----CAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSD 272
                G           PE    G+F  K+D +SFGV L+E+ +            +V +
Sbjct: 199 --YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256

Query: 273 LVKDTHDLACPSN 285
            V     +  P N
Sbjct: 257 FVTSGGRMDPPKN 269

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 51/190 (26%), Positives = 75/190 (39%), Gaps = 40/190 (21%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            +  H HI+KLIG   E P+ I + E    G L    L   +   +   L   +  A  +
Sbjct: 446 RQFDHPHIVKLIGVITENPVWI-IMELCTLGEL-RSFLQVRKFSLDLASL---ILYAYQL 500

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
             ALAYL      H    R I  RN     +L +  +  KL DF LS  + +     +  
Sbjct: 501 STALAYLESKRFVH----RDIAARN-----VLVSSNDCVKLGDFGLSRYMED-----STY 546

Query: 231 VMGTWG-----YCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVK 275
              + G     + APE +    F   SDV+ FGV ++E+L             DV   ++
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

Query: 276 DTHDLACPSN 285
           +   L  P N
Sbjct: 607 NGERLPMPPN 616

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 54/255 (21%), Positives = 97/255 (38%), Gaps = 63/255 (24%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            ++ + +I++LIG C    + + V E    G L  + L   +       +    ++   +
Sbjct: 391 HQLDNPYIVRLIGVCQAEALML-VMEMAGGGPL-HKFLVGKREEIPVSNV---AELLHQV 445

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     +L    + AK+ DF LS ++   +++ T  
Sbjct: 446 SMGMKYLEEKNFVH----RNLAARN-----VLLVNRHYAKISDFGLSKALGADDSYYTAR 496

Query: 231 VMGTWGY--CAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKDTH 278
             G W     APE +    F+ +SDV+S+GV ++E L+          G +V   ++   
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556

Query: 279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS 338
            + CP                   P             +L+    L  +C      DRP 
Sbjct: 557 RMECPPE----------------CP------------PELY---ALMSDCWIYKWEDRPD 585

Query: 339 MVDVAKKLRQIYRSL 353
            + V +++R  Y SL
Sbjct: 586 FLTVEQRMRACYYSL 600

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 33/216 (15%), Positives = 66/216 (30%), Gaps = 23/216 (10%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
               +  +K     L     +LV E   YGTL + I        + +     +  AM ++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENVA-----------KLFDFSLSI---SIPEG 223
           + +  +H      I+  + K    +     +             L D   SI     P+G
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACP 283
                     T G+   E +    +N + D F     ++ +L G   + +        C 
Sbjct: 240 TIFTAKC--ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG---TYMKVKNEGGECK 294

Query: 284 SNEYLKNYFEDNRFTEIVDPII-VEDVLSIEKEQQL 318
                +     + + E    ++ + D   +     L
Sbjct: 295 PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 62/253 (24%), Positives = 91/253 (35%), Gaps = 64/253 (25%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     E PI I V E +  G+L D  L      +  L L   + +A  I 
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDF-LKGETGKY--LRLPQLVDMAAQIA 373

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
             +AY+      H    R +   N     IL  E  V K+ DF L+  I + E       
Sbjct: 374 SGMAYVERMNYVH----RDLRAAN-----ILVGENLVCKVADFGLARLIEDNEYTARQGA 424

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKDTHDLA 281
                + APE    G F  KSDV+SFG+ L EL T       G    +V D V+  + + 
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 484

Query: 282 CPSN--EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM 339
           CP    E L                                   L  +C +  P +RP+ 
Sbjct: 485 CPPECPESLH---------------------------------DLMCQCWRKEPEERPTF 511

Query: 340 VDVAKKLRQIYRS 352
             +   L   + S
Sbjct: 512 EYLQAFLEDYFTS 524

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 57/256 (22%), Positives = 102/256 (39%), Gaps = 52/256 (20%)

Query: 117 ARMSHNHILKLIGCCLETPI-PI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM 174
             + H +I+K  G C E     I L+ E +  G+L + +      +   + LK +LK A+
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAV 133

Query: 175 DIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            I   + YL      H    R +  RN     +L   E+  K+ DF L+ +I   + + T
Sbjct: 134 QICKGMDYLGSRQYVH----RDLAARN-----VLVESEHQVKIGDFGLTKAIETDKEYYT 184

Query: 229 DTVMGT----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACP 283
                     W   APE +    F   SDV+SFGV L ELLT     S  +     +  P
Sbjct: 185 VKDDRDSPVFW--YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242

Query: 284 SNEYLKNYFEDNRFTEIVDPIIVEDVLS-IEKEQQLHASA-------QLSFECIKDSPAD 335
           ++  +                    +++ +++ ++L           QL  +C +  P++
Sbjct: 243 THGQMTV----------------TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSN 286

Query: 336 RPSMVDVAKKLRQIYR 351
           R S  ++ +    + +
Sbjct: 287 RTSFQNLIEGFEALLK 302

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 62/253 (24%), Positives = 91/253 (35%), Gaps = 64/253 (25%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     E PI I V E +  G+L D  L      +  L L   + +A  I 
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDF-LKGETGKY--LRLPQLVDMAAQIA 290

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
             +AY+      H    R +   N     IL  E  V K+ DF L+  I + E       
Sbjct: 291 SGMAYVERMNYVH----RDLRAAN-----ILVGENLVCKVADFGLARLIEDNEYTARQGA 341

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKDTHDLA 281
                + APE    G F  KSDV+SFG+ L EL T       G    +V D V+  + + 
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 401

Query: 282 CPSN--EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM 339
           CP    E L                                   L  +C +  P +RP+ 
Sbjct: 402 CPPECPESLH---------------------------------DLMCQCWRKEPEERPTF 428

Query: 340 VDVAKKLRQIYRS 352
             +   L   + S
Sbjct: 429 EYLQAFLEDYFTS 441

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 45/200 (22%), Positives = 76/200 (38%), Gaps = 49/200 (24%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLLKH 168
            H +I+ L+G C +     ++ E    G L            +      +   E +  K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 169 RLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 222
            +     +   + YL      H    R +  RN     +L  E NV K+ DF L+  I  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIH----RDLAARN-----VLVTENNVMKIADFGLARDINN 209

Query: 223 GETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--------- 266
            + +   T        M      APE +   V+  +SDV+SFGV ++E+ T         
Sbjct: 210 IDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263

Query: 267 -GWDVSDLVKDTHDLACPSN 285
              ++  L+K+ H +  P+N
Sbjct: 264 PVEELFKLLKEGHRMDKPAN 283

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 79.5 bits (197), Expect = 4e-17
 Identities = 52/189 (27%), Positives = 74/189 (39%), Gaps = 40/189 (21%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
            + H HI+KLIG   E P  I + E   YG L    L   +   + L L   +  ++ I 
Sbjct: 69  NLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHY-LERNKNSLKVLTL---VLYSLQIC 123

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
            A+AYL      H    R I  RN     IL       KL DF LS  I + + +     
Sbjct: 124 KAMAYLESINCVH----RDIAVRN-----ILVASPECVKLGDFGLSRYIEDEDYYKAS-- 172

Query: 232 MGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------GWDVSDLVKD 276
             T     W   +PE +    F   SDV+ F V ++E+L+            DV  +++ 
Sbjct: 173 -VTRLPIKW--MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229

Query: 277 THDLACPSN 285
              L  P  
Sbjct: 230 GDRLPKPDL 238

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 48/202 (23%), Positives = 74/202 (36%), Gaps = 48/202 (23%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTL----------WDRILGAPQPHFEPLLL 166
             + H HI++  G C E    ++VFE +++G L             + G       PL L
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 167 KHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
              L +A  +   + YL      H    R +  RN      L  +  V K+ DF +S  I
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVH----RDLATRN-----CLVGQGLVVKIGDFGMSRDI 208

Query: 221 PEGETHITDTVMGT-------WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT------- 266
              +       +G        W    PE +    F  +SDV+SFGV L+E+ T       
Sbjct: 209 YSTDY----YRVGGRTMLPIRW--MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262

Query: 267 ---GWDVSDLVKDTHDLACPSN 285
                +  D +    +L  P  
Sbjct: 263 QLSNTEAIDCITQGRELERPRA 284

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 79.6 bits (197), Expect = 6e-17
 Identities = 43/202 (21%), Positives = 80/202 (39%), Gaps = 51/202 (25%)

Query: 120 SHNHILKLIGCCLETPIPILV-FESVQYGTL-----------WDRILGAPQPHFEPLLLK 167
            H +++ L+G C +   P++V  E  ++G L               +     + + L L+
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 168 HRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           H +  +  +   + +L      H    R +  RN     IL +E+NV K+ DF L+  I 
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIH----RDLAARN-----ILLSEKNVVKICDFGLARDIY 199

Query: 222 EGETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------- 266
           +   ++           M      APE +   V+  +SDV+SFGV L+E+ +        
Sbjct: 200 KDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

Query: 267 ---GWDVSDLVKDTHDLACPSN 285
                +    +K+   +  P  
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDY 275

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 79.8 bits (197), Expect = 7e-17
 Identities = 57/244 (23%), Positives = 93/244 (38%), Gaps = 37/244 (15%)

Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF- 161
            +  E     V   A M H +I++      E     +V +  + G L+ RI       F 
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           E  +L       + I  AL ++H    R I+ R+ K+  I   ++   +L DF ++  + 
Sbjct: 124 EDQILD----WFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL- 175

Query: 222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA 281
                +    +GT  Y +PE      +N KSD+++ G  L+EL T               
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT--------------- 220

Query: 282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLS---FECIKDSPADRPS 338
                 LK+ FE      +V  II      +      H S  L     +  K +P DRPS
Sbjct: 221 ------LKHAFEAGSMKNLVLKIISGSFPPVSL----HYSYDLRSLVSQLFKRNPRDRPS 270

Query: 339 MVDV 342
           +  +
Sbjct: 271 VNSI 274

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 78.4 bits (194), Expect = 9e-17
 Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 39/189 (20%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++ H  +++L     + PI I + E ++ G+L D  L  P      L +   L +A  I 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVD-FLKTPSGI--KLTINKLLDMAAQIA 119

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
             +A++      H    R +   N     IL ++    K+ DF L+  I + E    +  
Sbjct: 120 EGMAFIEERNYIH----RDLRAAN-----ILVSDTLSCKIADFGLARLIEDNEYTARE-- 168

Query: 232 MGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKD 276
            G      W   APE +  G F  KSDV+SFG+ L E++T       G    +V   ++ 
Sbjct: 169 -GAKFPIKW--TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

Query: 277 THDLACPSN 285
            + +  P N
Sbjct: 226 GYRMVRPDN 234

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 44/232 (18%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            + H ++++L+G C   P P  ++ E + YG L D  L         +     L +A  I
Sbjct: 272 EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLD-YLRECNRQ--EVSAVVLLYMATQI 327

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
             A+ YL      H    R +  RN      L  E ++ K+ DF LS  +          
Sbjct: 328 SSAMEYLEKKNFIH----RNLAARN-----CLVGENHLVKVADFGLSRLMTGDTYTAHAG 378

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKDTHDL 280
                 + APE +    F+ KSDV++FGV L+E+ T       G     V +L++  + +
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438

Query: 281 ACPSN--EYLKN-------YFEDNR--FTEIV---DPIIVEDVLSIEKEQQL 318
             P    E +         +   +R  F EI    + +  E  +S E E++L
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 45/200 (22%), Positives = 76/200 (38%), Gaps = 49/200 (24%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLLKH 168
            H +I+ L+G C +     ++ E    G L            +      +   E +  K 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 169 RLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 222
            +     +   + YL      H    R +  RN     +L  E NV K+ DF L+  I  
Sbjct: 205 LVSCTYQLARGMEYLASQKCIH----RDLAARN-----VLVTENNVMKIADFGLARDINN 255

Query: 223 GETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--------- 266
            + +   T        M      APE +   V+  +SDV+SFGV ++E+ T         
Sbjct: 256 IDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309

Query: 267 -GWDVSDLVKDTHDLACPSN 285
              ++  L+K+ H +  P+N
Sbjct: 310 PVEELFKLLKEGHRMDKPAN 329

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 60/262 (22%), Positives = 97/262 (37%), Gaps = 64/262 (24%)

Query: 117 ARMSHNHILKLIGCCLET-PIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK--- 171
             + H HI+K  GCC +     + LV E V  G+L D             L +H +    
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD------------YLPRHSIGLAQ 135

Query: 172 ---IAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 222
               A  I   +AYL      H    R +  RN     +L + + + K+ DF L+ ++PE
Sbjct: 136 LLLFAQQICEGMAYLHAQHYIH----RDLAARN-----VLLDNDRLVKIGDFGLAKAVPE 186

Query: 223 GETHITDTVMGT----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH 278
           G  +      G     W   APE ++   F   SDV+SFGV L+ELLT  D         
Sbjct: 187 GHEYYRVREDGDSPVFW--YAPECLKEYKFYYASDVWSFGVTLYELLTHCD-----SSQS 239

Query: 279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLS-IEKEQQLHASA-------QLSFECIK 330
                         +          + V  +   +E+ ++L            L   C +
Sbjct: 240 PPTKFLELIGIAQGQ----------MTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWE 289

Query: 331 DSPADRPSMVDVAKKLRQIYRS 352
              + RP+  ++   L+ ++  
Sbjct: 290 TEASFRPTFENLIPILKTVHEK 311

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 49/200 (24%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLLKH 168
            H +I+ L+G C +     ++ E    G L            +          E L  K 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 169 RLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 222
            +  A  +   + YL      H    R +  RN     +L  E+NV K+ DF L+  I  
Sbjct: 193 LVSCAYQVARGMEYLASKKCIH----RDLAARN-----VLVTEDNVMKIADFGLARDIHH 243

Query: 223 GETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--------- 266
            + +   T        M      APE +   ++  +SDV+SFGV L+E+ T         
Sbjct: 244 IDYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297

Query: 267 -GWDVSDLVKDTHDLACPSN 285
              ++  L+K+ H +  PSN
Sbjct: 298 PVEELFKLLKEGHRMDKPSN 317

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 39/169 (23%), Positives = 71/169 (42%), Gaps = 6/169 (3%)

Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL--VFESVQYGTLWDRILGAPQPH 160
               +  ++ V     + H +I++     ++     L  V E  + G L   I    +  
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105

Query: 161 FEPLLLKHRLKIAMDIVHALAYLH--FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
            + L  +  L++   +  AL   H        ++ R+ K + +  + +   KL DF L+ 
Sbjct: 106 -QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164

Query: 219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            +   +T    T +GT  Y +PE M    +NEKSD++S G  L+EL   
Sbjct: 165 IL-NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 50/260 (19%), Positives = 89/260 (34%), Gaps = 43/260 (16%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIP----ILVFESVQYGTLWDRILGAPQPHFE 162
           E            +H +IL+L+  CL          L+    + GTLW+ I         
Sbjct: 71  EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-N 129

Query: 163 PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF-SLSISIP 221
            L     L + + I   L  +H    +    R+ K + IL  +E    L D  S++ +  
Sbjct: 130 FLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186

Query: 222 EGETHIT-------DTVMGTWGYCAPE----YMRTGVFNEKSDVFSFGVFLFELLTGWDV 270
             E                T  Y APE         + +E++DV+S G  L+ ++ G   
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI-DERTDVWSLGCVLYAMMFG--- 242

Query: 271 SDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASA-QLSFECI 329
                       P        ++          + V++ LSI +  +  ++  QL    +
Sbjct: 243 ------EG----P--------YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMM 284

Query: 330 KDSPADRPSMVDVAKKLRQI 349
              P  RP +  +  +L  +
Sbjct: 285 TVDPHQRPHIPLLLSQLEAL 304

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 76.5 bits (189), Expect = 4e-16
 Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 41/190 (21%)

Query: 118 RMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++SH  ++K  G C  E PI I V E +  G L    L +     EP  L   L++  D+
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYI-VTEYISNGCL-LNYLRSHGKGLEPSQL---LEMCYDV 113

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              +A+L      H    R +  RN      L + +   K+ DF ++  + + +   +  
Sbjct: 114 CEGMAFLESHQFIH----RDLAARN-----CLVDRDLCVKVSDFGMTRYVLDDQYVSSV- 163

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVK 275
             GT     W   APE      ++ KSDV++FG+ ++E+ +        +   +V   V 
Sbjct: 164 --GTKFPVKW--SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

Query: 276 DTHDLACPSN 285
             H L  P  
Sbjct: 220 QGHRLYRPHL 229

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 76.1 bits (188), Expect = 6e-16
 Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 41/189 (21%)

Query: 119 MSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           +SH  +++L G C  + PI I + E +  G L    L   +  F+   L   L++  D+ 
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFI-ITEYMANGCL-LNYLREMRHRFQTQQL---LEMCKDVC 130

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
            A+ YL      H    R +  RN      L N++ V K+ DF LS  + + E   +   
Sbjct: 131 EAMEYLESKQFLH----RDLAARN-----CLVNDQGVVKVSDFGLSRYVLDDEYTSSV-- 179

Query: 232 MGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKD 276
            G+     W    PE +    F+ KSD+++FGV ++E+ +        +   + ++ +  
Sbjct: 180 -GSKFPVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

Query: 277 THDLACPSN 285
              L  P  
Sbjct: 237 GLRLYRPHL 245

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 75.7 bits (187), Expect = 6e-16
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 41/190 (21%)

Query: 118 RMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++SH  +++L G CL + PI + V E +++G L    L   +  F    L   L + +D+
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICL-VTEFMEHGCL-SDYLRTQRGLFAAETL---LGMCLDV 113

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              +AYL      H    R +  RN      L  E  V K+ DF ++  + + +   +  
Sbjct: 114 CEGMAYLEEACVIH----RDLAARN-----CLVGENQVIKVSDFGMTRFVLDDQYTSST- 163

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVK 275
             GT     W   +PE      ++ KSDV+SFGV ++E+ +            +V + + 
Sbjct: 164 --GTKFPVKW--ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

Query: 276 DTHDLACPSN 285
               L  P  
Sbjct: 220 TGFRLYKPRL 229

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.1 bits (188), Expect = 6e-16
 Identities = 50/202 (24%), Positives = 75/202 (37%), Gaps = 47/202 (23%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLL 165
             + H HI+K  G C +    I+VFE +++G L              + G P+     L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 166 LKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
           L   L IA  I   + YL      H    R +  RN      L     + K+ DF +S  
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVH----RDLATRN-----CLVGANLLVKIGDFGMSRD 182

Query: 220 IPEGETHITDTVMGT------WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT------- 266
           +   + +    V G       W    PE +    F  +SDV+SFGV L+E+ T       
Sbjct: 183 VYSTDYY---RVGGHTMLPIRW--MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237

Query: 267 ---GWDVSDLVKDTHDLACPSN 285
                +V + +     L  P  
Sbjct: 238 QLSNTEVIECITQGRVLERPRV 259

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 39/189 (20%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
            + H+ ++KL     + PI I + E +  G+L    L + +       L   +  +  I 
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSL-LDFLKSDEG--SKQPLPKLIDFSAQIA 294

Query: 178 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
             +A++      H    R +   N     IL +   V K+ DF L+  I + E    +  
Sbjct: 295 EGMAFIEQRNYIH----RDLRAAN-----ILVSASLVCKIADFGLARVIEDNEYTARE-- 343

Query: 232 MGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKD 276
            G      W   APE +  G F  KSDV+SFG+ L E++T       G    +V   ++ 
Sbjct: 344 -GAKFPIKW--TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400

Query: 277 THDLACPSN 285
            + +  P N
Sbjct: 401 GYRMPRPEN 409

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 47/155 (30%), Positives = 69/155 (44%), Gaps = 18/155 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
            + H +I+KL     E      LV E  + G L+D I+   +  F E         I   
Sbjct: 92  LLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIH--RMKFNE----VDAAVIIKQ 144

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 232
           ++  + YLH      IV R+ K   +L     ++ + K+ DF LS      +       +
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERL 199

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +R   ++EK DV+S GV LF LL G
Sbjct: 200 GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 40/190 (21%)

Query: 118 RMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            + H ++++L+G C  E P  I + E + YG L D +    +     ++L   L +A  I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYI-ITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQI 120

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
             A+ YL      H    R +  RN      L  E ++ K+ DF LS  +          
Sbjct: 121 SSAMEYLEKKNFIH----RDLAARN-----CLVGENHLVKVADFGLSRLMTGDTYTAHA- 170

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVK 275
             G      W   APE +    F+ KSDV++FGV L+E+ T       G     V +L++
Sbjct: 171 --GAKFPIKW--TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226

Query: 276 DTHDLACPSN 285
             + +  P  
Sbjct: 227 KDYRMERPEG 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 18/155 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
           ++ H +I+KL     E      LV E    G L+D I+   +  F E        +I   
Sbjct: 82  QLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIIS--RKRFSE----VDAARIIRQ 134

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 232
           ++  + Y+H      IV R+ K   +L    +++   ++ DF LS      +       +
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKI 189

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +  G ++EK DV+S GV L+ LL+G
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 53/211 (25%), Positives = 79/211 (37%), Gaps = 57/211 (27%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTL-------------------WDRILGAP 157
           A   + +I+KL+G C       L+FE + YG L                           
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 158 QPHFEPLLLKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKL 211
            P   PL    +L IA  +   +AYL      H    R +  RN      L  E  V K+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH----RDLATRN-----CLVGENMVVKI 215

Query: 212 FDFSLSISIPEGETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFEL 264
            DF LS +I   + +  D         M       PE +    +  +SDV+++GV L+E+
Sbjct: 216 ADFGLSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEI 269

Query: 265 LT----------GWDVSDLVKDTHDLACPSN 285
            +            +V   V+D + LACP N
Sbjct: 270 FSYGLQPYYGMAHEEVIYYVRDGNILACPEN 300

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 33/153 (21%), Positives = 53/153 (34%), Gaps = 11/153 (7%)

Query: 116 AARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
                H   ++L     E  I  L  E     +L            E  +         D
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWG----YLRD 165

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
            + ALA+LH    + +V  + K + I        KL DF L + +        +   G  
Sbjct: 166 TLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDP 220

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            Y APE ++   +   +DVFS G+ + E+    
Sbjct: 221 RYMAPELLQGS-YGTAADVFSLGLTILEVACNM 252

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 47/191 (24%), Positives = 75/191 (39%), Gaps = 39/191 (20%)

Query: 117 ARMSHNHILKLIGCCLETPIPIL-VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
            +  H +I++L G         + V E ++ G+L D  L      F  + L   + +   
Sbjct: 105 GQFDHPNIIRLEGVVTRGR-LAMIVTEYMENGSL-DTFLRTHDGQFTIMQL---VGMLRG 159

Query: 176 IVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           +   + YL      H    R +  RN     +L +   V K+ DF LS  + E +     
Sbjct: 160 VGAGMRYLSDLGYVH----RDLAARN-----VLVDSNLVCKVSDFGLSRVL-EDDPDAAY 209

Query: 230 TVMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLV 274
           T  G      W   APE +    F+  SDV+SFGV ++E+L             DV   V
Sbjct: 210 TTTGGKIPIRW--TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

Query: 275 KDTHDLACPSN 285
           ++ + L  P  
Sbjct: 268 EEGYRLPAPMG 278

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 46/243 (18%), Positives = 83/243 (34%), Gaps = 53/243 (21%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQY----------------GTLWDRILGAPQPH 160
           A++ H +I+   GC                                GTL   I       
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 161 F-EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
             + L L+    +   I   + Y+H    + ++ R+ K S I   +    K+ DF L  S
Sbjct: 119 LDKVLALE----LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD 279
           +            GT  Y +PE + +  + ++ D+++ G+ L ELL              
Sbjct: 172 LKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------ 217

Query: 280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM 339
                       FE ++F   +   I+ D+   +KE+ L          +   P DRP+ 
Sbjct: 218 --------CDTAFETSKFFTDLRDGIISDIFD-KKEKTLLQK------LLSKKPEDRPNT 262

Query: 340 VDV 342
            ++
Sbjct: 263 SEI 265

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 57/210 (27%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTL-------------------WDRILGAPQ 158
           +++H H++KL G C +    +L+ E  +YG+L                            
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141

Query: 159 PHFEPLLLKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLF 212
           P    L +   +  A  I   + YL      H    R +  RN     IL  E    K+ 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVH----RDLAARN-----ILVAEGRKMKIS 192

Query: 213 DFSLSISIPEGETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELL 265
           DF LS  + E ++++  +        M      A E +   ++  +SDV+SFGV L+E++
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIV 246

Query: 266 T----------GWDVSDLVKDTHDLACPSN 285
           T             + +L+K  H +  P N
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDN 276

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 18/155 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
           ++ H +I+KL     E      +V E    G L+D I+   +  F E        +I   
Sbjct: 77  KLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIK--RKRFSE----HDAARIIKQ 129

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 232
           +   + Y+H      IV R+ K   IL     ++   K+ DF LS    +    + D + 
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI- 184

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +R G ++EK DV+S GV L+ LL+G
Sbjct: 185 GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 18/185 (9%)

Query: 89  RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI-LVFESVQYG 147
           +         ++   + +E   N ++    + H +I+KL     E      LV E  + G
Sbjct: 73  QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGG 131

Query: 148 TLWDRILGAPQPHF-EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF--- 203
            L+++I+   +  F E         I   I+  + YLH      IV R+ K   IL    
Sbjct: 132 ELFEQIIN--RHKFDE----CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENK 182

Query: 204 NEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFE 263
           N     K+ DF LS    +         +GT  Y APE ++   +NEK DV+S GV ++ 
Sbjct: 183 NSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYI 239

Query: 264 LLTGW 268
           LL G+
Sbjct: 240 LLCGY 244

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.4 bits (181), Expect = 4e-15
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 43/190 (22%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++ H+++++L+G  +E    + +V E +  G+L D  L +       L     LK ++D+
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRS--VLGGDCLLKFSLDV 126

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
             A+ YL      H    R +  RN     +L +E+NVAK+ DF L+      E   T  
Sbjct: 127 CEAMEYLEGNNFVH----RDLAARN-----VLVSEDNVAKVSDFGLT-----KEASSTQD 172

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVK 275
                    W   APE +R   F+ KSDV+SFG+ L+E+ +            DV   V+
Sbjct: 173 --TGKLPVKW--TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

Query: 276 DTHDLACPSN 285
             + +  P  
Sbjct: 229 KGYKMDAPDG 238

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 43/190 (22%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++ H+++++L+G  +E    + +V E +  G+L D  L +       L     LK ++D+
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRS--VLGGDCLLKFSLDV 298

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
             A+ YL      H    R +  RN     +L +E+NVAK+ DF L+          + T
Sbjct: 299 CEAMEYLEGNNFVH----RDLAARN-----VLVSEDNVAKVSDFGLT-------KEASST 342

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVK 275
                    W   APE +R   F+ KSDV+SFG+ L+E+ +            DV   V+
Sbjct: 343 QDTGKLPVKW--TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400

Query: 276 DTHDLACPSN 285
             + +  P  
Sbjct: 401 KGYKMDAPDG 410

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 73.4 bits (180), Expect = 7e-15
 Identities = 40/219 (18%), Positives = 75/219 (34%), Gaps = 20/219 (9%)

Query: 63  SYDQKNVIAKDTSYNLYTMYKGF--WQERLISVLQFYGHECRPRAYESCINNVTYAARMS 120
             +   ++    ++      K      E  +           P   ++    +      S
Sbjct: 60  KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 180
             + +  +          +  +  +   L D +    +   E       L I + I  A+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAV 177

Query: 181 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS------------ISIPEGETHIT 228
            +LH    + ++ R+ K S I F  ++V K+ DF L             ++        T
Sbjct: 178 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             V GT  Y +PE +    ++ K D+FS G+ LFELL  
Sbjct: 235 GQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 41/203 (20%), Positives = 73/203 (35%), Gaps = 52/203 (25%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTL-------------WDRILGAPQPHFEPLLL 166
           +H +I+ L+G C      +++ E   YG L                     +     L L
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 167 KHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
           +  L  +  +   +A+L      H    R +  RN     IL     + K+ DF L+  I
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIH----RDLAARN-----ILLTHGRITKICDFGLARDI 195

Query: 221 PEGETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT------- 266
                ++           M      APE +   V+  +SDV+S+G+FL+EL +       
Sbjct: 196 KNDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 267 ----GWDVSDLVKDTHDLACPSN 285
                     ++K+   +  P +
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEH 272

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 45/187 (24%), Positives = 70/187 (37%), Gaps = 28/187 (14%)

Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV---------QY---GTLW 150
             A E  +  V   A++ H  I++     LE      +  S          Q      L 
Sbjct: 44  ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLK 103

Query: 151 DRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK 210
           D + G              L I + I  A+ +LH    + ++ R+ K S I F  ++V K
Sbjct: 104 DWMNGRCTIEERER--SVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK 158

Query: 211 LFDFSLS-----------ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
           + DF L            +  P          +GT  Y +PE +    ++ K D+FS G+
Sbjct: 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGL 218

Query: 260 FLFELLT 266
            LFELL 
Sbjct: 219 ILFELLY 225

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 20/135 (14%), Positives = 47/135 (34%), Gaps = 22/135 (16%)

Query: 146 YGTLWDRI--LGAPQPHFEPLLLKHRLKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCIL 202
              L      L +     + L+   RL++ + ++  LA LH +G    +V    +   I+
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIV 243

Query: 203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM----------RTGVFNEKS 252
            ++     L  F     + +G + ++       G+  PE               +     
Sbjct: 244 LDQRGGVFLTGFE--HLVRDGASAVSPI---GRGFAPPETTAERMLPFGQHHPTLMTFAF 298

Query: 253 DVFSFGVFLFELLTG 267
           D ++ G+ ++ +   
Sbjct: 299 DTWTLGLAIYWIWCA 313

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 16/157 (10%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRIL--GAPQPHF-EPLLLKHRLKIA 173
            + H HI++L+     +   + +VFE +    L   I+        + E           
Sbjct: 82  MLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE----AVASHYM 136

Query: 174 MDIVHALAYLHFGFPRPIVFRNFKTSCILF-NEENVA--KLFDFSLSISIPEGETHITDT 230
             I+ AL Y H      I+ R+ K  C+L  ++EN A  KL  F ++I + E        
Sbjct: 137 RQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           V GT  + APE ++   + +  DV+  GV LF LL+G
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 26/229 (11%), Positives = 71/229 (31%), Gaps = 28/229 (12%)

Query: 58  KLATNSYDQKNV----IAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNV 113
             AT+    ++                + +   +   + +L+   ++ + + +   I   
Sbjct: 90  LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149

Query: 114 TYAARMSHNHILKLIGCCLETPIPILVF----ESVQYGTLWDRILGAPQPHFEPLLLKHR 169
                     ++++     +  +    F          T  + +L     H + L+   R
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHAR 208

Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L++ + ++  LA LH      +V    +   I+ ++     L  F   +   +G      
Sbjct: 209 LQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARV--- 260

Query: 230 TVMGTWGYCAPEYM-----------RTGVFNEKSDVFSFGVFLFELLTG 267
               + G+  PE             R  +     D ++ G+ ++ +   
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 37/203 (18%), Positives = 73/203 (35%), Gaps = 49/203 (24%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLL 165
           AR+ H +++ L+G   +     ++F    +G L                   +     L 
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 166 LKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
               + +   I   + YL      H    + +  RN     +L  ++   K+ D  L   
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVH----KDLATRN-----VLVYDKLNVKISDLGLFRE 177

Query: 220 IPEGETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT------ 266
           +   + +            M      APE +  G F+  SD++S+GV L+E+ +      
Sbjct: 178 VYAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

Query: 267 ----GWDVSDLVKDTHDLACPSN 285
                 DV +++++   L CP +
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCPDD 254

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 48/199 (24%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWD---------RILGAPQPHFEPLLLKHRL 170
            H +I+ L+G C      +++ E   YG L +             A          +  L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 171 KIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 224
             +  +   +A+L      H    R +  RN     +L    +VAK+ DF L+  I    
Sbjct: 168 HFSSQVAQGMAFLASKNCIH----RDVAARN-----VLLTNGHVAKIGDFGLARDIMNDS 218

Query: 225 THITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT----------- 266
            +I           M      APE +   V+  +SDV+S+G+ L+E+ +           
Sbjct: 219 NYIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272

Query: 267 GWDVSDLVKDTHDLACPSN 285
                 LVKD + +A P+ 
Sbjct: 273 NSKFYKLVKDGYQMAQPAF 291

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 50/190 (26%), Positives = 79/190 (41%), Gaps = 37/190 (19%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            + SH++I++L G   +    +++ E ++ G L D+ L      F  L L   + +   I
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQL---VGMLRGI 156

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     IL N   V K+ DF LS  + E +   T T
Sbjct: 157 AAGMKYLANMNYVH----RDLAARN-----ILVNSNLVCKVSDFGLSRVL-EDDPEATYT 206

Query: 231 VMGT-----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVK 275
             G      W   APE +    F   SDV+SFG+ ++E++T            +V   + 
Sbjct: 207 TSGGKIPIRW--TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264

Query: 276 DTHDLACPSN 285
           D   L  P +
Sbjct: 265 DGFRLPTPMD 274

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 36/160 (22%), Positives = 65/160 (40%), Gaps = 18/160 (11%)

Query: 118 RMSHNHILKLIGCCLETP-------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
           +++H +++       +         +P+L  E  + G L   +    + +   L      
Sbjct: 68  KLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFE-NCCGLKEGPIR 124

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHI 227
            +  DI  AL YLH      I+ R+ K   I+     +  + K+ D   +  + +GE  +
Sbjct: 125 TLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--L 179

Query: 228 TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
               +GT  Y APE +    +    D +SFG   FE +TG
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 33/158 (20%), Positives = 55/158 (34%), Gaps = 20/158 (12%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
           H ++++   C  +      +  E     TL + +      H         + +       
Sbjct: 77  HPNVIRYF-CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG----LEPITLLQQTTSG 130

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEEN-----VAKLFDFSLSISIPEGE--THITDTVM 232
           LA+LH      IV R+ K   IL +  N      A + DF L   +  G         V 
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 233 GTWGYCAPEYMRTGVF---NEKSDVFSFGVFLFELLTG 267
           GT G+ APE +            D+FS G   + +++ 
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 35/189 (18%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            +  H +I++L G   ++   ++V E ++ G+L D  L      F  + L   + +   I
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQL---VGMLRGI 156

Query: 177 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
              + YL      H    R +  RN     IL N   V K+ DF L   + +       T
Sbjct: 157 ASGMKYLSDMGYVH----RDLAARN-----ILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207

Query: 231 VMGT----WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-------GW---DVSDLVKD 276
             G     W   +PE +    F   SDV+S+G+ L+E+++            DV   V +
Sbjct: 208 RGGKIPIRW--TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265

Query: 277 THDLACPSN 285
            + L  P +
Sbjct: 266 GYRLPPPMD 274

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 53/155 (34%), Positives = 78/155 (50%), Gaps = 17/155 (10%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
           R+SH +I+KL     ETP  I LV E V  G L+DRI+   + ++ E    +        
Sbjct: 104 RLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVE--KGYYSE----RDAADAVKQ 156

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 232
           I+ A+AYLH      IV R+ K   +L+     +   K+ DF LS  +      +  TV 
Sbjct: 157 ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVC 211

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT GYCAPE +R   +  + D++S G+  + LL G
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 26/155 (16%), Positives = 64/155 (41%), Gaps = 12/155 (7%)

Query: 119 MSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRIL---GAPQPHFEPLLLKHRLKIAM 174
           + + + L   G  +     + +++E ++  ++           + +   + ++    I  
Sbjct: 100 IKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 234
            ++++ +Y+H    + I  R+ K S IL ++    KL DF  S  + + +        GT
Sbjct: 159 SVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK---GSRGT 213

Query: 235 WGYCAPE--YMRTGVFNEKSDVFSFGVFLFELLTG 267
           + +  PE     +     K D++S G+ L+ +   
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 70.1 bits (172), Expect = 7e-14
 Identities = 54/277 (19%), Positives = 95/277 (34%), Gaps = 47/277 (16%)

Query: 80  TMYKGFWQE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP 137
           T+YKG   E    ++  +    +      +           + H +I++       T   
Sbjct: 41  TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100

Query: 138 ----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 193
               +LV E +  GTL   +       F+ + +K        I+  L +LH   P PI+ 
Sbjct: 101 KKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIH 154

Query: 194 RNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           R+ K   I         K+ D  L+             V+GT  + APE       +E  
Sbjct: 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEKY-DESV 210

Query: 253 DVFSFGVFLFELLTG---WDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDV 309
           DV++FG+ + E+ T    +          +    +  Y +        T  V P   + V
Sbjct: 211 DVYAFGMCMLEMATSEYPY---------SECQNAAQIYRR-------VTSGVKPASFDKV 254

Query: 310 LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
              E ++ +         CI+ +  +R S     K L
Sbjct: 255 AIPEVKEIIE-------GCIRQNKDERYS----IKDL 280

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 15/133 (11%), Positives = 35/133 (26%), Gaps = 12/133 (9%)

Query: 139 LVFESVQYGTLWDRI--LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 196
           L+  +     L      L           +     +   ++   A L     + +V  +F
Sbjct: 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHF 220

Query: 197 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM--RTGVFNEKSDV 254
               +    +    L D S    +                Y   E++   T  F    + 
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNA 276

Query: 255 FSFGVFLFELLTG 267
           +  G+ ++ +   
Sbjct: 277 WQLGLSIYRVWCL 289

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 70.0 bits (172), Expect = 8e-14
 Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 11/168 (6%)

Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI--LGAPQPH 160
            +A   CI  +    +++H +++K     +E     +V E    G L   I      +  
Sbjct: 73  AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 132

Query: 161 F-EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
             E  + K      + +  AL ++H    R ++ R+ K + +      V KL D  L   
Sbjct: 133 IPERTVWK----YFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-R 184

Query: 220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
               +T    +++GT  Y +PE +    +N KSD++S G  L+E+   
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 70.4 bits (173), Expect = 9e-14
 Identities = 45/200 (22%), Positives = 69/200 (34%), Gaps = 54/200 (27%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLLKHR 169
           H +I+ L+G C       L  E   +G L            D            L  +  
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 170 LKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           L  A D+   + YL      H    R +  RN     IL  E  VAK+ DF LS      
Sbjct: 145 LHFAADVARGMDYLSQKQFIH----RDLAARN-----ILVGENYVAKIADFGLS------ 189

Query: 224 ETHITDTVMGT--------WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--------- 266
                +  +          W   A E +   V+   SDV+S+GV L+E+++         
Sbjct: 190 --RGQEVYVKKTMGRLPVRW--MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245

Query: 267 -GWDVSDLVKDTHDLACPSN 285
              ++ + +   + L  P N
Sbjct: 246 TCAELYEKLPQGYRLEKPLN 265

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 47/261 (18%), Positives = 81/261 (31%), Gaps = 78/261 (29%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
           ++SH H++   G C+     ILV E V++G+L D  L   +     L     L++A  + 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSL-DTYLKKNKNCINILWK---LEVAKQLA 123

Query: 178 HALAYL------HFGFPRPIVFRN---FKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
            A+ +L      H      +  +N    +            KL D  +SI++   +    
Sbjct: 124 AAMHFLEENTLIH----GNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175

Query: 229 DTVMGTWGY------CAPEYMRTG-VFNEKSDVFSFGVFLFELLT----------GWDVS 271
                            PE +      N  +D +SFG  L+E+ +               
Sbjct: 176 -------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228

Query: 272 DLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKD 331
              +D H L  P                    +                 A L   C+  
Sbjct: 229 QFYEDRHQLPAPKA----------------AEL-----------------ANLINNCMDY 255

Query: 332 SPADRPSMVDVAKKLRQIYRS 352
            P  RPS   + + L  ++  
Sbjct: 256 EPDHRPSFRAIIRDLNSLFTP 276

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 20/164 (12%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
            + H +I++L            L+F+ V  G L++ I+   + ++ E             
Sbjct: 66  LLKHPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVA--REYYSE----ADASHCIQQ 118

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVA-KLFDFSLSISIPEGETHITDTVM 232
           I+ A+ + H      +V RN K   +L     +  A KL DF L+I +   +        
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSD 272
           GT GY +PE +R   + +  D+++ GV L+ LL G    WD   
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 34/178 (19%)

Query: 117 ARMSHNHILKLIGCCLETPIPI-------------LVFESVQYGTLWDRILGAPQPHFEP 163
           A ++H ++++     LE    +             +  E  + GTL+D I          
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR- 115

Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS------ 217
                  ++   I+ AL+Y+H    + I+ R+ K   I  +E    K+ DF L+      
Sbjct: 116 ---DEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

Query: 218 -------ISIPEGETHITDTVMGTWGYCAPEYMR-TGVFNEKSDVFSFGVFLFELLTG 267
                       G +    + +GT  Y A E +  TG +NEK D++S G+  FE++  
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 36/151 (23%), Positives = 60/151 (39%), Gaps = 13/151 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            + H +IL++          I L+ E    G L+  +       F+    +       ++
Sbjct: 70  HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--QKHGRFDE---QRSATFMEEL 123

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
             AL Y H    R ++ R+ K   +L   +   K+ DF  S+  P        T+ GT  
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---TMCGTLD 177

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           Y  PE +     +EK D++  GV  +E L G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 36/151 (23%), Positives = 65/151 (43%), Gaps = 13/151 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            + H +IL+L G        + L+ E    GT++  +       F+    +       ++
Sbjct: 65  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL--QKLSKFDE---QRTATYITEL 118

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
            +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P   +     + GT  
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLD 172

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           Y  PE +   + +EK D++S GV  +E L G
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 21/164 (12%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
           ++ H +I++L     +      LVF+ V  G L++ I+   +  + E             
Sbjct: 84  KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVA--REFYSE----ADASHCIQQ 136

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVA-KLFDFSLSISIPEGETHITDTVM 232
           I+ ++AY H      IV RN K   +L     +  A KL DF L+I + + E        
Sbjct: 137 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA 191

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSD 272
           GT GY +PE ++   +++  D+++ GV L+ LL G    WD   
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 18/155 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
            + H +I++L     E    I LV E    G L++R++   +  F E        +I  D
Sbjct: 62  SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVH--KRVFRE----SDAARIMKD 114

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 232
           ++ A+AY H      +  R+ K    LF   + ++  KL DF L+     G+     T +
Sbjct: 115 VLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKV 169

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y +P+ +  G++  + D +S GV ++ LL G
Sbjct: 170 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 18/155 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
           ++ H +I+KL     E      +V E    G L+D I+   +  F E        +I   
Sbjct: 77  KLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIK--RKRFSE----HDAARIIKQ 129

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 232
           +   + Y+H      IV R+ K   IL     ++   K+ DF LS    +         +
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRI 184

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT  Y APE +R G ++EK DV+S GV L+ LL+G
Sbjct: 185 GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 68.0 bits (167), Expect = 3e-13
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 27/160 (16%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 170
           ++ H +I++L     +      LVF+ V  G L++ I+            +         
Sbjct: 61  KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVA-----------REFYSEADAS 108

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVA-KLFDFSLSISIPEGETHI 227
                I+ ++AY H      IV RN K   +L     +  A KL DF L+I + + E   
Sbjct: 109 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163

Query: 228 TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
                GT GY +PE ++   +++  D+++ GV L+ LL G
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 68.0 bits (167), Expect = 4e-13
 Identities = 43/193 (22%), Positives = 74/193 (38%), Gaps = 45/193 (23%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQP--HF-EPLLLKHRLKIA 173
            + H +I+K+     E    + +V E+ + G L +RI+ A        E     +  ++ 
Sbjct: 76  SLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSE----GYVAELM 130

Query: 174 MDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDT 230
             +++ALAY H    + +V ++ K   ILF   +  +  K+ DF L+      E      
Sbjct: 131 KQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TN 185

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----------------------- 267
             GT  Y APE  +      K D++S GV ++ LLTG                       
Sbjct: 186 AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244

Query: 268 ----WDVSDLVKD 276
                 ++    D
Sbjct: 245 AVECRPLTPQAVD 257

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 42/208 (20%), Positives = 74/208 (35%), Gaps = 57/208 (27%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTL------------------WDRILGAPQPHF 161
           SH +I+ L+G C  +    L+FE   YG L                   ++     +   
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 162 EPLLLKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFS 215
             L  +  L  A  +   + +L      H    R +  RN     +L     V K+ DF 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVH----RDLAARN-----VLVTHGKVVKICDFG 217

Query: 216 LSISIPEGETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-- 266
           L+  I     ++           M      APE +  G++  KSDV+S+G+ L+E+ +  
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLG 271

Query: 267 ---------GWDVSDLVKDTHDLACPSN 285
                      +   L+++   +  P  
Sbjct: 272 VNPYPGIPVDANFYKLIQNGFKMDQPFY 299

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 67.7 bits (166), Expect = 6e-13
 Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 20/158 (12%)

Query: 119 MSHNHILKLIGCCLETPIPI-----LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKI 172
               HI+ ++    E          ++ E ++ G L+ RI       F E    +   +I
Sbjct: 79  SGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE----REAAEI 133

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITD 229
             DI  A+ +LH      I  R+ K   +L+    ++ V KL DF  +    +       
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ--- 187

Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           T   T  Y APE +    +++  D++S GV ++ LL G
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 67.7 bits (166), Expect = 6e-13
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 16/152 (10%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDIVH 178
           H +I+KL        +   LV E +  G L++RI    + HF E         I   +V 
Sbjct: 65  HPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKK--KKHFSE----TEASYIMRKLVS 117

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           A++++H      +V R+ K   +LF   N+    K+ DF  +   P     +      T 
Sbjct: 118 AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            Y APE +    ++E  D++S GV L+ +L+G
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 29/162 (17%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------K 171
           +++H  I+K+     +     +V E ++ G L+D+++G             RL       
Sbjct: 196 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-----------NKRLKEATCKL 243

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHIT 228
               ++ A+ YLH      I+ R+ K   +L     E+ + K+ DF  S  + E    + 
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LM 298

Query: 229 DTVMGTWGYCAPE---YMRTGVFNEKSDVFSFGVFLFELLTG 267
            T+ GT  Y APE    + T  +N   D +S GV LF  L+G
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 30/173 (17%), Positives = 58/173 (33%), Gaps = 31/173 (17%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRIL--GAPQPHFEPLLLKHRLKIAMDIV 177
           H ++++   C   T   + +  E      L D +        + +     + + +   I 
Sbjct: 68  HPNVIRYY-CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEENV-------------AKLFDFSLSISIPEGE 224
             +A+LH      I+ R+ K   IL +  +                + DF L   +  G+
Sbjct: 126 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 225 ---THITDTVMGTWGYCAPEYMRTGVF-------NEKSDVFSFGVFLFELLTG 267
                  +   GT G+ APE +                D+FS G   + +L+ 
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 18/155 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
           ++ H +I+ L     E+     LV + V  G L+DRIL   +  + E    K    +   
Sbjct: 62  KIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILE--RGVYTE----KDASLVIQQ 114

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 232
           ++ A+ YLH      IV R+ K   +L+    E +   + DF LS     G      T  
Sbjct: 115 VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS---TAC 168

Query: 233 GTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           GT GY APE +    +++  D +S GV  + LL G
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 50/202 (24%), Positives = 66/202 (32%), Gaps = 51/202 (25%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 170
           ++ H +I +L     E    I LV E    G L D++            +          
Sbjct: 84  KLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 171 -----------------------------KIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 201
                                         I   I  AL YLH    + I  R+ K    
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENF 199

Query: 202 LF--NEENVAKLFDFSLSISIP---EGETHITDTVMGTWGYCAPEYMRTGV--FNEKSDV 254
           LF  N+    KL DF LS        GE +   T  GT  + APE + T    +  K D 
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259

Query: 255 FSFGVFLFELLTG----WDVSD 272
           +S GV L  LL G      V+D
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVND 281

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 32/117 (27%), Positives = 59/117 (50%), Gaps = 9/117 (7%)

Query: 151 DRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK 210
           D++L       E +L K    +++ ++  L YL       I+ R+ K S IL N     K
Sbjct: 119 DQVLKKAGRIPEQILGK----VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 172

Query: 211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           L DF +S  + +    + ++ +GT  Y +PE ++   ++ +SD++S G+ L E+  G
Sbjct: 173 LCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 30/160 (18%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------KIA 173
           H +I++L     ET     LVF+ ++ G L+D +             K  L      KI 
Sbjct: 83  HPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTE-----------KVTLSEKETRKIM 130

Query: 174 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 233
             ++  +  LH      IV R+ K   IL +++   KL DF  S  +  GE      V G
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCG 185

Query: 234 TWGYCAPEYMRTGVF------NEKSDVFSFGVFLFELLTG 267
           T  Y APE +   +        ++ D++S GV ++ LL G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 64.1 bits (157), Expect = 8e-12
 Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 23/157 (14%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 170
            ++H H++   G   E    + +V E  +  +L +               +  L      
Sbjct: 71  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEAR 118

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
                IV    YLH      ++ R+ K   +  NE+   K+ DF L+ +  E +      
Sbjct: 119 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV 174

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y APE +     + + DV+S G  ++ LL G
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 64.2 bits (157), Expect = 9e-12
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 17/153 (11%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDIVH 178
           H +I+ L     +    + +V E ++ G L D+IL   Q  F E    +    +   I  
Sbjct: 75  HPNIITLKDVY-DDGKYVYVVTELMKGGELLDKILR--QKFFSE----REASAVLFTITK 127

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILF--NEENVA--KLFDFSLSISIPEGETHITDTVMGT 234
            + YLH    + +V R+ K S IL+     N    ++ DF  +  +   E  +  T   T
Sbjct: 128 TVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYT 183

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + APE +    ++   D++S GV L+ +LTG
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 24/164 (14%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDIVH 178
           H HI+ LI    E+   + LVF+ ++ G L+D +    +    E    K    I   ++ 
Sbjct: 159 HPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTE--KVALSE----KETRSIMRSLLE 211

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYC 238
           A+++LH      IV R+ K   IL ++    +L DF  S  +  GE      + GT GY 
Sbjct: 212 AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYL 266

Query: 239 APEYMRTGVF------NEKSDVFSFGVFLFELLTG----WDVSD 272
           APE ++  +        ++ D+++ GV LF LL G    W    
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 29/162 (17%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------K 171
           +++H  I+K+     +     +V E ++ G L+D+++G             RL       
Sbjct: 71  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-----------NKRLKEATCKL 118

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHIT 228
               ++ A+ YLH      I+ R+ K   +L     E+ + K+ DF  S  + E    + 
Sbjct: 119 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LM 173

Query: 229 DTVMGTWGYCAPE---YMRTGVFNEKSDVFSFGVFLFELLTG 267
            T+ GT  Y APE    + T  +N   D +S GV LF  L+G
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 21/164 (12%)

Query: 118 RMSHNHILKLIGC--CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
           +++H +I+KL        T   +L+ E    G+L+  +      +   L     L +  D
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRD 120

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLFDFSLSISIPEGETHITDTV 231
           +V  + +L       IV RN K   I+     + ++V KL DF  +  + + E     ++
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSL 175

Query: 232 MGTWGYCAPEYMRTGV--------FNEKSDVFSFGVFLFELLTG 267
            GT  Y  P+     V        +    D++S GV  +   TG
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 49/255 (19%), Positives = 83/255 (32%), Gaps = 55/255 (21%)

Query: 119 MSHNHILKLIGCCLETPIP-------ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 171
             H +I++                   L+   +  G L + +         PL     LK
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLK 140

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF---SLSISIPEGETHIT 228
           I      A+ ++H   P PI+ R+ K   +L + +   KL DF   +     P+      
Sbjct: 141 IFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 229 D--------TVMGTWGYCAPE---YMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT 277
                    T   T  Y  PE           EK D+++ G  L+ L             
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC------------ 247

Query: 278 HDLACPSNEYLKNYFEDNRFTEIVD---PIIVEDVLSIEKEQQLHASAQLSFECIKDSPA 334
                    + ++ FED     IV+    I   D          H    L    ++ +P 
Sbjct: 248 ---------FRQHPFEDGAKLRIVNGKYSIPPHDTQY----TVFH---SLIRAMLQVNPE 291

Query: 335 DRPSMVDVAKKLRQI 349
           +R S+ +V  +L++I
Sbjct: 292 ERLSIAEVVHQLQEI 306

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 35/163 (21%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 170
            ++H +I+KL    +ET   + L+ E    G ++D ++              R+      
Sbjct: 70  ILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKEKEAR 117

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
                IV A+ Y H    + IV R+ K   +L + +   K+ DF  S     G     D 
Sbjct: 118 SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDA 172

Query: 231 VMGTWGYCAPEYMRTGVFNEK------SDVFSFGVFLFELLTG 267
             G   Y APE     +F  K       DV+S GV L+ L++G
Sbjct: 173 FCGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 18/156 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
           ++ H++++ L     E    + L+ E V  G L+D +  A +    E    +        
Sbjct: 71  QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL--AQKESLSE----EEATSFIKQ 123

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA----KLFDFSLSISIPEGETHITDTV 231
           I+  + YLH    + I   + K   I+  ++N+     KL DF L+  I +G       +
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI 178

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  + APE +       ++D++S GV  + LL+G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 63.3 bits (155), Expect = 1e-11
 Identities = 38/151 (25%), Positives = 60/151 (39%), Gaps = 10/151 (6%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++ H  IL+L     E    + LV E    G +   +    +P  E    + R      I
Sbjct: 67  QLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN---EAR-HFMHQI 121

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
           +  + YLH      I+ R+   S +L       K+ DF L+ +  +       T+ GT  
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPN 177

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           Y +PE         +SDV+S G   + LL G
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 19/156 (12%)

Query: 121 HNHILKLIGCCLETPIPI-----LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAM 174
             HI++++    E          +V E +  G L+ RI       F E    +   +I  
Sbjct: 114 CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE----REASEIMK 168

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTV 231
            I  A+ YLH      I  R+ K   +L+       + KL DF  +       +    T 
Sbjct: 169 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTP 223

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             T  Y APE +    +++  D++S GV ++ LL G
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 21/164 (12%)

Query: 118 RMSHNHILKLIGC--CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
           +++H +I+KL        T   +L+ E    G+L+  +      +   L     L +  D
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRD 120

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLFDFSLSISIPEGETHITDTV 231
           +V  + +L       IV RN K   I+     + ++V KL DF  +  + + E     ++
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSL 175

Query: 232 MGTWGYCAPEYMRTGV--------FNEKSDVFSFGVFLFELLTG 267
            GT  Y  P+     V        +    D++S GV  +   TG
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 23/157 (14%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 170
            ++H H++   G   E    + +V E  +  +L +               +  L      
Sbjct: 97  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEAR 144

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
                IV    YLH      ++ R+ K   +  NE+   K+ DF L+ +  E +      
Sbjct: 145 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV 200

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + GT  Y APE +     + + DV+S G  ++ LL G
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 31/153 (20%), Positives = 60/153 (39%), Gaps = 13/153 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            + H  ++ L     E    + +++E +  G L++++        E       ++    +
Sbjct: 210 VLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMSE----DEAVEYMRQV 264

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGT 234
              L ++H       V  + K   I+F     N  KL DF L+  +   ++       GT
Sbjct: 265 CKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGT 319

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + APE          +D++S GV  + LL+G
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 61.5 bits (150), Expect = 6e-11
 Identities = 37/162 (22%), Positives = 68/162 (41%), Gaps = 29/162 (17%)

Query: 118 RMSHNHILKL---IGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL---- 170
           ++ H +++KL   +    E  +  +VFE V  G + +                  L    
Sbjct: 92  KLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPT------------LKPLSEDQ 138

Query: 171 --KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
                 D++  + YLH+   + I+ R+ K S +L  E+   K+ DF +S +  +G   + 
Sbjct: 139 ARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSDALL 194

Query: 229 DTVMGTWGYCAPE---YMRTGVFNEKSDVFSFGVFLFELLTG 267
              +GT  + APE     R     +  DV++ GV L+  + G
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 61.1 bits (149), Expect = 9e-11
 Identities = 44/163 (26%), Positives = 66/163 (40%), Gaps = 26/163 (15%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDIVH 178
           H ++L+LI    E      LVFE ++ G++   I    + HF E         +  D+  
Sbjct: 70  HRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHK--RRHFNE----LEASVVVQDVAS 122

Query: 179 ALAYLHFGFPRPIVFRNFKTSCILF-NEENVA--KLFDFSLSISIPEGETHITD------ 229
           AL +LH    + I  R+ K   IL  +   V+  K+ DF L   I               
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 230 TVMGTWGYCAPEYMRTGVFNEKS-----DVFSFGVFLFELLTG 267
           T  G+  Y APE +              D++S GV L+ LL+G
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 18/156 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
           ++ H +I+ L     E    + L+ E V  G L+D +  A +    E    +        
Sbjct: 71  QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFL--AQKESLSE----EEATSFIKQ 123

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA----KLFDFSLSISIPEGETHITDTV 231
           I+  + YLH    + I   + K   I+  ++N+     KL DF L+  I +G       +
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNI 178

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  + APE +       ++D++S GV  + LL+G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 33/160 (20%), Positives = 59/160 (36%), Gaps = 24/160 (15%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
            + I++L      T   I +V E      L   +        + +    R     +++ A
Sbjct: 87  SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWLK-----KKKSIDPWERKSYWKNMLEA 139

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTWGYC 238
           +  +H      IV  + K +  L  +  + KL DF ++  +    T +  D+ +GT  Y 
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 239 APE-----------YMRTGVFNEKSDVFSFGVFLFELLTG 267
            PE                  + KSDV+S G  L+ +  G
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 32/153 (20%), Positives = 58/153 (37%), Gaps = 13/153 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++ H  ++ L     E    + L+ E +  G L+DRI        E       +      
Sbjct: 104 QLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSE----AEVINYMRQA 158

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGT 234
              L ++H      IV  + K   I+    + +  K+ DF L+  +   E         T
Sbjct: 159 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTAT 213

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + APE +        +D+++ GV  + LL+G
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 18/156 (11%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
            + H +++ L     E    + L+ E V  G L+D +  A +    E    +   +    
Sbjct: 70  EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFL--AEKESLTE----EEATEFLKQ 122

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA----KLFDFSLSISIPEGETHITDTV 231
           I++ + YLH      I   + K   I+  + NV     K+ DF L+  I  G       +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  + APE +       ++D++S GV  + LL+G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 37/156 (23%), Positives = 56/156 (35%), Gaps = 21/156 (13%)

Query: 120 SHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EP---LLLKHRLKIAM 174
           S   ++ L     E    I L+ E    G ++   L        E     L+K       
Sbjct: 87  SCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ------ 139

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTV 231
            I+  + YLH      IV  + K   IL          K+ DF +S  I          +
Sbjct: 140 -ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREI 193

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           MGT  Y APE +        +D+++ G+  + LLT 
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 32/160 (20%), Positives = 58/160 (36%), Gaps = 24/160 (15%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
            + I++L      T   I +V E      L   +        + +    R     +++ A
Sbjct: 115 SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWLK-----KKKSIDPWERKSYWKNMLEA 167

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTWGYC 238
           +  +H      IV  + K +  L  +  + KL DF ++  +    T +  D+ +G   Y 
Sbjct: 168 VHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 239 APE-----------YMRTGVFNEKSDVFSFGVFLFELLTG 267
            PE                  + KSDV+S G  L+ +  G
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 59.1 bits (144), Expect = 3e-10
 Identities = 39/159 (24%), Positives = 63/159 (39%), Gaps = 24/159 (15%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EP---LLLKHRLKI 172
            + H +I+ L     E    + L+ E V  G L+D +  A +    E      LK     
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQ---- 116

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLFDFSLSISIPEGETHIT 228
              I+  + YLH    + I   + K   I+           KL DF ++  I  G     
Sbjct: 117 ---ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EF 168

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + GT  + APE +       ++D++S GV  + LL+G
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 33/160 (20%), Positives = 59/160 (36%), Gaps = 24/160 (15%)

Query: 121 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
            + I++L      T   I +V E      L   +        + +    R     +++ A
Sbjct: 68  SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWLK-----KKKSIDPWERKSYWKNMLEA 120

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTWGYC 238
           +  +H      IV  + K +  L  +  + KL DF ++  +    T +  D+ +GT  Y 
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 239 APE-----------YMRTGVFNEKSDVFSFGVFLFELLTG 267
            PE                  + KSDV+S G  L+ +  G
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L ++H    R +V+R+ K + IL +E    ++ D  L+    + + H     +GT 
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 354

Query: 236 GYCAPEYMRTGVFNEKS-DVFSFGVFLFELLTGW 268
           GY APE ++ GV  + S D FS G  LF+LL G 
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 37/153 (24%), Positives = 63/153 (41%), Gaps = 13/153 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           ++ H ++++L     E+   I LV E V  G L+DRI+       E       +     I
Sbjct: 142 QLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTE----LDTILFMKQI 196

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGT 234
              + ++H      I+  + K   IL    +    K+ DF L+      E        GT
Sbjct: 197 CEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGT 251

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + APE +     +  +D++S GV  + LL+G
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I   L  LH      IV+R+ K   IL ++    ++ D  L++ +PEG+T      +GT 
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTV 349

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           GY APE ++   +    D ++ G  L+E++ G 
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 57.6 bits (140), Expect = 1e-09
 Identities = 30/154 (19%), Positives = 62/154 (40%), Gaps = 15/154 (9%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 175
              H +IL L     E+   + ++FE +    +++RI         E    +  +     
Sbjct: 57  IARHRNILHLHESF-ESMEELVMIFEFISGLDIFERIN-TSAFELNE----REIVSYVHQ 110

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMG 233
           +  AL +LH      I   + +   I++     +  K+ +F  +  +  G+      +  
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFT 165

Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
              Y APE  +  V +  +D++S G  ++ LL+G
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 18/101 (17%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           +V AL YL     + I+ R+ K   IL +E     + DF+++  +P        T+ GT 
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTK 178

Query: 236 GYCAPEYMRTGVFNEKS--------DVFSFGVFLFELLTGW 268
            Y APE     +F+ +         D +S GV  +ELL G 
Sbjct: 179 PYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 32/147 (21%), Positives = 60/147 (40%), Gaps = 27/147 (18%)

Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
              + + L L+H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL 239

Query: 217 SISIPEGETHITDTV-------MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT--- 266
           +  I +   ++           M      APE +   V+  +SDV+SFGV L+E+ +   
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293

Query: 267 --------GWDVSDLVKDTHDLACPSN 285
                     +    +K+   +  P  
Sbjct: 294 SPYPGVKIDEEFCRRLKEGTRMRAPDY 320

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 55.3 bits (134), Expect = 7e-09
 Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 14/104 (13%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---THI 227
           KIA+ IV AL +LH      ++ R+ K S +L N     K+ DF +S     G       
Sbjct: 113 KIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVA 165

Query: 228 TDTVMGTWGYCAPE----YMRTGVFNEKSDVFSFGVFLFELLTG 267
            D   G   Y APE     +    ++ KSD++S G+ + EL   
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 41/164 (25%), Positives = 63/164 (38%), Gaps = 36/164 (21%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFES-VQYGTLWDRILGAPQPHFEPLLLKHRL----- 170
           R+ H +I+K++    E      LV E       L+  I               RL     
Sbjct: 85  RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFID-----------RHPRLDEPLA 132

Query: 171 -KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
             I   +V A+ YL     + I+ R+ K   I+  E+   KL DF  +  +  G+  +  
Sbjct: 133 SYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFY 187

Query: 230 TVMGTWGYCAPEYMRTGVFNEKS------DVFSFGVFLFELLTG 267
           T  GT  YCAPE     V           +++S GV L+ L+  
Sbjct: 188 TFCGTIEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFE 226

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 54.8 bits (132), Expect = 9e-09
 Identities = 17/152 (11%), Positives = 40/152 (26%), Gaps = 38/152 (25%)

Query: 116 AARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
            +R+    + +++         ++V E ++ G+L +    +P P          ++    
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-------GAIRAMQS 137

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           +  A    H      +       S +  + +    L                        
Sbjct: 138 LAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP--------------------- 173

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
                        N + D+   G  L+ LL  
Sbjct: 174 ATMPDA-------NPQDDIRGIGASLYALLVN 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           IV AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    ++ +GT
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y +PE +      + SD+++ G  +++L+ G 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 27/93 (29%), Positives = 49/93 (52%), Gaps = 4/93 (4%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV  L +LH    R I++R+ K   +L +++   ++ D  L++ +  G+T  T    GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTP 353

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           G+ APE +    ++   D F+ GV L+E++   
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 19/107 (17%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           K+ + IV AL YL       ++ R+ K S IL +E    KL DF +S         + D 
Sbjct: 128 KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS-------GRLVDD 178

Query: 231 V-----MGTWGYCAPE-----YMRTGVFNEKSDVFSFGVFLFELLTG 267
                  G   Y APE           ++ ++DV+S G+ L EL TG
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 5/94 (5%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           IV AL YLH    + +V+R+ K   ++ +++   K+ DF L    I +G T    T  GT
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGT 312

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE +    +    D +  GV ++E++ G 
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 53.7 bits (130), Expect = 2e-08
 Identities = 45/163 (27%), Positives = 66/163 (40%), Gaps = 35/163 (21%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM-- 174
              H HI+KL    + TP    +V E V  G L+D I               R++     
Sbjct: 67  LFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICK-----------HGRVEEMEAR 114

Query: 175 ----DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
                I+ A+ Y H      +V R+ K   +L +    AK+ DF LS  + +G      T
Sbjct: 115 RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 169

Query: 231 VMGTWGYCAPEYMRTGVFNEK------SDVFSFGVFLFELLTG 267
             G+  Y APE     V + +       D++S GV L+ LL G
Sbjct: 170 SCGSPNYAAPE-----VISGRLYAGPEVDIWSCGVILYALLCG 207

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 18/106 (16%)

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
           KI +  V AL +L       I+ R+ K S IL +     KL DF +S         + D+
Sbjct: 129 KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS-------GQLVDS 179

Query: 231 V-----MGTWGYCAPE----YMRTGVFNEKSDVFSFGVFLFELLTG 267
           +      G   Y APE          ++ +SDV+S G+ L+EL TG
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 52.6 bits (127), Expect = 4e-08
 Identities = 37/159 (23%), Positives = 60/159 (37%), Gaps = 24/159 (15%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA--- 173
            ++H +++K  G          L  E    G L+DRI                +      
Sbjct: 61  MLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQ 108

Query: 174 ---MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITD 229
                ++  + YLH      I  R+ K   +L +E +  K+ DF L+ +        + +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165

Query: 230 TVMGTWGYCAPE-YMRTGVFNEKSDVFSFGVFLFELLTG 267
            + GT  Y APE   R     E  DV+S G+ L  +L G
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 51.9 bits (125), Expect = 8e-08
 Identities = 36/158 (22%), Positives = 61/158 (38%), Gaps = 28/158 (17%)

Query: 120 SHNHILKLIGCCLETPIPI-LVFE-SVQYGTLWDRILGAPQPHFEPLLLKHRL------K 171
            H  +++L+    ET     LV E  +    L+D I             K  L       
Sbjct: 96  GHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYIT-----------EKGPLGEGPSRC 143

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSISIPEGETHITDT 230
               +V A+ + H    R +V R+ K   IL +     AKL DF     + +        
Sbjct: 144 FFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT---D 197

Query: 231 VMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG 267
             GT  Y  PE++    ++   + V+S G+ L++++ G
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 36/225 (16%), Positives = 72/225 (32%), Gaps = 54/225 (24%)

Query: 58  KLATNSYDQKNV----IAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNV 113
                  D   V    + KD   +   +  G      + +L+                  
Sbjct: 60  YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS----------- 108

Query: 114 TYAARMSHNHILKLIGCCLETPIPI-LVFESVQ-YGTLWDRILGAPQPHFEPLLLKHRL- 170
                     +++L+    E P    L+ E  +    L+D I             +  L 
Sbjct: 109 ---------GVIRLLDW-FERPDSFVLILERPEPVQDLFDFIT-----------ERGALQ 147

Query: 171 -----KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE--NVAKLFDFSLSISIPEG 223
                     ++ A+ + H      ++ R+ K   IL +     + KL DF     + + 
Sbjct: 148 EELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL-KLIDFGSGALLKDT 203

Query: 224 ETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTG 267
                    GT  Y  PE++R   ++   + V+S G+ L++++ G
Sbjct: 204 VYT---DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 37/159 (23%), Positives = 61/159 (38%), Gaps = 24/159 (15%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 170
            ++H +++K  G          L  E    G L+DRI                +      
Sbjct: 61  MLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQ 108

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITD 229
           +    ++  + YLH      I  R+ K   +L +E +  K+ DF L+ +        + +
Sbjct: 109 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165

Query: 230 TVMGTWGYCAPE-YMRTGVFNEKSDVFSFGVFLFELLTG 267
            + GT  Y APE   R     E  DV+S G+ L  +L G
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 7/100 (7%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 232
             ++V AL  +H       + R+ K   +L ++    KL DF   + + +      DT +
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230

Query: 233 GTWGYCAPEYMRT----GVFNEKSDVFSFGVFLFELLTGW 268
           GT  Y +PE +++    G +  + D +S GVFL+E+L G 
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 8/98 (8%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           +V A+  +H       V R+ K   IL +     +L DF   + + E  T  +   +GT 
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 236 GYCAPEYMRTGVFNEKS-----DVFSFGVFLFELLTGW 268
            Y +PE ++     +       D +S GV ++E+L G 
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 42/155 (27%), Positives = 65/155 (41%), Gaps = 13/155 (8%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMD 175
            + H +I++ +G   E     +  E V  G+L    R    P    E  +          
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF----YTKQ 130

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGT 234
           I+  L YLH      IV R+ K   +L N  + V K+ DF  S  +       T+T  GT
Sbjct: 131 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-TETFTGT 186

Query: 235 WGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTG 267
             Y APE +  G   + + +D++S G  + E+ TG
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 50.6 bits (122), Expect = 3e-07
 Identities = 34/95 (35%), Positives = 47/95 (49%), Gaps = 8/95 (8%)

Query: 176 IVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           I  AL +LH  G    I++R+ K   I+ N +   KL DF L   SI +G    T T  G
Sbjct: 130 ISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCG 183

Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           T  Y APE +     N   D +S G  ++++LTG 
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 13/156 (8%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           A +S   I+ L G   E P   +  E ++ G+L   I          L     L      
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYYLGQA 159

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSISIPEGETHIT----DTV 231
           +  L YLH    R I+  + K   +L + + + A L DF  ++ +       +    D +
Sbjct: 160 LEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            GT  + APE +     + K D++S    +  +L G
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 28/175 (16%), Positives = 54/175 (30%), Gaps = 35/175 (20%)

Query: 116 AARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL--GAPQPHF-EPLLLKHRLKI 172
           A    H+H+++      E    ++  E    G+L D I        +F E  L      +
Sbjct: 65  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----L 120

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV-------------------AKLFD 213
            + +   L Y+H      +V  + K S I  +  ++                    K+ D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
                 I            G   + A E ++       K+D+F+  + +      
Sbjct: 178 LGHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 46/163 (28%), Positives = 65/163 (39%), Gaps = 35/163 (21%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA--- 173
              H HI+KL    + TP  I +V E V  G L+D I               RL      
Sbjct: 72  LFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICK-----------NGRLDEKESR 119

Query: 174 ---MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
                I+  + Y H      +V R+ K   +L +    AK+ DF LS  + +G      T
Sbjct: 120 RLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 174

Query: 231 VMGTWGYCAPEYMRTGVFNEK------SDVFSFGVFLFELLTG 267
             G+  Y APE     V + +       D++S GV L+ LL G
Sbjct: 175 SCGSPNYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCG 212

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 50.2 bits (121), Expect = 3e-07
 Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 8/95 (8%)

Query: 176 IVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 233
           +  AL +LH  G    I++R+ K   IL +EE   KL DF LS  SI   +     +  G
Sbjct: 135 LALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 188

Query: 234 TWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
           T  Y APE +      + +D +SFGV +FE+LTG 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 27/96 (28%), Positives = 50/96 (52%), Gaps = 4/96 (4%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  +I+  L YLH       + R+ K + +L +E    KL DF ++  + + +    +T 
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTF 179

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE ++   ++ K+D++S G+   EL  G
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTV 231
           A +I   L +L     + I++R+ K   ++ + E   K+ DF +   +I +G T  T T 
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTF 502

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            GT  Y APE +    + +  D ++FGV L+E+L G 
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 32/168 (19%), Positives = 60/168 (35%), Gaps = 38/168 (22%)

Query: 118 RMSHNHILKLIG-CCLETPIPI-LVFESVQYGT--LWDRILGAPQPHFEPLLLKHRLKIA 173
           R+ H ++++L+     E    + +V E    G   + D +             + R  + 
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP------------EKRFPVC 109

Query: 174 M------DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETH 226
                   ++  L YLH    + IV ++ K   +L       K+    ++    P     
Sbjct: 110 QAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNE-------KSDVFSFGVFLFELLTG 267
              T  G+  +  PE     + N        K D++S GV L+ + TG
Sbjct: 167 TCRTSQGSPAFQPPE-----IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           I   L +L     + I++R+ K   ++ + E   K+ DF +   +I +G T  T T  GT
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGT 184

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE +    + +  D ++FGV L+E+L G 
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 49.9 bits (120), Expect = 4e-07
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           I  AL YLH    R I++R+ K   +L + E   KL D+ +    +  G+T  T T  GT
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGT 173

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE +R   +    D ++ GV +FE++ G 
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           I  AL YLH    R I++R+ K   +L + E   KL D+ +    +  G+T  T T  GT
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGT 216

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE +R   +    D ++ GV +FE++ G 
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 49.5 bits (119), Expect = 7e-07
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           I+  L +LH    + IV+R+ K   IL +++   K+ DF +   ++       T+T  GT
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGT 181

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE +    +N   D +SFGV L+E+L G 
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 49.1 bits (118), Expect = 8e-07
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           IV AL YLH    R +V+R+ K   ++ +++   K+ DF L    I +G T    T  GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGT 168

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE +    +    D +  GV ++E++ G 
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 47/163 (28%), Positives = 69/163 (42%), Gaps = 36/163 (22%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM-- 174
            + H HI+KL    + TP  I +V E    G L+D I+            K R+      
Sbjct: 65  LLRHPHIIKLYDV-ITTPTDIVMVIEYAG-GELFDYIVE-----------KKRMTEDEGR 111

Query: 175 ----DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 230
                I+ A+ Y H      IV R+ K   +L ++    K+ DF LS  + +G  +   T
Sbjct: 112 RFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKT 166

Query: 231 VMGTWGYCAPEYMRTGVFNEK------SDVFSFGVFLFELLTG 267
             G+  Y APE     V N K       DV+S G+ L+ +L G
Sbjct: 167 SCGSPNYAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVG 204

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 48.9 bits (117), Expect = 9e-07
 Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 12/103 (11%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF----SLSISIPEGETHI 227
           I  +++  L YLH       + R+ K   IL  E+   ++ DF     L+         +
Sbjct: 126 ILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182

Query: 228 TDTVMGT--WGYCAPEYM-RTGVFNEKSDVFSFGVFLFELLTG 267
             T +GT  W   APE M +   ++ K+D++SFG+   EL TG
Sbjct: 183 RKTFVGTPCW--MAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           I+ AL +LH    + I++R+ K   +L + E   KL DF +    I  G T  T T  GT
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGT 187

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE ++  ++    D ++ GV L+E+L G 
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 33/96 (34%), Positives = 45/96 (46%), Gaps = 7/96 (7%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV AL +LH      I++R+ K   IL +      L DF LS      ET       GT 
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 236 GYCAPE---YMRTGVFNEKSDVFSFGVFLFELLTGW 268
            Y AP+      +G  ++  D +S GV ++ELLTG 
Sbjct: 225 EYMAPDIVRGGDSG-HDKAVDWWSLGVLMYELLTGA 259

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 32/94 (34%), Positives = 43/94 (45%), Gaps = 6/94 (6%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 234
           I  AL YLH      IV+R+ K   IL + +    L DF L   +I    T  T T  GT
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGT 202

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
             Y APE +    ++   D +  G  L+E+L G 
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 10/100 (10%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV A+  +H       V R+ K   IL +     +L DF   + +    T  +   +GT 
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 236 GYCAPE-------YMRTGVFNEKSDVFSFGVFLFELLTGW 268
            Y +PE          TG +  + D ++ GVF +E+  G 
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 23/92 (25%), Positives = 44/92 (47%), Gaps = 5/92 (5%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  + +LH      I+ R+ K S I+   +   K+ DF L+ +       +T  V+  +
Sbjct: 136 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRY 191

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            Y APE +    + E  D++S G  + E++ G
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 22/92 (23%), Positives = 43/92 (46%), Gaps = 5/92 (5%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  + +LH      I+ R+ K S I+   +   K+ DF L+ +       +T  V+  +
Sbjct: 173 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRY 228

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            Y APE +    + E  D++S G  + E++  
Sbjct: 229 -YRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 33/162 (20%), Positives = 59/162 (36%), Gaps = 26/162 (16%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRI-LGAPQPHFEPLLLKHRLKIAM---D 175
           +H +I+      +      +V   + YG+  D I         E         IA     
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IAYILQG 136

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG------ETHITD 229
           ++ AL Y+H       V R+ K S IL + +    L     ++S+               
Sbjct: 137 VLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 230 TVMGT--WGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTG 267
             +    W   +PE ++  +  ++ KSD++S G+   EL  G
Sbjct: 194 YSVKVLPW--LSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 23/93 (24%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           IV    YLH      +++R+ K   +L +++   ++ DF  +  +       T T+ GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTP 202

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
              APE + +  +N+  D ++ GV ++E+  G+
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 14/151 (9%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM---DI 176
              H++K  G   +     +V E    G++ D I    +   E        +IA      
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-------EIATILQST 134

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
           +  L YLHF      + R+ K   IL N E  AKL DF ++  + +      +TV+GT  
Sbjct: 135 LKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPF 190

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           + APE ++   +N  +D++S G+   E+  G
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 46.1 bits (110), Expect = 8e-06
 Identities = 35/161 (21%), Positives = 66/161 (40%), Gaps = 10/161 (6%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  IN +       + +I+  +   L      +V E +  G+L D +          +  
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDE 115

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
                +  + + AL +LH      ++ R+ K+  IL   +   KL DF     I   ++ 
Sbjct: 116 GQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
              T++GT  + APE +    +  K D++S G+   E++ G
Sbjct: 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 36/165 (21%), Positives = 60/165 (36%), Gaps = 37/165 (22%)

Query: 118 RMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA--- 173
            + H +I++     + TP  + ++ E    G L++RI               R       
Sbjct: 72  SLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICN-----------AGRFSEDEAR 119

Query: 174 ---MDIVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHIT 228
                ++  ++Y H      I  R+ K    L   +     K+ DF  S S         
Sbjct: 120 FFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP 174

Query: 229 DTVMGTWGYCAPEYMRTGVFNEK------SDVFSFGVFLFELLTG 267
            + +GT  Y APE     V   +      +DV+S GV L+ +L G
Sbjct: 175 KSTVGTPAYIAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 4/96 (4%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +   ++ ALAYLH    + ++ R+ K+  IL   +   KL DF     I +       ++
Sbjct: 146 VCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL 201

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE +   ++  + D++S G+ + E++ G
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 34/156 (21%), Positives = 55/156 (35%), Gaps = 40/156 (25%)

Query: 121 HNHILKLIGCCLETPIPI-----LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAM 174
             HI++++    E          +V E +  G L+ RI       F E    +   +I  
Sbjct: 70  CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE----REASEIMK 124

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTV 231
            I  A+ YLH      I  R+ K   +L+       + KL DF                 
Sbjct: 125 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
                  A E      +++  D++S GV ++ LL G
Sbjct: 167 -------AKETTGEK-YDKSCDMWSLGVIMYILLCG 194

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 25/93 (26%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L Y+H      I+ R+ K   +  NE+   K+ DF L+      ++ +T  V+  W
Sbjct: 137 MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRW 190

Query: 236 GYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTG 267
            Y APE +     + +  D++S G  + E++TG
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 42.2 bits (100), Expect = 1e-04
 Identities = 37/171 (21%), Positives = 65/171 (38%), Gaps = 38/171 (22%)

Query: 118 RMSHNHILKLIGCCLETPIPI--------LVFESVQYGTLWD--RILGAPQPHFEPLLLK 167
            + H +++ LI  C     P         LVF+  ++    D   +L      F    +K
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIK 127

Query: 168 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL----SISIPEG 223
               +   +++ L Y+H      I+ R+ K + +L   + V KL DF L    S++    
Sbjct: 128 R---VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 224 ETHITDTVMGTWGYCAPE-------YMRTGVFNEKSDVFSFGVFLFELLTG 267
               T+ V+  W Y  PE       Y    +     D++  G  + E+ T 
Sbjct: 182 PNRYTNRVVTLW-YRPPELLLGERDY-GPPI-----DLWGAGCIMAEMWTR 225

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 8/93 (8%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+         +T  V   W
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRW 194

Query: 236 GYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTG 267
            Y APE M     +N+  D++S G  + ELLTG
Sbjct: 195 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 42.1 bits (100), Expect = 2e-04
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 7/93 (7%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           +  AL YLH    + I++R+ K   IL ++    K+ DF  +  +P+    +T T+ GT 
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTP 167

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW 268
            Y APE + T  +N+  D +SFG+ ++E+L G+
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 13/103 (12%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           I  +I+  L++LH      ++ R+ K   +L  E    KL DF +S  +        +T 
Sbjct: 134 ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTF 189

Query: 232 MGT--WGYCAPE-----YMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  W   APE           ++ KSD++S G+   E+  G
Sbjct: 190 IGTPYW--MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 11/99 (11%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +    +  LAYLH      ++ R+ K   IL +E  + KL DF  +  +        ++ 
Sbjct: 159 VTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSF 210

Query: 232 MGTWGYCAPE---YMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  + APE    M  G ++ K DV+S G+   EL   
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 13/103 (12%)

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 231
           +   ++ AL +LH    + I+ R+ K   +L   E   +L DF +S    +      D+ 
Sbjct: 122 VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK-RDSF 177

Query: 232 MGT--WGYCAPE-----YMRTGVFNEKSDVFSFGVFLFELLTG 267
           +GT  W   APE      M+   ++ K+D++S G+ L E+   
Sbjct: 178 IGTPYW--MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 42/163 (25%), Positives = 59/163 (36%), Gaps = 34/163 (20%)

Query: 120 SHNHILKLIGCCLETPIPI-----LVFESVQY--GTLWDRILGAPQPHFEPLLLKHRLKI 172
            H ++++L+  C  +         LVFE V     T  D+    P P      +K    +
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETIK---DL 125

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL--SISIPEGETHITDT 230
               +  L +LH      IV R+ K   IL       KL DF L    S     T +   
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--- 179

Query: 231 VMGTWGYCAPE------YMRTGVFNEKSDVFSFGVFLFELLTG 267
           V+  W Y APE      Y  T V     D++S G    E+   
Sbjct: 180 VVTLW-YRAPEVLLQSTY-ATPV-----DMWSVGCIFAEMFRR 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 41/163 (25%), Positives = 61/163 (37%), Gaps = 34/163 (20%)

Query: 120 SHNHILKLIGCCLETPIPI-----LVFESVQY--GTLWDRILGAPQPHFEPLLLKHRLKI 172
            H ++++L   C  +         LVFE V     T  D++   P+P      +K    +
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK---DM 125

Query: 173 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL--SISIPEGETHITDT 230
              ++  L +LH      +V R+ K   IL       KL DF L    S     T +   
Sbjct: 126 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--- 179

Query: 231 VMGTWGYCAPE------YMRTGVFNEKSDVFSFGVFLFELLTG 267
           V+  W Y APE      Y  T V     D++S G    E+   
Sbjct: 180 VVTLW-YRAPEVLLQSSY-ATPV-----DLWSVGCIFAEMFRR 215

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.0 bits (95), Expect = 6e-04
 Identities = 56/369 (15%), Positives = 105/369 (28%), Gaps = 97/369 (26%)

Query: 6   SKFKDRTDERTLMVRTDKRAL-------------MMRSGASVLKELIASSNG--KYYPYR 50
             F      R       ++AL             ++ SG + +   +  S        ++
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK 183

Query: 51  IF---------SAQEIKLATNSY---DQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYG 98
           IF             +++        D       D S N   +     Q  L  +L+   
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN-IKLRIHSIQAELRRLLK--- 239

Query: 99  HECRPRAYESC---INNVTYAARMSHNHILKL--IGC-CLETPIPILVFESVQYGTLWDR 152
                + YE+C   + NV       +        + C  L T     V + +   T    
Sbjct: 240 ----SKPYENCLLVLLNV------QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289

Query: 153 ILGAPQPHFEP-----LLLK------HRLKIAMDIVHALAYLHFG---FPRPIVFRNFKT 198
            L        P     LLLK        L   +   +                 + N+K 
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349

Query: 199 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFG 258
                N + +  + + SL++  P     +              + R  VF   + +    
Sbjct: 350 ----VNCDKLTTIIESSLNVLEPAEYRKM--------------FDRLSVFPPSAHI-PTI 390

Query: 259 VFLFELLTGW------DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSI 312
           +    L+  W      DV  +V   H  +      ++   +++  + I   I +E  + +
Sbjct: 391 LL--SLI--WFDVIKSDVMVVVNKLHKYSL-----VEKQPKESTIS-IPS-IYLELKVKL 439

Query: 313 EKEQQLHAS 321
           E E  LH S
Sbjct: 440 ENEYALHRS 448

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 40.0 bits (94), Expect = 8e-04
 Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 8/93 (8%)

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L Y+H      +V R+ K   +  NE+   K+ DF L+      +  +T  V+  W
Sbjct: 135 MLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRW 188

Query: 236 GYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTG 267
            Y APE + +   +N+  D++S G  + E+LTG
Sbjct: 189 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	353
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.27
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.91
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.3
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.92
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.75
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.61
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.57
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.5
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.28
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.25
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.18
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.15
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.13
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.96
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.26
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.58
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.06
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.99
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.41
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.08

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-60  Score=430.69  Aligned_cols=263  Identities=21%  Similarity=0.323  Sum_probs=209.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      +++...+.||+|+||   .||+|.+.+ .||||+++....+....+.|.+|+.+|++++|||||+++|+|.+ +.+||||
T Consensus        36 ~~l~l~~~iG~G~fG---~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           36 SEVMLSTRIGSGSFG---TVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             TSCCEEEECCCCSSS---EEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHeEEeeEEeeCCCc---EEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            456667889999999   999999865 58999997665567778899999999999999999999999864 5689999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      |||++|+|.+++....    ..+++.+++.|+.|||.||.|||   +++||||||||+|||+++++.+||+|||+|+...
T Consensus       111 Ey~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             ECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999999997654    46899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCC-CccccccccCCcccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          222 EGE-THITDTVMGTWGYCAPEYMRT---GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       222 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ... .......+||+.|||||++.+   +.|+.++|||||||++|||+||+.||......        ..+.........
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--------~~~~~~~~~~~~  255 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--------DQIIFMVGRGYA  255 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------HHHHHHHHTTCC
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcCCC
Confidence            322 223456789999999999864   45899999999999999999999999743221        112222211111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                      .    +...     ..+..++..+.+|+.+||+.||++||||.+|++.|+.|..+|
T Consensus       256 ~----p~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          256 S----PDLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             C----CCST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             C----CCcc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            0    0000     001145677889999999999999999999999999887654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-61  Score=435.40  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=214.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ++|...+.||+|+||   .||+|.+       ++..||||++...  +....++|.+|+++|++++|||||+++|+|.++
T Consensus        13 ~~~~l~~~lG~G~fG---~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFG---KVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CC---CEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCc---EEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            467778899999999   9999986       3678999999765  667778999999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCC--------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQ--------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE  206 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  206 (353)
                      +..|||||||++|+|.++|.....        .....+++.+++.|+.|||.||.|||   +++|+||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence            999999999999999999976420        11146899999999999999999999   8999999999999999999


Q ss_pred             CceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCCh
Q 018633          207 NVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~  284 (353)
                      +.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.....        
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------  236 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------  236 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence            99999999999876443322 2234578999999999999999999999999999999999 8999874321        


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .+...... .+.....             +..++.++.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus       237 ~~~~~~i~-~~~~~~~-------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          237 NEVIECIT-QGRVLQR-------------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHHHH-HTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHH-cCCCCCC-------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            22222222 2211110             114567788999999999999999999999999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-60  Score=434.92  Aligned_cols=261  Identities=21%  Similarity=0.290  Sum_probs=208.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ++|...+.||+|+||   .||+|.+       ++..||||++...  +....++|.+|+++|++++|||||+++|+|.+.
T Consensus        41 ~d~~l~~~LG~G~fG---~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFG---KVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGEEEEEEEEECSSE---EEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEEEEEccCCCc---EEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            456667889999999   9999986       3688999999765  667778999999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCC----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQP----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                      +..|||||||++|+|.+++......          ...++++.+++.|+.|||.||.|||   +++||||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence            9999999999999999999765321          1146899999999999999999999   89999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLAC  282 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~  282 (353)
                      .++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.....      
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------  266 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------  266 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999987644332 22345679999999999999999999999999999999999 8999874322      


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                        .+........... .             .+..++.++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       267 --~~~~~~i~~g~~~-~-------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          267 --TEAIDCITQGREL-E-------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             --HHHHHHHHHTCCC-C-------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --HHHHHHHHcCCCC-C-------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence              1222222211111 1             0114566788999999999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.2e-61  Score=437.70  Aligned_cols=251  Identities=20%  Similarity=0.251  Sum_probs=206.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++.+  +++.||||++..........+.|.+|+.+|++++|||||++++++.+++.+||
T Consensus        24 e~Y~~~~~lG~G~fg---~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCEEEEEEC---------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeEEEecCCCe---EEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            579999999999999   9999998  79999999998766566778899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||||+||+|.+++.....   ..+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus       101 VmEy~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             EEeCCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence            9999999999999976542   45789999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      .... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||....        ..+....... ..++.
T Consensus       175 ~~~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~-~~~~~  244 (350)
T 4b9d_A          175 LNST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIIS-GSFPP  244 (350)
T ss_dssp             CCHH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH-TCCCC
T ss_pred             ecCC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHc-CCCCC
Confidence            6432 122345689999999999999999999999999999999999999997432        1122222221 11111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .             +...+.++.+||.+||+.||++|||+.++++
T Consensus       245 ~-------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 V-------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             C-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1             0145667889999999999999999999975

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.5e-60  Score=429.86  Aligned_cols=257  Identities=18%  Similarity=0.292  Sum_probs=208.7

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      +...+.||+|+||   .||+|.+       +++.||||++.... .....++|.+|+.++++++|||||+++|+|.+++.
T Consensus        28 ~~~~~~lG~G~fG---~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           28 VRFMEELGEDRFG---KVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             EEEEEEEEECSSC---EEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CeEeeEeccCCCc---EEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            4445789999999   9999986       45789999997553 34456789999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          137 PILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      .+||||||++|+|.++|......           ....+++..++.|+.|||.||.|||   +++||||||||+|||+++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECC
Confidence            99999999999999999654211           0136899999999999999999999   899999999999999999


Q ss_pred             CCceEEeccCCccccCCCC-CccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCC
Q 018633          206 ENVAKLFDFSLSISIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACP  283 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~  283 (353)
                      ++.+||+|||+|+...... ........||+.|||||++.+..|+.++|||||||++|||+| |..||.....       
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------  253 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------  253 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------
Confidence            9999999999998764332 222345689999999999999999999999999999999999 8999874322       


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                       .+... ....+.....             +..++..+.+|+.+||+.||++||||.+|++.|++.
T Consensus       254 -~~~~~-~i~~~~~~~~-------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 -QDVVE-MIRNRQVLPC-------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHHH-HHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHHH-HHHcCCCCCC-------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             12222 2222211111             115667789999999999999999999999999753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.3e-59  Score=416.32  Aligned_cols=245  Identities=18%  Similarity=0.253  Sum_probs=199.4

Q ss_pred             CCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee----CCccE
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE----TPIPI  138 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~  138 (353)
                      ...+.||+|+||   .||+|.+  ++..||+|++..........+.|.+|+.+|++++|||||+++++|.+    .+.+|
T Consensus        29 ~~~~~iG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           29 KFDIEIGRGSFK---TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             EeeeEEecCcCc---EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            345579999999   9999998  78899999997665566777889999999999999999999999875    34589


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeecC-CCceEEeccC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFNE-ENVAKLFDFS  215 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~-~~~~kl~dfg  215 (353)
                      ||||||++|+|.+++...     ..+++..+..|+.||+.||.|||   +++  |+||||||+|||++. ++.+||+|||
T Consensus       106 lvmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence            999999999999999765     46899999999999999999999   887  999999999999985 7899999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +|+.....   ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.......       ... ......
T Consensus       178 la~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------~~~-~~i~~~  245 (290)
T 3fpq_A          178 LATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIY-RRVTSG  245 (290)
T ss_dssp             GGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHH-HHHTTT
T ss_pred             CCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------HHH-HHHHcC
Confidence            99764322   2456789999999999864 69999999999999999999999996332211       111 111111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+..            .+...+.++.+|+.+||..||++|||+.++++
T Consensus       246 ~~~~~------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 VKPAS------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCCGG------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11110            11133456789999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.3e-59  Score=425.16  Aligned_cols=253  Identities=18%  Similarity=0.162  Sum_probs=206.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +.|...+.||+|+||   .||+|.+  +++.||||++....       .+.+|+.+|++++|||||++++++.+++.+||
T Consensus        58 ~~~~~~~~lG~G~fG---~Vy~a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFG---EVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEETTT-------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheEeCcEeccCCCe---EEEEEEECCCCCEEEEEEECHHH-------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456677789999999   9999998  79999999997652       12479999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ceEEeccCCcc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSI  218 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~dfg~a~  218 (353)
                      |||||+||+|.+++...     ..+++..++.++.||+.||.|||   +++||||||||+|||++.+| .+||+|||+|+
T Consensus       128 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             EECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            99999999999999765     46899999999999999999999   99999999999999999987 69999999998


Q ss_pred             ccCCCCCc----cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          219 SIPEGETH----ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       219 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .+......    .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.......     ..   ......
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~---~~i~~~  271 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----LC---LKIASE  271 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----CH---HHHHHS
T ss_pred             EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HH---HHHHcC
Confidence            77543221    1234679999999999999999999999999999999999999997433221     10   011111


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ...       .     ...+...+..+.+|+.+||+.||++|||+.|+++.|......
T Consensus       272 ~~~-------~-----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          272 PPP-------I-----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             CCG-------G-----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC-------c-----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            000       0     001114567788999999999999999999999999887654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.2e-58  Score=414.60  Aligned_cols=268  Identities=19%  Similarity=0.292  Sum_probs=203.3

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC----ccE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP----IPI  138 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~  138 (353)
                      +|...+.||+|+||   .||+|.++|+.||||++...   ......+..|+..+.+++|||||+++|+|.+++    .+|
T Consensus         4 ~i~L~~~iG~G~fG---~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            4 TIVLQESIGKGRFG---EVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GEEEEEEEEECSSS---EEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             EEEEEEEEeeCCCe---EEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            46667889999999   99999999999999999654   222223345666677899999999999998654    479


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC--------CeEeeccCCCceeecCCCceE
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR--------PIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~iiH~dlkp~Nill~~~~~~k  210 (353)
                      ||||||++|+|.++++..      .+++..+.+++.|++.||+|||   ++        +|+||||||+|||++.++.+|
T Consensus        78 lV~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             EEecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence            999999999999999763      5899999999999999999999   55        999999999999999999999


Q ss_pred             EeccCCccccCCCCCc---cccccccCCccccccccccC------CCCccccchhhHHHHHHHHhCCCCCCccccccCC-
Q 018633          211 LFDFSLSISIPEGETH---ITDTVMGTWGYCAPEYMRTG------VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-  280 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-  280 (353)
                      |+|||+|+........   ......||+.|||||++.+.      .++.++|||||||++|||+||..|+......... 
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            9999999876543322   12346799999999999754      3778999999999999999999887644332210 


Q ss_pred             -----CCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          281 -----ACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       281 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                           ..+....+.........    ++.+....   .....+..+.+|+.+||+.||++||||.+|++.|+++.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~----rp~~p~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCEQKL----RPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCC----CCCCCGGG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhcccccchHHHHHHHHhcccC----CCCCCccc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                 11122222222221111    11111111   0115667889999999999999999999999999998764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.3e-59  Score=423.47  Aligned_cols=248  Identities=17%  Similarity=0.232  Sum_probs=207.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ..|+..+.||+|+||   .||+|.+  +++.||||++...  .....+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus        74 ~~y~~~~~iG~G~fG---~V~~a~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTG---IVCIATVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEGG--GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEEeEEeecCcCe---EEEEEEECCCCCEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            458888899999999   9999999  7999999999755  33345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||||++|+|.+++..      ..+++..+..++.||+.||.|||   +++||||||||+|||++.+|.+||+|||+|+.
T Consensus       149 vmEy~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  219 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  219 (346)
T ss_dssp             EECCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCcee
Confidence            9999999999999875      35899999999999999999999   99999999999999999999999999999988


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      +..... ...+.+||+.|||||++.+..|+.++|||||||++|||++|..||.....        .+....... .....
T Consensus       220 ~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~-~~~~~  289 (346)
T 4fih_A          220 VSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRD-NLPPR  289 (346)
T ss_dssp             CCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH-SSCCC
T ss_pred             cCCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHc-CCCCC
Confidence            754322 34567899999999999999999999999999999999999999974221        112221111 11101


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...           ....+.++.+|+.+||..||++|||+.|+++
T Consensus       290 ~~~-----------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          290 LKN-----------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CSC-----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCc-----------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000           0145567889999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.8e-59  Score=427.26  Aligned_cols=273  Identities=18%  Similarity=0.304  Sum_probs=220.4

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC-Cc
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSH-NH  123 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-~n  123 (353)
                      +..++++...++|...+.||+|+||   .||+|.+.       ++.||||++.... .....+.|.+|+.+|.+++| ||
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG---~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpn  129 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLN  129 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSE---EEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCCcccEecHHHeEEeeEEecCCCe---EEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCc
Confidence            3445566667889999999999999   99999872       3689999997653 44556789999999999975 99


Q ss_pred             eeeccceeeeC-CccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018633          124 ILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI  191 (353)
Q Consensus       124 iv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  191 (353)
                      ||+++|+|.+. +.++||||||++|+|.++|+.....           ....+++..++.++.|||.||.|||   +++|
T Consensus       130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~i  206 (353)
T 4ase_A          130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC  206 (353)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCe
Confidence            99999999764 5689999999999999999754210           1145899999999999999999999   9999


Q ss_pred             EeeccCCCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCC
Q 018633          192 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWD  269 (353)
Q Consensus       192 iH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~  269 (353)
                      |||||||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |..
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654432 23455679999999999999999999999999999999998 899


Q ss_pred             CCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          270 VSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       270 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ||......        +.+......+.....             +..++.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       287 Pf~~~~~~--------~~~~~~i~~g~~~~~-------------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          287 PYPGVKID--------EEFCRRLKEGTRMRA-------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             SSTTCCCS--------HHHHHHHHHTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCHH--------HHHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            98743221        122222222211111             114556788999999999999999999999999998


Q ss_pred             HHh
Q 018633          350 YRS  352 (353)
Q Consensus       350 ~~~  352 (353)
                      .++
T Consensus       346 lq~  348 (353)
T 4ase_A          346 LQA  348 (353)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.9e-59  Score=419.29  Aligned_cols=249  Identities=15%  Similarity=0.213  Sum_probs=208.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...++||+|+||   .||++.+  +++.||||++..... .....+.+.+|+++|++++|||||++++++.+++..
T Consensus        31 ~~dy~i~~~lG~G~fg---~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFS---TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             GGGEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEecccCe---EEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            3579999999999999   9999998  799999999965421 233457799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |||||||+||+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus       108 yivmEy~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla  179 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTA  179 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence            9999999999999999765     46899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCC-CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      +.+.... .....+.+||+.|||||++.+..|+.++||||+||++|||+||..||.....        .+....... ..
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~-~~  250 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIK-LE  250 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-TC
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-CC
Confidence            8875432 2335677899999999999999999999999999999999999999974321        111111111 11


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                      + .         .+    ...+.++.+|+.+||..||++|||+.|++
T Consensus       251 ~-~---------~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 Y-D---------FP----EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C-C---------CC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             C-C---------CC----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            1 0         00    13455678999999999999999998864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.5e-58  Score=406.84  Aligned_cols=246  Identities=21%  Similarity=0.293  Sum_probs=191.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++.+  +++.||+|++..... .....+.+.+|+.+|++++|||||++++++.+.+..|
T Consensus        13 g~Y~i~~~lG~G~fg---~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFG---KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             -CCEEEEEEEC---C---CEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             eCeEEEEEEecCcCe---EEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            679999999999999   9999998  799999999976532 2344567999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||| +|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        90 ivmEy~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             EEEECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             EEEeCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCe
Confidence            999999 58999999765     46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ......  ...+.+||+.|||||++.+..+ +.++||||+||++|+|+||+.||....        ......... ...+
T Consensus       161 ~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i~-~~~~  229 (275)
T 3hyh_A          161 IMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNIS-NGVY  229 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HTCC
T ss_pred             ecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCC
Confidence            764332  2346789999999999998876 579999999999999999999997322        111111111 1111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .          .    +...+..+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~----------~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 T----------L----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             C----------C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C----------C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0          0    0134566789999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-57  Score=424.87  Aligned_cols=248  Identities=17%  Similarity=0.233  Sum_probs=208.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +.|...+.||+|+||   .||+|.+  +++.||||++...  .....+.+.+|+.+|++++|||||+++++|.+++.+||
T Consensus       151 ~~y~~~~~iG~G~fG---~V~~a~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTG---IVCIATVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEST--TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeeEeccCcCc---EEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            458888999999999   9999999  7999999999765  33445678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||||+||+|.+++...      .+++..+..|+.||+.||.|||   +++||||||||+|||++.+|.+||+|||+|+.
T Consensus       226 VmEy~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~  296 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  296 (423)
T ss_dssp             EEECCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred             EEeCCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceE
Confidence            99999999999998753      5899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      +..... ...+.+||+.|||||++.+..|+.++|||||||++|||++|..||.....        .+....... .....
T Consensus       297 ~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~-~~~~~  366 (423)
T 4fie_A          297 VSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRD-NLPPR  366 (423)
T ss_dssp             CCSSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH-SCCCC
T ss_pred             CCCCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHc-CCCCC
Confidence            754332 34567899999999999999999999999999999999999999974221        112221111 11111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +..           ....+..+.+|+.+||..||++|||+.|+++
T Consensus       367 ~~~-----------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          367 LKN-----------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CSC-----------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Ccc-----------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000           0134567889999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-58  Score=414.48  Aligned_cols=243  Identities=21%  Similarity=0.239  Sum_probs=195.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++|...+.||+|+||   .||++..     +++.||+|++............+.+|+.+|++++|||||++++++.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg---~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFG---KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGC---EEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCe---EEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            569999999999999   9998876     46899999997654333445578899999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      +|+|||||+||+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EEEEEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence            99999999999999999765     46899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      |+...... ....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.....        .+....... ..
T Consensus       173 a~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~-~~  242 (304)
T 3ubd_A          173 SKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILK-AK  242 (304)
T ss_dssp             EEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CC
T ss_pred             ceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHc-CC
Confidence            98654332 224567899999999999999999999999999999999999999974321        112222111 11


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                      +.          .    +...+.++.+|+.+||+.||++|||+
T Consensus       243 ~~----------~----p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 LG----------M----PQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             CC----------C----CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CC----------C----CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence            10          0    11345678899999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.3e-56  Score=400.97  Aligned_cols=251  Identities=20%  Similarity=0.305  Sum_probs=191.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC---
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP---  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---  135 (353)
                      .++|+..+.||+|+||   .||+|.+  +++.||||++.... .....+.+.+|+.+|++++|||||++++++.+.+   
T Consensus         4 l~dy~~~~~lG~G~fg---~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFG---VVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHHEEEEEEEEECC-----EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred             chhCEEeeEEecCCCe---EEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence            3468899999999999   9999998  79999999997542 4455678999999999999999999999987654   


Q ss_pred             ---------ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC
Q 018633          136 ---------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE  206 (353)
Q Consensus       136 ---------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  206 (353)
                               ..|+|||||++|+|.+++.....  ....++..++.|+.||+.||.|||   +++|+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~  154 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMD  154 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCC
Confidence                     36899999999999999986542  134566778899999999999999   9999999999999999999


Q ss_pred             CceEEeccCCccccCCCCCc-----------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          207 NVAKLFDFSLSISIPEGETH-----------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                      +.+||+|||+|+........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||....
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~  231 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM  231 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence            99999999999876543211           1234579999999999999999999999999999999996   664211


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                +.......          ......++ .....+..+.+|+.+||+.||++|||+.++++
T Consensus       232 ----------~~~~~~~~----------~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 ----------ERVRTLTD----------VRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ----------HHHHHHHH----------HHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------HHHHHHHH----------HhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                      11110000          00011111 11244556678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-53  Score=393.07  Aligned_cols=263  Identities=15%  Similarity=0.192  Sum_probs=204.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee------
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE------  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~------  133 (353)
                      ++|...+.||+|+||   .||+|.+  +|+.||||++..........+.+.+|+.+|++++|||||++++++..      
T Consensus        54 ~~Y~~~~~lG~G~fG---~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           54 DEYEIIETIGNGAYG---VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             SSEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CCeEEEEEEecccCe---EEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            568889999999999   9999998  79999999998765566677889999999999999999999998764      


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..|||||||+ |+|.+++...     ..+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred             CCEEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEee
Confidence            357899999996 7899999765     46899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCC---CccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          214 FSLSISIPEGE---THITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       214 fg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ||+|+.+....   .....+.+||+.|+|||++.+. .++.++||||+||++|||++|+.||.......        .+.
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--------~l~  273 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--------QLQ  273 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--------HHH
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--------HHH
Confidence            99998764322   1223567899999999998875 46899999999999999999999997543211        111


Q ss_pred             HHhhc-Cccc-ccccch-----------hhhccch---HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFED-NRFT-EIVDPI-----------IVEDVLS---IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~-~~~~-~~~~~~-----------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... +... ......           +....+.   ......+..+.+|+.+||..||++|||+.|+++
T Consensus       274 ~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          274 LIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11100 0000 000000           0000000   000123567889999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.1e-52  Score=379.56  Aligned_cols=290  Identities=28%  Similarity=0.477  Sum_probs=241.4

Q ss_pred             CCcceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCcee
Q 018633           47 YPYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHIL  125 (353)
Q Consensus        47 ~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv  125 (353)
                      ...+.|++.++...+++|...+.||+|+||   .||+|.+ +++.||+|++.... .......+.+|+.++++++||||+
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv   90 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFG---KVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLL   90 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSS---EEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCc---EEEEEEecCCCEEEEEEecccc-CchHHHHHHHHHHHHHhccCCCcc
Confidence            346789999999999999999999999999   9999988 78999999997653 122233689999999999999999


Q ss_pred             eccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC---CeEeeccCCCcee
Q 018633          126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR---PIVFRNFKTSCIL  202 (353)
Q Consensus       126 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---~iiH~dlkp~Nil  202 (353)
                      ++++++.+.+..++||||+++|+|.+++....... ..+++..++.++.|++.||.|||   ++   +|+||||||+|||
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil  166 (326)
T 3uim_A           91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANIL  166 (326)
T ss_dssp             CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTC-CCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEE
T ss_pred             ceEEEEecCCceEEEEEeccCCCHHHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEE
Confidence            99999999999999999999999999998754322 45899999999999999999999   67   9999999999999


Q ss_pred             ecCCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          203 FNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       203 l~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                      ++.++.+||+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  246 (326)
T 3uim_A          167 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV  246 (326)
T ss_dssp             ECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred             ECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence            99999999999999987755444445556799999999999888899999999999999999999999975444333344


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                      ....+..............+........    ...+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          247 MLLDWVKGLLKEKKLEALVDVDLQGNYK----DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             BHHHHHTTTTSSCCSTTSSCTTCTTSCC----HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hHHHHHHHHhhchhhhhhcChhhccccC----HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            4555555555555555555554444433    2677889999999999999999999999999974

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.8e-52  Score=384.20  Aligned_cols=198  Identities=18%  Similarity=0.245  Sum_probs=170.2

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCL  132 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~  132 (353)
                      ...+.|...+.||+|+||   .||+|..     +++.||+|++...    ....++.+|+.+|+.+ +|||||++++++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg---~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFS---SVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             GGGGTCEEEEEEEECSSE---EEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             CccCcEEEEEEEecccCc---EEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            346789999999999999   9999875     4689999998654    2345688999999998 5999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEE
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKL  211 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl  211 (353)
                      +.+..|+|||||++|+|.+++.        .+++.++..++.||+.||.|||   +++|+||||||+|||++.+ +.+||
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl  159 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYAL  159 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             ECCEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEE
Confidence            9999999999999999999883        4788999999999999999999   9999999999999999877 79999


Q ss_pred             eccCCccccCCCCC---------------------------ccccccccCCccccccccccCC-CCccccchhhHHHHHH
Q 018633          212 FDFSLSISIPEGET---------------------------HITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFE  263 (353)
Q Consensus       212 ~dfg~a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~e  263 (353)
                      +|||+|+.......                           ......+||+.|+|||++.+.. |+.++||||+||++||
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e  239 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS  239 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence            99999976543211                           1123457999999999998764 8999999999999999


Q ss_pred             HHhCCCCCCcc
Q 018633          264 LLTGWDVSDLV  274 (353)
Q Consensus       264 l~tg~~p~~~~  274 (353)
                      |++|+.||...
T Consensus       240 ll~G~~Pf~~~  250 (361)
T 4f9c_A          240 LLSGRYPFYKA  250 (361)
T ss_dssp             HHHTCSSSSCC
T ss_pred             HHHCCCCCCCC
Confidence            99999999643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.5e-51  Score=373.89  Aligned_cols=288  Identities=30%  Similarity=0.459  Sum_probs=235.5

Q ss_pred             ceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeecc
Q 018633           50 RIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLI  128 (353)
Q Consensus        50 ~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~  128 (353)
                      ..+++.++...+++|...+.||+|+||   .||+|.+ +++.||+|++...  .....+.+.+|+.++++++||||++++
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~  101 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFG---KVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLI  101 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSS---EEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEE
T ss_pred             eeecHHHHHHHHhccCccceeecCCCe---eEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            445566677788999999999999999   9999998 6899999998766  455678899999999999999999999


Q ss_pred             ceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc
Q 018633          129 GCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV  208 (353)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  208 (353)
                      +++.+.+..++||||+++|+|.+++....... ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPT-MSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV  177 (321)
T ss_dssp             EECCCTTCCEEEEECCTTCBTGGGSSSSCCCS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCC
T ss_pred             EEEcCCCeEEEEEEcCCCCcHHHHHhccCCCc-cccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCC
Confidence            99999999999999999999999997654221 35899999999999999999999   899999999999999999999


Q ss_pred             eEEeccCCccccCCCC-CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          209 AKLFDFSLSISIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      +||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ......+
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~  255 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEW  255 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHH
T ss_pred             EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHH
Confidence            9999999997654322 222344568999999999998899999999999999999999999997543322  2233334


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .........+...+++.......    ...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          256 AVESHNNGQLEQIVDPNLADKIR----PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             THHHHTTTCCCSSSSSSCTTCSC----HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhhccccccHHHhcChhhccccC----HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            33344444455555544433332    26778899999999999999999999999999988763

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.1e-51  Score=398.78  Aligned_cols=251  Identities=15%  Similarity=0.218  Sum_probs=209.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++...  .....+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus       156 l~~Y~i~~~lG~G~fg---~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFG---VVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEeeccCe---EEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            4679999999999999   9999998  7999999999776  4566778999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC--CceEEeccCC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE--NVAKLFDFSL  216 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~--~~~kl~dfg~  216 (353)
                      ||||||+||+|.+++....    ..+++..+..++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+
T Consensus       231 iv~E~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             EEEeecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence            9999999999999987543    46999999999999999999999   9999999999999999854  8999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      |+.+.....  ....+||+.|||||++.+..|+.++|||||||++|||++|..||.....        .+....... ..
T Consensus       304 a~~~~~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~-~~  372 (573)
T 3uto_A          304 TAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKS-CD  372 (573)
T ss_dssp             CEECCTTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHT-TC
T ss_pred             eeEccCCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHh-CC
Confidence            988754332  4456899999999999999999999999999999999999999974322        111111111 11


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      + ..         +.......+..+.+||.+||..||++|||+.|+++
T Consensus       373 ~-~~---------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          373 W-NM---------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             C-CC---------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-CC---------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 00         00001134567789999999999999999999976

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.7e-51  Score=398.22  Aligned_cols=248  Identities=16%  Similarity=0.187  Sum_probs=199.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC----ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC----RPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ++|...++||+|+||   .||++..  +++.||+|++.+...    .........+++.+++.++|||||++++++.+.+
T Consensus       189 ddf~i~k~LG~G~fG---~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             GGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEecccCe---EEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            679999999999999   9999998  899999999964321    1112222334467777889999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      .+|||||||+||+|.++|...     ..+++..+..++.||+.||.|||   +++||||||||+|||++.+|.+||+|||
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccc
Confidence            999999999999999999765     46899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      +|+......   ..+.+||+.|||||++.. ..|+.++|||||||++|||++|..||.......     .......... 
T Consensus       338 lA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~-  408 (689)
T 3v5w_A          338 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLT-  408 (689)
T ss_dssp             TCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHH-
T ss_pred             eeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcC-
Confidence            998765432   346789999999999975 579999999999999999999999997433221     1111111111 


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVA  343 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl  343 (353)
                      ...            .  .+...+.++.+|+.+||..||.+|++     +.+|+
T Consensus       409 ~~~------------~--~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          409 MAV------------E--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             CCC------------C--CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             CCC------------C--CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            000            0  01144567889999999999999998     56665

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.2e-50  Score=365.00  Aligned_cols=271  Identities=25%  Similarity=0.349  Sum_probs=210.8

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeecccee
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCC  131 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~  131 (353)
                      ++..++....++|...+.||+|+||   .||++.+++..||+|++..........+.|.+|+.++++++||||+++++++
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g---~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFG---TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSE---EEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCcccccCChhHceeeeEeecCCCe---EEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3334444556789999999999999   9999999999999999987765667778899999999999999999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeecCCCce
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~~  209 (353)
                      .+.+..++||||+++|+|.+++......  ..+++..++.++.|++.||.|||   +++  |+||||||+|||++.++.+
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~  178 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTV  178 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHH--HHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCE
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcE
Confidence            9999999999999999999999765311  24899999999999999999999   889  9999999999999999999


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....        .+...
T Consensus       179 kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~  249 (309)
T 3p86_A          179 KVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVA  249 (309)
T ss_dssp             EECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHH
T ss_pred             EECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence            999999997643322 223456799999999999998999999999999999999999999874322        11111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ...........             +...+..+.+|+.+||+.||++|||+.++++.|+.+.++
T Consensus       250 ~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          250 AVGFKCKRLEI-------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHSCCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHhcCCCCCC-------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11111110000             013455788999999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.3e-49  Score=356.49  Aligned_cols=287  Identities=24%  Similarity=0.395  Sum_probs=229.7

Q ss_pred             CcceecHHHHHHHhhCcCCC------CceeeCCCCCccEEEEEEeCCeEEEEEEecCCC--CChhHHHHHHHHHHHHhhc
Q 018633           48 PYRIFSAQEIKLATNSYDQK------NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHE--CRPRAYESCINNVTYAARM  119 (353)
Q Consensus        48 ~~~~~~~~e~~~~~~~~~~~------~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l  119 (353)
                      ....|++.++.+++++|+..      +.||+|+||   .||+|.++++.||+|++....  ......+.+.+|+.+++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g---~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l   87 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFG---VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC   87 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSE---EEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCe---EEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence            46789999999999999988      899999999   999999999999999986542  2345567899999999999


Q ss_pred             CCCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       120 ~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      +||||+++++++.+.+..++||||+++|+|.+++......  .++++..++.++.|++.||.|||   +++|+||||||+
T Consensus        88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~  162 (307)
T 2nru_A           88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSA  162 (307)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred             CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHH
Confidence            9999999999999999999999999999999998753221  45899999999999999999999   899999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH  278 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~  278 (353)
                      ||+++.++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            99999999999999999987644322 12334578999999998864 58899999999999999999999997544322


Q ss_pred             CCCCChHHHHHHHhh-cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          279 DLACPSNEYLKNYFE-DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .    .......... ...+...+++.+..     .+...+..+.+++.+||+.||.+|||+.++++.|+++.+|
T Consensus       242 ~----~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s  307 (307)
T 2nru_A          242 L----LLDIKEEIEDEEKTIEDYIDKKMND-----ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS  307 (307)
T ss_dssp             B----TTHHHHHHHTTSCCHHHHSCSSCSC-----CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred             H----HHHHHHHhhhhhhhhhhhccccccc-----cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence            1    1111111111 11111222222111     1126678899999999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.2e-50  Score=363.78  Aligned_cols=259  Identities=21%  Similarity=0.274  Sum_probs=213.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  ++..||+|++...  .....+.|.+|+.++++++||||+++++++.+++..+
T Consensus         9 ~~~~~~~~~lG~G~~g---~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFG---QAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSE---EEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCE---EEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            3568888999999999   9999998  6899999998665  5677888999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        84 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  156 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLAR  156 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccce
Confidence            9999999999999998754    46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCcc-------------ccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCC-CCh
Q 018633          219 SIPEGETHI-------------TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA-CPS  284 (353)
Q Consensus       219 ~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~-~~~  284 (353)
                      .........             .....||+.|+|||++.+..++.++||||||+++|+|++|..|+.......... ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  236 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV  236 (310)
T ss_dssp             ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred             ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence            764332211             114579999999999999999999999999999999999999986433222110 011


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .....                 ...    +..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       237 ~~~~~-----------------~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          237 RGFLD-----------------RYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             HHHHH-----------------HTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcccc-----------------ccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11000                 000    013445678999999999999999999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.9e-49  Score=359.43  Aligned_cols=271  Identities=21%  Similarity=0.243  Sum_probs=212.7

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc---
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI---  136 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~---  136 (353)
                      ..++|...+.||+|+||   .||+|.+.++.||||++...   ......+.+|+.++.+++|||||++++++.....   
T Consensus        22 ~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFG---CVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TTEEEEEEEEEECSTTC---EEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             chhhchhhheecccCce---EEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            34679999999999999   99999999999999999654   3444566779999999999999999999987543   


Q ss_pred             -cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC----------CeEeeccCCCceeecC
Q 018633          137 -PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR----------PIVFRNFKTSCILFNE  205 (353)
Q Consensus       137 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~----------~iiH~dlkp~Nill~~  205 (353)
                       +++||||+++|+|.+++...      .+++..++.++.|++.||.|||   +.          +|+||||||+|||++.
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             eEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECC
Confidence             69999999999999999763      4899999999999999999999   88          9999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCc-cccccccCCccccccccccC-----CCCccccchhhHHHHHHHHhCCCCCCccccccC
Q 018633          206 ENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTG-----VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD  279 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~  279 (353)
                      ++.+||+|||+++........ ......||+.|+|||++.+.     .++.++|||||||++|||+||..||........
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~  246 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM  246 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred             CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence            999999999999876543322 23346799999999999763     466789999999999999999999975443221


Q ss_pred             CC-------CChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          280 LA-------CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       280 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ..       .+.......................       ....+..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ-------KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGG-------SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhhhhccCCchhhhhhhhhcccCCCCcccccc-------ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            10       1111111111111111111111111       114567799999999999999999999999999999764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-49  Score=363.88  Aligned_cols=250  Identities=20%  Similarity=0.270  Sum_probs=209.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||+|.+  +++.||||++..........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        12 ~~~~~y~~~~~lG~G~~g---~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFA---KVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CEETTEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CccCCEEEEEEEeeCCCE---EEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            345689999999999999   9999998  89999999997765566777889999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .|+||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             EEEEEECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence            99999999999999998765     35889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +.......  ......||+.|+|||++.+..++ .++|||||||++|+|++|..||.....        ........ ..
T Consensus       161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~-~~  229 (328)
T 3fe3_A          161 SNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVL-RG  229 (328)
T ss_dssp             CGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HC
T ss_pred             ceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hC
Confidence            98764432  24566899999999999887765 799999999999999999999974321        11111111 11


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...          .+    ...+..+.+|+.+||..||.+|||+.++++
T Consensus       230 ~~~----------~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          230 KYR----------IP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCC----------CC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCC----------CC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            110          00    034456789999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.9e-48  Score=350.91  Aligned_cols=249  Identities=19%  Similarity=0.254  Sum_probs=206.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++...  .....+.+.+|+.++++++||||+++++++...+..+
T Consensus        19 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASG---TVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTE---EEEEEEBTTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhceeeeeeeccCCCe---EEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence            4679999999999999   9999987  8899999998755  3344577899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...      .+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus        94 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  164 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence            999999999999999763      4789999999999999999999   8999999999999999999999999999988


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......        ........... .
T Consensus       165 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~-~  234 (297)
T 3fxz_A          165 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGT-P  234 (297)
T ss_dssp             ECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCS-C
T ss_pred             ecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-C
Confidence            7654332 244567999999999999999999999999999999999999999643211        11111111111 0


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....           +...+..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ELQN-----------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CCSC-----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCC-----------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0000           1144567889999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.4e-49  Score=351.63  Aligned_cols=257  Identities=21%  Similarity=0.348  Sum_probs=213.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .++|...+.||+|+||   .||++.+ ++..||+|++....   ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFG---LVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSC---EEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             hhhceeeheecCCCcc---EEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            3568888999999999   9999999 88899999997653   234679999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  155 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRF  155 (269)
T ss_dssp             EEECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             EEEeCCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccc
Confidence            999999999999997654    46899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .............+|..|+|||++.+..++.++||||||+++|+|++ |..||.....        ............. 
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~~-  226 (269)
T 4hcu_A          156 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRL-  226 (269)
T ss_dssp             BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCC-
T ss_pred             ccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCccC-
Confidence            64433323344567788999999998899999999999999999999 8999874221        1122211111000 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                        ..           +...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       227 --~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          227 --YK-----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             --CC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --CC-----------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence              00           013355688999999999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9e-49  Score=358.71  Aligned_cols=258  Identities=20%  Similarity=0.285  Sum_probs=209.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++|...+.||+|+||   .||+|.+     .+..||||++.... .....+.|.+|+.++++++||||+++++++.+.+.
T Consensus        49 ~~y~i~~~lG~G~~g---~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           49 SRIHIEKIIGSGDSG---EVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGEEEEEEEEETTTE---EEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hHeEEeeEEEeCCCc---EEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            467778999999999   9999998     34569999997653 45566789999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             cEEEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence            999999999999999997654    46899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          217 SISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       217 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ++........  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....        .........
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~  269 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEE  269 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHT
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHc
Confidence            9876543221  1223456778999999998899999999999999999999 9999863322        112222111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .....              .+..++..+.+|+.+||..||++|||+.++++.|+.+.++
T Consensus       270 ~~~~~--------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          270 GYRLP--------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             TCCCC--------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCC--------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            11110              0014556788999999999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.3e-48  Score=352.52  Aligned_cols=261  Identities=18%  Similarity=0.235  Sum_probs=214.0

Q ss_pred             cceecHHHHHHHhhC----------cCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHH
Q 018633           49 YRIFSAQEIKLATNS----------YDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYA  116 (353)
Q Consensus        49 ~~~~~~~e~~~~~~~----------~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l  116 (353)
                      ...+++++++.+++.          |+..+.||+|+||   .||+|..  +++.||||++...  .....+.+.+|+.++
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g---~V~~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l   96 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTG---IVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIM   96 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHH
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCe---EEEEEEECCCCcEEEEEEEecc--chhHHHHHHHHHHHH
Confidence            456899999988875          6666789999999   9999998  6899999999765  345567899999999


Q ss_pred             hhcCCCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeecc
Q 018633          117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF  196 (353)
Q Consensus       117 ~~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl  196 (353)
                      ++++||||+++++++...+..++||||+++++|.+++..      ..+++..+..++.|++.||.|||   +++|+||||
T Consensus        97 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dl  167 (321)
T 2c30_A           97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI  167 (321)
T ss_dssp             TTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             HhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCC
Confidence            999999999999999999999999999999999998864      35889999999999999999999   899999999


Q ss_pred             CCCceeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccc
Q 018633          197 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKD  276 (353)
Q Consensus       197 kp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~  276 (353)
                      ||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus       168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~  246 (321)
T 2c30_A          168 KSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP  246 (321)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             CHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999999887644322 23456799999999999988999999999999999999999999874321


Q ss_pred             ccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                              ........ ....+....           ....+..+.+++.+||+.||++|||+.++++
T Consensus       247 --------~~~~~~~~-~~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 --------VQAMKRLR-DSPPPKLKN-----------SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             --------HHHHHHHH-HSSCCCCTT-----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --------HHHHHHHh-cCCCCCcCc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    11111111 111111100           0134556889999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.9e-48  Score=361.50  Aligned_cols=263  Identities=17%  Similarity=0.288  Sum_probs=212.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe---------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccce
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW---------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGC  130 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~  130 (353)
                      .++|...+.||+|+||   .||+|.+         ++..||+|++.... .....+.+.+|+.+++++ +||||++++++
T Consensus        80 ~~~~~~~~~LG~G~fg---~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFG---QVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             GGGEEEEEEESCCSSS---EEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             HHHCEeeeEEeeCCCe---eEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3568888899999999   9999975         34579999997652 455677899999999999 89999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      |.+.+..|+||||+++|+|.+++......           ....+++..++.++.||+.||.|||   +++|+||||||+
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~  232 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAAR  232 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchh
Confidence            99999999999999999999999765321           0135789999999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDT  277 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~  277 (353)
                      |||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999987644322 12234567889999999999899999999999999999999 99998743221


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .        ..... .......         .    +..++..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       313 ~--------~~~~~-~~~~~~~---------~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          313 E--------LFKLL-KEGHRMD---------K----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             G--------HHHHH-HTTCCCC---------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H--------HHHHH-hcCCCCC---------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1        11111 1111100         0    114556788999999999999999999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-48  Score=364.71  Aligned_cols=261  Identities=22%  Similarity=0.326  Sum_probs=212.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||+|.+  ++..||||.+.... .....+.|.+|+.++++++||||+++++++.+.+.
T Consensus       111 ~~~~~~~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFG---EVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             CCGGGEEEEEEEEEETTE---EEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             EchHHeEEeeEeccCCCC---eEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            345678888999999999   9999999  68999999987542 44556679999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             cEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence            999999999999999997643    46899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcc-ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          217 SISIPEGETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       217 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      ++......... .....++..|+|||++.+..++.++||||||+++|||+| |..||.....         .........
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------~~~~~~~~~  330 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTREFVEK  330 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------HHHHHHHHT
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHc
Confidence            97654322111 122345678999999998899999999999999999998 9999874322         111222221


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .....         .    +..++..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus       331 ~~~~~---------~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          331 GGRLP---------C----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             TCCCC---------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCC---------C----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            11100         0    113456788999999999999999999999999998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-48  Score=350.31  Aligned_cols=268  Identities=21%  Similarity=0.292  Sum_probs=208.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee-
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-  133 (353)
                      .++|...+.||+|+||   .||++.+      +++.||||++...  .....+.|.+|+.++++++||||+++++++.. 
T Consensus         9 ~~~~~~~~~lg~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFG---SVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCE---EEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3568888999999999   9999983      7899999999766  56667889999999999999999999999864 


Q ss_pred             -CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          134 -TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       134 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                       ....++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~  156 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG  156 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEc
Confidence             356899999999999999997754    45899999999999999999999   8999999999999999999999999


Q ss_pred             ccCCccccCCCCC--ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc----CCCCChH-
Q 018633          213 DFSLSISIPEGET--HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH----DLACPSN-  285 (353)
Q Consensus       213 dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~----~~~~~~~-  285 (353)
                      |||++........  .......++..|+|||++.+..++.++||||||+++|+|+||..|+.......    ....... 
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            9999987643322  11234457778999999999999999999999999999999999876422110    0000000 


Q ss_pred             --HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          286 --EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       286 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                        ...........             ....+..++..+.+++.+||+.||++|||+.++++.|+++.+.+
T Consensus       237 ~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          237 IVFHLIELLKNNG-------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHHHHHTTC-------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHhccC-------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence              00000000000             00011145677899999999999999999999999999998764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.2e-48  Score=342.42  Aligned_cols=255  Identities=20%  Similarity=0.288  Sum_probs=210.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--CccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--PIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~~~~  138 (353)
                      .++|...+.||+|+||   .||+|.+++..||+|++..........+.|.+|+.++++++||||+++++++.+.  +..+
T Consensus         9 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSG---ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGGCEEEEEEEEETTE---EEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             HHHhHHHHHhcCCCcc---eEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            3568888999999999   9999999999999999987765677778899999999999999999999999876  7889


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeecCCCceEEeccCC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      +||||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++  ++||||||+|||++.++.++|+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~  159 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADV  159 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred             eeecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccc
Confidence            99999999999999987542   35899999999999999999999   888  99999999999999999999999988


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCc---cccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNE---KSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +.....      ....||+.|+|||++.+..++.   ++||||||+++|||++|..||.....        .........
T Consensus       160 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~  225 (271)
T 3kmu_A          160 KFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVAL  225 (271)
T ss_dssp             CCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHH
T ss_pred             eeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHh
Confidence            755322      2346889999999998765444   79999999999999999999874322        111122211


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......             +...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       226 ~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 EGLRPTI-------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             SCCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             cCCCCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1111111             01345678899999999999999999999999998854

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.9e-48  Score=342.88  Aligned_cols=256  Identities=17%  Similarity=0.299  Sum_probs=211.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .++|...+.||+|+||   .||++.+ ++..||+|++....   ...+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus         7 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFG---VVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTE---EEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             hhheeeeeeeccCCCc---eEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence            4678889999999999   9999998 67789999997652   234678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             EEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             EEEccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            999999999999997653    45899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .............+|..|+|||++.+..++.++||||||+++|+|++ |..||......        ............ 
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~-  224 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHRL-  224 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCC-
T ss_pred             cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCCC-
Confidence            65544333444556778999999998889999999999999999999 99998743221        111111111100 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                        ..+           ...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       225 --~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 --YRP-----------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             --CCC-----------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             --CCC-----------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence              000           0234568899999999999999999999999988753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-48  Score=362.47  Aligned_cols=273  Identities=18%  Similarity=0.305  Sum_probs=218.2

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCc
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNH  123 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~n  123 (353)
                      +...++....++|...+.||+|+||   .||+|.+       +++.||||++.... .....+.+.+|+.++.++ +|||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpn   87 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLN   87 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSE---EEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcccccccccceeeceeecCCCCc---eEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcc
Confidence            4556666778899999999999999   9999974       55899999997652 445567899999999999 7999


Q ss_pred             eeeccceeeeCC-ccEEEEEeccCCChhhhhccCCCCC------------------------------------------
Q 018633          124 ILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPH------------------------------------------  160 (353)
Q Consensus       124 iv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------  160 (353)
                      |+++++++.+.+ ..++||||+++|+|.+++.......                                          
T Consensus        88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            999999998755 4899999999999999997653210                                          


Q ss_pred             -------------------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          161 -------------------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       161 -------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                                         ...+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                               012889999999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          222 EGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       222 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      .... .......||..|+|||++.+..++.++||||||+++|||+| |..||.......        .............
T Consensus       245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~  316 (359)
T 3vhe_A          245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------EFCRRLKEGTRMR  316 (359)
T ss_dssp             SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--------HHHHHHHHTCCCC
T ss_pred             ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--------HHHHHHHcCCCCC
Confidence            3322 22345678899999999999999999999999999999998 999987432211        1111111111111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .             +...+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus       317 ~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          317 A-------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             C-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            0             013455688999999999999999999999999998864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-47  Score=343.74  Aligned_cols=264  Identities=21%  Similarity=0.301  Sum_probs=203.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhh--cCCCceeeccceeeeC----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAAR--MSHNHILKLIGCCLET----  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~~~~~~----  134 (353)
                      .++|...+.||+|+||   .||+|.++++.||||++...     ....+.+|.+++..  ++||||+++++++...    
T Consensus         7 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            7 ARDITLLECVGKGRYG---EVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             GGGCEEEEEEEECSSE---EEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cCcEEEEEeeccCCCc---EEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            4679999999999999   99999999999999998543     44566777777776  7899999999997643    


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC-----CCCeEeeccCCCceeecCCCce
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF-----PRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~dlkp~Nill~~~~~~  209 (353)
                      ...++||||+++|+|.+++..      ..+++..++.++.|++.||.|||+..     +++|+||||||+|||++.++.+
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             ceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence            458999999999999999954      35899999999999999999999321     5789999999999999999999


Q ss_pred             EEeccCCccccCCCCCcc---ccccccCCccccccccccC------CCCccccchhhHHHHHHHHhC----------CCC
Q 018633          210 KLFDFSLSISIPEGETHI---TDTVMGTWGYCAPEYMRTG------VFNEKSDVFSFGVFLFELLTG----------WDV  270 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~tg----------~~p  270 (353)
                      ||+|||+++.........   .....||+.|+|||++.+.      .++.++||||||+++|||+||          ..|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            999999997664433221   2345799999999999876      456799999999999999999          666


Q ss_pred             CCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          271 SDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      |.......    ......................       ......+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus       233 f~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          233 FYDVVPND----PSFEDMRKVVCVDQQRPNIPNR-------WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTSCSS----CCHHHHHHHHTTSCCCCCCCGG-------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCCCC----cchhhhhHHHhccCCCCCCChh-------hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            65332211    1111111111111111111110       01125678899999999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.9e-48  Score=347.09  Aligned_cols=259  Identities=20%  Similarity=0.265  Sum_probs=199.6

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ..++|...+.||+|+||   .||+|.+     .+..||+|.+.... .....+.+.+|+.++++++||||+++++++. +
T Consensus        13 ~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFG---DVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSS---EEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ehHHeEEEeEeeecCCe---eEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            34678889999999999   9999987     24579999987642 4556778999999999999999999999984 5


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      +..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             CccEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcc
Confidence            67899999999999999997653    36889999999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      |+++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||.......        ...... 
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~-  231 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIE-  231 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHH-
T ss_pred             ccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHH-
Confidence            9998765443333344566788999999998899999999999999999997 999987433221        111111 


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .......             +...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       232 ~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          232 NGERLPM-------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             TTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCC-------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111000             014456788999999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3e-48  Score=361.70  Aligned_cols=258  Identities=18%  Similarity=0.260  Sum_probs=200.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      .++|...+.||+|+||   .||+|.+     ++..||||++.... .....+.|.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~lG~G~fg---~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFG---EVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             GGGCCCCEEEEECSSS---EEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HhhceeeeEEeeCCCe---EEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            3578899999999999   9999986     36679999997653 4556778999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ceEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence            9999999999999999997654    46899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCcc--ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          216 LSISIPEGETHI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       216 ~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      +++.........  .....+|..|+|||++.+..++.++||||||+++|||++ |..||.....        ........
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~  264 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVD  264 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHH
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence            998764432211  122345678999999998999999999999999999998 9999863321        11111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .....          ..    +..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       265 ~~~~~----------~~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          265 EGYRL----------PP----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             TTEEC----------CC----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCC----------CC----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            11000          00    01455678899999999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.4e-48  Score=348.12  Aligned_cols=261  Identities=19%  Similarity=0.300  Sum_probs=207.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  ++..||+|++.... ......+.|.+|+.++.+++||||+++++++.+++..
T Consensus        10 ~~~y~i~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMS---TVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             ETTEEEEEEEEEETTE---EEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hccEEEEEEEccCCCE---EEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            3568899999999999   9999997  78999999985442 2445567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++...     .++++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        87 ~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             EEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            9999999999999999765     35899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ...............||+.|+|||++.+..++.++||||||+++|+|++|..||......        ......... ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------~~~~~~~~~-~~  229 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--------SIAIKHIQD-SV  229 (294)
T ss_dssp             TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--------HHHHHHHSS-CC
T ss_pred             cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhhc-cC
Confidence            876544433345567999999999999989999999999999999999999999743211        111111111 11


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-SMVDVAKKLRQIY  350 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~vl~~L~~l~  350 (353)
                      +..     ...    .....+..+.+++.+||+.||++|| ++.++.+.|.++.
T Consensus       230 ~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          230 PNV-----TTD----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             CCH-----HHH----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             CCc-----chh----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            000     000    0113556788999999999999999 8999999987654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-47  Score=355.95  Aligned_cols=253  Identities=20%  Similarity=0.223  Sum_probs=207.7

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh----hHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP----RAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ..+.|...+.||+|+||   .||++..  ++..||+|++.......    ...+.+.+|+.++++++||||+++++++.+
T Consensus        10 ~~~~y~~~~~LG~G~fg---~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFA---IVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             GGGTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hhhceEEeeEEeeCcCE---EEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            45679999999999999   9999998  78999999997653221    235789999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC----ce
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN----VA  209 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~  209 (353)
                      .+..++||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++    .+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~v  158 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHI  158 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCE
Confidence            99999999999999999999764     46899999999999999999999   89999999999999998776    79


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ||+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        .+...
T Consensus       159 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~  228 (361)
T 2yab_A          159 KLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA  228 (361)
T ss_dssp             EECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH
T ss_pred             EEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence            999999998765432  23456799999999999988999999999999999999999999974321        11111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ... ...+          ..........+..+.+|+.+||..||++|||+.++++
T Consensus       229 ~i~-~~~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          229 NIT-AVSY----------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHH-TTCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHH-hcCC----------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111 1110          0011111244567889999999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-48  Score=351.78  Aligned_cols=250  Identities=13%  Similarity=0.180  Sum_probs=207.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  ++..||+|.+...   ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus         4 ~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFG---IVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             hhceEeeeEEecCCCe---EEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence            4678889999999999   9999998  7899999998754   345667899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC--CCceEEeccCC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE--ENVAKLFDFSL  216 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~--~~~~kl~dfg~  216 (353)
                      +||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.  ++.+||+|||+
T Consensus        78 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~  150 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             EEEEeCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence            9999999999999997653    36899999999999999999999   999999999999999987  78999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      +........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....        .+....... ..
T Consensus       151 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~-~~  219 (321)
T 1tki_A          151 ARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMN-AE  219 (321)
T ss_dssp             CEECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-TC
T ss_pred             CeECCCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHc-CC
Confidence            987754332  3456789999999999988899999999999999999999999974221        111221111 11


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..          .........+..+.+|+.+||..||++|||+.++++
T Consensus       220 ~~----------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          220 YT----------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CC----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC----------CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00          001111145667889999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=361.04  Aligned_cols=255  Identities=19%  Similarity=0.246  Sum_probs=208.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||++..  +++.+|+|++..........+.+.+|+.++++++|||||++++++.+.+.
T Consensus         8 ~~~~~Y~i~~~LG~G~fg---~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFS---VVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHHHHEEEEEEEEEC--C---EEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             cccCCeEEEEEeccCCCe---EEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            456789999999999999   9999988  89999999998765556667789999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec---CCCceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN---EENVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~d  213 (353)
                      .|+||||+++|+|.+.+...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++   .++.+||+|
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             EEEEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEcc
Confidence            99999999999999998765     45899999999999999999999   99999999999999998   467899999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ........ 
T Consensus       157 FG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~-  226 (444)
T 3soa_A          157 FGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIK-  226 (444)
T ss_dssp             CSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH-
T ss_pred             CceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHH-
Confidence            999977654332 23456799999999999988999999999999999999999999963221        11111111 


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... ...+.         ....+..+.+|+.+||+.||++|||+.++++
T Consensus       227 ~~~~~-~~~~~---------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          227 AGAYD-FPSPE---------WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HTCCC-CCTTT---------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hCCCC-CCccc---------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11110 00000         0134567889999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.2e-48  Score=367.42  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=208.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-ccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-IPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-~~~l  139 (353)
                      .++|...+.||+|+||   .||+|.+.++.||||++....    ..+.|.+|+.+|++++|||||++++++.+.. ..++
T Consensus       192 ~~~~~~~~~lG~G~fg---~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFG---DVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             hHHeEEEeeecCcCCe---eEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            4678888999999999   999999999999999997652    4577999999999999999999999987665 7899


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       265 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            9999999999999986532   34789999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....    .....++..|+|||++.+..++.++||||||+++|||+| |..||.......        ........... 
T Consensus       339 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~-  405 (450)
T 1k9a_A          339 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKM-  405 (450)
T ss_dssp             CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTTCCC-
T ss_pred             cccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC-
Confidence            4322    123357889999999999999999999999999999998 999987432211        11111111110 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .             .+..++..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       406 ~-------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          406 D-------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             C-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             C-------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            0             0114567788999999999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.5e-47  Score=353.15  Aligned_cols=254  Identities=21%  Similarity=0.313  Sum_probs=209.3

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||++.+  ++..||+|++..........+.+.+|+.++++++||||+++++++.+.+.
T Consensus        26 ~~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFS---VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHHHHEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CcccCeEEeeEEecCCCe---EEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            456789999999999999   9999998  78999999998765566677889999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC---CceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl~d  213 (353)
                      .|+||||+++|+|.+.+...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.+   +.+||+|
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEee
Confidence            99999999999999988764     46889999999999999999999   8999999999999999865   4599999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ....... .
T Consensus       175 fG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i-~  243 (362)
T 2bdw_A          175 FGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQI-K  243 (362)
T ss_dssp             CTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-H
T ss_pred             cCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH-H
Confidence            99998765332  23456799999999999988999999999999999999999999864221        1111111 1


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...... ..+         .....+..+.+|+.+||..||++|||+.++++
T Consensus       244 ~~~~~~-~~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          244 AGAYDY-PSP---------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HTCCCC-CTT---------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hCCCCC-Ccc---------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111100 000         00134567889999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2e-47  Score=344.86  Aligned_cols=263  Identities=12%  Similarity=0.056  Sum_probs=211.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||+|++....    ..+.+.+|+.++..+ +|+|++++++++.+....
T Consensus         9 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFG---VIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSC---EEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccceEEEEEEeecCCE---EEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            4579999999999999   9999996  89999999986542    234578899999999 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc-----eEEe
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV-----AKLF  212 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~-----~kl~  212 (353)
                      ++||||+ +++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.     +||+
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~  153 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVV  153 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             EEEEEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence            9999999 899999998654    45899999999999999999999   999999999999999987765     9999


Q ss_pred             ccCCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          213 DFSLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       213 dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      |||+++........      ......||+.|+|||++.+..++.++||||||+++|||++|..||.......     ...
T Consensus       154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~  228 (298)
T 1csn_A          154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQ  228 (298)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHH
T ss_pred             ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-----cHH
Confidence            99999876543221      2345679999999999998899999999999999999999999997543221     111


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                      ........         ... ..........+..+.+++.+||+.||++|||+.+|++.|+++.+.+
T Consensus       229 ~~~~~~~~---------~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          229 KYERIGEK---------KQS-TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHHHHHHH---------HHH-SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhh---------ccC-ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            11111100         000 0000001134678899999999999999999999999999998753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.2e-48  Score=347.75  Aligned_cols=258  Identities=16%  Similarity=0.294  Sum_probs=209.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ..++|...+.||+|+||   .||++.+ ++..||+|++....   ...+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus        22 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFG---VVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CGGGEEEEEECC---CE---EEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CHHHHHhHhhcCCCCCc---eEEEEEEcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            35678888999999999   9999998 77789999997653   23467899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++.
T Consensus        96 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             EEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccc
Confidence            9999999999999997643    46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ..............+|+.|+|||++.+..++.++||||||+++|+|+| |..||.....        .............
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~  240 (283)
T 3gen_A          169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLRL  240 (283)
T ss_dssp             GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTCCC
T ss_pred             cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHhcccCC
Confidence            764433222334556788999999998899999999999999999998 9999874322        1111111111000


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                        . .           +...+..+.+++.+||+.||++|||+.++++.|.++.+.
T Consensus       241 --~-~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          241 --Y-R-----------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             --C-C-----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --C-C-----------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence              0 0           002345688999999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-47  Score=343.30  Aligned_cols=262  Identities=22%  Similarity=0.392  Sum_probs=201.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      .++|...+.||+|+||   .||+|.+.+ .||+|++..........+.|.+|+.++++++||||+++++++ ..+..++|
T Consensus        23 ~~~y~~~~~lG~G~~g---~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFG---TVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSE---EEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             ccceeeeeEecCCCCe---EEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            4678889999999999   999999855 499999987765677788899999999999999999999965 55678999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++|+|||++...
T Consensus        98 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccc
Confidence            99999999999997554    46899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCC-CccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          221 PEGE-THITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       221 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .... ........||+.|+|||++.   ...++.++||||||+++|+|++|..||......        ...........
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~  242 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--------DQIIEMVGRGS  242 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--------HHHHHHHHHTS
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcccc
Confidence            4321 22234457899999999986   566889999999999999999999999743221        12222222222


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ........         ...++..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus       243 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 LSPDLSKV---------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCCTTSS---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCcchhhc---------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11111110         01445678899999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.7e-47  Score=344.64  Aligned_cols=268  Identities=18%  Similarity=0.184  Sum_probs=204.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ..++|...+.||+|+||   .||++.+ +++.||+|++............+.+|+.++++++||||+++++++.+.+..+
T Consensus        19 l~~~y~~~~~lG~G~~g---~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYG---VVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             SSCEEEEEEEEEECSSC---EEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             hHhhhHhhhhccCCCCe---EEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            34679999999999999   9999999 8899999999766444555678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||++ |+|.+.+....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        96 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           96 LVFEFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             EEEECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEcCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence            9999998 58888887654    45899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......     ..............
T Consensus       168 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~~~~~~  241 (311)
T 3niz_A          168 AFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-----QLPKIFSILGTPNP  241 (311)
T ss_dssp             ETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----HHHHHHHHHCCCCT
T ss_pred             ecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHHCCCCh
Confidence            7643322 2344578999999999876 458999999999999999999999997543322     11111111110000


Q ss_pred             ---ccccc---------chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 ---TEIVD---------PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ---~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                         ....+         ...............+.++.+|+.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               00000         000000000001134567889999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-48  Score=373.16  Aligned_cols=262  Identities=19%  Similarity=0.313  Sum_probs=212.5

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++....++|...+.||+|+||   .||+|.+ ++..||||++....   ...+.|.+|+.+|++++|||||++++++. 
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg---~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-  253 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFG---EVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-  253 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSE---EEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred             cceeechHHeEEEEEcccCCce---EEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence            3444556778888999999999   9999999 68899999997652   34678999999999999999999999986 


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..++||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECS
T ss_pred             CCccEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEee
Confidence            6678999999999999999975421   25788899999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ||+++..............+|..|+|||++....++.++||||||+++|||+| |..||.....        .+......
T Consensus       328 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~  399 (454)
T 1qcf_A          328 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALE  399 (454)
T ss_dssp             TTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHH
T ss_pred             CCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence            99998764332222234456788999999998899999999999999999999 9999874321        11221111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .....+              .+..++..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       400 ~~~~~~--------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          400 RGYRMP--------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             HTCCCC--------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             cCCCCC--------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            111110              011456678899999999999999999999999988754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=342.95  Aligned_cols=256  Identities=22%  Similarity=0.400  Sum_probs=200.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      ++|...+.||+|+||   .||++.+.++.||+|++...    ...+.|.+|+.++++++||||+++++++.  +..++||
T Consensus         8 ~~~~~~~~lg~G~~g---~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFG---VVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSS---EEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred             hHeeeeeEeecCCCc---eEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence            468888999999999   99999999999999998644    45678999999999999999999999987  4589999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc-eEEeccCCcccc
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV-AKLFDFSLSISI  220 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~-~kl~dfg~a~~~  220 (353)
                      ||+++|+|.+++.....  ...+++..++.++.|++.||.|||+...++|+||||||+|||++.++. +||+|||++...
T Consensus        79 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             ECCTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EcCCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            99999999999976532  124688899999999999999999211189999999999999998886 799999998765


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ...    .....||..|+|||++.+..++.++||||||+++|||++|..||......      ......... .......
T Consensus       157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~~  225 (307)
T 2eva_A          157 QTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVH-NGTRPPL  225 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHH-TTCCCCC
T ss_pred             ccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHh-cCCCCCc
Confidence            322    22346899999999999889999999999999999999999998743211      111111111 1111111


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .             ...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       226 ~-------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          226 I-------------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             B-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             c-------------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            0             13455678999999999999999999999999998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-46  Score=343.18  Aligned_cols=274  Identities=21%  Similarity=0.321  Sum_probs=207.0

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc--CCCceeeccceee
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARM--SHNHILKLIGCCL  132 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~~~~~~~  132 (353)
                      ..-....++|...+.||+|+||   .||+|.++++.||||++...     ....+.+|.+++..+  +||||+++++++.
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYG---EVWMGKWRGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTE---EEEEEEETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             ccccccccceEEEeEeecCCCe---EEEEEEECCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            3334556789999999999999   99999999999999998544     234455566666654  8999999999998


Q ss_pred             eC----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC--------CeEeeccCCCc
Q 018633          133 ET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR--------PIVFRNFKTSC  200 (353)
Q Consensus       133 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~iiH~dlkp~N  200 (353)
                      ..    ...++||||+++|+|.+++...      .+++..++.++.|++.||.|||   ++        +|+||||||+|
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~N  172 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKN  172 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGG
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHH
Confidence            77    6789999999999999999753      5889999999999999999999   77        99999999999


Q ss_pred             eeecCCCceEEeccCCccccCCCCCc---cccccccCCccccccccccCCCCcc------ccchhhHHHHHHHHhCCCCC
Q 018633          201 ILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTWGYCAPEYMRTGVFNEK------SDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~------~Di~slG~il~el~tg~~p~  271 (353)
                      ||++.++.+||+|||+++........   ......||+.|+|||++.+...+..      +|||||||++|||+||..|+
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            99999999999999999776433221   1235579999999999987766654      99999999999999995443


Q ss_pred             Ccccccc------CCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          272 DLVKDTH------DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       272 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .......      ...........................       ....++..+.+|+.+||+.||++|||+.++++.
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW-------SSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-------GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhhhccCccccccc-------hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            2211100      000111122222221111111111111       112677889999999999999999999999999


Q ss_pred             HHHHHHh
Q 018633          346 LRQIYRS  352 (353)
Q Consensus       346 L~~l~~~  352 (353)
                      |+++.++
T Consensus       326 L~~l~~~  332 (337)
T 3mdy_A          326 LAKMSES  332 (337)
T ss_dssp             HHHHHHT
T ss_pred             HHHHHhh
Confidence            9999876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-47  Score=351.20  Aligned_cols=267  Identities=22%  Similarity=0.321  Sum_probs=213.9

Q ss_pred             HHHHhhCcCCCCceeeCCCCCccEEEEEEeCC-------eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccc
Q 018633           57 IKLATNSYDQKNVIAKDTSYNLYTMYKGFWQE-------RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIG  129 (353)
Q Consensus        57 ~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~  129 (353)
                      +....++|...+.||+|+||   .||++.+.+       ..||+|++.... .....+.|.+|+.++++++||||+++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~  117 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFG---RVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLG  117 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSC---EEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             eEecHHHCeeeeeeeecCCe---eEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            33456789999999999999   999998843       889999997653 4556678999999999999999999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCC-------------------CccccHHHHHHHHHHHHHHHHHHhcCCCCC
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPH-------------------FEPLLLKHRLKIAMDIVHALAYLHFGFPRP  190 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  190 (353)
                      ++.+.+..++||||+++|+|.+++.......                   ...+++..++.++.||+.||.|||   +++
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~  194 (343)
T 1luf_A          118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERK  194 (343)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            9999999999999999999999997643110                   146889999999999999999999   999


Q ss_pred             eEeeccCCCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CC
Q 018633          191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GW  268 (353)
Q Consensus       191 iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~  268 (353)
                      |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|+| |.
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999876543221 12334567889999999998899999999999999999999 99


Q ss_pred             CCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          269 DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       269 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                      .||.....        .+... ..........             +..++..+.+++.+||+.||++|||+.++++.|++
T Consensus       275 ~p~~~~~~--------~~~~~-~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~  332 (343)
T 1luf_A          275 QPYYGMAH--------EEVIY-YVRDGNILAC-------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR  332 (343)
T ss_dssp             CTTTTSCH--------HHHHH-HHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcCCCCCh--------HHHHH-HHhCCCcCCC-------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence            99873221        11111 1112211111             01345678899999999999999999999999998


Q ss_pred             HHHh
Q 018633          349 IYRS  352 (353)
Q Consensus       349 l~~~  352 (353)
                      +.+.
T Consensus       333 ~~~~  336 (343)
T 1luf_A          333 MCER  336 (343)
T ss_dssp             TTC-
T ss_pred             HHhh
Confidence            7643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-47  Score=370.36  Aligned_cols=257  Identities=21%  Similarity=0.359  Sum_probs=211.8

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..++|...+.||+|+||   .||+|.+  ++..||||.+....   ...+.|.+|+.+|++++|||||+++++|.+.+..
T Consensus       218 ~~~~~~~~~~lG~G~fg---~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYG---EVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CGGGEEEEEESGGGTTS---SEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             CHHHceeeeEecCCCCe---EEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            34567778899999999   9999999  48999999997652   3467899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             EEEEEccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccc
Confidence            999999999999999976432   45889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      +..............++..|+|||++....++.++|||||||++|||+| |..||.......        .. .......
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--------~~-~~~~~~~  436 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VY-ELLEKDY  436 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HH-HHHHTTC
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--------HH-HHHHcCC
Confidence            8765443333344556788999999998899999999999999999999 889987432211        11 1111110


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      ..         .    .+..++..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus       437 ~~---------~----~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 RM---------E----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CC---------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CC---------C----CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            00         0    01145567889999999999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-47  Score=353.06  Aligned_cols=249  Identities=17%  Similarity=0.201  Sum_probs=204.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++..  +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lG~G~fg---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecCCCe---EEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence            3578889999999999   9999998  789999999865321 123456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        81 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a  152 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccch
Confidence            9999999999999988764     35889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      +...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....        ......... ...
T Consensus       153 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~~  222 (337)
T 1o6l_A          153 KEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILM-EEI  222 (337)
T ss_dssp             BCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC
T ss_pred             hhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CCC
Confidence            7643322 224566899999999999998999999999999999999999999863221        111111111 110


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                      .          .+    ...+..+.+|+.+||+.||++||     ++.++++
T Consensus       223 ~----------~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 R----------FP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C----------CC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C----------CC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            0          00    13456778999999999999999     8888865

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.1e-48  Score=346.28  Aligned_cols=260  Identities=21%  Similarity=0.357  Sum_probs=216.5

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||+|.+  ++..||+|++...   ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~~~~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYG---EVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             CCGGGEEEEEESGGGTTC---SEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccccceeEEeecCCCCce---eEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            456778889999999999   9999999  5899999999765   3456789999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||+
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             EEEEEEcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence            9999999999999999976543   46899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +...............+|..|+|||++.+..++.++||||||+++|+|++ |..||.......        ... .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------~~~-~~~~~  228 (288)
T 3kfa_A          158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYE-LLEKD  228 (288)
T ss_dssp             GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHH-HHHTT
T ss_pred             ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHH-HHhcc
Confidence            98775544444455567889999999998899999999999999999999 989987433211        111 11111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ....         .    +...+..+.+++.+||..||.+|||+.++++.|+++...
T Consensus       229 ~~~~---------~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          229 YRME---------R----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CCCC---------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC---------C----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            0000         0    013456788999999999999999999999999988753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.2e-48  Score=342.35  Aligned_cols=256  Identities=21%  Similarity=0.332  Sum_probs=211.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++|...+.||+|+||   .||++.+ ++..||+|++....   ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~y~~~~~lg~G~~g---~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFG---LVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTE---EEEEEEETTTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hheeeeeEecCCCce---eEEEEEecCCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            568888999999999   9999999 78899999997653   2346799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++...
T Consensus        82 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             ECCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EeCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccc
Confidence            99999999999997654    45789999999999999999999   999999999999999999999999999999776


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ............+|..|+|||++.+..++.++||||||+++|+|++ |..||.....        ............  .
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~--~  224 (267)
T 3t9t_A          155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFR--L  224 (267)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC--C
T ss_pred             ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCc--C
Confidence            4332222334567788999999998889999999999999999999 8999874221        111111111100  0


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      . .           +...+..+.+++.+||+.||++|||+.++++.|.++.++
T Consensus       225 ~-~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          225 Y-K-----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             C-C-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C-C-----------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            0 0           003345678999999999999999999999999999764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=351.82  Aligned_cols=265  Identities=20%  Similarity=0.298  Sum_probs=214.7

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe---------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW---------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLI  128 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~  128 (353)
                      ...++|...+.||+|+||   .||+|.+         .+..||+|++.... .......+.+|+.+++++ +|||||+++
T Consensus        66 i~~~~y~i~~~LG~G~~g---~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFG---QVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             CCGGGEEEEEEEEECSSE---EEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cchhheEeeeEEecCCCe---EEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            345678888999999999   9999986         23679999997653 455668899999999999 899999999


Q ss_pred             ceeeeCCccEEEEEeccCCChhhhhccCCCCC-----------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccC
Q 018633          129 GCCLETPIPILVFESVQYGTLWDRILGAPQPH-----------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK  197 (353)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  197 (353)
                      +++.+.+..++||||+++|+|.+++.......           ...+++..++.++.|++.||.|||   +++|+|||||
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk  218 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLA  218 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCC
Confidence            99999999999999999999999997654210           135899999999999999999999   8999999999


Q ss_pred             CCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccc
Q 018633          198 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVK  275 (353)
Q Consensus       198 p~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~  275 (353)
                      |+|||++.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987644322 22334567889999999999899999999999999999999 999986322


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                              ..+.... ..........             ..++..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       299 --------~~~~~~~-~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          299 --------VEELFKL-LKEGHRMDKP-------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             --------HHHHHHH-HHTTCCCCCC-------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------HHHHHHH-HHcCCCCCCC-------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                    1122221 1111111100             13456788999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-46  Score=342.81  Aligned_cols=264  Identities=20%  Similarity=0.311  Sum_probs=214.1

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      ..++|...+.||+|+||   .||++.+       ++..||+|++.... .....+.+.+|+.++++++||||+++++++.
T Consensus        21 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFG---KVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             CGGGEEEEEEEEECSSS---EEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             chhheeeeeeecccCCe---eEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            35678888999999999   9999976       34789999997543 4566788999999999999999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCC-------------------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQP-------------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF  193 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  193 (353)
                      +.+..++||||+++|+|.+++......                   ....+++..++.++.|++.||.|||   +++|+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence            999999999999999999999765320                   0135899999999999999999999   899999


Q ss_pred             eccCCCceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCC
Q 018633          194 RNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVS  271 (353)
Q Consensus       194 ~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~  271 (353)
                      |||||+|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999876443322 2234457788999999998889999999999999999999 99998


Q ss_pred             CccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          272 DLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......        . ............             +...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       254 ~~~~~~~--------~-~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          254 PGIPPER--------L-FNLLKTGHRMER-------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             TTCCGGG--------H-HHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHH--------H-HHHhhcCCcCCC-------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            7432211        1 111111111110             01445678899999999999999999999999999876


Q ss_pred             h
Q 018633          352 S  352 (353)
Q Consensus       352 ~  352 (353)
                      .
T Consensus       312 ~  312 (314)
T 2ivs_A          312 K  312 (314)
T ss_dssp             T
T ss_pred             h
Confidence            4

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.1e-47  Score=347.38  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=202.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..|
T Consensus         6 ~~~y~i~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTCEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeeEEecCCCE---EEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            4678999999999999   9999988  78999999986542 2233467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        82 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~  153 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT  153 (323)
T ss_dssp             EEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccc
Confidence            999999999999998765     46899999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCC-ccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          219 SIPEGET-HITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       219 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......       ...........
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~  226 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKT  226 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-------HHHHHHHTTCT
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHhcccc
Confidence            6532221 22345679999999999987775 789999999999999999999997433221       11111111110


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....             ....+..+.+|+.+||..||++|||+.++++
T Consensus       227 ~~~~-------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          227 YLNP-------------WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             TSTT-------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCc-------------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000             0134566789999999999999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=347.77  Aligned_cols=253  Identities=19%  Similarity=0.221  Sum_probs=206.7

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC----hhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR----PRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ..+.|...+.||+|+||   .||++..  ++..||+|++......    ....+.+.+|+.++++++||||+++++++.+
T Consensus         9 ~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFA---VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             HHHHEEEEEEEECCSSE---EEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cccceEeceEEeeCCCe---EEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            34568889999999999   9999998  6899999998765321    1246789999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC----ce
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN----VA  209 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~  209 (353)
                      .+..++||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++    .+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~  157 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRI  157 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCE
Confidence            99999999999999999999754     46899999999999999999999   99999999999999998887    79


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ||+|||+++.......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....        .....
T Consensus       158 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~  227 (326)
T 2y0a_A          158 KIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA  227 (326)
T ss_dssp             EECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH
T ss_pred             EEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHH
Confidence            9999999987643322  3456799999999999988999999999999999999999999863221        11111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .... ...          ..........+..+.+|+.+||..||++|||+.++++
T Consensus       228 ~~~~-~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          228 NVSA-VNY----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHH-TCC----------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHh-cCC----------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111 100          0011111144567889999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-47  Score=350.34  Aligned_cols=261  Identities=14%  Similarity=0.109  Sum_probs=209.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||+|..  +++.||||++....    ..+.+.+|+.+++++ +||||+++++++...+..
T Consensus         8 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFG---ELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTT---SEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             cCCeEEEEEeeccCCc---eEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            4679999999999999   9999996  89999999986542    224588999999999 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc-----eEEe
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV-----AKLF  212 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~-----~kl~  212 (353)
                      ++||||+ +++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.     +||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             EEEEEeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence            9999999 899999998653    46899999999999999999999   899999999999999998887     9999


Q ss_pred             ccCCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          213 DFSLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       213 dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      |||+++........      ......||+.|+|||++.+..++.++||||||+++|||++|..||.......     ...
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-----~~~  227 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-----LKE  227 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-----HHH
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc-----HHH
Confidence            99999876433221      1245679999999999999999999999999999999999999997543211     111


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ....... .        ... ..........+ .+.+++..||+.||.+||++.+|.+.|+++.+.
T Consensus       228 ~~~~i~~-~--------~~~-~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          228 RYQKIGD-T--------KRA-TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHHHHHH-H--------HHH-SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHh-h--------hcc-CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            1111100 0        000 00000000233 889999999999999999999999999988764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=349.45  Aligned_cols=245  Identities=17%  Similarity=0.167  Sum_probs=199.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||||++............+..|+..+.++ +||||++++++|.+++..+
T Consensus        57 ~~y~~~~~LG~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYG---EVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHEEEEEEEEEETTE---EEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hheeeeheeccCCCe---EEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            678889999999999   9999999  689999999876654556666777777777766 8999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+ +++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus       134 lv~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             EEEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence            999999 579999887654    46899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ......  ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....           +... ...   
T Consensus       206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~-~~~---  267 (311)
T 3p1a_A          206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQL-RQG---  267 (311)
T ss_dssp             ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHH-TTT---
T ss_pred             ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHH-hcc---
Confidence            764332  2345579999999999875 789999999999999999999777652211           1111 111   


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                               ..+...+...+..+.+++.+||+.||++|||+.++++
T Consensus       268 ---------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          268 ---------YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                     0111112245678899999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.5e-47  Score=346.42  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=201.2

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC-
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP-  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~-  135 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||||++.... .....+.+.+|+.++++++|||||++++++.+.+ 
T Consensus         3 ~~~~~y~~~~~lG~G~~g---~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFG---VVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHHHEEEEEEEECC-CS---EEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhhhcCceeeEecCCCCe---EEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            345679999999999999   9999998  78999999997543 3456688999999999999999999999986543 


Q ss_pred             --------------------------------------------------------ccEEEEEeccCCChhhhhccCCCC
Q 018633          136 --------------------------------------------------------IPILVFESVQYGTLWDRILGAPQP  159 (353)
Q Consensus       136 --------------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~  159 (353)
                                                                              ..++||||+++|+|.+++......
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    279999999999999999875432


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCC-----------ccc
Q 018633          160 HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-----------HIT  228 (353)
Q Consensus       160 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-----------~~~  228 (353)
                        ...++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.......           ...
T Consensus       159 --~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          159 --EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             --GGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             --cchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence              45567778999999999999999   99999999999999999999999999999987654321           112


Q ss_pred             cccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhc
Q 018633          229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVED  308 (353)
Q Consensus       229 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (353)
                      ....||+.|+|||++.+..++.++||||||+++|||++|..|+....          .. ......            ..
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------~~-~~~~~~------------~~  290 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------RI-ITDVRN------------LK  290 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------HH-HHHHHT------------TC
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------HH-HHHhhc------------cC
Confidence            34579999999999999899999999999999999999876632100          00 000000            11


Q ss_pred             cchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          309 VLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       309 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      . +......+..+.+++.+||+.||++|||+.++++
T Consensus       291 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          291 F-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             C-CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             C-CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            1 1122255667789999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.9e-47  Score=337.80  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=195.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCC--hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECR--PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||+|.+.+..||+|++......  ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         6 ~~~~~~~~~lg~G~~g---~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFG---KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTE---EEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             hhheeeeeeeccCCCe---EEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            3578889999999999   99999999999999998654321  233577899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC---eEeeccCCCceeecC--------CC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP---IVFRNFKTSCILFNE--------EN  207 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---iiH~dlkp~Nill~~--------~~  207 (353)
                      +||||+++++|.+++..      ..+++..++.++.|++.||.|||   +++   |+||||||+|||++.        ++
T Consensus        83 lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             EEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             EEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCc
Confidence            99999999999998854      35889999999999999999999   777   999999999999986        77


Q ss_pred             ceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          208 VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      .++|+|||++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......        ..
T Consensus       154 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~  222 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AV  222 (271)
T ss_dssp             CEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HH
T ss_pred             ceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence            89999999997654322   23457899999999999888999999999999999999999998743221        11


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ....... ......            +...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       223 ~~~~~~~-~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          223 AYGVAMN-KLALPI------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHHHTS-CCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHhhhcC-CCCCCC------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1111111 110000            013456788999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-47  Score=349.64  Aligned_cols=266  Identities=18%  Similarity=0.304  Sum_probs=197.6

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCe---EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QER---LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ...++|...+.||+|+||   .||+|.+  ++.   .||+|++..........+.+.+|+.++++++||||+++++++..
T Consensus        20 i~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFG---SVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             CC---CEEEEEEEEETTE---EEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cChhHeEEeceecccCCe---EEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            345679999999999999   9999988  232   79999997765455667889999999999999999999999987


Q ss_pred             CCcc------EEEEEeccCCChhhhhccCCCC-CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC
Q 018633          134 TPIP------ILVFESVQYGTLWDRILGAPQP-HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE  206 (353)
Q Consensus       134 ~~~~------~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  206 (353)
                      ....      ++||||+++|+|.+++...... ....+++..++.++.|++.||.|||   +++|+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCC
Confidence            6654      9999999999999988643211 1125899999999999999999999   8999999999999999999


Q ss_pred             CceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCCh
Q 018633          207 NVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~  284 (353)
                      +.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.......      
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------  247 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------  247 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------
Confidence            99999999999776443321 1233456788999999999999999999999999999999 899987433221      


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                        ........... ..             +...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       248 --~~~~~~~~~~~-~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          248 --IYNYLIGGNRL-KQ-------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             --HHHHHHTTCCC-CC-------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHHHHhcCCCC-CC-------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              11111111110 00             013456788999999999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=345.02  Aligned_cols=250  Identities=18%  Similarity=0.237  Sum_probs=196.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC------------------------hhHHHHHHHHHH
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR------------------------PRAYESCINNVT  114 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~  114 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++......                        ....+.+.+|+.
T Consensus        12 ~~~y~~~~~lG~G~~g---~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYG---VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             ETTEEEEEEEEC--CC---EEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ecceEEEeEEeecCCE---EEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            4679999999999999   9999988  7899999998654211                        112456899999


Q ss_pred             HHhhcCCCceeeccceeee--CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 018633          115 YAARMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV  192 (353)
Q Consensus       115 ~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii  192 (353)
                      ++++++||||+++++++.+  .+..++||||+++++|.+++..      ..+++..++.++.|++.||.|||   +++|+
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~iv  159 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKII  159 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            9999999999999999986  5678999999999999886543      46899999999999999999999   89999


Q ss_pred             eeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccCC---CCccccchhhHHHHHHHHhCCC
Q 018633          193 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV---FNEKSDVFSFGVFLFELLTGWD  269 (353)
Q Consensus       193 H~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~el~tg~~  269 (353)
                      ||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..   ++.++||||||+++|+|++|..
T Consensus       160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            999999999999999999999999987654322 234567999999999997655   4788999999999999999999


Q ss_pred             CCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          270 VSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       270 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ||.....        ....... ....... ..           ....+..+.+++.+||+.||++|||+.++++
T Consensus       239 pf~~~~~--------~~~~~~~-~~~~~~~-~~-----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          239 PFMDERI--------MCLHSKI-KSQALEF-PD-----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSCCSSH--------HHHHHHH-HHCCCCC-CS-----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCccH--------HHHHHHH-hcccCCC-CC-----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9863221        1111111 1111100 00           0034556889999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=353.58  Aligned_cols=265  Identities=17%  Similarity=0.276  Sum_probs=209.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecccee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCC  131 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~  131 (353)
                      ..++|...+.||+|+||   .||+|.+       ++..||+|++.... .....+.+.+|+.++.++ +||||+++++++
T Consensus        43 ~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFG---KVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSE---EEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeeecCCCCc---eeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            45678889999999999   9999986       45689999997542 334557899999999999 899999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCC------------------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQP------------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF  193 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  193 (353)
                      ...+..++||||+++|+|.+++......                  ....+++..++.++.||+.||.|||   +++|+|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence            9999999999999999999999765321                  0124789999999999999999999   899999


Q ss_pred             eccCCCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCC
Q 018633          194 RNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVS  271 (353)
Q Consensus       194 ~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~  271 (353)
                      |||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|+| |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999999999976643322 22344567889999999998899999999999999999998 99998


Q ss_pred             CccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          272 DLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......        .............         .    +...+..+.+|+.+||..||.+|||+.++++.|..+.+
T Consensus       276 ~~~~~~~--------~~~~~~~~~~~~~---------~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          276 PGIPVDA--------NFYKLIQNGFKMD---------Q----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TTCCCSH--------HHHHHHHTTCCCC---------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ccCCcHH--------HHHHHHhcCCCCC---------C----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            7432211        1111111111000         0    01345678899999999999999999999999998765


Q ss_pred             h
Q 018633          352 S  352 (353)
Q Consensus       352 ~  352 (353)
                      .
T Consensus       335 ~  335 (344)
T 1rjb_A          335 D  335 (344)
T ss_dssp             -
T ss_pred             H
Confidence            4

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.8e-47  Score=337.87  Aligned_cols=258  Identities=21%  Similarity=0.286  Sum_probs=206.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ..++|...+.||+|+||   .||+|.+     ++..||+|.+.... .....+.+.+|+.++++++||||+++++++.+ 
T Consensus        10 ~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFG---EVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSS---EEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred             cccceEEEEEEEecCCe---eEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence            35678899999999999   9999986     23469999987652 45567889999999999999999999999864 


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      +..++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+||
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             CCCEEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCcc
Confidence            45789999999999999997643    45889999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      |++...............+|..|+|||++.+..++.++||||||+++|+|++ |..||.......        .... ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~-~~  228 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGV-LE  228 (281)
T ss_dssp             CGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHH-HH
T ss_pred             CCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHH-Hh
Confidence            9998765443333344567889999999998899999999999999999998 999987433221        1111 11


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......             +...+..+.+++.+||..||++|||+.++++.|+++..
T Consensus       229 ~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          229 KGDRLPK-------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             HTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCC-------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            1110000             01345568899999999999999999999999998875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.4e-48  Score=352.55  Aligned_cols=257  Identities=19%  Similarity=0.348  Sum_probs=201.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCe----EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QER----LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .++|...+.||+|+||   .||+|.+  +++    .||+|.+.... .....+.|.+|+.++++++||||++++++|.+.
T Consensus        14 ~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFG---TVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGGEEEEEEEEEETTE---EEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHHcccceEEeeCCCe---EEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            3568889999999999   9999987  444    35888775442 344567899999999999999999999999865


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      . .++|+||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Df  161 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccC
Confidence            4 789999999999999998754    46899999999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          215 SLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       215 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |+++........ ......+|..|+|||++.+..++.++||||||+++|||+| |..||.......         .....
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------~~~~~  232 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSIL  232 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHH
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------HHHHH
Confidence            999876543322 2234456889999999999999999999999999999999 999987432211         11111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......         .    +..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       233 ~~~~~~~---------~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          233 EKGERLP---------Q----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HTTCCCC---------C----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HcCCCCC---------C----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111000         0    01345578899999999999999999999999998864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=353.70  Aligned_cols=262  Identities=18%  Similarity=0.260  Sum_probs=209.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++|...+.||+|+||   .||+|.+       ++..||||++.... .......+.+|+.++++++|||||++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFG---EVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSS---CEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCE---EEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3568888999999999   8888884       46689999986542 45566789999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCC--CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC---c
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQ--PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---V  208 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~  208 (353)
                      ....++||||+++|+|.+++.....  .....+++..++.++.||+.||.|||   +++|+||||||+|||++.++   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCce
Confidence            9999999999999999999976432  11135889999999999999999999   99999999999999999555   5


Q ss_pred             eEEeccCCccccCCCC-CccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHH
Q 018633          209 AKLFDFSLSISIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~  286 (353)
                      +||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.....        ..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~  294 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QE  294 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence            9999999997542211 122344567899999999999999999999999999999998 9999874321        11


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ....... ......             +..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       295 ~~~~i~~-~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          295 VLEFVTS-GGRMDP-------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHHHHHT-TCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHc-CCCCCC-------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            1111111 111000             01345568899999999999999999999999988765

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-47  Score=346.17  Aligned_cols=265  Identities=17%  Similarity=0.269  Sum_probs=214.4

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecccee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCC  131 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~  131 (353)
                      ..++|...+.||+|+||   .||+|.+       ++..||+|++.... .....+.+.+|+.++.++ +||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFG---KVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             CGGGEEEEEEEEECSSE---EEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ChhhhhHHHhhCccCCc---ceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            34678889999999999   9999974       56899999997653 345568899999999999 899999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCC-------------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCC
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQP-------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT  198 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  198 (353)
                      .+.+..++||||+++|+|.+++......             ....+++..++.++.|++.||.|||   +++|+||||||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp  173 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA  173 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCcc
Confidence            9999999999999999999999765421             0124899999999999999999999   89999999999


Q ss_pred             CceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCcccc
Q 018633          199 SCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKD  276 (353)
Q Consensus       199 ~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~  276 (353)
                      +||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|+| |..||.....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999999999999999999876543322 2334567888999999998899999999999999999999 9999874322


Q ss_pred             ccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ..        ........... ...            +...+..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus       254 ~~--------~~~~~~~~~~~-~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          254 DS--------KFYKMIKEGFR-MLS------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             SH--------HHHHHHHHTCC-CCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hh--------HHHHHhccCCC-CCC------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11        11111111100 000            013456788999999999999999999999999998865

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=345.34  Aligned_cols=269  Identities=17%  Similarity=0.239  Sum_probs=201.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHH--HhhcCCCceeeccceeee-----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTY--AARMSHNHILKLIGCCLE-----  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~~~~~~~~-----  133 (353)
                      .++|...+.||+|+||   .||+|.++++.||||++...     ....+..|.++  +..++||||+++++++..     
T Consensus        12 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYG---AVYKGSLDERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TTSEEEEEEEEECSSE---EEEEEEETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             hHHhheeeecccCCCe---EEEEEEECCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            4678899999999999   99999999999999998644     23445455544  445899999999986542     


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC---------CeEeeccCCCceeec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR---------PIVFRNFKTSCILFN  204 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---------~iiH~dlkp~Nill~  204 (353)
                      ...+++||||+++|+|.+++...      ..++..++.++.|++.||.|||   ++         +|+||||||+|||++
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~  154 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVK  154 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred             CceEEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEc
Confidence            33578999999999999999764      3578889999999999999999   88         999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCC-------ccccccccCCcccccccccc-------CCCCccccchhhHHHHHHHHhCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGET-------HITDTVMGTWGYCAPEYMRT-------GVFNEKSDVFSFGVFLFELLTGWDV  270 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~tg~~p  270 (353)
                      .++.+||+|||+++.......       .......||+.|+|||++.+       ..++.++|||||||++|||++|..|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            999999999999987643221       11234579999999999976       3567899999999999999999877


Q ss_pred             CCccccccCCCC---------ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 018633          271 SDLVKDTHDLAC---------PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVD  341 (353)
Q Consensus       271 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  341 (353)
                      |...........         +.................+.......      ...+..+.+|+.+||+.||++|||+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (336)
T 3g2f_A          235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN------SLAVRSLKETIEDCWDQDAEARLTAQX  308 (336)
T ss_dssp             GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCC------SHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccc------cchHHHHHHHHHHHhcCChhhCcchHH
Confidence            654333221111         11111111111111111111111111      146678999999999999999999999


Q ss_pred             HHHHHHHHHHh
Q 018633          342 VAKKLRQIYRS  352 (353)
Q Consensus       342 vl~~L~~l~~~  352 (353)
                      +++.|+++...
T Consensus       309 ~l~~L~~ll~~  319 (336)
T 3g2f_A          309 AEERMAELMMI  319 (336)
T ss_dssp             HHHHHHHHHHC
T ss_pred             HHHHHHHHHHH
Confidence            99999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6e-48  Score=368.56  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=203.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ...++|...+.||+|+||   .||+|.+ .+..||||++....   ...+.|.+|+.+|++++||||+++++++.+ +..
T Consensus       181 i~~~~~~~~~~lG~G~fg---~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFG---EVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             CCGGGEEEEEEEEECSSC---EEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cChhHceeeeeecCCCCe---EEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            445667778899999999   9999999 56789999997653   235679999999999999999999999876 678


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence            999999999999999975321   34789999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      +..............+|..|+|||++....++.++||||||+++|||++ |..||.....        .+..........
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~  399 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYR  399 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCC
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            8765433322334457788999999998999999999999999999999 8999863221        112211111111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      . .             .+..++..+.+|+.+||+.||++|||+.++++.|+.+..+
T Consensus       400 ~-~-------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 M-P-------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             C-C-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             C-C-------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            0 0             0114566788999999999999999999999999887643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-46  Score=352.23  Aligned_cols=276  Identities=16%  Similarity=0.184  Sum_probs=207.7

Q ss_pred             HhhCcCCCCceeeC--CCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           60 ATNSYDQKNVIAKD--TSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        60 ~~~~~~~~~~lg~G--~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ..++|...+.||+|  +||   .||++.+  +++.||||++..........+.+.+|+.+++.++|||||++++++.+++
T Consensus        23 ~~~~y~~~~~lG~G~~~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLM---TVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTE---EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             CCCcEEEEecccCCcCCce---EEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            45679999999999  999   9999999  6999999999876556667788999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEEEEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence            99999999999999999976532   45889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCC------CccccccccCCcccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          216 LSISIPEGE------THITDTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       216 ~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      .+.......      ........||..|+|||++.+  ..++.++|||||||++|||++|..||................
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            876542211      111233478999999999987  569999999999999999999999997543322100000000


Q ss_pred             HHHHhhc------------------Ccccccccch-----hhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          288 LKNYFED------------------NRFTEIVDPI-----IVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       288 ~~~~~~~------------------~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .......                  ..........     .........+...+..+.+|+.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000000                  0000000000     0000000112245677899999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-46  Score=337.83  Aligned_cols=264  Identities=17%  Similarity=0.193  Sum_probs=204.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++.+  +++.||+|++............+.+|+.++++++||||+++++++.+++..++
T Consensus         2 ~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYG---TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCceeeeEecCCCCe---EEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence            468888999999999   9999998  78999999998765556667889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++ |+|.+.+....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        79 v~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           79 VFEFCD-QDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             EEECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            999997 56767665543    46899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc----
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED----  294 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  294 (353)
                      ...... ......||..|+|||++.+.. ++.++|||||||++|+|++|..|+......       ..........    
T Consensus       151 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-------~~~~~~i~~~~~~~  222 (292)
T 3o0g_A          151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRIFRLLGTP  222 (292)
T ss_dssp             CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-------HHHHHHHHHHHCCC
T ss_pred             cCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-------HHHHHHHHHHhCCC
Confidence            643322 234567899999999997766 899999999999999999998886432221       1111111110    


Q ss_pred             --Cccccccc---ch---h--hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 --NRFTEIVD---PI---I--VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 --~~~~~~~~---~~---~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                        ..+.....   ..   .  ............+..+.+|+.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence              00000000   00   0  000000000134567889999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-46  Score=336.58  Aligned_cols=254  Identities=22%  Similarity=0.381  Sum_probs=203.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHH-----HHHHHHHHHHhhcCCCceeeccceeee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAY-----ESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~-----~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..........     +.+.+|+.++++++||||+++++++.+
T Consensus        18 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFG---LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             STTEEEEEECCCCSSS---CEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hccceehhccccCCce---eEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            4678889999999999   9999998  78999999986553222221     679999999999999999999999865


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeecCCCc---
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFNEENV---  208 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~~~~---  208 (353)
                      ..  ++||||+++|+|.+.+....    ..+++..++.++.|++.||.|||   +++  |+||||||+|||++.++.   
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             CC--eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCc
Confidence            54  79999999999999887654    46899999999999999999999   888  999999999999987776   


Q ss_pred             --eEEeccCCccccCCCCCccccccccCCccccccccc--cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          209 --AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR--TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       209 --~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                        +||+|||+++....    ......||+.|+|||++.  ...++.++||||||+++|+|++|..||.......      
T Consensus       166 ~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------  235 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------  235 (287)
T ss_dssp             CCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH------
T ss_pred             eeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH------
Confidence              99999999875432    234567899999999984  4557899999999999999999999997433211      


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ........... .....            +...+..+.+++.+||+.||++|||+.++++.|++|
T Consensus       236 ~~~~~~~~~~~-~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          236 IKFINMIREEG-LRPTI------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHHHHSC-CCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHHHhccC-CCCCC------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11111111111 11110            014456788999999999999999999999999763

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-46  Score=350.14  Aligned_cols=251  Identities=17%  Similarity=0.214  Sum_probs=206.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .+.|...+.||+|+||   .||+|.+  +++.||+|++...  .......+.+|+.++++++||||+++++++.+....+
T Consensus        50 ~~~y~i~~~LG~G~~g---~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFG---VVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCE---EEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence            4679999999999999   9999998  7889999999765  4555678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC--CCceEEeccCC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE--ENVAKLFDFSL  216 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~--~~~~kl~dfg~  216 (353)
                      +||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.  .+.+||+|||+
T Consensus       125 lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEeccc
Confidence            9999999999999987653    46899999999999999999999   999999999999999974  47899999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ++.......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ......... ..
T Consensus       198 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~~-~~  266 (387)
T 1kob_A          198 ATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKR-CD  266 (387)
T ss_dssp             CEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHH-CC
T ss_pred             ceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CC
Confidence            987654322  3345799999999999988899999999999999999999999974322        111111111 11


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.  .+...        ....+..+.+|+.+||..||++|||+.++++
T Consensus       267 ~~--~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          267 WE--FDEDA--------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             CC--CCSST--------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CC--CCccc--------cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00  00000        0134567889999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-46  Score=351.91  Aligned_cols=253  Identities=20%  Similarity=0.287  Sum_probs=201.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPI  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~  136 (353)
                      .++|...++||+|+||   .||++.+  +++.||+|++..... .....+.+.+|..++.++ +|||||++++++.+.+.
T Consensus        51 ~~~y~~~~~LG~G~fG---~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYA---KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             hhHcEEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            4679999999999999   9999998  789999999976532 223345688999999887 79999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecce
Confidence            99999999999999998764     36899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........................
T Consensus       200 a~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  278 (396)
T 4dc2_A          200 CKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  278 (396)
T ss_dssp             CBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred             eeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence            97643222 23456789999999999999999999999999999999999999997543322111111121211111111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                      ..          .    +...+..+.+|+.+||+.||++||++
T Consensus       279 ~~----------~----p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 IR----------I----PRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CC----------C----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cC----------C----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            00          0    01345677899999999999999996

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=341.53  Aligned_cols=272  Identities=16%  Similarity=0.199  Sum_probs=209.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC--cc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP--IP  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~  137 (353)
                      +.|...+.||+|+||   .||+|.+  +++.||||++.... .....+.+.+|+.++++++||||+++++++...+  ..
T Consensus         9 ~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            9 HLWLLSDILGQGATA---NVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             EEEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCEEEEEEecCCCCe---EEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            568889999999999   9999999  58999999997542 2334677889999999999999999999988655  77


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee----cCCCceEEec
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLFD  213 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~d  213 (353)
                      ++||||+++++|.+++......  ..+++..++.++.|++.||.|||   +++|+||||||+|||+    +.++.+||+|
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             EEEEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            9999999999999999765321  23899999999999999999999   9999999999999999    7888899999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccc--------cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMR--------TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~  285 (353)
                      ||+++.......  .....||..|+|||++.        +..++.++|||||||++|||++|..||........    ..
T Consensus       160 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~  233 (319)
T 4euu_A          160 FGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR----NK  233 (319)
T ss_dssp             CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG----CH
T ss_pred             CCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch----hH
Confidence            999987654332  34557999999999986        46789999999999999999999999974333221    11


Q ss_pred             HHHHHHhhcCccc---cc---ccch--hhhccc--hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFT---EI---VDPI--IVEDVL--SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       286 ~~~~~~~~~~~~~---~~---~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                      .............   .+   ....  .....+  .......+..+.+++.+||+.||++|||+.++++....
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            2222222111100   00   0000  000000  01123677888999999999999999999999987754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-46  Score=339.53  Aligned_cols=259  Identities=20%  Similarity=0.306  Sum_probs=207.3

Q ss_pred             HhhCcCCCC-ceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           60 ATNSYDQKN-VIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        60 ~~~~~~~~~-~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ..+.|.... .||+|+||   .||+|.+    .+..||+|++..........+.+.+|+.++++++||||+++++++ ..
T Consensus        14 ~~~~y~~~~~~lg~G~~g---~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFG---TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSE---EEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             cchhhhhccCccccccCe---eeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            345677776 99999999   9999955    468899999976644455678899999999999999999999999 66


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      +..++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+||
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccC
Confidence            7789999999999999999865     35889999999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCCcc--ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHH
Q 018633          215 SLSISIPEGETHI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       215 g~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      |++..........  .....+|..|+|||++.+..++.++||||||+++|+|++ |..||......        . ....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~-~~~~  232 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------E-VTAM  232 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------H-HHHH
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------H-HHHH
Confidence            9998765443321  223346788999999988889999999999999999999 99998743221        1 1111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .........             +...+..+.+++.+||+.||++|||+.++++.|++++..
T Consensus       233 ~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          233 LEKGERMGC-------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            211111110             014456788999999999999999999999999998864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-47  Score=351.88  Aligned_cols=247  Identities=19%  Similarity=0.272  Sum_probs=201.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 i~~Y~i~~~lG~G~~g---~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFG---KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             ETTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCEEEEEEEecCCCe---EEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            3679999999999999   9999998  889999999864311 112235788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+ +|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        85 ~lv~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s  155 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS  155 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred             EEEEECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccc
Confidence            9999999 68999988764     35899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .......  .....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......                  
T Consensus       156 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------------  215 (336)
T 3h4j_B          156 NIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------------  215 (336)
T ss_dssp             BTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------------
T ss_pred             eeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------------
Confidence            7764332  2345679999999999988776 689999999999999999999997432211                  


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                         +..........  .+...+..+.+|+.+||..||.+|||+.++++
T Consensus       216 ---~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          216 ---LFKKVNSCVYV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---CBCCCCSSCCC--CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---HHHHHHcCCCC--CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               11110000000  00134566789999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-46  Score=341.78  Aligned_cols=267  Identities=21%  Similarity=0.357  Sum_probs=202.7

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ...++|...+.||+|+||   .||+|.+     ++..||+|.+..........+.+.+|+.++++++||||+++++++.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFG---SVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCC---CEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             cCHHHeeeccceeecCCe---EEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            445678888999999999   8888876     34589999998765566677889999999999999999999999986


Q ss_pred             CC-----ccEEEEEeccCCChhhhhccCCC-CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC
Q 018633          134 TP-----IPILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN  207 (353)
Q Consensus       134 ~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  207 (353)
                      .+     ..++||||+++|+|.+++..... .....+++..++.++.|++.||.|||   +++|+||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence            54     35999999999999998853211 11146899999999999999999999   99999999999999999999


Q ss_pred             ceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChH
Q 018633          208 VAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~  285 (353)
                      .+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......       
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------  257 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------  257 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------
Confidence            9999999999776433221 1234457789999999998899999999999999999999 888886432211       


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                       .......... ...             +...+..+.+++.+||..||++|||+.++++.|+++.+++
T Consensus       258 -~~~~~~~~~~-~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          258 -MYDYLLHGHR-LKQ-------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             -HHHHHHTTCC-CCC-------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -HHHHHHcCCC-CCC-------------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             1111111110 000             0144567889999999999999999999999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=339.10  Aligned_cols=259  Identities=22%  Similarity=0.283  Sum_probs=205.7

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--C---CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--Q---ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .|...++||+|+||   .||+|.+  +   +..||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFG---VVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTE---EEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCc---eEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            35556889999999   9999986  2   2379999987542 455678899999999999999999999999876554


Q ss_pred             -EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          138 -ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       138 -~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                       ++||||+.+|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             cEEEEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence             99999999999999997644    46789999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC---CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          217 SISIPEGE---THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       217 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ++......   ........+|..|+|||.+.+..++.++||||||+++|+|++|..|+.......       .. .....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-------~~-~~~~~  242 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DL-THFLA  242 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-------GH-HHHHH
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-------HH-HHHhh
Confidence            97654322   112234567889999999999899999999999999999999666644222111       01 11111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                      .......             +...+..+.+++.+||+.||.+|||+.++++.|+++.+++
T Consensus       243 ~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          243 QGRRLPQ-------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             TTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCCCCC-------------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            1110000             0134567889999999999999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.8e-46  Score=335.64  Aligned_cols=258  Identities=19%  Similarity=0.305  Sum_probs=209.9

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ..++|...+.||+|+||   .||+|.+ ++..||+|++....   ...+.+.+|+.++++++||||+++++++. .+..+
T Consensus        11 ~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFG---EVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTE---EEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             CHHhhhheeeecCCCCe---EEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence            34678889999999999   9999998 67789999997652   33567999999999999999999999986 45689


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence            99999999999999875321   25889999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ..............++..|+|||++.+..++.++||||||+++|+|++ |..||.....        .+....... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~-~~~  228 (279)
T 1qpc_A          158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLER-GYR  228 (279)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHT-TCC
T ss_pred             cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHHhc-ccC
Confidence            775443333344567788999999988889999999999999999999 8889864221        111111111 100


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .. .            +...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       229 ~~-~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          229 MV-R------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CC-C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC-C------------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            00 0            013456788999999999999999999999999998765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.9e-47  Score=352.32  Aligned_cols=256  Identities=19%  Similarity=0.251  Sum_probs=204.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC---CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE---CRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      .+.|...+.||+|+||   .||++.+  +++.||+|++....   ......+.+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFS---VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG   99 (351)
T ss_dssp             HHHEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccceEEeeEEeeCCCE---EEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            4569999999999999   9999988  78999999985431   01224577999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc---eEEe
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLF  212 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kl~  212 (353)
                      ..|+||||+++|+|.+.+....... ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.   +||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAG-FVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEe
Confidence            9999999999999988776432110 34789999999999999999999   999999999999999986654   9999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....         ........
T Consensus       176 Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~  245 (351)
T 3c0i_A          176 GFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGII  245 (351)
T ss_dssp             CCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHH
T ss_pred             cCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHH
Confidence            9999987654322 2345679999999999998899999999999999999999999997421         11111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      . ....          ..+......+..+.+|+.+||..||++|||+.++++
T Consensus       246 ~-~~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 K-GKYK----------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             H-TCCC----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c-CCCC----------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1 1110          001111134667889999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-46  Score=335.57  Aligned_cols=257  Identities=20%  Similarity=0.327  Sum_probs=209.3

Q ss_pred             hCcCCCC-ceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKN-VIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~-~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++|.... .||+|+||   .||+|.+    ++..||+|++.... .....+.+.+|+.++++++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g---~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFG---SVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTE---EEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCce---eEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4455555 89999999   9999975    67889999997652 456678899999999999999999999999 5667


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             cEEEEEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccc
Confidence            899999999999999987543    46899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          217 SISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       217 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +.........  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......        ... ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~-~~i~  227 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVM-AFIE  227 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHH-HHHH
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHH-HHHh
Confidence            9876443321  1233456889999999988889999999999999999999 99998743221        111 1111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .......             +...+..+.+++.+||+.||++|||+.++++.|.+++.+
T Consensus       228 ~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          228 QGKRMEC-------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             TTCCCCC-------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCcCCC-------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111110             014556788999999999999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-47  Score=360.52  Aligned_cols=261  Identities=17%  Similarity=0.182  Sum_probs=209.8

Q ss_pred             cHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccc
Q 018633           53 SAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIG  129 (353)
Q Consensus        53 ~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~  129 (353)
                      .+.++...+++|...++||+|+||   .||++.+  +++.||+|++..... .......+.+|..++..++||||+++++
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG---~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFG---EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCE---EEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            345555667899999999999999   9999998  689999999864310 1112234889999999999999999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                      +|.+.+..|+||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+
T Consensus       142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~v  214 (437)
T 4aw2_A          142 AFQDDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI  214 (437)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             EEeeCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCE
Confidence            9999999999999999999999997643    46899999999999999999999   9999999999999999999999


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                      ||+|||+++.............+||+.|+|||++.     ...++.++|||||||++|||++|..||......       
T Consensus       215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------  287 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------  287 (437)
T ss_dssp             EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------
T ss_pred             EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------
Confidence            99999999877554444445578999999999987     456899999999999999999999999743211       


Q ss_pred             HHHHHHHhhc---CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCC--CCCHHHHHH
Q 018633          285 NEYLKNYFED---NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD--RPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~vl~  344 (353)
                       +........   ..++...             ...+..+.+|+.+||..+|+.  ||++.++++
T Consensus       288 -~~~~~i~~~~~~~~~p~~~-------------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          288 -ETYGKIMNHKERFQFPTQV-------------TDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             -HHHHHHHTHHHHCCCCSSC-------------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             -HHHHhhhhccccccCCccc-------------ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence             111111110   1111100             024567789999999888888  999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-46  Score=338.08  Aligned_cols=264  Identities=16%  Similarity=0.149  Sum_probs=205.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeecccee-eeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCC-LETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~-~~~~  135 (353)
                      ...++|...+.||+|+||   .||+|.+  +++.||+|++....    ..+.+.+|+.++..++|++++..++.+ ...+
T Consensus         6 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFG---DIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             -----CEEEEEEEECSSS---EEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             ccCCceEEeeeecCCCCe---EEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            455789999999999999   9999996  89999999875542    224588899999999998888777766 5667


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee---cCCCceEEe
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLF  212 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~  212 (353)
                      ..++||||+ +++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||+   +.++.+||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             ceEEEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEe
Confidence            789999999 899999987543    46899999999999999999999   9999999999999999   788999999


Q ss_pred             ccCCccccCCCCC------ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          213 DFSLSISIPEGET------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       213 dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      |||+++.......      .......||..|+|||++.+..++.++|||||||++|+|++|..||.........  ....
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~  228 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYE  228 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhh
Confidence            9999987654322      1223567899999999999989999999999999999999999999754332210  0000


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ....            ...... ........+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       229 ~~~~------------~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          229 RISE------------KKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHH------------HHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhc------------ccccch-hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            0000            000000 0000013457889999999999999999999999999998764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=348.27  Aligned_cols=245  Identities=20%  Similarity=0.224  Sum_probs=197.6

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .+.||+|+||   .||+|.+  ++..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        94 ~~~lG~G~~g---~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFG---QVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEECC--------CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ceEEecCcCE---EEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            5679999999   9999988  7899999999876  4566788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee--cCCCceEEeccCCccccCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPE  222 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill--~~~~~~kl~dfg~a~~~~~  222 (353)
                      ++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||+  +.++.+||+|||+++....
T Consensus       169 ~~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          169 DGGELFDRIIDES----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             TTCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            9999999887543    46899999999999999999999   8999999999999999  5678999999999987654


Q ss_pred             CCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccccc
Q 018633          223 GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVD  302 (353)
Q Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|..||.....        .......... .+. ...
T Consensus       242 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~-~~~-~~~  309 (373)
T 2x4f_A          242 REK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILAC-RWD-LED  309 (373)
T ss_dssp             TCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHT-CCC-SCS
T ss_pred             ccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc-cCC-CCh
Confidence            332  3445799999999999988899999999999999999999999974322        1222222211 100 000


Q ss_pred             chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          303 PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .         .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       310 ~---------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          310 E---------EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             G---------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h---------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0         00134567889999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-46  Score=340.39  Aligned_cols=265  Identities=21%  Similarity=0.247  Sum_probs=206.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC-
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET-  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-  134 (353)
                      +.|...+.||+|+||   .||++.+      +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+. 
T Consensus        21 ~~~~~~~~lg~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGEEEEEEEEECSSE---EEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhccCCCCce---EEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            457888999999999   9999983      78999999997553 344567899999999999999999999999876 


Q ss_pred             -CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                       +..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++|+|
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECc
Confidence             66899999999999999996543    45899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCC--ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc------CCCCChH
Q 018633          214 FSLSISIPEGET--HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH------DLACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~------~~~~~~~  285 (353)
                      ||++........  .......||..|+|||++.+..++.++||||||+++|+|++|..|+.......      .......
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            999987754432  22344568888999999998899999999999999999999998864221100      0000000


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      ...........             ....+...+..+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus       250 ~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLVNTLKEGK-------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHTTC-------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhccC-------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00111111000             00001145567889999999999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=354.54  Aligned_cols=246  Identities=20%  Similarity=0.268  Sum_probs=196.6

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLET  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~  134 (353)
                      ...++|...++||+|+||   .||++.+  +++.||+|++..... .....+.+.+|..++..+ +||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lG~G~fg---~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~   96 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFG---KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP   96 (353)
T ss_dssp             ---CCEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CchhheEEEEEEeeCCCE---EEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence            335689999999999999   9999998  789999999865421 233456788999999998 699999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      +..|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DF  168 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADF  168 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccc
Confidence            9999999999999999999765     36899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      |+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....        ..........
T Consensus       169 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~  239 (353)
T 3txo_A          169 GMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILND  239 (353)
T ss_dssp             TTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC
T ss_pred             cceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC
Confidence            9997643222 224566899999999999988899999999999999999999999974322        1112221111


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                       ..            ..  +...+..+.+|+.+||..||++||++
T Consensus       240 -~~------------~~--p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          240 -EV------------VY--PTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             -CC------------CC--CTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             -CC------------CC--CCCCCHHHHHHHHHHhhhCHHHccCC
Confidence             10            00  01344567899999999999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8e-47  Score=344.55  Aligned_cols=246  Identities=18%  Similarity=0.266  Sum_probs=203.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++..  +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            5 LQDFQILRTLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             GGGEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             hHHcEEEEEEeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            3568889999999999   9999998  789999999865421 123456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        82 ~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a  153 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFA  153 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcc
Confidence            9999999999999999765     45889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      +.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||.....        .......... ..
T Consensus       154 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~-~~  220 (318)
T 1fot_A          154 KYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNA-EL  220 (318)
T ss_dssp             EECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHC-CC
T ss_pred             eecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-CC
Confidence            875332    3456799999999999998999999999999999999999999974221        1111111111 10


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                       .         .+    ...+..+.+++.+||..||++||     ++.++++
T Consensus       221 -~---------~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 -R---------FP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -C---------CC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -C---------CC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence             0         00    13455778999999999999999     7888764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.9e-46  Score=343.80  Aligned_cols=253  Identities=20%  Similarity=0.287  Sum_probs=202.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPI  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~  136 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..... .....+.+.+|..++.++ +||||+++++++.+.+.
T Consensus         8 ~~~y~~~~~lG~G~fg---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhheEEEEEEEecCCe---EEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            3568889999999999   9999998  689999999976532 345567789999999988 79999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999999998764     35899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........................
T Consensus       157 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~  235 (345)
T 3a8x_A          157 CKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  235 (345)
T ss_dssp             CBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred             cccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence            97643222 22456689999999999999899999999999999999999999997433222111111111111111111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                      ..          .    +...+..+.+|+.+||+.||.+||++
T Consensus       236 ~~----------~----p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 IR----------I----PRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CC----------C----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CC----------C----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            10          0    01345678899999999999999995

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.1e-46  Score=333.51  Aligned_cols=253  Identities=21%  Similarity=0.316  Sum_probs=208.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..++|...+.||+|+||   .||++.+  ++..||+|++..........+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFS---VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhcCcCCe---EEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            45789999999999999   9999988  689999999977655666778899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc---eEEecc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLFDF  214 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kl~df  214 (353)
                      ++||||+++++|.+.+...     ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.   +||+||
T Consensus        81 ~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Df  152 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADF  152 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence            9999999999999888764     35889999999999999999999   899999999999999976655   999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      |++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....        ....... ..
T Consensus       153 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~-~~  221 (284)
T 3kk8_A          153 GLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQI-KA  221 (284)
T ss_dssp             TTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HH
T ss_pred             eeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHH-Hh
Confidence            99977643322  3456789999999999998999999999999999999999999864221        1111111 11


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... ..+         .....+..+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~-~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          222 GAYDY-PSP---------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TCCCC-CTT---------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccC-Cch---------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11100 000         00134566889999999999999999999976

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-47  Score=351.71  Aligned_cols=257  Identities=20%  Similarity=0.306  Sum_probs=195.9

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe---C--CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee-CCcc
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW---Q--ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-TPIP  137 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~  137 (353)
                      |...+.||+|+||   .||+|.+   +  ...||+|.+.... .....+.|.+|+.++++++||||++++++|.. ++..
T Consensus        91 ~~~~~~LG~G~fg---~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           91 VHFNEVIGRGHFG---CVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEECCSSS---EEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eecCcEeeeCCCe---EEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            4456789999999   9999987   2  2468999886542 45567889999999999999999999998754 5678


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccc
Confidence            99999999999999997654    45789999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCc---cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          218 ISIPEGETH---ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       218 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +........   ......+|..|+|||++.+..++.++||||||+++|||+| |.+||.......     ..   ... .
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~---~~~-~  310 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----IT---VYL-L  310 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HH---HHH-H
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HH---HHH-H
Confidence            765432211   1233457788999999999999999999999999999999 666765432211     11   111 1


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                      .....  ..           +..++..+.+++.+||+.||++|||+.++++.|+++..++
T Consensus       311 ~~~~~--~~-----------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          311 QGRRL--LQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             TTCCC--CC-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             cCCCC--CC-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            11100  00           0134567889999999999999999999999999998753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.7e-47  Score=346.23  Aligned_cols=256  Identities=18%  Similarity=0.319  Sum_probs=202.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeE----EEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERL----ISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ++|...+.||+|+||   .||+|.+  ++..    ||+|.+.... .......+.+|+.++++++||||+++++++. ++
T Consensus        13 ~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           13 TELRKLKVLGSGVFG---TVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTEEEEEEEECCSSC---EEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             hHceeeeeeeecCCc---eEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            468888999999999   9999998  4443    7888775442 2333456788999999999999999999986 56


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             ccEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCC
Confidence            6889999999999999997653    46889999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          216 LSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       216 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +++........ ......||..|+|||++.+..++.++||||||+++|+|+| |..||.......        . .....
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~-~~~~~  231 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------V-PDLLE  231 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------H-HHHHH
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------H-HHHHH
Confidence            99877543322 2344567889999999998999999999999999999999 999987432211        1 11111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......             +..++..+.+++.+||..||++|||+.++++.|.++..
T Consensus       232 ~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          232 KGERLAQ-------------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TTCBCCC-------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             cCCCCCC-------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1110000             00233456789999999999999999999999988753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.7e-47  Score=339.26  Aligned_cols=263  Identities=18%  Similarity=0.222  Sum_probs=200.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++|...+.||+|+||   .||++.+ +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~G~~g---~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYG---VVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTE---EEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCE---EEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            468888999999999   9999998 689999999976543344457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||++ ++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        79 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           79 FEHLD-QDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EECCS-EEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEecC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            99998 59999887653    45889999999999999999999   899999999999999999999999999999776


Q ss_pred             CCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh---cC-
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE---DN-  295 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-  295 (353)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......        .......   .. 
T Consensus       151 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~  221 (288)
T 1ob3_A          151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--------QLMRIFRILGTPN  221 (288)
T ss_dssp             CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCCC
T ss_pred             Ccccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHHCCCC
Confidence            43221 23345789999999998764 58999999999999999999999997433211        1111111   00 


Q ss_pred             --ccccc-----ccchhhh--ccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 --RFTEI-----VDPIIVE--DVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 --~~~~~-----~~~~~~~--~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                        .++..     .++....  ..+ .......+..+.+|+.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              00000     0000000  000 0000134567789999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.2e-47  Score=359.19  Aligned_cols=259  Identities=16%  Similarity=0.204  Sum_probs=207.3

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeecccee
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCC  131 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~  131 (353)
                      .++....++|...++||+|+||   .||++.+  +++.||+|++..... .....+.+.+|+.+++.++|||||++++++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG---~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~  138 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF  138 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhcccCccccEEEEEEEcCCCE---EEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4444556889999999999999   9999998  788999999864310 111234578999999999999999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                      .+.+..|+||||+++|+|.+++...      .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||
T Consensus       139 ~~~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL  209 (410)
T 3v8s_A          139 QDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKL  209 (410)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEE
Confidence            9999999999999999999998753      4789999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCC----CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV----FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      +|||+++.............+||+.|+|||++.+..    ++.++|||||||++|||++|..||.....        ...
T Consensus       210 ~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~  281 (410)
T 3v8s_A          210 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGT  281 (410)
T ss_dssp             CCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH
T ss_pred             eccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhH
Confidence            999999877554433345678999999999997655    88999999999999999999999973321        111


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCC--CCCHHHHHH
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPAD--RPSMVDVAK  344 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~~vl~  344 (353)
                      ..........         ...+.  ....+..+.+|+.+||..+|.+  ||++.+|++
T Consensus       282 ~~~i~~~~~~---------~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          282 YSKIMNHKNS---------LTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHTHHHH---------CCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHhcccc---------ccCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            1111110000         00000  0034567889999999999988  999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-46  Score=340.30  Aligned_cols=273  Identities=18%  Similarity=0.305  Sum_probs=217.3

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCc
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNH  123 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~n  123 (353)
                      +...++....++|...+.||+|+||   .||++.+       +++.||+|++.... .....+.+.+|+.++.++ +|||
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~   92 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLN   92 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSE---EEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             ccccceecchhheeeeeEEcCCCce---eEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCC
Confidence            4455555667889999999999999   9999974       56899999997653 445567899999999999 6999


Q ss_pred             eeeccceeeeCC-ccEEEEEeccCCChhhhhccCCCCC-----------CccccHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018633          124 ILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPH-----------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPI  191 (353)
Q Consensus       124 iv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  191 (353)
                      |+++++++...+ ..++||||+++|+|.+++.......           ...+++..++.++.|++.||.|||   +++|
T Consensus        93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i  169 (316)
T 2xir_A           93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC  169 (316)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            999999987654 5899999999999999998654210           022899999999999999999999   8999


Q ss_pred             EeeccCCCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCC
Q 018633          192 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWD  269 (353)
Q Consensus       192 iH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~  269 (353)
                      +||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|+| |..
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987644332 22344567889999999999899999999999999999998 999


Q ss_pred             CCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          270 VSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       270 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ||.......        ..............             +...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       250 p~~~~~~~~--------~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          250 PYPGVKIDE--------EFCRRLKEGTRMRA-------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             SSTTCCCSH--------HHHHHHHHTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccchhH--------HHHHHhccCccCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            986432211        11111111111110             003445688999999999999999999999999998


Q ss_pred             HHh
Q 018633          350 YRS  352 (353)
Q Consensus       350 ~~~  352 (353)
                      .++
T Consensus       309 ~~~  311 (316)
T 2xir_A          309 LQA  311 (316)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.4e-47  Score=352.30  Aligned_cols=250  Identities=18%  Similarity=0.260  Sum_probs=202.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..... .....+.+.+|+.+++.++|||||++++++.+.+..
T Consensus        14 ~~~y~i~~~LG~G~fG---~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             GGGEEEEEEEECCTTC---CEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3578899999999999   9999988  788999999864421 223456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a  162 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIA  162 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEecccee
Confidence            9999999999999999765     46899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCcccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRT---GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      +......  ......||+.|+|||++..   ..++.++|||||||++|||++|..||.......     ......... .
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~~-~  234 (384)
T 4fr4_A          163 AMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVHTFE-T  234 (384)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHHHHH-H
T ss_pred             eeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHh-h
Confidence            8764332  2456789999999999864   458999999999999999999999997432211     111111111 1


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-HHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-MVDVA  343 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~vl  343 (353)
                      ... .         .    +...+..+.+|+.+||+.||++||+ +.+++
T Consensus       235 ~~~-~---------~----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          235 TVV-T---------Y----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             CCC-C---------C----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             ccc-C---------C----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            100 0         0    0134567889999999999999998 66654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-46  Score=348.96  Aligned_cols=268  Identities=14%  Similarity=0.114  Sum_probs=204.1

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-C------CeEEEEEEecCCCCChhHH-----------HHHHHHHHHHhhcCC
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-Q------ERLISVLQFYGHECRPRAY-----------ESCINNVTYAARMSH  121 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-~------~~~vavK~~~~~~~~~~~~-----------~~~~~E~~~l~~l~H  121 (353)
                      ..++|...+.||+|+||   .||+|.+ .      ++.||+|++....  ....           ..+..|+..+..++|
T Consensus        33 ~~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h  107 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFG---CIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKY  107 (364)
T ss_dssp             TCCEEEEEEECCCC-CC---EEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred             CCCeEEEEEEEecCCCe---EEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence            34579999999999999   9999988 2      4789999987652  1111           224456667778889


Q ss_pred             CceeeccceeeeC----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccC
Q 018633          122 NHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK  197 (353)
Q Consensus       122 ~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  197 (353)
                      |||+++++++...    ...++||||+ +++|.+++....    ..+++..++.++.||+.||.|||   +++|+|||||
T Consensus       108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlk  179 (364)
T 3op5_A          108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIK  179 (364)
T ss_dssp             CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred             CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCC
Confidence            9999999998765    4589999999 899999997753    46899999999999999999999   8999999999


Q ss_pred             CCceeec--CCCceEEeccCCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCC
Q 018633          198 TSCILFN--EENVAKLFDFSLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD  269 (353)
Q Consensus       198 p~Nill~--~~~~~kl~dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~  269 (353)
                      |+|||++  .++.+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus       180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~  259 (364)
T 3op5_A          180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL  259 (364)
T ss_dssp             GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999  8899999999999776432211      1134459999999999999889999999999999999999999


Q ss_pred             CCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          270 VSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       270 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ||.......    .......... ...+..+.++.+..       ...+..+.+++..||+.||++|||+.++++.|+++
T Consensus       260 Pf~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          260 PWEDNLKDP----KYVRDSKIRY-RENIASLMDKCFPA-------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             TTGGGTTCH----HHHHHHHHHH-HHCHHHHHHHHSCT-------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CccccccCH----HHHHHHHHHh-hhhHHHHHHHhccc-------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            997432211    0000000000 01111111111100       13367789999999999999999999999999998


Q ss_pred             HHh
Q 018633          350 YRS  352 (353)
Q Consensus       350 ~~~  352 (353)
                      .+.
T Consensus       328 ~~~  330 (364)
T 3op5_A          328 LKA  330 (364)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            865

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.6e-47  Score=339.72  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=202.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CC-------eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeecccee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QE-------RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCC  131 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~  131 (353)
                      .++|...+.||+|+||   .||+|.+  ++       ..||+|.+...  .....+.+.+|+.++++++||||+++++++
T Consensus         7 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFT---KIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             GGGEEEEEEEEEETTE---EEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             hhHeeeeeeeccCCCc---eEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            3568888999999999   9999987  23       57999998765  456678899999999999999999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc---
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---  208 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---  208 (353)
                      .+.+..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.   
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~  154 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKT  154 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGG
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccc
Confidence            99999999999999999999998753    35899999999999999999999   999999999999999998876   


Q ss_pred             -----eEEeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          209 -----AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       209 -----~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                           +||+|||++.....     .....||..|+|||++.+ ..++.++||||||+++|+|++|..|+.....      
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~------  223 (289)
T 4fvq_A          155 GNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD------  223 (289)
T ss_dssp             TBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------
T ss_pred             cccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc------
Confidence                 99999999865422     233457889999999987 6689999999999999999996655432211      


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                       ..............+.                ..+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       224 -~~~~~~~~~~~~~~~~----------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          224 -SQRKLQFYEDRHQLPA----------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             -HHHHHHHHHTTCCCCC----------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             -hHHHHHHhhccCCCCC----------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             1111111111111111                123456789999999999999999999999988754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-47  Score=350.43  Aligned_cols=251  Identities=20%  Similarity=0.266  Sum_probs=203.4

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeee
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLE  133 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~  133 (353)
                      ....++|...+.||+|+||   .||++.+  +++.||+|++..... .....+.+..|..++..+ +||||+++++++.+
T Consensus        13 ~~~~~~y~~~~~lG~G~fg---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   89 (345)
T ss_dssp             ---CTTEEEEEEEEECSSS---EEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCChHHeEEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            3556789999999999999   9999998  789999999965411 123456688899999987 89999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~D  161 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIAD  161 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeE
Confidence            99999999999999999999764     35889999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....        .........
T Consensus       162 FG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~  232 (345)
T 1xjd_A          162 FGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRM  232 (345)
T ss_dssp             CTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred             ChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHh
Confidence            99997653322 224567899999999999998999999999999999999999999974321        111111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV-DVA  343 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~vl  343 (353)
                       ... .         .+    ...+..+.+|+.+||..||++||++. +++
T Consensus       233 -~~~-~---------~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          233 -DNP-F---------YP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -CCC-C---------CC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -CCC-C---------CC----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence             100 0         00    13456778999999999999999986 554

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-45  Score=352.99  Aligned_cols=267  Identities=18%  Similarity=0.227  Sum_probs=199.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC---
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP---  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---  135 (353)
                      .++|...+.||+|+||   .||++.+  +++.||||++..........+.+.+|+.+++.++|||||++++++....   
T Consensus        61 ~~~y~~~~~lG~G~~g---~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQG---IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             ETTEEEEEEEEECSSC---EEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             cCCeEEEEEeecCCCe---EEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence            4678889999999999   9999988  7999999999766545667788999999999999999999999997553   


Q ss_pred             ---ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          136 ---IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       136 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                         ..|+||||++ ++|.+.+..       .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       138 ~~~~~~lv~E~~~-~~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          138 EFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             cCCeEEEEEeCCC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEE
Confidence               4699999997 467776642       4788999999999999999999   8999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSN  285 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~  285 (353)
                      |||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........       ...+..
T Consensus       207 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          207 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             CCCCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEEeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            999998764322  23456899999999999999999999999999999999999999975432110       000111


Q ss_pred             HH-------HHHHhhcC-c-----ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EY-------LKNYFEDN-R-----FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~-------~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+       ...+.... .     ++......+... ........+..+.+|+.+||..||++|||+.++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA-DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCC-SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCccccccc-ccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11       11111100 0     000000000000 01112234678899999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5e-47  Score=351.98  Aligned_cols=252  Identities=18%  Similarity=0.220  Sum_probs=193.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..++|...+.||+|+||   .||++..  +++.||+|++....   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        18 ~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFG---VARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTS---SEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcEEEEEEeccCCCE---EEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            34679999999999999   9999998  78999999997652   2336688999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc--eEEeccC
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV--AKLFDFS  215 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--~kl~dfg  215 (353)
                      ++||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.  +||+|||
T Consensus        92 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             EEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            9999999999999998754     35899999999999999999999   999999999999999987765  9999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCcc-ccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEK-SDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      +++......  ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......    ............
T Consensus       164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~  237 (361)
T 3uc3_A          164 YSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQRILSV  237 (361)
T ss_dssp             CC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHHHHTT
T ss_pred             ccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHHHhcC
Confidence            987542222  2345579999999999988887655 899999999999999999997543322    111111111111


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       ..            ........+..+.+|+.+||..||++|||+.++++
T Consensus       238 -~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          238 -KY------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -CC------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -CC------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence             00            00000023456789999999999999999999976

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-46  Score=337.65  Aligned_cols=259  Identities=20%  Similarity=0.303  Sum_probs=203.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee-eCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL-ETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~-~~~  135 (353)
                      ..|...+.||+|+||   .||+|.+     ....||+|.+.... .....+.+.+|+.++++++||||+++++++. .++
T Consensus        25 ~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFG---CVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTE---EEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCc---eEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            457778999999999   9999986     22368999987642 4556788999999999999999999999865 456


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             ceEEEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccc
Confidence            7899999999999999997644    45789999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCC---ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhC-CCCCCccccccCCCCChHHHHHHH
Q 018633          216 LSISIPEGET---HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG-WDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       216 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      +++.......   .......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||.......        .....
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~  245 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYL  245 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------HHHHH
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHH
Confidence            9976643221   112344677889999999988999999999999999999995 45554322211        11111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                      ..... ..  .           +...+..+.+++.+||+.||++|||+.++++.|+++...+
T Consensus       246 ~~~~~-~~--~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          246 LQGRR-LL--Q-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HTTCC-CC--C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             hcCCC-CC--C-----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11100 00  0           0134456889999999999999999999999999998753

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.6e-46  Score=336.31  Aligned_cols=263  Identities=16%  Similarity=0.159  Sum_probs=208.4

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeecccee-eeCCc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCC-LETPI  136 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~-~~~~~  136 (353)
                      ..++|...+.||+|+||   .||+|.+  +++.||+|++....    ..+.+.+|+.+++.++|++++..++++ ...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFG---DIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ETTTEEEEEEEEEETTE---EEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             eccEEEEEEEEccCCCe---EEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            35679999999999999   9999997  89999999986552    224688999999999999877777666 45667


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee---cCCCceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~d  213 (353)
                      .++||||+ +++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||+   +.++.+||+|
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             eEEEEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence            89999999 899999997543    46899999999999999999999   9999999999999999   4788999999


Q ss_pred             cCCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          214 FSLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       214 fg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      ||++.........      ......||..|+|||++.+..++.++||||||+++|+|++|..||.........  .....
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~  229 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYER  229 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHH
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--hhhhh
Confidence            9999876543321      124567999999999999989999999999999999999999999854332210  00000


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ...            ...... ........+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       230 ~~~------------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          230 ISE------------KKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHH------------HHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hcc------------cccCCc-hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            000            000000 0000113457789999999999999999999999999998765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=344.01  Aligned_cols=258  Identities=21%  Similarity=0.297  Sum_probs=202.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeC------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQ------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +.|...+.||+|+||   .||+|.+.      +..||+|.+.... .......+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFG---EVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             TTEEEEEEEEECSSS---EEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHhhcccEEecCCCe---EEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            345557899999999   99999872      2459999997653 4455678999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCC
Confidence            9999999999999999997653    46899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          216 LSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       216 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      +++........  ......+|..|+|||++.+..++.++||||||+++|||++ |..||.....        ........
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~  264 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAIN  264 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHH
Confidence            99876433211  1223346778999999998899999999999999999999 9999863221        11111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .....+.              +...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       265 ~~~~~~~--------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          265 DGFRLPT--------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             TTCCCCC--------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCcCCC--------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1111100              013456788999999999999999999999999998753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.3e-45  Score=336.84  Aligned_cols=276  Identities=18%  Similarity=0.266  Sum_probs=213.7

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhh--cCCCceeeccc
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAAR--MSHNHILKLIG  129 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~~~~  129 (353)
                      .+..--....++|...+.||+|+||   .||+|.++++.||+|++...     ....+.+|++++..  ++||||+++++
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~  103 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFG---EVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIA  103 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTE---EEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred             CceeecccccccEEEEeeecCCCCc---EEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence            3444444566789999999999999   99999999999999998543     45678889999988  78999999999


Q ss_pred             eeeeCC----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC-----CCCeEeeccCCCc
Q 018633          130 CCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF-----PRPIVFRNFKTSC  200 (353)
Q Consensus       130 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~dlkp~N  200 (353)
                      ++...+    ..++||||+++|+|.+++...      .+++..++.++.|++.||.|||+..     +++|+||||||+|
T Consensus       104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~N  177 (342)
T 1b6c_B          104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN  177 (342)
T ss_dssp             EEECCCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGG
T ss_pred             eecccCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHH
Confidence            998775    789999999999999999753      5889999999999999999999321     4689999999999


Q ss_pred             eeecCCCceEEeccCCccccCCCCCc---cccccccCCccccccccccC------CCCccccchhhHHHHHHHHhC----
Q 018633          201 ILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTWGYCAPEYMRTG------VFNEKSDVFSFGVFLFELLTG----  267 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~tg----  267 (353)
                      ||++.++.+||+|||++.........   ......||+.|+|||++.+.      .++.++||||||+++|||+||    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            99999999999999999776443322   12455789999999998765      244789999999999999999    


Q ss_pred             ------CCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 018633          268 ------WDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVD  341 (353)
Q Consensus       268 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  341 (353)
                            ..||.......    .....+............+....       .....+..+.+|+.+||+.||++|||+.+
T Consensus       258 ~~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSD----PSVEEMRKVVCEQKLRPNIPNRW-------QSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             TBCCCCCCTTTTTSCSS----CCHHHHHHHHTTSCCCCCCCGGG-------GTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CcccccccCccccCcCc----ccHHHHHHHHHHHHhCCCCcccc-------cchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence                  56665332211    11122222221111111111111       11156778999999999999999999999


Q ss_pred             HHHHHHHHHHh
Q 018633          342 VAKKLRQIYRS  352 (353)
Q Consensus       342 vl~~L~~l~~~  352 (353)
                      +++.|+++.+.
T Consensus       327 i~~~L~~i~~~  337 (342)
T 1b6c_B          327 IKKTLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHHHHHHHH
Confidence            99999999764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=360.83  Aligned_cols=264  Identities=16%  Similarity=0.172  Sum_probs=209.2

Q ss_pred             ecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeecc
Q 018633           52 FSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLI  128 (353)
Q Consensus        52 ~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~  128 (353)
                      +.++++....++|...++||+|+||   .||++..  +++.||+|++..... .....+.+.+|..++..++||||++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG---~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  127 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFS---EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH  127 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            3455666667899999999999999   9999998  789999999965311 122334588999999999999999999


Q ss_pred             ceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc
Q 018633          129 GCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV  208 (353)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  208 (353)
                      +++.+.+..|+||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.
T Consensus       128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          128 FAFQDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred             EEEeeCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCC
Confidence            99999999999999999999999997643    36899999999999999999999   999999999999999999999


Q ss_pred             eEEeccCCccccCCCCCccccccccCCccccccccc-------cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCC
Q 018633          209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR-------TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA  281 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~  281 (353)
                      +||+|||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|..||.....     
T Consensus       201 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----  275 (412)
T 2vd5_A          201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----  275 (412)
T ss_dssp             EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----
T ss_pred             EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----
Confidence            999999999877554433344568999999999987       35689999999999999999999999974321     


Q ss_pred             CChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCC---CCHHHHHH
Q 018633          282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR---PSMVDVAK  344 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~~vl~  344 (353)
                         .+..........         .... +......+..+.+|+.+||. +|.+|   |++.++++
T Consensus       276 ---~~~~~~i~~~~~---------~~~~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          276 ---AETYGKIVHYKE---------HLSL-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ---HHHHHHHHTHHH---------HCCC-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ---HHHHHHHHhccc---------CcCC-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence               111111111000         0000 00111456678899999999 99998   58888764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.6e-47  Score=348.76  Aligned_cols=246  Identities=15%  Similarity=0.205  Sum_probs=204.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        40 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGGEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEeecCcCc---EEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            4679999999999999   9999998  789999999865421 123456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       117 ~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a  188 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccc
Confidence            9999999999999999764     35889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      +.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||.....        ......... ...
T Consensus       189 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~~  255 (350)
T 1rdq_E          189 KRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVS-GKV  255 (350)
T ss_dssp             EECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC
T ss_pred             eeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHc-CCC
Confidence            876432    3356799999999999998999999999999999999999999973221        111111111 111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                      .          .+    ...+..+.+++.+||+.||.+||+     +.++++
T Consensus       256 ~----------~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 R----------FP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C----------CC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C----------CC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            0          00    134567889999999999999998     777754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.6e-47  Score=347.17  Aligned_cols=267  Identities=16%  Similarity=0.260  Sum_probs=212.1

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CC-----eEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccc
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QE-----RLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIG  129 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~  129 (353)
                      ....++|...+.||+|+||   .||+|.+  .+     ..||+|.+.... .....+.+.+|+.++.++ +||||+++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFG---KVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSE---EEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCHHHceeeeEeccCCCc---ceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3445788889999999999   9999987  22     479999997653 445667899999999999 8999999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCC---------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCc
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQP---------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC  200 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  200 (353)
                      ++.+.+..++||||+++|+|.+++......         ....+++..++.++.|++.||.|||   +++|+||||||+|
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N  194 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARN  194 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccce
Confidence            999999999999999999999998753100         0035789999999999999999999   8999999999999


Q ss_pred             eeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCcccccc
Q 018633          201 ILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTH  278 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~  278 (353)
                      ||++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|+| |..||.......
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            9999999999999999976543322 22334567889999999998899999999999999999999 888987432211


Q ss_pred             CCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                              .............         .    +...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       275 --------~~~~~~~~~~~~~---------~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          275 --------KFYKLVKDGYQMA---------Q----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             --------HHHHHHHHTCCCC---------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------HHHHHHhcCCCCC---------C----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                    1111111111000         0    002345678999999999999999999999999988653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-45  Score=338.87  Aligned_cols=263  Identities=18%  Similarity=0.292  Sum_probs=211.8

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe---------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW---------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIG  129 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~  129 (353)
                      ..++|...+.||+|+||   .||+|.+         ++..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus        33 ~~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFG---QVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             CGGGEEEEEEEEECSSC---EEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CHhHeEEeeEEeecCce---eEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            34678899999999999   9999986         35689999997653 455677899999999999 8999999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCC-----------CccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCC
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPH-----------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT  198 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  198 (353)
                      ++.+.+..++||||+++|+|.+++.......           ...+++..++.++.|++.||.|||   +++|+||||||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp  185 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA  185 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCcc
Confidence            9999999999999999999999998654210           124889999999999999999999   89999999999


Q ss_pred             CceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCcccc
Q 018633          199 SCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKD  276 (353)
Q Consensus       199 ~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~  276 (353)
                      +|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... 
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-  264 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-  264 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-
Confidence            9999999999999999999876543321 1233456788999999988889999999999999999999 999986322 


Q ss_pred             ccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                             ..+....... ......             +..++..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       265 -------~~~~~~~~~~-~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          265 -------VEELFKLLKE-GHRMDK-------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             -------HHHHHHHHHH-TCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHHHHhc-CCCCCC-------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                   1122211111 111000             01345678899999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-46  Score=340.88  Aligned_cols=265  Identities=18%  Similarity=0.262  Sum_probs=202.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++..  ++..||+|++.... ......+.+.+|+.++++++||||+++++++...+..
T Consensus        31 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFS---EVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             GGGEEEEEEEECC--C---EEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ccceEEEEeecCCCCc---eEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            4578999999999999   9999997  78999999997532 2455678899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++...... ...+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             EEEEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            9999999999999988642110 045889999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||......      ..... .......+
T Consensus       184 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~  255 (310)
T 2wqm_A          184 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLC-KKIEQCDY  255 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHH-HHHHTTCS
T ss_pred             eeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHH-HHhhcccC
Confidence            76543222 233457899999999999889999999999999999999999998632211      11111 11111111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .....            ...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       256 ~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          256 PPLPS------------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             CCCCT------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcc------------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            11110            13456788999999999999999999999999998754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.3e-47  Score=337.49  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=200.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC-CccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET-PIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~l  139 (353)
                      .++|...+.||+|+||   .||++.++++.||+|++...    ...+.+.+|+.++++++||||+++++++.+. +..++
T Consensus        20 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFG---DVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSC---EEEEEEETTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             hhhceEEeEEecCCCc---eEEEEEEcCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            4678899999999999   99999999999999998755    2457799999999999999999999997654 57899


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++.....   ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence            9999999999999975421   23788999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....    .....++..|+|||++.+..++.++||||||+++|+|+| |..||.......        ...... .....
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~-~~~~~  233 (278)
T 1byg_A          167 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVE-KGYKM  233 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHT-TTCCC
T ss_pred             cccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHh-cCCCC
Confidence            5332    223457889999999998899999999999999999998 999987432211        111111 11000


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .         .    +...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       234 ~---------~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          234 D---------A----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             C---------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C---------C----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            0         0    014456788999999999999999999999999998753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=366.68  Aligned_cols=250  Identities=21%  Similarity=0.334  Sum_probs=200.8

Q ss_pred             ceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEec
Q 018633           69 VIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESV  144 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  144 (353)
                      .||+|+||   .||+|.+    ++..||||++.... .....+.|.+|+.+|++++|||||+++++|.. +..++||||+
T Consensus       343 ~LG~G~fG---~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~  417 (613)
T 2ozo_A          343 ELGCGNFG---SVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA  417 (613)
T ss_dssp             EEEECSSS---EEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             EEecCCCc---EEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeC
Confidence            69999999   9999977    45679999997652 34467889999999999999999999999976 5689999999


Q ss_pred             cCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCC
Q 018633          145 QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE  224 (353)
Q Consensus       145 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~  224 (353)
                      ++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       418 ~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          418 GGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             TTCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             CCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999999997653    46899999999999999999999   8999999999999999999999999999998764332


Q ss_pred             Ccc--ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccccc
Q 018633          225 THI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIV  301 (353)
Q Consensus       225 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
                      ...  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||......        +.. .....+..... 
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~-~~i~~~~~~~~-  560 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVM-AFIEQGKRMEC-  560 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHH-HHHHTTCCCCC-
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHH-HHHHcCCCCCC-
Confidence            211  223345688999999998999999999999999999998 99998743221        111 11111111110 


Q ss_pred             cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          302 DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                                  +..++..+.+|+.+||+.||++|||+.+|++.|+.++.+
T Consensus       561 ------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          561 ------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ------------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                        114567788999999999999999999999999998764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.7e-46  Score=342.00  Aligned_cols=264  Identities=21%  Similarity=0.204  Sum_probs=203.3

Q ss_pred             HHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC---CChhHHHHHHHHHHHHhhcCCCceeeccce
Q 018633           56 EIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE---CRPRAYESCINNVTYAARMSHNHILKLIGC  130 (353)
Q Consensus        56 e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~~~~~  130 (353)
                      ++....++|...+.||+|+||   .||++.+  ++..||+|++....   ......+.+.+|+.++++++||||++++++
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   96 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYG---VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV   96 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhheeecceeeecCCe---EEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence            345677889999999999999   9999988  78899999986431   134556789999999999999999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCC-----------------------------------CCccccHHHHHHHHHH
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQP-----------------------------------HFEPLLLKHRLKIAMD  175 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~  175 (353)
                      +.+.+..++||||+++|+|.+++......                                   ....+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            99999999999999999999988521000                                   0024567788899999


Q ss_pred             HHHHHHHHhcCCCCCeEeeccCCCceeecCCC--ceEEeccCCccccCCCC---CccccccccCCcccccccccc--CCC
Q 018633          176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEEN--VAKLFDFSLSISIPEGE---THITDTVMGTWGYCAPEYMRT--GVF  248 (353)
Q Consensus       176 i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~--~~kl~dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~  248 (353)
                      ++.||.|||   +++|+||||||+|||++.++  .+||+|||++.......   ........||+.|+|||++.+  ..+
T Consensus       177 i~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          177 IFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            999999999   89999999999999998766  89999999998653321   112345679999999999875  568


Q ss_pred             CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHc
Q 018633          249 NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFEC  328 (353)
Q Consensus       249 ~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  328 (353)
                      +.++||||||+++|||++|..||.....        ..............  ..+         .....+..+.+|+.+|
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~--~~~---------~~~~~~~~~~~li~~~  314 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCF--ENP---------NYNVLSPLARDLLSNL  314 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCT--TSG---------GGGGSCHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhccccc--CCc---------ccccCCHHHHHHHHHH
Confidence            9999999999999999999999974322        12222222211100  000         0013456788999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 018633          329 IKDSPADRPSMVDVAK  344 (353)
Q Consensus       329 l~~dP~~Rps~~~vl~  344 (353)
                      |+.||.+|||+.++++
T Consensus       315 l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          315 LNRNVDERFDAMRALQ  330 (345)
T ss_dssp             SCSCTTTSCCHHHHHH
T ss_pred             cCCChhHCCCHHHHhc
Confidence            9999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-46  Score=358.38  Aligned_cols=248  Identities=22%  Similarity=0.274  Sum_probs=204.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        15 ~~~Y~l~~~LG~G~fg---~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           15 IGHYILGDTLGVGTFG---KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             ETTEEEEEEEECCSSS---CEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ecCEEEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3678899999999999   9999998  799999999965411 112356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        92 ~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a  163 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS  163 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccch
Confidence            9999999999999999764     46899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .......  .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....        ........ ...
T Consensus       164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~-~~~  232 (476)
T 2y94_A          164 NMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKIC-DGI  232 (476)
T ss_dssp             EECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHH-TTC
T ss_pred             hhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHh-cCC
Confidence            8765432  2345679999999999988765 6899999999999999999999974321        11111111 111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.          .    +...+..+.+|+.+||..||++|||+.++++
T Consensus       233 ~~----------~----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 FY----------T----PQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CC----------C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cC----------C----CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            10          0    0023456789999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-46  Score=341.73  Aligned_cols=260  Identities=20%  Similarity=0.282  Sum_probs=199.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..... .......+.+|+.++.+++||||+++++++......
T Consensus        11 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A           11 SDRYELGEILGFGGMS---EVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             TTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             cCcEEEEEEEccCCCE---EEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            4679999999999999   9999997  889999999976532 345567899999999999999999999998866544


Q ss_pred             ----EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          138 ----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       138 ----~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                          |+||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECC
T ss_pred             CcccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEee
Confidence                9999999999999999764     35889999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCC--ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          214 FSLSISIPEGET--HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       214 fg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ||++........  .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....        .......
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~  231 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQH  231 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHH
Confidence            999977644322  122345689999999999998999999999999999999999999974322        1111111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHH-HHHHHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV-DVAKKLRQIY  350 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~vl~~L~~l~  350 (353)
                      .......           ........+..+.+++.+||+.||++||++. ++...|.++.
T Consensus       232 ~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          232 VREDPIP-----------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHCCCCC-----------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             hcCCCCC-----------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            1111100           0000113566788999999999999999654 4555555543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.1e-46  Score=339.36  Aligned_cols=263  Identities=22%  Similarity=0.337  Sum_probs=207.7

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--C
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--P  135 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--~  135 (353)
                      |...+.||+|+||   .||++.+      +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.  .
T Consensus        33 ~~~~~~lG~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           33 LKKIRDLGEGHFG---KVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             EEEEEEEEECSSE---EEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             HhhhheecCCCCe---EEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            4888999999999   8877754      68899999997652 456678899999999999999999999999874  5


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++|+|.+++...      .+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             eEEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcc
Confidence            689999999999999999764      4789999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccC--CCCChH----HH
Q 018633          216 LSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD--LACPSN----EY  287 (353)
Q Consensus       216 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~--~~~~~~----~~  287 (353)
                      ++.........  ......+|..|+|||++.+..++.++||||||+++|+|++|..||........  ......    ..
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  259 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR  259 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred             ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence            99877543321  22345678889999999988899999999999999999999999864321100  000000    00


Q ss_pred             HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ..........             ...+..++..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus       260 ~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          260 LTELLERGER-------------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHHHHTTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcccC-------------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            0011111100             000114567789999999999999999999999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=337.78  Aligned_cols=269  Identities=18%  Similarity=0.251  Sum_probs=201.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||++.+  +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         3 ~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            3 EKYEKIGKIGEGSYG---VVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             CCEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEeeEEeecCCe---EEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence            568889999999999   9999998  68999999997765556667889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++++|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++..
T Consensus        80 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             EEECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            99999999998887654     45889999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHHHHH
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYLKNY  291 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~~  291 (353)
                      ...... ......||..|+|||++.+ ..++.++||||||+++|+|++|..||.........       ...... ....
T Consensus       152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  229 (311)
T 4agu_A          152 LTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR-HQQV  229 (311)
T ss_dssp             CC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH-HHHH
T ss_pred             ccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc-cccc
Confidence            643322 2345578999999999876 56899999999999999999999999754322100       000000 0111


Q ss_pred             hhcCcccc---cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNRFTE---IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.......   ..++....... ......+..+.+|+.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLE-LKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHH-HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcCCCccccchhh-hhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            11110000   00000000000 000145567889999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.5e-46  Score=337.30  Aligned_cols=262  Identities=16%  Similarity=0.177  Sum_probs=201.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||+|++..... .....+.+.+|+.++.+++||||+++++++..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMG---DVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ---CCEEEEEEEEECSSS---EEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             cEeccEEEEEEEcCCCCe---eEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            345789999999999999   9999998  789999999875532 3344578999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             eEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCc
Confidence            999999999999999999764     35889999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ++...............||..|+|||++.+..++.++||||||+++|+|++|..||.....         ..........
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~  250 (309)
T 2h34_A          180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQA  250 (309)
T ss_dssp             C----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSC
T ss_pred             cCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccC
Confidence            9877654433334456789999999999988899999999999999999999999874221         1111111111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-SMVDVAKKLRQIYR  351 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~vl~~L~~l~~  351 (353)
                       ...   ..       ..+...+..+.+++.+||+.||++|| |+.++++.|+++..
T Consensus       251 -~~~---~~-------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          251 -IPR---PS-------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             -CCC---GG-------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             -CCC---cc-------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence             000   00       00113455788999999999999999 99999999987643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=345.19  Aligned_cols=257  Identities=19%  Similarity=0.336  Sum_probs=200.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeE----EEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERL----ISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .++|...+.||+|+||   .||+|.+  +++.    ||+|.+.... .....+.+.+|+.++++++||||+++++++...
T Consensus        14 ~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFG---TVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             TTTEEEEEEEEECSSE---EEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             HhHceEEEEeeeCCCe---EEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            3579999999999999   9999997  4544    5777775442 445667899999999999999999999999865


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      . .++|+||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~Df  161 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             C-ceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccC
Confidence            4 789999999999999998754    46899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          215 SLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       215 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |+++........ ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.......        .. ...
T Consensus       162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~-~~~  232 (327)
T 3lzb_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------IS-SIL  232 (327)
T ss_dssp             TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HH-HHH
T ss_pred             cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HH-HHH
Confidence            999876433221 1233456788999999999999999999999999999999 999987433221        11 111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ........             +...+..+.+++.+||+.||.+|||+.++++.|.++..
T Consensus       233 ~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          233 EKGERLPQ-------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HTTCCCCC-------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HcCCCCCC-------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11110000             01345568899999999999999999999999998864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-46  Score=348.07  Aligned_cols=247  Identities=20%  Similarity=0.288  Sum_probs=201.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .+.|...+.||+|+||   .||+|..  +++.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        53 ~~~y~~~~~lG~G~~g---~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFG---AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             HHHEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhheeeeeEEccCCCE---EEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence            3458888999999999   9999997  899999999975432 344557899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||++ |+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  201 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA  201 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             EEEEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCc
Confidence            99999997 78888886443    46899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .....     .....||+.|+|||++.   ...++.++|||||||++|||++|..||.....        ..........
T Consensus       202 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~~  268 (348)
T 1u5q_A          202 SIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQN  268 (348)
T ss_dssp             BSSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS
T ss_pred             eecCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhc
Confidence            76532     23457899999999985   46789999999999999999999999864321        1112222211


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      . .+....            ...+..+.+|+.+||+.||++|||+.++++
T Consensus       269 ~-~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          269 E-SPALQS------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             C-CCCCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C-CCCCCC------------CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            1 111100            134556789999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.9e-46  Score=342.19  Aligned_cols=266  Identities=22%  Similarity=0.281  Sum_probs=210.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee--e
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL--E  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~--~  133 (353)
                      ++|...+.||+|+||   .||++.+      ++..||+|++...  .....+.+.+|+.++++++||||+++++++.  +
T Consensus        23 ~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           23 RHLKYISQLGKGNFG---SVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGEEEEEEEEEETTE---EEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhccCCCCe---EEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            578889999999999   9999983      7889999999876  5667788999999999999999999999986  4


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~D  170 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIAD  170 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcc
Confidence            556899999999999999997643    46899999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc------CCCCChH
Q 018633          214 FSLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH------DLACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~------~~~~~~~  285 (353)
                      ||++.........  ......||..|+|||++.+..++.++||||||+++|+|++|..||.......      ....+..
T Consensus       171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3lxl_A          171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL  250 (327)
T ss_dssp             GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred             cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence            9999876543321  2234567888999999998889999999999999999999999986432210      0000011


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ............             ...+..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus       251 ~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          251 SRLLELLEEGQR-------------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHHHTTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHHHHhhcccC-------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            111111111100             000114567788999999999999999999999999987653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.3e-46  Score=339.70  Aligned_cols=267  Identities=19%  Similarity=0.227  Sum_probs=190.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus         4 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYA---TVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------C---EEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCE---EEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            3568999999999999   9999988  68999999997553 2334467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCC-CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          139 LVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      +||||++ |+|.+++..... .....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999998 699998864321 11135889999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc-C
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED-N  295 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  295 (353)
                      +....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......        ........ +
T Consensus       156 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~  226 (317)
T 2pmi_A          156 RAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--------QLKLIFDIMG  226 (317)
T ss_dssp             EETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHC
T ss_pred             eecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHhC
Confidence            87643222 23455789999999999764 58999999999999999999999997433211        11111100 0


Q ss_pred             c-----c------ccc---ccc----hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 R-----F------TEI---VDP----IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~-----~------~~~---~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .     +      ...   +..    .+.....+......+..+.+|+.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0     0      000   000    00000000000124567889999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4e-46  Score=333.10  Aligned_cols=250  Identities=20%  Similarity=0.280  Sum_probs=204.5

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..+.|...+.||+|+||   .||+|.+  ++..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         7 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWG---EVKIAVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeeEEeecCCE---EEEEEEeCCCCcEEEEEeehhh--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            45679999999999999   9999998  6778999998765  334567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee---cCCCceEEecc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDF  214 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~df  214 (353)
                      ++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||+   +.++.++|+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Df  153 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDF  153 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence            9999999999999988764     35889999999999999999999   9999999999999999   78899999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      |++.......  ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.....        ......... 
T Consensus       154 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~-  221 (277)
T 3f3z_A          154 GLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIRE-  221 (277)
T ss_dssp             TTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-
T ss_pred             ccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh-
Confidence            9998764432  2345678999999999865 489999999999999999999999874321        111111111 


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....          .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          222 GTFT----------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCCC----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCC----------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1110          000111134567889999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.8e-46  Score=338.92  Aligned_cols=253  Identities=19%  Similarity=0.228  Sum_probs=207.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh----hHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP----RAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ..+.|...+.||+|+||   .||++.+  ++..||+|++.......    ...+.+.+|+.++++++||||+++++++.+
T Consensus        10 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFA---IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             HHHHEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhccEEEeeEeeecCCE---EEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            45678999999999999   9999998  68999999997653221    246789999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC----ce
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN----VA  209 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~  209 (353)
                      .+..++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++    .+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~  158 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHI  158 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCE
Confidence            99999999999999999999764     46899999999999999999999   89999999999999999887    79


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      +|+|||++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....        .....
T Consensus       159 kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~  228 (321)
T 2a2a_A          159 KLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA  228 (321)
T ss_dssp             EECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH
T ss_pred             EEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHH
Confidence            9999999987654322  3455789999999999988999999999999999999999999864221        11111


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .... ...          ..+.......+..+.+++.+||..||++|||+.++++
T Consensus       229 ~i~~-~~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          229 NITS-VSY----------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHT-TCC----------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHh-ccc----------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111 100          0011111144567889999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2e-46  Score=347.72  Aligned_cols=278  Identities=19%  Similarity=0.209  Sum_probs=212.8

Q ss_pred             cceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-----C
Q 018633           49 YRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-----H  121 (353)
Q Consensus        49 ~~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----H  121 (353)
                      ...+++++-....++|...+.||+|+||   .||++.+  +++.||||++...   ....+.+..|+.+++.++     |
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h   95 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFG---RVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINN   95 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCe---EEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCC
Confidence            4456666666778899999999999999   9999999  8899999999753   455677888999999997     9


Q ss_pred             CceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCce
Q 018633          122 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI  201 (353)
Q Consensus       122 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  201 (353)
                      |||+++++++...+..++||||+ +++|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+||
T Consensus        96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI  168 (360)
T 3llt_A           96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENI  168 (360)
T ss_dssp             GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred             CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccE
Confidence            99999999999999999999999 8999999986543   35889999999999999999999   99999999999999


Q ss_pred             eecC-------------------------CCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchh
Q 018633          202 LFNE-------------------------ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFS  256 (353)
Q Consensus       202 ll~~-------------------------~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  256 (353)
                      |++.                         ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHH
Confidence            9975                         788999999999765332    23567899999999999999999999999


Q ss_pred             hHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHHhhcCcccccccch-----hhhc------------cchH
Q 018633          257 FGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNYFEDNRFTEIVDPI-----IVED------------VLSI  312 (353)
Q Consensus       257 lG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~------------~~~~  312 (353)
                      |||++|+|++|..||........       .............. .......+..     ....            ..+.
T Consensus       245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  323 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK-TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL  323 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTT-SGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhh-ccCccccCcccceecCcccccchhhhhhhhhcccc
Confidence            99999999999999975332110       00001111111100 0000000000     0000            0000


Q ss_pred             HHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          313 EKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       313 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........+.+|+.+||+.||++|||+.++++
T Consensus       324 ~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            11122367889999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=343.33  Aligned_cols=251  Identities=22%  Similarity=0.329  Sum_probs=189.3

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...+.|...+.||+|+||   .||+|.+  +++.||+|++...    ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        50 ~~~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATS---IVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             CGGGTEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCcEEEeeEEeeCCCE---EEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            345779999999999999   9999999  6789999999755    234678899999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---CCceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---ENVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~d  213 (353)
                      .++||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.   ++.+||+|
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEcc
Confidence            99999999999999998764     45889999999999999999999   899999999999999975   88999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|..||......        ........
T Consensus       195 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~i~  264 (349)
T 2w4o_A          195 FGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--------QFMFRRIL  264 (349)
T ss_dssp             CC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--------HHHHHHHH
T ss_pred             CccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--------HHHHHHHH
Confidence            99997654322  234567899999999999889999999999999999999999998633221        11111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... ...+.         ....+..+.+|+.+||..||++|||+.++++
T Consensus       265 ~~~~~-~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          265 NCEYY-FISPW---------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTCCC-CCTTT---------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCCc-cCCch---------hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11110 00000         0134567889999999999999999999886

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.8e-46  Score=367.87  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=202.6

Q ss_pred             CceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||+|.+    .+..||||++..........+.|.+|+.+|++++|||||+++++|. .+..++||||
T Consensus       375 ~~LG~G~fG---~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~  450 (635)
T 4fl3_A          375 KELGSGNFG---TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEM  450 (635)
T ss_dssp             EEEEECSSE---EEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEEC
T ss_pred             CEeccCCCE---EEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEc
Confidence            369999999   9999966    4678999999876445566788999999999999999999999986 4568899999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      +++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       451 ~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          451 AELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             CTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             cCCCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            9999999999765     46889999999999999999999   899999999999999999999999999999876543


Q ss_pred             CC--ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          224 ET--HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       224 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..  .......+|..|+|||++.+..++.++|||||||++|||++ |..||......        + +............
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~-~~~~i~~~~~~~~  593 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------E-VTAMLEKGERMGC  593 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------H-HHHHHHTTCCCCC
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------H-HHHHHHcCCCCCC
Confidence            32  11233456788999999999999999999999999999998 99998743221        1 1222222111111


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                                   +..++..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus       594 -------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          594 -------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                         114556788999999999999999999999999998765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.1e-46  Score=350.00  Aligned_cols=203  Identities=22%  Similarity=0.292  Sum_probs=166.5

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~  135 (353)
                      ...++|...+.||+|+||   .||+|.+  +++.||||++............+.+|+.++.++. ||||+++++++...+
T Consensus         6 ~~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYG---IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             HHHTTEEEEEC----------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             cccCceEEEEEeeeCCCe---EEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            456789999999999999   9999988  7899999999766556677788999999999998 999999999997544


Q ss_pred             --ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          136 --IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       136 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                        ..|+||||++ ++|.+++...      .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~D  152 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVAD  152 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCEEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecC
Confidence              6899999997 6999988753      5788999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCC--------------------CccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCC
Q 018633          214 FSLSISIPEGE--------------------THITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSD  272 (353)
Q Consensus       214 fg~a~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~  272 (353)
                      ||+++......                    ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus       153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            99998653211                    111234579999999999976 568999999999999999999999997


Q ss_pred             cc
Q 018633          273 LV  274 (353)
Q Consensus       273 ~~  274 (353)
                      ..
T Consensus       233 ~~  234 (388)
T 3oz6_A          233 GS  234 (388)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-46  Score=344.31  Aligned_cols=248  Identities=20%  Similarity=0.265  Sum_probs=180.5

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEEEEEe
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      .+.||+|+||   .||++.+  +++.||||++...     ....+.+|+.++..+. ||||+++++++.+....|+||||
T Consensus        16 ~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFS---ICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTE---EEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CCccccCCCe---EEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence            4789999999   9999998  6899999998543     4567889999999998 99999999999999999999999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC---ceEEeccCCcccc
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISI  220 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---~~kl~dfg~a~~~  220 (353)
                      +++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++   .+||+|||+++..
T Consensus        88 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           88 LNGGELFERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             CCSCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            9999999999865     46899999999999999999999   99999999999999997665   8999999999866


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .....+.... .....+.  
T Consensus       160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~-i~~~~~~--  234 (325)
T 3kn6_A          160 PPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKK-IKKGDFS--  234 (325)
T ss_dssp             CC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHH-HTTTCCC--
T ss_pred             CCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHH-HHcCCCC--
Confidence            43322 23456789999999999988999999999999999999999999975433210 0111111111 1111110  


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                              .........+..+.+|+.+||..||++|||+.+++
T Consensus       235 --------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          235 --------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             --------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             --------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence                    01111124567889999999999999999998876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=339.91  Aligned_cols=268  Identities=21%  Similarity=0.280  Sum_probs=210.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .++|...+.||+|+||   .||++.+      +++.||+|++...  .....+.+.+|+.++++++||||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFG---SVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSE---EEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCe---EEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            3568888999999999   9999983      6899999999765  556678899999999999999999999998764


Q ss_pred             C--ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          135 P--IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       135 ~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                      +  ..++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~  187 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG  187 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEEC
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEe
Confidence            4  7899999999999999998754    35889999999999999999999   8999999999999999999999999


Q ss_pred             ccCCccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc----CCCCC---
Q 018633          213 DFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH----DLACP---  283 (353)
Q Consensus       213 dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~----~~~~~---  283 (353)
                      |||++.........  ......++..|+|||++.+..++.++||||||+++|+|+||..|+.......    .....   
T Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  267 (326)
T ss_dssp             CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred             cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence            99999876543321  1233456778999999998889999999999999999999998875321000    00000   


Q ss_pred             hHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          284 SNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                      ....+.........             ...+..++..+.+++.+||+.||++|||+.++++.|+++.+++
T Consensus       268 ~~~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          268 IVFHLIELLKNNGR-------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHHHHHHHTTCC-------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhhcCCC-------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            00000111111000             0001145567889999999999999999999999999998753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3e-46  Score=341.10  Aligned_cols=272  Identities=19%  Similarity=0.322  Sum_probs=216.2

Q ss_pred             ceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC
Q 018633           50 RIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHN  122 (353)
Q Consensus        50 ~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~  122 (353)
                      ..+..+++....++|...+.||+|+||   .||+|.+.       +..||+|.+.... .......+.+|+.++++++||
T Consensus        13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~   88 (322)
T 1p4o_A           13 DVYVPDEWEVAREKITMSRELGQGSFG---MVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCH   88 (322)
T ss_dssp             SCCCCCTTBCCGGGEEEEEEEEECSSS---EEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCT
T ss_pred             cccChhhhcchhhheeeeeEeccCCce---EEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCC
Confidence            335555666778899999999999999   88888763       6789999997542 445567799999999999999


Q ss_pred             ceeeccceeeeCCccEEEEEeccCCChhhhhccCCC-----CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccC
Q 018633          123 HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK  197 (353)
Q Consensus       123 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  197 (353)
                      ||+++++++.+.+..++||||+++|+|.+++.....     .....+++..++.++.|++.||.|||   +++|+|||||
T Consensus        89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dik  165 (322)
T 1p4o_A           89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLA  165 (322)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCS
T ss_pred             CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCc
Confidence            999999999999999999999999999999875310     01134688999999999999999999   8999999999


Q ss_pred             CCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccc
Q 018633          198 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVK  275 (353)
Q Consensus       198 p~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~  275 (353)
                      |+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            9999999999999999999876533221 12234467889999999998899999999999999999999 888886332


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      .        ...... ..........             ...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       246 ~--------~~~~~~-~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          246 N--------EQVLRF-VMEGGLLDKP-------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             H--------HHHHHH-HHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             H--------HHHHHH-HHcCCcCCCC-------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            1        111111 1111111110             144567889999999999999999999999997653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-46  Score=347.06  Aligned_cols=249  Identities=19%  Similarity=0.249  Sum_probs=202.4

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCC
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETP  135 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~  135 (353)
                      ..++|...+.||+|+||   .||++..  +++.||+|++..... .....+.+.+|..++..+ +||||+++++++.+.+
T Consensus        18 ~~~~y~~~~~lG~G~fg---~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             -CTTEEEEEEEEEETTE---EEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             chHHcEEEEEEeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            45679999999999999   9999998  578999999865421 123456788999999988 7999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            999999999999999999764     35889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....        ......... .
T Consensus       167 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~-~  236 (353)
T 2i0e_A          167 MCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIME-H  236 (353)
T ss_dssp             TCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-C
T ss_pred             cccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-C
Confidence            997643222 224567899999999999988999999999999999999999999974221        111111111 1


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVA  343 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl  343 (353)
                      ...          .    +...+..+.+|+.+||..||++||+     +.+++
T Consensus       237 ~~~----------~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~  275 (353)
T 2i0e_A          237 NVA----------Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  275 (353)
T ss_dssp             CCC----------C----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred             CCC----------C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            100          0    0134567889999999999999995     45554

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.5e-46  Score=341.80  Aligned_cols=249  Identities=18%  Similarity=0.237  Sum_probs=192.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHEC--RPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++|...+.||+|+||   .||++..     +++.||+|++.....  .......+.+|+.++++++||||+++++++.+
T Consensus        16 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYG---KVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGGEEEEEEEEEETTE---EEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHHeEEEEEEEeCCCE---EEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            4679999999999999   8888875     688999999976532  22345668899999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~D  164 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTD  164 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEe
Confidence            99999999999999999998764     35789999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....        .........
T Consensus       165 fg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~  235 (327)
T 3a62_A          165 FGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILK  235 (327)
T ss_dssp             CSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH
T ss_pred             CCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh
Confidence            99987643222 223456799999999999988899999999999999999999999974321        111111111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                      . ..          ..+    ...+..+.+++.+||..||++||     ++.++++
T Consensus       236 ~-~~----------~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          236 C-KL----------NLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             T-CC----------CCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             C-CC----------CCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            1 00          000    13456778999999999999999     6777764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=343.15  Aligned_cols=244  Identities=19%  Similarity=0.237  Sum_probs=203.2

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh------hHHHHHHHHHHHHhhcCCCceeecccee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP------RAYESCINNVTYAARMSHNHILKLIGCC  131 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~~~~~~  131 (353)
                      ..++|...+.||+|+||   .||++.+  +++.||||++.......      ...+.+.+|+.++++++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g---~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFG---FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSC---SEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccceEEEeEEEecCCE---EEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            35679999999999999   9999987  89999999997653211      1345678899999999999999999999


Q ss_pred             eeCCccEEEEEeccCC-ChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          132 LETPIPILVFESVQYG-TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                      .+.+..++||||+.+| +|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+|
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k  170 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIK  170 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEE
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEE
Confidence            9999999999999777 999998765     35899999999999999999999   89999999999999999999999


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      |+|||++........  .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......           
T Consensus       171 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------  237 (335)
T 3dls_A          171 LIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------  237 (335)
T ss_dssp             ECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------
T ss_pred             EeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------
Confidence            999999987654332  344679999999999988776 789999999999999999999987422211           


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                                  .......      ...+..+.+|+.+||+.||++|||+.++++.
T Consensus       238 ------------~~~~~~~------~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 ------------EAAIHPP------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------------TTCCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------------hhccCCC------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0000000      0234567899999999999999999999863

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=346.40  Aligned_cols=252  Identities=18%  Similarity=0.270  Sum_probs=197.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC--CceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSH--NHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~~~~~~~~~~~~  137 (353)
                      .+.|...+.||+|+||   .||++.+ +++.||||++..........+.+.+|+.++.+++|  |||+++++++.+++..
T Consensus         8 ~~~y~i~~~lG~G~~g---~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSS---KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SCEEEEEEEESCCSSE---EEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cCEEEEEEEEecCCCe---EEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4568889999999999   9999988 78899999997665566677889999999999987  9999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++|||+ .+++|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++ ++.+||+|||++
T Consensus        85 ~lv~e~-~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             EEEEeC-CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence            999995 578999999875     46889999999999999999999   89999999999999997 678999999999


Q ss_pred             cccCCCCCc-cccccccCCcccccccccc-----------CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChH
Q 018633          218 ISIPEGETH-ITDTVMGTWGYCAPEYMRT-----------GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       218 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~  285 (353)
                      +........ ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||......       .
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~  227 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------I  227 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------H
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------H
Confidence            876443321 2345679999999999865           56889999999999999999999999632211       1


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ............         ...+.    ..+..+.+|+.+||+.||.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~---------~~~~~----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 SKLHAIIDPNHE---------IEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHHHHCTTSC---------CCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhcCCcc---------cCCcc----cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111111111100         00000    223467899999999999999999999753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.6e-46  Score=340.24  Aligned_cols=266  Identities=15%  Similarity=0.169  Sum_probs=195.6

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ....++|...+.||+|+||   .||++.+  +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYG---EVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             --CGGGEEEEEEEEECSSS---EEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             ccchhhEEEEEEEEecCCe---EEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            3556789999999999999   9999987  8999999999766444555677889999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee-----cCCCceE
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF-----NEENVAK  210 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill-----~~~~~~k  210 (353)
                      ..++||||++ |+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||+     +.++.+|
T Consensus       107 ~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          107 RLHLIFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             EEEEEEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred             EEEEEEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEE
Confidence            9999999998 6999999765     35889999999999999999999   8999999999999999     4555699


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      |+|||+++....... ......||..|+|||++.+.. ++.++|||||||++|+|++|..||.......        ...
T Consensus       178 l~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~  248 (329)
T 3gbz_A          178 IGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--------QLF  248 (329)
T ss_dssp             ECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH
T ss_pred             ECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--------HHH
Confidence            999999987643322 234457899999999998744 8999999999999999999999997433211        111


Q ss_pred             HHhhc------Cc---------ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFED------NR---------FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~------~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....      ..         +....................+..+.+|+.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            11110      00         000000000000011111124567889999999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.3e-47  Score=359.88  Aligned_cols=249  Identities=16%  Similarity=0.192  Sum_probs=194.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++..  +++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..
T Consensus       147 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             GGGEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             hHHcEEeEEEeeCcCE---EEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            4679999999999999   9999998  78999999986532 1234456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccCC
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      |+||||+++|+|.+++...     ..+++..+..++.||+.||.|||   + ++|+||||||+|||++.++.+||+|||+
T Consensus       224 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             EEEEeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCC
Confidence            9999999999999998764     46889999999999999999999   7 8999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.....        ......... ..
T Consensus       296 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~  365 (446)
T 4ejn_A          296 CKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILM-EE  365 (446)
T ss_dssp             CCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CC
T ss_pred             ceeccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHh-CC
Confidence            976433222 24457899999999999999999999999999999999999999964221        111111111 11


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                      ..          .+    ...+..+.+|+.+||+.||++||     |+.++++
T Consensus       366 ~~----------~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 IR----------FP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC----------CC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC----------CC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            00          00    13445678999999999999999     9999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=366.03  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=208.8

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ....++|...+.||+|+||   .||+|.+ .+..||||++....   ...+.|.+|+.+|++++|||||++++++.+ +.
T Consensus       263 ~i~~~~~~~~~~lG~G~fg---~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFG---EVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSE---EEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ecchhhhhhheecccCCCe---EEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            3445667778899999999   9999999 56789999997653   235679999999999999999999999876 67


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             ceEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence            8999999999999999975321   34789999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ++..............++..|+|||++....++.++||||||+++|||++ |..||.....        .+.........
T Consensus       410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~  481 (535)
T 2h8h_A          410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGY  481 (535)
T ss_dssp             TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTC
T ss_pred             ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC
Confidence            98764322222233456788999999998899999999999999999999 8999863321        11221111111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .. .         .    +..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       482 ~~-~---------~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          482 RM-P---------C----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CC-C---------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CC-C---------C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            10 0         0    01455678899999999999999999999999988754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=333.90  Aligned_cols=250  Identities=20%  Similarity=0.291  Sum_probs=183.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFA---GVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             cccceeeeeecCCCce---EEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            4578889999999999   9999997  789999999864311 112346789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~  159 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA  159 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecce
Confidence            99999999999999997653    46899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||........        .         
T Consensus       160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~---------  221 (278)
T 3cok_A          160 TQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------L---------  221 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------
T ss_pred             eeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------H---------
Confidence            87643222 22345789999999999988899999999999999999999999874332110        0         


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                          ..........  +...+..+.+++.+||+.||++|||+.++++
T Consensus       222 ----~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          222 ----NKVVLADYEM--PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ------CCSSCCCC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----HHHhhcccCC--ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                0000000000  0134456789999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1e-45  Score=332.71  Aligned_cols=247  Identities=18%  Similarity=0.241  Sum_probs=199.7

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee----CCc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE----TPI  136 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~  136 (353)
                      .|...+.||+|+||   .||+|.+  ++..||+|++..........+.+.+|+.++++++||||+++++++..    ...
T Consensus        27 ~~~~~~~lg~G~~g---~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           27 FLKFDIEIGRGSFK---TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             EEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             eEEeeeeccCCCCe---EEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            36667789999999   9999998  78899999998765567778889999999999999999999999875    355


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeec-CCCceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFN-EENVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~-~~~~~kl~d  213 (353)
                      .++||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++  |+||||||+|||++ .++.+||+|
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEee
Confidence            89999999999999999764     35789999999999999999999   888  99999999999997 789999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||++.......   .....||+.|+|||++. +.++.++||||||+++|+|++|..||.......       ....... 
T Consensus       176 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~-  243 (290)
T 1t4h_A          176 LGLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVT-  243 (290)
T ss_dssp             TTGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHT-
T ss_pred             CCCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------HHHHHHh-
Confidence            99997653322   33457899999999886 458999999999999999999999986432211       1111111 


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .......            .+...+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          244 SGVKPAS------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTCCCGG------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCccc------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111000            01123356889999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.4e-46  Score=349.90  Aligned_cols=250  Identities=18%  Similarity=0.269  Sum_probs=198.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC--CCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMS--HNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~~~~~  138 (353)
                      +.|...+.||+|+||   .||++.+ +++.||||++..........+.+.+|+.++.+++  ||||+++++++...+..|
T Consensus        56 ~~y~~~~~LG~G~fg---~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           56 RIYSILKQIGSGGSS---KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             EEEEEEEEEECCSSE---EEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CceEEEEEEccCCCe---EEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            458999999999999   9999988 7889999999766556667788999999999997  599999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||| +.+++|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++ ++.+||+|||+++
T Consensus       133 lv~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             EEEe-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            9999 5578999999865     35788899999999999999999   99999999999999996 5889999999998


Q ss_pred             ccCCCCCc-cccccccCCcccccccccc-----------CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          219 SIPEGETH-ITDTVMGTWGYCAPEYMRT-----------GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       219 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      ........ ......||+.|+|||++.+           ..++.++|||||||++|||++|..||.....       ...
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~  275 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QIS  275 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHH
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHH
Confidence            76443221 2345679999999999865           3688999999999999999999999963221       111


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...........         ...+.    ..+..+.+|+.+||+.||++|||+.++++
T Consensus       276 ~~~~~~~~~~~---------~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          276 KLHAIIDPNHE---------IEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHHHCTTSC---------CCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCcccc---------CCCCc----cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            11111111100         00000    12346789999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-46  Score=341.44  Aligned_cols=260  Identities=20%  Similarity=0.262  Sum_probs=204.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeE--EEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERL--ISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~  136 (353)
                      ++|...+.||+|+||   .||++.+  ++..  ||+|.+.... .....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus        25 ~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             GGCEEEEEEECGGGC---EEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHccceeeeecCCCc---eEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            678889999999999   9999987  6664  4899886542 344567799999999999 89999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCC-----------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          137 PILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      .++||||+++|+|.+++.....           .....+++..++.++.|++.||.|||   +++|+||||||+|||++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECG
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcC
Confidence            9999999999999999976530           01136899999999999999999999   999999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCCh
Q 018633          206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~  284 (353)
                      ++.+||+|||+++.....  .......++..|+|||++.+..++.++||||||+++|+|+| |..||.....        
T Consensus       178 ~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------  247 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------  247 (327)
T ss_dssp             GGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------
T ss_pred             CCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------
Confidence            999999999998743221  11233456788999999988889999999999999999998 9999864321        


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ....... .......         .    +...+..+.+|+.+||..||++|||+.++++.|.++.+.
T Consensus       248 ~~~~~~~-~~~~~~~---------~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          248 AELYEKL-PQGYRLE---------K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HHHHHHG-GGTCCCC---------C----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHh-hcCCCCC---------C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1111111 1110000         0    013456788999999999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.4e-45  Score=325.94  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=204.9

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..++|...+.||+|+||   .||++.+  +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (276)
T ss_dssp             HHHHEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             eecceEEEEEeecCCCc---EEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence            34678889999999999   9999998  68999999986542 234567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||.+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCc
Confidence            9999999999999998754     46899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCC-ccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          218 ISIPEGET-HITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       218 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      ........ .......||..|+|||++.+..+ +.++||||||+++|+|++|..||.......       .....+....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~  225 (276)
T 2yex_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKK  225 (276)
T ss_dssp             EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-------HHHHHHHTTC
T ss_pred             cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHhhhcc
Confidence            76533221 12345678999999999987665 789999999999999999999997533221       1111111111


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...   .     .     ....+..+.+++.+||+.||++|||+.++++
T Consensus       226 ~~~---~-----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 TYL---N-----P-----WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TTS---T-----T-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccc---C-----c-----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            000   0     0     0134556789999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.6e-45  Score=346.26  Aligned_cols=252  Identities=18%  Similarity=0.266  Sum_probs=191.3

Q ss_pred             hhCcCCC-CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhh-cCCCceeeccceeee---
Q 018633           61 TNSYDQK-NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAAR-MSHNHILKLIGCCLE---  133 (353)
Q Consensus        61 ~~~~~~~-~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~~~~~~~~---  133 (353)
                      .++|... ++||+|+||   .||++.+  +++.||||++...       ..+.+|+.++.+ .+||||+++++++..   
T Consensus        60 ~~~y~~~~~~LG~G~~g---~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGING---KVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             GGTEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccceeccceeeeccCe---EEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            3456554 689999999   9999998  7899999998643       456788888754 579999999999875   


Q ss_pred             -CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---CCce
Q 018633          134 -TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---ENVA  209 (353)
Q Consensus       134 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~  209 (353)
                       ....|+||||+++|+|.+++.....   ..+++..++.|+.||+.||.|||   +++|+||||||+|||++.   ++.+
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCE
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccE
Confidence             5678999999999999999986532   35899999999999999999999   899999999999999997   7899


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ||+|||+++......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......  
T Consensus       204 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~--  278 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTR--  278 (400)
T ss_dssp             EECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHH--
T ss_pred             EEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHH--
Confidence            999999998764322  234567899999999999889999999999999999999999999754332210 001111  


Q ss_pred             HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                        .....+. ...+         .....+..+.+|+.+||+.||++|||+.++++.
T Consensus       279 --i~~~~~~-~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          279 --IRMGQYE-FPNP---------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             --HHHTCCC-CCTT---------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --HHcCccc-CCCc---------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              1111110 0000         001345678899999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5e-46  Score=332.70  Aligned_cols=256  Identities=18%  Similarity=0.250  Sum_probs=205.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--CCc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--TPI  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~  136 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|.+..........+.+.+|+.++++++||||+++++++.+  .+.
T Consensus         5 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYG---RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             hhheeeehhccCCCCc---EEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            4578889999999999   9999998  78999999998765566677889999999999999999999998854  567


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC-----eEeeccCCCceeecCCCceEE
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP-----IVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~dlkp~Nill~~~~~~kl  211 (353)
                      .++||||+++++|.+++....... ..+++..++.++.|++.||.|||   +++     |+||||||+||+++.++.+||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl  157 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKL  157 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEE
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccC-CCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence            899999999999999987532111 34899999999999999999999   777     999999999999999999999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      +|||++........ ......||..|+|||++.+..++.++||||||+++|+|++|..||.....        ... ...
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~-~~~  227 (279)
T 2w5a_A          158 GDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KEL-AGK  227 (279)
T ss_dssp             CCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH-HHH
T ss_pred             ecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHH-HHH
Confidence            99999877643321 23345789999999999988899999999999999999999999874321        111 111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      ........+.             ...+..+.+++.+||+.||++|||+.++++.+
T Consensus       228 i~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          228 IREGKFRRIP-------------YRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HhhcccccCC-------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            1122211110             13456788999999999999999999998754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-45  Score=351.41  Aligned_cols=196  Identities=18%  Similarity=0.287  Sum_probs=158.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET----  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----  134 (353)
                      .++|...+.||+|+||   .||++.+  +++.||||++..........+.+.+|+.+|++++|||||++++++...    
T Consensus        52 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYG---HVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CTTEEECCC----------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             CCCeEEeeEeeecCCe---EEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence            4679999999999999   9999987  789999999977655666778899999999999999999999998543    


Q ss_pred             -CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                       ...|+||||+. |+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus       129 ~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          129 FDELYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecc
Confidence             56899999985 7999988764     46899999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCC--------------------------ccccccccCCcccccccc-ccCCCCccccchhhHHHHHHHHh
Q 018633          214 FSLSISIPEGET--------------------------HITDTVMGTWGYCAPEYM-RTGVFNEKSDVFSFGVFLFELLT  266 (353)
Q Consensus       214 fg~a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t  266 (353)
                      ||+++.......                          ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            999987642211                          112345789999999986 45669999999999999999999


Q ss_pred             CC
Q 018633          267 GW  268 (353)
Q Consensus       267 g~  268 (353)
                      |.
T Consensus       280 g~  281 (458)
T 3rp9_A          280 MI  281 (458)
T ss_dssp             TS
T ss_pred             hc
Confidence            43

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=332.88  Aligned_cols=266  Identities=21%  Similarity=0.246  Sum_probs=199.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC---ChhHHHHHHHHHHHHhhcC---CCceeeccce
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC---RPRAYESCINNVTYAARMS---HNHILKLIGC  130 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~---H~niv~~~~~  130 (353)
                      ..+++|...+.||+|+||   .||++.+  +++.||+|++.....   .......+.+|+.++++++   ||||++++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYG---TVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             ----CCEEEEEECCSSSC---CEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             ccccceEEEEEEecCCCe---EEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            346789999999999999   9999997  889999999864321   1122345667777777665   9999999999


Q ss_pred             eeeCC-----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          131 CLETP-----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       131 ~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      +....     ..++||||+. |+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTS  155 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECT
T ss_pred             eeccCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcC
Confidence            98765     4789999997 699999987643   34899999999999999999999   899999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChH
Q 018633          206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~  285 (353)
                      ++.+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......       
T Consensus       156 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------  226 (308)
T 3g33_A          156 GGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-------  226 (308)
T ss_dssp             TSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-------
T ss_pred             CCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------
Confidence            9999999999997764332  2345678999999999999999999999999999999999999997433211       


Q ss_pred             HHHHHHhhc------Ccccccc---cchhhhc---cchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EYLKNYFED------NRFTEIV---DPIIVED---VLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~~~~~~~~------~~~~~~~---~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       ........      ..++...   .......   .........+..+.+|+.+||+.||++|||+.++++
T Consensus       227 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          227 -QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             -HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence             11111110      0000000   0000000   000001134577889999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.8e-45  Score=346.02  Aligned_cols=200  Identities=19%  Similarity=0.242  Sum_probs=171.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET----  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----  134 (353)
                      .++|...+.||+|+||   .||++.+  +++.||||++..........+.+.+|+.+|++++||||+++++++...    
T Consensus        25 ~~~y~~~~~lG~G~~g---~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYG---YVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CTTEEEEEEEEEETTE---EEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             cCCEEEEEEEeecCCE---EEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            5689999999999999   9999998  789999999987655666778899999999999999999999999766    


Q ss_pred             -CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                       +..|+||||+. |+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCeEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEcc
Confidence             56899999996 6999999764     46899999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCCc---------------------cccccccCCcccccccc-ccCCCCccccchhhHHHHHHHHhCCCCC
Q 018633          214 FSLSISIPEGETH---------------------ITDTVMGTWGYCAPEYM-RTGVFNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       214 fg~a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~tg~~p~  271 (353)
                      ||+++........                     ......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9999876433211                     12456899999999986 4556999999999999999999976665


Q ss_pred             C
Q 018633          272 D  272 (353)
Q Consensus       272 ~  272 (353)
                      .
T Consensus       253 ~  253 (432)
T 3n9x_A          253 I  253 (432)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.5e-46  Score=348.35  Aligned_cols=245  Identities=12%  Similarity=0.096  Sum_probs=190.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHH---HHHhhcCCCceeecc------
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNV---TYAARMSHNHILKLI------  128 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~---~~l~~l~H~niv~~~------  128 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++.... ......+.+.+|+   .++++++|||||+++      
T Consensus        72 ~~~y~~~~~lG~G~~g---~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPY---AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             CEEEEEEEEEEEETTE---EEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CceEEEcceeecCCCE---EEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            3567778999999999   9999997  68999999997442 2445678899999   555566799999999      


Q ss_pred             -ceeeeCC-----------------ccEEEEEeccCCChhhhhccCCC--CCCccccHHHHHHHHHHHHHHHHHHhcCCC
Q 018633          129 -GCCLETP-----------------IPILVFESVQYGTLWDRILGAPQ--PHFEPLLLKHRLKIAMDIVHALAYLHFGFP  188 (353)
Q Consensus       129 -~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  188 (353)
                       +++.+.+                 ..|+||||+ +|+|.+++.....  .....+++..++.|+.||+.||.|||   +
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~  224 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---H  224 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---h
Confidence             5544443                 378999999 5899999975321  00134567888999999999999999   8


Q ss_pred             CCeEeeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccC-----------CCCccccchhh
Q 018633          189 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-----------VFNEKSDVFSF  257 (353)
Q Consensus       189 ~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~sl  257 (353)
                      ++|+||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||
T Consensus       225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             CCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence            9999999999999999999999999999986422    2345567 999999999887           79999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC
Q 018633          258 GVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP  337 (353)
Q Consensus       258 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  337 (353)
                      ||++|||++|..||.......                     .........      ...+..+.+|+.+||+.||++||
T Consensus       300 G~il~elltg~~Pf~~~~~~~---------------------~~~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rp  352 (377)
T 3byv_A          300 GLVIYWIWCADLPITKDAALG---------------------GSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRL  352 (377)
T ss_dssp             HHHHHHHHHSSCCC------C---------------------CSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGCC
T ss_pred             HHHHHHHHHCCCCCccccccc---------------------chhhhhhhc------cCCCHHHHHHHHHHcCCCchhCC
Confidence            999999999999986432211                     001000000      03455788999999999999999


Q ss_pred             CHHHHHH
Q 018633          338 SMVDVAK  344 (353)
Q Consensus       338 s~~~vl~  344 (353)
                      |+.++++
T Consensus       353 t~~e~l~  359 (377)
T 3byv_A          353 LPLQAME  359 (377)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=346.93  Aligned_cols=274  Identities=16%  Similarity=0.209  Sum_probs=212.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC--cc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP--IP  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--~~  137 (353)
                      +.|...+.||+|+||   .||+|.+  +++.||||++.... .....+.+.+|+.++++++||||+++++++...+  ..
T Consensus         9 ~~y~i~~~LG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            9 HLWLLSDILGQGATA---NVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             EEEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CceEEEEEEEcCCCe---EEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            568889999999999   9999999  58999999997542 2334677889999999999999999999998655  67


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee----cCCCceEEec
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLFD  213 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~d  213 (353)
                      ++||||+++|+|.+++......  ..+++..++.++.|++.||.|||   +++|+||||||+|||+    +.++.+||+|
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             EEEEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence            9999999999999999764321  23899999999999999999999   9999999999999999    7788899999


Q ss_pred             cCCccccCCCCCccccccccCCcccccccccc--------CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRT--------GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~  285 (353)
                      ||+++......  ......||..|+|||++.+        ..++.++|||||||++|||++|..||.......    ...
T Consensus       160 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~----~~~  233 (396)
T 4eut_A          160 FGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNK  233 (396)
T ss_dssp             GGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT----TCH
T ss_pred             CCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc----chH
Confidence            99998764332  2345679999999999865        467889999999999999999999997433222    112


Q ss_pred             HHHHHHhhcCccccccc---ch------hhhcc--chHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVD---PI------IVEDV--LSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~---~~------~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ........... .....   ..      +....  ...........+.+++.+||+.||++|||+.++++.+..++.
T Consensus       234 ~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          234 EVMYKIITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHHHHHSCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHhcCCC-cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            22222222111 00000   00      00000  001113677888999999999999999999999999998875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.4e-45  Score=353.86  Aligned_cols=253  Identities=21%  Similarity=0.270  Sum_probs=203.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...+.|...+.||+|+||   .||++.+  +++.||+|++............+.+|+.++++++||||+++++++.+.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFG---EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             HHHHHEEEEEEEECCSSS---EEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ChhcceEEeEEEeecCCE---EEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            445679999999999999   9999998  78999999986442233456789999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec---CCCceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN---EENVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~d  213 (353)
                      .|+||||+++|+|.+.+...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++   .++.+||+|
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEE
Confidence            99999999999999988765     35899999999999999999999   99999999999999995   456799999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||+++......  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....        ........ 
T Consensus       168 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~-  235 (486)
T 3mwu_A          168 FGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVE-  235 (486)
T ss_dssp             CSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-
T ss_pred             CCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-
Confidence            99998764432  2345679999999999875 589999999999999999999999974321        12222211 


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+....          ......+..+.+|+.+||..||++|||+.++++
T Consensus       236 ~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          236 TGKYAFDL----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HTCCCSCS----------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hCCCCCCC----------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111000          000134567889999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-46  Score=348.75  Aligned_cols=248  Identities=19%  Similarity=0.239  Sum_probs=193.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHH-HhhcCCCceeeccceeeeCCc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTY-AARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~-l~~l~H~niv~~~~~~~~~~~  136 (353)
                      .++|...+.||+|+||   .||++..  ++..||+|++..... .......+.+|..+ ++.++||||+++++++.+.+.
T Consensus        37 ~~~y~~~~~lG~G~fg---~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             GGGEEEEEEEECCTTC---EEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             hhheEEEEEEeeCCCe---EEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            4679999999999999   9999998  688999999976532 23344567778777 567899999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             EEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcc
Confidence            99999999999999998764     35788999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.....        .+........ .
T Consensus       186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~-~  255 (373)
T 2r5t_A          186 CKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNK-P  255 (373)
T ss_dssp             CGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHS-C
T ss_pred             ccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhc-c
Confidence            97643222 224567899999999999998999999999999999999999999974321        1111111111 0


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                      . .         .+    ...+..+.+|+.+||+.||.+||++.+.+
T Consensus       256 ~-~---------~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 L-Q---------LK----PNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             C-C---------CC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             c-C---------CC----CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            0 0         00    03445678999999999999999985433

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.4e-46  Score=333.31  Aligned_cols=249  Identities=19%  Similarity=0.333  Sum_probs=200.7

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ..++|...+.||+|+||   .||++.+  ++..||+|++..... .......+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFG---NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ecccEEEeeEEecCCCe---EEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            35679999999999999   9999988  677999999854321 12234678999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||+
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~  155 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW  155 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred             EEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccc
Confidence            99999999999999998765     35889999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      +.......   .....||..|+|||.+.+..++.++||||||+++|+|++|..||.....        ........ ...
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~  223 (279)
T 3fdn_A          156 SVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVE  223 (279)
T ss_dssp             ESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-HTC
T ss_pred             cccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHHH-hCC
Confidence            86543322   3355789999999999988899999999999999999999999873221        11111111 110


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      .          ..+    ...+..+.+|+.+||+.||++|||+.++++.
T Consensus       224 ~----------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 F----------TFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             C----------CCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             C----------CCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0          000    1344567899999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=340.58  Aligned_cols=256  Identities=14%  Similarity=0.143  Sum_probs=205.3

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEE-----e--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC---CCceeec
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGF-----W--QERLISVLQFYGHECRPRAYESCINNVTYAARMS---HNHILKL  127 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~-----~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~  127 (353)
                      ....+.|...+.||+|+||   .||+|.     .  +++.||+|++...     ...++.+|+.++..++   |+||+++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFA---QVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSE---EEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             EECCEEEEEEEEeeccCCE---EEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            3445678888999999999   999993     2  7889999999654     3456778888888887   9999999


Q ss_pred             cceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC--
Q 018633          128 IGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE--  205 (353)
Q Consensus       128 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~--  205 (353)
                      ++++...+..|+||||+++|+|.+++..........+++..++.++.||+.||.|||   +++|+||||||+|||++.  
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGG
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccc
Confidence            999999999999999999999999997432111146899999999999999999999   999999999999999998  


Q ss_pred             ---------CCceEEeccCCccccCC-CCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          206 ---------ENVAKLFDFSLSISIPE-GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       206 ---------~~~~kl~dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                               ++.+||+|||+|+.... ..........||..|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence                     89999999999976432 12223456679999999999999899999999999999999999999986432


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCC-CCHHHHHHHHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR-PSMVDVAKKLRQIYR  351 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~~vl~~L~~l~~  351 (353)
                      ...                ........    ..       .....+.+++..|++.+|.+| |++.++.+.|+++..
T Consensus       290 ~~~----------------~~~~~~~~----~~-------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          290 GGE----------------CKPEGLFR----RL-------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             TTE----------------EEECSCCT----TC-------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCc----------------eeechhcc----cc-------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            211                00000000    00       123456688999999999999 578888888888765

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=331.18  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=198.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|....+||+|+||   .||+|.+  ++..||+|.+...  .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        22 ~~~~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYG---IVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSS---EEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCCCCcEEEeecCcE---EEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            345556699999999   9999998  7889999999766  44556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-CCceEEeccCCcc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSI  218 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~dfg~a~  218 (353)
                      ||||+++++|.+++......  ..+++..++.++.|++.||.|||   +++|+||||||+||+++. ++.++|+|||++.
T Consensus        97 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEEeCCCCCHHHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            99999999999999765321  35678889999999999999999   899999999999999987 8999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccccCC--CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....... ......||..|+|||++.+..  ++.++||||||+++|+|++|..||.......      ........ ...
T Consensus       172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~-~~~  243 (295)
T 2clq_A          172 RLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGM-FKV  243 (295)
T ss_dssp             ESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHH-HCC
T ss_pred             ccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhcc-ccc
Confidence            7643222 234557899999999987654  7899999999999999999999986432211      00000000 000


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...         .    +...+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~---------~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 HPE---------I----PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCC---------C----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccc---------c----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000         0    0134567789999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-45  Score=330.70  Aligned_cols=254  Identities=20%  Similarity=0.219  Sum_probs=197.2

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..+.|...+.||+|+||   .||++..  ++..||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        20 i~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFG---DVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             HHHHEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeccCCCe---EEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            34679999999999999   9999998  78899999987653 233467899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee---cCCCceEEecc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDF  214 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~df  214 (353)
                      ++||||+++|+|.+.+....... ..+++..++.++.|++.||.|||   +++|+||||||+|||+   +.++.+||+||
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARG-KALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            99999999999999885431100 35889999999999999999999   9999999999999999   45678999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      |++.......  ......||..|+|||++. ..++.++||||||+++|+|++|..||.....        ..........
T Consensus       172 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~  240 (285)
T 3is5_A          172 GLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYK  240 (285)
T ss_dssp             CCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC
T ss_pred             ecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccC
Confidence            9997654332  234567899999999985 5688999999999999999999999874321        1111111110


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      . ......           ....+..+.+|+.+||+.||++|||+.++++
T Consensus       241 ~-~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 E-PNYAVE-----------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C-CCCCC-------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             C-cccccc-----------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 000000           0023456789999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.8e-46  Score=345.89  Aligned_cols=269  Identities=17%  Similarity=0.227  Sum_probs=204.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  ++..||+|++.... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        32 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           32 DDDFEKISELGAGNGG---VVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             GGGEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeeeeecCCCCe---EEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            4578999999999999   9999999  68999999987653 4556678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC-CeEeeccCCCceeecCCCceEEeccCCc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      +||||+++++|.+++...     ..+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.++|+|||++
T Consensus       108 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             EEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             EEEECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence            999999999999999764     35889999999999999999999   75 8999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHHHH
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYLKN  290 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~  290 (353)
                      ......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........       ..........
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          180 GQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             HHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             cccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            654221   123457899999999999989999999999999999999999999753321100       0000000000


Q ss_pred             H--------------hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 Y--------------FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .              .......+..+.......+.......+..+.+|+.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            0              00000000111111111111111134567899999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-45  Score=338.23  Aligned_cols=260  Identities=16%  Similarity=0.209  Sum_probs=197.3

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC---
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP---  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---  135 (353)
                      .+.|...+.||+|+||   .||+|.+  +++.||||++..........+.+.+|+.++++++||||+++++++...+   
T Consensus        24 ~~~y~~~~~lG~G~~g---~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYG---AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             BSSEEEEEEC---------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             cceEEEeEEeeecCCe---EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence            4678889999999999   9999998  7899999999766556666788999999999999999999999997653   


Q ss_pred             ---ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          136 ---IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       136 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                         ..|+||||+ +++|.+++...      .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             cCceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEE
Confidence               469999999 78999998753      4789999999999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCCh
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPS  284 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~  284 (353)
                      |||+++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........       ...+.
T Consensus       171 Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          171 DFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99999875432    234578999999999877 6799999999999999999999999975432110       00011


Q ss_pred             HHHHH--------HHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLK--------NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..++.        .+...  ++.....    ..... ....+..+.+|+.+||..||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~--~~~~~~~----~~~~~-~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKG--LPELEKK----DFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHH--SCCCCCC----CGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhhhHHHHHHHHh--CCCCCCC----CHHHH-CCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            11100        00000  0000000    00000 0134567889999999999999999999886

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.7e-45  Score=337.89  Aligned_cols=267  Identities=16%  Similarity=0.231  Sum_probs=197.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC---
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP---  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---  135 (353)
                      .++|...+.||+|+||   .||++.+  +++.||||++..........+.+.+|+.+++.++||||+++++++...+   
T Consensus        24 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQG---IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             ETTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             hhheeEeeeeEecCCE---EEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            4679999999999999   9999988  7899999999766545667788999999999999999999999987654   


Q ss_pred             ---ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          136 ---IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       136 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                         ..|+||||++ |+|.+.+..       .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       101 ~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~  169 (371)
T 2xrw_A          101 EFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL  169 (371)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEE
Confidence               6799999997 688888752       4788999999999999999999   8999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc-------CCCCChH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH-------DLACPSN  285 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~  285 (353)
                      |||+++......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......       ....+..
T Consensus       170 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          170 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             Eeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999997654322  2345678999999999999899999999999999999999999997543211       0001111


Q ss_pred             HH-------HHHHhhcC-cc-----cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EY-------LKNYFEDN-RF-----TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~-------~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+       ........ .+     .........+ .........+..+.+|+.+||..||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFP-ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCc-ccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            10       00111000 00     0000000000 011122245778999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.1e-45  Score=352.89  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=199.5

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..+.|...+.||+|+||   .||++.+  ++..||+|++............+.+|+.+++.++|||||++++++.+.+..
T Consensus        35 ~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYG---EVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             HHHHEEEEEEEECC------EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhcCeEEeeEEecCCCE---EEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            34568889999999999   9999998  788999999976644445567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC---CceEEecc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFDF  214 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl~df  214 (353)
                      |+|||||++|+|.+.+...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++..   +.+||+||
T Consensus       112 ~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  183 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDF  183 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEEC
Confidence            9999999999999988765     35889999999999999999999   8999999999999999764   55999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      |++.......  ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....        .+...... .
T Consensus       184 G~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~-~  251 (494)
T 3lij_A          184 GLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVE-K  251 (494)
T ss_dssp             TTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-H
T ss_pred             CCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-h
Confidence            9998764332  234567999999999986 5699999999999999999999999974322        12222221 1


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... ..+.         ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       252 ~~~~~-~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          252 GKYTF-DSPE---------WKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             TCCCC-CSGG---------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCC-Cchh---------cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            11100 0000         0134567889999999999999999999885

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.8e-45  Score=345.92  Aligned_cols=254  Identities=17%  Similarity=0.258  Sum_probs=193.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC------ChhHHHHHHHHHHHHhhcCCCceeeccce
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC------RPRAYESCINNVTYAARMSHNHILKLIGC  130 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~~~~~  130 (353)
                      ...++|...+.||+|+||   .||+|.+  +++.||+|++.....      .......+.+|+.+|++++||||++++++
T Consensus       132 ~~~~~y~~~~~LG~G~~g---~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  208 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACG---EVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF  208 (419)
T ss_dssp             HHHTTEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             hhhccEEEEeEEeeCCCe---EEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            456789999999999999   9999998  789999999865421      11223358899999999999999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC---
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---  207 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~---  207 (353)
                      +. .+..++||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++   
T Consensus       209 ~~-~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          209 FD-AEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             EE-SSEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSC
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcc
Confidence            75 45579999999999999988765     46899999999999999999999   89999999999999997544   


Q ss_pred             ceEEeccCCccccCCCCCccccccccCCcccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          208 VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT---GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                      .+||+|||+++......  ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......    ..
T Consensus       280 ~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~  353 (419)
T 3i6u_A          280 LIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SL  353 (419)
T ss_dssp             CEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CH
T ss_pred             eEEEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HH
Confidence            59999999998764322  2345679999999999853   568899999999999999999999997432221    01


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .    .........          ..+......+..+.+|+.+||+.||++|||+.++++
T Consensus       354 ~----~~i~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          354 K----DQITSGKYN----------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             H----HHHHTTCCC----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H----HHHhcCCCC----------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1    111111110          001111145677889999999999999999999886

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-45  Score=337.32  Aligned_cols=271  Identities=20%  Similarity=0.294  Sum_probs=202.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        24 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYG---MVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             GGGEEEEEEGGGGTTS---SEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhheeeeEEeecCCE---EEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            4578888999999999   9999998  6899999999766555666778899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus       101 lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR  172 (331)
T ss_dssp             EEEECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             EEEecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence            999999988888776544     35899999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChHHHHHH
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSNEYLKN  290 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~  290 (353)
                      ....... ......||..|+|||++.+. .++.++||||||+++|+|++|..||.........       ..... ....
T Consensus       173 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  250 (331)
T 4aaa_A          173 TLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP-RHQE  250 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH-HHHH
T ss_pred             eecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh-hhhh
Confidence            6543222 23455789999999999775 6899999999999999999999999754321100       00000 0011


Q ss_pred             HhhcC-cccccccchhhhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDN-RFTEIVDPIIVEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+... .+.....+....... ....+..+..+.+|+.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11110 011111111110000 0111145678899999999999999999998875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=340.02  Aligned_cols=262  Identities=19%  Similarity=0.230  Sum_probs=204.5

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee----
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE----  133 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----  133 (353)
                      ..++|...+.||+|+||   .||++..  +++.||+|++...  .....+.+.+|+.+++.++||||+++++++..    
T Consensus        27 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFS---YVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             TTEEEEEEEEEEC--CE---EEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             CCeEEEEEEEecCCCCe---EEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            34679999999999999   9999997  8899999998765  56677889999999999999999999999873    


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      ....++||||+++|+|.+++....... ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++|+|
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKG-NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEe
Confidence            346899999999999999887521111 46899999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCCc--------cccccccCCccccccccccCC---CCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          214 FSLSISIPEGETH--------ITDTVMGTWGYCAPEYMRTGV---FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       214 fg~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                      ||++.........        ......||+.|+|||++....   ++.++||||||+++|+|++|..||.......   .
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~  254 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---D  254 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---S
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---c
Confidence            9998765321110        012345789999999987544   7889999999999999999999986322111   0


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      .....    ... .. ..       ..    ....+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       255 ~~~~~----~~~-~~-~~-------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          255 SVALA----VQN-QL-SI-------PQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             CHHHH----HHC-C---C-------CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhhHH----hhc-cC-CC-------Cc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            00000    000 00 00       00    0134567889999999999999999999999998764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.4e-45  Score=336.23  Aligned_cols=261  Identities=16%  Similarity=0.170  Sum_probs=206.2

Q ss_pred             HHHHHHHhhCcCCC-CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccc
Q 018633           54 AQEIKLATNSYDQK-NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIG  129 (353)
Q Consensus        54 ~~e~~~~~~~~~~~-~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~  129 (353)
                      ++......+.|... +.||+|+||   .||++.+  +++.||+|++............+.+|+.++..+. ||||+++++
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFA---VVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCe---EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34444566667766 889999999   9999998  6899999999766445556788999999999995 699999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---C
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---E  206 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~  206 (353)
                      ++.+.+..++||||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.   +
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~  170 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPL  170 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTB
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCC
Confidence            99999999999999999999999865432   46899999999999999999999   899999999999999987   7


Q ss_pred             CceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          207 NVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      +.+||+|||+++.......  .....||+.|+|||++.+..++.++||||||+++|+|++|..||......        .
T Consensus       171 ~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~  240 (327)
T 3lm5_A          171 GDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--------E  240 (327)
T ss_dssp             CCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H
T ss_pred             CcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------H
Confidence            8999999999987643322  34467999999999999899999999999999999999999998743221        1


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....... .... .         ........+..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~i~~-~~~~-~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          241 TYLNISQ-VNVD-Y---------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHH-TCCC-C---------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHh-cccc-c---------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            1111111 1000 0         00000134566889999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-45  Score=329.33  Aligned_cols=250  Identities=20%  Similarity=0.297  Sum_probs=204.6

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee---
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE---  133 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~---  133 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||+|++....      +.+.+|+.++++++||||+++++++..   
T Consensus         8 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFG---QVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHEEEEEEEECSSSC---CEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             hhccccceeeeeccCCce---EEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            345679999999999999   9999998  68999999997652      356789999999999999999998864   


Q ss_pred             -------------CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCc
Q 018633          134 -------------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC  200 (353)
Q Consensus       134 -------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  200 (353)
                                   ....++||||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~N  152 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSN  152 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHH
Confidence                         3457999999999999999975432   35889999999999999999999   8999999999999


Q ss_pred             eeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC
Q 018633          201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL  280 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~  280 (353)
                      ||++.++.+||+|||++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..|+....     
T Consensus       153 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  225 (284)
T 2a19_B          153 IFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----  225 (284)
T ss_dssp             EEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----
T ss_pred             EEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----
Confidence            9999999999999999987654322  334568999999999998889999999999999999999988864210     


Q ss_pred             CCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          281 ACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                           ..... .....+..                ..+..+.+++.+||+.||++|||+.++++.|..+..+
T Consensus       226 -----~~~~~-~~~~~~~~----------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          226 -----KFFTD-LRDGIISD----------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             -----HHHHH-HHTTCCCT----------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             -----HHHHH-hhcccccc----------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                 11111 11111110                2344577899999999999999999999999887543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.8e-45  Score=328.36  Aligned_cols=249  Identities=20%  Similarity=0.303  Sum_probs=205.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .+.|...+.||+|+||   .||+|.+  +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        21 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFG---EVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             GGTEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHHHHhhhhcccCCe---EEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            3568888999999999   9999987  78999999997653 2345678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++..      ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++.
T Consensus        97 lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG  167 (303)
T ss_dssp             EEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccce
Confidence            99999999999999864      35889999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ...... .......||..|+|||++.+..++.++||||||+++|+|++|..||.....        ..... ........
T Consensus       168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~-~~~~~~~~  237 (303)
T 3a7i_A          168 QLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLF-LIPKNNPP  237 (303)
T ss_dssp             ECBTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHH-HHHHSCCC
T ss_pred             ecCccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHH-HhhcCCCC
Confidence            764332 223456789999999999988999999999999999999999999864321        11111 11111111


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      ..     .        ...+..+.+|+.+||+.||++|||+.++++.
T Consensus       238 ~~-----~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          238 TL-----E--------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CC-----C--------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CC-----c--------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            10     0        0344568899999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-45  Score=352.80  Aligned_cols=252  Identities=22%  Similarity=0.298  Sum_probs=206.2

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ..+.|...+.||+|+||   .||++..  +++.||||++..... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        24 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFG---EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHHHEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ccCceEEeeEEecCCCE---EEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34679999999999999   9999998  789999999865532 24456789999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee---cCCCceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~d  213 (353)
                      .++||||+++|+|.+.+...     ..+++..++.++.||+.||.|||   +++|+||||||+|||+   +.++.+||+|
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            99999999999999998765     46899999999999999999999   8999999999999999   4678999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||+++.......  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....        ........ 
T Consensus       173 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~-  240 (484)
T 3nyv_A          173 FGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVE-  240 (484)
T ss_dssp             TTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-
T ss_pred             eeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-
Confidence            999987654332  344579999999999865 689999999999999999999999974322        11222211 


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+....          ......+..+.+|+.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          241 KGKYTFEL----------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HCCCCCCS----------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCCCC----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            11111000          000145567889999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.9e-45  Score=332.19  Aligned_cols=261  Identities=20%  Similarity=0.250  Sum_probs=198.4

Q ss_pred             hhCcCC-CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCc
Q 018633           61 TNSYDQ-KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPI  136 (353)
Q Consensus        61 ~~~~~~-~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~  136 (353)
                      .+.|.. .+.||+|+||   .||++.+  +++.||||++...  .....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus        11 ~~~y~i~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHA---RVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSE---EEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ceeEEecCceecCCceE---EEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            456776 4789999999   9999987  7899999999765  344567899999999995 69999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc---eEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~kl~d  213 (353)
                      .++||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.   +||+|
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             EEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence            99999999999999999764     35889999999999999999999   899999999999999988765   99999


Q ss_pred             cCCccccCCCCC------ccccccccCCcccccccccc-----CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          214 FSLSISIPEGET------HITDTVMGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       214 fg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                      ||++........      .......||+.|+|||++..     ..++.++|||||||++|+|++|..||...........
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            999876532211      11224568999999999875     4588999999999999999999999975433221000


Q ss_pred             ---Ch---HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 ---PS---NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                         ..   .............          ..+.......+..+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          238 RGEACPACQNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             ---CCHHHHHHHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccchhHHHHHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence               00   0001111111110          0011111134567889999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-45  Score=339.06  Aligned_cols=252  Identities=20%  Similarity=0.284  Sum_probs=200.6

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~  135 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||+|++....      ..+.+|++++.++ +||||+++++++.+.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYS---VCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             CHHHHEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEEeeCCCE---EEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            345679999999999999   9999998  78999999997652      1245688889888 6999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC----CceEE
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE----NVAKL  211 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~----~~~kl  211 (353)
                      ..|+||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||+...    +.+||
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEE
Confidence            999999999999999998765     46899999999999999999999   9999999999999998433    35999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      +|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     ...+.... 
T Consensus       162 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~~~~-  234 (342)
T 2qr7_A          162 CDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----TPEEILAR-  234 (342)
T ss_dssp             CCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----CHHHHHHH-
T ss_pred             EECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----CHHHHHHH-
Confidence            99999987643322 234567899999999998888999999999999999999999999743211     11111111 


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....+.. ..     .    .....+..+.+|+.+||..||++|||+.++++
T Consensus       235 i~~~~~~~-~~-----~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          235 IGSGKFSL-SG-----G----YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHCCCCC-CS-----T----TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HccCCccc-Cc-----c----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111110 00     0    00134567889999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=341.28  Aligned_cols=263  Identities=14%  Similarity=0.160  Sum_probs=204.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeC----------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceee----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQ----------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILK----  126 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~----  126 (353)
                      .++|...+.||+|+||   .||+|.+.          ++.||+|.+...       +.+.+|+.++++++||||++    
T Consensus        41 ~~~y~~~~~lg~G~~g---~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQG---ILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             SCEEEEEEEEEEETTE---EEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCe---EEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhh
Confidence            3679999999999999   99999882          689999998654       46889999999999999998    


Q ss_pred             -----------ccceeee-CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEee
Q 018633          127 -----------LIGCCLE-TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR  194 (353)
Q Consensus       127 -----------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  194 (353)
                                 +++++.. ++..++||||+ +++|.+++.....   ..+++..++.++.||+.||.|||   +++|+||
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~  183 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLH---ENEYVHG  183 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCS
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCC
Confidence                       5566665 67789999999 8999999986522   46899999999999999999999   8999999


Q ss_pred             ccCCCceeecCCC--ceEEeccCCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHh
Q 018633          195 NFKTSCILFNEEN--VAKLFDFSLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT  266 (353)
Q Consensus       195 dlkp~Nill~~~~--~~kl~dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  266 (353)
                      ||||+|||++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++||||||+++|||++
T Consensus       184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  263 (352)
T 2jii_A          184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY  263 (352)
T ss_dssp             CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999998  8999999999766432211      1234579999999999998899999999999999999999


Q ss_pred             CCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          267 GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       267 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      |..||.......   .......... .. ....+.+......       ..+..+.+++.+||+.||++|||+.++++.|
T Consensus       264 g~~pf~~~~~~~---~~~~~~~~~~-~~-~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  331 (352)
T 2jii_A          264 GFLPWTNCLPNT---EDIMKQKQKF-VD-KPGPFVGPCGHWI-------RPSETLQKYLKVVMALTYEEKPPYAMLRNNL  331 (352)
T ss_dssp             SCCTTGGGTTCH---HHHHHHHHHH-HH-SCCCEECTTSCEE-------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred             CCCCcccCCcCH---HHHHHHHHhc-cC-ChhhhhhhccccC-------CCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence            999997543111   0000111111 00 1111111100000       2356788999999999999999999999999


Q ss_pred             HHHHHh
Q 018633          347 RQIYRS  352 (353)
Q Consensus       347 ~~l~~~  352 (353)
                      +++.+.
T Consensus       332 ~~~~~~  337 (352)
T 2jii_A          332 EALLQD  337 (352)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            999865

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-45  Score=331.15  Aligned_cols=249  Identities=15%  Similarity=0.172  Sum_probs=201.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETP  135 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~  135 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||+|++............+.+|+..+..+ +||||+++++++.+.+
T Consensus         8 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFG---SVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHHHHEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             cccchhhhhhhhcCCCce---EEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            456789999999999999   9999999  799999999987654556677899999999999 8999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC---------
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE---------  206 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---------  206 (353)
                      ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.+         
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------
T ss_pred             eEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccc
Confidence            999999999999999999754210 034789999999999999999999   8999999999999999844         


Q ss_pred             ----------CceEEeccCCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          207 ----------NVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       207 ----------~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                                ..++|+|||.+.......     ...||..|+|||++.+. .++.++||||||+++|+|++|.+++....
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             cccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence                      479999999998764322     34589999999999765 56789999999999999999988754211


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                 .... ......+.+.             ...+..+.+++.+||+.||++|||+.++++
T Consensus       236 -----------~~~~-~~~~~~~~~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 -----------QWHE-IRQGRLPRIP-------------QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -----------HHHH-HHTTCCCCCS-------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------HHHH-HHcCCCCCCC-------------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                       1111 1111111111             134567889999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.5e-45  Score=351.48  Aligned_cols=253  Identities=21%  Similarity=0.241  Sum_probs=202.5

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh-----------hHHHHHHHHHHHHhhcCCCcee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP-----------RAYESCINNVTYAARMSHNHIL  125 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv  125 (353)
                      ...+.|...+.||+|+||   .||++..  ++..||+|++.......           ...+.+.+|+.++++++||||+
T Consensus        33 ~i~~~Y~~~~~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  109 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYG---EVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII  109 (504)
T ss_dssp             CGGGTEEEEEEEEC--CE---EEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred             CcccceEEEeEecccCCe---EEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence            346789999999999999   9999998  78899999997653221           3457799999999999999999


Q ss_pred             eccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       126 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      ++++++.+....|+|||||++|+|.+.+...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~  181 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLEN  181 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESS
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEec
Confidence            9999999999999999999999999988764     35899999999999999999999   899999999999999987


Q ss_pred             CC---ceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          206 EN---VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       206 ~~---~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                      ++   .+||+|||++.......  ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....      
T Consensus       182 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------  252 (504)
T 3q5i_A          182 KNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------  252 (504)
T ss_dssp             TTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred             CCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------
Confidence            76   69999999998764432  234567999999999986 5689999999999999999999999974322      


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                        ........ ...+.          .........+..+.+|+.+||..||.+|||+.++++
T Consensus       253 --~~~~~~i~-~~~~~----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          253 --QDIIKKVE-KGKYY----------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             --HHHHHHHH-HCCCC----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHHHHH-cCCCC----------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              11221111 11110          000111145677889999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.7e-47  Score=345.06  Aligned_cols=265  Identities=18%  Similarity=0.234  Sum_probs=194.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYA---TVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCE---EEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            468888999999999   9999998  78999999986542 11222245689999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||++ |+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus        78 v~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  149 (324)
T 3mtl_A           78 VFEYLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARA  149 (324)
T ss_dssp             EEECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred             Eecccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCccccc
Confidence            999997 69999887654    45889999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc---C
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED---N  295 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  295 (353)
                      ...... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.......     ...........   .
T Consensus       150 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~  223 (324)
T 3mtl_A          150 KSIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTEE  223 (324)
T ss_dssp             C-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTT
T ss_pred             ccCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChH
Confidence            543222 2344578999999999876 568999999999999999999999997533211     00011110000   0


Q ss_pred             cccccccch---------hhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPI---------IVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .++......         .............+..+.+|+.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            011110000         0000000001134567889999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.7e-45  Score=364.40  Aligned_cols=260  Identities=21%  Similarity=0.283  Sum_probs=206.9

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ...++|...+.||+|+||   .||+|.+     .+..||+|.+.... .....+.|.+|+.++++++||||+++++++. 
T Consensus       387 i~~~~y~i~~~LG~G~fG---~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFG---DVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             CCGGGEEEEEEEECCSSC---CEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccccEEEeeEEeeCCCE---EEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            344667888899999999   9999987     24679999987542 4556688999999999999999999999985 


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      ++..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEe
Confidence            466899999999999999997653    35889999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ||+++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||.....        ........
T Consensus       535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~~i~  606 (656)
T 2j0j_A          535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIE  606 (656)
T ss_dssp             CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred             cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHH
Confidence            99998765443333344567789999999998899999999999999999997 9999874322        11111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .... ...             +..++..+.+++.+||..||++|||+.++++.|+++.+.
T Consensus       607 ~~~~-~~~-------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          607 NGER-LPM-------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HTCC-CCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCC-CCC-------------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            1111 000             014456788999999999999999999999999998753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.7e-45  Score=325.32  Aligned_cols=252  Identities=19%  Similarity=0.231  Sum_probs=202.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC----hhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR----PRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|.+......    ....+.+.+|+.++++++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFA---IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK   80 (283)
T ss_dssp             HHHEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhHHhhcccCce---EEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence            3568889999999999   9999998  6899999998765322    12467899999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC----ceE
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN----VAK  210 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~k  210 (353)
                      +..++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++++||||||+||+++.++    .++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred             CeEEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceE
Confidence            9999999999999999999754     35899999999999999999999   89999999999999998877    899


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      |+|||++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....        ......
T Consensus       153 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~  222 (283)
T 3bhy_A          153 LIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTN  222 (283)
T ss_dssp             ECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH
T ss_pred             EEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHH
Confidence            999999987643322  2345689999999999988899999999999999999999999874321        111111


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .. ....          ..........+..+.+++.+||..||++|||+.++++
T Consensus       223 ~~-~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          223 IS-AVNY----------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HH-TTCC----------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hH-hccc----------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            11 1100          0011111144567889999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-44  Score=336.78  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=206.5

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC--C----hhHHHHHHHHHHHHhhc-CCCcee
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC--R----PRAYESCINNVTYAARM-SHNHIL  125 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~--~----~~~~~~~~~E~~~l~~l-~H~niv  125 (353)
                      .......++|...+.||+|+||   .||++.+  +|+.||||++.....  .    ....+.+.+|+.++.++ +||||+
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g---~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv  163 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSS---VVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII  163 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             hhhhhhhhhcccceEEecCCCE---EEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            3344556789999999999999   9999998  689999999865531  1    12246788999999999 799999


Q ss_pred             eccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          126 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       126 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      ++++++...+..++||||+++++|.+++...     ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.
T Consensus       164 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~  235 (365)
T 2y7j_A          164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDD  235 (365)
T ss_dssp             CEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred             EEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            9999999999999999999999999998754     35889999999999999999999   899999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCccccccccCCcccccccccc------CCCCccccchhhHHHHHHHHhCCCCCCccccccC
Q 018633          206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT------GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD  279 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~  279 (353)
                      ++.++|+|||++........  .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||.....   
T Consensus       236 ~~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---  310 (365)
T 2y7j_A          236 NMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---  310 (365)
T ss_dssp             TCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred             CCCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---
Confidence            99999999999987654332  345679999999999863      3588999999999999999999999864221   


Q ss_pred             CCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                           ....... ......          .........+..+.+++.+||+.||++|||+.++++
T Consensus       311 -----~~~~~~i-~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          311 -----ILMLRMI-MEGQYQ----------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -----HHHHHHH-HHTCCC----------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----HHHHHHH-HhCCCC----------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 1111111 111110          000001134567889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=337.28  Aligned_cols=258  Identities=19%  Similarity=0.246  Sum_probs=190.3

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceee---
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCL---  132 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~---  132 (353)
                      ....+|...+.||+|+||   .||++.+  +++.||+|++...  .....+.+.+|+.++.++. ||||+++++++.   
T Consensus        25 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFA---FVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             ETTEEEEEEEEEECCSSE---EEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             ccCceEEEEEEEccCCce---EEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            344578999999999999   9999998  8899999998665  5666778999999999996 999999999984   


Q ss_pred             -----eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeecC
Q 018633          133 -----ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFNE  205 (353)
Q Consensus       133 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~~  205 (353)
                           .....++||||+. |+|.+++......  ..+++..++.++.|++.||.|||   +++  |+||||||+|||++.
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~  173 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSN  173 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECT
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECC
Confidence                 3345799999996 7999988652211  46899999999999999999999   888  999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCc-----------cccccccCCcccccccc---ccCCCCccccchhhHHHHHHHHhCCCCC
Q 018633          206 ENVAKLFDFSLSISIPEGETH-----------ITDTVMGTWGYCAPEYM---RTGVFNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~slG~il~el~tg~~p~  271 (353)
                      ++.+||+|||+++........           ......||+.|+|||++   .+..++.++||||||+++|+|++|..||
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            999999999999876433221           11245689999999998   5667899999999999999999999998


Q ss_pred             CccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          272 DLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .......        .    . .........            ...+..+.+|+.+||+.||++|||+.++++.|..+..
T Consensus       254 ~~~~~~~--------~----~-~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          254 EDGAKLR--------I----V-NGKYSIPPH------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -------------------------CCCCTT------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHH--------h----h-cCcccCCcc------------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            6432211        0    0 000000000            0223346789999999999999999999999998875


Q ss_pred             h
Q 018633          352 S  352 (353)
Q Consensus       352 ~  352 (353)
                      .
T Consensus       309 ~  309 (337)
T 3ll6_A          309 A  309 (337)
T ss_dssp             H
T ss_pred             c
Confidence            3

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.3e-45  Score=328.76  Aligned_cols=250  Identities=21%  Similarity=0.291  Sum_probs=201.5

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..++|...+.||+|+||   .||++.+  +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         7 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFS---EVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhccceeeeeccCCCCc---eEEEEEECCCCCEEEEEEEecc--cccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            34678889999999999   9999998  7899999999765  333456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee---cCCCceEEecc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDF  214 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~df  214 (353)
                      ++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+||++   +.++.++|+||
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             EEEEEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccC
Confidence            9999999999999988754     35889999999999999999999   8999999999999999   77899999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      |++......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....        ........ .
T Consensus       154 g~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~-~  221 (304)
T 2jam_A          154 GLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIK-E  221 (304)
T ss_dssp             STTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH-H
T ss_pred             CcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-c
Confidence            998754322   12345689999999999988999999999999999999999999874221        11111111 1


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .... ...+         .....+..+.+++.+||..||++|||+.++++
T Consensus       222 ~~~~-~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          222 GYYE-FESP---------FWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CCCC-CCTT---------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCC-CCcc---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1110 0000         00134567889999999999999999999976

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.6e-45  Score=332.39  Aligned_cols=262  Identities=18%  Similarity=0.274  Sum_probs=205.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .++|...+.||+|+||   .||+|.+       ++..||+|.+.... .......+.+|+.++++++||||+++++++.+
T Consensus        29 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFG---EVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSS---CEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCe---eEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            4679999999999999   8888873       56689999996442 45566789999999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCC--CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---CCc
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQP--HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---ENV  208 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~  208 (353)
                      .+..++||||+++|+|.+++......  ....+++..++.++.|++.||.|||   +++|+||||||+|||++.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcce
Confidence            99999999999999999999865321  1135889999999999999999999   899999999999999984   446


Q ss_pred             eEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHH
Q 018633          209 AKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~  286 (353)
                      ++|+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|+| |..||.....        ..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~  253 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QE  253 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HH
Confidence            99999999875533221 12334567889999999998899999999999999999998 8889863221        11


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .. ...........             +...+..+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       254 ~~-~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          254 VL-EFVTSGGRMDP-------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HH-HHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH-HHHhcCCCCCC-------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            11 11111111100             01345678899999999999999999999999988764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-45  Score=358.54  Aligned_cols=254  Identities=20%  Similarity=0.280  Sum_probs=206.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...++||+|+||   .||++..  +++.||+|++..... .......+.+|+.+|++++|||||++++++.+.+..
T Consensus       183 ~~~f~~~~~LG~G~fG---~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFG---EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             GGGEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEeeCCCE---EEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            4678889999999999   9999998  799999999865321 123346688999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccc
Confidence            999999999999999876532   35899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      +.......  .....||+.|+|||++.+..++.++|||||||++|||++|..||.......     ....+.........
T Consensus       334 ~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-----~~~~i~~~i~~~~~  406 (576)
T 2acx_A          334 VHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKEVPE  406 (576)
T ss_dssp             EECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-----CHHHHHHHHHHCCC
T ss_pred             eecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-----hHHHHHHHhhcccc
Confidence            87654332  345589999999999998889999999999999999999999997533211     11111111111100


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                                ..+    ...+..+.+|+.+||..||.+||     ++.++++
T Consensus       407 ----------~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 ----------EYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----------CCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----------cCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                      000    13456788999999999999999     6788764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=341.12  Aligned_cols=265  Identities=15%  Similarity=0.119  Sum_probs=197.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChh---------HHHHHHHHHHHHhhcCCCceee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPR---------AYESCINNVTYAARMSHNHILK  126 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~  126 (353)
                      .++|...+.||+|+||   .||+|.+     ++..||+|++........         ....+.+|+..+..++||||++
T Consensus        36 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFG---LIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC---------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCe---EEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            3578889999999999   9999998     467899999876521110         1134678889999999999999


Q ss_pred             ccceeee----CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCcee
Q 018633          127 LIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL  202 (353)
Q Consensus       127 ~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  202 (353)
                      +++++..    ....++||||+ +++|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  183 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLL  183 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEE
Confidence            9999987    67899999999 89999998765     36899999999999999999999   899999999999999


Q ss_pred             ecCCC--ceEEeccCCccccCCCCC------ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcc
Q 018633          203 FNEEN--VAKLFDFSLSISIPEGET------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLV  274 (353)
Q Consensus       203 l~~~~--~~kl~dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~  274 (353)
                      ++.++  .+||+|||+++.......      .......||..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98877  999999999977643211      1124557999999999999888999999999999999999999999632


Q ss_pred             ccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          275 KDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ....    ...........     ..+...+....+   ....+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       264 ~~~~----~~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          264 LKDP----VAVQTAKTNLL-----DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             TTCH----HHHHHHHHHHH-----HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             cccc----HHHHHHHHhhc-----ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1111    00000000000     000000000000   003456789999999999999999999999999764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.5e-46  Score=333.28  Aligned_cols=254  Identities=17%  Similarity=0.202  Sum_probs=188.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++..........+.+.++...++.++||||+++++++.+.+..+
T Consensus         6 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            6 ADDLEPIMELGRGAYG---VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             HHhhhhHHhcCCCCCe---EEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            4678899999999999   9999998  8999999999765433444445556666688899999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC-CeEeeccCCCceeecCCCceEEeccCCc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      +||||++ |+|.+++....... ..+++..++.++.|++.||.|||   ++ +|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           83 ICMELMD-TSLDKFYKQVIDKG-QTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEECCS-EEHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             EEEehhc-cchHHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            9999997 68877765421100 46899999999999999999999   87 9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCcccccccc----ccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYM----RTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ........  .....||+.|+|||++    .+..++.++||||||+++|+|++|..||.....       ..........
T Consensus       158 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~  228 (290)
T 3fme_A          158 GYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQVVE  228 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHHHHH
T ss_pred             cccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHHHhc
Confidence            77643322  3345789999999996    455689999999999999999999999863221       1112222222


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .... ...            ....+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~-~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          229 EPSP-QLP------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             SCCC-CCC------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCC-Ccc------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111 000            0134567889999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.6e-45  Score=329.80  Aligned_cols=249  Identities=18%  Similarity=0.238  Sum_probs=205.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+..
T Consensus        14 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFA---KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TEEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEeecCCE---EEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            4568889999999999   9999998  68899999986543 2345667899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  162 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA  162 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence            9999999999999988754     35889999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ........ ......||..|+|||++.+..++.++||||||+++|+|++|..||.....        .+...... ....
T Consensus       163 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~  232 (294)
T 2rku_A          163 TKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIK-KNEY  232 (294)
T ss_dssp             EECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTCC
T ss_pred             eecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-hccC
Confidence            87643222 23456789999999999988899999999999999999999999874321        11111111 1110


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       .         .+    ...+..+.+++.+||+.||++|||+.++++
T Consensus       233 -~---------~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 -S---------IP----KHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             -C---------CC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -C---------Cc----cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence             0         00    033456789999999999999999999876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-45  Score=354.40  Aligned_cols=251  Identities=17%  Similarity=0.274  Sum_probs=202.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...++||+|+||   .||++.+  +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+....|
T Consensus       185 ~~f~~~~~LG~G~fG---~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFG---EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             GGEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hheEEEEEEeeCCCe---EEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            578888899999999   9999998  789999999965421 1233567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++|+|.+++....... ..+++..++.++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+++
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~-~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDN-PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTS-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEeccCCCHHHHHHHhhccc-ccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence            9999999999999987643211 46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......    ............ .. 
T Consensus       338 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~----~~~~~~~~i~~~-~~-  410 (543)
T 3c4z_A          338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRVLEQ-AV-  410 (543)
T ss_dssp             ECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC----CHHHHHHHHHHC-CC-
T ss_pred             eccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch----hHHHHHHHHhhc-cc-
Confidence            7654332 2345689999999999999899999999999999999999999997542211    111111111111 00 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                               ..    +...+..+.+|+.+||+.||++||++
T Consensus       411 ---------~~----p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 ---------TY----PDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ---------CC----CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             ---------CC----CcccCHHHHHHHHHhccCCHhHCCCC
Confidence                     00    01445677899999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-45  Score=332.20  Aligned_cols=259  Identities=21%  Similarity=0.390  Sum_probs=197.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe---CC--eEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW---QE--RLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~---~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .++|...+.||+|+||   .||+|.+   ++  ..||+|++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus        17 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGGEEEEEECC----C---CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhHeeeeeeecCCCce---eEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4578999999999999   8888876   22  3689999875432 345567899999999999999999999998765


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      . .++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+||
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             C-ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccc
Confidence            4 889999999999999997643    46889999999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHH
Q 018633          215 SLSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       215 g~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      |++.........  ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.....        .......
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~  237 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKI  237 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHH
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHH
Confidence            999876543322  1234567788999999988889999999999999999999 9999874321        1222222


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ........             .+...+..+.+++.+||+.||++|||+.++++.|.++..
T Consensus       238 ~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          238 DKEGERLP-------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HTSCCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HccCCCCC-------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            11111000             001445678899999999999999999999999988743

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2e-44  Score=333.22  Aligned_cols=268  Identities=15%  Similarity=0.210  Sum_probs=202.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee-----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-----  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-----  133 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++............+.+|+.+++.++||||+++++++..     
T Consensus        16 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFG---EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             GGGEEEEEECSSCSTT---SEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             ccceeEEEEEecCCCc---EEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            4679999999999999   9999998  78999999997665445556678899999999999999999999987     


Q ss_pred             ---CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          134 ---TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       134 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                         .+..++||||++ |+|.+.+....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+|
T Consensus        93 ~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~k  164 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLK  164 (351)
T ss_dssp             ----CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred             ccCCceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEE
Confidence               346899999997 58888876654    46899999999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCC---ccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          211 LFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       211 l~dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      |+|||+++.......   .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......     ...
T Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~  239 (351)
T 3mi9_A          165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLA  239 (351)
T ss_dssp             ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHH
T ss_pred             EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHH
Confidence            999999987643221   12345678999999999876 458999999999999999999999997533211     000


Q ss_pred             HHHHHhhc---Ccccccc-----cch--hhhccch----HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          287 YLKNYFED---NRFTEIV-----DPI--IVEDVLS----IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       287 ~~~~~~~~---~~~~~~~-----~~~--~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........   ..++...     +..  .......    ......+..+.+|+.+||+.||++|||+.++++
T Consensus       240 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00000000   0000000     000  0000000    000112456889999999999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.3e-45  Score=328.43  Aligned_cols=247  Identities=18%  Similarity=0.283  Sum_probs=203.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  ++..||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        13 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFG---NVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhceeeheecCCCCe---EEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            3678899999999999   9999998  688999999864311 122346789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  161 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS  161 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEeccccc
Confidence            9999999999999998764     35889999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      .......   .....|+..|+|||++.+..++.++||||||+++|+|++|..||......        ........ ...
T Consensus       162 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~-~~~  229 (284)
T 2vgo_A          162 VHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRRIVN-VDL  229 (284)
T ss_dssp             EECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHT-TCC
T ss_pred             ccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHHHhc-ccc
Confidence            7654322   34567899999999999888999999999999999999999998743211        11111111 110


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                ..+    ...+..+.+++.+||+.||.+|||+.++++
T Consensus       230 ----------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 ----------KFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ----------CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----------CCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                      000    134456789999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=328.22  Aligned_cols=250  Identities=20%  Similarity=0.263  Sum_probs=199.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..+.|...+.||+|+||   .||+|.+  +++.||+|.+...    ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus        27 ~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYG---SVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             ---CEEEEEECC----C---EEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhhhheeeccCCCe---EEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            35678899999999999   9999998  5899999999754    2346789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  172 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA  172 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccc
Confidence            99999999999999986432    46899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ....... .......||..|+|||++.+..++.++||||||+++|+|++|..||......        ...... .....
T Consensus       173 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~-~~~~~  242 (314)
T 3com_A          173 GQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMI-PTNPP  242 (314)
T ss_dssp             EECBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHH-HHSCC
T ss_pred             hhhhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHH-hcCCC
Confidence            7764322 2234557899999999999888999999999999999999999998743211        111111 11111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....           +...+..+.+++.+||..||++|||+.++++
T Consensus       243 ~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          243 PTFRK-----------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCCSS-----------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccCC-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            01000           1134567889999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.3e-45  Score=330.32  Aligned_cols=252  Identities=18%  Similarity=0.220  Sum_probs=198.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..+.|...+.||+|+||   .||+|.+  ++..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        17 ~~~~y~i~~~lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFG---KVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTC---CEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             CccceeecceeccCCCe---EEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            44678889999999999   9999999  5889999998765  455678899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||++
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            99999999999999887543    45899999999999999999999   899999999999999999999999999987


Q ss_pred             cccCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ...... ........||..|+|||++.     ...++.++||||||+++|+|++|..||.....        ........
T Consensus       165 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~  235 (302)
T 2j7t_A          165 AKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIA  235 (302)
T ss_dssp             HHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH
T ss_pred             cccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHh
Confidence            543111 11123456899999999983     56688999999999999999999999874322        11111111


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .. .......           +...+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~-~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          236 KS-DPPTLLT-----------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HS-CCCCCSS-----------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cc-CCcccCC-----------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11 1111100           1134567889999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-44  Score=346.89  Aligned_cols=262  Identities=15%  Similarity=0.153  Sum_probs=207.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC-ceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHN-HILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++....    ....+.+|+.++..++|+ +|..+..++...+..
T Consensus         6 ~~~y~i~~~LG~G~fG---~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFG---EIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             TTTEECCCCCEECSSC---EEEEEEETTTCCEEEEEEEETTC----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CCcEEEEEEEeeCCCE---EEEEEEECCCCcEEEEEEecccc----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4679999999999999   9999997  78999999886552    223578899999999974 555566666777888


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee---cCCCceEEecc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDF  214 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill---~~~~~~kl~df  214 (353)
                      ++||||+ +++|.+++....    ..+++..++.|+.||+.||.|||   +++|+||||||+|||+   +.++.+||+||
T Consensus        79 ~lvme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeC
Confidence            9999999 899999997543    46899999999999999999999   9999999999999999   68899999999


Q ss_pred             CCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          215 SLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       215 g~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      |+++........      ......||..|+|||++.+..++.++|||||||++|||++|..||.......     .....
T Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-----~~~~~  225 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKY  225 (483)
T ss_dssp             TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-----HHHHH
T ss_pred             CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh-----HHHHH
Confidence            999876543321      1235679999999999999999999999999999999999999997543321     01111


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ....         ........ ......++.++.+|+..||+.+|++||++.+|++.|+++...
T Consensus       226 ~~i~---------~~~~~~~~-~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          226 EKIS---------EKKVATSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHHH---------HHHHHSCH-HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHh---------hccccccH-HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            1100         00000000 011114467889999999999999999999999999998753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=335.45  Aligned_cols=261  Identities=19%  Similarity=0.242  Sum_probs=200.0

Q ss_pred             ceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceee
Q 018633           50 RIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILK  126 (353)
Q Consensus        50 ~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~  126 (353)
                      ..+++.++....++|...+.||+|+||   .||+|.+  +++.||+|++...   ....+.+.+|+.++.++ +||||++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~   85 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYG---QVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIAT   85 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECC---SSTTHHHHHHHHHHHHHCCSTTBCC
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCE---EEEEEEECCCCCeEEEEEEecC---cccHHHHHHHHHHHHhccCCCCeee
Confidence            334455555677889999999999999   9999999  8899999998654   23446788999999999 7999999


Q ss_pred             ccceeee------CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCc
Q 018633          127 LIGCCLE------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC  200 (353)
Q Consensus       127 ~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  200 (353)
                      +++++..      .+..++||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~N  159 (326)
T 2x7f_A           86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQN  159 (326)
T ss_dssp             EEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGG
T ss_pred             eeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHH
Confidence            9999986      4578999999999999999976532   46889999999999999999999   8999999999999


Q ss_pred             eeecCCCceEEeccCCccccCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          201 ILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       201 ill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                      ||++.++.+||+|||++....... .......||..|+|||++.     ...++.++||||||+++|+|++|..||....
T Consensus       160 Il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          160 VLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             EEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999987654322 1234457899999999986     4568899999999999999999999986332


Q ss_pred             cccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..        ....... ....+....            ...+..+.+++.+||..||++|||+.++++
T Consensus       239 ~~--------~~~~~~~-~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          239 PM--------RALFLIP-RNPAPRLKS------------KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HH--------HHHHHHH-HSCCCCCSC------------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH--------HHHHHhh-cCccccCCc------------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11        1111111 111111110            034567889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.9e-45  Score=335.94  Aligned_cols=249  Identities=18%  Similarity=0.240  Sum_probs=205.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        40 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFA---KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TEEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCceEEEEEEeeCCCe---EEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            4678889999999999   9999998  68899999986543 2345677899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       117 ~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  188 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA  188 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCc
Confidence            9999999999999988754     35889999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ........ ......||..|+|||++.+..++.++||||||+++|+|++|..||.....        ......... ...
T Consensus       189 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~-~~~  258 (335)
T 2owb_A          189 TKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKK-NEY  258 (335)
T ss_dssp             EECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-TCC
T ss_pred             eecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHhc-CCC
Confidence            87643222 23456789999999999988899999999999999999999999874221        111111111 110


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       .+         +    ...+..+.+|+.+||+.||++|||+.++++
T Consensus       259 -~~---------~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 -SI---------P----KHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -CC---------C----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -CC---------C----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00         0    033456788999999999999999999876

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=333.36  Aligned_cols=266  Identities=19%  Similarity=0.221  Sum_probs=197.6

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC---hhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR---PRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||+|++......   ....+.+.+|+.++++++||||+++++++.+
T Consensus         7 ~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFA---TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ------CEEEEEEEETTE---EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             HHhcccEEEeEEeecCCE---EEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            445779999999999999   9999998  6899999999754211   1123468899999999999999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..++||||++ ++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D  155 (346)
T 1ua2_A           84 KSNISLVFDFME-TDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLAD  155 (346)
T ss_dssp             TTCCEEEEECCS-EEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCceEEEEEcCC-CCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEe
Confidence            999999999998 58988887654    46788899999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......        ......+
T Consensus       156 fg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--------~~~~~i~  226 (346)
T 1ua2_A          156 FGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--------DQLTRIF  226 (346)
T ss_dssp             CGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred             cccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHH
Confidence            999987643322 23456789999999998764 4889999999999999999999998743321        1111111


Q ss_pred             hc------Cccccc---ccchhhhccch----HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 ED------NRFTEI---VDPIIVEDVLS----IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~------~~~~~~---~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..      ..++..   .+.......+.    ......+..+.+|+.+||..||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            11      000000   00000000000    000134577899999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-44  Score=340.70  Aligned_cols=198  Identities=20%  Similarity=0.243  Sum_probs=174.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc------CCCceeeccceee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM------SHNHILKLIGCCL  132 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~~~~~~~  132 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++...   ....+.+.+|+.++..+      .|+||+++++++.
T Consensus        96 ~~ry~~~~~LG~G~fg---~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFG---QVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             TTTEEEEEEEEESSSE---EEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cCcEEEEEEcccCccE---EEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            4568889999999999   9999988  6899999999754   45567788899999887      5779999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc--eE
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV--AK  210 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--~k  210 (353)
                      ..+..++||||+. ++|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.  +|
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vk  242 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIK  242 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEE
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceE
Confidence            9999999999996 799999876543   35899999999999999999999   899999999999999999887  99


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                      |+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       243 L~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          243 VIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             ECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999765332    235678999999999999999999999999999999999999997543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1e-44  Score=336.38  Aligned_cols=271  Identities=15%  Similarity=0.152  Sum_probs=200.5

Q ss_pred             cHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCC---------ChhHHHHHHHHHHHHhhcCCC
Q 018633           53 SAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHEC---------RPRAYESCINNVTYAARMSHN  122 (353)
Q Consensus        53 ~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~H~  122 (353)
                      ..+++....++|...+.||+|+||   .||+|.+ ++..||||++.....         .....+.+.+|+.++++++||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   89 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYG---AVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP   89 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTE---EEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred             HHHHHHHhccceEEeEEeccCCCE---EEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence            456778889999999999999999   9999988 889999999865422         122347899999999999999


Q ss_pred             ceeeccceeeeC-----CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccC
Q 018633          123 HILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK  197 (353)
Q Consensus       123 niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  197 (353)
                      ||+++++++...     ...|+||||++ |+|.+.+....    ..+++..++.++.|++.||.|||   +++|+|||||
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk  161 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLH  161 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCC
Confidence            999999998543     35799999998 78988887653    46899999999999999999999   8999999999


Q ss_pred             CCceeecCCCceEEeccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCcccc
Q 018633          198 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKD  276 (353)
Q Consensus       198 p~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~  276 (353)
                      |+|||++.++.+||+|||++.......  ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999997543322  2345578999999999877 6689999999999999999999999974332


Q ss_pred             ccCCCCChHHHHHHHhhc---Cc-----------ccccccchhh---hccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          277 THDLACPSNEYLKNYFED---NR-----------FTEIVDPIIV---EDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~---~~-----------~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                      ..        ........   ..           ..........   ...........+..+.+|+.+||+.||++|||+
T Consensus       240 ~~--------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  311 (362)
T 3pg1_A          240 YN--------QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST  311 (362)
T ss_dssp             HH--------HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HH--------HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence            11        11111100   00           0000000000   000000111345678899999999999999999


Q ss_pred             HHHHH
Q 018633          340 VDVAK  344 (353)
Q Consensus       340 ~~vl~  344 (353)
                      .++++
T Consensus       312 ~ell~  316 (362)
T 3pg1_A          312 EQALR  316 (362)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            99985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=339.89  Aligned_cols=264  Identities=17%  Similarity=0.245  Sum_probs=204.7

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      ++.....++|...+.||+|+||   .||+|.+.+ .||+|++..........+.+.+|+.++++++||||+++++++.+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g---~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFG---QVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSS---EEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccCCHHHeEEeeEeccCCce---EEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            3344456789999999999999   999999865 499999876544444556788999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                      +..++||||+++++|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++ ++.++|+||
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred             CceEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeec
Confidence            99999999999999999997653    46889999999999999999999   89999999999999998 679999999


Q ss_pred             CCccccCCCC----CccccccccCCcccccccccc---------CCCCccccchhhHHHHHHHHhCCCCCCccccccCCC
Q 018633          215 SLSISIPEGE----THITDTVMGTWGYCAPEYMRT---------GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA  281 (353)
Q Consensus       215 g~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~  281 (353)
                      |++.......    ........||..|+|||++..         ..++.++||||||+++|+|++|..||.....     
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----  248 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----  248 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            9986543211    112234568899999999864         3478899999999999999999999874321     


Q ss_pred             CChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                         ........ ....+.....            ..+..+.+++.+||..||++|||+.++++.|+++.+
T Consensus       249 ---~~~~~~~~-~~~~~~~~~~------------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          249 ---EAIIWQMG-TGMKPNLSQI------------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             ---HHHHHHHH-TTCCCCCCCS------------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             ---HHHHHHhc-cCCCCCCCcC------------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence               11111111 1111111100            234457899999999999999999999999987654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-46  Score=342.93  Aligned_cols=255  Identities=18%  Similarity=0.230  Sum_probs=202.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhc-CCCceeeccceee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHEC--RPRAYESCINNVTYAARM-SHNHILKLIGCCL  132 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~  132 (353)
                      .++|...+.||+|+||   .||++..     +++.||||++.....  .....+.+.+|+.++.++ +||||+++++++.
T Consensus        53 ~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           53 IENFELLKVLGTGAYG---KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             GGGEEEEEEEEETTTE---EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccceEEEEEeccCCCE---EEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            3679999999999999   9998887     689999999865321  123345677899999999 6999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                      ..+..++||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~  201 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT  201 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEES
T ss_pred             eCceEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEe
Confidence            999999999999999999999764     35889999999999999999999   8999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCcccccccccc--CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      |||+++..............||+.|+|||++.+  ..++.++|||||||++|||++|..||.......    ........
T Consensus       202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~  277 (355)
T 1vzo_A          202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRR  277 (355)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHH
T ss_pred             eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----hHHHHHHH
Confidence            999998764433333445679999999999985  347899999999999999999999997432211    11111111


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAKK  345 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~~  345 (353)
                      ..... .          ..    +...+..+.+|+.+||..||++||     |+.++++.
T Consensus       278 ~~~~~-~----------~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          278 ILKSE-P----------PY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHCC-C----------CC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HhccC-C----------CC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            11110 0          00    013455678999999999999999     89988753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.7e-44  Score=335.52  Aligned_cols=259  Identities=18%  Similarity=0.176  Sum_probs=185.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET----  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----  134 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++..........+.+.+|+.+++.++||||+++++++...    
T Consensus        28 ~~~y~~~~~lG~G~~g---~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           28 PERYQNLSPVGSGAYG---SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             ETTEEEEEECC----C---CEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCceEEeeEEeecCCe---EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            4689999999999999   9999987  799999999976654566778899999999999999999999998654    


Q ss_pred             --CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          135 --PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       135 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                        ...|+|+|++ +++|.+++..      ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             GCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEe
Confidence              5679999999 6899988865      35889999999999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      |||+++.....    .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.......        .+...
T Consensus       175 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~l~~i  242 (367)
T 2fst_X          175 DFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--------QLKLI  242 (367)
T ss_dssp             C-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHH
T ss_pred             ecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH
Confidence            99999765332    234578999999999877 678999999999999999999999997543211        11111


Q ss_pred             hhc--Ccccc----cccch-------hh--hccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FED--NRFTE----IVDPI-------IV--EDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~--~~~~~----~~~~~-------~~--~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...  ....+    +....       +.  .... .......+..+.+|+.+||..||++|||+.++++
T Consensus       243 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            100  00000    00000       00  0000 0000123567889999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-44  Score=329.59  Aligned_cols=263  Identities=14%  Similarity=0.176  Sum_probs=199.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeee--CC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLE--TP  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~--~~  135 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||+|++...     ..+.+.+|+.++++++ ||||+++++++.+  ..
T Consensus        35 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYS---EVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCceEEEEEecccCCe---EEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            3678889999999999   9999987  8899999998654     3467899999999998 9999999999987  56


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ceEEecc
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDF  214 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~df  214 (353)
                      ..++||||+++++|.+++.        .+++..++.++.|++.||.|||   +++|+||||||+|||++.++ .+||+||
T Consensus       107 ~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             ceEEEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence            7899999999999998874        4788899999999999999999   99999999999999999776 8999999


Q ss_pred             CCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCC-----hHHHH
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACP-----SNEYL  288 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~-----~~~~~  288 (353)
                      |+++.......  .....||..|+|||++.+ ..++.++|||||||++|+|++|..||............     .....
T Consensus       176 g~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~  253 (330)
T 3nsz_A          176 GLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  253 (330)
T ss_dssp             TTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             CCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence            99987644332  345678999999999877 56899999999999999999999998533221100000     00000


Q ss_pred             HHHhhcCcc--cccc--------cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRF--TEIV--------DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~--~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .........  ....        ................+..+.+|+.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000  0000        0000000000011135677899999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-44  Score=334.10  Aligned_cols=267  Identities=15%  Similarity=0.180  Sum_probs=202.3

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC--
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--  134 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~--  134 (353)
                      ...++|...+.||+|+||   .||++.+  ++..||+|++.... .....+.+.+|+.++.+++||||+++++++...  
T Consensus        24 ~~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYG---MVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             CCTTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccccEEEEEEeecCCCe---EEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            445689999999999999   9999988  78999999997542 455567899999999999999999999998754  


Q ss_pred             ---CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          135 ---PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       135 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                         ...++||||+. |+|.+++...      .+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl  169 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKI  169 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEE
Confidence               36899999997 6999988753      5889999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCc--cccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          212 FDFSLSISIPEGETH--ITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      +|||++.........  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||........     ....
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~i  244 (364)
T 3qyz_A          170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-----LNHI  244 (364)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-----HHHH
T ss_pred             EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-----HHHH
Confidence            999999876432211  12445799999999987654 489999999999999999999999975433220     0000


Q ss_pred             HHHhhcCcc---cccccch-------h--hhccc-hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRF---TEIVDPI-------I--VEDVL-SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~---~~~~~~~-------~--~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .........   ....+..       .  ..... .......+..+.+|+.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000   0000000       0  00000 0000134567889999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-45  Score=342.90  Aligned_cols=255  Identities=9%  Similarity=0.001  Sum_probs=181.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc--CCCceeecc-------
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM--SHNHILKLI-------  128 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~H~niv~~~-------  128 (353)
                      ..+|...+.||+|+||   .||+|.+  +++.||+|++..... .....+.+.+|+.++..+  +||||++++       
T Consensus        61 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~  137 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRS---VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS  137 (371)
T ss_dssp             EEEEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred             ceeeeeeeeccCCCCE---EEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence            3458889999999999   9999997  789999999987643 234556778886555555  699988755       


Q ss_pred             ceeeeC-----------------CccEEEEEeccCCChhhhhccCCCCCCccccHHHH------HHHHHHHHHHHHHHhc
Q 018633          129 GCCLET-----------------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR------LKIAMDIVHALAYLHF  185 (353)
Q Consensus       129 ~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~  185 (353)
                      +++...                 ...|+||||++ |+|.+++....    ..+++..+      +.++.||+.||.||| 
T Consensus       138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH-  211 (371)
T 3q60_A          138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ-  211 (371)
T ss_dssp             EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH-
Confidence            344332                 23799999998 89999997642    22344444      677899999999999 


Q ss_pred             CCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCCcccccccccc--CCCCccccchhhHHHHHH
Q 018633          186 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFE  263 (353)
Q Consensus       186 ~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~e  263 (353)
                        +++|+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++|||||||++||
T Consensus       212 --~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          212 --SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             --HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             --HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence              999999999999999999999999999999876321    224456799999999987  679999999999999999


Q ss_pred             HHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          264 LLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       264 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                      |++|..||..........          +............    .........+..+.+|+.+||+.||++|||+.+++
T Consensus       286 lltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  351 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGS----------WKRPSLRVPGTDS----LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM  351 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTC----------CCBCCTTSCCCCS----CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred             HHhCCCCCCCcCcccccc----------hhhhhhhhccccc----cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            999999997543221000          0000000000000    00000014456788999999999999999999997


Q ss_pred             H
Q 018633          344 K  344 (353)
Q Consensus       344 ~  344 (353)
                      +
T Consensus       352 ~  352 (371)
T 3q60_A          352 E  352 (371)
T ss_dssp             T
T ss_pred             c
Confidence            4

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.8e-44  Score=321.46  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=204.4

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC---C----hhHHHHHHHHHHHHhhcC-CCceeecc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC---R----PRAYESCINNVTYAARMS-HNHILKLI  128 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-H~niv~~~  128 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||+|++.....   .    ....+.+.+|+.++.++. ||||++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSS---VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             -CTTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             chhhccceeeeecCCCce---EEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            445789999999999999   9999998  789999999965421   1    233567889999999996 99999999


Q ss_pred             ceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc
Q 018633          129 GCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV  208 (353)
Q Consensus       129 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~  208 (353)
                      +++.+.+..++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~  162 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMN  162 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCc
Confidence            9999999999999999999999999764     36889999999999999999999   999999999999999999999


Q ss_pred             eEEeccCCccccCCCCCccccccccCCccccccccc------cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR------TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                      ++|+|||++........  .....||..|+|||++.      ...++.++||||||+++|+|++|..||.....      
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------  234 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------  234 (298)
T ss_dssp             EEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred             EEEecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------
Confidence            99999999987644322  34557899999999985      34588999999999999999999999863221      


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                        ........ ...... ..+         .....+..+.+++.+||+.||++|||+.++++
T Consensus       235 --~~~~~~~~-~~~~~~-~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 --MLMLRMIM-SGNYQF-GSP---------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHHHHH-HTCCCC-CTT---------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHHHHh-cCCccc-Ccc---------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              11111111 111100 000         00145567889999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.1e-45  Score=336.52  Aligned_cols=264  Identities=15%  Similarity=0.217  Sum_probs=205.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCCh---------------hHHHHHHHHHHHHhhcCCCcee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRP---------------RAYESCINNVTYAARMSHNHIL  125 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~H~niv  125 (353)
                      .++|...+.||+|+||   .||++.++++.||+|++.......               ...+.+.+|+.++++++||||+
T Consensus        30 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           30 INDYRIIRTLNQGKFN---KIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             ETTEEEEEEEECCSSC---CEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cCceEEEEEEcCCCCe---EEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            4689999999999999   999999999999999986442111               1127899999999999999999


Q ss_pred             eccceeeeCCccEEEEEeccCCChhhh------hccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCC
Q 018633          126 KLIGCCLETPIPILVFESVQYGTLWDR------ILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKT  198 (353)
Q Consensus       126 ~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp  198 (353)
                      ++++++.+.+..++||||+++|+|.++      +.....   ..+++..++.++.|++.||.|||   + ++|+||||||
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p  180 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT---CFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKP  180 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSC---CCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCG
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc---cCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCCh
Confidence            999999999999999999999999998      554222   56899999999999999999999   7 9999999999


Q ss_pred             CceeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccC-CCCc-cccchhhHHHHHHHHhCCCCCCcccc
Q 018633          199 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNE-KSDVFSFGVFLFELLTGWDVSDLVKD  276 (353)
Q Consensus       199 ~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Di~slG~il~el~tg~~p~~~~~~  276 (353)
                      +||+++.++.++|+|||++......   ......||..|+|||++.+. .++. ++||||||+++|+|++|..||.....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             HhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999999999999999999775432   23456789999999999877 6666 99999999999999999999974332


Q ss_pred             ccCCCCChHHHHHHHhhcCcccccc--cch---hhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          277 THDLACPSNEYLKNYFEDNRFTEIV--DPI---IVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .       ....... .........  ...   .............+..+.+|+.+||+.||++|||+.++++
T Consensus       258 ~-------~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          258 L-------VELFNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             S-------HHHHHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H-------HHHHHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1       1111111 111110000  000   0000000011245677899999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-44  Score=330.11  Aligned_cols=254  Identities=18%  Similarity=0.258  Sum_probs=197.5

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC------ChhHHHHHHHHHHHHhhcCCCceeeccce
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC------RPRAYESCINNVTYAARMSHNHILKLIGC  130 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~~~~~  130 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||||++.....      .......+.+|+.++++++||||++++++
T Consensus         7 ~l~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   83 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACG---EVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF   83 (322)
T ss_dssp             HHHHHEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhceeEeeEEecCCCE---EEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence            345679999999999999   9999998  789999999865421      11233458899999999999999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc--
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV--  208 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~--  208 (353)
                      +.... .++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.  
T Consensus        84 ~~~~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~  154 (322)
T 2ycf_A           84 FDAED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDC  154 (322)
T ss_dssp             EESSS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSC
T ss_pred             EcCCc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCC
Confidence            86654 89999999999999988754     46889999999999999999999   999999999999999987654  


Q ss_pred             -eEEeccCCccccCCCCCccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh
Q 018633          209 -AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS  284 (353)
Q Consensus       209 -~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~  284 (353)
                       +||+|||++......  .......||+.|+|||++.   ...++.++||||||+++|+|++|..||.......    ..
T Consensus       155 ~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~  228 (322)
T 2ycf_A          155 LIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SL  228 (322)
T ss_dssp             CEEECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CH
T ss_pred             eEEEccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HH
Confidence             999999999876432  1233457899999999974   4568899999999999999999999987433221    01


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .    .........          ..+......+..+.+++.+||..||++|||+.++++
T Consensus       229 ~----~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          229 K----DQITSGKYN----------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             H----HHHHHTCCC----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             H----HHHHhCccc----------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1    111111110          001111145677889999999999999999999984

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.8e-45  Score=329.91  Aligned_cols=266  Identities=18%  Similarity=0.295  Sum_probs=186.2

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||+|++.... .....+.+.+|+.++.+++||||+++++++...+.
T Consensus        12 i~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATA---VVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             -CCCCCEEEEECC---CC---CEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cchhhhhhhheeccccce---EEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            445789999999999999   9999987  78899999986542 23445678999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccC---CCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          137 PILVFESVQYGTLWDRILGA---PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .++||||+++++|.+++...   .......+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEe
Confidence            99999999999999988641   0001146899999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCCC----ccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          214 FSLSISIPEGET----HITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       214 fg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      ||++........    .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......        ..
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~  236 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--------VL  236 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HH
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--------HH
Confidence            999876543221    11234578999999999876 568999999999999999999999997533221        11


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... ................    ...+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          237 MLTLQ-NDPPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHHT-SSCCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhc-cCCCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111 1111110000000000    033457889999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.4e-45  Score=325.01  Aligned_cols=248  Identities=22%  Similarity=0.285  Sum_probs=194.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~y~i~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFG---KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             ETTEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eccEEEEeeecCCCCe---EEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            3578889999999999   9999998  689999999864311 123356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      ++||||+++++|.+++...     ..+++..++.++.|++.||.|||   +++++||||||+||+++.++.++|+|||++
T Consensus        87 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             EEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccc
Confidence            9999999999999999764     35789999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      .......  ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.....        ...... .....
T Consensus       159 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~-~~~~~  227 (276)
T 2h6d_A          159 NMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKK-IRGGV  227 (276)
T ss_dssp             GCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHCC
T ss_pred             cccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHH-hhcCc
Confidence            7764332  2334578999999999987765 6899999999999999999999863221        111111 11111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..          .+    ...+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~----------~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 FY----------IP----EYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CC----------CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc----------Cc----hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            00          00    023456789999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.5e-44  Score=332.79  Aligned_cols=257  Identities=16%  Similarity=0.167  Sum_probs=198.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc-
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP-  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~-  137 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||+|++............+.+|+.+++.++||||+++++++...+.. 
T Consensus        41 ~~~y~~~~~lG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYG---SVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             ETTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             cccEEEEeEEecCCCe---EEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            4678889999999999   9999988  799999999987655666678899999999999999999999999877654 


Q ss_pred             -----EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          138 -----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       138 -----~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                           ++||||+. ++|.+.+.       ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             cceeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEE
Confidence                 99999997 78888774       34889999999999999999999   8999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      |||+++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......        .....
T Consensus       187 Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i  254 (371)
T 4exu_A          187 DFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--------QLTQI  254 (371)
T ss_dssp             STTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHH
T ss_pred             ecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHH
Confidence            99999765332    234578999999999887 678999999999999999999999997433211        11111


Q ss_pred             hhcCc--ccccc---------------cchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FEDNR--FTEIV---------------DPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~~~--~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....  ..+..               ........ .......+..+.+|+.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhH-HHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            10000  00000               00000000 0001134678899999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-44  Score=335.83  Aligned_cols=267  Identities=16%  Similarity=0.197  Sum_probs=196.0

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC-
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET-  134 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-  134 (353)
                      ....++|...+.||+|+||   .||++.+  +++.||+|++....      ....+|+.+++.++|||||++++++... 
T Consensus         3 ~~~~~~y~~~~~lG~G~fg---~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~   73 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFG---IVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTG   73 (383)
T ss_dssp             ---CTTEEEEEEEECC-CE---EEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred             ccccceEEEEEEEEeccCE---EEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecC
Confidence            3556789999999999999   9999988  88999999986552      1234799999999999999999998543 


Q ss_pred             -------------------------------------CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHH
Q 018633          135 -------------------------------------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV  177 (353)
Q Consensus       135 -------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~  177 (353)
                                                           ...++||||++ |+|.+.+....... ..+++..++.++.||+
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSG-RSIPMNLISIYIYQLF  151 (383)
T ss_dssp             ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTT-CCCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcC-CCCCHHHHHHHHHHHH
Confidence                                                 34789999998 68877765311100 4689999999999999


Q ss_pred             HHHHHHhcCCCCCeEeeccCCCceeec-CCCceEEeccCCccccCCCCCccccccccCCccccccccccCC-CCccccch
Q 018633          178 HALAYLHFGFPRPIVFRNFKTSCILFN-EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVF  255 (353)
Q Consensus       178 ~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~  255 (353)
                      .||.|||   +++|+||||||+|||++ .++.+||+|||+++.......  .....||..|+|||++.+.. ++.++|||
T Consensus       152 ~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9999999   99999999999999998 688999999999987644332  34557899999999987654 89999999


Q ss_pred             hhHHHHHHHHhCCCCCCccccccC-------CCCChHHHHHHHh---hcCcccccccchhhhccchHHHHHHHHHHHHHH
Q 018633          256 SFGVFLFELLTGWDVSDLVKDTHD-------LACPSNEYLKNYF---EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLS  325 (353)
Q Consensus       256 slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  325 (353)
                      ||||++|||++|..||........       ...+..+.+...-   ....++......+...    .+...+..+.+|+
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li  302 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI----LPEGTPSLAIDLL  302 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH----SCTTCCHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh----CCCCCCHHHHHHH
Confidence            999999999999999975432110       0111111111110   0001111111111111    1113456788999


Q ss_pred             HHchhcCCCCCCCHHHHHH
Q 018633          326 FECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       326 ~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+||..||++|||+.++++
T Consensus       303 ~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          303 EQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHCCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhhCCCHHHHhc
Confidence            9999999999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.2e-44  Score=321.21  Aligned_cols=253  Identities=21%  Similarity=0.272  Sum_probs=204.7

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||+|++..........+.+.+|+.++++++||||+++++++.+.+.
T Consensus        19 ~~~~~y~i~~~lg~G~~g---~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFG---EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHhhcceeeEEEcCCCCE---EEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            445679999999999999   9999998  78999999997654445567889999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC---CceEEec
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE---NVAKLFD  213 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~---~~~kl~d  213 (353)
                      .++||||+++++|.+.+...     ..+++..++.++.|++.||.|||   +++++||||||+||+++.+   +.+||+|
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             EEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEec
Confidence            99999999999999988654     35889999999999999999999   8999999999999999754   4699999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      ||++........  .....||..|+|||.+.+ .++.++||||||+++|+|++|..||.....        ........ 
T Consensus       168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~-  235 (287)
T 2wei_A          168 FGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVE-  235 (287)
T ss_dssp             TTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-
T ss_pred             cCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-
Confidence            999877643322  234468899999999865 489999999999999999999999874321        11122111 


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .........          .....+..+.+++.+||..||++|||+.++++
T Consensus       236 ~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          236 TGKYAFDLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HCCCCCCSG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            111110000          00134567889999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.8e-45  Score=361.74  Aligned_cols=245  Identities=19%  Similarity=0.245  Sum_probs=201.5

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCC
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARM-SHNHILKLIGCCLETP  135 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~  135 (353)
                      ..++|...++||+|+||   .||++.+  +++.||||++..... .....+.+..|..++..+ +||||+++++++.+.+
T Consensus       339 ~~~~f~~~~~LG~G~fG---~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             -CTTEEEEEESSBTTTB---CEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             cccceEEEEEEccCCCE---EEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            45679999999999999   9999998  788999999865311 123456788999999988 6999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      .+|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecc
Confidence            999999999999999999765     35899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....        .+........ 
T Consensus       488 la~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~-  557 (674)
T 3pfq_A          488 MCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-  557 (674)
T ss_dssp             TCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSS-
T ss_pred             eeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-
Confidence            998643322 224567899999999999999999999999999999999999999974322        1122222111 


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM  339 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  339 (353)
                      ..          ..    +...+..+.+|+.+||+.||++||++
T Consensus       558 ~~----------~~----p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          558 NV----------AY----PKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             CC----------CC----CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             CC----------CC----CccCCHHHHHHHHHHccCCHHHCCCC
Confidence            10          00    01445678899999999999999997

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=323.45  Aligned_cols=253  Identities=15%  Similarity=0.190  Sum_probs=198.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhcCCCceeeccceee--e
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC--RPRAYESCINNVTYAARMSHNHILKLIGCCL--E  133 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~--~  133 (353)
                      ..++|...+.||+|+||   .||++.+  ++..||+|++.....  .....+.+.+|+.++++++||||+++++++.  +
T Consensus         3 l~~~y~i~~~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYG---KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE   79 (305)
T ss_dssp             --CCBCCCCEEEECSSC---EEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred             cccceeEeeEEecCCCe---EEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            34689999999999999   9999998  788999999865421  1234678999999999999999999999984  4


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..++||||++++ |.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.++|+|
T Consensus        80 ~~~~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           80 KQKMYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             --CEEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCeEEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeec
Confidence            56789999999865 7777765432   46889999999999999999999   89999999999999999999999999


Q ss_pred             cCCccccCCCC-CccccccccCCccccccccccCC--CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          214 FSLSISIPEGE-THITDTVMGTWGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       214 fg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ||++....... ........||..|+|||++.+..  ++.++||||||+++|+|++|..||.....        ......
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~  224 (305)
T 2wtk_C          153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFEN  224 (305)
T ss_dssp             CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHH
T ss_pred             cccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHH
Confidence            99998764322 22234567899999999987644  47899999999999999999999874221        111111


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK  345 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~  345 (353)
                      . ......          .+    ...+..+.+++.+||+.||++|||+.++++.
T Consensus       225 i-~~~~~~----------~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          225 I-GKGSYA----------IP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             H-HHCCCC----------CC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             H-hcCCCC----------CC----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1 111110          00    0345567899999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=325.97  Aligned_cols=257  Identities=15%  Similarity=0.159  Sum_probs=197.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc--
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI--  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~--  136 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++..........+.+.+|+.++++++||||+++++++...+.  
T Consensus        23 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYG---SVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             ETTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CceEEEeeeEecCCCe---EEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            3678889999999999   9999988  79999999997765556667889999999999999999999999987654  


Q ss_pred             ----cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          137 ----PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       137 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                          .++||||++ ++|.+++.       ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~  168 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL  168 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred             cceeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEe
Confidence                499999997 68888774       24789999999999999999999   8999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      |||++......    .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......        .....
T Consensus       169 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------~~~~i  236 (353)
T 3coi_A          169 DFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--------QLTQI  236 (353)
T ss_dssp             STTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--------HHHHH
T ss_pred             ecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH
Confidence            99999765322    234578999999999876 678999999999999999999999997433211        11111


Q ss_pred             hhc-Ccc-----ccccc-----------chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          292 FED-NRF-----TEIVD-----------PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       292 ~~~-~~~-----~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ... +..     ..+.+           ......... .....+..+.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100 000     00000           000000000 00134667889999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.5e-44  Score=334.56  Aligned_cols=263  Identities=15%  Similarity=0.217  Sum_probs=201.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC--------CCceeeccce
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS--------HNHILKLIGC  130 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~~~~~  130 (353)
                      .++|...+.||+|+||   .||++.+  +++.||+|++...   ....+.+.+|+.+++.++        ||||++++++
T Consensus        36 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFS---TVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             TTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             CCeEEEEEEeeecCCe---eEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            4679999999999999   9999987  7899999999754   456678899999999996        7889999999


Q ss_pred             ee----eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC-CeEeeccCCCceeecC
Q 018633          131 CL----ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFKTSCILFNE  205 (353)
Q Consensus       131 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~  205 (353)
                      +.    +....++||||+ +++|.+.+.....   ..+++..++.++.||+.||.|||   ++ +|+||||||+|||++.
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~  182 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSV  182 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECC
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEec
Confidence            87    456789999999 5677777765432   46899999999999999999999   88 9999999999999987


Q ss_pred             CC-------------------------------------------------ceEEeccCCccccCCCCCccccccccCCc
Q 018633          206 EN-------------------------------------------------VAKLFDFSLSISIPEGETHITDTVMGTWG  236 (353)
Q Consensus       206 ~~-------------------------------------------------~~kl~dfg~a~~~~~~~~~~~~~~~gt~~  236 (353)
                      ++                                                 .+||+|||++......    .....||..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~  258 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQ  258 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGG
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCc
Confidence            75                                                 7999999999776432    234578999


Q ss_pred             cccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh-----------cCc---------
Q 018633          237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE-----------DNR---------  296 (353)
Q Consensus       237 y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~---------  296 (353)
                      |+|||++.+..++.++|||||||++|||++|..||........  ............           ...         
T Consensus       259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY--TRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSS--CHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccccc--CchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            9999999998999999999999999999999999975432210  000001100000           000         


Q ss_pred             --cccccc-------chhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 --FTEIVD-------PIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 --~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                        ...+..       ..+....  ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTS--CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhHhhhhhc--ccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence              000000       0000000  011256778999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2e-44  Score=327.94  Aligned_cols=264  Identities=17%  Similarity=0.257  Sum_probs=200.9

Q ss_pred             CcceecHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC--CCce
Q 018633           48 PYRIFSAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMS--HNHI  124 (353)
Q Consensus        48 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--H~ni  124 (353)
                      +.+.++++.+....++|...+.||+|+||   .||++.+ +++.||+|++..........+.+.+|+.++.+++  ||||
T Consensus        14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i   90 (313)
T 3cek_A           14 GTENLYFQSMSVKGRIYSILKQIGSGGSS---KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI   90 (313)
T ss_dssp             ------CCEEEETTEEEEEEEEEECCSSE---EEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTB
T ss_pred             CCCCCCeeeeeeccceEEEEEEecCCCCE---EEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCce
Confidence            33444555555666789999999999999   9999988 7889999999766556677788999999999998  5999


Q ss_pred             eeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          125 LKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       125 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                      +++++++.+.+..++||| +.+++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++
T Consensus        91 v~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~  161 (313)
T 3cek_A           91 IRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV  161 (313)
T ss_dssp             CCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE
T ss_pred             EEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE
Confidence            999999999999999999 5578999999865     36789999999999999999999   89999999999999997


Q ss_pred             CCCceEEeccCCccccCCCCCc-cccccccCCcccccccccc-----------CCCCccccchhhHHHHHHHHhCCCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRT-----------GVFNEKSDVFSFGVFLFELLTGWDVSD  272 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~il~el~tg~~p~~  272 (353)
                      + +.+||+|||++......... ......||+.|+|||++.+           ..++.++||||||+++|+|++|..||.
T Consensus       162 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (313)
T 3cek_A          162 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  240 (313)
T ss_dssp             T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence            4 89999999999876433221 2234578999999999865           468889999999999999999999986


Q ss_pred             ccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          273 LVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....       ..............         ..+.    ..+..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~-------~~~~~~~~~~~~~~---------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          241 QIINQ-------ISKLHAIIDPNHEI---------EFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             TCCSH-------HHHHHHHHCTTSCC---------CCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHH-------HHHHHHHHhccccc---------CCcc----cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            32211       11111111111000         0000    22456789999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.2e-43  Score=326.21  Aligned_cols=263  Identities=18%  Similarity=0.192  Sum_probs=200.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC---
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET---  134 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~---  134 (353)
                      ..++|...+.||+|+||   .||+|.+  +++.||||++.... .......+.+|+.++++++||||+++++++...   
T Consensus         9 i~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYG---VVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             SCTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             cccceEEeeEEcCCCCe---EEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            35679999999999999   9999998  69999999996542 455567889999999999999999999988754   


Q ss_pred             --CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          135 --PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       135 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                        ...++||||+. |+|.+++...      .+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~  154 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVC  154 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred             ccceEEEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEE
Confidence              67899999997 6999988753      5789999999999999999999   8999999999999999999999999


Q ss_pred             ccCCccccCCCCCc---------cccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          213 DFSLSISIPEGETH---------ITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       213 dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                      |||++.........         ......||..|+|||++.. ..++.++|||||||++|+|++|..||.......    
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----  230 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH----  230 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH----
Confidence            99999876432211         1123468999999998765 678999999999999999999999997543211    


Q ss_pred             ChHHHHHHHhh---cCc----ccccccchh----------hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFE---DNR----FTEIVDPII----------VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~---~~~----~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                          .......   ...    .........          ............+..+.+|+.+||+.||++|||+.++++
T Consensus       231 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          231 ----QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             ----HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                1110000   000    000000000          000000001145567889999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-43  Score=319.58  Aligned_cols=251  Identities=19%  Similarity=0.314  Sum_probs=192.3

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee----
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE----  133 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----  133 (353)
                      ..++|...+.||+|+||   .||+|.+  +++.||+|++...   ....+.+.+|+.++++++||||+++++++.+    
T Consensus         4 ~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFG---QVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHHEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred             ccccchhhheeccCCcE---EEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence            45679999999999999   9999998  7899999999653   4566789999999999999999999998865    


Q ss_pred             ---------CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          134 ---------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       134 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                               .+..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~  150 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFID  150 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEc
Confidence                     346799999999999999997643    46788999999999999999999   89999999999999999


Q ss_pred             CCCceEEeccCCccccCCCC-------------CccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCC
Q 018633          205 EENVAKLFDFSLSISIPEGE-------------THITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDV  270 (353)
Q Consensus       205 ~~~~~kl~dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p  270 (353)
                      .++.+||+|||++.......             ........||..|+|||++.+. .++.++||||||+++|+|++   |
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p  227 (303)
T 1zy4_A          151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P  227 (303)
T ss_dssp             TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred             CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence            99999999999987654221             1112345689999999999764 68999999999999999998   4


Q ss_pred             CCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          271 SDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      |......       ...... ......  ...    ...    +...+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~-------~~~~~~-~~~~~~--~~~----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          228 FSTGMER-------VNILKK-LRSVSI--EFP----PDF----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CSSHHHH-------HHHHHH-HHSTTC--CCC----TTC----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCchhH-------HHHHHh-cccccc--ccC----ccc----cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            4311100       011111 111100  000    011    1134456789999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.4e-43  Score=322.49  Aligned_cols=264  Identities=18%  Similarity=0.241  Sum_probs=202.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc------eeecccee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH------ILKLIGCC  131 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~~~~~~  131 (353)
                      .++|...+.||+|+||   .||++.+   +++.||+|++...   ....+.+.+|+.+++.++|+|      |+++++++
T Consensus        13 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFG---KVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             TTTEEEEEEEEEETTE---EEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             cCceEEEEEEecCCCe---EEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            3579999999999999   9999986   6899999999754   455678899999999997665      99999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC------
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE------  205 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~------  205 (353)
                      .+.+..++||||+ +++|.+++.....   .++++..++.++.|++.||.|||   +++|+||||||+|||++.      
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  159 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEA  159 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEE
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccc
Confidence            9999999999999 7999999976542   36889999999999999999999   899999999999999987      


Q ss_pred             -------------CCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 018633          206 -------------ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSD  272 (353)
Q Consensus       206 -------------~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~  272 (353)
                                   ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             EC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence                         668999999999765332    235578999999999998899999999999999999999999997


Q ss_pred             ccccccCC-------CCChHHHHHHHhhcCc--------cccccc---------chhhhccchHHHHHHHHHHHHHHHHc
Q 018633          273 LVKDTHDL-------ACPSNEYLKNYFEDNR--------FTEIVD---------PIIVEDVLSIEKEQQLHASAQLSFEC  328 (353)
Q Consensus       273 ~~~~~~~~-------~~~~~~~~~~~~~~~~--------~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~c  328 (353)
                      ........       .......... .....        +.....         ..+....  ......+..+.+|+.+|
T Consensus       236 ~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~  312 (339)
T 1z57_A          236 THDSKEHLAMMERILGPLPKHMIQK-TRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM--LSQDVEHERLFDLIQKM  312 (339)
T ss_dssp             CSCHHHHHHHHHHHHCSCCHHHHHH-CSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC--SCCSHHHHHHHHHHHHH
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHhh-ccchhHHhhccccccccccccchhhhcCcchhhhc--ccchhhHHHHHHHHHHH
Confidence            53321100       0000000000 00000        000000         0000000  00114567899999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 018633          329 IKDSPADRPSMVDVAK  344 (353)
Q Consensus       329 l~~dP~~Rps~~~vl~  344 (353)
                      |+.||++|||+.++++
T Consensus       313 L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          313 LEYDPAKRITLREALK  328 (339)
T ss_dssp             TCSSTTTSCCHHHHTT
T ss_pred             hCcCcccccCHHHHhc
Confidence            9999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=321.26  Aligned_cols=261  Identities=16%  Similarity=0.211  Sum_probs=193.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee------
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL------  132 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~------  132 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||+|++...  .....+.+.+|+.++++++||||+++++++.      
T Consensus        10 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNG---LVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             TTTEEEEEECC--------CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             CCceeEEEEeccCCCe---EEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            3578889999999999   9999998  5899999999765  5667788999999999999999999998873      


Q ss_pred             --------eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          133 --------ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       133 --------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                              +.+..++||||++ |+|.+++..      ..+++..++.++.|++.||.|||   +++|+||||||+|||++
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFIN  154 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEE
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEc
Confidence                    3467899999998 699998864      35789999999999999999999   89999999999999997


Q ss_pred             -CCCceEEeccCCccccCCCCC--ccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCC
Q 018633          205 -EENVAKLFDFSLSISIPEGET--HITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL  280 (353)
Q Consensus       205 -~~~~~kl~dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~  280 (353)
                       .++.+||+|||+++.......  .......+|..|+|||.+.. ..++.++||||||+++|+|++|..||.......  
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--  232 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--  232 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence             567999999999987643211  11234567889999998865 678999999999999999999999997543211  


Q ss_pred             CCChHHHHHHHhhcCc-------------ccccccchhhhccch--HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          281 ACPSNEYLKNYFEDNR-------------FTEIVDPIIVEDVLS--IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       281 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                            ..........             ..............+  ......+..+.+++.+||+.||++|||+.++++
T Consensus       233 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          233 ------QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             ------HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                  1111111100             000000000000000  001135678899999999999999999999976

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.9e-44  Score=337.85  Aligned_cols=265  Identities=20%  Similarity=0.266  Sum_probs=192.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC-----
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET-----  134 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-----  134 (353)
                      ..|...+.||+|+||   .||+|.+  +++.||||++....      ..+.+|+.++++++|||||++++++...     
T Consensus        54 ~~y~~~~~lG~G~fg---~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFG---VVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ceEEeeeEEeeCCCE---EEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            358888999999999   9999999  68999999986542      1234799999999999999999998542     


Q ss_pred             -CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-CceEEe
Q 018633          135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLF  212 (353)
Q Consensus       135 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-~~~kl~  212 (353)
                       ...++||||++ ++|.+.+...... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.+ +.+||+
T Consensus       125 ~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          125 EVYLNLVLDYVP-ETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             EEEEEEEEECCC-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             ceeEEeehhccc-ccHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEec
Confidence             13679999998 4776665431100 046899999999999999999999   9999999999999999965 578999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCCh
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPS  284 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~  284 (353)
                      |||+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........       ...+.
T Consensus       200 DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~  277 (420)
T 1j1b_A          200 DFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  277 (420)
T ss_dssp             CCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             cchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999987644332  3356789999999998765 689999999999999999999999975432110       00111


Q ss_pred             HHHHHHHhhcCcccccccchhhhc-cchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVED-VLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+.+...  ...+.+...+.+... .....+...+..+.+|+.+||..||++|||+.++++
T Consensus       278 ~~~~~~~--~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          278 REQIREM--NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHH--CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhh--ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            1111111  011111100100000 000000133567889999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-43  Score=324.69  Aligned_cols=266  Identities=19%  Similarity=0.239  Sum_probs=201.8

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc---CCCceeeccceee
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQFYGHECRPRAYESCINNVTYAARM---SHNHILKLIGCCL  132 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~  132 (353)
                      ...++|...+.||+|+||   .||++.+   +++.||+|++............+.+|+.+++.+   +||||+++++++.
T Consensus         8 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYG---KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             CGGGTEEEEEEEEEETTE---EEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CchhceeeeeeecccccE---EEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            456789999999999999   9999987   578999999865432333334567788777776   8999999999987


Q ss_pred             -----eCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC
Q 018633          133 -----ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN  207 (353)
Q Consensus       133 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  207 (353)
                           .....++||||++ |+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~  157 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSG  157 (326)
T ss_dssp             EEECSSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred             ecccCCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCC
Confidence                 4567899999998 799999876543   35889999999999999999999   89999999999999999999


Q ss_pred             ceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHH
Q 018633          208 VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY  287 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  287 (353)
                      .+||+|||++......  .......||..|+|||++.+..++.++||||||+++|+|++|..||.......        .
T Consensus       158 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~  227 (326)
T 1blx_A          158 QIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--------Q  227 (326)
T ss_dssp             CEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------H
T ss_pred             CEEEecCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--------H
Confidence            9999999998765322  12345678999999999998899999999999999999999999997433211        1


Q ss_pred             HHHHhhc------Ccccccc---cchhh---hccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          288 LKNYFED------NRFTEIV---DPIIV---EDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       288 ~~~~~~~------~~~~~~~---~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .......      ..+....   .....   ...........+..+.+|+.+||+.||++|||+.++++
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1111110      0000000   00000   00000000134567889999999999999999999984

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2e-43  Score=331.60  Aligned_cols=263  Identities=17%  Similarity=0.229  Sum_probs=192.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc----
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI----  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~----  136 (353)
                      .+|...++||+|+||   .||++.+ .+..||+|++....      ....+|+.+++.++||||+++++++...+.    
T Consensus        40 ~~Y~~~~~lG~G~~g---~V~~a~~~~~~~~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFG---VVFQAKLVESDEVAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEETTE---EEEEEEETTTEEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             ceEEEeEEEeeCCCe---EEEEEEECCCCeEEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            468889999999999   9999999 66679999886542      112369999999999999999999965443    


Q ss_pred             --cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec-CCCceEEec
Q 018633          137 --PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN-EENVAKLFD  213 (353)
Q Consensus       137 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~d  213 (353)
                        .++||||+++ ++.+.+...... ...+++..++.++.||+.||.|||   +++|+||||||+|||++ .++.+||+|
T Consensus       111 ~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~D  185 (394)
T 4e7w_A          111 VFLNLVLEYVPE-TVYRASRHYAKL-KQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLID  185 (394)
T ss_dssp             EEEEEEEECCSE-EHHHHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             eEEEEEeeccCc-cHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEee
Confidence              7899999985 554444321000 046889999999999999999999   99999999999999999 789999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~  285 (353)
                      ||+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|..||........       ...+..
T Consensus       186 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          186 FGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR  263 (394)
T ss_dssp             CTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             CCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999987644332  3456789999999998765 489999999999999999999999975432110       011111


Q ss_pred             HHHHHHh---hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EYLKNYF---EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+....   ....++......+.    ...+...+..+.+|+.+||..||++|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFS----KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHH----HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccccccCCcHH----HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            1111110   00111111110000    0011134567899999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.5e-43  Score=326.62  Aligned_cols=279  Identities=16%  Similarity=0.180  Sum_probs=191.2

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      .+.....++|...+.||+|+||   .||+|.+  ++..||||++...   ......+.+|+..+..++||||+++++++.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFG---TVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHHHHTTEEEC-------------CEEEEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCe---EEEEEEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            4556778899999999999999   9999998  6899999998654   233345678888899999999999999997


Q ss_pred             eCCc-------cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          133 ETPI-------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       133 ~~~~-------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      ..+.       .++||||+++ +|.+.+...... ...+++..+..++.|++.||.|||.. +++|+||||||+|||++.
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEET
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeC
Confidence            6443       7899999984 665544321100 14678899999999999999999943 679999999999999996


Q ss_pred             -CCceEEeccCCccccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccC----
Q 018633          206 -ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD----  279 (353)
Q Consensus       206 -~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~----  279 (353)
                       ++.+||+|||+++.......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||........    
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence             89999999999987654332  34557899999999986654 89999999999999999999999975432110    


Q ss_pred             ---CCCChHHHHHHHhhcCcccccccchh--hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          280 ---LACPSNEYLKNYFEDNRFTEIVDPII--VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       280 ---~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                         ...+....+.............+...  ............+..+.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence               00111111111100000000000000  000000000024678899999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=329.82  Aligned_cols=273  Identities=16%  Similarity=0.199  Sum_probs=183.1

Q ss_pred             hhCcCC-CCceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--
Q 018633           61 TNSYDQ-KNVIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--  133 (353)
Q Consensus        61 ~~~~~~-~~~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--  133 (353)
                      .+.|.. .++||+|+||   .||+|.+    ++..||+|++....    ....+.+|+.+|++++|||||++++++..  
T Consensus        19 ~~~y~~~g~~lG~G~~g---~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYG---HVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHHEECSSCCCC--------EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhcCcEeeecCCe---EEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            344654 5589999999   9999986    47899999997552    23468899999999999999999999954  


Q ss_pred             CCccEEEEEeccCCChhhhhccCCC----CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee----cC
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQ----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF----NE  205 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill----~~  205 (353)
                      ....++||||++ |+|.+++.....    .....+++..++.++.||+.||.|||   +++|+||||||+|||+    +.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCC
Confidence            667899999997 688887753210    01135899999999999999999999   9999999999999999    67


Q ss_pred             CCceEEeccCCccccCCCCC--ccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          206 ENVAKLFDFSLSISIPEGET--HITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                      ++.+||+|||+++.......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            78999999999987643221  223456789999999999874 489999999999999999999999975443211111


Q ss_pred             -ChHHHHHHHhhcCc------cccccc---------chhhhccchH-HH-------HHHHHHHHHHHHHchhcCCCCCCC
Q 018633          283 -PSNEYLKNYFEDNR------FTEIVD---------PIIVEDVLSI-EK-------EQQLHASAQLSFECIKDSPADRPS  338 (353)
Q Consensus       283 -~~~~~~~~~~~~~~------~~~~~~---------~~~~~~~~~~-~~-------~~~~~~l~~li~~cl~~dP~~Rps  338 (353)
                       .....+...+....      +..+..         .......... ..       ...+..+.+|+.+||..||++|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence             11111111111000      000000         0000000000 00       011456789999999999999999


Q ss_pred             HHHHHH
Q 018633          339 MVDVAK  344 (353)
Q Consensus       339 ~~~vl~  344 (353)
                      +.++++
T Consensus       328 a~e~L~  333 (405)
T 3rgf_A          328 SEQAMQ  333 (405)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9e-43  Score=325.87  Aligned_cols=203  Identities=19%  Similarity=0.229  Sum_probs=174.4

Q ss_pred             HHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CC-----ceeeccc
Q 018633           58 KLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HN-----HILKLIG  129 (353)
Q Consensus        58 ~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~~~~  129 (353)
                      ....++|...+.||+|+||   .||+|.+  +++.||||++...   ......+.+|+.++..++ |+     +|+++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFG---QVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CEETTTEEEEEEEEEETTE---EEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             CEeeeeEEEEEEEeecCCE---EEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            3456789999999999999   9999988  7899999999754   455677888999999886 55     4999999


Q ss_pred             eeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec--CCC
Q 018633          130 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN--EEN  207 (353)
Q Consensus       130 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~--~~~  207 (353)
                      ++...+..|+||||++ |+|.+++.....   ..+++..++.++.|++.||.|||+. ..+|+||||||+|||++  .++
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence            9999999999999996 699999986542   3588999999999999999999932 36899999999999994  578


Q ss_pred             ceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccc
Q 018633          208 VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVK  275 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~  275 (353)
                      .+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            8999999999876432    235678999999999999899999999999999999999999998543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.3e-44  Score=325.47  Aligned_cols=257  Identities=17%  Similarity=0.197  Sum_probs=178.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHH-HHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVT-YAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++.+  +++.||||++.... .......+..|+. +++.++||||+++++++.+.+..
T Consensus        21 ~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYG---SVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             SCSEEC-CEEEECSSE---EEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhehheeccCCCE---EEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            4678999999999999   9999998  69999999997653 3344455666666 77788999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC-CeEeeccCCCceeecCCCceEEeccCC
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      ++||||++ |+|.+++..........+++..+..++.|++.||.|||   ++ +|+||||||+|||++.++.+||+|||+
T Consensus        97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            99999998 58887775311000146889999999999999999999   88 999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCcccccccc----ccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYM----RTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      ++.......  .....||..|+|||++    .+..++.++||||||+++|+|++|..||........       ......
T Consensus       173 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~  243 (327)
T 3aln_A          173 SGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVV  243 (327)
T ss_dssp             SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCC
T ss_pred             ceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HHHHHh
Confidence            977643221  2334689999999998    456689999999999999999999999874322110       000000


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       ......     +....    ....+..+.+|+.+||+.||++|||+.++++
T Consensus       244 -~~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          244 -KGDPPQ-----LSNSE----EREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -CSCCCC-----CCCCS----SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -cCCCCC-----CCCcc----cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence             000000     00000    0134567889999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.6e-43  Score=326.30  Aligned_cols=263  Identities=16%  Similarity=0.197  Sum_probs=199.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-----------CCceeec
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-----------HNHILKL  127 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~~  127 (353)
                      .++|...+.||+|+||   .||++.+  +++.||||++...   ....+.+.+|+.++.+++           ||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARYILVRKLGWGHFS---TVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeEEEEEeeeecCCe---EEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            3579999999999999   9999997  8999999999754   445677899999999887           8999999


Q ss_pred             cceeeeCC----ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC-CeEeeccCCCcee
Q 018633          128 IGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFKTSCIL  202 (353)
Q Consensus       128 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nil  202 (353)
                      ++++...+    ..++||||+ +++|.+++.....   ..+++..++.++.||+.||.|||   ++ +|+||||||+|||
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIl  164 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVL  164 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeE
Confidence            99998654    789999999 7999999976543   35889999999999999999999   87 9999999999999


Q ss_pred             ec------CCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccc
Q 018633          203 FN------EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKD  276 (353)
Q Consensus       203 l~------~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~  276 (353)
                      ++      ..+.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          165 MEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            94      4458999999999776432    2345789999999999998999999999999999999999999975432


Q ss_pred             ccCCCCChHHHHHHHhh---------------------cCccccccc--------chhhhccchHHHHHHHHHHHHHHHH
Q 018633          277 THDLACPSNEYLKNYFE---------------------DNRFTEIVD--------PIIVEDVLSIEKEQQLHASAQLSFE  327 (353)
Q Consensus       277 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~  327 (353)
                      ...  ............                     .......+.        ..+....  ..+...+..+.+|+.+
T Consensus       241 ~~~--~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~  316 (373)
T 1q8y_A          241 HSY--TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY--KFSKDEAKEISDFLSP  316 (373)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT--CCCHHHHHHHHHHHGG
T ss_pred             ccc--CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc--cCCcchHHHHHHHHHH
Confidence            110  000111111100                     000000000        0000000  0113677889999999


Q ss_pred             chhcCCCCCCCHHHHHH
Q 018633          328 CIKDSPADRPSMVDVAK  344 (353)
Q Consensus       328 cl~~dP~~Rps~~~vl~  344 (353)
                      ||+.||++|||+.++++
T Consensus       317 ~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          317 MLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GGCSSTTTCBCHHHHHT
T ss_pred             HhccCccccCCHHHHhh
Confidence            99999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=322.46  Aligned_cols=254  Identities=19%  Similarity=0.228  Sum_probs=182.1

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||++.+  +++.||||++..........+.+..+..+++.++||||+++++++.+.+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCG---QVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             CCGGGEEEEEEC---------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhhccccccceeeecCCe---eEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            345678888999999999   9999998  68999999997664333334445556667888899999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCC-CeEeeccCCCceeecCCCceEEeccC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      .++||||+ ++.+..+.....    ..+++..++.++.|++.||.|||   ++ +|+||||||+||+++.++.+||+|||
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence            99999999 455555544322    46889999999999999999999   75 99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ++.......  ......||+.|+|||++.     ...++.++||||||+++|+|++|..||......       ......
T Consensus       171 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~  241 (318)
T 2dyl_A          171 ISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTK  241 (318)
T ss_dssp             TC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHH
T ss_pred             CchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHH
Confidence            987654322  233456899999999984     456889999999999999999999998742211       112222


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..... ......     .      ...+..+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~-~~~~~~-----~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          242 VLQEE-PPLLPG-----H------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHSC-CCCCCS-----S------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HhccC-CCCCCc-----c------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            22111 111000     0      024456789999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.9e-42  Score=319.67  Aligned_cols=266  Identities=15%  Similarity=0.213  Sum_probs=200.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--C-CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc------eeecccee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--Q-ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH------ILKLIGCC  131 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~~~~~~  131 (353)
                      .++|...+.||+|+||   .||++.+  + +..||+|++...   ....+.+.+|+.++++++|++      ++.+++++
T Consensus        18 ~~~y~~~~~lg~G~~g---~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFG---KVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             TTTEEEEEEEEEETTE---EEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             cccEEEEEEeeccCCe---EEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            4679999999999999   9999987  3 478999999754   455678899999999998766      89999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee--------
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF--------  203 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill--------  203 (353)
                      ...+..++||||+ +++|.+.+.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||+        
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEE
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccc
Confidence            9999999999999 5788787766532   46899999999999999999999   9999999999999999        


Q ss_pred             -----------cCCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 018633          204 -----------NEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSD  272 (353)
Q Consensus       204 -----------~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~  272 (353)
                                 +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                       56789999999999765332    234578999999999998899999999999999999999999997


Q ss_pred             ccccccCC-------CCChHHHHHHHhhcCcccc----cccch------hhhccc-----hHHHHHHHHHHHHHHHHchh
Q 018633          273 LVKDTHDL-------ACPSNEYLKNYFEDNRFTE----IVDPI------IVEDVL-----SIEKEQQLHASAQLSFECIK  330 (353)
Q Consensus       273 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~----~~~~~------~~~~~~-----~~~~~~~~~~l~~li~~cl~  330 (353)
                      ........       ......+... ........    ..+..      ......     .......+..+.+|+.+||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          241 THENREHLVMMEKILGPIPSHMIHR-TRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHH-CSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCHHHHHHHHHHHcCCCcHHHhhh-ccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            54321100       0000000000 00000000    00000      000000     00001345688999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 018633          331 DSPADRPSMVDVAK  344 (353)
Q Consensus       331 ~dP~~Rps~~~vl~  344 (353)
                      .||++|||+.++++
T Consensus       320 ~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          320 FDPAQRITLAEALL  333 (355)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.5e-43  Score=323.03  Aligned_cols=253  Identities=19%  Similarity=0.284  Sum_probs=173.2

Q ss_pred             HHhhCcCCC-CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--
Q 018633           59 LATNSYDQK-NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--  133 (353)
Q Consensus        59 ~~~~~~~~~-~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--  133 (353)
                      ...++|... ++||+|+||   .||++.+  +++.||+|++...   .....+   ....+..+.||||+++++++..  
T Consensus        25 ~~~~~y~i~~~~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~---~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNG---KVLECFHRRTGQKCALKLLYDS---PKARQE---VDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEESS---HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeEecceeeeeCCCe---EEEEEEECCCCCEEEEEEecCc---HHHHHH---HHHHHHhcCCCChHHHHHHHhhcc
Confidence            345778874 579999999   9999998  6899999998654   222222   2234566789999999999876  


Q ss_pred             --CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---CCc
Q 018633          134 --TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---ENV  208 (353)
Q Consensus       134 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~  208 (353)
                        ....++||||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.   ++.
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~  169 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAV  169 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCce
Confidence              4458999999999999999986543   46899999999999999999999   899999999999999976   455


Q ss_pred             eEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      +||+|||++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|..||..........     ..
T Consensus       170 ~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~  241 (336)
T 3fhr_A          170 LKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-----GM  241 (336)
T ss_dssp             EEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-----hH
Confidence            9999999997654322   335578999999999988889999999999999999999999986433221000     00


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .........          ..+.......+..+.+|+.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          242 KRRIRLGQY----------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhcccc----------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000000          0000000134567889999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=333.40  Aligned_cols=249  Identities=20%  Similarity=0.260  Sum_probs=186.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~l  139 (353)
                      ..+|...++||+|+||.|  |+++..+++.||||++....     ...+.+|+.+++++ +|||||++++++.+....|+
T Consensus        23 ~~~y~~~~~LG~G~~G~V--~~~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTI--VYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             TEEEEEEEEEEECGGGCE--EEEEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             cEEEecCCeeecCcCEEE--EEEEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            456888999999999933  46677799999999996542     22356899999999 79999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-----CCceEEecc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-----ENVAKLFDF  214 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-----~~~~kl~df  214 (353)
                      |||||+ |+|.+++.....    .++...++.++.||+.||.|||   +++|+||||||+|||++.     ...+||+||
T Consensus        96 v~E~~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             EEECCC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            999997 699999976542    3444456789999999999999   899999999999999943     346889999


Q ss_pred             CCccccCCCCC--ccccccccCCccccccccc---cCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHH
Q 018633          215 SLSISIPEGET--HITDTVMGTWGYCAPEYMR---TGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       215 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      |+++.......  .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.....         ...
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~  238 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQA  238 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHH
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHH
Confidence            99987653321  1234567999999999997   4567889999999999999999 8888853211         111


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........... ..+          .......+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~-~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          239 NILLGACSLDC-LHP----------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHTTCCCCTT-SCT----------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhccCCccc-cCc----------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11111111100 000          0144556789999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=319.09  Aligned_cols=246  Identities=19%  Similarity=0.288  Sum_probs=191.4

Q ss_pred             HHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh----hHHHHHHHHHHHHhhc----CCCcee
Q 018633           56 EIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP----RAYESCINNVTYAARM----SHNHIL  125 (353)
Q Consensus        56 e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~H~niv  125 (353)
                      +.....++|...+.||+|+||   .||+|.+  +++.||+|++.......    .....+.+|+.++.++    +||||+
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~  101 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFG---TVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI  101 (312)
T ss_dssp             --------CEEEEEEEEETTE---EEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred             chhhhhhceEEeeEEEcCCCE---EEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence            344567789999999999999   9999988  78899999997553211    2234567899999999    899999


Q ss_pred             eccceeeeCCccEEEEEe-ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec
Q 018633          126 KLIGCCLETPIPILVFES-VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN  204 (353)
Q Consensus       126 ~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~  204 (353)
                      ++++++...+..++|+|+ +++++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+||+++
T Consensus       102 ~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~  173 (312)
T 2iwi_A          102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILID  173 (312)
T ss_dssp             CEEEEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEE
T ss_pred             eEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEe
Confidence            999999999999999999 7889999999764     35899999999999999999999   89999999999999999


Q ss_pred             -CCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCC-ccccchhhHHHHHHHHhCCCCCCccccccCCCC
Q 018633          205 -EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC  282 (353)
Q Consensus       205 -~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~  282 (353)
                       .++.+||+|||++.......   .....||..|+|||++.+..+. .++||||||+++|+|++|..||......     
T Consensus       174 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----  245 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-----  245 (312)
T ss_dssp             TTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----
T ss_pred             CCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-----
Confidence             88999999999998764432   3355689999999999877664 5899999999999999999998632110     


Q ss_pred             ChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                               .. ... ..         +    ...+..+.+++.+||+.||++|||+.++++
T Consensus       246 ---------~~-~~~-~~---------~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 ---------LE-AEL-HF---------P----AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---------HH-TCC-CC---------C----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------hh-hcc-CC---------c----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     00 000 00         0    034456789999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.4e-42  Score=329.67  Aligned_cols=250  Identities=17%  Similarity=0.252  Sum_probs=183.1

Q ss_pred             cCCCCceeeCCCCCccEEE-EEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMY-KGFWQERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      |...++||+|+||   +|| .+..+++.||||++...     ..+.+.+|+.++.++ +|||||++++++.+.+..|+||
T Consensus        17 ~~~~~~LG~G~~g---~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           17 VVSEKILGYGSSG---TVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             EEEEEEEEECSTT---CEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             eeccCeEeeCCCe---EEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            4456789999999   765 44558999999998644     345678999999987 7999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCC--ccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC-------------
Q 018633          142 ESVQYGTLWDRILGAPQPHF--EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-------------  206 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~-------------  206 (353)
                      |||. |+|.+++........  ....+..++.++.||+.||.|||   +++|+||||||+|||++.+             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCc
Confidence            9996 799999976532110  01123345789999999999999   8999999999999999654             


Q ss_pred             CceEEeccCCccccCCCCCc---cccccccCCcccccccccc-------CCCCccccchhhHHHHHHHHh-CCCCCCccc
Q 018633          207 NVAKLFDFSLSISIPEGETH---ITDTVMGTWGYCAPEYMRT-------GVFNEKSDVFSFGVFLFELLT-GWDVSDLVK  275 (353)
Q Consensus       207 ~~~kl~dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t-g~~p~~~~~  275 (353)
                      +.+||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||+| |..||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            48999999999877543321   1234579999999999865       568999999999999999999 899986322


Q ss_pred             cccCCCCChHHHHHHHhhcC-cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          276 DTHDLACPSNEYLKNYFEDN-RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...          ....... .....         ........+..+.+|+.+||+.||++|||+.++++
T Consensus       245 ~~~----------~~i~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SRE----------SNIIRGIFSLDEM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             THH----------HHHHHTCCCCCCC---------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhH----------HHHhcCCCCcccc---------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            110          0111110 11000         00001256778899999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.4e-43  Score=323.43  Aligned_cols=249  Identities=16%  Similarity=0.263  Sum_probs=199.9

Q ss_pred             cHHHHHHHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh----hHHHHHHHHHHHHhhcC--CCce
Q 018633           53 SAQEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP----RAYESCINNVTYAARMS--HNHI  124 (353)
Q Consensus        53 ~~~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--H~ni  124 (353)
                      +..+.....++|...+.||+|+||   .||+|.+  +++.||||++.......    ...+.+.+|+.++++++  ||||
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFG---SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSC---EEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             cccccCCccCceEEEEEEeeCCCe---EEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            334444556789999999999999   9999988  88999999996553211    12345778999999997  5999


Q ss_pred             eeccceeeeCCccEEEEEeccC-CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceee
Q 018633          125 LKLIGCCLETPIPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF  203 (353)
Q Consensus       125 v~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill  203 (353)
                      +++++++.+.+..++|+|++.+ ++|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||+
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll  182 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILI  182 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEE
Confidence            9999999999999999999976 8999998764     35889999999999999999999   9999999999999999


Q ss_pred             c-CCCceEEeccCCccccCCCCCccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCC
Q 018633          204 N-EENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA  281 (353)
Q Consensus       204 ~-~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~  281 (353)
                      + .++.+||+|||++.......   .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.....     
T Consensus       183 ~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----  254 (320)
T 3a99_A          183 DLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----  254 (320)
T ss_dssp             ETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             eCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----
Confidence            9 78899999999998764322   334578999999999987765 6889999999999999999999863211     


Q ss_pred             CChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                               .... ..  ...            ...+..+.+|+.+||+.||++|||+.++++
T Consensus       255 ---------~~~~-~~--~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 ---------IIRG-QV--FFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---------HHHC-CC--CCS------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------hhcc-cc--ccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     0000 00  000            023456789999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-42  Score=341.13  Aligned_cols=277  Identities=16%  Similarity=0.177  Sum_probs=202.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee-----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-----  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-----  133 (353)
                      .++|...+.||+|+||   .||++.+  +++.||||++.... .....+.+.+|+.++++++||||+++++++..     
T Consensus        13 ~grY~i~~~LG~G~fG---~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFG---YVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ----CCCCCCCBCSSS---BCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCeEEEEEEeeCCCe---EEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            3789999999999999   8999988  78999999987642 55667889999999999999999999999765     


Q ss_pred             -CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCc---e
Q 018633          134 -TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---A  209 (353)
Q Consensus       134 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~---~  209 (353)
                       ++..++||||+++|+|.+++......  ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.   +
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEE
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeE
Confidence             66789999999999999999865421  35888899999999999999999   899999999999999997664   8


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH-
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL-  288 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-  288 (353)
                      ||+|||++........  .....||..|+|||++.+..++.++||||||+++|+|++|..||................. 
T Consensus       164 KL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          164 KIIDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN  241 (676)
T ss_dssp             EECSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred             EEcccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence            9999999987644332  3456789999999999999999999999999999999999999964321110000000000 


Q ss_pred             HHHhhcCccccc--ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHH-----HHHHHHHHH
Q 018633          289 KNYFEDNRFTEI--VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVD-----VAKKLRQIY  350 (353)
Q Consensus       289 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~-----vl~~L~~l~  350 (353)
                      ............  ......  .+.......+..+.+++.+||.+||++|||+.+     ..+.+..+.
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp--~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLP--TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSC--CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhhhccccccccccC--CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            000000000000  000000  000011146678899999999999999999987     445555544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-41  Score=304.41  Aligned_cols=230  Identities=10%  Similarity=0.031  Sum_probs=185.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||+|++..... .....+.|.+|+.++.+++||||+++++++.+.+..|
T Consensus        31 ~~y~i~~~lg~G~~g---~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPL---QFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             TTEEEEEEEEBSTTC---EEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CcEEEEEEEcccCCe---EEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            579999999999999   9999999  589999999976643 2455688999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++...       ....++..++.|++.||.|||   +++|+||||||+|||++.++.+||+++|   
T Consensus       108 lv~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             EEEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---
Confidence            999999999999998542       244567889999999999999   9999999999999999999999998544   


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                                        |++       .++.++|||||||++|||+||+.||..........                 
T Consensus       175 ------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------------  212 (286)
T 3uqc_A          175 ------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------------  212 (286)
T ss_dssp             ------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------------
T ss_pred             ------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------------
Confidence                              222       36789999999999999999999998543322000                 


Q ss_pred             ccccchhhhccch--HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          299 EIVDPIIVEDVLS--IEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       299 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                       ............  ......+..+.+++.+||+.||++| |+.++++.|+++..
T Consensus       213 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          213 -PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             -ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             -HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence             000000010000  0111456678999999999999999 99999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-41  Score=340.67  Aligned_cols=241  Identities=22%  Similarity=0.269  Sum_probs=196.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc-
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI-  136 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~-  136 (353)
                      .++|...+.||+|+||   .||++.+   +++.||||++.... .......+.+|+.++.+++|||||++++++...+. 
T Consensus        79 ~~~y~i~~~lg~G~~g---~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLG---WIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TTTEEEEEEEEEETTE---EEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCceEEEEEEeeCCCe---EEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            3789999999999999   9999987   58999999986542 45566789999999999999999999999987665 


Q ss_pred             ----cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          137 ----PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       137 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                          .|+||||+++++|.+++..       .+++..++.++.||+.||.|||   +++|+||||||+|||++.+ .+||+
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEEC
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEE
Confidence                6999999999999887643       4789999999999999999999   8999999999999999875 89999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHh
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      |||+++.....     ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+.......              
T Consensus       224 DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------  283 (681)
T 2pzi_A          224 DLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------  283 (681)
T ss_dssp             CCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------
T ss_pred             ecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------
Confidence            99999876432     3557999999999987654 889999999999999999988866321110              


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-SMVDVAKKLRQIYR  351 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~vl~~L~~l~~  351 (353)
                          ..        ..   ......+..+.+++.+||+.||++|| ++.++...|..+.+
T Consensus       284 ----~~--------~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          284 ----LP--------ED---DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ----CC--------TT---CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ----cc--------cc---ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                00        00   01113456788999999999999999 57778777777654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.1e-41  Score=303.06  Aligned_cols=229  Identities=17%  Similarity=0.264  Sum_probs=180.1

Q ss_pred             HhhCcCCC-CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHH-hhcCCCceeeccceeee--
Q 018633           60 ATNSYDQK-NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYA-ARMSHNHILKLIGCCLE--  133 (353)
Q Consensus        60 ~~~~~~~~-~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~~~~~~~~--  133 (353)
                      ..++|... ++||+|+||   .||++.+  +++.||+|++...       ..+.+|+.++ +.++||||+++++++..  
T Consensus        15 ~~~~y~~~~~~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGING---KVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             GGGTEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccchhhcCcccccCCCe---EEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            34567766 789999999   9999988  7899999998654       4577888888 55689999999999886  


Q ss_pred             --CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---CCc
Q 018633          134 --TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---ENV  208 (353)
Q Consensus       134 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~  208 (353)
                        ....++||||+++|+|.+++.....   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.   ++.
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~  158 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAI  158 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCc
Confidence              6678999999999999999987543   46899999999999999999999   999999999999999998   788


Q ss_pred             eEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          209 AKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       209 ~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      ++|+|||++....                       +..++.++|||||||++|+|++|..||.........        
T Consensus       159 ~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--------  207 (299)
T 3m2w_A          159 LKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------  207 (299)
T ss_dssp             EEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------
T ss_pred             EEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--------
Confidence            9999999986542                       134678999999999999999999999643321100        


Q ss_pred             HHHhhcCcccccccchhhh--ccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVE--DVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                               ..........  ..+.......+..+.+++.+||+.||++|||+.++++
T Consensus       208 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          208 ---------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ---------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                     0000000000  0111111245678899999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-41  Score=320.29  Aligned_cols=245  Identities=12%  Similarity=0.091  Sum_probs=181.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCC-Cceeeccce------
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSH-NHILKLIGC------  130 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~------  130 (353)
                      +.+|...++||+|+||   .||+|.+  +++.||||++.... ......+.|.+|+.++..++| +|......+      
T Consensus        77 ~~~~~~~~~LG~G~fG---~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~  153 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPY---AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  153 (413)
T ss_dssp             CEEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred             ceeEEEecccccCCCE---EEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence            3457777899999999   9999998  69999999987432 123346779999999999987 322211111      


Q ss_pred             ---------------eee-----CCccEEEEEeccCCChhhhhccCC--CCCCccccHHHHHHHHHHHHHHHHHHhcCCC
Q 018633          131 ---------------CLE-----TPIPILVFESVQYGTLWDRILGAP--QPHFEPLLLKHRLKIAMDIVHALAYLHFGFP  188 (353)
Q Consensus       131 ---------------~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  188 (353)
                                     +..     ....+++|+++ +++|.+++....  ......+++..++.++.|++.||.|||   +
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~  229 (413)
T 3dzo_A          154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---H  229 (413)
T ss_dssp             CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred             hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence                           111     12356777766 589998884110  000156889999999999999999999   9


Q ss_pred             CCeEeeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCCcccccccc----------ccCCCCccccchhhH
Q 018633          189 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM----------RTGVFNEKSDVFSFG  258 (353)
Q Consensus       189 ~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Di~slG  258 (353)
                      ++|+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++||||||
T Consensus       230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             CCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence            99999999999999999999999999998765322    345567 999999999          555588899999999


Q ss_pred             HHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC
Q 018633          259 VFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS  338 (353)
Q Consensus       259 ~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps  338 (353)
                      |++|||++|+.||.......                     ..........      ..+..+.+|+.+||+.||++|||
T Consensus       305 vil~elltg~~Pf~~~~~~~---------------------~~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt  357 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDDAALG---------------------GSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLL  357 (413)
T ss_dssp             HHHHHHHHSSCCCCTTGGGS---------------------CSGGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHCCCCCCCcchhh---------------------hHHHHHhhcc------cCCHHHHHHHHHHccCChhhCcC
Confidence            99999999999997433221                     1111111000      23456889999999999999999


Q ss_pred             HHHHHH
Q 018633          339 MVDVAK  344 (353)
Q Consensus       339 ~~~vl~  344 (353)
                      +.++++
T Consensus       358 ~~~~l~  363 (413)
T 3dzo_A          358 PLQAME  363 (413)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            888754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.3e-41  Score=307.91  Aligned_cols=245  Identities=11%  Similarity=0.047  Sum_probs=186.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCC------ChhHHHHHHHHHHHHhhcC--------------
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHEC------RPRAYESCINNVTYAARMS--------------  120 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~--------------  120 (353)
                      .++|...+.||+|+||   .||+|.++++.||||++.....      .....+.+.+|+.+++.++              
T Consensus        19 ~~~y~~~~~lG~G~~g---~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFG---EVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             HHHHHTCEEEEEETTE---EEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccchheeeecccCce---EEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            4668899999999999   9999999999999999976531      2334578899999999987              


Q ss_pred             ------------CCceeeccceeee-------------CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHH
Q 018633          121 ------------HNHILKLIGCCLE-------------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD  175 (353)
Q Consensus       121 ------------H~niv~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~  175 (353)
                                  ||||+++++++.+             .+..|+||||+++|++.+.+..      ..+++..++.++.|
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQ  169 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHH
Confidence                        5666666666654             6789999999999987777744      35789999999999


Q ss_pred             HHHHHHHHhcCCCCCeEeeccCCCceeecCCC--------------------ceEEeccCCccccCCCCCccccccccCC
Q 018633          176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEEN--------------------VAKLFDFSLSISIPEGETHITDTVMGTW  235 (353)
Q Consensus       176 i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~--------------------~~kl~dfg~a~~~~~~~~~~~~~~~gt~  235 (353)
                      |+.||.|||+  +++|+||||||+|||++.++                    .+||+|||+|+....      ....||+
T Consensus       170 i~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~  241 (336)
T 2vuw_A          170 LTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCD  241 (336)
T ss_dssp             HHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCC
T ss_pred             HHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEee
Confidence            9999999993  37899999999999999887                    899999999987643      2447999


Q ss_pred             ccccccccccCCCCccccchhhHHH-HHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHH
Q 018633          236 GYCAPEYMRTGVFNEKSDVFSFGVF-LFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEK  314 (353)
Q Consensus       236 ~y~aPE~~~~~~~~~~~Di~slG~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (353)
                      .|+|||++.+.. +.++|||||+++ .+++++|..||......       ..............        ........
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~--------~~~~~~~~  305 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-------HYLTDKMLKQMTFK--------TKCNTPAM  305 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-------HHHHHHHHHTCCCS--------SCCCSHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-------hHHHHhhhhhhccC--------cccchhhh
Confidence            999999998766 889999998777 77888898887421000       00000111110110        11112223


Q ss_pred             HHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 018633          315 EQQLHASAQLSFECIKDSPADRPSMVDVA  343 (353)
Q Consensus       315 ~~~~~~l~~li~~cl~~dP~~Rps~~~vl  343 (353)
                      ...+..+.+|+.+||+.|     |+.+++
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            367889999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.6e-34  Score=282.27  Aligned_cols=171  Identities=15%  Similarity=0.121  Sum_probs=129.0

Q ss_pred             CCeEEEEEEecCCCC--------ChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCccEEEEEeccCCChhhhhccCC
Q 018633           87 QERLISVLQFYGHEC--------RPRAYESCINNVTYAARM-SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAP  157 (353)
Q Consensus        87 ~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  157 (353)
                      .|..+++|.+.....        .....++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.+++... 
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~-  336 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG-  336 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-
Confidence            678899999865421        234457799999999999 5999999999999999999999999999999999875 


Q ss_pred             CCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCccccccccCCcc
Q 018633          158 QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGY  237 (353)
Q Consensus       158 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y  237 (353)
                          .+++..   +|+.||+.||.|+|   ++|||||||||+|||++.+|.+||+|||+|+....... ...+.+||+.|
T Consensus       337 ----~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~Y  405 (569)
T 4azs_A          337 ----EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFV  405 (569)
T ss_dssp             ----CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHH
T ss_pred             ----CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhh
Confidence                345554   58899999999999   99999999999999999999999999999987654332 34567899999


Q ss_pred             ccccccccCCCCccccchhhHHHHHHHHhCCCC
Q 018633          238 CAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDV  270 (353)
Q Consensus       238 ~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p  270 (353)
                      +|||++.+ .+..++|+||+|++++++.++..+
T Consensus       406 mAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          406 FVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHC------------------CCCCTTHHH
T ss_pred             ccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            99999875 466789999999998877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.2e-30  Score=253.35  Aligned_cols=186  Identities=14%  Similarity=0.095  Sum_probs=148.5

Q ss_pred             CCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChh------HHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPR------AYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ...++||+|+||   .||++.+.+..+++|+.........      ..+.|.+|++++++++||||+++..++...+..|
T Consensus       339 ~~~~~LG~G~fg---~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEA---DIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCE---EEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCE---EEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence            345689999999   9999988899999998754432211      2456899999999999999997777777888889


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+++++|.+++..             +..++.|++.||.|||   +++|+||||||+|||++.  .+||+|||+++
T Consensus       416 lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~  477 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGK  477 (540)
T ss_dssp             EEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred             EEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCE
Confidence            99999999999998864             4579999999999999   999999999999999998  99999999998


Q ss_pred             ccCCCCCcc------ccccccCCcccccccccc--CCCCccccchhhHHHHHHHHhCCCCC
Q 018633          219 SIPEGETHI------TDTVMGTWGYCAPEYMRT--GVFNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       219 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~p~  271 (353)
                      .........      .....||+.|+|||++..  ..|+..+|+||..+-..+.+.++.+|
T Consensus       478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            875432211      235689999999999986  56888999999999888888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=5.6e-26  Score=203.04  Aligned_cols=150  Identities=12%  Similarity=0.055  Sum_probs=119.4

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCCh----------------hHHHHHHHHHHHHhhcCC
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRP----------------RAYESCINNVTYAARMSH  121 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~H  121 (353)
                      .....|...+.||+|+||   .||+|.+ +++.||+|.+.......                .....+.+|+.++++++ 
T Consensus        87 ~~~~~~~~~~~iG~G~~g---~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKES---AVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HTTSCSEEEEEEEECSSE---EEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             hCCeEEEecCEeccCCCc---eEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            334455566899999999   9999999 78999999996542111                24567899999999999 


Q ss_pred             CceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCce
Q 018633          122 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI  201 (353)
Q Consensus       122 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Ni  201 (353)
                       | +++++++. .+..|+||||+++|+|.+ +..           .....++.|++.||.|||   +++|+||||||+||
T Consensus       163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NI  224 (282)
T 1zar_A          163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNV  224 (282)
T ss_dssp             -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSE
T ss_pred             -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHE
Confidence             5 77777654 456799999999999988 421           112369999999999999   99999999999999


Q ss_pred             eecCCCceEEeccCCccccCCCCCccccccccCCcccccccccc
Q 018633          202 LFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT  245 (353)
Q Consensus       202 ll~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~  245 (353)
                      |++ ++.+||+|||+++..              ..+.|||++..
T Consensus       225 Ll~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~r  253 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSVEV--------------GEEGWREILER  253 (282)
T ss_dssp             EEE-TTEEEECCCTTCEET--------------TSTTHHHHHHH
T ss_pred             EEE-CCcEEEEECCCCeEC--------------CCCCHHHHHHH
Confidence            999 999999999998643              34789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=5.8e-21  Score=168.35  Aligned_cols=138  Identities=12%  Similarity=0.073  Sum_probs=105.2

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe--CCeE--EEEEEecCCCCCh----------------------hHHHHHHHHHHHHh
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW--QERL--ISVLQFYGHECRP----------------------RAYESCINNVTYAA  117 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~--~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~  117 (353)
                      |...+.||+|+||   .||+|.+  +|+.  ||||++.......                      .....+.+|+.+|.
T Consensus        49 ~~i~~~ig~G~~g---~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  125 (258)
T 1zth_A           49 TAMGGVISTGKEA---NVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE  125 (258)
T ss_dssp             EEEEEEEEECSSE---EEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceE---EEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence            5667889999999   9999998  8989  9999875432110                      11236889999999


Q ss_pred             hcCCCce--eeccceeeeCCccEEEEEeccC-C----ChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC
Q 018633          118 RMSHNHI--LKLIGCCLETPIPILVFESVQY-G----TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP  190 (353)
Q Consensus       118 ~l~H~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  190 (353)
                      ++.|+|+  ..++++    +..++||||+.+ |    +|.+....        .++..+..++.|++.||.|||.  +.+
T Consensus       126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~g  191 (258)
T 1zth_A          126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAE  191 (258)
T ss_dssp             HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSC
T ss_pred             HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCC
Confidence            9998864  333332    367899999942 4    55554321        2344667899999999999994  579


Q ss_pred             eEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          191 IVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       191 iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |+||||||+|||++.  .++|+|||+|...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999998  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.5e-19  Score=164.71  Aligned_cols=142  Identities=13%  Similarity=0.066  Sum_probs=99.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCC------------hhHHHHHHHHHHHHhhcCCCceeecc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECR------------PRAYESCINNVTYAARMSHNHILKLI  128 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~H~niv~~~  128 (353)
                      .-|.....||+|++|   .||+|.. +|+.||||++.....+            ......+..++++.+...|+|+++++
T Consensus        95 ~iY~I~~~IG~Gk~a---~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~  171 (397)
T 4gyi_A           95 DVYSVGSRIGVGKES---DIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY  171 (397)
T ss_dssp             SCSEEEEEEEECSSE---EEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEecCEeeeCCce---EEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence            348888999999999   9999998 8999999987533110            11122333344444444455554444


Q ss_pred             ceeeeC------CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCcee
Q 018633          129 GCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL  202 (353)
Q Consensus       129 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nil  202 (353)
                      ......      ...+|||||++|++|.++...           .....++.|++.+|.+||   .++||||||||.|||
T Consensus       172 ~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          172 EEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLA---KHGLIHGDFNEFNIL  237 (397)
T ss_dssp             HTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             hcCCCCCeeeeccCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEE
Confidence            332211      234799999998888765421           122467899999999999   899999999999999


Q ss_pred             ecCCC----------ceEEeccCCcccc
Q 018633          203 FNEEN----------VAKLFDFSLSISI  220 (353)
Q Consensus       203 l~~~~----------~~kl~dfg~a~~~  220 (353)
                      ++.++          .+.|+||+.+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98776          3899999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=8.6e-14  Score=122.46  Aligned_cols=147  Identities=10%  Similarity=-0.023  Sum_probs=112.3

Q ss_pred             HHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCC
Q 018633           57 IKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETP  135 (353)
Q Consensus        57 ~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~  135 (353)
                      +....++|.....++.|+.+   .||+....+..+++|......  ......+.+|+.+++.+. +..+.++++++.+.+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~---~v~~~~~~~~~~vlK~~~~~~--~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPA---KVYKLVGENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSS---EEEEEECSSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHHhccceeEeeccCCCCC---eEEEEECCCCcEEEEeCCccc--CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            34455678777778888888   888888778899999986531  122345889999999995 677888999998888


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFG-----------------------------  186 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------  186 (353)
                      ..|+||||++|.+|.+.+...          .....++.+++.+|..||..                             
T Consensus        84 ~~~lv~e~i~G~~l~~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             ceEEEEEecCCeehhhccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence            999999999999987754211          11236788999999999951                             


Q ss_pred             ---------------------------CCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          187 ---------------------------FPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       187 ---------------------------~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                                                 ....++|+|++|.||+++....+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                       01458999999999999876556799999763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=2e-12  Score=113.19  Aligned_cols=128  Identities=9%  Similarity=-0.022  Sum_probs=93.3

Q ss_pred             eeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc--eeeccceeeeCCccEEEEEeccCC
Q 018633           71 AKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH--ILKLIGCCLETPIPILVFESVQYG  147 (353)
Q Consensus        71 g~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~g  147 (353)
                      +.|..+   .||+... ++..+++|.....     ....+.+|+.+++.+.+.+  +.+++++...++..++||||++|.
T Consensus        29 ~gg~~~---~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~  100 (264)
T 1nd4_A           29 IGCSDA---AVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ  100 (264)
T ss_dssp             CTTSSC---EEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             cCCCCc---eEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCc
Confidence            344557   8888876 5678999987543     2245778999999987545  455888887777889999999988


Q ss_pred             ChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 018633          148 TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF----------------------------------------  187 (353)
Q Consensus       148 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  187 (353)
                      +|.  ...        ...   ..++.+++..|..||...                                        
T Consensus       101 ~l~--~~~--------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A          101 DLL--SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             ETT--TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             ccC--cCc--------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            884  211        111   256778888888888321                                        


Q ss_pred             ---------------CCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          188 ---------------PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       188 ---------------~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                                     ...++|+|++|.||+++.++.+.|+||+.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                           01299999999999998776667999998643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.27  E-value=1.3e-11  Score=113.51  Aligned_cols=143  Identities=14%  Similarity=0.143  Sum_probs=105.6

Q ss_pred             CCceeeCCCCCccEEEEEEeCCeEEEEEEec--CCCCChhHHHHHHHHHHHHhhcC--CCceeeccceeeeC---CccEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFWQERLISVLQFY--GHECRPRAYESCINNVTYAARMS--HNHILKLIGCCLET---PIPIL  139 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~~---~~~~l  139 (353)
                      .+.|+.|.++   .||+....+..+++|+..  ... .......+.+|+.+++.+.  +..+.++++++.+.   +..++
T Consensus        43 ~~~l~~G~sn---~~y~v~~~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSN---PTFKLVTPGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCS---CEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEEcCCcccc---eEEEEEECCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            4568889999   888888877788888875  331 1123456888999999998  45678888888766   45899


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF--------------------------------  187 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------  187 (353)
                      ||||++|.++.+...       ..++...+..++.+++..|..||...                                
T Consensus       119 vme~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EEECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEEecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            999999877754221       34677888899999999999999520                                


Q ss_pred             -----------------------CCCeEeeccCCCceeecCCCc--eEEeccCCcccc
Q 018633          188 -----------------------PRPIVFRNFKTSCILFNEENV--AKLFDFSLSISI  220 (353)
Q Consensus       188 -----------------------~~~iiH~dlkp~Nill~~~~~--~kl~dfg~a~~~  220 (353)
                                             ...++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                   256999999999999987653  689999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=5.3e-11  Score=106.93  Aligned_cols=186  Identities=15%  Similarity=0.166  Sum_probs=118.5

Q ss_pred             CCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCc--eeeccceeeeCC---ccEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNH--ILKLIGCCLETP---IPILV  140 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~~~~~~~~~~---~~~lv  140 (353)
                      .+.++.|.+.   .||+..   ..+++|....    ......+.+|+++|+.+. +..  +.+++......+   ..|+|
T Consensus        25 i~~~~~G~~n---~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDC---IAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSE---EEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcc---eEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568889888   777653   4577887542    245677899999999884 333  334444433332   35899


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFG----------------------------------  186 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------  186 (353)
                      |++++|.+|.+...       ..++..++..++.+++..|..||..                                  
T Consensus        95 m~~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             EECCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             EcccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            99999988865332       2356677778888888888888841                                  


Q ss_pred             ---------------------CCCCeEeeccCCCceeecC--CCceEEeccCCccccCCCCCccccccccCCcccccccc
Q 018633          187 ---------------------FPRPIVFRNFKTSCILFNE--ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYM  243 (353)
Q Consensus       187 ---------------------~~~~iiH~dlkp~Nill~~--~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~  243 (353)
                                           ....++|+|++|.||+++.  ...+.|+||+.+...... .......... .-..|+..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~-~~~~~~~~  245 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDD-EEYGMEFV  245 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTT-TSCCHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhc-cccCHHHH
Confidence                                 0135799999999999997  456789999988654221 1000000000 00122211


Q ss_pred             cc-----C---------CCCccccchhhHHHHHHHHhCCCCC
Q 018633          244 RT-----G---------VFNEKSDVFSFGVFLFELLTGWDVS  271 (353)
Q Consensus       244 ~~-----~---------~~~~~~Di~slG~il~el~tg~~p~  271 (353)
                      ..     +         ......+.|+++.++|.+.+|..+|
T Consensus       246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            10     0         0112257899999999999997664

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=2.4e-07  Score=83.07  Aligned_cols=135  Identities=9%  Similarity=0.026  Sum_probs=91.2

Q ss_pred             CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC---ceeeccceee-eCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHN---HILKLIGCCL-ETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~~~~~~~-~~~~~~lv~e~  143 (353)
                      ..++.|...   .||+.   +..+++|+..    .......+.+|+++|..+.+.   .+.+++.++. ..+..++|||+
T Consensus        25 ~~l~~G~~n---~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           25 ESLGEGFRN---YAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEECSSE---EEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eecCCCcce---eEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            457778777   67765   5667788742    234567889999999999753   2455565553 34567899999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFG-------------------------------------  186 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------  186 (353)
                      ++|.+|.+...       ..++......++.+++..|..||..                                     
T Consensus        95 i~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           95 VQGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             CCSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             cCCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            99888865321       1234444455555555555555521                                     


Q ss_pred             --------------------CCCCeEeeccCCCceeecC---CCc-eEEeccCCccc
Q 018633          187 --------------------FPRPIVFRNFKTSCILFNE---ENV-AKLFDFSLSIS  219 (353)
Q Consensus       187 --------------------~~~~iiH~dlkp~Nill~~---~~~-~kl~dfg~a~~  219 (353)
                                          ....++|+|+.|.||+++.   ++. ..|+||+.+..
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                1335799999999999987   355 48999997754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=2.4e-07  Score=81.26  Aligned_cols=134  Identities=10%  Similarity=0.023  Sum_probs=94.0

Q ss_pred             eeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccEEEEEeccC
Q 018633           70 IAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPILVFESVQY  146 (353)
Q Consensus        70 lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~  146 (353)
                      +..|..|.  .||+-..  .+..+++|.-..     .....+.+|+..|+.+. +--+.++++++.+.+..++|||+++|
T Consensus        32 ~~~G~S~~--~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           32 DNVGQSGA--TIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EECSSSSC--EEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             ccCCCcCC--eEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            44455541  4676554  466788887643     34567889999999886 33366788888888899999999998


Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF---------------------------------------  187 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------  187 (353)
                      .++.+.....         ......++.+++..|.-||...                                       
T Consensus       105 ~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          105 KTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             EEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             ccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            8877654321         1122346667777777777210                                       


Q ss_pred             ----------------CCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          188 ----------------PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       188 ----------------~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                                      ...++|+|+.|.||+++..+.+-|+||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                            11379999999999999877677999997743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.30  E-value=9e-07  Score=80.91  Aligned_cols=81  Identities=6%  Similarity=-0.154  Sum_probs=52.0

Q ss_pred             Cce-eeCCCCCccEEEEEEeC--------CeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcC-C--CceeeccceeeeC
Q 018633           68 NVI-AKDTSYNLYTMYKGFWQ--------ERLISVLQFYGHEC-RPRAYESCINNVTYAARMS-H--NHILKLIGCCLET  134 (353)
Q Consensus        68 ~~l-g~G~~g~~~~v~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-H--~niv~~~~~~~~~  134 (353)
                      +.| +.|...   .+|+....        +..+++|....... .......+.+|+.+++.+. +  -.+.++++++.+.
T Consensus        26 ~~l~~~G~~n---~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           26 SGVDSTGMSS---ETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEECTTSSEE---EEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EECCCCCccc---eEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345 666667   67766543        67788887654310 0001245678888888885 2  3466777777654


Q ss_pred             ---CccEEEEEeccCCChhh
Q 018633          135 ---PIPILVFESVQYGTLWD  151 (353)
Q Consensus       135 ---~~~~lv~e~~~~gsL~~  151 (353)
                         +..++|||+++|.++.+
T Consensus       103 ~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCCB
T ss_pred             CccCCceEEEEecCCCChhh
Confidence               35789999999877654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.03  E-value=5.7e-05  Score=68.15  Aligned_cols=32  Identities=13%  Similarity=0.196  Sum_probs=28.3

Q ss_pred             CCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          188 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            57899999999999998788899999997643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.93  E-value=7e-05  Score=67.01  Aligned_cols=75  Identities=8%  Similarity=-0.065  Sum_probs=59.0

Q ss_pred             CCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC---CCceeeccceeeeCCccEEEEEe
Q 018633           67 KNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS---HNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      ...|+.|...   .+|+...++..+++|.....     ....+..|++.|+.|.   ...+.++++++...+..++|||+
T Consensus        41 ~~~l~gG~~n---~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMN---EIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSS---EEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccce---eeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            3457888888   88887777788888886533     3567889999999885   35678888888777889999999


Q ss_pred             ccCCCh
Q 018633          144 VQYGTL  149 (353)
Q Consensus       144 ~~~gsL  149 (353)
                      +++.++
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.92  E-value=2.9e-05  Score=71.92  Aligned_cols=76  Identities=12%  Similarity=0.117  Sum_probs=48.7

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC--C---hhHHHHHHHHHHHHhhcCC--Cc-eeeccceeeeCCc
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC--R---PRAYESCINNVTYAARMSH--NH-ILKLIGCCLETPI  136 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~H--~n-iv~~~~~~~~~~~  136 (353)
                      .+.||.|..+   .||++..  .++.+++|.......  .   ....+++..|++++..+..  |. +.+++.+  +.+.
T Consensus        35 ~~~lg~G~~n---~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~  109 (397)
T 2olc_A           35 CQEIGDGNLN---YVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM  109 (397)
T ss_dssp             EEECCSSSSE---EEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred             EEECCCCceE---EEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc
Confidence            3468889899   8999865  567899998653210  0   1123456789999988742  33 3445543  4456


Q ss_pred             cEEEEEeccCC
Q 018633          137 PILVFESVQYG  147 (353)
Q Consensus       137 ~~lv~e~~~~g  147 (353)
                      .++|||++++.
T Consensus       110 ~~lvmE~l~g~  120 (397)
T 2olc_A          110 AVTVMEDLSHL  120 (397)
T ss_dssp             TEEEECCCTTS
T ss_pred             cEEEEEeCCCc
Confidence            78999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.75  E-value=0.00015  Score=63.95  Aligned_cols=77  Identities=9%  Similarity=0.003  Sum_probs=53.5

Q ss_pred             cCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC---ceeeccceeeeCCccEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHN---HILKLIGCCLETPIPIL  139 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~~~~~~~~~~~~~l  139 (353)
                      ......+|.|..+   .||+... +|+.+++|+....  .......|..|++.|+.|.--   -+.+++++    +..++
T Consensus        17 v~~v~~~g~G~~~---~vyrv~l~DG~~~~vK~~~~~--~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~l   87 (288)
T 3f7w_A           17 VAAVAERGHSHRW---HLYRVELADGTPLFVKALPDD--APALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTL   87 (288)
T ss_dssp             EEEEEEEEEETTE---EEEEEEETTSCEEEEEECCTT--CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEE
T ss_pred             eEEEEecCCCCCe---EEEEEEECCCCEEEEEEeCCC--CcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceE
Confidence            3445668999999   9999888 7889999987654  233345678899999988532   23344443    23478


Q ss_pred             EEEeccCCCh
Q 018633          140 VFESVQYGTL  149 (353)
Q Consensus       140 v~e~~~~gsL  149 (353)
                      ||||++++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=0.00044  Score=61.85  Aligned_cols=162  Identities=10%  Similarity=0.058  Sum_probs=88.0

Q ss_pred             ceecHHHHHHHhhCcCCC-----CceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc-
Q 018633           50 RIFSAQEIKLATNSYDQK-----NVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH-  123 (353)
Q Consensus        50 ~~~~~~e~~~~~~~~~~~-----~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-  123 (353)
                      ..++.+++......|...     +.|+.|...   .+|+...++..+++|.....    ...+.+..|+.++..+...+ 
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n---~~~~v~~~~g~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~   77 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVEN---SNFLLHTTKDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGL   77 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---E---EEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTC
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCccc---ceEEEEeCCccEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCC
Confidence            346777777777777652     234456666   78887775557888988652    11234556777777765222 


Q ss_pred             -eeeccce------eeeCCccEEEEEeccCCChhh--------------hhccC----CCCC---CccccHHHHHH----
Q 018633          124 -ILKLIGC------CLETPIPILVFESVQYGTLWD--------------RILGA----PQPH---FEPLLLKHRLK----  171 (353)
Q Consensus       124 -iv~~~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~~---~~~l~~~~~~~----  171 (353)
                       +.+++..      ....+..++++++++|.++..              .++..    ..+.   .....|.....    
T Consensus        78 ~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~  157 (322)
T 2ppq_A           78 SCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEE  157 (322)
T ss_dssp             CCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGG
T ss_pred             CCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHH
Confidence             2333322      122356789999999765421              11110    0000   00011221100    


Q ss_pred             --------HHHHHHHHHHHHhc----CCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          172 --------IAMDIVHALAYLHF----GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       172 --------i~~~i~~~L~~LH~----~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                              +...+...+.++..    ....+++|+|+.+.|||++.+..+.|+||+.+.
T Consensus       158 ~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          158 RADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                    00113344445441    124579999999999999877656899999764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.61  E-value=0.0012  Score=59.22  Aligned_cols=163  Identities=12%  Similarity=0.091  Sum_probs=90.3

Q ss_pred             CcceecHHHHHHHhhCcCC-----CCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC
Q 018633           48 PYRIFSAQEIKLATNSYDQ-----KNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSH  121 (353)
Q Consensus        48 ~~~~~~~~e~~~~~~~~~~-----~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H  121 (353)
                      +...++.+++......|..     ...++ |...   .||+... +|+.+++|......   .....+..|..++..+..
T Consensus         7 ~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n---~~y~v~~~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~   79 (328)
T 1zyl_A            7 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYEN---RVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVN   79 (328)
T ss_dssp             CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSS---EEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCCCceEEeec-Cccc---ceEEEEcCCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHH
Confidence            4555677777766655532     22355 6666   8888776 56679999986431   123456678888887752


Q ss_pred             Cc--eeeccce-----eeeCCccEEEEEeccCCChhh--------------hhcc----CCCCCCccccHHHH-------
Q 018633          122 NH--ILKLIGC-----CLETPIPILVFESVQYGTLWD--------------RILG----APQPHFEPLLLKHR-------  169 (353)
Q Consensus       122 ~n--iv~~~~~-----~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~~~~~~~l~~~~~-------  169 (353)
                      ..  +++++..     ....+..++||++++|.++..              .++.    ........+.+...       
T Consensus        80 ~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T 1zyl_A           80 DEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKL  159 (328)
T ss_dssp             TTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHH
T ss_pred             cCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHH
Confidence            22  3444443     122445678999998754421              0110    00000011111110       


Q ss_pred             ---------------HHHHHHHHHHHHHHhc-CCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          170 ---------------LKIAMDIVHALAYLHF-GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       170 ---------------~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                                     ...+..++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       160 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          160 FEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                           1111222222222210 1156689999999999998 4 899999987754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.57  E-value=0.0005  Score=64.13  Aligned_cols=77  Identities=14%  Similarity=0.220  Sum_probs=47.2

Q ss_pred             CCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCcccccccc--CCccccccccccC---CCCccccchhhHHHHH
Q 018633          188 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG--TWGYCAPEYMRTG---VFNEKSDVFSFGVFLF  262 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Di~slG~il~  262 (353)
                      ...++|+|++|.||+++.++ +.|+||+.+......- .. .....  ...|.+|+.....   .-....++.+....+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            78899999999999998776 9999999886542110 00 01111  1345666654311   1112344557777777


Q ss_pred             HHHhC
Q 018633          263 ELLTG  267 (353)
Q Consensus       263 el~tg  267 (353)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.50  E-value=0.00031  Score=62.35  Aligned_cols=74  Identities=8%  Similarity=0.031  Sum_probs=43.2

Q ss_pred             cCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCce-eeccceeeeCCccEEEEE
Q 018633           64 YDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHI-LKLIGCCLETPIPILVFE  142 (353)
Q Consensus        64 ~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e  142 (353)
                      +...+.|+.|...   .+|+.    ..+++|+.....  .. .....+|+.+++.+...++ .++++++  .+.-++|+|
T Consensus        20 ~~~i~~l~gG~tN---~~~~~----~~~vlR~~~~~~--~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTN---LVFRA----GDLCLRIPGKGT--EE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSE---EEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred             ccceeEcCCcccc---cccee----eeEEEECCCCCc--cc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence            3335678888888   77776    567788775431  11 1122457777777752222 3455543  334578999


Q ss_pred             ec-cCCCh
Q 018633          143 SV-QYGTL  149 (353)
Q Consensus       143 ~~-~~gsL  149 (353)
                      |+ ++.+|
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 65454

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.28  E-value=0.0018  Score=54.10  Aligned_cols=103  Identities=13%  Similarity=-0.012  Sum_probs=65.5

Q ss_pred             CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCCCCc
Q 018633          147 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH  226 (353)
Q Consensus       147 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~~  226 (353)
                      -||.+.|....    .+++++++|.++.|.+.+|.-+-.  .+.-..+=+.|..|++..+|.+.+.+ +.+.        
T Consensus        33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc--------
Confidence            37888888766    689999999999999999887621  11111233446888888888887764 1110        


Q ss_pred             cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCC
Q 018633          227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDV  270 (353)
Q Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p  270 (353)
                           .....+.|||... ...+.+.=|||||+++|..+-=..|
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 0122466888763 3345677899999999998874333

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.25  E-value=0.00072  Score=62.07  Aligned_cols=141  Identities=14%  Similarity=0.094  Sum_probs=79.3

Q ss_pred             ceeeCCCCCccEEEEEEeC---------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccE
Q 018633           69 VIAKDTSYNLYTMYKGFWQ---------ERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPI  138 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~  138 (353)
                      .|.-|-..   .+|+....         +..+++++.-..   ........+|.++++.+. +.-..++++++.+    .
T Consensus        57 ~lsGG~TN---~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           57 PVSGGLSN---LLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             EC-----C---CEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EcCCcccc---cEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            45556666   66776652         467888885332   123456678999998886 3223556666543    2


Q ss_pred             EEEEeccCCChhhh-----------------hccCCC--CCCccccHHHHHHHHHHHHH-------------------HH
Q 018633          139 LVFESVQYGTLWDR-----------------ILGAPQ--PHFEPLLLKHRLKIAMDIVH-------------------AL  180 (353)
Q Consensus       139 lv~e~~~~gsL~~~-----------------l~~~~~--~~~~~l~~~~~~~i~~~i~~-------------------~L  180 (353)
                      +||||++|.+|..-                 ++....  .......+.++.++..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            89999998665421                 111110  00011124455555544322                   22


Q ss_pred             HHHh-----cCCCCCeEeeccCCCceeecCC----CceEEeccCCccc
Q 018633          181 AYLH-----FGFPRPIVFRNFKTSCILFNEE----NVAKLFDFSLSIS  219 (353)
Q Consensus       181 ~~LH-----~~~~~~iiH~dlkp~Nill~~~----~~~kl~dfg~a~~  219 (353)
                      ..|.     ......++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332     1123468999999999999876    6899999998743

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.18  E-value=0.0011  Score=61.92  Aligned_cols=71  Identities=13%  Similarity=0.096  Sum_probs=46.2

Q ss_pred             CceeeCCCCCccEEEEEEeC---------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCce-eeccceeeeCCcc
Q 018633           68 NVIAKDTSYNLYTMYKGFWQ---------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHI-LKLIGCCLETPIP  137 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~  137 (353)
                      ..|+.|...   .+|+....         +..+++|+....    ...+.+.+|..++..+...++ .++++.+.+    
T Consensus        79 ~~l~gG~tN---~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           79 SRIKGGMSN---MLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEECCCTTE---EEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEeCCCccc---ceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            346666666   78887763         467888887432    112456689999998863333 556665542    


Q ss_pred             EEEEEeccCCCh
Q 018633          138 ILVFESVQYGTL  149 (353)
Q Consensus       138 ~lv~e~~~~gsL  149 (353)
                      .+|+||++|.+|
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            389999986454

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.15  E-value=0.003  Score=56.69  Aligned_cols=33  Identities=21%  Similarity=0.243  Sum_probs=28.2

Q ss_pred             CCCeEeeccCCCceeecCC----CceEEeccCCcccc
Q 018633          188 PRPIVFRNFKTSCILFNEE----NVAKLFDFSLSISI  220 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~----~~~kl~dfg~a~~~  220 (353)
                      ...++|+|+.+.||+++.+    +.+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            5679999999999999874    67899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.13  E-value=0.00088  Score=61.23  Aligned_cols=71  Identities=13%  Similarity=0.030  Sum_probs=40.7

Q ss_pred             ceeeCCCCCccEEEEEEeCC----------eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc-eeeccceeeeCCcc
Q 018633           69 VIAKDTSYNLYTMYKGFWQE----------RLISVLQFYGHECRPRAYESCINNVTYAARMSHNH-ILKLIGCCLETPIP  137 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~~~~~~~~~~~~  137 (353)
                      .|+.|...   .+|+....+          ..+++|+....  . ........|..++..+...+ +.++++..  .  -
T Consensus        40 ~l~~G~~N---~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~--~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~  109 (369)
T 3c5i_A           40 QILSGLTN---QLFEVGLKEETANNYNSIRTRVLFRIYGKH--V-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G  109 (369)
T ss_dssp             EC----CC---EEEEEEECHHHHTTCTTSCCEEEEEECCTT--G-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred             EeCCcccc---eEEEEEeCCCCcccccCCCceEEEEecCCC--c-cceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence            45666666   788777643          67888876543  1 11112357888888876333 34556543  2  3


Q ss_pred             EEEEEeccCCCh
Q 018633          138 ILVFESVQYGTL  149 (353)
Q Consensus       138 ~lv~e~~~~gsL  149 (353)
                      ++||||++|.++
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999987544

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.07  E-value=0.0019  Score=60.78  Aligned_cols=71  Identities=8%  Similarity=-0.084  Sum_probs=44.3

Q ss_pred             ceeeCCCCCccEEEEEEeCC--eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCce-eeccceeeeCCccEEEEEecc
Q 018633           69 VIAKDTSYNLYTMYKGFWQE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHI-LKLIGCCLETPIPILVFESVQ  145 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~  145 (353)
                      .|+.|-..   .+|+....+  ..+++|+.....  .... .-.+|..++..|...++ .++++++. +   .+|+||++
T Consensus       115 ~lsgG~tN---~~y~v~~~~~~~~~vLRi~g~~~--~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~  184 (458)
T 2qg7_A          115 IINGGITN---ILIKVKDMSKQAKYLIRLYGPKT--DEII-NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMD  184 (458)
T ss_dssp             EECC--CE---EEEEEEETTTTEEEEEEEECC-C--CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCC
T ss_pred             EcCCCeEe---EEEEEEECCCCceEEEEECCCCh--hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeC
Confidence            45556666   788888755  888888874331  1111 11478899999875544 45677663 2   36999998


Q ss_pred             CCCh
Q 018633          146 YGTL  149 (353)
Q Consensus       146 ~gsL  149 (353)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7555

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.96  E-value=0.0056  Score=55.21  Aligned_cols=32  Identities=9%  Similarity=0.221  Sum_probs=27.8

Q ss_pred             CCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          188 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45789999999999999878899999987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.58  E-value=0.019  Score=53.33  Aligned_cols=31  Identities=13%  Similarity=0.307  Sum_probs=26.6

Q ss_pred             CCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          188 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       188 ~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ...++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            346899999999999 7788899999998754

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.06  E-value=0.028  Score=52.98  Aligned_cols=61  Identities=7%  Similarity=-0.098  Sum_probs=17.3

Q ss_pred             CCceeeCCCCCccEEEEEEeCC--eEEEE------EEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee
Q 018633           67 KNVIAKDTSYNLYTMYKGFWQE--RLISV------LQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE  133 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~  133 (353)
                      .+.||   ||   .||+|.+.+  ..||+      |.......+......|.+|..++..++|||+++.+++...
T Consensus       147 ~~~lG---fG---~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YT---TLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BC---CC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---ch---hhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            34565   99   999999943  57888      7766554445556678999999999999999999988653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.99  E-value=0.19  Score=46.14  Aligned_cols=30  Identities=23%  Similarity=0.316  Sum_probs=24.8

Q ss_pred             CeEeeccCCCceee------cCCCceEEeccCCccc
Q 018633          190 PIVFRNFKTSCILF------NEENVAKLFDFSLSIS  219 (353)
Q Consensus       190 ~iiH~dlkp~Nill------~~~~~~kl~dfg~a~~  219 (353)
                      .++|+|+.+.|||+      +.+..+.++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4456799999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.41  E-value=0.8  Score=37.94  Aligned_cols=117  Identities=4%  Similarity=-0.049  Sum_probs=76.1

Q ss_pred             CCCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       120 ~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      .||+.+.. .+-.+.+.+.+.++.-  .+...+-.-      ..++...+++++..|+....+++     .-+|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcC--cccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecc
Confidence            58888766 4555556544444443  333332211      35678889999999988876555     3478889999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccch-hhHHHHHHHHhCCCCCCcc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVF-SFGVFLFELLTGWDVSDLV  274 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~-slG~il~el~tg~~p~~~~  274 (353)
                      ||+++.++.+++.-.|+...+.+..             +.+|           |.| .+=+++..+++++..|...
T Consensus       109 NL~f~~~~~p~i~~RGik~~l~P~~-------------~~ee-----------~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVVDPLP-------------VSEA-----------EFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTBSCCC-------------CCHH-----------HHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             eEEEcCCCCEEEEEccCccCCCCCC-------------CCHH-----------HHHHHHHHHHHHHHcCCCCHHHH
Confidence            9999999999999888643321110             0111           222 4667888888988887643

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.08  E-value=1.7  Score=36.05  Aligned_cols=83  Identities=11%  Similarity=0.061  Sum_probs=57.3

Q ss_pred             CCCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHH-HHhcCCCCCeEeeccCC
Q 018633          120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALA-YLHFGFPRPIVFRNFKT  198 (353)
Q Consensus       120 ~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~iiH~dlkp  198 (353)
                      .||++  -..+-.+++.+.+.++.-+++.=...+        ..++...+++++..|+.-.. +++     .-+|--|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence            57877  333335566665666654333222333        24677888888888877665 444     457888999


Q ss_pred             CceeecCCCceEEeccCCc
Q 018633          199 SCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       199 ~Nill~~~~~~kl~dfg~a  217 (353)
                      +||+++.++.+++.-.|+-
T Consensus       113 ~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GGEEECTTCCEEESCCEET
T ss_pred             ceEEEeCCCcEEEEEcCCc
Confidence            9999999999999988864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	353
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-40
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-38
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-36
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-35
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-34
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-33
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-33
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-32
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-31
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-31
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-31
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-30
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-30
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-29
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-29
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-29
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-27
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-27
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-27
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-25
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-25
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-24
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-24
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-24
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-22
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-22
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-22
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-21
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-21
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-21
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-20
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-20
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-20
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-19
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-18
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-18
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-18
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-18
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-17
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-16
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-16
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-16
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 7e-40
 Identities = 58/282 (20%), Positives = 114/282 (40%), Gaps = 38/282 (13%)

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL 139
           T+YKG W    ++V         P+  ++  N V    +  H +IL  +G     P   +
Sbjct: 23  TVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 80

Query: 140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           V +  +  +L+  +            +   + IA      + YLH    + I+ R+ K++
Sbjct: 81  VTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSN 133

Query: 200 CILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTWGYCAPEYMRT---GVFNEKSDVF 255
            I  +E+   K+ DF L+        +H  + + G+  + APE +R      ++ +SDV+
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193

Query: 256 SFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIE-- 313
           +FG+ L+EL+TG                     +  + +    + +  ++    LS +  
Sbjct: 194 AFGIVLYELMTG---------------------QLPYSNINNRDQIIFMVGRGYLSPDLS 232

Query: 314 --KEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
             +     A  +L  EC+K    +RP    +   +  + RSL
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 7e-38
 Identities = 49/246 (19%), Positives = 97/246 (39%), Gaps = 28/246 (11%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           ++ +       ++ H  +++L     + PI  ++ E ++ G+L D +     P    L +
Sbjct: 53  DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLK---TPSGIKLTI 108

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              L +A  I   +A++     R  + R+ + + IL ++    K+ DF L+  I + E  
Sbjct: 109 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
             +       + APE +  G F  KSDV+SFG+ L E++T                    
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG------------------ 207

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
             +  +      E++   +      +  +       QL   C K+ P DRP+   +   L
Sbjct: 208 --RIPYPGMTNPEVIQ-NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

Query: 347 RQIYRS 352
              + +
Sbjct: 265 EDFFTA 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 6e-37
 Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 28/246 (11%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  I       ++SH  +++L G CLE     LVFE +++G L D +             
Sbjct: 45  EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA---- 100

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
           +  L + +D+   +AYL       ++ R+      L  E  V K+ DF ++  + + +  
Sbjct: 101 ETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
            +        + +PE      ++ KSDV+SFGV ++E+ +                    
Sbjct: 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG------------------ 199

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
             K  +E+   +E+V+ I     L   +    H   Q+   C K+ P DRP+   + ++L
Sbjct: 200 --KIPYENRSNSEVVEDISTGFRLYKPRLASTHV-YQIMNHCWKERPEDRPAFSRLLRQL 256

Query: 347 RQIYRS 352
            +I  S
Sbjct: 257 AEIAES 262

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-36
 Identities = 54/293 (18%), Positives = 113/293 (38%), Gaps = 32/293 (10%)

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI- 138
            +++G W+   ++V  F   E R    E+ I        + H +IL  I    +      
Sbjct: 18  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQ---TVMLRHENILGFIAADNKDNGTWT 74

Query: 139 ---LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLH-----FGFPRP 190
              LV +  ++G+L+D +      +   + ++  +K+A+     LA+LH           
Sbjct: 75  QLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128

Query: 191 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI---TDTVMGTWGYCAPEYMRTGV 247
           I  R+ K+  IL  +     + D  L++        I    +  +GT  Y APE +   +
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188

Query: 248 ------FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE--DNRFTE 299
                   +++D+++ G+  +E+     +  + +D             +  E       +
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248

Query: 300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS 352
            + P I     S E  + +   A++  EC   + A R + + + K L Q+ + 
Sbjct: 249 KLRPNIPNRWQSCEALRVM---AKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-35
 Identities = 50/308 (16%), Positives = 111/308 (36%), Gaps = 35/308 (11%)

Query: 57  IKLATNSYDQKNVIAKDTSYNLYTMYKGFWQE-RLISVLQFYGHECRPRAYESCINNVTY 115
           ++L  + +++ + +          ++K   +   L+   +    E +P      I  +  
Sbjct: 1   MELKDDDFEKISELGAGNGG---VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57

Query: 116 AARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
               +  +I+   G         +  E +  G+L   +          +  +   K+++ 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIA 112

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           ++  L YL       I+ R+ K S IL N     KL DF +S  + +   +   + +GT 
Sbjct: 113 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTR 167

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG---------------------WDVSDLV 274
            Y +PE ++   ++ +SD++S G+ L E+  G                      D ++  
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 275 KDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPA 334
                   P + Y  +        E++D I+ E    +              +C+  +PA
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 335 DRPSMVDV 342
           +R  +  +
Sbjct: 288 ERADLKQL 295

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 3e-35
 Identities = 52/271 (19%), Positives = 108/271 (39%), Gaps = 36/271 (13%)

Query: 80  TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI- 138
            +  G ++   ++V             ++ +   +   ++ H+++++L+G  +E    + 
Sbjct: 22  DVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77

Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           +V E +  G+L D +    +           LK ++D+  A+ YL        V R+   
Sbjct: 78  IVTEYMAKGSLVDYLRSRGRSVLGG---DCLLKFSLDVCEAMEYLE---GNNFVHRDLAA 131

Query: 199 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFG 258
             +L +E+NVAK+ DF L+      +     T      + APE +R   F+ KSDV+SFG
Sbjct: 132 RNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKFSTKSDVWSFG 187

Query: 259 VFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQL 318
           + L+E+ +                      +  +      ++V  +     +    +   
Sbjct: 188 ILLWEIYSFG--------------------RVPYPRIPLKDVVPRVEKGYKMDAP-DGCP 226

Query: 319 HASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
            A  ++   C     A RPS + + ++L  I
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 8e-35
 Identities = 41/243 (16%), Positives = 90/243 (37%), Gaps = 28/243 (11%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           +  I        +SH  +++L G C +     ++ E +  G L + +    +        
Sbjct: 44  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQT 99

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
           +  L++  D+  A+ YL     +  + R+      L N++ V K+ DF LS  + + E  
Sbjct: 100 QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
            +        +  PE +    F+ KSD+++FGV ++E+ +                    
Sbjct: 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG------------------ 198

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
             K  +E    +E  +  I + +              + + C  +   +RP+   +   +
Sbjct: 199 --KMPYERFTNSETAE-HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

Query: 347 RQI 349
             +
Sbjct: 256 LDV 258

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 1e-34
 Identities = 52/280 (18%), Positives = 103/280 (36%), Gaps = 36/280 (12%)

Query: 80  TMYKGFWQE----RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP 135
           T+ KG++Q     + ++V         P   +  +       ++ + +I+++IG C E  
Sbjct: 22  TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 80

Query: 136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 195
             +LV E  + G L   +          +  K+ +++   +   + YL        V R+
Sbjct: 81  SWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRD 132

Query: 196 FKTSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTWGYCAPEYMRTGVFNEKSD 253
                +L   ++ AK+ DF LS ++   E +            + APE +    F+ KSD
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192

Query: 254 VFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIE 313
           V+SFGV ++E  +                    Y +  +   + +E+   +   + +   
Sbjct: 193 VWSFGVLMWEAFS--------------------YGQKPYRGMKGSEVTAMLEKGERMGCP 232

Query: 314 KEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL 353
                     L   C      +RP    V  +LR  Y  +
Sbjct: 233 AGCPREM-YDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 2e-34
 Identities = 56/247 (22%), Positives = 92/247 (37%), Gaps = 28/247 (11%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+ +       ++ H  +++L     E PI I V E +  G+L D + G    +     L
Sbjct: 57  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLR---L 112

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              + +A  I   +AY+        V R+ + + IL  E  V K+ DF L+  I + E  
Sbjct: 113 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
                     + APE    G F  KSDV+SFG+ L EL T                    
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG------------------ 211

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
             +  +      E++D +     +    E        L  +C +  P +RP+   +   L
Sbjct: 212 --RVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMCQCWRKEPEERPTFEYLQAFL 268

Query: 347 RQIYRSL 353
              + S 
Sbjct: 269 EDYFTST 275

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 5e-34
 Identities = 51/249 (20%), Positives = 100/249 (40%), Gaps = 31/249 (12%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  +       ++ + +I++LIG C +    +LV E    G L   ++G      E + +
Sbjct: 54  EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG----KREEIPV 108

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
            +  ++   +   + YL     +  V R+     +L    + AK+ DF LS ++   +++
Sbjct: 109 SNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165

Query: 227 IT--DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS 284
            T          + APE +    F+ +SDV+S+GV ++E L+                  
Sbjct: 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS------------------ 207

Query: 285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK 344
             Y +  ++  +  E++  I     +    E        L  +C      DRP  + V +
Sbjct: 208 --YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL-YALMSDCWIYKWEDRPDFLTVEQ 264

Query: 345 KLRQIYRSL 353
           ++R  Y SL
Sbjct: 265 RMRACYYSL 273

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  123 bits (310), Expect = 1e-33
 Identities = 56/270 (20%), Positives = 94/270 (34%), Gaps = 44/270 (16%)

Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI------ 153
           E                A   + +I+KL+G C       L+FE + YG L + +      
Sbjct: 54  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113

Query: 154 -------------LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 200
                             P   PL    +L IA  +   +AYL     R  V R+  T  
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRN 170

Query: 201 ILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
            L  E  V K+ DF LS +I   +             +  PE +    +  +SDV+++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230

Query: 260 FLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLH 319
            L+E+ +                         +      E++  +   ++L+  +   L 
Sbjct: 231 VLWEIFSYG--------------------LQPYYGMAHEEVIYYVRDGNILACPENCPLE 270

Query: 320 ASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
               L   C    PADRPS   + + L+++
Sbjct: 271 L-YNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 3e-33
 Identities = 55/250 (22%), Positives = 101/250 (40%), Gaps = 30/250 (12%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +P A +  I  V     + H ++++L G  L  P+  +V E    G+L DR     + H 
Sbjct: 51  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDR----LRKHQ 105

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
              LL    + A+ +   + YL     +  + R+     +L    ++ K+ DF L  ++P
Sbjct: 106 GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162

Query: 222 EGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD 279
           + + H  + +     + +CAPE ++T  F+  SD + FGV L+E+ T             
Sbjct: 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT------------- 209

Query: 280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM 339
                  Y +  +     ++I+  I  E       E        +  +C    P DRP+ 
Sbjct: 210 -------YGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

Query: 340 VDVAKKLRQI 349
           V +   L + 
Sbjct: 263 VALRDFLLEA 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-33
 Identities = 50/242 (20%), Positives = 88/242 (36%), Gaps = 36/242 (14%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           +          V   + + H +IL+L G   +     L+ E    GT++  +        
Sbjct: 46  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKL 100

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
                +       ++ +AL+Y H    + ++ R+ K   +L       K+ DF  S+  P
Sbjct: 101 SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157

Query: 222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLA 281
                   T+ GT  Y  PE +   + +EK D++S GV  +E L G              
Sbjct: 158 SSRRT---TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------------- 200

Query: 282 CPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQ-LSFECIKDSPADRPSMV 340
                  K  FE N + E    I   +         +   A+ L    +K +P+ RP + 
Sbjct: 201 -------KPPFEANTYQETYKRISRVE---FTFPDFVTEGARDLISRLLKHNPSQRPMLR 250

Query: 341 DV 342
           +V
Sbjct: 251 EV 252

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (300), Expect = 5e-32
 Identities = 49/316 (15%), Positives = 111/316 (35%), Gaps = 44/316 (13%)

Query: 52  FSAQEIKLATNSYDQKNVIAKDTSYNLY------TMYKGFW-----QERLISVLQFYGHE 100
           F+ ++   A   + ++  I+      +        +  G       +E  +++       
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SG 65

Query: 101 CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH 160
              +     ++  +   +  H +++ L G   ++   +++ E ++ G+L   +       
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 161 FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
                    + +   I   + YL        V R+     IL N   V K+ DF LS  +
Sbjct: 126 TV----IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 221 PEGETHITDT----VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKD 276
            +  +  T T          + APE ++   F   SDV+S+G+ ++E+++          
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS---------- 228

Query: 277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADR 336
                     Y +  + D    ++++  I +D           A  QL  +C +     R
Sbjct: 229 ----------YGERPYWDMTNQDVIN-AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277

Query: 337 PSMVDVAKKLRQIYRS 352
           P    +   L ++ R+
Sbjct: 278 PKFGQIVNTLDKMIRN 293

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-31
 Identities = 41/237 (17%), Positives = 84/237 (35%), Gaps = 32/237 (13%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  IN +       + +I+  +   L      +V E +  G+L D +             
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------E 115

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
                +  + + AL +LH      ++ R+ K+  IL   +   KL DF     I   ++ 
Sbjct: 116 GQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
            + T++GT  + APE +    +  K D++S G+   E++ G                   
Sbjct: 173 RS-TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG------------------- 212

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQ-LSFECIKDSPADRPSMVDV 342
             +  + +      +  I       ++  ++L A  +     C+      R S  ++
Sbjct: 213 --EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (295), Expect = 2e-31
 Identities = 48/246 (19%), Positives = 95/246 (38%), Gaps = 27/246 (10%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  +        + H ++++L+G C   P   ++ E + YG L D +    +        
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--- 114

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              L +A  I  A+ YL     +  + R+      L  E ++ K+ DF LS  +      
Sbjct: 115 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
                     + APE +    F+ KSDV++FGV L+E+ T                    
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG------------------ 213

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
              + +     +++ + ++ +D      E       +L   C + +P+DRPS  ++ +  
Sbjct: 214 --MSPYPGIDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

Query: 347 RQIYRS 352
             +++ 
Sbjct: 271 ETMFQE 276

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 3e-31
 Identities = 46/256 (17%), Positives = 93/256 (36%), Gaps = 32/256 (12%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPH 160
                   +         SH ++L L+G CL +   P++V   +++G L +      +  
Sbjct: 68  DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNE 123

Query: 161 FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
                +K  +   + +   + +L     +  V R+      + +E+   K+ DF L+  +
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 221 PEGE---THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT 277
            + E    H          + A E ++T  F  KSDV+SFGV L+EL+T           
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG--------- 231

Query: 278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP 337
                         + D    +I   ++    L   +        ++  +C       RP
Sbjct: 232 -----------APPYPDVNTFDITVYLLQGRRLLQPEYCPDPL-YEVMLKCWHPKAEMRP 279

Query: 338 SMVDVAKKLRQIYRSL 353
           S  ++  ++  I+ + 
Sbjct: 280 SFSELVSRISAIFSTF 295

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-30
 Identities = 43/240 (17%), Positives = 83/240 (34%), Gaps = 28/240 (11%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETP--IPILVFESVQYGTLWDRILGAPQPHFEPL 164
           +  ++ V     + H +I++     ++       +V E  + G L   I    +   + L
Sbjct: 48  QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYL 106

Query: 165 LLKHRLKIAMDIVHALAYLH--FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 222
             +  L++   +  AL   H        ++ R+ K + +  + +   KL DF L+  +  
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166

Query: 223 GETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC 282
             +      +GT  Y +PE M    +NEKSD++S G  L+EL                  
Sbjct: 167 DTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL--------------- 210

Query: 283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDV 342
                    F      E+   I       I          ++    +      RPS+ ++
Sbjct: 211 ------MPPFTAFSQKELAGKIREGKFRRIPYRYSDEL-NEIITRMLNLKDYHRPSVEEI 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-30
 Identities = 46/247 (18%), Positives = 81/247 (32%), Gaps = 42/247 (17%)

Query: 119 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE---------------- 162
            SH +I+ L+G C  +    L+FE   YG L + +    +   E                
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 163 --PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
              L  +  L  A  +   + +L F   +  V R+     +L     V K+ DF L+  I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 221 PEGETHITD-TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD 279
                ++          + APE +  G++  KSDV+S+G+ L+E+ +             
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG----------- 263

Query: 280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSM 339
                     N +           +I       +          +   C       RPS 
Sbjct: 264 ---------VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314

Query: 340 VDVAKKL 346
            ++   L
Sbjct: 315 PNLTSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-30
 Identities = 43/255 (16%), Positives = 96/255 (37%), Gaps = 32/255 (12%)

Query: 99  HECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ 158
               P+A +  ++     A + + H+ +L+G CL + + ++  + + +G L D +     
Sbjct: 48  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKD 106

Query: 159 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
                   ++ L   + I   + YL     R +V R+     +L       K+ DF L+ 
Sbjct: 107 NIGS----QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159

Query: 219 SIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT 277
            +   E  +  +       + A E +   ++  +SDV+S+GV ++EL+T           
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT----------- 208

Query: 278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASA-QLSFECIKDSPADR 336
                    +    ++    +EI    I+E    + +          +  +C       R
Sbjct: 209 ---------FGSKPYDGIPASEISS--ILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 257

Query: 337 PSMVDVAKKLRQIYR 351
           P   ++  +  ++ R
Sbjct: 258 PKFRELIIEFSKMAR 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 4e-30
 Identities = 54/243 (22%), Positives = 88/243 (36%), Gaps = 29/243 (11%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E  +       +  H HI+KLIG   E P+ I + E    G L        Q     L L
Sbjct: 53  EKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSF----LQVRKYSLDL 107

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
              +  A  +  ALAYL     +  V R+     +L +  +  KL DF LS  + +   +
Sbjct: 108 ASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE 286
                     + APE +    F   SDV+ FGV ++E+L                     
Sbjct: 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM-------------------- 204

Query: 287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL 346
           +    F+  +  +++  I   + L +           L  +C    P+ RP   ++  +L
Sbjct: 205 HGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL-YSLMTKCWAYDPSRRPRFTELKAQL 263

Query: 347 RQI 349
             I
Sbjct: 264 STI 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 4e-30
 Identities = 43/247 (17%), Positives = 86/247 (34%), Gaps = 35/247 (14%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
                E  +  +   A   H +I+KL+          ++ E    G +   +L       
Sbjct: 49  SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE----LE 104

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
            PL       +    + AL YLH      I+ R+ K   ILF  +   KL DF +S    
Sbjct: 105 RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161

Query: 222 EGETHITDTVMGTWGYCAPEYMRT-----GVFNEKSDVFSFGVFLFELLTGWDVSDLVKD 276
                  D+ +GT  + APE +         ++ K+DV+S G+ L E+            
Sbjct: 162 RTIQR-RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI--------- 211

Query: 277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQ-LSFECIKDSPAD 335
                       +    +     ++  I   +  ++ +  +  ++ +    +C++ +   
Sbjct: 212 ------------EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259

Query: 336 RPSMVDV 342
           R +   +
Sbjct: 260 RWTTSQL 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (282), Expect = 2e-29
 Identities = 47/244 (19%), Positives = 84/244 (34%), Gaps = 37/244 (15%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
               ++  I  V +  ++ H + ++  GC L      LV E           +     H 
Sbjct: 55  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HK 109

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           +PL       +    +  LAYLH      ++ R+ K   IL +E  + KL DF  +  + 
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Query: 222 EGETHITDTVMGTWGYCAPEY---MRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH 278
                  ++ +GT  + APE    M  G ++ K DV+S G+   EL              
Sbjct: 167 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER----------- 210

Query: 279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS 338
                     K    +      +  I   +  +++              C++  P DRP+
Sbjct: 211 ----------KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260

Query: 339 MVDV 342
              +
Sbjct: 261 SEVL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-29
 Identities = 48/240 (20%), Positives = 82/240 (34%), Gaps = 37/240 (15%)

Query: 121 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP-----------LLLKHR 169
           H +I+ L+G C       L  E   +G L D +  +     +P           L  +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 170 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 229
           L  A D+   + YL     +  + R+     IL  E  VAK+ DF LS            
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK 289
                  + A E +   V+   SDV+S+GV L+E+++                       
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG--------------------G 224

Query: 290 NYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI 349
             +      E+ + +     L             L  +C ++ P +RPS   +   L ++
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCDDEV-YDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 5e-29
 Identities = 42/244 (17%), Positives = 84/244 (34%), Gaps = 37/244 (15%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRI-------------LGAPQPHFEPLLL 166
           +H +I+ L+G C      +++ E   YG L + +                 +     L L
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
           +  L  +  +   +A+L     +  + R+     IL     + K+ DF L+  I     +
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 227 ITDT-VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN 285
           +          + APE +   V+  +SDV+S+G+FL+EL +                   
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG----------------- 244

Query: 286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKK 345
               + +           +I E    +  E        +   C    P  RP+   + + 
Sbjct: 245 ---SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 346 LRQI 349
           + + 
Sbjct: 302 IEKQ 305

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 5e-29
 Identities = 49/240 (20%), Positives = 91/240 (37%), Gaps = 30/240 (12%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+    +     ++H +++K  G   E  I  L  E    G L+DRI          +  
Sbjct: 48  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPE 102

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGET 225
               +    ++  + YLH      I  R+ K   +L +E +  K+ DF L+         
Sbjct: 103 PDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159

Query: 226 HITDTVMGTWGYCAPEYMRTGVFN-EKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS 284
            + + + GT  Y APE ++   F+ E  DV+S G+ L  +L G       +   D    S
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG-------ELPWDQPSDS 212

Query: 285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK 344
            +   ++ E   +      I    +  + K              + ++P+ R ++ D+ K
Sbjct: 213 CQEYSDWKEKKTYLNPWKKIDSAPLALLHK-------------ILVENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 6e-29
 Identities = 45/250 (18%), Positives = 96/250 (38%), Gaps = 36/250 (14%)

Query: 116 AARMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRI-----------LGAPQPHFEP 163
                H +++ L+G C +   P+ ++ E  ++G L   +           +     + + 
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 164 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 223
           L L+H +  +  +   + +L     R  + R+     IL +E+NV K+ DF L+  I + 
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 224 ETHI-TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLAC 282
             ++          + APE +   V+  +SDV+SFGV L+E+ +                
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-------------- 233

Query: 283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDV 342
                  + +   +  E     + E       +       Q   +C    P+ RP+  ++
Sbjct: 234 ------ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287

Query: 343 AKKLRQIYRS 352
            + L  + ++
Sbjct: 288 VEHLGNLLQA 297

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 2e-28
 Identities = 48/271 (17%), Positives = 94/271 (34%), Gaps = 39/271 (14%)

Query: 80  TMYKGFWQE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET--- 134
           T+YKG   E    ++  +    +      +           + H +I++       T   
Sbjct: 24  TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83

Query: 135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 193
               +LV E +  GTL   +       F+ + +K        I+  L +LH   P PI+ 
Sbjct: 84  KKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIH 137

Query: 194 RNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKS 252
           R+ K   I         K+ D  L+             V+GT  + APE      ++E  
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EKYDESV 193

Query: 253 DVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSI 312
           DV++FG+ + E+ T                      +  + + +    +   +   V   
Sbjct: 194 DVYAFGMCMLEMATS---------------------EYPYSECQNAAQIYRRVTSGVKPA 232

Query: 313 EKEQQLHASAQ-LSFECIKDSPADRPSMVDV 342
             ++      + +   CI+ +  +R S+ D+
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 2e-28
 Identities = 48/255 (18%), Positives = 92/255 (36%), Gaps = 30/255 (11%)

Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP 159
               +     +       + SH++I++L G   +    +++ E ++ G L   +      
Sbjct: 47  GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---- 102

Query: 160 HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
                 +   + +   I   + YL        V R+     IL N   V K+ DF LS  
Sbjct: 103 KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159

Query: 220 IPEGE--THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT 277
           + +    T+ T        + APE +    F   SDV+SFG+ ++E++T  +        
Sbjct: 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219

Query: 278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP 337
           H++     + + + F      +    I                  QL  +C +   A RP
Sbjct: 220 HEVM----KAINDGFRLPTPMDCPSAIY-----------------QLMMQCWQQERARRP 258

Query: 338 SMVDVAKKLRQIYRS 352
              D+   L ++ R+
Sbjct: 259 KFADIVSILDKLIRA 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 1e-27
 Identities = 46/242 (19%), Positives = 88/242 (36%), Gaps = 36/242 (14%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRI-----------LGAPQPHFEPLLLKH 168
            H +I+ L+G C +     ++ E    G L + +                   E L  K 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI- 227
            +  A  +   + YL     +  + R+     +L  E+NV K+ DF L+  I   + +  
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 228 TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEY 287
           T        + APE +   ++  +SDV+SFGV L+E+ T                     
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------------------- 234

Query: 288 LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR 347
             + +      E+   ++ E     +     +    +  +C    P+ RP+   + + L 
Sbjct: 235 -GSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 348 QI 349
           +I
Sbjct: 293 RI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 4e-27
 Identities = 35/152 (23%), Positives = 63/152 (41%), Gaps = 9/152 (5%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           +R+ H   +KL     +           + G L   I                     +I
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEI 117

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGTW 235
           V AL YLH    + I+ R+ K   IL NE+   ++ DF  + +  PE +    ++ +GT 
Sbjct: 118 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            Y +PE +      + SD+++ G  +++L+ G
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 5e-27
 Identities = 47/257 (18%), Positives = 100/257 (38%), Gaps = 30/257 (11%)

Query: 99  HECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI----- 153
                R     +N  +     + +H+++L+G   +    +++ E +  G L   +     
Sbjct: 60  EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 119

Query: 154 LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD 213
             A  P   P  L   +++A +I   +AYL+       V R+      +  E+   K+ D
Sbjct: 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176

Query: 214 FSLSISIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSD 272
           F ++  I E +        +    + +PE ++ GVF   SDV+SFGV L+E+ T      
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---- 232

Query: 273 LVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDS 332
                           +  ++     +++  ++   +L            +L   C + +
Sbjct: 233 ----------------EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML-FELMRMCWQYN 275

Query: 333 PADRPSMVDVAKKLRQI 349
           P  RPS +++   +++ 
Sbjct: 276 PKMRPSFLEIISSIKEE 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  102 bits (256), Expect = 2e-25
 Identities = 30/163 (18%), Positives = 64/163 (39%), Gaps = 11/163 (6%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           E+    +   + + H  ++ L     +    ++++E +  G L++++          +  
Sbjct: 68  ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSE 123

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN--EENVAKLFDFSLSISIPEGE 224
              ++    +   L ++H       V  + K   I+F     N  KL DF L+  +   +
Sbjct: 124 DEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180

Query: 225 THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +       GT  + APE          +D++S GV  + LL+G
Sbjct: 181 SV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  100 bits (250), Expect = 4e-25
 Identities = 55/258 (21%), Positives = 103/258 (39%), Gaps = 38/258 (14%)

Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQ 158
           P  Y         AA ++H  I+ +           P+P +V E V   TL D +     
Sbjct: 48  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----- 102

Query: 159 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
               P+  K  +++  D   AL + H      I+ R+ K + I+ +  N  K+ DF ++ 
Sbjct: 103 HTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 159

Query: 219 SIPEGETHI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKD 276
           +I +    +  T  V+GT  Y +PE  R    + +SDV+S G  L+E+LTG         
Sbjct: 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG--------- 210

Query: 277 THDLACPSNEYLKNYFEDNRFTEIVDPIIVED-VLSIEKEQQLHASAQ-LSFECIKDSPA 334
                       +  F  +    +    + ED +    + + L A    +  + +  +P 
Sbjct: 211 ------------EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPE 258

Query: 335 DRP-SMVDVAKKLRQIYR 351
           +R  +  ++   L +++ 
Sbjct: 259 NRYQTAAEMRADLVRVHN 276

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  100 bits (250), Expect = 1e-24
 Identities = 30/153 (19%), Positives = 58/153 (37%), Gaps = 11/153 (7%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            ++ H  ++ L     +    +L+ E +  G L+DRI          +     +      
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQA 136

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGT 234
              L ++H      IV  + K   I+    + +  K+ DF L+  +   E         T
Sbjct: 137 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTAT 191

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + APE +        +D+++ GV  + LL+G
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.0 bits (246), Expect = 3e-24
 Identities = 39/152 (25%), Positives = 60/152 (39%), Gaps = 9/152 (5%)

Query: 116 AARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 175
           +    H  +  +            V E +  G L   I            L      A +
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAE 111

Query: 176 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTW 235
           I+  L +LH    + IV+R+ K   IL +++   K+ DF +      G+     T  GT 
Sbjct: 112 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTP 167

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
            Y APE +    +N   D +SFGV L+E+L G
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.2 bits (244), Expect = 5e-24
 Identities = 29/153 (18%), Positives = 60/153 (39%), Gaps = 11/153 (7%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
               H +IL L          +++FE +    +++RI          L  +  +     +
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQV 111

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGT 234
             AL +LH      I   + +   I++     +  K+ +F  +  +  G+      +   
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTA 166

Query: 235 WGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             Y APE  +  V +  +D++S G  ++ LL+G
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 95.9 bits (238), Expect = 4e-23
 Identities = 35/151 (23%), Positives = 60/151 (39%), Gaps = 7/151 (4%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
            ++ H +I+ L           L+ + V  G L+DRI+            +   ++   +
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQV 116

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
           + A+ YLH         +         +E++   + DF LS     G      T  GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPG 174

Query: 237 YCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           Y APE +    +++  D +S GV  + LL G
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 93.0 bits (230), Expect = 2e-22
 Identities = 44/271 (16%), Positives = 91/271 (33%), Gaps = 17/271 (6%)

Query: 80  TMYKGFWQE-RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI 138
            +YK         ++ +    +       + I  ++    + H++I+KL          +
Sbjct: 17  VVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV 76

Query: 139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 198
           LVFE +         +         L         + +++ +AY H    R ++ R+ K 
Sbjct: 77  LVFEHLDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKP 128

Query: 199 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFG 258
             +L N E   K+ DF L+ +        T  ++  W       M +  ++   D++S G
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188

Query: 259 VFLFELLTGW-------DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLS 311
               E++ G        +   L++    L  P+++   N  E  ++             S
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248

Query: 312 IEKEQQLHASAQLSFECIKDSPADRPSMVDV 342
             K         L  + +K  P  R +    
Sbjct: 249 FLKGLDESG-IDLLSKMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 4e-22
 Identities = 46/252 (18%), Positives = 83/252 (32%), Gaps = 21/252 (8%)

Query: 100 ECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP 159
           E +     + +  +     +SH +I+ L+          LVF+ ++            + 
Sbjct: 38  EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII-----KD 92

Query: 160 HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 219
           +   L   H     +  +  L YLH      I+ R+ K + +L +E  V KL DF L+ S
Sbjct: 93  NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 149

Query: 220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW-------DVSD 272
                   T  V+  W           ++    D+++ G  L ELL          D+  
Sbjct: 150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209

Query: 273 LVKDTHDLACPSNEYLKNYFEDNRFTEIVD--PIIVEDVLSIEKEQQLHASAQLSFECIK 330
           L +    L  P+ E   +      +        I +  + S   +  L     L      
Sbjct: 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD----LIQGLFL 265

Query: 331 DSPADRPSMVDV 342
            +P  R +    
Sbjct: 266 FNPCARITATQA 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.9 bits (230), Expect = 7e-22
 Identities = 35/152 (23%), Positives = 64/152 (42%), Gaps = 12/152 (7%)

Query: 117 ARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
           +      I+ +            + + +  G L   +                   A +I
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEI 116

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWG 236
           +  L ++H    R +V+R+ K + IL +E    ++ D  L+    + + H +   +GT G
Sbjct: 117 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHG 170

Query: 237 YCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG 267
           Y APE ++ GV ++  +D FS G  LF+LL G
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.7 bits (227), Expect = 8e-22
 Identities = 50/248 (20%), Positives = 85/248 (34%), Gaps = 39/248 (15%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           R  + E     V+    + H +++ L          IL+ E V  G L+D          
Sbjct: 53  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-----FLAEK 107

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA----KLFDFSLS 217
           E L  +   +    I++ + YLH      I   + K   I+  + NV     K+ DF L+
Sbjct: 108 ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

Query: 218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDT 277
             I  G       + GT  + APE +       ++D++S GV  + LL+G          
Sbjct: 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---------- 212

Query: 278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLS---FECIKDSPA 334
                       + F  +   E +   +       E E   + SA         +   P 
Sbjct: 213 -----------ASPFLGDTKQETLA-NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 260

Query: 335 DRPSMVDV 342
            R ++ D 
Sbjct: 261 KRMTIQDS 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 90.5 bits (224), Expect = 2e-21
 Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 16/154 (10%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
            H +I++L           LVF+ ++ G L+D +          L  K   KI   ++  
Sbjct: 68  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRALLEV 122

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCA 239
           +  LH      IV R+ K   IL +++   KL DF  S  +  GE      V GT  Y A
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177

Query: 240 PEYMRTGV------FNEKSDVFSFGVFLFELLTG 267
           PE +   +      + ++ D++S GV ++ LL G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.3 bits (226), Expect = 2e-21
 Identities = 44/231 (19%), Positives = 81/231 (35%), Gaps = 30/231 (12%)

Query: 119 MSHNHILKLIGCC----LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM 174
               HI++++             ++V E +  G L+ RI        +    +   +I  
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMK 118

Query: 175 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTV 231
            I  A+ YLH      I  R+ K   +L+  +    + KL DF  +       +    T 
Sbjct: 119 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTP 173

Query: 232 MGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY 291
             T  Y APE +    +++  D++S GV ++ LL G+         H LA       +  
Sbjct: 174 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRIR 230

Query: 292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDV 342
                F       + E+V  + +              +K  P  R ++ + 
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIR------------NLLKTEPTQRMTITEF 269

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 3e-21
 Identities = 42/270 (15%), Positives = 84/270 (31%), Gaps = 17/270 (6%)

Query: 82  YKGFWQE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL 139
           YK   +    ++++ +            + I  ++    ++H +I+KL+          L
Sbjct: 19  YKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78

Query: 140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 199
           VFE +                   + L         ++  LA+ H      ++ R+ K  
Sbjct: 79  VFEFLHQDLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQ 131

Query: 200 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGV 259
            +L N E   KL DF L+ +        T  V+  W       +    ++   D++S G 
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191

Query: 260 FLFELLTGW-------DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSI 312
              E++T         ++  L +    L  P             +         +D   +
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251

Query: 313 EKEQQLHASAQLSFECIKDSPADRPSMVDV 342
                    + LS + +   P  R S    
Sbjct: 252 VPPLDEDGRSLLS-QMLHYDPNKRISAKAA 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 1e-20
 Identities = 46/241 (19%), Positives = 87/241 (36%), Gaps = 23/241 (9%)

Query: 117 ARMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 170
            ++ H +I++L      +          LV + V       R+        + L + +  
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET--VYRVARHYSRAKQTLPVIYVK 125

Query: 171 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITD 229
                +  +LAY+H      I  R+ K   +L + +  V KL DF  +  +  GE +++ 
Sbjct: 126 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 181

Query: 230 TVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW-------DVSDLVKDTHDLAC 282
            +   +            +    DV+S G  L ELL G         V  LV+    L  
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 283 PSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASA-QLSFECIKDSPADRPSMVD 341
           P+ E ++    +  +TE   P I     +     +    A  L    ++ +P  R + ++
Sbjct: 242 PTREQIREM--NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 342 V 342
            
Sbjct: 300 A 300

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 1e-20
 Identities = 38/238 (15%), Positives = 76/238 (31%), Gaps = 10/238 (4%)

Query: 110 INNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKH 168
           +  + +     H ++++L   C  +        ++ +  +   +        EP +  + 
Sbjct: 58  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117

Query: 169 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 228
              +   ++  L +LH      +V R+ K   IL       KL DF L+           
Sbjct: 118 IKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 172

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG----WDVSDLVKDTHDLACPS 284
            +V+ T  Y APE +    +    D++S G    E+          SD+ +    L    
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232

Query: 285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDV 342
               +++  D               +             L  +C+  +PA R S    
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.2 bits (218), Expect = 2e-20
 Identities = 38/166 (22%), Positives = 75/166 (45%), Gaps = 12/166 (7%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           R +  E   +     + ++H  I+++ G   +     ++ + ++ G L+           
Sbjct: 44  RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-----LRKS 98

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
           +          A ++  AL YLH    + I++R+ K   IL ++    K+ DF  +  +P
Sbjct: 99  QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155

Query: 222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
           +       T+ GT  Y APE + T  +N+  D +SFG+ ++E+L G
Sbjct: 156 DVTY----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.7 bits (216), Expect = 2e-20
 Identities = 40/272 (14%), Positives = 83/272 (30%), Gaps = 17/272 (6%)

Query: 80  TMYKGFWQE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP 137
           T++K   +E   ++++ +    +       S +  +     + H +I++L          
Sbjct: 17  TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76

Query: 138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 197
            LVFE                     L  +        ++  L + H    R ++ R+ K
Sbjct: 77  TLVFEFCDQDLKKY-----FDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLK 128

Query: 198 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSF 257
              +L N     KL +F L+ +        +  V+  W           +++   D++S 
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188

Query: 258 GVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQ 317
           G    EL           D  D        L    E+   +    P      +       
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248

Query: 318 LHASAQLSFE-------CIKDSPADRPSMVDV 342
           ++   +L+          +K +P  R S  + 
Sbjct: 249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 84.9 bits (209), Expect = 2e-19
 Identities = 35/243 (14%), Positives = 65/243 (26%), Gaps = 32/243 (13%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
               I  +  C  E    ++V E +                     LK  L +A  ++  
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF-----CSRKFSLKTVLLLADQMISR 115

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKL---FDFSLSISIPEGETHI------TDT 230
           + Y+H    +  + R+ K    L        L    DF L+    +  TH          
Sbjct: 116 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172

Query: 231 VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN 290
           + GT  Y +         + + D+ S G  L     G                + +  K 
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG-------SLPWQGLKAATKRQKY 225

Query: 291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY 350
                +       ++ +   S          A     C      D+P    + +  R ++
Sbjct: 226 ERISEKKMSTPIEVLCKGYPS--------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

Query: 351 RSL 353
              
Sbjct: 278 HRQ 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.0 bits (204), Expect = 2e-18
 Identities = 47/257 (18%), Positives = 80/257 (31%), Gaps = 26/257 (10%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP-----ILVFESVQYGTLWDRILGA 156
                +  +  +    R  H +I+ +        I       LV   +  G    ++L  
Sbjct: 46  HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM--GADLYKLL-- 101

Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
                + L   H       I+  L Y+H      ++ R+ K S +L N     K+ DF L
Sbjct: 102 ---KTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL 155

Query: 217 SISIPEGETHIT--DTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTG------ 267
           +        H       + T  Y APE M     + +  D++S G  L E+L+       
Sbjct: 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215

Query: 268 -WDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQ-LS 325
              +  L      L  PS E L           ++       V          + A  L 
Sbjct: 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 275

Query: 326 FECIKDSPADRPSMVDV 342
            + +  +P  R  +   
Sbjct: 276 DKMLTFNPHKRIEVEQA 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 2e-18
 Identities = 33/166 (19%), Positives = 55/166 (33%), Gaps = 9/166 (5%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
                   +          H  +  L            V E    G L+  +        
Sbjct: 45  AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RE 99

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
                +       +IV AL YLH    R +V+R+ K   ++ +++   K+ DF L     
Sbjct: 100 RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156

Query: 222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
                   T  GT  Y APE +    +    D +  GV ++E++ G
Sbjct: 157 SDGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 81.8 bits (201), Expect = 2e-18
 Identities = 31/245 (12%), Positives = 66/245 (26%), Gaps = 34/245 (13%)

Query: 120 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 179
               I  +     E    +LV + +  G   + +L      F     K     A  ++  
Sbjct: 59  GCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV---KTVAMAAKQMLAR 113

Query: 180 LAYLHFGFPRPIVFRNFKTSCILFNE-----ENVAKLFDFSLSISIPEGETHI------T 228
           +  +H    + +V+R+ K    L         N+  + DF +     +  T         
Sbjct: 114 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 229 DTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL 288
             + GT  Y +         + + D+ + G      L G                +    
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG-------SLPWQGLKAATNKQ 223

Query: 289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ 348
           K      R  E      + ++ +   E+      +        +    P    +     +
Sbjct: 224 KY----ERIGEKKQSTPLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSK 275

Query: 349 IYRSL 353
           +   L
Sbjct: 276 VLERL 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.3 bits (200), Expect = 3e-18
 Identities = 25/152 (16%), Positives = 54/152 (35%), Gaps = 12/152 (7%)

Query: 118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 177
               + +++L+         +L+ E  +        +         L  +        ++
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVL 120

Query: 178 HALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTWG 236
            A+ + H      ++ R+ K   IL +      KL DF     + +          GT  
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRV 174

Query: 237 YCAPEYMRTG-VFNEKSDVFSFGVFLFELLTG 267
           Y  PE++R        + V+S G+ L++++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.3 bits (197), Expect = 1e-17
 Identities = 40/169 (23%), Positives = 63/169 (37%), Gaps = 11/169 (6%)

Query: 102 RPRAYESCINNVTYAARMSH-NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH 160
           + +  E           +     ++ L           L+ + +  G L+  +       
Sbjct: 68  KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----SQ 122

Query: 161 FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 220
            E            +IV AL +LH      I++R+ K   IL +      L DF LS   
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179

Query: 221 PEGETHITDTVMGTWGYCAPEYMRTGV--FNEKSDVFSFGVFLFELLTG 267
              ET       GT  Y AP+ +R G    ++  D +S GV ++ELLTG
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.6 bits (190), Expect = 1e-16
 Identities = 38/281 (13%), Positives = 91/281 (32%), Gaps = 21/281 (7%)

Query: 80  TMYKGFWQE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP 137
            ++K   ++  + +++ +      +     + +  +     + H +++ LI  C     P
Sbjct: 25  EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84

Query: 138 ILVFESVQY---GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 194
               +   Y         + G          L    ++   +++ L Y+H      I+ R
Sbjct: 85  YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHR 141

Query: 195 NFKTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTG-VFNE 250
           + K + +L   + V KL DF L+ +    +    +     + T  Y  PE +     +  
Sbjct: 142 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201

Query: 251 KSDVFSFGVFLFELLTGW-------DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDP 303
             D++  G  + E+ T         +   L   +      + E   N      + ++   
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261

Query: 304 IIVEDVLSIEKEQQLHASAQLSF--ECIKDSPADRPSMVDV 342
              +  +    +  +     L    + +   PA R    D 
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (187), Expect = 3e-16
 Identities = 39/279 (13%), Positives = 87/279 (31%), Gaps = 29/279 (10%)

Query: 80  TMYKGFWQE--RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP 137
            +           +++ + Y         +     +     M H +++ L+         
Sbjct: 33  AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92

Query: 138 ------ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 191
                  LV   +  GT   +++       E L       +   ++  L Y+H      I
Sbjct: 93  DDFTDFYLVMPFM--GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIH---AAGI 142

Query: 192 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEK 251
           + R+ K   +  NE+   K+ DF L+      ++ +T  V+  W       +    + + 
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYTQT 199

Query: 252 SDVFSFGVFLFELLTGW-------DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPI 304
            D++S G  + E++TG         +  L +       P  E+++    D     +    
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259

Query: 305 IVEDVLSIEKEQQLHASAQ-LSFECIKDSPADRPSMVDV 342
            +E              A  L  + +      R +  + 
Sbjct: 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 76.0 bits (186), Expect = 4e-16
 Identities = 32/166 (19%), Positives = 66/166 (39%), Gaps = 12/166 (7%)

Query: 102 RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF 161
           + +  E  +N       ++   ++KL     +     +V E V  G ++  +        
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRI 135

Query: 162 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 221
                 H    A  IV    YLH      +++R+ K   +L +++   ++ DF  +  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192

Query: 222 EGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
                   T+ GT    APE + +  +N+  D ++ GV ++E+  G
Sbjct: 193 GRTW----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 71.8 bits (175), Expect = 1e-14
 Identities = 37/242 (15%), Positives = 77/242 (31%), Gaps = 30/242 (12%)

Query: 119 MSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 176
               +I+ L     +  +  P LVFE V                 + L          +I
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEI 138

Query: 177 VHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTW 235
           + AL Y H      I+ R+ K   ++ + E+   +L D+ L+     G+ +    V   +
Sbjct: 139 LKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY 194

Query: 236 GYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW--------DVSDLVKDTHDLACPSNEY 287
                  +   +++   D++S G  L  ++           +   LV+    L       
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 288 L---KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFE----CIKDSPADRPSMV 340
                N   D RF +I+     +        +  H  +  + +     ++     R +  
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

Query: 341 DV 342
           + 
Sbjct: 315 EA 316

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 67.0 bits (162), Expect = 5e-13
 Identities = 30/158 (18%), Positives = 58/158 (36%), Gaps = 4/158 (2%)

Query: 112 NVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 171
           + T    M  NHILKL+          +    V      + +    +     + L +  +
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 172 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDT 230
           I+  ++  L Y+H      I+  + K   +L    +    L    ++            T
Sbjct: 130 ISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 231 -VMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG 267
             + T  Y +PE +    +   +D++S    +FEL+TG
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 225

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.4 bits (153), Expect = 8e-12
 Identities = 43/244 (17%), Positives = 78/244 (31%), Gaps = 15/244 (6%)

Query: 107 ESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL 166
           +     +     M H +++ L+         +  F  V   T             + L  
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120

Query: 167 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 226
            H   +   I+  L Y+H      I+ R+ K S +  NE+   K+ DF L+      +  
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 174

Query: 227 ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW-------DVSDLVKDTHD 279
           +T  V   W       +    +N+  D++S G  + ELLTG         +  L      
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

Query: 280 LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQ-LSFECIKDSPADRPS 338
           +  P  E LK    ++    I     +  +         +  A  L  + +      R +
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

Query: 339 MVDV 342
               
Sbjct: 295 AAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.3 bits (145), Expect = 8e-11
 Identities = 44/265 (16%), Positives = 87/265 (32%), Gaps = 38/265 (14%)

Query: 103 PRAYESCINNVTYAARMSHNHILKLIGCCL------ETPIPILVFESVQYGTLWDRILGA 156
               +     +     ++H +I+ L+          E     LV E +         +  
Sbjct: 57  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 116

Query: 157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 216
                     +    +   ++  + +LH      I+ R+ K S I+   +   K+ DF L
Sbjct: 117 DH--------ERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165

Query: 217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG-------WD 269
           + +   G + +    + T  Y APE +    + E  D++S G  + E++           
Sbjct: 166 ARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

Query: 270 VSDLVKDTHDLACPSNEYLKNYFEDNR--------FTEIVDPIIVEDVLSIEKEQQLHAS 321
           +    K    L  P  E++K      R        +  +  P +  D L     +     
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283

Query: 322 AQLSFECIKD----SPADRPSMVDV 342
           A  + + +       PA R S+ D 
Sbjct: 284 ASQARDLLSKMLVIDPAKRISVDDA 308

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 37.8 bits (87), Expect = 7e-04
 Identities = 20/122 (16%), Positives = 39/122 (31%), Gaps = 12/122 (9%)

Query: 99  HECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ 158
            E R             +AR     + KL G     P       +     L         
Sbjct: 43  KEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA--VPKVYAWEGNAVLMELI------DA 94

Query: 159 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 218
                + +++  ++   I+  +A  +    R IV  +     +L +EE +  + DF  S+
Sbjct: 95  KELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150

Query: 219 SI 220
            +
Sbjct: 151 EV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	353
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.15
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.65
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.09
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.46
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	82.8

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-59  Score=412.21  Aligned_cols=264  Identities=22%  Similarity=0.348  Sum_probs=210.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      .++|...+.||+|+||   .||+|.+.+ .||||++..........+.|.+|+.+|++++|||||+++|++. .+..++|
T Consensus         7 ~~~~~~~~~lG~G~fg---~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFG---TVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSC---EEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccEEEEEEEeeCCCc---EEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence            4678889999999999   999999865 5999999766556777889999999999999999999999875 4568999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      ||||++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        82 ~Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             EECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence            99999999999997654    46899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCC-ccccccccCCcccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          221 PEGET-HITDTVMGTWGYCAPEYMRT---GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       221 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ..... .......||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.....        ............
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~  226 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRGY  226 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHHTS
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCC
Confidence            44322 22345679999999999864   3589999999999999999999999974322        112222222211


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhC
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRSL  353 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~l  353 (353)
                      ......     .    .+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+++
T Consensus       227 ~~p~~~-----~----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         227 LSPDLS-----K----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CCCCGG-----G----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCcch-----h----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            111000     0    01145667889999999999999999999999999998875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-58  Score=408.79  Aligned_cols=257  Identities=21%  Similarity=0.349  Sum_probs=201.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++|...+.||+|+||   .||+|.+ ++..||||++...   ....++|.+|+.++++++|||||+++|+|.+++..++|
T Consensus         5 ~~~~~~~~iG~G~fg---~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFG---LVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSC---CEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCe---EEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            457778899999999   9999999 7889999999765   23346799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++|+|.+++....    ..+++..++.++.|+|.||.|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        79 ~E~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             EECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             EEecCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheec
Confidence            99999999999987654    46889999999999999999999   999999999999999999999999999999877


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ............||..|+|||++.+..++.++|||||||++|||+|+..|+....       ...+...........   
T Consensus       152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~~~---  221 (263)
T d1sm2a_         152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDISTGFRL---  221 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-------CHHHHHHHHHHTCCC---
T ss_pred             cCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHhcCCC---
Confidence            5544433445678999999999999999999999999999999999655443211       111222221111110   


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ..           +..++.++.+|+.+||+.||++|||+++|++.|+++.++
T Consensus       222 ~~-----------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         222 YK-----------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC-----------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            00           113456788999999999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.2e-59  Score=417.42  Aligned_cols=267  Identities=17%  Similarity=0.271  Sum_probs=205.1

Q ss_pred             ecHHHHHHHhhCc---------CCCCceeeCCCCCccEEEEEEe--CC---eEEEEEEecCCCCChhHHHHHHHHHHHHh
Q 018633           52 FSAQEIKLATNSY---------DQKNVIAKDTSYNLYTMYKGFW--QE---RLISVLQFYGHECRPRAYESCINNVTYAA  117 (353)
Q Consensus        52 ~~~~e~~~~~~~~---------~~~~~lg~G~~g~~~~v~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~  117 (353)
                      ++++++..++.+|         ...++||+|+||   .||+|.+  ++   ..||||++.... .....+.|.+|+.+|+
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg---~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~   82 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFG---EVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMG   82 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSS---EEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCe---EEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHH
Confidence            4555555555444         445789999999   9999988  23   368899886553 4556678999999999


Q ss_pred             hcCCCceeeccceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccC
Q 018633          118 RMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK  197 (353)
Q Consensus       118 ~l~H~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  197 (353)
                      +++|||||+++|+|.+++..++|||||++|+|.+++....    ..+++.+++.++.||+.||.|||   +++|+|||||
T Consensus        83 ~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlK  155 (299)
T d1jpaa_          83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLA  155 (299)
T ss_dssp             TCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred             hCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccc
Confidence            9999999999999999999999999999999999887654    46899999999999999999999   8999999999


Q ss_pred             CCceeecCCCceEEeccCCccccCCCCCcc----ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCC
Q 018633          198 TSCILFNEENVAKLFDFSLSISIPEGETHI----TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSD  272 (353)
Q Consensus       198 p~Nill~~~~~~kl~dfg~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~  272 (353)
                      |+|||++.++.+||+|||+|+.........    .....||+.|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus       156 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~  235 (299)
T d1jpaa_         156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW  235 (299)
T ss_dssp             GGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence            999999999999999999998765432211    122457899999999999999999999999999999998 899987


Q ss_pred             ccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          273 LVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ....        .+...........+              .+..++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus       236 ~~~~--------~~~~~~i~~~~~~~--------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         236 DMTN--------QDVINAIEQDYRLP--------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             TCCH--------HHHHHHHHTTCCCC--------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCH--------HHHHHHHHcCCCCC--------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            4321        12222221111110              011456678899999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-58  Score=413.39  Aligned_cols=259  Identities=21%  Similarity=0.339  Sum_probs=214.7

Q ss_pred             HHhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           59 LATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        59 ~~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ...++|...+.||+|+||   .||+|.+  +++.||||++...   ....++|.+|+.+|++++|||||+++|+|.+++.
T Consensus        14 i~~~~~~~~~~iG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          14 MERTDITMKHKLGGGQYG---EVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CCGGGEEEEEETTTTTTS---SEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ecHHHeEEeeEEeeCCCe---EEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            345678888999999999   9999998  6899999998765   2345789999999999999999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .++|||||++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             eEEEeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccc
Confidence            9999999999999999876433   46899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      |+..............||+.|+|||++.+..++.++|||||||++|||++|..|+.....       ... .........
T Consensus       162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~-~~~~i~~~~  233 (287)
T d1opja_         162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQ-VYELLEKDY  233 (287)
T ss_dssp             TTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHH-HHHHHHTTC
T ss_pred             eeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHH-HHHHHhcCC
Confidence            988765544444556688999999999999999999999999999999998777642221       111 112221111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      ...             .+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       234 ~~~-------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         234 RME-------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCC-------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111             11145567889999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=404.19  Aligned_cols=258  Identities=19%  Similarity=0.309  Sum_probs=210.7

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .++|...+.||+|+||   .||+|.+ ++..||||++....   ...+.|.+|+.++++++|||||+++|++.+ +..++
T Consensus        12 ~~~~~~~~~iG~G~fg---~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFG---EVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTE---EEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCc---EEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            4568888899999999   9999999 67889999997652   345679999999999999999999998754 56799


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|.+++.....   ..+++..++.|+.||+.||.|||   +++|+||||||+|||+++++.+||+|||+|+.
T Consensus        85 v~Ey~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEeCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEE
Confidence            9999999999987765432   35899999999999999999999   89999999999999999999999999999988


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      .............||+.|+|||++.+..++.++|||||||++|||+||..|+.....       ..+..... ..+....
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i-~~~~~~~  230 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNL-ERGYRMV  230 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHH-HTTCCCC
T ss_pred             ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHH-HhcCCCC
Confidence            765544444566789999999999988999999999999999999997666542211       11111111 1111000


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                                   .+...+.++.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus       231 -------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         231 -------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                         0114556788999999999999999999999999998765

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=402.90  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=203.9

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|+..+.||+|+||   .||+|.+  +++.||||++.... .....+.+.+|+.+|++++|||||++++++.+++..|
T Consensus         4 ~~dy~~~~~lG~G~fg---~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTEEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CcceEEEEEEecCcCe---EEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence            3578889999999999   9999998  78999999997653 2334567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|||||++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        80 ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~  151 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT  151 (271)
T ss_dssp             EEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEeccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhhe
Confidence            999999999999999754     46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCC-ccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          219 SIPEGET-HITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       219 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ....... ......+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.......       ...........
T Consensus       152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~~~~~~~~  224 (271)
T d1nvra_         152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKT  224 (271)
T ss_dssp             ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-------HHHHHHHTTCT
T ss_pred             eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcCCC
Confidence            7643332 22355689999999999988776 578999999999999999999997543221       11111111111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ....             ....+.++.+|+.+||+.||++|||+.++++
T Consensus       225 ~~~~-------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 YLNP-------------WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TSTT-------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCc-------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1000             0134567789999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=405.68  Aligned_cols=257  Identities=20%  Similarity=0.327  Sum_probs=209.9

Q ss_pred             hCcCCCCc-eeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCc
Q 018633           62 NSYDQKNV-IAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~-lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~  136 (353)
                      ++|...++ ||+|+||   .||+|.+    ++..||||++.... .....++|.+|+.+|++++|||||+++|+|.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg---~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFG---SVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTE---EEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCe---EEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            45655564 9999999   9999976    45579999997653 45667889999999999999999999999864 56


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL  216 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~  216 (353)
                      .|+|||||++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchh
Confidence            899999999999999886554    46899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          217 SISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       217 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      |+........  ......||+.|+|||++.+..++.++|||||||++|||+| |..||.....        .+.. ....
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~-~~i~  226 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVM-AFIE  226 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHH-HHHH
T ss_pred             hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHH-HHHH
Confidence            9887544322  1234568899999999999999999999999999999998 8999874322        1111 2222


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .+.....             +..++.++.+|+.+||+.||++|||+.+|++.|+.++.+
T Consensus       227 ~~~~~~~-------------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         227 QGKRMEC-------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTCCCCC-------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCC-------------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            2211111             114556788999999999999999999999999987654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=400.89  Aligned_cols=248  Identities=19%  Similarity=0.244  Sum_probs=207.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||||++...  .....+.+.+|+.++++++|||||++++++.+++..|+
T Consensus        20 ~~Y~~~~~iG~G~fg---~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASG---TVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSC---EEEEEEBTTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCcCc---EEEEEEECCCCCEEEEEEEecc--cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            469999999999999   9999998  7999999998765  33445789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||||++|+|.+++...      .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        95 vmEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~  165 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (293)
T ss_dssp             EEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhhee
Confidence            99999999999987653      5899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|+||..||.....        ............. .
T Consensus       166 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~~~~-~  235 (293)
T d1yhwa1         166 ITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTP-E  235 (293)
T ss_dssp             CCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSC-C
T ss_pred             eccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCCC-C
Confidence            754332 34566899999999999999999999999999999999999999973321        1122222211111 1


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..           .+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 LQ-----------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CS-----------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CC-----------CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10           01145567889999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=401.99  Aligned_cols=246  Identities=20%  Similarity=0.344  Sum_probs=206.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||+|++..... .....+.+.+|+.++++++|||||++++++.+++..|
T Consensus         6 ~dy~i~~~iG~G~fg---~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           6 EDFEIGRPLGKGKFG---NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hHeEEEEEEecCCCc---EEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            568889999999999   9999998  788999999864321 2234567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|||||++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ivmEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EEEeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceee
Confidence            999999999999999765     46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .+...... ...+.
T Consensus       155 ~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~-~~~~~  222 (263)
T d2j4za1         155 HAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEFT  222 (263)
T ss_dssp             CCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTCCC
T ss_pred             ecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHH-cCCCC
Confidence            764332   3456799999999999999999999999999999999999999973221        11111111 11110


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                                .    +...+.++.+|+.+||+.||++|||+.|+++
T Consensus       223 ----------~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 ----------F----PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------C----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                      0    0134567889999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-58  Score=407.08  Aligned_cols=256  Identities=18%  Similarity=0.234  Sum_probs=196.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee--CCcc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE--TPIP  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~--~~~~  137 (353)
                      ++|+..+.||+|+||   .||+|.+  +++.||+|++..........+.+.+|+.++++++|||||++++++.+  ++.+
T Consensus         4 edy~~~~~iG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYG---RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             hhCEEeEEEecCCCe---EEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            578899999999999   9999998  78999999998776566777889999999999999999999999864  4568


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC--CCCeEeeccCCCceeecCCCceEEeccC
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF--PRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      |+|||||++|+|.+++....... ..+++..++.++.||+.||.|||+..  .++|+||||||+|||++.++.+||+|||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEecCCCCcHHHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            99999999999999886432100 46899999999999999999999311  1349999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcC
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDN  295 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (353)
                      +|+....... ......||+.|+|||++.+..++.++|||||||++|||+||..||.....        .+.... ....
T Consensus       160 ~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~-i~~~  229 (269)
T d2java1         160 LARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGK-IREG  229 (269)
T ss_dssp             HHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHH-HHHT
T ss_pred             ceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHH-HHcC
Confidence            9988754322 24457899999999999999999999999999999999999999973221        111111 1222


Q ss_pred             cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+..+.             ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~-------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 KFRRIP-------------YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCC-------------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            221110             134567889999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=398.03  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=201.7

Q ss_pred             CceeeCCCCCccEEEEEEe----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEEEe
Q 018633           68 NVIAKDTSYNLYTMYKGFW----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVFES  143 (353)
Q Consensus        68 ~~lg~G~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  143 (353)
                      +.||+|+||   .||+|.+    .++.||||++......+...++|.+|+.+|++++|||||+++|+|.+ +..++||||
T Consensus        13 k~iG~G~fG---~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFG---TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSE---EEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCcccCCCe---EEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence            569999999   9999986    34689999997665455667889999999999999999999999864 567899999


Q ss_pred             ccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccCCC
Q 018633          144 VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG  223 (353)
Q Consensus       144 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~  223 (353)
                      |++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          89 AELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             CTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            9999999999865     46899999999999999999999   899999999999999999999999999999877544


Q ss_pred             CCcc--ccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCccccc
Q 018633          224 ETHI--TDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTEI  300 (353)
Q Consensus       224 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||+| |..||.....        .+. ......+.....
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~-~~~i~~~~~~~~  231 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEV-TAMLEKGERMGC  231 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHH-HHHHHTTCCCCC
T ss_pred             ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHH-HHHHHcCCCCCC
Confidence            3322  234578999999999999999999999999999999998 8999873221        111 122222111111


Q ss_pred             ccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          301 VDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                                   +..++.++.+|+.+||+.||++|||+.+|++.|+..+.
T Consensus       232 -------------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         232 -------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence                         11456678899999999999999999999999988654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-57  Score=397.67  Aligned_cols=252  Identities=17%  Similarity=0.297  Sum_probs=211.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++|+..+.||+|+||   +||+|.+ +++.||||++....   ...++|.+|+.++++++|||||+++|+|.+++..++|
T Consensus         4 ~~~~~~~~iG~G~fg---~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFG---VVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTE---EEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCe---EEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            578899999999999   9999999 77899999998653   3356899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++..
T Consensus        78 ~Ey~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             EECCTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             EEccCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheec
Confidence            99999999999876654    46889999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ............||..|+|||.+.+..++.++|||||||++|||+| |+.||......        +.........+.  
T Consensus       151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~~--  220 (258)
T d1k2pa_         151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRL--  220 (258)
T ss_dssp             SSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCCC--
T ss_pred             cCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCCC--
Confidence            5544433445678999999999999999999999999999999998 78898743221        122222111110  


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQ  348 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~  348 (353)
                       ..           +...+.++.+|+.+||+.||++|||+.++++.|..
T Consensus       221 -~~-----------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 -YR-----------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -CC-----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -CC-----------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             00           11445678899999999999999999999998854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-57  Score=401.99  Aligned_cols=250  Identities=18%  Similarity=0.223  Sum_probs=206.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +.|+..+.||+|+||   .||+|.+  ++..||||++...  .....+.|.+|+.+|++++|||||++++++.+++..|+
T Consensus        12 d~Y~i~~~iG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFG---KVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCc---EEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            468888999999999   9999998  7899999999766  45566789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||||++|+|.+++....    .++++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        87 vmEy~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK  159 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhc
Confidence            999999999999876543    46899999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCCccccccccCCccccccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMR-----TGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      .... ........||+.|+|||++.     ...|+.++|||||||++|||+||..||.......        ........
T Consensus       160 ~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~  230 (288)
T d2jfla1         160 NTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKS  230 (288)
T ss_dssp             CHHH-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHS
T ss_pred             cCCC-cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcC
Confidence            5321 11234568999999999984     4558899999999999999999999997433221        11111111


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       ..+.+..           +...+.++.+|+.+||+.||++|||+.|+++
T Consensus       231 -~~~~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 -EPPTLAQ-----------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -CCCCCSS-----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCc-----------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1111100           1145667889999999999999999999976

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=396.34  Aligned_cols=244  Identities=18%  Similarity=0.258  Sum_probs=197.8

Q ss_pred             CCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee----CCccEE
Q 018633           66 QKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE----TPIPIL  139 (353)
Q Consensus        66 ~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~----~~~~~l  139 (353)
                      ....||+|+||   .||+|.+  ++..||+|++..........+.|.+|+++|++++|||||++++++.+    .+.+|+
T Consensus        13 ~~~~iG~G~fg---~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          13 FDIEIGRGSFK---TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEECSSE---EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eeeEEecCcCc---EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            34579999999   9999998  68899999997765566677889999999999999999999999865    345799


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCC--eEeeccCCCceeec-CCCceEEeccCC
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRNFKTSCILFN-EENVAKLFDFSL  216 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~Nill~-~~~~~kl~dfg~  216 (353)
                      ||||+++|+|.+++...     ..+++..++.++.||+.||+|||   +++  |+||||||+|||++ .++.+||+|||+
T Consensus        90 vmE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            99999999999999765     46899999999999999999999   877  99999999999996 578999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      |+.....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.......       ...... ....
T Consensus       162 a~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i-~~~~  229 (270)
T d1t4ha_         162 ATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRV-TSGV  229 (270)
T ss_dssp             GGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHH-TTTC
T ss_pred             ceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHH-HcCC
Confidence            9765332   2346689999999999865 69999999999999999999999996322111       111111 1111


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+.            ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 KPA------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCG------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCc------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111            011133456789999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-56  Score=394.89  Aligned_cols=258  Identities=21%  Similarity=0.276  Sum_probs=203.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeC--C----eEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQ--E----RLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      +.|+..++||+|+||   .||+|.+.  +    ..||||++.... ......+|.+|+.++++++|||||+++|+|.+.+
T Consensus         7 ~~~~~~~~iG~G~fG---~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFG---EVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTEEEEEEEEECSSS---EEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHeEeeeEEeeCCCe---EEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            457888999999999   99999872  2    479999996553 4555678999999999999999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+.+|+|.+.+....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ceEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccc
Confidence            9999999999999998887654    46899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh
Q 018633          216 LSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       216 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +|+........  ......||+.|+|||++.+..++.++|||||||++|||++|..|+....       ...+.... ..
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~-i~  227 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKA-IN  227 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHH-HH
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHHHHHH-Hh
Confidence            99876443221  2234568999999999999999999999999999999999766654221       11122222 11


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .+...         ..    +..++..+.+|+.+||+.||++||||.+|++.|+++.+
T Consensus       228 ~~~~~---------~~----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         228 DGFRL---------PT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             TTCCC---------CC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ccCCC---------CC----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            11110         00    11455678899999999999999999999999998875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-57  Score=409.52  Aligned_cols=269  Identities=18%  Similarity=0.249  Sum_probs=205.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|+..+.||+|+||   .||+|.+  ++..||+|++.... .....+.+.+|+.+|++++|||||+++++|.+.+..|
T Consensus         5 ~d~y~~~~~iG~G~fg---~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGG---VVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSC---CEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCe---EEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5789999999999999   9999998  78999999997653 4455678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCC-CCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      +|||||++|+|.+++.+.     ..+++..+..++.|++.||.|||   + ++|+||||||+|||++.++.+||+|||+|
T Consensus        81 iVmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             EEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             EEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence            999999999999999765     36899999999999999999999   6 48999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC--------CCCh-----
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL--------ACPS-----  284 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~--------~~~~-----  284 (353)
                      +.....   .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.........        ....     
T Consensus       153 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         153 GQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  229 (322)
T ss_dssp             HHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred             cccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence            876332   234568999999999999999999999999999999999999999753321100        0000     


Q ss_pred             HHH----HHHHhhcCcc----cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEY----LKNYFEDNRF----TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~----~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...    ..........    .+..+.......+.......+.++.+|+.+||..||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            000    0000000000    00000000000000000123467889999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-56  Score=393.80  Aligned_cols=258  Identities=20%  Similarity=0.265  Sum_probs=200.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      .++|...+.||+|+||   .||+|.+     .+..||||++.... .....+.|.+|+.+|++++|||||+++|++. ++
T Consensus         6 ~~~~~l~~~iG~G~fg---~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           6 RERIELGRCIGEGQFG---DVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             GGGEEEEEEEEECSSS---EEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             HHHeEEEEEEeeCCCc---EEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            3568888999999999   9999987     23578999886542 4556778999999999999999999999985 56


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             eEEEEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccch
Confidence            7899999999999999877654    46899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      +|+..............||+.|+|||++.+..++.++|||||||++|||+| |.+||.......        ....... 
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~-  224 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIEN-  224 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHT-
T ss_pred             hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHHHHc-
Confidence            998765544444456678999999999999999999999999999999998 888887433222        1111111 


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      +.....             +..++..+.+|+.+||+.||++|||+.+|++.|.++.+.
T Consensus       225 ~~~~~~-------------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         225 GERLPM-------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             TCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCC-------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            111110             114566788999999999999999999999999998753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-56  Score=401.08  Aligned_cols=245  Identities=19%  Similarity=0.262  Sum_probs=202.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .|+..+.||+|+||   .||+|.+  +++.||||++..... .....+.+.+|+.+|++++|||||++++++.+++..|+
T Consensus        16 ~y~~l~~lG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          16 LFSDLREIGHGSFG---AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HEEEEEEEEECSSS---EEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hcEeeEEEecCCCe---EEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            48888999999999   9999998  789999999976532 34455779999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |||||++|+|..++...     .++++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        93 v~E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence            99999999987666544     46899999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCCccccccccCCcccccccccc---CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRT---GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ...     .....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.....        .+........ .
T Consensus       165 ~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~~-~  230 (309)
T d1u5ra_         165 MAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQN-E  230 (309)
T ss_dssp             SSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS-C
T ss_pred             cCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhC-C
Confidence            533     235679999999999864   4589999999999999999999999873221        1122222211 1


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .+....            ...+..+.+|+.+||+.||++|||+.++++
T Consensus       231 ~~~~~~------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 SPALQS------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCCSC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCC------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            111111            134567889999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=403.96  Aligned_cols=258  Identities=18%  Similarity=0.285  Sum_probs=205.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CC-----eEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeee
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QE-----RLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLE  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~  133 (353)
                      ++|...++||+|+||   .||+|.+  .+     ..||+|++.... .......|.+|+.+|.++ +|||||+++++|.+
T Consensus        37 ~~~~l~~~lG~G~fG---~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          37 ENLEFGKVLGSGAFG---KVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGEEEEEEEEECSSE---EEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeeCCCe---EEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            568888999999999   9999987  22     369999986543 334556799999999998 89999999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCC------------------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQP------------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN  195 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~d  195 (353)
                      .+..++|||||++|+|.+++......                  ....+++..++.++.|++.||.|||   +++|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecc
Confidence            99999999999999999999765321                  1135889999999999999999999   89999999


Q ss_pred             cCCCceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCc
Q 018633          196 FKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDL  273 (353)
Q Consensus       196 lkp~Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~  273 (353)
                      |||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876443322 2345678999999999999999999999999999999998 8999874


Q ss_pred             cccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 018633          274 VKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLR  347 (353)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~  347 (353)
                      ....        .............             ..+..++..+.+||.+||+.||++|||+++|++.|.
T Consensus       270 ~~~~--------~~~~~~~~~~~~~-------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVD--------ANFYKLIQNGFKM-------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCS--------HHHHHHHHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHH--------HHHHHHHhcCCCC-------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3221        1122222211110             011145567889999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=399.73  Aligned_cols=249  Identities=15%  Similarity=0.211  Sum_probs=203.4

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||||++..... .....+.+.+|+.+|++++|||||++++++.+++..|
T Consensus         8 ~dy~i~~~lG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           8 EDFKFGKILGEGSFS---TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             GGEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCEEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            579999999999999   9999998  789999999864321 2334577999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|||||++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+|+
T Consensus        85 ivmEy~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             EEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccce
Confidence            999999999999988765     46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCC-CccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          219 SIPEGE-THITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       219 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      .+.... ........||+.|+|||++.+..++.++|||||||++|||++|..||.....        ......... ..+
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~-~~~  227 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIK-LEY  227 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHT-TCC
T ss_pred             ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHc-CCC
Confidence            775432 2233456899999999999999999999999999999999999999974321        111111111 111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                       .         .+    ...+..+.+|+.+||+.||++|||++|+++
T Consensus       228 -~---------~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         228 -D---------FP----EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -C---------CC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -C---------CC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             0         00    134556789999999999999999998643

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-54  Score=397.78  Aligned_cols=251  Identities=16%  Similarity=0.227  Sum_probs=209.1

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||+|.+  +|+.||||++...  .....+.+.+|+.+|++++|||||++++++.+++..|
T Consensus        25 l~~Y~i~~~lG~G~fg---~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFG---VVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTE---EEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             ccCeEEEEEEecCcCe---EEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4679999999999999   9999998  7999999999766  4566788999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec--CCCceEEeccCC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN--EENVAKLFDFSL  216 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~--~~~~~kl~dfg~  216 (353)
                      +|||||++|+|.+++....    ..+++..++.|+.||+.||.|||   +++|+||||||+|||++  .++.+||+|||+
T Consensus       100 ivmE~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence            9999999999999986543    46899999999999999999999   99999999999999995  467899999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      |+.......  .....||+.|+|||++.+..++.++|||||||++|||++|..||.....        .+........ .
T Consensus       173 a~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~-~  241 (350)
T d1koaa2         173 TAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSC-D  241 (350)
T ss_dssp             CEECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT-C
T ss_pred             heecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-C
Confidence            988754332  4456899999999999999999999999999999999999999973321        1222222111 1


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .. . +        .......+..+.+|+.+||..||++|||+.|+++
T Consensus       242 ~~-~-~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         242 WN-M-D--------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CC-S-C--------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CC-C-C--------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00 0 0        0001134567889999999999999999999976

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-55  Score=395.44  Aligned_cols=252  Identities=20%  Similarity=0.296  Sum_probs=190.5

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      ..+.|...+.||+|+||   .||+|.+  +++.||||++..... ......+.+|+.+|++++|||||++++++.+++..
T Consensus         7 i~d~Y~~~~~lG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFS---EVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             GGGTEEEEEESBSGGGG---GEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CccceEEEEEEeeccCe---EEEEEEECCCCCEEEEEEEchHHh-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34668999999999999   9999998  789999999976532 23346688999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec---CCCceEEecc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN---EENVAKLFDF  214 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~---~~~~~kl~df  214 (353)
                      |+|||||++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||+.   .++.+||+||
T Consensus        83 ~lvmE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEecc
Confidence            9999999999999999765     46899999999999999999999   99999999999999994   5789999999


Q ss_pred             CCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          215 SLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       215 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      |+|+......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.....        ......... 
T Consensus       155 G~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~-  223 (307)
T d1a06a_         155 GLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILK-  223 (307)
T ss_dssp             --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHT-
T ss_pred             ceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-
Confidence            9998764332  23456799999999999999999999999999999999999999973221        111111111 


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .... . .        .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       224 ~~~~-~-~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         224 AEYE-F-D--------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TCCC-C-C--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCC-C-C--------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1110 0 0        0001145567889999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=391.44  Aligned_cols=257  Identities=22%  Similarity=0.302  Sum_probs=202.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      .++|...+.||+|+||   .||+|.+ ++..||||++....   ...+.|.+|+.++++++|||||+++|+|.+ +..++
T Consensus        16 ~~~~~i~~~iG~G~fg---~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFG---EVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSC---EEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCe---EEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            3578888999999999   9999999 66789999997653   345789999999999999999999999854 56789


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+++|+|..++.....   ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        89 v~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             EEEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhh
Confidence            9999999999988865432   35899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      .............||+.|+|||++....++.++|||||||++|||+||..|+.....       ..+........... .
T Consensus       163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~~~~-~  234 (285)
T d1fmka3         163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRM-P  234 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCC-C
T ss_pred             ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCC-C
Confidence            754444334556789999999999999999999999999999999997766543221       11122221111110 1


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                               .    +..++.++.+|+.+||+.||++|||+.+|++.|+....
T Consensus       235 ---------~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         235 ---------C----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ---------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ---------C----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                     0    11455678899999999999999999999999887654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=388.97  Aligned_cols=251  Identities=22%  Similarity=0.305  Sum_probs=199.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee-CCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-TPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-~~~~~lv  140 (353)
                      ++|...+.||+|+||   .||+|.+++..||||++...    ...+.|.+|++++++++|||||+++|+|.+ .+.+|+|
T Consensus         7 ~~~~~~~~lG~G~fg---~Vy~~~~~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           7 KELKLLQTIGKGEFG---DVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGEEEEEEEEECSSC---EEEEEEETTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHeEEeEEEecCCCe---EEEEEEECCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            457777889999999   99999999999999999654    345779999999999999999999999865 4668999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      |||+++|+|.+++.....   ..+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.+|++|||+++..
T Consensus        80 ~ey~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceec
Confidence            999999999999975421   35899999999999999999999   899999999999999999999999999999765


Q ss_pred             CCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhhcCcccc
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFEDNRFTE  299 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
                      ...    .....+|..|+|||++.+..++.++|||||||++|||+| |..||......        +...... .+..+.
T Consensus       154 ~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--------~~~~~i~-~~~~~~  220 (262)
T d1byga_         154 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVE-KGYKMD  220 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHHHHT-TTCCCC
T ss_pred             CCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHH-cCCCCC
Confidence            332    234567889999999999999999999999999999998 67776632221        1111111 111111


Q ss_pred             cccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          300 IVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .             +...+.++.+|+.+||+.||++|||+.++++.|+++..
T Consensus       221 ~-------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         221 A-------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             C-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-------------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            1             11345678899999999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.4e-54  Score=395.11  Aligned_cols=251  Identities=17%  Similarity=0.217  Sum_probs=209.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .+.|...+.||+|+||   .||+|.+  +++.||||++...  .......+.+|+.+|++++|||||++++++.+++..|
T Consensus        28 ~d~Y~i~~~lG~G~fg---~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFG---VVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCe---EEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4679999999999999   9999998  7999999999766  4556678899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeec--CCCceEEeccCC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN--EENVAKLFDFSL  216 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~--~~~~~kl~dfg~  216 (353)
                      +|||||++|+|.+.+....    .++++..++.|+.||+.||.|||   +++|+||||||+|||++  .++.+||+|||+
T Consensus       103 ivmE~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         103 LILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEcCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeeccc
Confidence            9999999999998876653    46999999999999999999999   99999999999999997  578999999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      |+.......  .....||+.|+|||++.+..++.++|||||||++|||+||..||.....        ......... ..
T Consensus       176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~-~~  244 (352)
T d1koba_         176 ATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKR-CD  244 (352)
T ss_dssp             CEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHH-CC
T ss_pred             ceecCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CC
Confidence            988754332  4556799999999999999999999999999999999999999974322        111111111 11


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..  ...        ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       245 ~~--~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         245 WE--FDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CC--CCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CC--CCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10  000        000134567889999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=388.55  Aligned_cols=252  Identities=19%  Similarity=0.224  Sum_probs=208.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC----ChhHHHHHHHHHHHHhhcCCCceeeccceeeeC
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC----RPRAYESCINNVTYAARMSHNHILKLIGCCLET  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~  134 (353)
                      .+.|...+.||+|+||   .||+|.+  +|+.||||++.....    .....+.|.+|+.+|++++|||||++++++.+.
T Consensus         9 ~d~Y~~~~~lG~G~fg---~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFA---VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             GGTEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCEEEeEEEecCCCe---EEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            4679999999999999   9999998  789999999865432    223467899999999999999999999999999


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC----ceE
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN----VAK  210 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~----~~k  210 (353)
                      +..|+|||||++|+|.+++...     ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++    .+|
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             CEEEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceE
Confidence            9999999999999999999765     46899999999999999999999   99999999999999998776    599


Q ss_pred             EeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          211 LFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       211 l~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      ++|||+|+.......  .....||+.|+|||++.+..++.++|||||||++|||++|..||.....        .+....
T Consensus       158 l~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~  227 (293)
T d1jksa_         158 IIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLAN  227 (293)
T ss_dssp             ECCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred             ecchhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHH
Confidence            999999988754332  3456789999999999998999999999999999999999999974321        112111


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ... ...          ..+...+...+..+.+|+.+||+.||++|||+.++++
T Consensus       228 i~~-~~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         228 VSA-VNY----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHT-TCC----------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHh-cCC----------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111 110          0111112245677889999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-54  Score=390.62  Aligned_cols=267  Identities=22%  Similarity=0.294  Sum_probs=214.0

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeec
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKL  127 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~  127 (353)
                      .+++...++|+..+.||+|+||   .||+|.+       +++.||||++.... .....++|.+|+.+|++++||||+++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG---~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~   81 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFG---RVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKL   81 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSC---EEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhccCCHHHcEEeEEEeeCCCe---EEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccc
Confidence            3444556789999999999999   9999986       34789999987552 45567789999999999999999999


Q ss_pred             cceeeeCCccEEEEEeccCCChhhhhccCCC-------------------CCCccccHHHHHHHHHHHHHHHHHHhcCCC
Q 018633          128 IGCCLETPIPILVFESVQYGTLWDRILGAPQ-------------------PHFEPLLLKHRLKIAMDIVHALAYLHFGFP  188 (353)
Q Consensus       128 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  188 (353)
                      +++|.+.+..++||||+++|+|.+++.....                   .....+++..++.|+.|++.||+|||   +
T Consensus        82 ~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~  158 (301)
T d1lufa_          82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---E  158 (301)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---c
Confidence            9999999999999999999999999864321                   01135889999999999999999999   9


Q ss_pred             CCeEeeccCCCceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhC
Q 018633          189 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTG  267 (353)
Q Consensus       189 ~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg  267 (353)
                      ++|+||||||+|||++.++.+||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus       159 ~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         159 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence            9999999999999999999999999999986643322 223456788999999999999999999999999999999999


Q ss_pred             C-CCCCccccccCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 018633          268 W-DVSDLVKDTHDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKL  346 (353)
Q Consensus       268 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L  346 (353)
                      . +||.....        .+.... ...+..+...             ...+..+.+|+.+||+.||++||||.+|++.|
T Consensus       239 ~~~p~~~~~~--------~e~~~~-v~~~~~~~~p-------------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L  296 (301)
T d1lufa_         239 GLQPYYGMAH--------EEVIYY-VRDGNILACP-------------ENCPLELYNLMRLCWSKLPADRPSFCSIHRIL  296 (301)
T ss_dssp             TCCTTTTSCH--------HHHHHH-HHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCCCH--------HHHHHH-HHcCCCCCCC-------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            6 45653221        122222 2222221111             14456788999999999999999999999999


Q ss_pred             HHHH
Q 018633          347 RQIY  350 (353)
Q Consensus       347 ~~l~  350 (353)
                      +++.
T Consensus       297 ~~i~  300 (301)
T d1lufa_         297 QRMC  300 (301)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=382.34  Aligned_cols=271  Identities=19%  Similarity=0.298  Sum_probs=203.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC----ccE
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP----IPI  138 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~----~~~  138 (353)
                      .|...+.||+|+||   .||+|.++|+.||||++...   ......+..|+..+.+++|||||+++|+|.+.+    .+|
T Consensus         4 ~~~l~~~iG~G~fg---~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           4 TIVLQESIGKGRFG---EVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GEEEEEEEECCSSS---EEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             EEEEEEEEeeCCCe---EEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            46667789999999   99999999999999998644   222222334555566789999999999998654    579


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC-----CCCeEeeccCCCceeecCCCceEEec
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF-----PRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      +|||||++|+|.+++++.      .+++..++.++.|+|.||.|||+.+     +++|+||||||+|||++.++.+||+|
T Consensus        78 lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            999999999999999763      5889999999999999999999321     36999999999999999999999999


Q ss_pred             cCCccccCCCCCc---cccccccCCccccccccccCC------CCccccchhhHHHHHHHHhCCCCCCccccccC-----
Q 018633          214 FSLSISIPEGETH---ITDTVMGTWGYCAPEYMRTGV------FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-----  279 (353)
Q Consensus       214 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-----  279 (353)
                      ||+++........   ......||+.|+|||++.+..      ++.++|||||||++|||+||..|+........     
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            9999877543321   234567999999999987542      67899999999999999999988754332211     


Q ss_pred             -CCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          280 -LACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       280 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                       ...+...............    +.+....   ........+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~----p~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKLR----PNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCC----CCCCGGG---GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHhccccC----CCCCccc---CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence             0111222222222222211    1111110   1115667789999999999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=392.15  Aligned_cols=256  Identities=19%  Similarity=0.348  Sum_probs=202.8

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCe----EEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QER----LISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ++|+..++||+|+||   .||+|.+  +++    .||+|++.... .....++|.+|+.++++++|||||+++|+|.++ 
T Consensus         9 ~dy~~~~~lG~G~fG---~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFG---TVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTEEEEEEEEECSSE---EEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             HHCEEeeEEecCCCe---EEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            358899999999999   9999988  343    68999886542 445577899999999999999999999999765 


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++++||+.+|+|.+.+....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             CeeEEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccc
Confidence            5678899999999999887654    57899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHhh
Q 018633          216 LSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYFE  293 (353)
Q Consensus       216 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (353)
                      +|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||.......        . .....
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------~-~~~i~  227 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------I-SSILE  227 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------H-HHHHH
T ss_pred             cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------H-HHHHH
Confidence            99887544332 2234568999999999999999999999999999999999 788876432211        1 11111


Q ss_pred             cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          294 DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      .+....             .+..++..+.+|+.+||+.||++|||+.++++.|.++..
T Consensus       228 ~~~~~~-------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         228 KGERLP-------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HTCCCC-------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCC-------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            111000             011455678899999999999999999999999988753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=393.18  Aligned_cols=249  Identities=17%  Similarity=0.205  Sum_probs=207.0

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||++..  +++.||+|++.+... .....+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus         4 l~dy~~~~~lG~G~fg---~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             hHhcEEEEEEecCcCe---EEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            3579999999999999   9999998  799999999965421 223467789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+|||||++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|
T Consensus        81 ~iv~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a  152 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ccceeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccc
Confidence            9999999999999998875     46889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      +....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||......        +...... ...+
T Consensus       153 ~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~i~-~~~~  222 (337)
T d1o6la_         153 KEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELIL-MEEI  222 (337)
T ss_dssp             BCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH-HCCC
T ss_pred             cccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHHHHHh-cCCC
Confidence            87643322 345678999999999999999999999999999999999999999743221        1111111 1111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                       ..             +...+.++.+||.+||+.||++||+     +.++++
T Consensus       223 -~~-------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 -RF-------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CC-------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CC-------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence             00             0134566789999999999999995     777765

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-53  Score=379.14  Aligned_cols=261  Identities=20%  Similarity=0.293  Sum_probs=205.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC--
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETP--  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~--  135 (353)
                      .+.|...+.||+|+||   .||+|.+  +++.||||++..... .....+.|.+|+.++++++|||||++++++...+  
T Consensus         6 ~drY~i~~~lG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           6 SDRYELGEILGFGGMS---EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             TTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred             cceeEEeEEEeeCCCe---EEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence            4669999999999999   9999998  799999999976543 3455678999999999999999999999998654  


Q ss_pred             --ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          136 --IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       136 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                        .+|+||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++..+++|
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECC
T ss_pred             CceEEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeeh
Confidence              378999999999999988765     46899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCC--ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          214 FSLSISIPEGET--HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       214 fg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ||.+........  .......||+.|+|||++.+..++.++|||||||++|||+||..||.....        .+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~  226 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQH  226 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHH
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHH
Confidence            999876543322  223456899999999999998999999999999999999999999974321        1222222


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-SMVDVAKKLRQIYR  351 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~~vl~~L~~l~~  351 (353)
                      ........    .       ......+..+.+++.+||+.||++|| |+++++..|.++..
T Consensus       227 ~~~~~~~~----~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         227 VREDPIPP----S-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHCCCCCG----G-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HhcCCCCC----c-------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            22111100    0       00013456788999999999999999 89999999998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-55  Score=385.76  Aligned_cols=256  Identities=21%  Similarity=0.392  Sum_probs=197.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe---C--CeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW---Q--ERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~---~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ++|+..+.||+|+||   .||+|.+   +  ...||||++..... .....++|.+|+.+|++++|||||+++|+|.+ +
T Consensus         8 ~d~~~~~~iG~G~fg---~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGEEEEEECC----C---CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             HHeEEEEEEecCCCe---EEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            458888899999999   8999986   2  24789999876532 34456789999999999999999999999965 4


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..++||||+++|+|.+.+....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             chheeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccch
Confidence            6789999999999998887654    46899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCCc--cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccccCCCCChHHHHHHHh
Q 018633          216 LSISIPEGETH--ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDTHDLACPSNEYLKNYF  292 (353)
Q Consensus       216 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (353)
                      +++........  ......||..|+|||++.+..++.++||||||+++|||+| |..||.....        .+......
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~  228 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKID  228 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHH
Confidence            99987554332  1234567889999999999999999999999999999998 8999873222        22222222


Q ss_pred             hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 018633          293 EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQI  349 (353)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l  349 (353)
                      ........             +...+..+.+|+.+||+.||++|||+.+|++.|.+.
T Consensus       229 ~~~~~~~~-------------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 KEGERLPR-------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TSCCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hCCCCCCC-------------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22111110             114456788999999999999999999999998864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=384.09  Aligned_cols=254  Identities=20%  Similarity=0.307  Sum_probs=205.1

Q ss_pred             CCceeeCCCCCccEEEEEEe-C----CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC-CccEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFW-Q----ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET-PIPILV  140 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~-~~~~lv  140 (353)
                      .++||+|+||   +||+|.+ .    ...||||++... ......++|.+|+++|++++|||||+++|++.+. +..++|
T Consensus        32 ~~~iG~G~fg---~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFG---CVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTE---EEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ceEEeecCCe---EEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            3679999999   9999998 1    236899998753 2566778899999999999999999999998764 578999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      ||||++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++..
T Consensus       108 ~E~~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             EEEeecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence            99999999999887654    46788899999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCc---cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          221 PEGETH---ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       221 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      ......   ......||+.|+|||.+....++.++||||||+++|||+||..||.......       +....... +..
T Consensus       181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------~~~~~i~~-g~~  252 (311)
T d1r0pa_         181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQ-GRR  252 (311)
T ss_dssp             TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHT-TCC
T ss_pred             cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHc-CCC
Confidence            543322   2234578999999999999999999999999999999999888876322211       11111111 111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      +.             .+..++..+.+|+.+||+.||++|||+.||++.|+++..+
T Consensus       253 ~~-------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 LL-------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CC-------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            10             0113456788999999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=386.13  Aligned_cols=265  Identities=18%  Similarity=0.287  Sum_probs=202.0

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeecccee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCC  131 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~  131 (353)
                      ..++|...+.||+|+||   .||+|.+       +++.||||++.... .....+.+.+|+..+.++ +|+|||.+++++
T Consensus        11 ~~~~y~~~~~iG~G~fG---~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             CGGGEEEEEEEEECSSC---EEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHEEEeeEEeecCCe---EEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            34678889999999999   9999986       34689999987543 445567788999988887 589999999998


Q ss_pred             eeC-CccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          132 LET-PIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       132 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      ... +..++|||||++|+|.+++......           ....+++..++.++.||+.||.|||   +++|+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcc
Confidence            754 4689999999999999999754210           1135889999999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCC-CCCCccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW-DVSDLVKDT  277 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~-~p~~~~~~~  277 (353)
                      |||++.++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||. .||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987644332 2234567999999999999999999999999999999999975 466532211


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                              .........+......             ...+..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus       244 --------~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         244 --------EEFCRRLKEGTRMRAP-------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             --------HHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------HHHHHHHhcCCCCCCC-------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                    1122222222111111             13456788999999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.5e-54  Score=387.21  Aligned_cols=245  Identities=18%  Similarity=0.268  Sum_probs=204.3

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++.+  +++.||||++..... .....+.+.+|+.++++++|||||++++++.+.+..|
T Consensus         4 ~dy~i~~~lG~G~fg---~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           4 QDFQILRTLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             GGEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hHeEEEEEEecCcCc---EEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            568889999999999   9999998  689999999864421 2334678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +|||||+||+|..++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        81 ivmE~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             EEECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             eEeeecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccce
Confidence            999999999999988766     45788889999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .....    ....+||+.|+|||++.+..++.++|||||||++|||+||+.||.....        .+........ .. 
T Consensus       153 ~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~-~~-  218 (316)
T d1fota_         153 YVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNA-EL-  218 (316)
T ss_dssp             ECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHC-CC-
T ss_pred             Eeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcC-CC-
Confidence            76432    3456899999999999999999999999999999999999999974221        1122221111 10 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                               ..+    ...+..+.+++.+||..||.+||     |++++++
T Consensus       219 ---------~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 ---------RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---------CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------CCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                     000    13455678999999999999996     8888875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=387.44  Aligned_cols=260  Identities=20%  Similarity=0.268  Sum_probs=204.5

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCe--EEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeeeCCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QER--LISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLETPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~~~~  136 (353)
                      ++|+..++||+|+||   .||+|.+  ++.  .||||++.... .....+.|.+|+++|.++ +|||||+++|+|.+.+.
T Consensus        10 ~~~~~~~~iG~G~fg---~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGC---EEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCc---EEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            578888999999999   9999998  444  57888875442 344567899999999999 69999999999999999


Q ss_pred             cEEEEEeccCCChhhhhccCCC-----------CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC
Q 018633          137 PILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE  205 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~  205 (353)
                      .++||||+++|+|.+++.....           .....+++..++.++.||+.||.|||   +++|+||||||+|||++.
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcC
Confidence            9999999999999999975420           11146899999999999999999999   999999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCC-CCCccccccCCCCCh
Q 018633          206 ENVAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWD-VSDLVKDTHDLACPS  284 (353)
Q Consensus       206 ~~~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~-p~~~~~~~~~~~~~~  284 (353)
                      ++.+||+|||+++.......  .....||..|+|||.+.+..++.++|||||||++|||++|.. ||....        .
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~  232 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------C  232 (309)
T ss_dssp             GGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------H
T ss_pred             CCceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------H
Confidence            99999999999976543222  234568999999999999999999999999999999999765 554221        1


Q ss_pred             HHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          285 NEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      .+.........+. .             .+...+.++.+|+.+||+.||++||||.+|++.|+++.+.
T Consensus       233 ~~~~~~i~~~~~~-~-------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         233 AELYEKLPQGYRL-E-------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHHHHHGGGTCCC-C-------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHhcCCC-C-------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1111111111110 0             0114556788999999999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-52  Score=372.44  Aligned_cols=251  Identities=22%  Similarity=0.294  Sum_probs=205.6

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC-------hhHHHHHHHHHHHHhhcC-CCceeecccee
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR-------PRAYESCINNVTYAARMS-HNHILKLIGCC  131 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-H~niv~~~~~~  131 (353)
                      ++|+..+.||+|+||   +||++.+  +++.||||++......       ....+.+.+|+.++++++ |||||++++++
T Consensus         3 ~~y~~~~~iG~G~~g---~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~   79 (277)
T d1phka_           3 ENYEPKEILGRGVSS---VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   79 (277)
T ss_dssp             TTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             ccCEEceEEecCcCe---EEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence            578899999999999   9999998  8899999998755321       223456899999999997 99999999999


Q ss_pred             eeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEE
Q 018633          132 LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKL  211 (353)
Q Consensus       132 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl  211 (353)
                      .+++..|||||||++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||
T Consensus        80 ~~~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          80 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             ccCcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEE
Confidence            9999999999999999999999765     46899999999999999999999   999999999999999999999999


Q ss_pred             eccCCccccCCCCCccccccccCCcccccccccc------CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRT------GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSN  285 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~  285 (353)
                      +|||+++.......  .....||..|+|||.+.+      ..++.++||||+||++|||++|..||.....        .
T Consensus       152 ~DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~  221 (277)
T d1phka_         152 TDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------M  221 (277)
T ss_dssp             CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred             ccchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------H
Confidence            99999988754332  345679999999999853      3478899999999999999999999974321        1


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........ .... .         +.......++++.+|+.+||+.||++|||+.+|++
T Consensus       222 ~~~~~i~~-~~~~-~---------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         222 LMLRMIMS-GNYQ-F---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHHH-TCCC-C---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHh-CCCC-C---------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111121 1111 0         00001145678899999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-53  Score=383.20  Aligned_cols=249  Identities=18%  Similarity=0.264  Sum_probs=200.7

Q ss_pred             hhCcCCC-CceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceeee---
Q 018633           61 TNSYDQK-NVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCLE---  133 (353)
Q Consensus        61 ~~~~~~~-~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~~---  133 (353)
                      .++|... ++||+|+||   .||+|.+  +++.||||++...       ..+.+|+.++.++ +|||||++++++.+   
T Consensus        10 ~~~y~i~~~~lG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGING---KVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccCEEEeeEEeeeccCe---EEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            4678876 469999999   9999998  7899999998654       4577899987665 79999999999875   


Q ss_pred             -CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---CCce
Q 018633          134 -TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---ENVA  209 (353)
Q Consensus       134 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~  209 (353)
                       +..+|+|||||+||+|.+++.....   ..+++..++.|+.||+.||.|||   +++|+||||||+|||++.   .+.+
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCE
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccc
Confidence             4568999999999999999976532   46999999999999999999999   999999999999999985   5679


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ||+|||+|+.......  .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.........        .
T Consensus       154 Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--------~  223 (335)
T d2ozaa1         154 KLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------P  223 (335)
T ss_dssp             EECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------
T ss_pred             cccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--------H
Confidence            9999999987654332  45668999999999999999999999999999999999999999754322200        0


Q ss_pred             HHhhcCcccccccchhhh--ccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFEDNRFTEIVDPIIVE--DVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                               .+.......  ..+.......+.++.+|+.+||+.||++|||+.++++
T Consensus       224 ---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         224 ---------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---------HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                     000000000  1111122256778999999999999999999999976

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=382.97  Aligned_cols=250  Identities=13%  Similarity=0.173  Sum_probs=206.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++...   ......+.+|+.+|++++|||||++++++.+++.+|
T Consensus         4 ~~rY~i~~~lG~G~fg---~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFG---IVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEecCCCe---EEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            4678889999999999   9999998  7899999999765   334566889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC--CceEEeccCC
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE--NVAKLFDFSL  216 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~--~~~kl~dfg~  216 (353)
                      +|||||++|+|.+++....    ..+++.+++.|+.||+.||.|||   +++|+||||||+|||++.+  ..+||+|||+
T Consensus        78 lvmE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             EEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccch
Confidence            9999999999999997653    36899999999999999999999   9999999999999999854  5899999999


Q ss_pred             ccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCc
Q 018633          217 SISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNR  296 (353)
Q Consensus       217 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (353)
                      ++......  ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.....        .......... .
T Consensus       151 ~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~-~  219 (321)
T d1tkia_         151 ARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNA-E  219 (321)
T ss_dssp             CEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHT-C
T ss_pred             hhccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-C
Confidence            98764433  24456789999999999999999999999999999999999999974321        1111111111 0


Q ss_pred             ccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          297 FTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +          ..+.......+.++.+|+.+||..||++|||+.|+++
T Consensus       220 ~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         220 Y----------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C----------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C----------CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0          0011111134667889999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-53  Score=380.85  Aligned_cols=264  Identities=16%  Similarity=0.252  Sum_probs=212.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe-------CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccceee
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW-------QERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGCCL  132 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~~~  132 (353)
                      .++|...+.||+|+||   .||+|.+       +++.||||++.... .......|.+|+.+++++ +|||||+++|+|.
T Consensus        22 ~~~~~l~~~iG~G~fg---~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFG---KVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GGGEEEEEEEEECSSE---EEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCe---EEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            4678888899999999   9999975       45689999997653 455667899999999999 6999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCCC-------------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQP-------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      +.+..++|||||++|+|.+++......             ....+++..++.++.||+.||.|||   +++++||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccc
Confidence            999999999999999999998765321             1136889999999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCcccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTH  278 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~  278 (353)
                      |||++.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+|+..|+.......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987754432 23345688999999999999999999999999999999999554443221111


Q ss_pred             CCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          279 DLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                             ..+......+....             .+...+..+.+|+.+||+.||.+||||.+|++.|++...
T Consensus       255 -------~~~~~~i~~~~~~~-------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         255 -------SKFYKMIKEGFRML-------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             -------HHHHHHHHHTCCCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHHHhcCCCCC-------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence                   11222222211111             111445678899999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-53  Score=387.85  Aligned_cols=245  Identities=15%  Similarity=0.203  Sum_probs=205.1

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-CChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-CRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPI  138 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~  138 (353)
                      ++|...+.||+|+||   .||++.+  +++.||||++.... ......+.+.+|+.+|+.++|||||++++++.+.+..+
T Consensus        41 d~y~i~~~lG~G~fg---~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cCeEEEEEeecCcCc---EEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            579999999999999   9999998  79999999986432 12334577899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          139 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       139 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                      +||||+.+|+|.+++...     ..+++..++.++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+
T Consensus       118 ~v~e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cccccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence            999999999999998765     36899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCccc
Q 018633          219 SIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRFT  298 (353)
Q Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (353)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||+||..||.....        ......... ... 
T Consensus       190 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~-~~~-  255 (350)
T d1rdqe_         190 RVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVS-GKV-  255 (350)
T ss_dssp             ECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC-
T ss_pred             ecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhc-CCC-
Confidence            76432    3456899999999999999999999999999999999999999973221        111111111 110 


Q ss_pred             ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 018633          299 EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRP-----SMVDVAK  344 (353)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~vl~  344 (353)
                                 ..  +...+..+.+|+.+||..||.+|+     |+.++++
T Consensus       256 -----------~~--p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 -----------RF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----------CC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----------CC--CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                       00  013456788999999999999994     8888875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=374.60  Aligned_cols=263  Identities=19%  Similarity=0.286  Sum_probs=207.8

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--C-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhc-CCCceeeccce
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--Q-------ERLISVLQFYGHECRPRAYESCINNVTYAARM-SHNHILKLIGC  130 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~~~~~  130 (353)
                      .++|...+.||+|+||   .||+|..  .       +..||||++.... ......++.+|+..+.++ +|||||+++++
T Consensus        12 ~~~~~l~~~iG~G~fg---~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFG---QVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             GGGEEEEEECC--------CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCc---EEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            3568888899999999   8888876  1       2479999997653 455667899999999998 79999999999


Q ss_pred             eeeCCccEEEEEeccCCChhhhhccCCCC-----------CCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCC
Q 018633          131 CLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS  199 (353)
Q Consensus       131 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  199 (353)
                      |.+++..++|||||++|+|.+++......           ....+++.+++.++.||+.||.|||   +++|+||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccc
Confidence            99999999999999999999999765321           1146899999999999999999999   999999999999


Q ss_pred             ceeecCCCceEEeccCCccccCCCCCc-cccccccCCccccccccccCCCCccccchhhHHHHHHHHh-CCCCCCccccc
Q 018633          200 CILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLT-GWDVSDLVKDT  277 (353)
Q Consensus       200 Nill~~~~~~kl~dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~p~~~~~~~  277 (353)
                      |||++.++.+||+|||+++........ ......||+.|+|||.+.+..|+.++|||||||++|||++ |..||..... 
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-  243 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  243 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence            999999999999999999876543322 2345678999999999999999999999999999999998 6777763221 


Q ss_pred             cCCCCChHHHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          278 HDLACPSNEYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                             .. +......+.....             +...+..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       244 -------~~-~~~~i~~~~~~~~-------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         244 -------EE-LFKLLKEGHRMDK-------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             -------HH-HHHHHHTTCCCCC-------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------HH-HHHHHHcCCCCCC-------------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                   11 2222222211111             113456788999999999999999999999999999753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.4e-52  Score=382.87  Aligned_cols=249  Identities=16%  Similarity=0.205  Sum_probs=197.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHH---HHHHHHhhcCCCceeeccceeeeCC
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCI---NNVTYAARMSHNHILKLIGCCLETP  135 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~---~E~~~l~~l~H~niv~~~~~~~~~~  135 (353)
                      ++|...++||+|+||   .||+|.+  +++.||||++..... .......+.   +|+.+++.++|||||++++++.+.+
T Consensus         4 ddy~i~~~lG~G~fg---~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           4 NDFSVHRIIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             TTEEEEEEEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             HhCeeeeEEecCCCe---EEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            679999999999999   9999998  789999999864321 111223334   4467777888999999999999999


Q ss_pred             ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccC
Q 018633          136 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS  215 (353)
Q Consensus       136 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg  215 (353)
                      ..|+|||||++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeec
Confidence            999999999999999999765     45789999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED  294 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (353)
                      +|+......   .....||+.|+|||++.. ..++.++|||||||++|||+||..||.......     .... ......
T Consensus       153 la~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~-~~~~~~  223 (364)
T d1omwa3         153 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEI-DRMTLT  223 (364)
T ss_dssp             TCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHH-HHHSSS
T ss_pred             eeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHH-HHhccc
Confidence            998765432   345689999999999975 468999999999999999999999997533221     1110 000000


Q ss_pred             CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          295 NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                      ..  ..        .    +...+..+.+||.+||+.||++|||     +.++++
T Consensus       224 ~~--~~--------~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 MA--VE--------L----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CC--CC--------C----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CC--CC--------C----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            00  00        0    0134567889999999999999999     677764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=377.66  Aligned_cols=263  Identities=17%  Similarity=0.185  Sum_probs=200.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      ++|...+.||+|+||   .||+|.+  +++.||||++..........+.+.+|+.+|++++|||||++++++.+++..|+
T Consensus         2 d~Y~~~~~lG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYG---VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEeccEEecCcCe---EEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence            579999999999999   9999998  68999999997654344456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      ||||+.+ ++.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        79 v~e~~~~-~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          79 VFEFLHQ-DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             EEECCSE-EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             EEeecCC-chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCccee
Confidence            9999974 55555543322   46899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc-Ccc
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED-NRF  297 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  297 (353)
                      ...... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.......        ........ +..
T Consensus       152 ~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--------~~~~i~~~~~~~  222 (298)
T d1gz8a_         152 FGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--------QLFRIFRTLGTP  222 (298)
T ss_dssp             HCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCC
T ss_pred             ccCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--------HHHHHHHhcCCC
Confidence            754332 345567999999999987665 5789999999999999999999997432211        11111100 000


Q ss_pred             c--------------ccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          298 T--------------EIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       298 ~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .              ............ ......+..+.+|+.+||..||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         223 DEVVWPGVTSMPDYKPSFPKWARQDFS-KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CTTTSTTGGGSTTCCTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhccccccccccccccccccccchh-hhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0              000000000000 011134567889999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=382.72  Aligned_cols=247  Identities=19%  Similarity=0.271  Sum_probs=202.7

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCC-ChhHHHHHHHHHHHHh-hcCCCceeeccceeeeCCcc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHEC-RPRAYESCINNVTYAA-RMSHNHILKLIGCCLETPIP  137 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~H~niv~~~~~~~~~~~~  137 (353)
                      ++|...+.||+|+||   +||+|.+  +++.||||++..... .....+.+..|..++. .++|||||++++++.+++..
T Consensus         2 ddy~i~~~iG~G~fg---~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           2 EDFILHKMLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             TTEEEEEEEEECSSS---EEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CCeEEeeEEecCCCc---EEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence            578889999999999   9999999  899999999964311 1234566778888776 68999999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS  217 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a  217 (353)
                      |+|||||++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||+++++.+||+|||++
T Consensus        79 yivmEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eEEEeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchh
Confidence            9999999999999999765     46889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhcCcc
Q 018633          218 ISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFEDNRF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (353)
                      +....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....        .+..... .....
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i-~~~~~  220 (320)
T d1xjda_         151 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSI-RMDNP  220 (320)
T ss_dssp             BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HHCCC
T ss_pred             hhcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHH-HcCCC
Confidence            87643322 34556899999999999999999999999999999999999999974321        1111111 11111


Q ss_pred             cccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 018633          298 TEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMV-DVA  343 (353)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~vl  343 (353)
                       .         .    +...+.++.+|+.+||..||++|||+. +++
T Consensus       221 -~---------~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         221 -F---------Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             -C---------C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -C---------C----CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence             0         0    013456688999999999999999985 664

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=375.17  Aligned_cols=262  Identities=19%  Similarity=0.314  Sum_probs=210.6

Q ss_pred             HhhCcCCCCceeeCCCCCccEEEEEEeC-------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceee
Q 018633           60 ATNSYDQKNVIAKDTSYNLYTMYKGFWQ-------ERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCL  132 (353)
Q Consensus        60 ~~~~~~~~~~lg~G~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~  132 (353)
                      ..++|...+.||+|+||   .||+|.+.       +..||||++.... .......|.+|+.++++++|||||+++|+|.
T Consensus        18 ~~~~~~l~~~lG~G~fG---~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          18 AREKITMSRELGQGSFG---MVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             CGGGEEEEEEEEECSSS---EEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cHHHeEEeeEEeeCCCe---EEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            34678888999999999   99988873       4789999997543 4556678999999999999999999999999


Q ss_pred             eCCccEEEEEeccCCChhhhhccCCC-----CCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC
Q 018633          133 ETPIPILVFESVQYGTLWDRILGAPQ-----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN  207 (353)
Q Consensus       133 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  207 (353)
                      ..+..++||||+++|+|.+++.....     .....+++..+..++.|++.||.|||   +++|+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence            99999999999999999998864311     11135688999999999999999999   89999999999999999999


Q ss_pred             ceEEeccCCccccCCCCC-ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCC-CCCCccccccCCCCChH
Q 018633          208 VAKLFDFSLSISIPEGET-HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGW-DVSDLVKDTHDLACPSN  285 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~-~p~~~~~~~~~~~~~~~  285 (353)
                      .+||+|||+|+....... .......||+.|+|||.+.+..++.++||||||+++|||+||. .||...        ...
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~  242 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNE  242 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHH
Confidence            999999999987643322 2234457899999999999999999999999999999999985 555422        222


Q ss_pred             HHHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 018633          286 EYLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIY  350 (353)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~  350 (353)
                      +...... .+......             ..++..+.+|+.+||+.||++|||+.+|++.|++..
T Consensus       243 ~~~~~i~-~~~~~~~p-------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         243 QVLRFVM-EGGLLDKP-------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHHHHH-TTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHHH-hCCCCCCc-------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            2222222 22211111             145567899999999999999999999999987653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=372.33  Aligned_cols=258  Identities=19%  Similarity=0.192  Sum_probs=193.7

Q ss_pred             CCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCC---hhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEEE
Q 018633           67 KNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECR---PRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILVF  141 (353)
Q Consensus        67 ~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv~  141 (353)
                      .++||+|+||   +||+|.+  +++.||||++......   ....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus         3 l~~lG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm   79 (299)
T d1ua2a_           3 LDFLGEGQFA---TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   79 (299)
T ss_dssp             EEEEEEETTE---EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             ceEeccCcCe---EEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence            4679999999   9999998  7899999998655321   112356899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccccC
Q 018633          142 ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP  221 (353)
Q Consensus       142 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~~  221 (353)
                      ||++++++..+....     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        80 E~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          80 DFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             ECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             hhhcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccC
Confidence            999987766555433     46888999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhhc------
Q 018633          222 EGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFED------  294 (353)
Q Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  294 (353)
                      .... ......||+.|+|||++... .++.++|||||||++|||+||..||......+        ........      
T Consensus       152 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--------~l~~i~~~~~~~~~  222 (299)
T d1ua2a_         152 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--------QLTRIFETLGTPTE  222 (299)
T ss_dssp             SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHHHCCCCT
T ss_pred             CCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--------HHHHHHHhcCCCCh
Confidence            4332 23456799999999998754 57999999999999999999999987433221        11111100      


Q ss_pred             Ccccc---cccchhhhccc----hHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          295 NRFTE---IVDPIIVEDVL----SIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       295 ~~~~~---~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..+..   ..........+    .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000   00000000000    0000133567889999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-51  Score=367.50  Aligned_cols=263  Identities=17%  Similarity=0.176  Sum_probs=200.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPILV  140 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~lv  140 (353)
                      ++|...+.||+|+||   +||+|.+ +++.||||++..........+.+.+|+.+|++++|||||++++++.+.+..+++
T Consensus         2 ~~Y~~~~~iG~G~fg---~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYG---VVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTE---EEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCc---EEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            578889999999999   9999998 789999999977644455567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCcccc
Q 018633          141 FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI  220 (353)
Q Consensus       141 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~~  220 (353)
                      +||+.++.+..+....     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+|++|||.+...
T Consensus        79 ~e~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EECCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEeehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence            9999876665554433     56899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh---cC-
Q 018633          221 PEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE---DN-  295 (353)
Q Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-  295 (353)
                      ..... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.......        .....+.   .. 
T Consensus       151 ~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--------~~~~i~~~~~~~~  221 (286)
T d1ob3a_         151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--------QLMRIFRILGTPN  221 (286)
T ss_dssp             CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCCC
T ss_pred             ccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--------HHHHHHHhhCCCC
Confidence            54332 23455689999999998754 47899999999999999999999997433211        1111110   00 


Q ss_pred             --------cccccccchh--hhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 --------RFTEIVDPII--VEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 --------~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                              ..........  ............+..+.+|+.+||+.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0000000000  000000001134567889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-51  Score=367.11  Aligned_cols=264  Identities=17%  Similarity=0.185  Sum_probs=197.4

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe---CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhc---CCCceeeccceeee-
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW---QERLISVLQFYGHECRPRAYESCINNVTYAARM---SHNHILKLIGCCLE-  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~~~~~~~~-  133 (353)
                      .++|...+.||+|+||   .||+|.+   +++.||||++............+.+|+.+|+.+   +|||||+++++|.. 
T Consensus         6 ~~~Y~i~~~LG~G~fg---~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           6 DQQYECVAEIGEGAYG---KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGTEEEEEEEEEETTE---EEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCCEEEEEEEecccCe---EEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            4679999999999999   9999987   367899999865533333444567788877766   79999999999863 


Q ss_pred             ----CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCce
Q 018633          134 ----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA  209 (353)
Q Consensus       134 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~  209 (353)
                          ....+++|||++++++........    ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~  155 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQI  155 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCe
Confidence                346899999998766654443332    46889999999999999999999   9999999999999999999999


Q ss_pred             EEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHH
Q 018633          210 KLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLK  289 (353)
Q Consensus       210 kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  289 (353)
                      ||+|||+++.....  .......||+.|+|||++.+..|+.++||||+||++|||++|..||.......        ...
T Consensus       156 kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------~~~  225 (305)
T d1blxa_         156 KLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--------QLG  225 (305)
T ss_dssp             EECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHH
T ss_pred             eecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--------HHH
Confidence            99999998765322  23456789999999999999999999999999999999999999997433211        111


Q ss_pred             HHhhc------------CcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFED------------NRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .....            .......................+..+.+|+.+||+.||++|||+.|+++
T Consensus       226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11100            00000000000000000001134567789999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=365.63  Aligned_cols=240  Identities=16%  Similarity=0.273  Sum_probs=195.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCCh----hHHHHHHHHHHHHhhcC--CCceeeccceeee
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRP----RAYESCINNVTYAARMS--HNHILKLIGCCLE  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--H~niv~~~~~~~~  133 (353)
                      ++|...++||+|+||   .||+|.+  +++.||||++.......    ....++.+|+.+|++++  |||||++++++.+
T Consensus         4 ~~Y~i~~~lG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~   80 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFG---SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER   80 (273)
T ss_dssp             TTEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CeEEEeEEEeeCCCe---EEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence            568889999999999   9999998  78999999986542111    12244678999999997  8999999999999


Q ss_pred             CCccEEEEEeccC-CChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-CCceEE
Q 018633          134 TPIPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKL  211 (353)
Q Consensus       134 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl  211 (353)
                      .+..++||||+.+ +++.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++. ++.+||
T Consensus        81 ~~~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          81 PDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             CCeEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEE
Confidence            9999999999975 5777777654     46899999999999999999999   999999999999999985 479999


Q ss_pred             eccCCccccCCCCCccccccccCCccccccccccCCC-CccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHH
Q 018633          212 FDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVF-NEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKN  290 (353)
Q Consensus       212 ~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  290 (353)
                      +|||+|+.....   ......||+.|+|||++.+..+ +.++|||||||++|||+||..||.....              
T Consensus       153 ~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------  215 (273)
T d1xwsa_         153 IDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------  215 (273)
T ss_dssp             CCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------
T ss_pred             Cccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------
Confidence            999999875432   2345689999999999987765 5779999999999999999999874211              


Q ss_pred             HhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          291 YFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .... ..  ...            ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       216 i~~~-~~--~~~------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 IIRG-QV--FFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHC-CC--CCS------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Hhhc-cc--CCC------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0110 00  000            033456789999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-49  Score=355.17  Aligned_cols=268  Identities=15%  Similarity=0.184  Sum_probs=196.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee-----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-----  133 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-----  133 (353)
                      .++|...+.||+|+||   +||+|.+  +++.||||++...........++.+|+.+|++++||||+++++++..     
T Consensus         9 ~~rY~i~~~LG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           9 VSKYEKLAKIGQGTFG---EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGGEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cCCEEEEEEEecCcCe---EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            3679999999999999   9999998  78999999987665455566789999999999999999999999865     


Q ss_pred             ---CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceE
Q 018633          134 ---TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK  210 (353)
Q Consensus       134 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~k  210 (353)
                         .+..|+||||+.++.+..... ..    ..++...++.++.|++.||.|||   +++|+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~-~~----~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~k  157 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSN-VL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLK  157 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTC-TT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred             cccCceEEEEEeccCCCccchhhh-cc----cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEE
Confidence               346899999998766544333 22    46888999999999999999999   99999999999999999999999


Q ss_pred             EeccCCccccCCCCC---ccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          211 LFDFSLSISIPEGET---HITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       211 l~dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      |+|||+++.......   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......     ...
T Consensus       158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-----~~~  232 (318)
T d3blha1         158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLA  232 (318)
T ss_dssp             ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHH
T ss_pred             eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-----HHH
Confidence            999999977653322   123445799999999998765 58999999999999999999999997432211     000


Q ss_pred             HHHHHhhc---Ccccccccc-------hhhhccch----HHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          287 YLKNYFED---NRFTEIVDP-------IIVEDVLS----IEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       287 ~~~~~~~~---~~~~~~~~~-------~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........   .........       ........    .........+.+|+.+||++||++|||+.|+++
T Consensus       233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00000000   000000000       00000000    011123456789999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-48  Score=351.39  Aligned_cols=261  Identities=16%  Similarity=0.145  Sum_probs=200.2

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeecc-ceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLI-GCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~-~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++....    ..+++.+|+++++.++|+|+|..+ +++.+.+..
T Consensus         6 g~rY~l~~~iG~G~fG---~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFG---DIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             TTTEEEEEEEEECSSS---EEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CCEEEEeEEEeeCCCc---EEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            3569999999999999   9999998  68999999886552    224578899999999987766554 555677788


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC---CCceEEecc
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE---ENVAKLFDF  214 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~---~~~~kl~df  214 (353)
                      ++||||+. ++|.+.+....    ..+++..+..++.|++.||+|||   +++|+||||||+|||++.   +..++++||
T Consensus        79 ~ivme~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEEEcC-Cchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeecc
Confidence            99999995 67777766544    46899999999999999999999   999999999999998753   557999999


Q ss_pred             CCccccCCCCCc------cccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHH
Q 018633          215 SLSISIPEGETH------ITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYL  288 (353)
Q Consensus       215 g~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  288 (353)
                      |+|+........      ......||+.|+|||++.+..++.++|||||||++|||+||..||...........     .
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-----~  225 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-----Y  225 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------------H
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-----H
Confidence            999877543321      23456799999999999999999999999999999999999999975433221100     0


Q ss_pred             HHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 018633          289 KNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYR  351 (353)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~  351 (353)
                      ....         ....... .+.....++.++.+++..||+.+|++||++.++.+.|+++..
T Consensus       226 ~~~~---------~~~~~~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         226 ERIS---------EKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHH---------HHHHHSC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhh---------cccCCCC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0000         0000000 000111456778999999999999999999999999988754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=358.88  Aligned_cols=262  Identities=15%  Similarity=0.172  Sum_probs=196.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC---
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP---  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---  135 (353)
                      .+.|...+.||+|+||   +||+|.+  +++.||||++.....+....+.+.+|+.+|++++|||||+++++|...+   
T Consensus        17 ~~~Y~~i~~lG~G~fg---~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYG---AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             BSSEEEEEEC---------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             CCcEEEEEEEecCCCe---EEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence            4678888999999999   9999998  6999999999876556677788999999999999999999999997654   


Q ss_pred             ---ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEe
Q 018633          136 ---IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF  212 (353)
Q Consensus       136 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  212 (353)
                         .+|+||||+ +++|..++..      ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+|++
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ccceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccc
Confidence               479999999 4677777654      35899999999999999999999   9999999999999999999999999


Q ss_pred             ccCCccccCCCCCccccccccCCccccccccccC-CCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCCh
Q 018633          213 DFSLSISIPEGETHITDTVMGTWGYCAPEYMRTG-VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPS  284 (353)
Q Consensus       213 dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~  284 (353)
                      |||+|+.....    .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.........       ..+.
T Consensus       164 Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         164 DFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             CCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            99999876432    3456799999999998764 4789999999999999999999999754321100       0000


Q ss_pred             HHHHHHHhh------cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLKNYFE------DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ...+.....      ...........+...     ....+..+.+|+.+||..||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASI-----LTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGT-----CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHh-----ccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000000      000000000000000     0133456789999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-48  Score=350.60  Aligned_cols=262  Identities=12%  Similarity=0.057  Sum_probs=207.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCC-CceeeccceeeeCCcc
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSH-NHILKLIGCCLETPIP  137 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~~~~~  137 (353)
                      .++|...+.||+|+||   .||+|.+  +++.||||++....    ....+.+|++.++.++| +|++.+++++.++...
T Consensus         4 g~~Y~i~~~iG~G~fG---~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFG---VIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSC---EEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCceEEEEEEecCCCe---EEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            3578999999999999   9999998  78999999886542    22356788999999985 8999999999999999


Q ss_pred             EEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecC-----CCceEEe
Q 018633          138 ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-----ENVAKLF  212 (353)
Q Consensus       138 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~-----~~~~kl~  212 (353)
                      ++||||+ +++|.+++....    ..++..++..++.|++.||.|||   +++|+||||||+|||++.     ++.+||+
T Consensus        77 ~~vme~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             EEEEEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEc
Confidence            9999999 589999887654    46899999999999999999999   999999999999999974     5789999


Q ss_pred             ccCCccccCCCCC------ccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHH
Q 018633          213 DFSLSISIPEGET------HITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNE  286 (353)
Q Consensus       213 dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  286 (353)
                      |||+|+.......      .......||+.|+|||++.+..++.++||||||+++|||+||..||.......     ...
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-----~~~  223 (293)
T d1csna_         149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQ  223 (293)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHH
T ss_pred             ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh-----HHH
Confidence            9999987643321      12345679999999999999999999999999999999999999997433322     111


Q ss_pred             HHHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 018633          287 YLKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAKKLRQIYRS  352 (353)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~~L~~l~~~  352 (353)
                      ........         ..... ........+.++.+++..|+..+|++||+++.+.+.|+++.+.
T Consensus       224 ~~~~i~~~---------~~~~~-~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         224 KYERIGEK---------KQSTP-LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             HHHHHHHH---------HHHSC-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhc---------cCCCC-hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            11111000         00000 0000113456788999999999999999999999999887654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=352.09  Aligned_cols=264  Identities=16%  Similarity=0.162  Sum_probs=206.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCCccEE
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETPIPIL  139 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~~~~l  139 (353)
                      +.|...+.||+|+||   +||+|.+  +++.||||++...........++.+|+.+|++++|||||++++++.+....++
T Consensus         2 ~ry~~i~~LG~G~fg---~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYG---TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSS---EEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEeeeEEecCcCe---EEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            468889999999999   9999998  78999999997665566778899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEeccCCccc
Q 018633          140 VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS  219 (353)
Q Consensus       140 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~~  219 (353)
                      |+|++.+++|..++...     ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.++.
T Consensus        79 v~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~  150 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             EEECCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             Eeeeccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhc
Confidence            99999998888777654     46789999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHHhh---cC
Q 018633          220 IPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNYFE---DN  295 (353)
Q Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  295 (353)
                      ...... ......++..|+|||.+.... ++.++|||||||++|||++|+.||.......       +.......   ..
T Consensus       151 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~  222 (292)
T d1unla_         151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-------DQLKRIFRLLGTP  222 (292)
T ss_dssp             CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-------HHHHHHHHHHCCC
T ss_pred             ccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-------HHHHHHHhhcCCC
Confidence            754332 234456778899999987665 6899999999999999999999975332211       11111110   00


Q ss_pred             ---cc------cccccc--hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          296 ---RF------TEIVDP--IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       296 ---~~------~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                         .+      ......  ..............+..+.+|+.+||+.||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00      000000  00000000011134567889999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=355.59  Aligned_cols=270  Identities=16%  Similarity=0.185  Sum_probs=196.6

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeCC---
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLETP---  135 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~~---  135 (353)
                      +++|...+.||+|+||   +||+|.+  +++.||||++.... .....+.+.+|+.+|++++|||||++++++....   
T Consensus         7 ~~rY~~~~~LG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYG---MVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CTTEEEEEECC---CC---CEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             CCCeEEEEEEeeccCe---EEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence            4568889999999999   9999988  79999999997542 4556778999999999999999999999987654   


Q ss_pred             -ccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEecc
Q 018633          136 -IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF  214 (353)
Q Consensus       136 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~df  214 (353)
                       ..+++++|+.+|+|.+++...      .+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          83 MKDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             CCCEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEccc
Confidence             235566677789999999753      5899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCCc--cccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCCh
Q 018633          215 SLSISIPEGETH--ITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPS  284 (353)
Q Consensus       215 g~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~  284 (353)
                      |+++........  ......||+.|+|||++.. ..++.++||||+||++|+|++|..||.........       ..+.
T Consensus       154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~  233 (345)
T d1pmea_         154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  233 (345)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence            999776433221  2345679999999999854 45789999999999999999999999754321100       0000


Q ss_pred             HHHHHHHh--hcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          285 NEYLKNYF--EDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       285 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ........  .................. ......+.++.+|+.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHH-HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000  000000000000000000 000123456889999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=361.04  Aligned_cols=262  Identities=19%  Similarity=0.252  Sum_probs=193.0

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC------
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET------  134 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~------  134 (353)
                      +|+..++||+|+||   +||+|.+  +++.||||++....      ..+.+|+.+|++++|||||+++++|...      
T Consensus        21 ~Y~~~k~LG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          21 SYTDTKVIGNGSFG---VVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEETTE---EEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             CcEeeeEEeeCcCe---EEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            58888999999999   9999999  78999999997652      1234799999999999999999998643      


Q ss_pred             CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ceEEec
Q 018633          135 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFD  213 (353)
Q Consensus       135 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~d  213 (353)
                      .+.|+|||||+++ +.+.+...... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++ .+||+|
T Consensus        92 ~~~~lv~Ey~~~~-~~~~l~~~~~~-~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          92 VYLNLVLDYVPET-VYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             CEEEEEEECCSEE-HHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECC
T ss_pred             eEEEEEEeccCCc-cHHHHHhhhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEec
Confidence            3478999999865 43333211000 046899999999999999999999   99999999999999999775 899999


Q ss_pred             cCCccccCCCCCccccccccCCcccccccccc-CCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRT-GVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~  285 (353)
                      ||+++.......  .....||..|+|||.+.+ ..++.++||||+||++|||++|..||........       ...+..
T Consensus       167 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         167 FGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  244 (350)
T ss_dssp             CTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence            999987654332  345679999999998765 4689999999999999999999999975432210       011111


Q ss_pred             HHHHHHhh---cCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EYLKNYFE---DNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +.+.....   ...++...........    ....+..+.+|+.+||..||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTS----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhhhhccchhhccccccccCchhhhc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22211111   0111111111110000    1134566889999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=353.45  Aligned_cols=266  Identities=18%  Similarity=0.222  Sum_probs=195.2

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee------
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE------  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~------  133 (353)
                      +.|...++||+|+||   +||+|.+  +++.||||++.....+.....++.+|+.++++++|||||++++++..      
T Consensus        17 ~~Y~i~~~LG~G~fg---~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQG---IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             TTEEEEEECSCC--C---EEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCeEEEEEeecCcCe---EEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            568899999999999   9999998  69999999998776566777889999999999999999999999864      


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      ....|+|||||.+ ++.+.+.       ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.++++|
T Consensus        94 ~~~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          94 FQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             CCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CceeEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeec
Confidence            3578999999975 4545553       35789999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccC-------CCCChHH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHD-------LACPSNE  286 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~  286 (353)
                      ||+++......  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||........       ...+..+
T Consensus       163 f~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             CCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            99987764332  24556789999999999999999999999999999999999999964332110       0000111


Q ss_pred             H-------HHHHhhcC------cccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          287 Y-------LKNYFEDN------RFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       287 ~-------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      +       ........      ............. ........+..+.+|+.+||..||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA-DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCC-SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccc-cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1       11111111      0011111111111 11223356788999999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.6e-48  Score=350.11  Aligned_cols=262  Identities=15%  Similarity=0.193  Sum_probs=198.0

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeee--CCc
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLE--TPI  136 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~--~~~  136 (353)
                      ++|...+.||+|+||   +||+|.+  +++.||||++...     ..+++.+|+.+|++++ ||||+++++++..  ...
T Consensus        35 d~y~i~~~LG~G~fg---~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          35 DDYQLVRKLGRGKYS---EVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             GGEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             cCeEEEEEEecCcCe---EEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            579999999999999   9999998  7999999998654     3567899999999996 9999999999874  356


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC-ceEEeccC
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFS  215 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~dfg  215 (353)
                      .++|||||++++|....        ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++ .+||+|||
T Consensus       107 ~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             EEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             eeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccc
Confidence            89999999999997764        35889999999999999999999   99999999999999998655 68999999


Q ss_pred             CccccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCCCCCh-----HHHHH
Q 018633          216 LSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPS-----NEYLK  289 (353)
Q Consensus       216 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~-----~~~~~  289 (353)
                      +|+.......  .....||+.|+|||.+.+.. ++.++||||+||++|+|++|..||.............     .....
T Consensus       176 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~  253 (328)
T d3bqca1         176 LAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY  253 (328)
T ss_dssp             GCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred             cceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence            9987654332  45567899999999987654 7999999999999999999999987443211000000     00000


Q ss_pred             HHhhcCc------ccccccc----hhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          290 NYFEDNR------FTEIVDP----IIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       290 ~~~~~~~------~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      .......      +......    ..............+.++.+|+.+||..||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111000      0000000    00000111111134567889999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=357.60  Aligned_cols=253  Identities=18%  Similarity=0.236  Sum_probs=202.9

Q ss_pred             hCcCCCCceeeCCCCCccEEEEEEe-----CCeEEEEEEecCCCC--ChhHHHHHHHHHHHHhhcCC-Cceeeccceeee
Q 018633           62 NSYDQKNVIAKDTSYNLYTMYKGFW-----QERLISVLQFYGHEC--RPRAYESCINNVTYAARMSH-NHILKLIGCCLE  133 (353)
Q Consensus        62 ~~~~~~~~lg~G~~g~~~~v~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~H-~niv~~~~~~~~  133 (353)
                      ++|...+.||+|+||   .||+|..     +++.||||++.....  .....+.+.+|+.++++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg---~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYG---KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTE---EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCe---EEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            679999999999999   8888865     578999999865421  22335678899999999976 899999999999


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                      .+..++||||+.+|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             CCceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEee
Confidence            99999999999999999998765     35678899999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccC--CCCccccchhhHHHHHHHHhCCCCCCccccccCCCCChHHHHHHH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTG--VFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDLACPSNEYLKNY  291 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  291 (353)
                      ||+++..............|++.|+|||.+.+.  .++.++|||||||++|||++|..||.......    .........
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~  248 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRI  248 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHH
T ss_pred             ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhc
Confidence            999987755444445667899999999998754  36789999999999999999999997543322    111111111


Q ss_pred             hhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 018633          292 FEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPS-----MVDVAK  344 (353)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~~vl~  344 (353)
                      ... ..              ..+...+..+.+|+.+||++||++|||     ++|+++
T Consensus       249 ~~~-~~--------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 LKS-EP--------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHC-CC--------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ccC-CC--------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            110 00              001145678889999999999999994     788865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=348.76  Aligned_cols=261  Identities=18%  Similarity=0.217  Sum_probs=197.5

Q ss_pred             hhCcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeeeC----
Q 018633           61 TNSYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLET----  134 (353)
Q Consensus        61 ~~~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~~----  134 (353)
                      .++|...+.||+|+||   +||+|.+  +++.||||++.....+....+.+.+|+.+|++++|||||++++++...    
T Consensus        17 ~~rY~i~~~LG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYG---SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTEEEEEECGGGTTS---SEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCeEEEEEEecCCCe---EEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            5679999999999999   9999998  799999999987655666778899999999999999999999998643    


Q ss_pred             -CccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCCceEEec
Q 018633          135 -PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD  213 (353)
Q Consensus       135 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~d  213 (353)
                       ...+++++|+.+|+|.+++..      ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+|++|
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~d  164 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD  164 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccc
Confidence             334667788889999998854      35899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCccccccccccCC-CCccccchhhHHHHHHHHhCCCCCCccccccCC-------CCChH
Q 018633          214 FSLSISIPEGETHITDTVMGTWGYCAPEYMRTGV-FNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL-------ACPSN  285 (353)
Q Consensus       214 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~  285 (353)
                      ||++.....    ......||..|+|||.+.+.. ++.++|||||||++|+|++|..||.........       ..+..
T Consensus       165 fg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         165 FGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             C----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            999865432    244567899999999877654 688999999999999999999999743321100       00000


Q ss_pred             HH--------HHHHhhcCcccccccchhhhccchHHHHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 018633          286 EY--------LKNYFEDNRFTEIVDPIIVEDVLSIEKEQQLHASAQLSFECIKDSPADRPSMVDVAK  344 (353)
Q Consensus       286 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~vl~  344 (353)
                      ..        ......  .........+.     ......+..+.+|+.+||..||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         241 ELLKKISSESARNYIQ--SLTQMPKMNFA-----NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHTTCCCHHHHHHHT--TSCCCCCCCHH-----HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhccchhhhhhhh--hcccCCCcchh-----hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00        000000  00000000000     000134567789999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-41  Score=310.08  Aligned_cols=267  Identities=15%  Similarity=0.137  Sum_probs=188.4

Q ss_pred             CcCCCCceeeCCCCCccEEEEEEe--CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-----------CCceeeccc
Q 018633           63 SYDQKNVIAKDTSYNLYTMYKGFW--QERLISVLQFYGHECRPRAYESCINNVTYAARMS-----------HNHILKLIG  129 (353)
Q Consensus        63 ~~~~~~~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~~~~  129 (353)
                      .|...++||+|+||   +||+|.+  +++.||||++...   ....+.+.+|+.+++.++           |+|||++++
T Consensus        14 rY~i~~~LG~G~fg---~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          14 RYILVRKLGWGHFS---TVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TEEEEEEEEECSSE---EEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cEEEEEEEeeCCCe---EEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            48889999999999   9999998  7999999999765   345577889999998875           578999999


Q ss_pred             eeeeC--CccEEEEEeccCCChhhhh-ccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCC
Q 018633          130 CCLET--PIPILVFESVQYGTLWDRI-LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE  206 (353)
Q Consensus       130 ~~~~~--~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~  206 (353)
                      ++...  ...+++++++..+...... .....   ..+++..+..++.||+.||.|||+  ..+|+||||||+|||++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEE
T ss_pred             Eeeeccccceeeeeeecccccccccccccccc---cCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeecc
Confidence            98653  4556777776554433222 22221   467889999999999999999993  3899999999999999866


Q ss_pred             C------ceEEeccCCccccCCCCCccccccccCCccccccccccCCCCccccchhhHHHHHHHHhCCCCCCccccccCC
Q 018633          207 N------VAKLFDFSLSISIPEGETHITDTVMGTWGYCAPEYMRTGVFNEKSDVFSFGVFLFELLTGWDVSDLVKDTHDL  280 (353)
Q Consensus       207 ~------~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~p~~~~~~~~~~  280 (353)
                      +      .++++|||.+......    .....||+.|+|||++....++.++||||+||++++|++|+.||.........
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence            5      3899999998765332    34567999999999999999999999999999999999999998743321100


Q ss_pred             C-------------CChHHHHH------HHhhcCcccccccchhhhccc------hHHHHHHHHHHHHHHHHchhcCCCC
Q 018633          281 A-------------CPSNEYLK------NYFEDNRFTEIVDPIIVEDVL------SIEKEQQLHASAQLSFECIKDSPAD  335 (353)
Q Consensus       281 ~-------------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~  335 (353)
                      .             ........      ..+..................      .......+..+.+|+.+||.+||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence            0             00000000      000000000000000000000      0011356788999999999999999


Q ss_pred             CCCHHHHHH
Q 018633          336 RPSMVDVAK  344 (353)
Q Consensus       336 Rps~~~vl~  344 (353)
                      |||++|+++
T Consensus       319 Rpta~e~L~  327 (362)
T d1q8ya_         319 RADAGGLVN  327 (362)
T ss_dssp             CBCHHHHHT
T ss_pred             CcCHHHHhc
Confidence            999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.5e-25  Score=186.85  Aligned_cols=163  Identities=13%  Similarity=0.102  Sum_probs=118.0

Q ss_pred             CCCCceeeCCCCCccEEEEEEe-CCeEEEEEEecCCCCC----------------hhHHHHHHHHHHHHhhcCCCceeec
Q 018633           65 DQKNVIAKDTSYNLYTMYKGFW-QERLISVLQFYGHECR----------------PRAYESCINNVTYAARMSHNHILKL  127 (353)
Q Consensus        65 ~~~~~lg~G~~g~~~~v~~~~~-~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~H~niv~~  127 (353)
                      ...+.||+|+||   .||+|.+ +|+.||||++.....+                ......+.+|+..+.++.|++++..
T Consensus         3 ~vg~~IG~G~~g---~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~   79 (191)
T d1zara2           3 AIGKLMGEGKES---AVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV   79 (191)
T ss_dssp             EEEEEEEECSSE---EEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred             hhCCEeeeCcce---EEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence            345789999999   9999998 8999999987533110                1112345678999999999999988


Q ss_pred             cceeeeCCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeeccCCCceeecCCC
Q 018633          128 IGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN  207 (353)
Q Consensus       128 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~Nill~~~~  207 (353)
                      +++.    ..+++|||+++..+.+            ++......++.|++.+|.|||   +++|+||||||+|||++++ 
T Consensus        80 ~~~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          80 YAWE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEEE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-
T ss_pred             EEec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-
Confidence            7653    2379999998765533            223334578999999999999   9999999999999999965 


Q ss_pred             ceEEeccCCccccCCCCCccccccccCCccccc------cccccCCCCccccchhhHHH
Q 018633          208 VAKLFDFSLSISIPEGETHITDTVMGTWGYCAP------EYMRTGVFNEKSDVFSFGVF  260 (353)
Q Consensus       208 ~~kl~dfg~a~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Di~slG~i  260 (353)
                      .++|+|||.|........         ..|...      +.+ ...|+.++|+||..--
T Consensus       140 ~~~liDFG~a~~~~~~~~---------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         140 GIWIIDFPQSVEVGEEGW---------REILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             EEEECCCTTCEETTSTTH---------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CEEEEECCCcccCCCCCc---------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            489999999876532221         011111      111 3457889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=1.3e-08  Score=86.93  Aligned_cols=149  Identities=10%  Similarity=-0.022  Sum_probs=99.2

Q ss_pred             HHHHHHhhCcCCCCceeeCCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeee
Q 018633           55 QEIKLATNSYDQKNVIAKDTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLE  133 (353)
Q Consensus        55 ~e~~~~~~~~~~~~~lg~G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~  133 (353)
                      .|+.+...+|...+..+-++.+   .||+...++..+++|+....  .......+.+|+..+..+. +--+.+++.++.+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~---~v~rv~~~~~~~vlk~~~~~--~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~   81 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPA---KVYKLVGENENLYLKMTDSR--YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSS---EEEEEECSSCEEEEEEECGG--GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCC---cEEEEEeCCCeEEEEEcCCC--cccchhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence            4566666666544433333345   78888777788888887654  2223345678888888775 3335667788788


Q ss_pred             CCccEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCC--------------------------
Q 018633          134 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF--------------------------  187 (353)
Q Consensus       134 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------  187 (353)
                      ++..++||++++|.++.+......       .   ...++.+++..+..||+..                          
T Consensus        82 ~~~~~lv~~~l~G~~~~~~~~~~~-------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          82 DGWSNLLMSEADGVLCSEEYEDEQ-------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHTTTCS-------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             CCceEEEEEecccccccccccccc-------c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            888999999999888765443211       1   1234555666666666211                          


Q ss_pred             ------------------------------CCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          188 ------------------------------PRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       188 ------------------------------~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                                                    ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                          1137899999999999977666799999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.15  E-value=1.7e-06  Score=72.88  Aligned_cols=121  Identities=10%  Similarity=0.006  Sum_probs=78.9

Q ss_pred             EEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCC--ceeeccceeeeCCccEEEEEeccCCChhhhhccC
Q 018633           80 TMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHN--HILKLIGCCLETPIPILVFESVQYGTLWDRILGA  156 (353)
Q Consensus        80 ~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  156 (353)
                      .||+... .+..+++|.....     ....+..|+..++.+...  .+.++++++.+++..++||++++|.++.+..   
T Consensus        26 ~v~r~~~~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~---   97 (255)
T d1nd4a_          26 AVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH---   97 (255)
T ss_dssp             EEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC---
T ss_pred             eEEEEEeCCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc---
Confidence            6788777 5666788876544     223466788888777532  3566788777888899999999976664321   


Q ss_pred             CCCCCccccHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------
Q 018633          157 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGF-------------------------------------------------  187 (353)
Q Consensus       157 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------------  187 (353)
                             ....   ..+.+++..|.-||...                                                 
T Consensus        98 -------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  167 (255)
T d1nd4a_          98 -------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  167 (255)
T ss_dssp             -------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             -------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence                   1111   12233444444444110                                                 


Q ss_pred             ------CCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          188 ------PRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       188 ------~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                            ...++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  1237999999999999987667899999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.65  E-value=6.2e-05  Score=67.46  Aligned_cols=76  Identities=12%  Similarity=0.148  Sum_probs=45.7

Q ss_pred             ceeeCCCCCccEEEEEEe--CCeEEEEEEecCCC-----CChhHHHHHHHHHHHHhhcC-C--CceeeccceeeeCCccE
Q 018633           69 VIAKDTSYNLYTMYKGFW--QERLISVLQFYGHE-----CRPRAYESCINNVTYAARMS-H--NHILKLIGCCLETPIPI  138 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~~~E~~~l~~l~-H--~niv~~~~~~~~~~~~~  138 (353)
                      .||.|...   .||+...  +++.+++|......     ..+-..++...|.+.|..+. +  ..+.+++.+  +....+
T Consensus        33 eig~G~~N---~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          33 EIGDGNLN---YVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             ECCSSSSE---EEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EeCCCceE---eEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence            56766666   8888776  46788888754311     01112334556888887663 2  345556554  455678


Q ss_pred             EEEEeccCCCh
Q 018633          139 LVFESVQYGTL  149 (353)
Q Consensus       139 lv~e~~~~gsL  149 (353)
                      +|||++++..+
T Consensus       108 lvmE~L~~~~~  118 (392)
T d2pula1         108 TVMEDLSHLKI  118 (392)
T ss_dssp             EEECCCTTSEE
T ss_pred             EEEeccCCccc
Confidence            99999976543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.26  E-value=0.00041  Score=59.79  Aligned_cols=164  Identities=10%  Similarity=0.017  Sum_probs=84.4

Q ss_pred             eecHHHHHHHhhCcCCCCceee--CCCCCccEEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCc-----
Q 018633           51 IFSAQEIKLATNSYDQKNVIAK--DTSYNLYTMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNH-----  123 (353)
Q Consensus        51 ~~~~~e~~~~~~~~~~~~~lg~--G~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-----  123 (353)
                      .+|.+|+......|...++..-  -..|-..+.|+...++..+++|++....    ..+.+..|+.++..|...+     
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccc
Confidence            3678899999999987554431  1122223678877766678999886531    2233445666677664322     


Q ss_pred             eeec-cce--eeeCCccEEEEEeccCCChhhh--------------hc----cCCCCCCccccHH---------------
Q 018633          124 ILKL-IGC--CLETPIPILVFESVQYGTLWDR--------------IL----GAPQPHFEPLLLK---------------  167 (353)
Q Consensus       124 iv~~-~~~--~~~~~~~~lv~e~~~~gsL~~~--------------l~----~~~~~~~~~l~~~---------------  167 (353)
                      .+.. -|.  ..-......++.+..+......              ++    .............               
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            2211 111  1123345666776665333210              00    0000000000000               


Q ss_pred             ---HHHHHHHHHHHHHHHHh-cCCCCCeEeeccCCCceeecCCCceEEeccCCcc
Q 018633          168 ---HRLKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI  218 (353)
Q Consensus       168 ---~~~~i~~~i~~~L~~LH-~~~~~~iiH~dlkp~Nill~~~~~~kl~dfg~a~  218 (353)
                         .....+......+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence               01112222222223222 1235689999999999999988777899999774

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.09  E-value=0.0016  Score=56.27  Aligned_cols=66  Identities=12%  Similarity=0.103  Sum_probs=42.9

Q ss_pred             EEEEEEe-CCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCce-----eecc--ceeeeCCccEEEEEeccCCC
Q 018633           80 TMYKGFW-QERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHI-----LKLI--GCCLETPIPILVFESVQYGT  148 (353)
Q Consensus        80 ~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~~~--~~~~~~~~~~lv~e~~~~gs  148 (353)
                      .||+... +|..+++|+.....   ...+++..|...+..|...++     +..-  ..+...+..+.++++++|..
T Consensus        37 ~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          37 RVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             EEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             eeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            7999988 78889999986552   234567778888887753222     1111  11234556788999987643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.46  E-value=0.0045  Score=54.87  Aligned_cols=71  Identities=11%  Similarity=0.009  Sum_probs=43.1

Q ss_pred             ceeeCCCCCccEEEEEEeC---------CeEEEEEEecCCCCChhHHHHHHHHHHHHhhcC-CCceeeccceeeeCCccE
Q 018633           69 VIAKDTSYNLYTMYKGFWQ---------ERLISVLQFYGHECRPRAYESCINNVTYAARMS-HNHILKLIGCCLETPIPI  138 (353)
Q Consensus        69 ~lg~G~~g~~~~v~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~~~~~~~~~~~~~  138 (353)
                      .|+-|-.-   .+|+....         ...|++++.- ..  .. .....+|..+++.+. +.-..++++++.+    .
T Consensus        49 ~l~GGltN---~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          49 RIKGGMSN---MLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EECCCTTE---EEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EcCCcccc---ceEEEEeCCCCccccCCCCcEEEEecC-Cc--ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            45555555   77777652         2456666654 31  12 233457899998886 4334567777643    5


Q ss_pred             EEEEeccCCChh
Q 018633          139 LVFESVQYGTLW  150 (353)
Q Consensus       139 lv~e~~~~gsL~  150 (353)
                      +|+||++|.+|.
T Consensus       118 ~I~efi~g~~l~  129 (395)
T d1nw1a_         118 RLEEYIPSRPLS  129 (395)
T ss_dssp             EEECCCCEEECC
T ss_pred             eEEEEeccccCC
Confidence            899999875553

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=82.80  E-value=4.8  Score=33.16  Aligned_cols=128  Identities=13%  Similarity=0.038  Sum_probs=72.8

Q ss_pred             EEEEEEeCCeEEEEEEecCCCCChhHHHHHHHHHHHHhhcCCCceeeccceeee-----------------------CCc
Q 018633           80 TMYKGFWQERLISVLQFYGHECRPRAYESCINNVTYAARMSHNHILKLIGCCLE-----------------------TPI  136 (353)
Q Consensus        80 ~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~~~~~~~~-----------------------~~~  136 (353)
                      -|+-...++..+++|.-     +....+.|..|+...-.+.-|...-+. .+..                       ...
T Consensus        83 Gv~FV~~e~gaiVlK~s-----~tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I~sel~~A  156 (342)
T d1cjaa_          83 GLFFVETESGVFIVKRS-----TNIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVITTLANQA  156 (342)
T ss_dssp             CEEEEEESSCEEEEECC-----TTHHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHHHHHTTCS
T ss_pred             eEEEEEcCCceEEEecC-----CchHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCChhHHHHHHHhcc
Confidence            34444557778888873     234557778888777778888754332 2111                       124


Q ss_pred             cEEEEEeccCCChhhhhccCCCCCCccccHHHHHHHHHHHHHHHHHHhcCCCCCeEeec-cCCCceeecCCC-ceEEecc
Q 018633          137 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN-FKTSCILFNEEN-VAKLFDF  214 (353)
Q Consensus       137 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~d-lkp~Nill~~~~-~~kl~df  214 (353)
                      ..++|||.+|.+|.+.-.....   ..+.... ..-+-.|+.-=.+++....-++.+|+ =.+.||+++.++ .+..+|=
T Consensus       157 ~~liMeYvpG~~l~e~~~~~a~---~~fs~~~-l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~IDs  232 (342)
T d1cjaa_         157 NILLMELVRGITLNKLTTTSAP---EVLTKST-MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPIDS  232 (342)
T ss_dssp             EEEEEECCCEEESTTCCSSSHH---HHSCHHH-HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECSC
T ss_pred             cceeeeccCCccccccccccch---hhhcHHH-HHHhhhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEEecC
Confidence            6799999998887654321110   1111211 11111222223466766566777774 278999998776 5666674


Q ss_pred             CCc
Q 018633          215 SLS  217 (353)
Q Consensus       215 g~a  217 (353)
                      |..
T Consensus       233 ~i~  235 (342)
T d1cjaa_         233 KII  235 (342)
T ss_dssp             CCC
T ss_pred             Ccc
Confidence            443